data_1yhp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yhp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.9 140.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.802 0.841 . . . . 0.0 110.535 168.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.57 142.44 56.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.329 0.652 . . . . 0.0 110.076 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.6 -17.35 54.82 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.673 -1.267 . . . . 0.0 113.042 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.51 3.75 11.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.919 1.688 . . . . 0.0 113.193 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -146.68 170.84 16.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.291 2.236 . . . . 0.0 109.061 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.77 162.26 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.82 -0.55 . . . . 0.0 110.487 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.14 143.94 28.63 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.801 -0.562 . . . . 0.0 110.98 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.3 147.07 38.32 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.449 1.099 . . . . 0.0 108.465 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.65 118.94 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 123.181 1.467 . . . . 0.0 110.241 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.78 48.73 1.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.969 1.307 . . . . 0.0 110.516 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.4 144.71 5.95 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.856 1.694 . . . . 0.0 111.074 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -55.91 137.53 50.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.09 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 72.56 40.14 0.66 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.349 1.46 . . . . 0.0 113.964 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.342 27.5 p 47.41 56.82 6.49 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.436 1.894 . . . . 0.0 114.582 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.7 p -123.74 -174.78 3.06 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.45 1.5 . . . . 0.0 112.213 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.05 -109.74 2.91 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.931 1.253 . . . . 0.0 112.683 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -107.36 163.59 12.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.663 0.785 . . . . 0.0 110.876 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 p -130.31 144.4 51.36 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.971 0.909 . . . . 0.0 111.425 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -141.74 151.14 42.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.204 1.402 . . . . 0.0 110.069 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.97 147.84 49.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.929 0.892 . . . . 0.0 111.681 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.96 137.57 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.077 0.951 . . . . 0.0 111.643 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.63 151.03 30.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.755 1.222 . . . . 0.0 109.584 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -63.73 150.45 44.47 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.529 -0.732 . . . . 0.0 111.157 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.23 50.34 57.07 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 122.115 -0.366 . . . . 0.0 113.862 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -137.16 141.25 42.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.202 1.401 . . . . 0.0 110.912 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.2 m -123.99 130.72 53.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.062 0.945 . . . . 0.0 109.577 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.84 117.21 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 100.61 7.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -80.1 162.5 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.734 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -106.54 152.25 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.318 0.647 . . . . 0.0 109.965 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -17.07 53.58 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.66 82.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.314 0.959 . . . . 0.0 114.312 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -84.73 108.34 17.38 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.196 0.998 . . . . 0.0 110.042 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.95 -23.06 52.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.031 -1.043 . . . . 0.0 112.757 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -60.09 -22.91 63.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.814 1.646 . . . . 0.0 112.226 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -65.76 -56.06 14.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.454 1.101 . . . . 0.0 112.422 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.32 -15.89 58.7 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.171 0.989 . . . . 0.0 113.65 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -23.36 65.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.629 1.572 . . . . 0.0 113.695 173.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -46.38 129.3 10.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 111.57 166.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmt -149.65 -31.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.294 1.038 . . . . 0.0 113.58 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -144.68 165.77 27.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.61 1.964 . . . . 0.0 110.682 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.61 168.32 23.67 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.347 -0.846 . . . . 0.0 110.867 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.01 128.5 20.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.906 0.882 . . . . 0.0 109.621 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.02 129.17 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 109.005 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.79 -98.1 0.01 OUTLIER Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.022 1.772 . . . . 0.0 116.617 -170.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.9 p -168.17 -25.68 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.681 1.192 . . . . 0.0 112.817 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -115.8 29.6 7.88 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.12 1.368 . . . . 0.0 111.266 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.24 116.38 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.838 1.655 . . . . 0.0 110.135 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -79.43 152.93 30.04 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.306 -0.871 . . . . 0.0 109.456 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 138.19 45.46 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.599 1.159 . . . . 0.0 109.242 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.92 119.48 23.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.7 pt -118.42 118.11 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.199 0.999 . . . . 0.0 111.298 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -124.15 142.63 51.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.771 1.628 . . . . 0.0 108.887 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.92 -44.22 3.05 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.965 0.906 . . . . 0.0 111.363 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -119.18 140.28 50.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.466 0.651 . . . . 0.0 111.025 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -140.97 120.29 13.04 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.826 1.25 . . . . 0.0 109.057 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -158.62 163.41 36.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.177 0.991 . . . . 0.0 111.046 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt -147.68 51.31 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.206 1.403 . . . . 0.0 111.065 -167.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -177.48 -31.64 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.961 2.105 . . . . 0.0 110.722 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -58.9 137.95 87.31 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.221 1.008 . . . . 0.0 112.994 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.01 -23.09 5.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.523 2.149 . . . . 0.0 113.578 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 t -76.0 120.26 80.86 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 119.015 0.825 . . . . 0.0 111.138 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.47 114.97 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.279 1.32 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.89 156.61 32.34 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.405 1.003 . . . . 0.0 113.592 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -65.4 123.9 20.83 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.305 1.052 . . . . 0.0 111.717 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -140.87 143.47 34.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.47 2.308 . . . . 0.0 108.822 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 125.97 6.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.345 1.069 . . . . 0.0 110.406 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.63 105.64 11.08 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.137 0.97 . . . . 0.0 109.904 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.18 121.24 13.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.613 0.765 . . . . 0.0 109.068 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.52 141.28 16.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.628 1.171 . . . . 0.0 112.398 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -59.78 -15.06 17.56 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.45 118.81 0.91 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.606 1.098 . . . . 0.0 111.444 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.37 169.33 1.05 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.264 1.826 . . . . 0.0 111.646 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.1 m -105.22 144.51 31.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.873 1.269 . . . . 0.0 110.455 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -124.33 98.31 5.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.373 1.069 . . . . 0.0 108.636 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.48 -35.94 7.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.324 1.049 . . . . 0.0 112.823 -164.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -143.96 112.09 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.405 1.482 . . . . 0.0 108.915 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 26.04 2.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.501 1.52 . . . . 0.0 111.006 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -51.39 -33.46 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.304 1.042 . . . . 0.0 112.574 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -58.18 -21.46 47.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.89 -9.27 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.326 1.45 . . . . 0.0 112.598 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 82.29 39.97 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.409 2.283 . . . . 0.0 112.266 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.16 -133.59 31.13 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.337 -1.477 . . . . 0.0 110.76 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.3 tp -146.81 160.89 41.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.938 1.369 . . . . 0.0 110.875 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 p -144.58 -35.96 0.33 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.86 0.864 . . . . 0.0 113.141 155.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -129.14 139.66 51.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.905 0.882 . . . . 0.0 110.635 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.66 135.64 48.75 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.121 0.969 . . . . 0.0 110.591 173.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -129.21 130.46 46.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.881 0.873 . . . . 0.0 109.401 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.82 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.378 1.471 . . . . 0.0 107.539 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.21 142.11 33.02 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.612 0.765 . . . . 0.0 110.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.95 32.0 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.862 3.041 . . . . 0.0 114.794 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.34 60.17 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.862 1.22 . . . . 0.0 113.763 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.73 -25.13 2.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.396 1.478 . . . . 0.0 112.768 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -118.13 141.71 48.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.684 1.594 . . . . 0.0 108.15 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -79.59 -33.68 41.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.383 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -149.01 174.44 12.29 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.582 1.953 . . . . 0.0 109.053 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.89 23.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.993 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -137.94 130.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.097 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.36 131.25 34.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.858 0.863 . . . . 0.0 110.11 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 m -133.04 142.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.402 1.081 . . . . 0.0 110.289 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -144.95 144.16 30.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.97 0.908 . . . . 0.0 110.545 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 pt -87.65 153.71 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.8 120.48 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.18 1.392 . . . . 0.0 108.335 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -58.96 103.08 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.96 1.304 . . . . 0.0 112.196 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 16.94 22.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.507 1.123 . . . . 0.0 111.359 168.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.82 -35.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.618 1.567 . . . . 0.0 113.035 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -96.8 170.88 8.87 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.6 1.16 . . . . 0.0 111.649 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -109.71 -45.56 3.64 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.47 -0.769 . . . . 0.0 113.044 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.6 m -71.48 -31.22 66.88 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.505 1.122 . . . . 0.0 112.528 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.93 -44.38 0.56 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.114 2.166 . . . . 0.0 114.117 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.04 42.06 0.36 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.014 2.245 . . . . 0.0 115.017 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.7 p -129.74 -1.16 4.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.861 2.064 . . . . 0.0 112.005 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -118.63 150.37 39.81 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.185 1.394 . . . . 0.0 111.653 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.96 127.67 29.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.762 1.225 . . . . 0.0 109.971 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.7 ttm -102.89 122.55 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.761 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.4 m -116.0 117.69 30.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.5 pt -122.66 142.15 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.76 0.79 . . . . 0.0 112.277 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 78.7 m -135.23 85.84 32.22 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.283 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.47 167.66 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.43 2.087 . . . . 0.0 111.766 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -33.9 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.64 2.376 . . . . 0.0 114.538 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 39.68 51.12 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.538 1.935 . . . . 0.0 114.528 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.13 148.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.901 1.68 . . . . 0.0 110.436 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -51.35 111.89 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.665 1.186 . . . . 0.0 111.36 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.29 134.62 39.47 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.516 0.726 . . . . 0.0 110.735 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.84 127.53 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.39 114.58 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.226 1.011 . . . . 0.0 109.061 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.28 146.02 46.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.42 0.688 . . . . 0.0 110.956 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -117.76 170.59 8.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.831 0.852 . . . . 0.0 110.552 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.3 69.93 1.63 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.62 1.2 . . . . 0.0 112.135 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.03 0.08 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.001 1.762 . . . . 0.0 111.309 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.52 161.93 36.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.698 1.199 . . . . 0.0 111.585 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.56 55.16 1.65 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.999 1.32 . . . . 0.0 111.935 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 60.33 93.1 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.225 2.21 . . . . 0.0 112.722 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.99 139.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.344 0.658 . . . . 0.0 111.645 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -97.94 123.6 42.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.874 0.869 . . . . 0.0 110.336 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 127.51 37.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.454 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.53 128.31 9.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.487 2.125 . . . . 0.0 110.999 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.5 mm -128.15 125.56 23.44 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.518 0.727 . . . . 0.0 109.619 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.44 178.02 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.419 2.079 . . . . 0.0 111.534 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -14.28 43.75 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.867 -1.145 . . . . 0.0 113.577 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp 55.21 -175.42 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.428 1.891 . . . . 0.0 112.319 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.7 t -153.63 106.3 2.54 Favored Pre-proline 0 C--O 1.241 0.606 0 O-C-N 121.265 -0.897 . . . . 0.0 111.282 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.26 165.14 69.22 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 119.386 0.816 . . . . 0.0 113.142 -9.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.64 -30.98 41.6 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.211 1.941 . . . . 0.0 114.082 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.98 2.09 13.59 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -73.69 144.51 45.76 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.992 -1.068 . . . . 0.0 112.004 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -70.28 157.97 36.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 113.117 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tt -125.94 122.48 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.649 1.18 . . . . 0.0 109.445 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.28 132.71 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 110.414 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -138.7 122.2 17.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.651 0.781 . . . . 0.0 110.758 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -82.29 134.38 35.27 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 171.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.04 119.59 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 109.557 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.1 p -124.16 113.38 18.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.338 1.055 . . . . 0.0 109.033 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 t -104.39 125.02 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -140.44 151.44 44.89 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.629 1.572 . . . . 0.0 109.115 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -67.26 141.55 57.2 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.81 -0.556 . . . . 0.0 111.979 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.9 p -67.9 -24.71 65.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.02 0.928 . . . . 0.0 113.16 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -144.34 179.67 7.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.716 2.006 . . . . 0.0 110.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.6 t -41.55 136.55 1.89 Allowed Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.216 1.806 . . . . 0.0 113.863 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.22 8.68 31.0 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 N-CA-C 114.683 0.994 . . . . 0.0 114.683 5.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.63 27.56 16.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.166 1.387 . . . . 0.0 112.719 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.77 151.11 36.11 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.25 -1.531 . . . . 0.0 113.157 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -78.57 128.43 33.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.999 1.32 . . . . 0.0 111.401 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.7 -38.41 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.431 1.493 . . . . 0.0 111.602 -175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.58 138.5 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.76 1.224 . . . . 0.0 108.557 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -150.12 76.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.23 1.012 . . . . 0.0 108.905 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.09 -168.56 14.85 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.715 1.626 . . . . 0.0 111.938 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -133.32 160.48 37.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.291 -1.123 . . . . 0.0 112.593 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.41 147.35 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.272 1.429 . . . . 0.0 108.124 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.2 131.38 52.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.377 0.608 . . . . 0.0 109.592 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -110.06 153.29 24.85 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -163.04 148.35 11.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -120.44 151.51 39.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.378 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 73.7 m -90.39 110.78 43.31 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.039 0.936 . . . . 0.0 108.66 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.45 52.3 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 124.993 3.796 . . . . 0.0 112.298 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.2 m -130.08 -40.22 1.33 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.792 2.037 . . . . 0.0 111.687 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 t -149.22 30.03 0.78 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.93 1.292 . . . . 0.0 111.408 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.19 35.87 43.25 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.86 -1.15 . . . . 0.0 113.151 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.59 118.2 18.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.905 0.882 . . . . 0.0 109.169 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.4 139.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.572 0.749 . . . . 0.0 109.917 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 49.5 m -143.36 158.36 43.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.599 1.56 . . . . 0.0 110.571 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.49 129.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.711 0.804 . . . . 0.0 110.904 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.04 129.89 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 107.979 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -140.45 122.85 16.01 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.835 1.254 . . . . 0.0 108.605 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -150.22 146.49 26.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -55.83 -18.02 7.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 113.811 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -59.2 -25.62 64.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.64 1.976 . . . . 0.0 114.207 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.1 p -145.12 -43.14 0.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.528 1.531 . . . . 0.0 113.096 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -60.58 135.58 92.1 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.065 1.746 . . . . 0.0 111.889 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.09 -172.44 1.54 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.022 2.482 . . . . 0.0 111.341 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.82 31.85 3.3 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.964 1.306 . . . . 0.0 113.593 -166.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -148.31 -32.41 0.25 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.228 1.811 . . . . 0.0 113.737 -164.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.3 ttt -125.1 140.04 53.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.272 2.229 . . . . 0.0 107.928 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.9 p -127.49 159.38 34.73 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.388 0.675 . . . . 0.0 109.864 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.03 131.28 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 t -116.58 147.77 41.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.134 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -85.45 83.68 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.669 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.42 -29.74 69.18 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.718 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.07 174.05 15.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.905 1.682 . . . . 0.0 111.171 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.77 140.58 57.54 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.989 -1.694 . . . . 0.0 110.333 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p 53.66 12.68 0.42 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.224 2.209 . . . . 0.0 114.836 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.3 t -133.91 105.25 6.66 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.595 1.158 . . . . 0.0 111.664 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -108.03 148.37 29.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.276 1.03 . . . . 0.0 111.833 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.8 tt -134.11 116.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.734 0.778 . . . . 0.0 109.252 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.3 125.11 37.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.998 1.319 . . . . 0.0 109.727 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -109.48 123.71 49.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.106 0.962 . . . . 0.0 109.187 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.49 96.57 6.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 111.077 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -87.57 -25.99 23.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.282 1.033 . . . . 0.0 112.329 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.2 t -90.56 176.34 6.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.733 1.213 . . . . 0.0 113.002 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.48 57.44 0.94 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.722 1.209 . . . . 0.0 110.06 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 116.99 -1.481 . . . . 0.0 113.371 173.091 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.545 0.212 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.42 154.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.892 1.277 . . . . 0.0 109.302 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.98 143.88 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.475 0.71 . . . . 0.0 110.983 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.0 -20.38 23.67 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.54 15.41 22.95 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.389 2.276 . . . . 0.0 113.348 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -140.26 169.33 17.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.462 -1.399 . . . . 0.0 110.033 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.49 145.66 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.837 0.855 . . . . 0.0 109.968 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.0 144.79 49.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.056 1.342 . . . . 0.0 109.201 -174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -132.85 120.27 21.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.1 1.36 . . . . 0.0 109.601 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.17 125.93 42.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.261 1.424 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.17 43.12 0.43 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.511 1.924 . . . . 0.0 112.602 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.1 137.91 2.49 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.758 2.123 . . . . 0.0 110.601 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -51.84 159.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.831 0.852 . . . . 0.0 111.289 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 t30 64.83 22.78 12.58 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m 54.84 57.16 5.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.34 1.456 . . . . 0.0 113.126 -173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.6 p -131.82 -177.92 4.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.737 1.215 . . . . 0.0 112.393 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.54 -119.08 4.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.283 0.944 . . . . 0.0 111.772 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.72 -178.22 3.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.241 1.416 . . . . 0.0 110.834 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p -136.6 153.81 50.85 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.794 -1.191 . . . . 0.0 111.387 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.27 155.19 41.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.105 1.362 . . . . 0.0 110.451 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.64 138.31 51.14 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 109.945 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.21 144.52 48.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.195 1.398 . . . . 0.0 110.705 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -79.99 149.17 30.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.535 1.134 . . . . 0.0 111.128 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -63.24 157.48 22.55 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.323 1.049 . . . . 0.0 111.688 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.3 39.54 97.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.387 0.518 . . . . 0.0 113.019 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.51 160.81 32.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.578 1.551 . . . . 0.0 109.758 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.4 p -138.96 151.15 46.64 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.276 -1.515 . . . . 0.0 109.099 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.84 116.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.306 1.051 . . . . 0.0 108.628 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 mtm105 -125.91 92.52 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 108.684 -164.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.34 153.0 21.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.418 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -95.83 147.05 24.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.419 0.687 . . . . 0.0 110.763 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -67.61 2.23 1.96 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.69 80.99 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.265 1.412 . . . . 0.0 114.736 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -133.9 120.56 20.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.934 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -13.18 2.15 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -57.16 -20.6 27.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.562 1.545 . . . . 0.0 112.49 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -65.16 -54.79 24.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.043 0.838 . . . . 0.0 111.749 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.65 -22.8 57.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.122 1.369 . . . . 0.0 113.251 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 42' ' ' MET . 63.9 mmtt -51.36 -42.07 61.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.964 1.306 . . . . 0.0 113.541 171.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -67.0 31.19 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 126.575 1.95 . . . . 0.0 114.042 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -64.01 -38.11 89.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.561 2.345 . . . . 0.0 113.917 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -112.22 151.9 29.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.749 1.159 . . . . 0.0 110.754 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 p -169.03 167.38 10.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 123.046 1.403 . . . . 0.0 113.154 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.84 125.56 14.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.126 1.37 . . . . 0.0 108.405 -172.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.8 133.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.225 1.81 . . . . 0.0 108.306 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.85 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.634 1.588 . . . . 0.0 115.886 -168.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -156.47 -22.63 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.239 1.416 . . . . 0.0 113.77 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.94 16.26 12.55 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.732 1.613 . . . . 0.0 111.801 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -145.36 152.36 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.412 1.885 . . . . 0.0 110.216 -173.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -116.99 156.78 26.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.687 1.195 . . . . 0.0 110.041 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.2 t -127.05 131.03 51.03 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.005 0.922 . . . . 0.0 108.725 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -112.87 140.14 47.91 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.143 1.377 . . . . 0.0 107.584 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -129.39 137.96 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.194 0.998 . . . . 0.0 109.363 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.1 120.24 8.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.269 1.428 . . . . 0.0 111.263 -161.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -95.27 -63.02 1.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.107 -0.995 . . . . 0.0 112.7 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.21 142.46 37.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.581 1.153 . . . . 0.0 109.54 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -134.42 105.7 6.7 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.921 -1.112 . . . . 0.0 109.431 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -142.0 152.44 43.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.209 1.404 . . . . 0.0 110.38 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.4 45.72 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.19 1.796 . . . . 0.0 111.012 -166.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -169.82 -26.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.476 2.31 . . . . 0.0 111.945 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -60.52 137.27 92.48 Favored Pre-proline 0 CA--C 1.543 0.712 0 C-N-CA 125.39 1.476 . . . . 0.0 112.673 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.61 -23.89 9.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.28 2.653 . . . . 0.0 112.937 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -99.61 117.29 63.95 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 124.744 1.217 . . . . 0.0 109.127 171.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.46 155.14 64.25 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.257 1.305 . . . . 0.0 110.033 168.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.6 -136.55 0.71 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.032 0.825 . . . . 0.0 112.947 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -122.76 137.93 54.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.234 1.016 . . . . 0.0 112.921 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.72 167.78 23.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.13 2.172 . . . . 0.0 109.797 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -157.19 142.28 17.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 111.339 170.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -94.85 98.59 10.84 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.733 1.213 . . . . 0.0 110.734 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.89 124.15 18.23 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.998 -1.063 . . . . 0.0 108.668 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.81 153.35 3.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.034 0.934 . . . . 0.0 112.849 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.24 -10.16 2.71 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.93 112.26 0.52 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.424 1.012 . . . . 0.0 111.859 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.05 159.67 2.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.343 1.857 . . . . 0.0 111.983 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 m -104.31 140.12 38.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.538 1.135 . . . . 0.0 110.066 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -130.95 121.06 24.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.658 1.583 . . . . 0.0 108.556 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.98 -22.9 2.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -66.12 0.8 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.733 1.213 . . . . 0.0 110.771 171.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 mp 41.01 34.87 0.31 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.043 2.137 . . . . 0.0 113.381 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -62.85 -31.19 72.16 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.765 -1.209 . . . . 0.0 112.406 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -63.19 -28.39 70.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.831 0.852 . . . . 0.0 113.284 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.71 -35.22 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.409 1.484 . . . . 0.0 110.978 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 54.38 55.07 8.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.148 1.379 . . . . 0.0 113.475 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.14 -152.99 16.86 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.448 1.499 . . . . 0.0 111.862 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -153.91 146.05 23.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.684 1.193 . . . . 0.0 111.525 166.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.25 -63.77 1.13 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 153.09 50.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.386 1.475 . . . . 0.0 110.809 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.38 147.68 22.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.908 0.861 . . . . 0.0 111.883 -170.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -139.02 120.97 15.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.48 1.512 . . . . 0.0 109.58 -168.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.11 118.51 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.253 0.621 . . . . 0.0 109.465 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.3 mt -125.64 126.81 24.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.554 1.142 . . . . 0.0 109.898 -164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.9 162.63 23.67 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.611 2.207 . . . . 0.0 112.185 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.29 -5.23 15.07 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.765 1.174 . . . . 0.0 115.644 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.7 -19.76 32.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.276 1.43 . . . . 0.0 113.606 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.53 165.63 24.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.746 1.618 . . . . 0.0 110.03 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.95 -46.81 3.69 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.955 -1.091 . . . . 0.0 111.634 -173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.27 148.05 47.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.68 1.592 . . . . 0.0 107.903 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.84 157.57 42.53 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.45 149.42 24.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.014 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 144.43 26.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.99 139.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.429 1.091 . . . . 0.0 109.596 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -143.15 157.97 44.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.562 1.145 . . . . 0.0 110.681 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.45 145.91 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.072 0.949 . . . . 0.0 112.181 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.44 105.02 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.519 1.928 . . . . 0.0 109.534 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.86 89.49 4.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 112.532 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.54 -32.0 36.86 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.182 -0.949 . . . . 0.0 112.477 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.44 -46.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.9 -24.6 35.58 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.469 0.577 . . . . 0.0 111.485 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t 65.72 -42.82 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.379 3.071 . . . . 0.0 115.437 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -57.42 -37.69 73.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.775 1.63 . . . . 0.0 112.833 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.69 176.11 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.928 1.691 . . . . 0.0 113.993 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.72 28.17 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.921 1.248 . . . . 0.0 114.639 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -140.78 30.58 1.86 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -162.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -120.16 147.52 44.79 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.79 1.636 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.95 126.21 33.5 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.966 1.306 . . . . 0.0 109.409 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 63.1 ttp -126.09 132.43 51.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.884 1.274 . . . . 0.0 110.148 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.9 m -123.09 106.76 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.337 1.455 . . . . 0.0 108.615 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.85 125.37 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.2 t -144.93 123.47 6.69 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.87 170.15 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.962 3.108 . . . . 0.0 113.004 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -42.46 106.43 0.06 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.391 1.876 . . . . 0.0 113.371 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? 47.07 57.03 6.08 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.801 1.64 . . . . 0.0 113.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -126.18 159.32 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.588 1.955 . . . . 0.0 109.919 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -55.23 109.67 0.57 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.152 0.981 . . . . 0.0 111.455 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.81 152.03 20.05 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.442 0.697 . . . . 0.0 111.518 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.61 150.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.262 1.025 . . . . 0.0 110.141 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.69 103.63 10.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 109.42 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.97 146.22 30.83 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.422 0.689 . . . . 0.0 109.61 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -133.82 144.02 48.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.204 1.002 . . . . 0.0 110.546 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.94 108.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.022 2.129 . . . . 0.0 111.025 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.54 -17.03 14.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.445 1.021 . . . . 0.0 114.49 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.0 136.48 57.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.823 1.311 . . . . 0.0 109.927 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -74.59 57.9 0.76 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.076 1.751 . . . . 0.0 112.51 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 63.37 90.49 0.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.858 2.463 . . . . 0.0 111.152 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.97 149.96 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 120.918 -1.114 . . . . 0.0 111.478 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 137.7 32.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.93 96.16 40.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.491 1.916 . . . . 0.0 108.143 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.1 138.5 30.93 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.546 2.164 . . . . 0.0 111.099 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.7 mt -128.36 129.9 23.57 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 108.812 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.47 169.96 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.53 2.82 . . . . 0.0 112.109 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -57.13 134.85 56.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.838 -0.539 . . . . 0.0 111.574 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 pp -144.41 150.3 37.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 110.184 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -142.61 136.63 14.64 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.168 0.987 . . . . 0.0 112.102 -171.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.96 154.0 73.1 Favored 'Cis proline' 0 CA--C 1.544 0.991 0 CA-C-N 119.381 0.815 . . . . 0.0 111.706 -6.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.45 -35.89 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.281 1.988 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.6 0.09 5.95 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.622 1.569 . . . . 0.0 114.225 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 p -68.37 133.58 48.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.162 1.346 . . . . 0.0 110.869 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.53 120.84 15.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.075 167.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.3 tt -104.48 116.8 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.053 1.741 . . . . 0.0 109.086 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.49 139.64 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.057 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.8 m -133.52 134.09 42.98 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.518 1.127 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.43 146.74 36.36 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.693 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.2 111.11 8.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 109.465 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 132.68 49.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.091 0.956 . . . . 0.0 109.382 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.54 136.18 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.153 0.981 . . . . 0.0 109.681 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.72 150.84 37.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.548 1.139 . . . . 0.0 111.668 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.98 140.38 57.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.198 0.599 . . . . 0.0 111.507 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.3 p -80.24 -7.31 58.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.64 177.46 9.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.71 2.004 . . . . 0.0 111.241 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -39.79 133.77 1.37 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.887 1.675 . . . . 0.0 114.205 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.29 8.49 17.56 Favored 'Cis proline' 0 CA--C 1.547 1.135 0 N-CA-C 115.044 1.132 . . . . 0.0 115.044 3.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.06 10.34 2.82 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.321 1.848 . . . . 0.0 114.454 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.22 162.07 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.408 1.483 . . . . 0.0 112.653 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -58.23 151.82 18.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.85 1.26 . . . . 0.0 111.755 170.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.37 -22.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.744 1.218 . . . . 0.0 113.193 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -151.94 142.89 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.608 1.963 . . . . 0.0 109.036 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -142.27 117.39 10.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.587 1.155 . . . . 0.0 108.923 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.68 -147.87 6.18 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.637 1.113 . . . . 0.0 112.097 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.51 172.42 15.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.048 1.339 . . . . 0.0 110.141 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.35 149.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.751 1.62 . . . . 0.0 107.854 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.5 130.8 54.81 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.938 -1.101 . . . . 0.0 109.113 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -111.91 158.27 19.66 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.113 -0.992 . . . . 0.0 110.849 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -163.18 146.16 10.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.908 1.683 . . . . 0.0 108.968 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -111.79 156.58 21.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.257 1.023 . . . . 0.0 110.811 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.6 m -126.81 101.37 26.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.76 1.624 . . . . 0.0 110.329 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -68.32 -10.11 27.96 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.911 3.074 . . . . 0.0 113.785 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.0 m -40.09 -43.5 1.61 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.835 2.054 . . . . 0.0 112.748 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -156.28 28.52 0.35 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.904 0.859 . . . . 0.0 112.941 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 55.98 55.25 30.1 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.115 -1.616 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -129.73 130.75 45.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.299 1.44 . . . . 0.0 109.222 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.7 159.39 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 121.565 -0.709 . . . . 0.0 110.407 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 87.1 m -148.29 111.51 4.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.085 0.954 . . . . 0.0 110.067 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.83 138.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.482 0.658 . . . . 0.0 109.966 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.33 129.03 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.524 1.93 . . . . 0.0 107.195 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 139.62 37.5 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.217 1.007 . . . . 0.0 109.695 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -160.02 164.43 33.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.156 1.382 . . . . 0.0 109.779 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -16.06 5.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.301 1.44 . . . . 0.0 114.001 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.158 1.783 . . . . 0.0 114.058 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 42.1 p -142.91 -47.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.344 1.458 . . . . 0.0 112.432 -170.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 196' ' ' THR . 0.0 OUTLIER -76.58 143.12 71.49 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.985 1.714 . . . . 0.0 111.533 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.36 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.855 2.37 . . . . 0.0 110.736 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -179.68 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 128.266 2.626 . . . . 0.0 111.708 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -58.08 -40.76 81.91 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.92 1.688 . . . . 0.0 112.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.5 ttt -104.67 140.13 38.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.767 1.627 . . . . 0.0 108.627 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.434 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 65.9 p -136.82 158.93 43.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.924 0.49 . . . . 0.0 110.961 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.0 p -124.62 139.02 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.968 0.907 . . . . 0.0 110.741 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 97.9 m -126.33 143.04 51.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.426 1.09 . . . . 0.0 109.404 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -73.05 79.1 1.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.338 1.455 . . . . 0.0 111.482 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -54.51 -33.62 60.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.034 1.734 . . . . 0.0 112.699 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.12 -179.67 8.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.854 1.662 . . . . 0.0 111.367 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -44.14 -42.46 6.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.916 2.087 . . . . 0.0 114.295 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.1 p -130.61 12.92 5.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.086 1.755 . . . . 0.0 112.907 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -103.88 126.02 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.387 -0.82 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -123.23 138.5 54.62 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.852 1.261 . . . . 0.0 110.977 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.28 116.99 44.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.747 0.819 . . . . 0.0 110.007 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.56 112.2 24.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.767 1.627 . . . . 0.0 108.612 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -94.06 142.73 27.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.439 -0.788 . . . . 0.0 109.684 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.49 122.26 30.78 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.115 0.966 . . . . 0.0 111.948 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -115.27 13.83 16.75 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.704 1.602 . . . . 0.0 112.312 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.7 t -154.17 165.11 37.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.515 1.526 . . . . 0.0 111.522 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.05 2.03 9.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.797 1.239 . . . . 0.0 113.418 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.539 1.936 . . . . 0.0 115.226 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.07 150.6 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.56 0.744 . . . . 0.0 111.581 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -95.25 150.6 20.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.505 0.722 . . . . 0.0 109.624 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.2 34.84 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.847 -1.158 . . . . 0.0 113.201 170.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -106.19 7.55 31.61 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.189 1.796 . . . . 0.0 113.426 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -142.76 -179.36 6.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.074 1.35 . . . . 0.0 111.379 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.24 152.25 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.407 1.483 . . . . 0.0 111.253 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.86 153.26 46.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.862 1.265 . . . . 0.0 110.701 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -136.88 117.12 13.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.382 1.073 . . . . 0.0 109.835 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -95.24 122.45 37.94 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.163 1.385 . . . . 0.0 111.229 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.88 59.04 1.55 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.781 1.232 . . . . 0.0 111.993 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.55 130.94 1.3 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.171 0.891 . . . . 0.0 111.11 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.13 146.12 9.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.876 0.87 . . . . 0.0 110.656 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 70.44 20.94 5.81 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.288 1.435 . . . . 0.0 114.705 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.84 58.41 2.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.681 1.192 . . . . 0.0 112.718 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 p -133.22 -174.54 3.52 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.301 1.44 . . . . 0.0 112.009 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.02 -142.98 40.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.905 0.764 . . . . 0.0 112.81 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -74.76 176.02 7.42 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.694 0.798 . . . . 0.0 112.451 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -136.21 157.24 47.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.562 1.145 . . . . 0.0 111.833 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.47 155.45 43.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.274 1.83 . . . . 0.0 110.118 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.45 143.93 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.544 1.138 . . . . 0.0 110.403 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -132.11 128.44 38.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.958 1.303 . . . . 0.0 109.012 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.36 148.81 30.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.814 0.845 . . . . 0.0 110.363 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -62.86 142.28 58.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.065 0.546 . . . . 0.0 111.449 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.61 66.63 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 122.211 -0.305 . . . . 0.0 112.486 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 152.67 39.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.49 1.116 . . . . 0.0 110.538 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -135.53 120.32 18.45 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 108.096 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.12 141.17 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.016 0.926 . . . . 0.0 109.413 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -135.35 133.45 38.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.244 1.018 . . . . 0.0 109.189 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.39 175.16 5.54 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.028 1.731 . . . . 0.0 109.595 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -123.41 133.99 54.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.682 0.793 . . . . 0.0 108.958 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.62 -14.28 12.96 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.279 1.032 . . . . 0.0 113.627 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.76 -25.54 52.02 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.961 1.267 . . . . 0.0 114.682 166.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -119.2 121.29 39.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.058 1.343 . . . . 0.0 109.852 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -12.48 6.22 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -63.68 -9.83 16.06 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.276 1.43 . . . . 0.0 112.959 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -70.39 -52.22 23.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.673 1.189 . . . . 0.0 112.037 164.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.61 -15.05 16.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.93 1.692 . . . . 0.0 113.513 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -40.79 -45.1 2.38 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.627 2.371 . . . . 0.0 113.069 169.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.98 50.32 0.59 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.429 1.492 . . . . 0.0 113.033 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -73.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.662 0.785 . . . . 0.0 111.219 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -93.36 160.11 14.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.192 0.997 . . . . 0.0 110.655 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -168.75 169.63 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.293 1.037 . . . . 0.0 112.374 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 156.01 41.94 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.334 1.064 . . . . 0.0 112.303 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.65 139.04 53.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 124.872 1.269 . . . . 0.0 109.282 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.16 -96.71 0.01 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.958 1.742 . . . . 0.0 116.073 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -166.95 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 113.243 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -123.99 26.36 7.59 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.644 1.977 . . . . 0.0 111.899 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.42 153.69 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.456 1.902 . . . . 0.0 109.023 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -125.41 149.48 48.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.614 1.566 . . . . 0.0 108.857 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.8 m -123.26 151.22 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 110.508 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.31 130.23 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.52 142.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.027 0.931 . . . . 0.0 109.637 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -137.25 127.41 26.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.159 1.384 . . . . 0.0 109.089 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -100.66 -53.32 3.11 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 111.379 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -101.6 98.51 8.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.858 0.863 . . . . 0.0 111.418 -172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.08 96.75 5.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.421 1.089 . . . . 0.0 112.828 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -156.14 164.53 38.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 112.27 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 6.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.26 2.224 . . . . 0.0 113.068 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.38 49.11 2.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.388 1.875 . . . . 0.0 112.122 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -148.59 145.44 20.11 Favored Pre-proline 0 N--CA 1.478 0.956 0 O-C-N 120.77 -1.206 . . . . 0.0 112.365 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.42 -14.15 20.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.922 2.415 . . . . 0.0 113.16 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -67.75 121.24 78.63 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 119.239 0.927 . . . . 0.0 109.956 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.56 95.66 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.199 1.933 . . . . 0.0 108.687 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.57 138.8 28.22 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.457 1.027 . . . . 0.0 112.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 115.42 2.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.714 0.757 . . . . 0.0 111.212 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CD2' ' HA ' ' A' ' 179' ' ' THR . 2.3 t80 -138.48 143.15 39.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.218 2.207 . . . . 0.0 109.48 -174.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.98 139.94 24.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.307 1.051 . . . . 0.0 109.614 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -100.11 103.61 15.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.08 1.352 . . . . 0.0 107.643 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.98 121.53 12.64 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.48 150.84 6.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.322 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -58.55 -15.5 11.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.16 124.73 1.6 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.644 152.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.05 158.36 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.657 2.383 . . . . 0.0 111.546 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -94.23 143.57 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.436 1.094 . . . . 0.0 110.829 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -128.1 102.04 6.55 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.507 1.923 . . . . 0.0 108.553 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -123.65 6.65 8.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.633 1.573 . . . . 0.0 112.772 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -140.35 45.03 1.86 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.896 1.679 . . . . 0.0 111.461 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 mp -75.26 30.67 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.079 1.351 . . . . 0.0 112.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.1 m -61.43 -35.65 78.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.753 1.621 . . . . 0.0 112.485 174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -61.11 -24.06 65.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.719 0.808 . . . . 0.0 112.715 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.4 mm -88.06 -25.58 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.655 1.982 . . . . 0.0 113.198 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 54.75 52.68 11.69 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.52 1.528 . . . . 0.0 113.372 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.32 -179.62 19.93 Favored Glycine 0 CA--C 1.538 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 112.567 -170.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -178.88 6.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.574 -1.545 . . . . 0.0 112.054 -169.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -148.13 -36.94 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.14 1.776 . . . . 0.0 113.164 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.91 147.03 47.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.762 1.225 . . . . 0.0 111.445 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -135.96 119.69 17.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.326 1.85 . . . . 0.0 108.416 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -115.05 138.93 50.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.37 0.668 . . . . 0.0 109.404 170.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.83 119.27 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.757 1.623 . . . . 0.0 107.411 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt -127.55 126.79 24.1 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 124.672 1.189 . . . . 0.0 109.467 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.88 161.41 33.23 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 121.74 1.627 . . . . 0.0 111.752 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.34 -3.15 17.56 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.09 45.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.004 1.322 . . . . 0.0 113.86 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -130.78 151.1 51.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.045 1.338 . . . . 0.0 110.507 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -82.09 -49.3 10.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.518 -0.739 . . . . 0.0 111.378 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -154.52 161.23 41.76 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.773 1.629 . . . . 0.0 110.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -131.21 154.41 48.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.108 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.44 137.16 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.945 1.298 . . . . 0.0 109.733 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.07 123.83 36.6 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.192 0.997 . . . . 0.0 108.986 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.88 132.26 71.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.651 1.58 . . . . 0.0 108.692 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -125.15 145.25 50.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.916 0.887 . . . . 0.0 110.185 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.71 128.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.05 143.17 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 122.069 0.938 . . . . 0.0 109.814 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.62 140.34 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.536 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 7.24 2.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.832 1.253 . . . . 0.0 112.168 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.52 -33.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.069 1.748 . . . . 0.0 112.907 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.44 172.61 12.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.789 1.236 . . . . 0.0 111.835 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.3 p -105.71 14.24 28.59 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.28 1.432 . . . . 0.0 112.944 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.4 m -107.0 31.03 5.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.787 2.435 . . . . 0.0 110.169 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.38 145.76 17.35 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.839 -1.163 . . . . 0.0 112.252 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.46 25.1 6.78 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.696 1.141 . . . . 0.0 112.956 -171.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.8 p -147.57 9.51 0.92 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.075 1.75 . . . . 0.0 114.033 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -127.28 143.74 51.18 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 110.784 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -131.03 130.87 43.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.074 1.349 . . . . 0.0 108.717 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -122.02 131.58 54.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.618 1.567 . . . . 0.0 110.365 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 m -95.52 133.86 39.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.856 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.57 110.78 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.801 1.64 . . . . 0.0 109.135 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -129.99 128.31 22.84 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.385 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.19 -91.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.142 2.561 . . . . 0.0 111.35 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -71.14 -171.76 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.032 0.92 . . . . 0.0 112.685 174.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -65.09 26.8 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 126.682 1.993 . . . . 0.0 113.786 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' TYR . 7.7 p -76.2 165.63 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.549 1.94 . . . . 0.0 110.831 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -56.05 114.77 2.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.331 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -58.61 147.98 30.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.741 0.816 . . . . 0.0 111.909 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -110.14 145.07 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.862 1.265 . . . . 0.0 110.274 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.81 117.21 32.81 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.858 1.263 . . . . 0.0 109.594 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.8 m -125.47 118.53 26.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.523 1.129 . . . . 0.0 108.646 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.36 138.59 49.23 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.09 1.356 . . . . 0.0 112.008 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.51 127.4 17.63 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.308 0.575 . . . . 0.0 111.978 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.57 -18.6 22.5 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.576 1.084 . . . . 0.0 113.67 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -57.75 137.14 56.83 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.865 1.333 . . . . 0.0 112.945 169.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.53 72.15 5.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.018 0.927 . . . . 0.0 110.526 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 61.83 85.73 0.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.516 1.926 . . . . 0.0 112.449 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.18 134.81 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.775 -1.203 . . . . 0.0 110.883 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -93.43 127.29 38.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.278 0.561 . . . . 0.0 110.944 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.4 tp -107.67 95.48 14.37 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.412 1.885 . . . . 0.0 107.995 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.37 146.47 40.0 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.958 1.772 . . . . 0.0 111.484 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.46 125.1 27.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.997 1.719 . . . . 0.0 108.496 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.67 -37.96 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.04 2.493 . . . . 0.0 113.125 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 168.4 7.76 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.298 2.639 . . . . 0.0 109.995 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 pp -163.44 37.8 0.09 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.163 1.385 . . . . 0.0 113.868 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.0 t -50.63 139.77 20.37 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.704 1.201 . . . . 0.0 114.211 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.35 142.08 67.63 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.979 1.028 . . . . 0.0 111.867 -6.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.24 -23.31 45.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.309 2.006 . . . . 0.0 113.051 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -75.86 -5.93 48.36 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.041 1.336 . . . . 0.0 114.548 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 161.73 16.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.584 1.084 . . . . 0.0 112.862 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -70.67 168.95 15.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.81 0.814 . . . . 0.0 113.097 167.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.38 135.72 53.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.536 1.535 . . . . 0.0 110.441 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.21 149.03 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.716 0.806 . . . . 0.0 109.231 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.3 t -150.43 155.16 39.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.079 . . . . 0.0 110.414 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -123.99 129.69 51.34 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.514 1.126 . . . . 0.0 109.798 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 tt -113.83 121.44 44.01 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.943 1.697 . . . . 0.0 109.463 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -139.61 114.75 9.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.622 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.7 p -108.63 141.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.631 1.173 . . . . 0.0 109.517 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -144.7 148.19 33.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.321 1.448 . . . . 0.0 110.009 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.29 128.9 37.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.196 0.598 . . . . 0.0 110.174 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.7 p -79.44 -2.32 41.39 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -132.97 151.14 52.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.772 2.029 . . . . 0.0 110.08 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.2 t -66.85 141.38 96.75 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.499 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.27 128.95 13.98 Favored 'Cis proline' 0 C--N 1.352 0.761 0 CA-C-N 120.565 1.238 . . . . 0.0 111.616 -7.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.43 41.22 0.14 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.95 1.7 . . . . 0.0 112.236 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -62.5 143.59 56.99 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 111.491 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -59.55 122.45 14.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.782 -0.574 . . . . 0.0 110.366 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 65.9 t -80.68 -56.91 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.6 155.22 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 170.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -142.11 76.8 1.55 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.792 1.237 . . . . 0.0 108.695 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.19 -165.72 12.74 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.614 2.054 . . . . 0.0 111.608 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.98 170.72 16.06 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.831 -1.393 . . . . 0.0 111.12 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -153.46 157.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.715 -1.241 . . . . 0.0 108.033 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -112.83 128.84 56.55 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.925 -1.109 . . . . 0.0 108.445 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.61 155.48 17.57 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.89 0.876 . . . . 0.0 109.88 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -157.96 158.02 34.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.207 1.403 . . . . 0.0 109.579 174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.38 150.35 49.89 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.713 1.605 . . . . 0.0 108.708 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 75.6 m -105.75 110.37 64.11 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.47 50.74 2.04 Favored 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 125.221 3.948 . . . . 0.0 112.765 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.6 m -137.3 -53.97 0.69 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.989 1.716 . . . . 0.0 111.439 -172.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.486 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 63.5 p -127.29 21.9 6.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.317 1.047 . . . . 0.0 112.791 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.79 31.74 64.72 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.19 -0.944 . . . . 0.0 113.205 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -78.22 150.51 33.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.453 0.701 . . . . 0.0 110.787 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.8 t -128.65 137.57 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.5 m -142.12 129.32 20.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.644 1.577 . . . . 0.0 109.124 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.51 141.36 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.225 1.01 . . . . 0.0 110.133 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.04 127.34 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 127.079 2.151 . . . . 0.0 107.986 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -137.68 116.49 12.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.297 1.439 . . . . 0.0 108.546 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.52 156.46 36.71 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.875 1.27 . . . . 0.0 110.706 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.48 -14.41 7.81 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.14 -24.51 66.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.84 1.656 . . . . 0.0 114.005 169.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.6 p -146.7 -56.11 0.26 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.96 1.704 . . . . 0.0 111.692 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.16 138.92 97.56 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 0.0 111.841 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.02 -88.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.579 2.186 . . . . 0.0 111.625 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? 158.23 -33.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 129.561 3.145 . . . . 0.0 112.674 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -54.19 -36.91 63.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 113.459 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 15.5 ttm -103.67 151.48 22.92 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.939 1.295 . . . . 0.0 109.181 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.7 p -134.39 153.93 51.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.089 1.356 . . . . 0.0 110.287 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.34 110.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.3 m -93.47 130.7 39.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.831 0.852 . . . . 0.0 108.869 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -76.27 82.35 3.05 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.75 1.22 . . . . 0.0 109.634 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.93 -44.72 96.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.041 0.936 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -147.6 -178.52 6.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.769 2.028 . . . . 0.0 110.106 166.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -53.55 141.96 23.96 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.664 -1.272 . . . . 0.0 110.836 158.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.8 p 50.66 10.69 0.07 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.258 2.223 . . . . 0.0 116.142 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.23 95.65 4.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.983 1.713 . . . . 0.0 108.711 -169.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -105.16 149.57 25.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.7 tt -134.61 123.28 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.99 109.27 22.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.731 1.612 . . . . 0.0 108.598 -170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.62 116.86 32.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.169 1.388 . . . . 0.0 108.92 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.79 99.14 9.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.176 0.59 . . . . 0.0 110.967 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -88.27 -15.71 35.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.228 2.211 . . . . 0.0 114.295 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.24 165.36 24.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.614 1.166 . . . . 0.0 111.995 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -128.0 54.06 1.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.952 1.701 . . . . 0.0 110.365 -170.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.151 1.78 . . . . 0.0 114.798 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.002 0.43 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.57 141.99 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 171.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.95 151.35 30.13 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.805 -0.559 . . . . 0.0 110.034 173.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.66 -17.26 46.39 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.59 -1.319 . . . . 0.0 113.48 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -115.17 17.83 16.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.986 1.714 . . . . 0.0 113.668 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -139.55 172.58 12.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.564 1.545 . . . . 0.0 110.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -145.42 144.77 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.792 0.837 . . . . 0.0 110.628 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -127.58 145.94 50.7 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.148 0.975 . . . . 0.0 111.222 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -128.06 124.49 37.2 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.477 1.511 . . . . 0.0 107.497 -164.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 122.16 42.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 123.94 1.829 . . . . 0.0 111.052 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -93.18 42.58 1.1 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.477 1.911 . . . . 0.0 111.504 -167.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.86 155.2 12.5 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.575 2.036 . . . . 0.0 111.499 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -60.8 141.52 56.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.372 0.586 . . . . 0.0 110.135 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.4 t30 46.66 43.21 12.46 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.832 1.253 . . . . 0.0 114.238 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.304 30.9 p 49.18 36.42 9.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.257 2.223 . . . . 0.0 116.054 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -88.16 -24.95 23.2 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.51 -91.93 1.0 Allowed Glycine 0 N--CA 1.476 1.362 0 CA-C-N 119.559 1.072 . . . . 0.0 113.585 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.13 176.7 6.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 110.333 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -138.56 157.76 45.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.449 1.099 . . . . 0.0 112.336 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.78 152.18 39.96 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.186 1.794 . . . . 0.0 110.152 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -124.41 122.25 37.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.508 1.523 . . . . 0.0 108.972 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.04 148.51 43.49 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.294 1.438 . . . . 0.0 109.482 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -101.02 153.1 19.83 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.339 0.656 . . . . 0.0 109.949 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 147.53 23.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.975 -0.453 . . . . 0.0 112.163 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.38 41.55 90.88 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -129.19 130.83 46.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.833 1.253 . . . . 0.0 111.106 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -114.69 129.96 56.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.224 1.01 . . . . 0.0 108.836 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.79 109.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.662 1.585 . . . . 0.0 109.069 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -101.7 101.12 11.58 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.257 1.023 . . . . 0.0 109.11 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -70.45 -179.15 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.884 0.85 . . . . 0.0 111.226 165.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -127.06 157.17 40.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.547 1.139 . . . . 0.0 109.328 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.99 -12.17 59.04 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.016 -1.053 . . . . 0.0 113.496 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.14 97.71 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.615 1.102 . . . . 0.0 114.248 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.1 118.34 27.61 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.406 1.103 . . . . 0.0 110.482 170.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -18.91 62.33 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.949 -1.094 . . . . 0.0 112.458 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -61.49 -20.64 63.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.433 1.893 . . . . 0.0 112.357 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -60.89 -51.95 67.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.797 1.639 . . . . 0.0 112.367 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -70.13 -14.82 62.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.388 1.475 . . . . 0.0 113.286 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.9 -22.95 64.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.558 1.943 . . . . 0.0 113.731 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -46.92 121.22 3.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.669 1.187 . . . . 0.0 110.941 162.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.1 tpt -152.41 -19.95 0.17 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.842 . . . . 0.0 111.921 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -146.69 154.38 41.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.846 2.059 . . . . 0.0 108.856 172.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 p -172.54 155.22 3.32 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.574 1.55 . . . . 0.0 109.697 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 150.66 43.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.939 1.352 . . . . 0.0 112.399 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.83 135.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.776 1.63 . . . . 0.0 108.199 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -98.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.446 1.498 . . . . 0.0 115.81 -171.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -160.29 -23.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.105 1.762 . . . . 0.0 112.473 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.56 25.63 8.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.714 1.605 . . . . 0.0 111.565 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.12 140.47 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 128.151 2.58 . . . . 0.0 108.831 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.64 153.12 29.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.448 0.699 . . . . 0.0 109.947 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.8 m -136.39 136.17 39.38 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.286 0.635 . . . . 0.0 109.732 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -125.79 130.63 51.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.72 131.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.454 1.501 . . . . 0.0 109.7 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -141.31 118.67 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.38 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -103.85 -39.46 6.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.643 0.777 . . . . 0.0 111.837 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -92.57 158.82 15.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.278 1.031 . . . . 0.0 111.098 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -159.59 128.72 5.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.639 1.176 . . . . 0.0 111.505 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -162.17 -21.91 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.273 0.6 OUTLIER 50.01 37.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 127.143 2.177 . . . . 0.0 114.234 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.57 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.1 1.76 . . . . 0.0 111.924 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -51.79 124.63 27.84 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.619 1.168 . . . . 0.0 113.467 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.42 -14.72 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.881 2.387 . . . . 0.0 113.008 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t -90.18 119.66 69.23 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 119.008 0.822 . . . . 0.0 109.804 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.84 117.71 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.219 1.279 . . . . 0.0 108.977 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.0 -152.86 3.34 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -85.46 104.36 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.602 -0.94 . . . . 0.0 109.958 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -140.08 155.21 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.827 1.651 . . . . 0.0 109.582 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.4 172.19 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.617 1.167 . . . . 0.0 110.777 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -119.59 94.36 4.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.458 1.503 . . . . 0.0 107.495 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -52.83 118.71 3.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.565 1.546 . . . . 0.0 109.063 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.45 149.26 10.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.588 0.755 . . . . 0.0 112.998 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.65 -13.8 11.18 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.8 118.99 0.87 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.343 0.973 . . . . 0.0 111.777 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.48 161.64 4.1 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.871 2.068 . . . . 0.0 111.207 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 m -115.45 131.4 56.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.082 1.353 . . . . 0.0 110.067 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -131.58 136.0 47.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.508 1.123 . . . . 0.0 110.104 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -138.47 10.75 2.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.467 1.107 . . . . 0.0 112.901 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.64 52.15 0.58 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.548 1.539 . . . . 0.0 109.94 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -74.13 39.16 0.11 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.922 1.289 . . . . 0.0 112.928 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -55.99 -30.67 62.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.002 1.721 . . . . 0.0 113.047 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -64.34 -18.24 64.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.6 mm -90.26 -23.42 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.627 1.571 . . . . 0.0 111.964 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 45.05 74.51 0.13 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.079 2.152 . . . . 0.0 114.537 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.4 -160.33 36.14 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.555 0.598 . . . . 0.0 112.096 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -143.44 177.89 8.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.917 0.887 . . . . 0.0 110.861 172.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.409 ' H ' ' CD2' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -152.15 -46.3 0.11 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.216 1.007 . . . . 0.0 111.825 164.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.498 ' HE3' ' CG2' ' A' ' 203' ' ' THR . 2.0 ptmm? -140.7 156.22 46.27 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.95 140.42 34.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.148 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -129.08 125.01 36.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.39 131.36 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.353 1.461 . . . . 0.0 108.702 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.76 143.81 41.12 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.344 1.458 . . . . 0.0 109.97 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.12 26.27 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.15 3.9 . . . . 0.0 115.452 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.82 26.9 61.07 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.585 1.088 . . . . 0.0 113.582 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.1 -42.15 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 111.297 -168.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.72 146.55 32.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 109.983 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -88.69 -39.94 13.63 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.814 0.816 . . . . 0.0 111.637 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -152.0 158.77 43.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 107.191 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.25 174.06 7.53 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.916 -0.49 . . . . 0.0 109.981 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.08 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 111.185 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -71.71 131.83 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.76 139.78 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.693 1.197 . . . . 0.0 109.839 170.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -139.65 142.58 36.99 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.547 -0.721 . . . . 0.0 110.025 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 pt -91.95 144.28 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 122.91 0.484 . . . . 0.0 110.254 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.3 t -133.0 109.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.137 1.375 . . . . 0.0 108.686 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.07 118.18 17.73 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.679 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.87 -12.82 14.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.95 0.9 . . . . 0.0 113.002 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.49 -51.96 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.856 1.262 . . . . 0.0 111.681 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -92.7 110.72 22.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.088 0.955 . . . . 0.0 109.233 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 t -75.25 39.32 0.15 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.134 1.374 . . . . 0.0 114.013 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 m -140.48 -39.18 0.43 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.591 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.52 -160.49 0.07 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.585 1.154 . . . . 0.0 113.34 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.78 7.43 61.69 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 120.398 -1.439 . . . . 0.0 116.136 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.9 p -144.82 28.96 1.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.759 1.78 . . . . 0.0 114.663 -159.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -133.66 145.29 49.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.681 1.593 . . . . 0.0 109.193 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -132.79 112.2 11.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.149 0.98 . . . . 0.0 110.376 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.0 ttp -111.09 105.96 14.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.414 2.286 . . . . 0.0 110.544 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.8 m -92.21 126.55 37.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.569 0.699 . . . . 0.0 109.173 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.03 132.05 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.105 1.362 . . . . 0.0 108.933 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -137.04 89.33 16.83 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 123.62 0.768 . . . . 0.0 109.269 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.38 167.1 17.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.978 2.452 . . . . 0.0 112.668 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -37.57 98.36 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.437 2.295 . . . . 0.0 113.611 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.268 19.4 pt20 43.01 52.82 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.065 1.746 . . . . 0.0 114.87 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.61 148.0 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.162 1.785 . . . . 0.0 110.942 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -51.85 112.37 0.76 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.057 1.343 . . . . 0.0 111.067 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 152.79 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.323 1.049 . . . . 0.0 111.993 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.43 141.09 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.758 -0.589 . . . . 0.0 111.936 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.88 91.3 3.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.704 1.602 . . . . 0.0 109.896 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.3 t -74.06 131.65 41.55 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 121.785 -0.572 . . . . 0.0 109.691 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.77 139.39 48.91 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.86 128.98 39.81 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.932 -0.48 . . . . 0.0 110.303 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.47 -11.03 59.71 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.98 1.276 . . . . 0.0 115.189 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 145.47 41.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.695 1.748 . . . . 0.0 111.95 169.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.67 55.45 0.37 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.934 1.694 . . . . 0.0 112.957 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 57.88 95.72 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.737 2.415 . . . . 0.0 112.197 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.8 t -51.97 130.22 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.156 0.982 . . . . 0.0 112.225 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -80.09 122.28 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.793 0.837 . . . . 0.0 111.251 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.6 101.84 11.44 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.262 163.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.6 121.99 6.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.742 1.628 . . . . 0.0 110.534 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.87 121.44 43.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.816 0.846 . . . . 0.0 108.901 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.53 168.36 23.82 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.262 2.642 . . . . 0.0 111.75 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 131.79 51.45 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.698 -0.626 . . . . 0.0 110.792 174.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.99 149.27 33.84 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.777 1.631 . . . . 0.0 110.047 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.1 m -138.27 135.18 18.13 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 0.0 110.559 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.17 150.0 82.08 Favored 'Cis proline' 0 CA--C 1.544 1.022 0 CA-C-N 119.252 0.769 . . . . 0.0 112.001 -5.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.52 -24.24 49.2 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.027 1.818 . . . . 0.0 113.092 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.83 1.78 29.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -69.89 156.25 39.36 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.357 1.075 . . . . 0.0 112.843 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -83.67 135.67 34.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.284 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.4 tt -115.73 116.58 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.941 1.696 . . . . 0.0 108.401 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.49 142.9 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.921 -0.487 . . . . 0.0 110.749 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.0 p -142.91 140.56 31.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 122.088 0.946 . . . . 0.0 111.994 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -90.16 140.18 29.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.387 0.675 . . . . 0.0 110.148 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.17 113.94 18.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.732 1.613 . . . . 0.0 108.736 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 98.56 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.31 1.044 . . . . 0.0 109.517 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 3.9 p -115.4 145.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.541 1.136 . . . . 0.0 110.056 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.54 160.84 39.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.186 1.395 . . . . 0.0 112.454 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.56 146.63 46.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.017 1.327 . . . . 0.0 111.335 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.6 p -85.33 -12.22 52.79 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.34 171.79 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.813 1.245 . . . . 0.0 110.884 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -60.56 145.37 87.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 120.965 -1.085 . . . . 0.0 112.315 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.65 12.06 26.2 Favored 'Cis proline' 0 CA--C 1.55 1.287 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 3.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.22 13.53 8.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.869 1.668 . . . . 0.0 113.683 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.07 152.82 32.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 112.338 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -52.3 139.11 25.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.922 0.889 . . . . 0.0 112.92 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.56 -20.39 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.406 1.482 . . . . 0.0 111.937 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.403 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 95.0 t -152.66 131.78 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 126.776 2.03 . . . . 0.0 108.329 168.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -122.79 129.65 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.236 1.415 . . . . 0.0 109.084 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 176.63 -165.37 35.58 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.903 0.724 . . . . 0.0 112.695 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.39 156.01 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.183 0.992 . . . . 0.0 110.738 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 156.46 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.49 1.916 . . . . 0.0 108.246 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.56 134.59 54.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.83 157.88 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.65 154.14 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 107.64 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -118.85 160.5 21.8 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.441 1.096 . . . . 0.0 108.608 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.4 m -121.54 106.63 37.38 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 121.235 -0.915 . . . . 0.0 108.598 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.77 53.83 2.88 Favored 'Trans proline' 0 CA--C 1.542 0.92 1 C-N-CA 125.506 4.137 . . . . 0.0 112.545 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -126.66 -44.71 1.66 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.754 2.022 . . . . 0.0 110.713 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 82.4 p -144.91 6.55 1.19 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.521 1.128 . . . . 0.0 113.843 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.17 34.77 40.31 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.576 -1.327 . . . . 0.0 113.171 -171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 149.81 35.86 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.884 -0.774 . . . . 0.0 110.752 173.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.21 132.2 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.681 1.192 . . . . 0.0 108.121 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 99.5 m -135.55 125.57 25.96 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.893 1.277 . . . . 0.0 109.307 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.56 130.0 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.334 1.054 . . . . 0.0 110.64 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 mt -108.83 141.33 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.275 2.23 . . . . 0.0 107.634 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 136.49 24.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.501 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -134.36 134.46 41.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.015 -170.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -58.39 -14.11 6.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.561 1.144 . . . . 0.0 113.955 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.07 -23.67 65.64 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.306 1.442 . . . . 0.0 114.492 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 p -145.28 -34.86 0.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.024 1.73 . . . . 0.0 113.646 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.25 129.99 89.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.775 0.83 . . . . 0.0 110.69 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.35 173.3 14.46 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.443 2.762 . . . . 0.0 112.069 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 5.97 32.32 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.214 1.406 . . . . 0.0 113.299 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -89.86 -37.2 14.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.968 1.707 . . . . 0.0 112.231 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.0 ttt -113.83 152.13 31.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.49 1.516 . . . . 0.0 109.279 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.5 p -133.21 144.31 49.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 0.0 110.756 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.88 119.94 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 88.5 m -115.42 114.51 25.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.036 1.334 . . . . 0.0 109.419 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.39 129.87 39.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.934 0.894 . . . . 0.0 110.972 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -31.89 3.78 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.326 1.05 . . . . 0.0 112.508 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -146.71 169.23 19.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.847 2.059 . . . . 0.0 109.702 171.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -59.19 -2.09 0.25 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.498 ' CG2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 t -156.64 32.62 0.31 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.586 2.354 . . . . 0.0 110.543 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -143.94 117.27 9.04 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.291 -1.506 . . . . 0.0 111.853 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 135.02 53.87 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.251 1.421 . . . . 0.0 110.616 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -118.15 117.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -97.69 91.72 5.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -75.51 127.08 32.32 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.231 0.612 . . . . 0.0 109.587 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.4 tp -111.18 110.56 21.12 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 111.679 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -107.78 17.35 22.63 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.986 2.114 . . . . 0.0 112.866 -173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 t -152.16 155.15 37.25 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.343 1.457 . . . . 0.0 111.723 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -9.73 15.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.107 0.963 . . . . 0.0 113.044 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.79 139.93 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.34 1.456 . . . . 0.0 110.643 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.81 149.56 37.88 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.714 -0.616 . . . . 0.0 110.918 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.55 -24.44 47.05 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 113.324 170.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -111.58 12.51 21.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.0 1.72 . . . . 0.0 112.962 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -146.4 173.34 12.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.63 1.572 . . . . 0.0 111.145 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.7 158.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.074 0.949 . . . . 0.0 110.788 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.9 149.45 48.98 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.187 0.995 . . . . 0.0 110.665 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -127.2 132.01 50.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.133 1.373 . . . . 0.0 108.184 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -126.55 123.21 37.2 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.245 1.498 . . . . 0.0 110.443 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -83.59 33.52 0.47 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.644 1.578 . . . . 0.0 112.574 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.53 148.56 11.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.972 1.748 . . . . 0.0 111.993 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.34 147.91 9.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.335 1.454 . . . . 0.0 112.025 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 49.62 42.67 23.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.323 1.049 . . . . 0.0 113.46 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m 56.38 65.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.873 1.669 . . . . 0.0 113.914 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -130.62 -179.88 5.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.883 1.273 . . . . 0.0 112.529 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 -95.09 1.23 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.01 1.291 . . . . 0.0 113.335 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.64 169.23 15.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.516 1.527 . . . . 0.0 110.36 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.9 p -135.07 149.72 50.14 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.048 0.939 . . . . 0.0 112.16 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 156.36 44.72 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.534 1.934 . . . . 0.0 110.271 -174.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.55 132.49 48.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.853 1.261 . . . . 0.0 109.642 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.25 122.0 30.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.077 1.351 . . . . 0.0 108.928 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -74.56 158.76 33.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.332 0.653 . . . . 0.0 110.926 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -64.98 154.78 36.63 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.505 -0.747 . . . . 0.0 111.622 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.15 45.51 96.38 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.367 0.508 . . . . 0.0 112.582 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -121.78 148.96 43.98 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.703 1.201 . . . . 0.0 110.319 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -136.95 119.3 15.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.32 117.81 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 109.664 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.558 ' HG3' ' HZ2' ' A' ' 88' ' ' LYS . 6.1 tmm_? -106.05 100.04 9.6 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.78 -176.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.79 162.33 26.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.239 170.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -107.91 162.91 13.59 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -67.02 -15.3 63.64 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.029 -1.045 . . . . 0.0 113.35 170.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.32 -20.55 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.308 0.956 . . . . 0.0 114.449 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -80.99 109.55 15.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.563 1.182 . . . . 0.0 111.01 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.14 66.72 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.531 -1.355 . . . . 0.0 112.623 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -57.42 -28.28 63.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.904 2.082 . . . . 0.0 113.514 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -73.26 -52.07 15.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.55 1.14 . . . . 0.0 111.742 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.74 -15.22 61.25 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.104 0.962 . . . . 0.0 112.989 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.88 0.93 4.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.102 2.561 . . . . 0.0 114.73 168.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -44.07 135.2 4.38 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.693 1.133 . . . . 0.0 110.222 164.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.76 -54.56 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.4 p -146.46 164.22 33.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.662 0.744 . . . . 0.0 112.004 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 p -161.68 159.68 27.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.226 -0.922 . . . . 0.0 110.423 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mp -123.87 132.07 53.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.337 1.055 . . . . 0.0 108.499 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -123.49 127.01 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 124.752 1.221 . . . . 0.0 109.512 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.548 2.023 . . . . 0.0 115.844 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -171.71 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.256 1.422 . . . . 0.0 114.0 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -120.93 29.49 7.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.928 1.691 . . . . 0.0 111.751 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.93 138.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.296 1.439 . . . . 0.0 110.776 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -115.45 132.87 56.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.684 1.194 . . . . 0.0 109.316 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.26 143.49 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -123.05 131.45 53.7 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.732 1.613 . . . . 0.0 108.749 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 pt -137.56 118.37 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.822 1.249 . . . . 0.0 111.037 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.08 138.03 53.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 110.311 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.4 -46.03 4.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.501 0.72 . . . . 0.0 112.917 -164.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -151.93 131.62 13.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.821 1.248 . . . . 0.0 108.684 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -146.56 138.48 24.74 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.263 1.425 . . . . 0.0 107.86 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.32 9.72 0.56 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.247 0.619 . . . . 0.0 111.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt 43.47 27.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 129.655 3.182 . . . . 0.0 116.259 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -173.39 -23.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.294 2.238 . . . . 0.0 111.429 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -46.98 136.71 8.06 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.125 1.37 . . . . 0.0 113.241 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.38 -5.38 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.294 2.662 . . . . 0.0 113.01 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 90.54 50.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 109.808 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.24 109.97 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.835 1.69 . . . . 0.0 108.092 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.37 159.1 20.99 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 153.62 18.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.454 1.121 . . . . 0.0 111.191 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -148.55 144.69 27.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.664 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.4 166.64 27.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.474 1.131 . . . . 0.0 111.071 170.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -126.34 111.63 14.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.055 1.342 . . . . 0.0 109.32 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.08 136.13 57.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.819 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.02 144.26 9.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 112.665 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.45 -10.82 8.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.46 109.62 0.41 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.04 1.781 . . . . 0.0 111.829 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.79 168.87 0.52 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.431 2.292 . . . . 0.0 111.331 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.1 m -111.21 142.38 43.49 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.527 1.131 . . . . 0.0 109.49 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -129.6 120.45 25.29 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.833 1.253 . . . . 0.0 108.095 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -128.7 -18.28 3.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.63 -80.42 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 109.419 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp 44.77 22.34 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.927 1.691 . . . . 0.0 113.762 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -78.29 -36.22 46.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.434 1.494 . . . . 0.0 110.055 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.6 t -69.07 -30.44 68.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.551 1.14 . . . . 0.0 112.859 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.39 -27.24 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.234 1.414 . . . . 0.0 112.105 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 57.02 45.57 20.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.491 1.516 . . . . 0.0 112.304 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.62 -167.94 43.87 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.533 1.063 . . . . 0.0 113.94 -172.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -173.55 4.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.071 1.349 . . . . 0.0 111.246 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 85.6 p -149.19 -34.63 0.19 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.843 1.257 . . . . 0.0 112.819 167.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HZ2' ' HG3' ' A' ' 30' ' ' ARG . 7.4 mttp -99.29 127.28 45.28 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.293 1.037 . . . . 0.0 110.093 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.35 136.37 54.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.184 1.393 . . . . 0.0 108.796 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -143.89 153.55 42.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.408 0.683 . . . . 0.0 109.265 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.69 114.42 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 124.75 1.22 . . . . 0.0 108.707 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.63 115.27 31.02 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.492 0.717 . . . . 0.0 110.636 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 95' ' ' ALA . 60.2 Cg_endo -71.73 166.22 30.12 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.938 2.425 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.1 33.65 0.19 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.158 2.313 . . . . 0.0 114.831 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 93' ' ' PRO . . . -117.71 -27.11 6.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.055 2.542 . . . . 0.0 110.986 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -140.41 161.23 38.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.038 1.735 . . . . 0.0 110.749 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -104.21 -45.64 4.65 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.095 -1.003 . . . . 0.0 112.501 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.34 165.18 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.186 1.794 . . . . 0.0 108.333 174.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.74 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.252 0.549 . . . . 0.0 109.753 169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.06 139.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.978 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -97.2 121.44 39.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.943 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 167.46 29.36 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.689 1.196 . . . . 0.0 109.623 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.34 148.63 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 125.38 1.472 . . . . 0.0 109.678 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.61 114.08 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.964 0.906 . . . . 0.0 109.149 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.93 88.72 2.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 111.92 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.41 19.48 20.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.86 1.264 . . . . 0.0 112.028 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.71 -66.08 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.544 1.538 . . . . 0.0 111.458 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -85.16 -19.59 31.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.949 1.3 . . . . 0.0 111.989 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t 62.51 39.46 11.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.651 1.981 . . . . 0.0 113.358 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.8 m -131.43 -38.36 1.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.762 1.225 . . . . 0.0 113.915 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.04 -177.86 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.163 1.385 . . . . 0.0 114.338 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.74 20.46 39.85 Favored Glycine 0 CA--C 1.54 1.653 0 O-C-N 120.618 -1.301 . . . . 0.0 115.037 -171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.6 p -139.63 17.66 2.53 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.772 1.629 . . . . 0.0 113.327 -166.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.38 132.45 27.89 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.404 1.882 . . . . 0.0 109.385 -170.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -117.23 121.89 42.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.541 1.136 . . . . 0.0 110.163 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttt -115.8 122.37 45.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.706 1.203 . . . . 0.0 109.637 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -119.41 116.22 25.72 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.02 1.328 . . . . 0.0 108.373 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.09 138.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.266 1.426 . . . . 0.0 108.818 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 t -154.67 99.2 2.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.405 0.682 . . . . 0.0 110.842 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.38 168.26 16.63 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.346 2.697 . . . . 0.0 112.905 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -34.99 95.0 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.138 2.175 . . . . 0.0 114.884 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 37.55 65.85 0.5 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.892 2.077 . . . . 0.0 115.099 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.2 155.26 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.663 . . . . 0.0 110.41 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.01 100.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.352 1.461 . . . . 0.0 111.811 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -59.01 151.39 22.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.444 0.64 . . . . 0.0 110.327 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.72 124.0 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.13 107.83 15.4 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.673 1.589 . . . . 0.0 108.802 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.88 160.49 24.64 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 160.72 16.19 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.197 0.599 . . . . 0.0 110.848 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.54 53.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.842 2.457 . . . . 0.0 114.727 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.01 -21.81 0.07 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.74 2.591 . . . . 0.0 113.776 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.21 156.96 23.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.156 1.478 . . . . 0.0 111.808 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.7 -16.64 29.93 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.302 -0.874 . . . . 0.0 112.793 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -176.66 115.97 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.78 2.832 . . . . 0.0 108.253 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.56 126.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.238 -1.539 . . . . 0.0 109.559 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 127.98 33.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.922 0.489 . . . . 0.0 110.87 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.23 109.55 54.15 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.161 1.384 . . . . 0.0 109.817 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.59 138.87 33.08 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.429 2.086 . . . . 0.0 110.556 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.62 123.76 18.57 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.733 1.213 . . . . 0.0 109.199 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.68 164.51 35.18 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.831 2.354 . . . . 0.0 112.055 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 134.02 55.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.29 0.567 . . . . 0.0 111.735 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.15 146.59 40.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.921 1.688 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.8 m -142.55 136.05 14.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 124.603 1.161 . . . . 0.0 109.874 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.7 154.95 75.72 Favored 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 119.844 0.98 . . . . 0.0 113.006 -4.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -64.33 -32.2 61.7 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.064 1.843 . . . . 0.0 112.509 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.59 -12.48 58.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.662 1.585 . . . . 0.0 114.168 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.32 174.75 6.07 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.161 0.981 . . . . 0.0 112.89 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.81 149.23 45.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.994 1.317 . . . . 0.0 111.574 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.28 122.76 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.964 1.706 . . . . 0.0 109.139 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.84 140.69 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.411 0.624 . . . . 0.0 110.722 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 t -141.14 137.93 33.1 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.87 1.268 . . . . 0.0 110.885 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -91.15 139.81 30.4 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -130.48 116.72 18.61 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.869 1.268 . . . . 0.0 108.47 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.29 124.81 37.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.67 133.25 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.719 1.208 . . . . 0.0 110.559 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.81 145.3 56.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.426 0.631 . . . . 0.0 111.585 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.7 p -81.68 -5.24 57.92 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.113 1.365 . . . . 0.0 113.076 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -135.56 166.55 22.95 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.087 1.755 . . . . 0.0 111.194 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 t -80.39 142.87 54.82 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.623 0.769 . . . . 0.0 112.671 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.36 132.3 21.32 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.117 1.077 . . . . 0.0 110.993 -9.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -75.08 36.26 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.627 1.571 . . . . 0.0 112.171 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.93 132.29 41.8 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.701 1.2 . . . . 0.0 109.565 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -52.36 148.44 6.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.221 -0.299 . . . . 0.0 110.96 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.57 -29.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.292 1.037 . . . . 0.0 112.404 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.96 143.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.935 1.694 . . . . 0.0 109.306 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.95 122.0 14.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.366 1.467 . . . . 0.0 109.035 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.21 -165.25 31.67 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 121.906 0.725 . . . . 0.0 114.262 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.36 144.96 34.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.426 1.09 . . . . 0.0 110.256 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.86 155.58 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.215 1.806 . . . . 0.0 108.934 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -125.32 126.05 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.406 -0.809 . . . . 0.0 108.867 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -95.98 139.38 32.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -133.24 150.39 51.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.376 1.87 . . . . 0.0 108.414 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -122.94 150.57 42.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.005 0.922 . . . . 0.0 109.417 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.25 105.89 56.14 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.676 0.79 . . . . 0.0 109.326 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.9 51.42 1.97 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.354 4.036 . . . . 0.0 113.614 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.7 m -132.57 -41.24 0.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.72 2.008 . . . . 0.0 111.703 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.8 t -145.92 23.68 1.37 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 123.078 1.418 . . . . 0.0 112.098 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.15 46.41 56.52 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.595 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -83.5 156.13 23.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.479 1.112 . . . . 0.0 110.423 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.23 134.82 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.9 m -124.83 150.26 46.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.855 2.062 . . . . 0.0 108.421 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 123.77 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.226 1.011 . . . . 0.0 109.155 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.11 133.5 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.3 1.44 . . . . 0.0 107.338 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.32 138.9 25.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.639 1.576 . . . . 0.0 107.635 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 147.68 50.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.786 1.235 . . . . 0.0 108.494 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.17 -17.84 59.19 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.311 -0.868 . . . . 0.0 112.593 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.35 -12.68 61.23 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.307 2.243 . . . . 0.0 114.013 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.4 p -137.02 -44.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.583 1.553 . . . . 0.0 111.872 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.68 160.97 74.51 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.107 1.763 . . . . 0.0 111.324 169.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.72 -2.16 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.848 3.032 . . . . 0.0 113.859 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 53.69 15.56 0.81 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.709 2.404 . . . . 0.0 115.113 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.39 -0.67 8.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.867 1.667 . . . . 0.0 113.398 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.7 ttt -125.62 148.61 48.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.817 2.047 . . . . 0.0 107.507 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -133.75 156.97 47.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.724 0.81 . . . . 0.0 109.846 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.9 t -117.58 125.31 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.251 0.621 . . . . 0.0 109.563 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 41.5 m -110.61 110.35 21.01 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.602 1.961 . . . . 0.0 108.229 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.09 103.97 5.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.086 0.955 . . . . 0.0 110.543 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.8 -34.55 19.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.317 0.647 . . . . 0.0 111.257 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -142.44 -177.62 5.36 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.301 1.84 . . . . 0.0 112.739 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -66.97 -17.39 64.9 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.9 p -138.68 10.37 2.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 112.644 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.4 m -125.18 114.13 18.59 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.279 1.032 . . . . 0.0 110.975 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.59 138.1 52.8 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.433 1.493 . . . . 0.0 109.258 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 48.8 mt -119.79 122.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.36 104.79 16.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.981 1.312 . . . . 0.0 109.094 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -87.23 126.88 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.774 0.83 . . . . 0.0 109.019 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.46 118.99 31.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.702 0.801 . . . . 0.0 109.981 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -110.86 -27.16 8.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.877 1.271 . . . . 0.0 113.374 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.7 m -103.8 177.88 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 112.209 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -134.3 72.97 1.47 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.248 1.419 . . . . 0.0 109.644 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.341 1.056 . . . . 0.0 113.672 178.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.369 0.604 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.66 152.27 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.363 1.465 . . . . 0.0 111.213 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 139.94 51.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.594 1.158 . . . . 0.0 111.082 171.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.6 -17.74 60.76 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.684 -1.26 . . . . 0.0 113.568 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.31 3.53 12.58 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.284 1.834 . . . . 0.0 113.837 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -149.1 173.19 13.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.076 2.55 . . . . 0.0 109.399 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.63 161.5 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.729 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -145.48 142.3 29.12 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.335 0.654 . . . . 0.0 110.341 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.51 138.04 54.04 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.413 1.485 . . . . 0.0 108.71 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.47 127.27 42.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.141 0.972 . . . . 0.0 110.365 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -80.49 58.24 3.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.145 1.378 . . . . 0.0 111.19 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.9 139.32 3.94 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.587 -0.696 . . . . 0.0 112.278 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.922 0.889 . . . . 0.0 108.831 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 75.99 34.02 0.56 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.789 1.636 . . . . 0.0 112.874 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.7 t 62.89 63.96 0.92 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.622 1.569 . . . . 0.0 112.831 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.6 p -137.28 -178.53 5.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.253 1.821 . . . . 0.0 112.99 -172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.84 -95.39 0.63 Allowed Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.63 1.586 . . . . 0.0 114.317 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -123.37 164.23 19.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.99 1.316 . . . . 0.0 110.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.7 p -132.92 149.32 52.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.72 1.208 . . . . 0.0 112.036 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.95 148.42 29.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.523 1.529 . . . . 0.0 109.603 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -126.93 146.31 50.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.106 0.962 . . . . 0.0 110.258 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.42 132.31 31.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.875 1.322 . . . . 0.0 111.721 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.7 146.75 49.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.964 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -62.66 142.62 58.0 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.415 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 52.45 34.75 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.083 0.401 . . . . 0.0 113.428 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 158.1 45.05 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.841 0.856 . . . . 0.0 112.101 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -138.6 135.33 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.69 119.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.321 1.048 . . . . 0.0 109.29 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -99.9 103.5 15.09 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.25 155.2 23.79 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.605 1.162 . . . . 0.0 110.663 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -103.48 137.22 41.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.445 0.698 . . . . 0.0 110.029 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -59.78 -17.37 35.04 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.77 -25.41 63.64 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.424 1.012 . . . . 0.0 114.342 170.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.01 119.18 38.54 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.534 1.167 . . . . 0.0 109.975 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -12.5 3.44 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 170.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -58.2 -25.82 62.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.196 1.398 . . . . 0.0 112.22 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.12 -56.03 10.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.098 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.07 -15.24 21.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.962 1.705 . . . . 0.0 113.771 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -28.52 44.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.807 1.643 . . . . 0.0 113.522 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -47.36 122.22 4.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.229 0.538 . . . . 0.0 111.575 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.9 tpt -149.23 -31.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 111.918 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.6 p -145.32 162.06 38.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 111.684 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.1 p -156.05 149.16 24.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.322 1.449 . . . . 0.0 110.407 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.27 136.23 53.19 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.56 129.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.232 1.413 . . . . 0.0 109.563 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.36 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.574 2.035 . . . . 0.0 116.11 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -166.36 -20.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 113.267 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -119.92 22.92 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.01 1.724 . . . . 0.0 111.607 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.21 143.25 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.93 2.092 . . . . 0.0 109.508 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -120.94 145.66 47.46 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.91 1.284 . . . . 0.0 109.807 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.4 m -112.29 142.89 44.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.606 1.194 . . . . 0.0 109.957 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.33 130.79 41.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.44 123.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.105 . . . . 0.0 109.639 -172.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -131.92 134.31 45.53 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.094 1.358 . . . . 0.0 110.549 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.58 -34.22 7.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.05 0.94 . . . . 0.0 112.935 -168.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.42 157.27 46.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.593 1.957 . . . . 0.0 107.223 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -142.39 131.79 23.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.111 0.964 . . . . 0.0 109.743 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.53 162.68 0.7 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.105 1.762 . . . . 0.0 110.68 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.34 15.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 112.556 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.14 28.82 1.1 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.04 2.136 . . . . 0.0 111.147 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 t -99.53 139.96 21.26 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.929 1.291 . . . . 0.0 112.456 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.39 -16.69 11.91 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.45 2.767 . . . . 0.0 114.281 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 t -124.92 137.59 29.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.73 150.32 83.53 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.43 -161.29 5.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.426 1.014 . . . . 0.0 112.241 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.16 134.8 51.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 108.59 167.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -159.43 155.66 27.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.568 1.547 . . . . 0.0 110.482 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -158.61 147.32 18.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.732 1.253 . . . . 0.0 113.027 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.73 95.26 9.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.848 2.059 . . . . 0.0 109.676 168.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.6 134.14 55.89 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.22 151.46 15.67 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.89 -8.61 7.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.46 89.93 0.11 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.236 -0.915 . . . . 0.0 112.644 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.1 p -162.42 169.41 20.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.355 1.074 . . . . 0.0 112.851 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -104.54 133.34 49.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.584 1.554 . . . . 0.0 109.107 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -128.67 115.4 17.97 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.084 0.954 . . . . 0.0 109.682 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -141.53 15.56 2.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 112.257 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -153.71 50.57 0.68 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.932 1.293 . . . . 0.0 109.96 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.01 42.25 0.39 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.649 1.18 . . . . 0.0 110.841 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -66.31 -30.08 70.42 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 119.971 -1.706 . . . . 0.0 112.385 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -63.26 -23.94 67.65 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.196 0.998 . . . . 0.0 112.88 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.24 -34.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.674 1.99 . . . . 0.0 111.421 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.92 40.83 22.1 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.898 1.679 . . . . 0.0 113.24 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 168.89 33.95 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.668 1.128 . . . . 0.0 112.287 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.44 -173.91 3.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.409 1.484 . . . . 0.0 112.39 -170.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 84.8 p -145.83 -28.18 0.43 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.36 139.26 51.64 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.501 1.52 . . . . 0.0 110.03 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.79 127.39 40.25 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.023 1.329 . . . . 0.0 107.673 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -136.91 130.44 31.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.703 0.801 . . . . 0.0 109.11 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.61 118.77 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.218 1.407 . . . . 0.0 107.541 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.84 123.27 27.46 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.473 1.109 . . . . 0.0 109.061 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.54 160.48 41.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.999 2.466 . . . . 0.0 111.107 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.17 24.6 0.2 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 125.831 1.682 . . . . 0.0 116.01 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.13 -20.94 6.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.236 2.215 . . . . 0.0 112.816 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.06 158.93 32.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.821 1.648 . . . . 0.0 109.399 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.13 -38.8 7.98 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.252 -0.905 . . . . 0.0 112.826 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 -149.98 155.52 40.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.101 1.361 . . . . 0.0 108.878 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.78 146.06 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.03 0.532 . . . . 0.0 110.072 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.02 134.55 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.253 1.021 . . . . 0.0 110.539 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -84.72 126.18 33.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.1 m -124.89 140.0 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.555 0.742 . . . . 0.0 109.548 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.29 161.83 30.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.295 1.038 . . . . 0.0 110.716 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.01 134.94 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.984 0.913 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.7 t -127.4 108.27 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -76.21 118.31 18.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.735 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -102.33 -21.69 14.26 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.319 1.047 . . . . 0.0 112.466 170.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.21 -67.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.192 0.997 . . . . 0.0 111.971 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -85.2 97.62 10.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.852 1.261 . . . . 0.0 110.393 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -70.17 47.84 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.26 1.824 . . . . 0.0 114.417 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.8 m -144.68 -36.16 0.32 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.123 2.569 . . . . 0.0 111.82 -171.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.29 -153.58 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 53.03 25.18 23.5 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 120.224 1.375 . . . . 0.0 116.203 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 m -143.82 5.66 1.36 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.974 1.71 . . . . 0.0 114.935 -167.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -133.58 120.3 20.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.431 1.493 . . . . 0.0 111.855 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.26 137.99 32.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.315 1.046 . . . . 0.0 109.916 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 119.38 34.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.261 2.224 . . . . 0.0 108.662 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 m -119.07 119.5 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.41 128.83 73.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -117.49 89.11 31.12 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.233 1.413 . . . . 0.0 109.226 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.07 160.36 49.01 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.668 2.912 . . . . 0.0 112.035 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -42.94 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.288 2.635 . . . . 0.0 116.084 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 44.48 39.7 3.39 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.836 1.654 . . . . 0.0 113.948 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.25 154.92 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.734 2.014 . . . . 0.0 109.683 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -45.95 98.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 112.752 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 151.06 36.17 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 0.0 111.046 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.46 125.41 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.882 0.873 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.17 105.45 17.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.012 1.325 . . . . 0.0 108.638 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.4 p -103.06 164.99 11.28 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.053 0.941 . . . . 0.0 110.796 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -142.46 159.9 41.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.764 0.825 . . . . 0.0 110.65 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -60.54 81.85 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 126.339 1.856 . . . . 0.0 114.526 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.22 0.18 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.939 1.733 . . . . 0.0 112.159 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.12 131.43 49.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.978 0.894 . . . . 0.0 111.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -74.95 70.52 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.32 1.448 . . . . 0.0 112.466 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 63.3 84.3 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.23 2.212 . . . . 0.0 110.919 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.61 147.96 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.603 -0.686 . . . . 0.0 110.599 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.1 146.06 24.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.886 0.474 . . . . 0.0 111.199 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.66 97.09 44.82 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.195 1.398 . . . . 0.0 108.106 166.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.51 137.51 27.99 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.542 2.161 . . . . 0.0 111.072 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.68 127.62 23.52 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.508 1.123 . . . . 0.0 107.997 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.22 -178.7 3.77 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.326 3.35 . . . . 0.0 111.327 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 149.41 47.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.84 0.829 . . . . 0.0 112.358 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.02 143.39 21.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.432 1.893 . . . . 0.0 109.46 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.8 m -125.83 130.62 23.98 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 124.275 1.03 . . . . 0.0 109.534 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.1 150.78 79.37 Favored 'Cis proline' 0 CA--C 1.545 1.038 0 CA-C-N 119.368 0.81 . . . . 0.0 112.435 -3.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.27 -22.69 39.76 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.76 1.64 . . . . 0.0 112.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.01 4.87 15.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.543 1.537 . . . . 0.0 114.548 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 148.71 46.68 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.727 -1.233 . . . . 0.0 111.992 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 155.57 36.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 112.182 168.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 tt -132.99 114.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 109.155 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 138.91 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.331 0.652 . . . . 0.0 109.844 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.1 p -142.57 145.99 34.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.033 0.921 . . . . 0.0 111.221 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -86.49 145.72 26.69 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 tt -134.6 122.49 22.39 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.993 0.917 . . . . 0.0 110.035 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 t -131.14 138.31 49.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.434 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.02 134.11 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.72 50.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.89 0.876 . . . . 0.0 109.885 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.26 129.46 40.04 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.156 -0.34 . . . . 0.0 110.253 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.9 p -77.41 -10.37 59.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.81 0.844 . . . . 0.0 112.855 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.74 164.43 17.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.085 2.154 . . . . 0.0 111.301 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.9 t -75.17 141.29 74.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.63 -0.669 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.35 129.58 15.45 Favored 'Cis proline' 0 C--N 1.354 0.861 0 CA-C-N 120.279 1.135 . . . . 0.0 111.091 -9.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -73.73 34.38 0.08 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.978 1.711 . . . . 0.0 113.546 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.23 151.17 23.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 113.039 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.21 102.62 2.14 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.916 0.886 . . . . 0.0 110.381 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.94 -39.1 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.82 2.048 . . . . 0.0 111.495 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.53 143.76 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.2 1.4 . . . . 0.0 108.252 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -148.77 74.46 1.27 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.962 0.905 . . . . 0.0 109.273 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -140.69 -156.13 6.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.424 1.488 . . . . 0.0 112.039 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 55.2 m -141.69 164.73 29.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.95 0.9 . . . . 0.0 110.434 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.73 156.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.444 1.498 . . . . 0.0 108.176 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.01 134.39 53.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.141 -0.974 . . . . 0.0 108.65 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.05 160.08 16.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.486 1.115 . . . . 0.0 109.609 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -159.22 154.31 25.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.269 1.428 . . . . 0.0 109.262 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -128.94 142.83 50.81 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.937 1.295 . . . . 0.0 109.168 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.6 m -101.86 109.66 60.21 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.376 0.67 . . . . 0.0 109.197 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.63 47.65 1.71 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 125.227 3.952 . . . . 0.0 113.098 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -130.27 -49.73 1.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.105 1.762 . . . . 0.0 110.462 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.2 p -138.46 24.71 2.68 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.196 1.398 . . . . 0.0 112.609 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.99 23.75 64.08 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.306 0.955 . . . . 0.0 114.154 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 158.73 35.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.327 1.051 . . . . 0.0 111.318 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.19 143.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.705 1.602 . . . . 0.0 107.819 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 59.4 m -139.49 128.73 23.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.841 1.256 . . . . 0.0 108.587 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.07 126.61 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.866 0.866 . . . . 0.0 110.233 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.71 130.18 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.902 1.281 . . . . 0.0 108.224 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -140.03 125.86 19.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.198 1.799 . . . . 0.0 108.468 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 158.56 42.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.164 1.386 . . . . 0.0 109.943 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.59 -18.36 19.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.648 1.179 . . . . 0.0 113.274 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.78 -24.88 64.45 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.967 1.707 . . . . 0.0 114.609 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.0 p -150.15 -44.17 0.13 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.756 1.223 . . . . 0.0 114.1 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.86 144.28 51.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.895 1.278 . . . . 0.0 110.072 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.47 -78.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 121.268 1.312 . . . . 0.0 113.437 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 156.06 -44.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 130.262 3.425 . . . . 0.0 112.003 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -57.97 -25.18 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.058 1.743 . . . . 0.0 113.533 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -119.46 131.85 55.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.737 1.615 . . . . 0.0 107.433 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -132.09 149.68 52.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 110.174 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.69 131.23 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.3 t -120.08 153.76 35.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.882 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -105.04 114.4 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.731 0.812 . . . . 0.0 109.897 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.48 -33.62 60.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -134.42 -175.6 3.93 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.352 1.061 . . . . 0.0 112.968 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.85 -30.91 68.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.361 1.064 . . . . 0.0 113.319 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.1 p -139.81 13.72 2.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.47 1.908 . . . . 0.0 112.591 -168.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 t -129.07 123.57 32.6 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.668 1.187 . . . . 0.0 110.958 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.04 146.63 51.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.812 1.645 . . . . 0.0 109.819 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.63 119.2 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.81 107.76 19.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.737 . . . . 0.0 109.685 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.25 140.69 29.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.842 1.657 . . . . 0.0 109.998 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.39 110.49 12.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.913 0.885 . . . . 0.0 110.569 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.5 13.06 13.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.567 1.947 . . . . 0.0 113.861 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.13 135.4 3.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.1 1.76 . . . . 0.0 109.849 166.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.91 -4.44 35.05 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.651 0 C-N-CA 126.206 1.802 . . . . 0.0 115.332 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -96.75 129.67 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.406 1.483 . . . . 0.0 110.122 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.74 148.31 49.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.24 -21.55 24.27 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.666 -1.271 . . . . 0.0 113.098 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -112.71 11.65 19.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.474 1.91 . . . . 0.0 113.729 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -144.08 172.65 12.6 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.912 2.085 . . . . 0.0 110.402 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.26 156.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.237 -0.914 . . . . 0.0 110.692 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 134.25 26.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.817 0.847 . . . . 0.0 110.783 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -118.5 154.46 32.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.425 1.09 . . . . 0.0 110.281 -168.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -138.15 126.12 22.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.782 1.277 . . . . 0.0 110.984 -166.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -96.92 44.01 1.06 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.287 1.041 . . . . 0.0 112.647 -165.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.57 137.6 3.84 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.72 1.628 . . . . 0.0 110.778 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -61.32 133.93 56.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.925 0.89 . . . . 0.0 109.6 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 83.94 27.5 0.09 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.913 2.085 . . . . 0.0 113.058 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.79 59.0 4.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.242 1.417 . . . . 0.0 113.154 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.3 p -128.05 -174.06 3.1 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.98 1.712 . . . . 0.0 112.032 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.6 -98.62 1.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.861 1.219 . . . . 0.0 112.634 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.2 175.97 8.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.205 1.402 . . . . 0.0 110.753 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -133.42 158.61 42.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 111.228 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.58 152.33 37.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.963 1.305 . . . . 0.0 110.491 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.49 140.96 52.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.768 0.827 . . . . 0.0 111.731 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -137.9 134.24 34.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.255 1.422 . . . . 0.0 110.393 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.71 159.37 20.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.727 0.811 . . . . 0.0 111.577 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 155.27 13.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.036 -0.415 . . . . 0.0 112.051 168.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.57 93.95 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.736 0.684 . . . . 0.0 113.254 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -125.16 124.34 41.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.448 1.099 . . . . 0.0 110.731 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -122.62 124.18 42.88 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 108.481 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.74 133.52 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.521 1.153 . . . . 0.0 109.858 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -114.51 83.69 1.93 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.649 1.98 . . . . 0.0 107.922 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.2 167.35 14.41 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.999 0.904 . . . . 0.0 111.382 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -117.96 159.81 22.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 109.807 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -17.97 63.63 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -36.24 73.55 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.052 1.31 . . . . 0.0 114.191 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -76.96 110.73 11.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.496 1.148 . . . . 0.0 109.345 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -24.31 66.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.182 -1.574 . . . . 0.0 112.563 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -61.47 -21.66 64.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.734 1.614 . . . . 0.0 112.363 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -71.88 -53.93 11.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.642 1.177 . . . . 0.0 112.243 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -24.29 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -55.05 -27.62 46.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.023 1.729 . . . . 0.0 114.467 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -51.2 108.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.435 1.016 . . . . 0.0 111.707 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.9 tpt -132.35 -29.03 1.62 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.028 0.931 . . . . 0.0 112.663 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.9 m -139.33 164.24 30.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.643 2.377 . . . . 0.0 109.438 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.5 163.26 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.43 1.092 . . . . 0.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pp -146.75 148.86 32.39 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 123.17 1.462 . . . . 0.0 111.326 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.04 133.33 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.086 1.754 . . . . 0.0 107.803 -167.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.44 -92.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.181 1.372 . . . . 0.0 116.002 -168.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -170.25 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.111 1.364 . . . . 0.0 113.772 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -122.11 28.17 7.65 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.679 1.992 . . . . 0.0 111.841 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -145.24 146.75 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.874 2.07 . . . . 0.0 109.375 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.43 149.78 38.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 109.138 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.1 144.85 44.22 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.958 0.903 . . . . 0.0 110.49 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -122.38 135.5 54.71 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.672 1.189 . . . . 0.0 109.27 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.5 mt -118.39 126.4 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.153 1.381 . . . . 0.0 108.475 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -131.59 124.74 30.61 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.062 0.945 . . . . 0.0 110.572 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -26.59 11.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.863 1.265 . . . . 0.0 111.809 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.38 150.68 34.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.828 1.251 . . . . 0.0 110.759 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -142.77 103.6 4.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.842 1.257 . . . . 0.0 109.027 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.73 155.29 19.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.286 1.434 . . . . 0.0 109.88 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.34 27.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.525 1.53 . . . . 0.0 111.764 -168.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.2 -29.68 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.92 2.088 . . . . 0.0 111.37 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 t -54.44 122.19 36.69 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.027 0.931 . . . . 0.0 112.566 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.97 -15.26 10.6 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.791 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 t -82.77 113.2 43.5 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.11 0.868 . . . . 0.0 110.174 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.8 127.53 14.69 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.107 1.204 . . . . 0.0 109.055 174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.08 -113.91 0.62 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.67 115.02 18.1 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 109.621 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.17 143.29 34.14 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.337 2.255 . . . . 0.0 107.882 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -158.64 166.71 31.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.608 1.163 . . . . 0.0 110.015 166.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -126.72 104.99 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 108.48 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.73 124.89 21.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.58 153.86 2.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.88 -18.77 14.4 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.62 126.49 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 160.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.14 164.32 0.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.927 2.091 . . . . 0.0 111.364 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.8 m -112.69 131.54 55.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 0.0 109.036 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -124.71 98.73 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.764 1.625 . . . . 0.0 107.571 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -112.39 17.57 19.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.246 1.018 . . . . 0.0 111.886 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -156.69 66.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.838 1.655 . . . . 0.0 110.803 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.0 31.22 1.28 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.161 -0.962 . . . . 0.0 111.874 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.3 m -56.58 -28.39 60.16 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 119.995 -1.691 . . . . 0.0 113.038 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -60.28 -26.66 66.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.711 -1.243 . . . . 0.0 114.106 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.63 -23.32 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.786 1.234 . . . . 0.0 112.484 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 55.41 50.42 14.83 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.672 1.989 . . . . 0.0 113.464 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.22 -170.49 44.69 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.529 -0.732 . . . . 0.0 111.31 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -175.0 5.16 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.66 -1.494 . . . . 0.0 111.987 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -135.02 -27.93 1.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.35 135.28 46.06 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.536 -0.728 . . . . 0.0 110.006 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.86 131.24 52.42 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.503 1.521 . . . . 0.0 108.945 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.31 137.78 54.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.397 0.618 . . . . 0.0 109.635 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.81 116.65 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 125.637 1.575 . . . . 0.0 106.879 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.69 130.39 24.48 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 109.352 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.12 162.07 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.753 1.636 . . . . 0.0 112.871 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.16 2.09 4.36 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.803 1.668 . . . . 0.0 116.029 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.28 -18.41 32.1 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.238 1.415 . . . . 0.0 113.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -132.75 161.05 35.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.763 1.625 . . . . 0.0 110.153 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -93.55 -55.19 3.36 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -139.99 164.34 30.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.615 1.566 . . . . 0.0 109.145 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 163.63 32.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.524 0.73 . . . . 0.0 109.4 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.407 HG21 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -135.5 142.59 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.151 0.58 . . . . 0.0 109.505 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.92 139.27 33.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.271 0.558 . . . . 0.0 110.479 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.55 137.14 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.479 1.111 . . . . 0.0 109.773 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -136.79 153.93 50.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.787 0.835 . . . . 0.0 111.111 -178.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.83 137.75 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 108.789 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -109.87 119.16 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.625 1.17 . . . . 0.0 109.346 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -63.62 89.67 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.433 1.893 . . . . 0.0 112.877 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.84 10.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.454 1.101 . . . . 0.0 112.987 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -80.69 -70.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.133 1.373 . . . . 0.0 110.508 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.23 169.42 8.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.477 1.511 . . . . 0.0 110.729 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.6 t -83.99 -47.45 10.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.957 0.503 . . . . 0.0 112.347 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -61.32 -39.13 89.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 41.44 -148.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.123 1.369 . . . . 0.0 112.271 -170.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.91 26.52 55.12 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 120.927 -1.108 . . . . 0.0 114.137 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.0 m -138.19 15.64 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.468 1.507 . . . . 0.0 114.622 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -133.71 114.26 13.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.542 1.537 . . . . 0.0 110.624 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -111.12 114.43 27.69 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.606 0.762 . . . . 0.0 110.495 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -107.47 117.98 35.53 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.786 2.034 . . . . 0.0 110.161 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -108.13 126.43 52.75 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.1 pt -118.19 140.3 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 110.056 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 m -145.24 93.98 5.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.188 0.995 . . . . 0.0 109.107 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.94 168.49 18.66 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.372 2.048 . . . . 0.0 112.627 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -35.91 101.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.771 2.428 . . . . 0.0 113.65 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.306 2.7 pp0? 42.15 42.08 2.31 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.619 2.367 . . . . 0.0 116.61 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.45 156.8 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.021 1.729 . . . . 0.0 112.099 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -52.33 119.88 4.92 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.219 1.808 . . . . 0.0 112.62 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 142.87 56.37 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.592 0.757 . . . . 0.0 111.513 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.14 117.66 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.624 1.17 . . . . 0.0 110.615 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.73 102.18 13.41 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.209 1.004 . . . . 0.0 110.059 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 3.9 t -93.5 152.16 19.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.51 0.724 . . . . 0.0 110.333 170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -143.49 146.88 33.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.511 1.124 . . . . 0.0 109.289 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -54.9 85.57 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.106 . . . . 0.0 114.052 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.63 -21.44 1.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.547 1.546 . . . . 0.0 113.463 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.66 135.45 56.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.32 1.06 . . . . 0.0 110.602 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.15 64.02 3.22 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.213 1.005 . . . . 0.0 111.725 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.41 ' CZ ' ' HE3' ' A' ' 103' ' ' LYS . 6.5 m-85 60.54 81.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.0 2.12 . . . . 0.0 111.423 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.79 131.97 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.15 -0.969 . . . . 0.0 110.403 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 136.89 32.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 110.515 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.12 98.64 48.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.573 1.949 . . . . 0.0 108.873 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -71.63 138.34 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.717 2.278 . . . . 0.0 111.409 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.49 126.93 22.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 108.541 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.86 167.18 23.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.723 2.949 . . . . 0.0 111.942 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -61.71 122.04 14.34 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.572 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.06 153.02 47.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.351 2.261 . . . . 0.0 109.438 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 t -137.86 136.05 19.48 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.575 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.76 150.41 65.26 Favored 'Cis proline' 0 CA--C 1.548 1.18 0 CA-C-N 119.771 0.954 . . . . 0.0 112.471 -7.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.47 -29.09 62.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.295 1.996 . . . . 0.0 112.494 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.47 3.75 15.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.266 1.427 . . . . 0.0 113.786 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.7 p -67.97 147.7 52.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.138 1.335 . . . . 0.0 112.198 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.15 121.09 16.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.889 0.875 . . . . 0.0 110.829 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.0 tt -109.54 116.51 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.819 0.848 . . . . 0.0 110.668 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.15 142.68 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.0 0.52 . . . . 0.0 109.808 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.6 t -144.63 137.83 26.96 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.982 0.913 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -99.85 139.19 35.88 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.232 0.539 . . . . 0.0 109.55 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.27 124.41 47.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.842 2.057 . . . . 0.0 107.643 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 113.77 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 2.0 p -124.23 140.64 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.181 1.392 . . . . 0.0 108.969 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -139.84 156.45 46.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.056 0.942 . . . . 0.0 111.524 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -65.24 134.34 53.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.2 p -71.96 -8.55 55.13 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.94 10.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.35 2.26 . . . . 0.0 110.383 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.9 t -40.09 134.59 1.43 Allowed Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 125.729 1.612 . . . . 0.0 114.212 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.65 2.36 21.03 Favored 'Cis proline' 0 CA--C 1.546 1.105 0 N-CA-C 114.854 1.059 . . . . 0.0 114.854 3.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 6.89 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.84 2.056 . . . . 0.0 114.243 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.13 156.41 38.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.911 1.285 . . . . 0.0 111.735 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -55.21 143.29 28.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.908 0.883 . . . . 0.0 111.802 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.75 -23.01 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.487 1.515 . . . . 0.0 112.205 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.431 ' CG2' HD22 ' A' ' 194' ' ' ASN . 75.2 t -155.89 141.82 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.75 1.62 . . . . 0.0 108.324 171.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -136.81 113.68 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.676 1.99 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.19 -179.11 39.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.139 0.876 . . . . 0.0 111.993 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.49 149.0 44.96 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.921 -0.752 . . . . 0.0 110.934 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.0 p -138.81 159.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.087 1.355 . . . . 0.0 109.133 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -115.43 130.73 56.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 109.917 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -104.91 152.31 22.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 0.0 109.521 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -149.86 162.86 39.49 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.759 2.024 . . . . 0.0 110.578 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -133.7 123.52 25.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.574 1.55 . . . . 0.0 108.93 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.8 m -77.82 112.51 25.32 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.367 0.667 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.4 54.05 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.542 3.494 . . . . 0.0 112.072 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.3 m -136.92 -52.65 0.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.262 1.425 . . . . 0.0 111.273 -170.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 32.1 p -130.26 12.91 5.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.235 1.414 . . . . 0.0 112.551 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.66 28.81 72.89 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.084 1.326 . . . . 0.0 113.626 -171.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -68.34 156.37 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.476 -1.014 . . . . 0.0 111.141 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -136.02 131.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.8 m -135.53 132.17 36.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.206 1.403 . . . . 0.0 109.23 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.02 117.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.26 1.024 . . . . 0.0 110.255 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -88.64 128.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 134.94 25.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.973 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -148.78 143.91 26.67 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.77 1.628 . . . . 0.0 109.678 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.17 -14.93 4.61 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.11 1.364 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -52.31 -30.43 28.27 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.324 1.85 . . . . 0.0 114.409 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 16.7 p -149.49 -34.72 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.705 1.602 . . . . 0.0 113.623 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -72.88 133.43 82.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 111.608 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.68 130.2 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.545 2.83 . . . . 0.0 111.546 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -73.56 -20.09 60.72 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.431 HD22 ' CG2' ' A' ' 167' ' ' VAL . 0.8 OUTLIER -74.86 -13.04 60.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.29 1.036 . . . . 0.0 113.493 177.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.8 mtp -112.53 150.91 30.63 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.515 1.526 . . . . 0.0 108.828 167.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.1 p -142.21 118.28 10.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.238 0.615 . . . . 0.0 109.614 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.17 107.92 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.486 0.66 . . . . 0.0 109.708 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 95.2 m -88.11 143.82 26.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.555 0.693 . . . . 0.0 109.753 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.26 71.14 10.66 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.72 1.208 . . . . 0.0 110.408 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.43 -42.78 64.4 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.301 1.44 . . . . 0.0 113.259 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.08 -177.38 6.54 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.076 1.75 . . . . 0.0 110.991 163.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -50.91 143.45 10.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.256 -1.528 . . . . 0.0 109.574 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 29.9 p 53.13 14.96 0.54 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 t -139.88 108.92 6.03 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.865 1.666 . . . . 0.0 110.958 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 100' ' ' VAL . 22.3 m-85 -120.76 147.62 45.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.177 0.991 . . . . 0.0 111.128 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . 0.272 9.8 tt -133.84 99.08 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 122.51 1.148 . . . . 0.0 110.513 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -73.36 109.91 7.25 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.305 1.842 . . . . 0.0 110.11 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -81.04 138.21 36.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.9 tp -132.07 111.65 11.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.37 1.068 . . . . 0.0 108.667 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -120.73 -3.38 9.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.432 1.493 . . . . 0.0 114.609 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -141.18 -178.55 5.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.012 1.325 . . . . 0.0 111.502 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.1 46.67 0.99 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.082 0.944 . . . . 0.0 113.181 -170.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt . . . . . 0 C--O 1.258 1.531 0 C-N-CA 128.214 2.606 . . . . 0.0 116.986 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.79 138.51 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.724 1.209 . . . . 0.0 110.291 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.58 140.57 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.15 -16.4 32.27 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.845 -1.159 . . . . 0.0 113.109 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.77 9.89 11.49 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 112.45 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -148.17 171.72 15.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.622 1.969 . . . . 0.0 110.738 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.27 150.99 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 O-C-N 121.035 -1.041 . . . . 0.0 112.412 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -149.64 151.14 33.25 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.807 -0.558 . . . . 0.0 109.631 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.6 159.4 42.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.741 -0.6 . . . . 0.0 110.877 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -130.86 136.46 48.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.223 1.009 . . . . 0.0 111.054 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.63 63.35 3.4 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.732 1.613 . . . . 0.0 111.287 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.47 135.72 1.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.686 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -58.58 126.73 28.82 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 90.28 22.7 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.735 2.414 . . . . 0.0 112.268 -174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.39 55.1 0.86 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.254 1.421 . . . . 0.0 111.408 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.8 p -129.24 -178.78 4.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.682 1.593 . . . . 0.0 112.367 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.95 -107.31 2.15 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.651 1.12 . . . . 0.0 113.773 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.0 167.87 9.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.9 p -133.7 152.22 51.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.835 0.854 . . . . 0.0 112.589 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.49 150.48 29.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -141.97 140.75 32.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.082 0.953 . . . . 0.0 110.734 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -145.52 142.5 29.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.364 1.066 . . . . 0.0 109.277 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.97 163.89 26.6 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.749 -1.219 . . . . 0.0 112.09 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.11 161.31 28.95 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.196 -0.94 . . . . 0.0 111.326 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.22 43.65 70.12 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 114.644 0.617 . . . . 0.0 114.644 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 169.88 19.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.438 1.495 . . . . 0.0 111.616 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.4 p -138.95 143.44 38.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.976 0.91 . . . . 0.0 111.502 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.59 129.15 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.149 0.979 . . . . 0.0 110.556 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.21 90.53 3.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.756 1.223 . . . . 0.0 108.921 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.42 166.42 14.62 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.973 0.892 . . . . 0.0 111.346 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -111.8 153.42 26.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.6 0.76 . . . . 0.0 110.163 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.92 57.43 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.65 73.59 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.815 1.198 . . . . 0.0 114.411 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -91.91 112.49 24.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.863 0.831 . . . . 0.0 109.381 167.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -21.75 33.9 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.529 -0.732 . . . . 0.0 111.494 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -61.32 -11.65 10.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.358 1.463 . . . . 0.0 112.533 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -67.32 -52.05 45.12 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.444 -1.41 . . . . 0.0 111.392 167.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.09 -10.7 55.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.509 1.524 . . . . 0.0 112.883 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.97 -27.09 63.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.838 1.655 . . . . 0.0 113.313 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -58.43 104.66 0.23 Allowed 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.63 -1.294 . . . . 0.0 111.671 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -27.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.917 1.687 . . . . 0.0 112.438 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 t -142.12 137.17 30.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.474 1.91 . . . . 0.0 111.173 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.73 120.06 13.04 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.462 1.125 . . . . 0.0 112.178 -173.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.46 112.97 24.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.894 1.678 . . . . 0.0 109.839 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 140.62 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.724 1.209 . . . . 0.0 109.429 173.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.05 -116.78 0.03 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.02 1.295 . . . . 0.0 114.552 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.7 m -147.08 -13.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.666 1.186 . . . . 0.0 113.024 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 36.03 3.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.493 1.517 . . . . 0.0 110.392 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.22 118.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.7 1.6 . . . . 0.0 110.959 -168.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -95.77 140.53 30.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.55 1.14 . . . . 0.0 110.652 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 51.6 m -125.79 112.93 16.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 108.916 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -109.25 134.6 51.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.45 144.04 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.437 0.637 . . . . 0.0 111.839 -171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -142.14 142.06 32.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.37 -166.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -118.62 -29.53 5.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.779 0.832 . . . . 0.0 111.588 -170.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.11 130.59 25.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.411 1.484 . . . . 0.0 111.85 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.93 121.53 41.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.192 0.597 . . . . 0.0 110.967 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -165.81 170.32 14.02 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 0.0 110.953 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.82 21.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.172 1.389 . . . . 0.0 111.539 -169.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.75 -17.19 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.808 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.2 t -41.81 138.88 1.7 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.427 1.491 . . . . 0.0 114.908 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.56 -9.05 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.445 2.763 . . . . 0.0 112.71 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -143.79 115.08 5.58 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.533 1.133 . . . . 0.0 111.52 172.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 49.62 1.92 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.388 2.726 . . . . 0.0 112.033 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 31.66 -107.41 0.02 OUTLIER Glycine 0 CA--C 1.527 0.827 0 C-N-CA 129.008 3.194 . . . . 0.0 114.548 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -123.44 144.64 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.016 0.926 . . . . 0.0 110.252 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.56 153.98 40.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.96 1.704 . . . . 0.0 110.259 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -161.86 153.99 19.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.734 0.814 . . . . 0.0 110.86 167.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.1 93.75 4.25 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.942 1.297 . . . . 0.0 109.172 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.74 134.81 57.45 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 176.3 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.54 -18.65 65.48 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.535 -1.353 . . . . 0.0 113.113 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 111.71 0.5 Allowed Glycine 0 CA--C 1.536 1.36 0 CA-C-N 119.028 0.831 . . . . 0.0 113.357 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 175.46 162.47 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.728 2.411 . . . . 0.0 111.023 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -109.28 142.53 40.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.018 1.327 . . . . 0.0 110.743 171.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -134.18 136.29 43.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.698 1.199 . . . . 0.0 108.676 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -150.24 -50.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.929 0.892 . . . . 0.0 111.374 -170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -81.23 46.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.981 1.312 . . . . 0.0 113.413 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.01 42.61 0.09 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.216 1.406 . . . . 0.0 113.433 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -60.29 -34.69 74.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 112.713 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -65.91 -26.42 67.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.6 mm -72.6 -38.91 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.397 1.079 . . . . 0.0 110.262 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.82 32.6 22.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.714 1.606 . . . . 0.0 113.297 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.14 39.8 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.216 1.389 . . . . 0.0 113.411 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -176.29 3.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 112.399 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -140.53 -31.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.0 136.77 37.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.194 0.998 . . . . 0.0 110.153 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.44 133.86 21.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.78 0.8 . . . . 0.0 110.093 -168.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.32 138.54 53.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.72 -170.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.78 121.92 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.33 135.57 27.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.143 0.577 . . . . 0.0 110.313 -166.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.44 152.59 34.39 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.04 1.827 . . . . 0.0 111.021 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.37 29.13 0.21 Allowed Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.851 1.691 . . . . 0.0 116.121 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.69 -18.23 3.92 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.605 1.962 . . . . 0.0 112.654 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -119.25 156.24 30.29 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.941 0.897 . . . . 0.0 110.167 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -88.24 -41.91 12.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.491 -0.755 . . . . 0.0 111.966 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -150.14 167.64 26.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.143 2.177 . . . . 0.0 108.561 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.63 166.55 23.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.668 -0.645 . . . . 0.0 110.72 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.92 149.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.238 0.615 . . . . 0.0 111.579 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.95 118.17 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.54 130.32 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.803 0.841 . . . . 0.0 111.326 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -127.6 145.58 50.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.39 1.076 . . . . 0.0 110.65 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.14 147.46 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 123.808 0.692 . . . . 0.0 111.651 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.69 127.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.312 1.054 . . . . 0.0 110.132 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -64.03 125.54 24.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.561 1.544 . . . . 0.0 112.242 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -35.14 2.48 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.63 -35.86 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.492 1.117 . . . . 0.0 113.383 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -120.33 139.96 51.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.039 1.336 . . . . 0.0 109.05 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -87.15 6.81 30.98 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.955 -1.091 . . . . 0.0 113.181 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -88.66 -33.65 17.52 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 48.44 -167.35 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.37 17.13 55.95 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 p -141.25 5.95 1.9 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.43 1.115 . . . . 0.0 113.247 -162.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -113.32 152.01 30.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.242 1.017 . . . . 0.0 112.7 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -127.81 134.76 49.47 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.248 1.419 . . . . 0.0 109.454 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -124.37 139.83 53.53 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.817 -0.552 . . . . 0.0 110.94 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -135.63 119.26 17.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.971 1.309 . . . . 0.0 109.404 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.91 115.15 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 108.968 -170.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.8 m -122.96 92.18 49.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.019 0.528 . . . . 0.0 112.123 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.48 169.52 21.57 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.232 2.621 . . . . 0.0 113.249 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.2 57.71 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.135 1.774 . . . . 0.0 115.269 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.82 -53.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 161.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.0 158.86 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.33 1.052 . . . . 0.0 111.716 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -154.52 -165.2 2.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.239 1.415 . . . . 0.0 110.182 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 56.88 58.79 3.83 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 122.52 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.562 1.945 . . . . 0.0 109.957 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.45 112.43 11.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.631 0.772 . . . . 0.0 110.069 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.7 t -97.48 137.55 36.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.682 0.393 . . . . 0.0 110.278 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -104.11 143.34 33.05 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.181 0.992 . . . . 0.0 109.932 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -56.19 131.62 48.31 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 121.962 -0.461 . . . . 0.0 110.984 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.84 8.66 44.9 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.823 1.202 . . . . 0.0 115.356 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.17 155.74 19.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.127 0.963 . . . . 0.0 112.354 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.44 49.55 1.17 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.51 1.124 . . . . 0.0 113.199 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 60.48 104.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.362 2.265 . . . . 0.0 112.44 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.28 141.0 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 134.25 35.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.745 0.784 . . . . 0.0 112.104 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 102.13 50.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 169.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.63 121.22 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.046 1.83 . . . . 0.0 111.827 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.8 mm -99.76 123.04 49.07 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.368 1.067 . . . . 0.0 110.106 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.99 178.47 7.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.811 2.341 . . . . 0.0 111.97 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 139.8 43.71 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.966 -1.084 . . . . 0.0 113.227 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.16 152.11 29.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.441 1.497 . . . . 0.0 111.724 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -145.14 135.69 12.1 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.215 1.406 . . . . 0.0 110.396 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.03 146.33 68.11 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 120.045 1.052 . . . . 0.0 110.782 -7.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.68 -31.05 33.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.502 2.135 . . . . 0.0 111.393 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.72 5.86 4.51 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.744 1.618 . . . . 0.0 114.979 168.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.5 t -77.1 149.16 35.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.104 0.866 . . . . 0.0 111.74 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.434 0.694 . . . . 0.0 111.374 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 tt -106.0 121.72 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.441 1.096 . . . . 0.0 110.912 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.75 135.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.068 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.4 p -143.2 127.75 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.548 0.689 . . . . 0.0 111.485 169.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 140.77 42.2 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.49 111.12 11.99 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.652 1.215 . . . . 0.0 109.425 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 p -109.06 144.09 37.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.634 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.34 133.57 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -138.9 147.8 42.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.755 1.222 . . . . 0.0 109.23 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -67.14 115.14 6.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.453 -0.78 . . . . 0.0 110.006 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -65.08 -16.78 63.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.339 1.056 . . . . 0.0 112.528 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -114.37 156.7 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 110.794 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 t -69.83 138.99 88.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.491 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.66 129.11 16.51 Favored 'Cis proline' 0 C--N 1.355 0.912 0 CA-C-N 120.721 1.293 . . . . 0.0 110.374 -5.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -76.0 36.68 0.14 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.174 1.39 . . . . 0.0 113.457 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 146.83 52.95 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.046 -1.659 . . . . 0.0 113.158 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -69.62 127.25 32.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.435 0.694 . . . . 0.0 111.01 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 -50.49 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 112.205 -171.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 24.4 m -146.57 139.18 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.884 1.274 . . . . 0.0 109.574 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -130.39 98.29 4.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.465 1.506 . . . . 0.0 108.019 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.05 11.46 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.326 1.441 . . . . 0.0 113.193 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.8 m -135.41 153.72 51.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.801 0.84 . . . . 0.0 111.502 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.51 165.09 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.682 1.593 . . . . 0.0 108.849 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.5 126.89 38.01 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.03 150.89 23.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.456 -0.777 . . . . 0.0 110.414 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -145.31 162.34 37.44 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 125.185 1.394 . . . . 0.0 108.344 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 170.11 19.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 169.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 178' ' ' THR . 71.5 m -133.64 105.52 11.86 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.63 0.772 . . . . 0.0 109.026 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 18.77 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.26 3.306 . . . . 0.0 113.037 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 176' ' ' SER . 84.8 m -63.65 -34.06 77.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.008 1.723 . . . . 0.0 112.5 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 t -164.3 26.83 0.07 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 123.176 1.465 . . . . 0.0 112.4 -173.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 60.59 27.99 67.01 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 119.259 -2.151 . . . . 0.0 113.778 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -79.07 142.89 36.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.69 0.745 . . . . 0.0 111.191 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.49 160.67 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.061 0.545 . . . . 0.0 111.414 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.4 m -148.99 129.98 14.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.901 1.28 . . . . 0.0 111.118 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.91 128.07 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.392 0.542 . . . . 0.0 110.433 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.41 130.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.361 1.077 . . . . 0.0 108.612 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.67 135.94 22.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 109.044 -176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -144.43 145.08 31.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.311 1.444 . . . . 0.0 109.693 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.57 -16.7 6.53 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.331 1.452 . . . . 0.0 113.786 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.4 -24.03 64.83 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.9 p -144.7 -30.2 0.45 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.121 1.369 . . . . 0.0 113.727 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -79.42 144.51 61.83 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.895 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.78 158.84 52.24 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.04 1.827 . . . . 0.0 112.284 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -93.65 -2.08 54.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -109.48 -16.47 13.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.135 1.374 . . . . 0.0 113.517 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.1 ttt -134.34 134.13 41.45 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.797 1.239 . . . . 0.0 107.966 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.3 p -136.73 153.36 50.88 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.86 138.61 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.039 0.536 . . . . 0.0 111.039 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 52.2 m -127.12 143.73 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.803 1.241 . . . . 0.0 109.4 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -75.03 85.42 2.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.468 0.652 . . . . 0.0 110.943 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.28 -42.69 82.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.984 1.314 . . . . 0.0 112.136 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -152.26 178.5 9.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.625 1.57 . . . . 0.0 109.696 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.45 135.3 54.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.668 -1.895 . . . . 0.0 110.944 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 m 58.61 23.21 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.558 1.143 . . . . 0.0 113.054 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.13 110.91 6.2 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.591 -0.693 . . . . 0.0 110.829 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.25 145.22 42.02 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.935 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.86 116.69 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.88 0.848 . . . . 0.0 110.663 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -96.7 117.1 30.29 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.267 1.427 . . . . 0.0 110.516 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -100.01 131.89 45.69 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.594 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.49 114.42 20.67 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.89 0.768 . . . . 0.0 112.943 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -117.09 25.4 10.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.734 1.214 . . . . 0.0 113.339 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.0 m -143.74 166.81 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 52.39 1.18 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.023 2.129 . . . . 0.0 110.86 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt . . . . . 0 C--O 1.294 3.401 0 CA-C-O 115.565 -2.16 . . . . 0.0 111.186 177.519 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.191 0.519 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.91 137.97 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.97 0.908 . . . . 0.0 111.365 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.57 147.93 29.38 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.736 -0.602 . . . . 0.0 110.488 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.12 -20.31 52.42 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.839 -1.163 . . . . 0.0 113.835 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -111.2 7.93 21.4 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.501 1.92 . . . . 0.0 113.636 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -143.92 -176.09 4.85 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 110.6 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.57 154.03 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.596 0.758 . . . . 0.0 112.733 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 144.41 49.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.902 1.281 . . . . 0.0 110.309 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -132.48 129.66 39.47 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.765 1.626 . . . . 0.0 107.465 -165.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -128.29 121.43 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 123.796 1.76 . . . . 0.0 109.872 -170.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.34 59.26 5.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.735 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.57 149.19 5.78 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.592 1.568 . . . . 0.0 111.357 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.59 151.55 5.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.562 1.145 . . . . 0.0 111.957 175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 49.74 41.54 22.27 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m 50.43 63.19 2.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.465 1.506 . . . . 0.0 113.636 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 18' ' ' GLY . 3.0 m -130.25 -178.21 4.65 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.876 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 17' ' ' THR . . . 74.02 -118.83 6.13 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.078 1.323 . . . . 0.0 111.972 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.11 166.41 11.26 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 117.685 0.742 . . . . 0.0 111.509 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -126.17 146.49 49.94 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.685 1.194 . . . . 0.0 110.965 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.74 155.8 41.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.78 1.232 . . . . 0.0 110.072 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -128.28 142.3 51.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -125.63 125.14 42.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.359 1.064 . . . . 0.0 109.312 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.61 129.01 34.29 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.955 0.902 . . . . 0.0 109.509 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 144.68 25.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.475 1.11 . . . . 0.0 112.875 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.02 41.45 9.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.062 0.839 . . . . 0.0 112.939 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.13 153.45 42.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.954 1.301 . . . . 0.0 111.698 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -129.39 131.08 46.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.958 1.303 . . . . 0.0 109.037 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.48 128.23 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 122.579 1.18 . . . . 0.0 109.753 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.6 mtm105 -124.36 89.46 3.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.817 1.247 . . . . 0.0 109.112 -171.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -78.22 168.69 19.45 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.821 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -116.18 157.85 24.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.632 1.173 . . . . 0.0 110.096 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.63 -19.68 65.06 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.263 -0.898 . . . . 0.0 113.073 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.93 -24.05 66.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.221 1.391 . . . . 0.0 114.464 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -98.67 105.14 17.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.283 1.041 . . . . 0.0 109.244 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -21.5 60.48 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.618 -1.301 . . . . 0.0 112.625 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -61.15 -24.21 66.12 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.64 1.976 . . . . 0.0 112.399 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -64.54 -56.14 15.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.693 1.597 . . . . 0.0 111.1 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.5 -18.55 65.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.424 1.49 . . . . 0.0 113.251 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -29.62 69.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.899 2.08 . . . . 0.0 113.222 172.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.27 118.62 3.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.784 0.72 . . . . 0.0 110.259 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 mmm -146.12 -16.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.126 0.97 . . . . 0.0 113.435 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.7 m -136.9 151.79 49.48 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 110.783 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.55 155.77 22.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.641 1.176 . . . . 0.0 110.743 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.7 121.7 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -92.23 136.69 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.352 0.661 . . . . 0.0 110.137 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -106.02 0.01 OUTLIER Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.85 2.166 . . . . 0.0 115.823 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -161.27 -21.78 0.05 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.794 1.638 . . . . 0.0 112.866 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.14 33.14 4.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.622 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.8 121.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.111 1.765 . . . . 0.0 110.109 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -84.69 145.63 27.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.856 -1.153 . . . . 0.0 109.558 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 58.5 m -126.65 147.82 49.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.594 -0.692 . . . . 0.0 110.771 173.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.85 140.09 52.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.667 0.787 . . . . 0.0 109.451 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 mt -122.44 138.14 53.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.454 1.102 . . . . 0.0 109.362 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -152.7 120.49 6.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.663 0.785 . . . . 0.0 112.379 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -83.51 -60.95 1.97 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.7 175.02 5.64 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.543 -0.723 . . . . 0.0 110.986 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -153.92 134.48 13.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.927 0.891 . . . . 0.0 110.31 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -164.8 155.09 14.01 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.314 1.445 . . . . 0.0 110.461 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.35 41.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 111.177 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.09 -34.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.148 1.779 . . . . 0.0 111.606 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 t -56.08 134.5 74.4 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.597 1.159 . . . . 0.0 113.251 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.1 -18.96 9.73 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.095 2.53 . . . . 0.0 113.312 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 t -101.74 130.64 24.14 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.503 1.121 . . . . 0.0 110.637 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.04 174.67 11.61 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.356 2.038 . . . . 0.0 111.657 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.89 -151.64 19.73 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 124.576 1.084 . . . . 0.0 112.558 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 109.01 18.91 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.057 0.543 . . . . 0.0 110.329 168.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.7 148.71 41.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.988 1.315 . . . . 0.0 110.169 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -162.49 137.65 6.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.753 0.821 . . . . 0.0 109.51 168.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -87.91 110.36 20.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 165.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.74 125.7 26.67 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.366 -0.834 . . . . 0.0 109.016 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.85 150.2 5.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.798 1.239 . . . . 0.0 112.181 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -15.49 6.35 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.18 104.86 0.26 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 112.143 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.47 160.62 3.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.98 1.712 . . . . 0.0 111.993 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.7 m -113.98 143.66 44.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.013 1.325 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -141.44 112.54 7.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.606 1.163 . . . . 0.0 109.928 -164.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -126.44 -32.72 2.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.48 1.112 . . . . 0.0 112.379 -170.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -96.58 59.33 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.276 2.63 . . . . 0.0 109.621 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.72 52.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.186 1.394 . . . . 0.0 111.629 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.8 m -62.33 -42.54 99.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.176 -1.578 . . . . 0.0 111.547 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -59.46 -28.21 66.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.004 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -128.95 54.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.418 1.887 . . . . 0.0 108.513 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -65.0 -15.63 62.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.685 1.194 . . . . 0.0 113.401 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.38 20.1 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.014 1.292 . . . . 0.0 109.881 155.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.07 150.28 43.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.205 1.802 . . . . 0.0 108.452 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -118.53 -42.59 2.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.303 0.641 . . . . 0.0 112.635 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.06 156.36 46.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.893 1.277 . . . . 0.0 111.73 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 52' ' ' CYS . 8.4 t80 -145.97 150.54 36.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.33 1.052 . . . . 0.0 111.458 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.35 129.67 27.43 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.403 1.081 . . . . 0.0 110.949 172.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.93 125.18 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.096 1.358 . . . . 0.0 109.209 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.93 147.67 57.38 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.06 1.344 . . . . 0.0 110.644 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.99 -177.03 1.16 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.261 3.307 . . . . 0.0 113.997 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.91 14.88 4.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.022 1.772 . . . . 0.0 114.144 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.7 -47.98 2.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.562 1.945 . . . . 0.0 110.34 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -91.44 157.9 16.8 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.49 1.116 . . . . 0.0 111.146 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -127.66 -37.06 2.0 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.948 1.299 . . . . 0.0 111.958 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -141.64 167.13 22.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.882 2.073 . . . . 0.0 108.066 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.7 159.6 41.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 109.793 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.65 130.05 59.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.082 0.953 . . . . 0.0 109.237 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -82.89 127.68 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.873 0.869 . . . . 0.0 108.816 172.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -119.58 144.6 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.747 0.819 . . . . 0.0 109.296 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -144.41 133.85 23.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.677 0.791 . . . . 0.0 109.826 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.0 pt -78.81 148.75 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.726 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -141.94 120.49 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.593 1.957 . . . . 0.0 107.542 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.15 110.93 4.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.471 0.708 . . . . 0.0 110.57 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 19.29 20.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.49 1.116 . . . . 0.0 112.379 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.8 t -126.45 -69.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.145 1.378 . . . . 0.0 111.597 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -89.08 134.61 33.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.442 0.697 . . . . 0.0 109.425 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -79.77 34.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.825 -1.172 . . . . 0.0 112.573 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 m -138.54 52.85 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.063 2.545 . . . . 0.0 108.536 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.23 144.35 41.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 166.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.09 6.34 4.91 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.362 1.458 . . . . 0.0 114.343 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.5 m -141.55 25.52 2.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.605 1.562 . . . . 0.0 113.388 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -128.82 136.72 50.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.278 1.831 . . . . 0.0 109.149 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.63 121.76 43.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.772 1.229 . . . . 0.0 109.683 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -105.23 144.9 31.38 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.0 0.92 . . . . 0.0 110.245 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -137.82 106.8 5.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.093 1.357 . . . . 0.0 107.348 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.4 tt -103.81 131.45 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 109.507 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.7 m -129.95 86.7 53.97 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.958 1.703 . . . . 0.0 109.043 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.28 163.95 35.95 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.422 2.748 . . . . 0.0 112.265 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -31.67 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.715 2.406 . . . . 0.0 114.39 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 34.01 36.15 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.693 2.397 . . . . 0.0 116.37 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -104.26 155.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.69 1.596 . . . . 0.0 109.999 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -48.9 100.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.852 1.661 . . . . 0.0 111.996 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -59.18 165.2 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.255 1.026 . . . . 0.0 111.435 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.2 136.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.101 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.64 123.6 42.31 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.19 168.02 20.6 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.438 0.695 . . . . 0.0 111.111 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -132.46 155.64 48.17 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.34 1.056 . . . . 0.0 110.323 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.56 116.54 1.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.41 . . . . 0.0 111.79 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.69 15.86 19.31 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -171.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.03 160.62 14.7 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.51 1.124 . . . . 0.0 113.712 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.57 50.02 1.89 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.262 1.425 . . . . 0.0 112.325 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 59.81 78.66 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.186 1.794 . . . . 0.0 111.823 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.1 t -40.92 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.068 1.747 . . . . 0.0 112.452 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -81.99 95.84 7.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 111.72 31.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.98 137.29 13.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.586 2.191 . . . . 0.0 112.008 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.5 mt -128.65 128.47 23.53 Favored Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 121.654 -0.654 . . . . 0.0 110.242 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.91 174.78 11.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.431 2.754 . . . . 0.0 113.38 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -60.33 134.98 57.58 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.737 -0.602 . . . . 0.0 109.951 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.39 146.15 49.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.176 1.39 . . . . 0.0 108.567 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.2 m -131.29 126.8 21.55 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 123.942 0.897 . . . . 0.0 110.216 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.44 155.82 81.93 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 119.008 0.681 . . . . 0.0 111.447 -5.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.0 -24.82 32.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.468 1.445 . . . . 0.0 113.364 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -72.22 -5.94 39.36 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 168.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 160.13 33.11 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.742 1.258 . . . . 0.0 112.935 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -103.14 162.68 12.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.15 1.38 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tt -129.1 132.26 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.638 1.975 . . . . 0.0 109.193 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.56 136.08 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.038 0.935 . . . . 0.0 111.126 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.3 t -143.72 150.11 38.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -112.29 136.69 51.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.019 1.328 . . . . 0.0 109.32 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.55 118.83 22.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.297 1.039 . . . . 0.0 109.166 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 t -125.64 123.04 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.233 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.03 140.4 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.027 1.331 . . . . 0.0 108.635 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -148.52 153.09 37.95 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.955 1.302 . . . . 0.0 110.379 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.65 135.71 56.2 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.058 0.543 . . . . 0.0 110.449 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -72.49 -12.85 61.26 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.458 1.103 . . . . 0.0 113.83 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -141.61 -179.09 5.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.98 2.512 . . . . 0.0 110.034 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 p -52.9 146.79 17.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.763 1.225 . . . . 0.0 113.459 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.94 3.58 17.33 Favored 'Cis proline' 0 CA--C 1.545 1.058 0 N-CA-C 114.878 1.068 . . . . 0.0 114.878 1.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.27 27.0 15.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.144 1.378 . . . . 0.0 113.026 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -80.86 139.34 36.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.054 1.342 . . . . 0.0 110.738 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -55.9 100.22 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.474 1.109 . . . . 0.0 112.232 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.49 -51.82 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.823 1.249 . . . . 0.0 110.443 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.4 t -145.36 126.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.742 1.217 . . . . 0.0 108.177 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.83 91.21 2.87 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.621 1.168 . . . . 0.0 108.361 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -150.79 -152.03 5.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.008 1.289 . . . . 0.0 111.103 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 m -143.05 170.15 16.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.749 0.785 . . . . 0.0 111.049 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.63 146.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.338 1.455 . . . . 0.0 108.52 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -101.37 143.02 31.92 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.01 154.17 33.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.331 1.052 . . . . 0.0 109.402 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -157.44 158.77 36.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.594 1.558 . . . . 0.0 108.261 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -128.36 145.32 51.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.525 0.73 . . . . 0.0 109.818 166.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.6 m -91.73 117.24 67.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 -10.07 27.76 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 2.747 . . . . 0.0 113.129 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.7 p -45.62 -38.47 6.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.088 2.155 . . . . 0.0 113.061 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.8 t -158.89 14.73 0.17 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.007 1.323 . . . . 0.0 112.933 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.39 29.91 76.37 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 119.793 -1.817 . . . . 0.0 112.882 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 160.35 31.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.705 1.202 . . . . 0.0 110.703 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.65 130.95 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.278 -0.889 . . . . 0.0 111.069 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.5 m -145.6 121.45 10.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.475 1.51 . . . . 0.0 110.13 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 1.8 m -86.71 142.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.487 0.66 . . . . 0.0 111.153 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 139.8 29.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.515 1.526 . . . . 0.0 107.927 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 123.04 18.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.788 1.235 . . . . 0.0 109.273 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -149.59 152.32 35.27 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.873 1.669 . . . . 0.0 110.046 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -17.01 5.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.98 1.312 . . . . 0.0 114.449 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.79 -26.6 58.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.665 1.586 . . . . 0.0 114.63 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.6 p -147.81 -38.8 0.19 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.623 1.569 . . . . 0.0 112.984 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -60.95 124.21 78.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.047 1.339 . . . . 0.0 110.827 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.8 -7.93 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.519 2.813 . . . . 0.0 113.554 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 65.39 -16.34 0.1 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 127.914 2.485 . . . . 0.0 115.461 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -73.52 -45.86 51.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.391 2.276 . . . . 0.0 112.716 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.7 ttt -114.17 135.78 53.66 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.219 1.008 . . . . 0.0 108.38 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -116.58 171.46 7.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.551 0.74 . . . . 0.0 109.323 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.07 131.38 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.385 -0.822 . . . . 0.0 109.689 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.4 m -109.2 132.72 53.86 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.571 1.148 . . . . 0.0 109.352 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -75.11 69.91 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.188 1.795 . . . . 0.0 110.624 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -53.96 -42.95 69.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.954 1.302 . . . . 0.0 111.848 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -160.37 178.36 9.67 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.469 1.907 . . . . 0.0 110.967 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -51.82 142.57 14.89 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.51 -1.369 . . . . 0.0 110.476 164.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.9 p 46.17 27.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.526 1.53 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.1 t -146.9 101.06 3.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.52 1.128 . . . . 0.0 111.369 -171.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -116.52 133.73 55.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.31 93.96 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -69.44 125.3 26.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.454 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -121.45 115.05 22.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.844 1.258 . . . . 0.0 111.606 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.77 108.94 7.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.366 1.466 . . . . 0.0 110.523 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -89.95 -15.37 32.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 -174.52 3.02 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.124 1.37 . . . . 0.0 111.511 171.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.99 41.04 0.65 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.632 0.254 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.11 142.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.247 1.019 . . . . 0.0 110.474 167.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.3 143.07 57.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.49 0.716 . . . . 0.0 109.944 173.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.74 -14.56 62.71 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.435 -1.416 . . . . 0.0 113.126 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -119.01 6.02 11.33 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.273 2.229 . . . . 0.0 113.384 -171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -146.9 175.05 10.95 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.127 2.171 . . . . 0.0 109.042 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.18 154.63 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.229 1.012 . . . . 0.0 110.587 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.49 143.8 31.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.18 131.74 51.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.977 1.311 . . . . 0.0 108.782 -165.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -114.8 135.02 54.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.116 1.436 . . . . 0.0 109.872 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.93 39.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.878 1.671 . . . . 0.0 111.235 -168.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.92 143.12 6.87 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.944 1.259 . . . . 0.0 111.866 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -55.46 147.65 17.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.15 0.98 . . . . 0.0 110.955 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.45 27.52 15.62 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.9 m 61.51 68.88 0.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.091 1.756 . . . . 0.0 113.101 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.1 p -131.66 -173.58 3.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.35 1.86 . . . . 0.0 111.514 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.91 -121.29 9.25 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.887 -1.133 . . . . 0.0 112.39 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.27 172.67 6.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 111.415 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.4 p -134.96 146.97 49.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 111.515 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.88 154.33 45.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.244 1.818 . . . . 0.0 109.255 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -129.98 150.73 51.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.829 0.823 . . . . 0.0 111.754 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -138.49 122.55 17.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.848 1.659 . . . . 0.0 110.341 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -68.76 128.63 37.34 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.934 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -52.41 139.63 24.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.979 0.912 . . . . 0.0 111.406 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.1 48.47 4.35 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.043 0.83 . . . . 0.0 112.896 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 177.42 9.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.113 0.965 . . . . 0.0 112.745 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 m -138.75 135.65 34.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.821 1.649 . . . . 0.0 109.155 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.28 120.65 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.265 1.826 . . . . 0.0 109.926 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -117.55 100.4 7.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.57 1.148 . . . . 0.0 108.883 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.51 173.49 7.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.28 1.032 . . . . 0.0 110.364 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -119.15 154.47 33.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -17.56 29.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.647 1.179 . . . . 0.0 113.429 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.84 -35.4 61.85 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.505 1.526 . . . . 0.0 114.477 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.43 119.84 18.22 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.795 1.298 . . . . 0.0 109.677 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.56 67.58 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.088 -1.632 . . . . 0.0 112.374 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -62.89 -25.22 68.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.541 1.536 . . . . 0.0 112.578 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.5 -56.5 10.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.524 1.53 . . . . 0.0 110.87 169.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.9 -21.51 66.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.012 1.325 . . . . 0.0 113.344 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -5.48 3.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.755 2.022 . . . . 0.0 115.336 170.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.2 139.25 1.44 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.883 0.765 . . . . 0.0 110.131 158.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tpt -160.53 -41.34 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.1 p -155.46 169.09 25.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.839 1.256 . . . . 0.0 111.386 171.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -159.54 172.71 17.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 110.814 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 141.95 50.5 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.365 1.466 . . . . 0.0 109.129 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.36 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.507 1.523 . . . . 0.0 109.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.02 -110.87 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.688 2.089 . . . . 0.0 115.42 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.5 m -152.92 -28.31 0.15 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.953 1.301 . . . . 0.0 112.9 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -113.94 31.56 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.516 1.926 . . . . 0.0 110.723 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.76 133.22 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.447 1.499 . . . . 0.0 109.548 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 154.01 21.17 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.47 -0.769 . . . . 0.0 109.858 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 104.33 6.54 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 0.0 109.365 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.98 130.47 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.806 0.843 . . . . 0.0 109.216 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.44 134.18 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 109.611 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.37 137.15 37.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 111.256 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.97 -47.27 4.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.801 1.241 . . . . 0.0 113.124 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -129.12 132.52 47.38 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.814 0.846 . . . . 0.0 109.296 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -129.65 96.42 4.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.064 1.346 . . . . 0.0 110.531 -165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.87 165.5 25.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.689 1.196 . . . . 0.0 111.658 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.34 17.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.092 1.357 . . . . 0.0 113.049 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -147.9 39.22 0.93 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.09 1.356 . . . . 0.0 111.277 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -125.94 136.63 28.72 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.68 1.192 . . . . 0.0 111.742 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.38 -18.24 16.02 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.774 2.316 . . . . 0.0 112.776 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -75.3 118.61 72.0 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.852 0.861 . . . . 0.0 109.453 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.14 86.78 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.87 2.38 . . . . 0.0 109.485 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -44.32 128.26 6.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.529 1.538 . . . . 0.0 112.852 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -57.92 125.96 25.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.69 0.757 . . . . 0.0 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -142.78 149.52 38.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.182 1.393 . . . . 0.0 108.569 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.53 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.028 0.918 . . . . 0.0 109.957 169.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.36 82.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.328 1.051 . . . . 0.0 109.046 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -43.43 125.29 3.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.326 1.45 . . . . 0.0 109.303 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.01 146.09 11.77 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.106 0.962 . . . . 0.0 112.18 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -57.82 -14.15 5.49 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.93 116.07 0.77 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.858 1.218 . . . . 0.0 111.598 160.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.34 168.85 2.76 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.298 1.839 . . . . 0.0 112.151 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.9 m -103.34 141.12 36.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.015 0.926 . . . . 0.0 109.477 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -119.35 89.27 3.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.818 1.247 . . . . 0.0 107.759 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.13 -0.64 14.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.366 1.466 . . . . 0.0 113.322 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -144.78 69.92 1.27 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.882 1.673 . . . . 0.0 109.779 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mp -92.86 10.36 31.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.6 m -52.68 -30.8 33.99 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.66 -1.275 . . . . 0.0 112.78 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -58.91 -27.45 65.27 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.9 -25.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.13 0.972 . . . . 0.0 111.424 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.7 t30 68.0 39.89 2.4 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 126.152 1.781 . . . . 0.0 113.986 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.18 153.92 30.62 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.07 -1.019 . . . . 0.0 110.932 -169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.58 148.6 31.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.033 1.333 . . . . 0.0 108.317 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.44 -40.79 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.738 1.215 . . . . 0.0 113.019 171.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -130.97 140.82 50.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.292 1.037 . . . . 0.0 110.404 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.24 142.08 50.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.911 1.285 . . . . 0.0 110.55 172.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -135.37 126.17 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.135 1.374 . . . . 0.0 107.991 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.46 107.7 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 122.487 1.137 . . . . 0.0 109.468 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.97 150.62 42.18 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.253 1.021 . . . . 0.0 109.357 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.66 27.45 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.614 3.543 . . . . 0.0 115.601 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.72 34.7 65.13 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.073 1.32 . . . . 0.0 113.792 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.46 -44.51 0.19 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.156 1.782 . . . . 0.0 110.063 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CD2' ' CB ' ' A' ' 139' ' ' PRO . 5.0 m-85 -83.1 153.1 25.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.168 1.387 . . . . 0.0 110.546 168.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -90.45 -41.12 11.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.529 1.132 . . . . 0.0 111.01 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -155.99 177.89 10.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.363 2.265 . . . . 0.0 108.784 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.47 159.43 43.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.674 0.79 . . . . 0.0 109.713 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -120.8 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.75 125.9 30.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.285 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.27 137.76 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 108.666 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -132.21 159.09 40.04 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.494 -0.754 . . . . 0.0 109.562 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.79 136.3 56.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.087 1.755 . . . . 0.0 109.009 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.43 135.61 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.718 1.207 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -91.6 117.92 30.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.659 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -109.19 4.51 22.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.622 1.169 . . . . 0.0 113.082 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.5 t -116.89 -60.98 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.299 1.44 . . . . 0.0 110.933 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.42 -20.61 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.338 1.055 . . . . 0.0 110.841 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.7 m 48.47 31.94 3.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.675 1.99 . . . . 0.0 113.846 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -127.83 31.43 5.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.123 1.769 . . . . 0.0 111.331 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -37.95 104.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.123 2.569 . . . . 0.0 113.293 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.24 10.76 0.05 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.9 p -149.36 14.87 0.89 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.306 1.442 . . . . 0.0 114.136 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -115.86 139.71 49.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.575 1.55 . . . . 0.0 108.064 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -115.12 140.75 48.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 109.067 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.45 ' HE1' ' CD1' ' A' ' 207' ' ' PHE . 1.3 ttp -134.46 127.66 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.797 0.839 . . . . 0.0 110.272 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.1 m -117.84 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.392 1.077 . . . . 0.0 109.124 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.77 122.9 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.361 1.864 . . . . 0.0 108.753 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.1 m -130.21 99.71 19.32 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.153 1.381 . . . . 0.0 110.175 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.85 169.59 18.67 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.969 3.113 . . . . 0.0 112.39 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -25.23 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.655 2.782 . . . . 0.0 113.724 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 41.53 48.9 3.53 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.97 1.708 . . . . 0.0 115.203 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.7 160.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.918 2.087 . . . . 0.0 111.362 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.85 129.12 9.31 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.762 1.625 . . . . 0.0 112.495 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -64.65 157.06 28.21 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.278 0.561 . . . . 0.0 111.505 169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.08 149.33 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 126.699 1.999 . . . . 0.0 109.701 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.44 91.79 3.72 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.978 0.911 . . . . 0.0 110.887 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.5 t -67.14 139.47 57.49 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -134.32 133.02 40.22 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.519 1.127 . . . . 0.0 108.692 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.59 129.06 40.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.412 0.685 . . . . 0.0 111.296 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.44 18.84 12.21 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.711 1.148 . . . . 0.0 114.867 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.03 156.16 16.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.203 1.401 . . . . 0.0 112.178 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.16 57.54 0.66 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.611 1.564 . . . . 0.0 111.84 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 57.21 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.204 2.201 . . . . 0.0 112.156 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.13 149.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.062 -1.024 . . . . 0.0 111.469 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -114.92 97.87 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.5 tp -75.05 116.39 53.75 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.415 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 65.9 Cg_endo -73.46 144.56 36.46 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.175 1.917 . . . . 0.0 112.694 172.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 mm -130.85 130.38 22.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.225 1.41 . . . . 0.0 109.063 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 178.76 4.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.751 2.301 . . . . 0.0 111.895 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 54.8 0.08 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.099 1.76 . . . . 0.0 113.6 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 pp -45.73 134.72 7.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.154 1.382 . . . . 0.0 111.164 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -139.68 133.81 15.83 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.989 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.02 150.04 78.26 Favored 'Cis proline' 0 CA--C 1.545 1.05 0 CA-C-N 119.216 0.756 . . . . 0.0 112.113 -5.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.08 -34.76 45.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.946 1.764 . . . . 0.0 112.431 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -63.77 -10.03 17.72 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 161.41 24.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.244 1.018 . . . . 0.0 112.654 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -84.73 161.28 20.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.976 . . . . 0.0 112.012 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.5 119.47 39.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 109.051 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.94 136.01 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.671 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 p -134.42 142.39 47.12 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.985 0.914 . . . . 0.0 110.319 170.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -101.81 136.87 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.41 152.29 50.79 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 123.137 1.446 . . . . 0.0 112.946 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.32 132.78 28.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.777 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 t -104.93 129.27 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -144.13 133.75 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.4 156.26 23.05 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.707 -0.621 . . . . 0.0 112.048 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.0 p -89.76 -27.13 20.24 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.46 169.03 9.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.962 2.105 . . . . 0.0 111.267 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -52.65 150.74 8.94 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.98 9.24 15.48 Favored 'Cis proline' 0 CA--C 1.547 1.146 0 N-CA-C 115.818 1.43 . . . . 0.0 115.818 2.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.28 30.07 17.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.256 1.022 . . . . 0.0 112.482 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 148.69 31.84 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.502 -1.374 . . . . 0.0 112.161 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.94 106.66 2.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.52 1.128 . . . . 0.0 111.539 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.63 -59.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.656 1.582 . . . . 0.0 109.956 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.53 143.07 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.103 -1.623 . . . . 0.0 108.957 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 101.21 3.64 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.085 1.354 . . . . 0.0 107.391 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.23 -164.81 15.93 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.461 1.029 . . . . 0.0 111.567 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.33 151.39 37.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.398 -1.06 . . . . 0.0 111.644 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.3 142.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.817 1.647 . . . . 0.0 109.285 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -107.51 105.36 15.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.607 -0.683 . . . . 0.0 109.162 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -84.11 160.9 20.81 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.726 0.774 . . . . 0.0 110.012 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -158.95 161.34 36.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.832 2.053 . . . . 0.0 108.197 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.76 141.46 50.37 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.884 0.874 . . . . 0.0 109.256 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.0 m -96.42 110.24 51.73 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.104 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.11 53.29 3.34 Favored 'Trans proline' 0 CA--C 1.541 0.85 1 C-N-CA 125.492 4.128 . . . . 0.0 112.704 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -134.86 -43.33 0.74 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 111.187 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.7 p -146.7 19.33 1.31 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.455 1.502 . . . . 0.0 113.584 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.41 31.7 63.06 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 120.414 -1.428 . . . . 0.0 113.584 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -85.64 146.7 26.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.582 1.153 . . . . 0.0 111.097 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.1 t -127.03 85.78 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.469 1.508 . . . . 0.0 110.218 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -81.98 163.15 22.34 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.92 -1.112 . . . . 0.0 111.638 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.84 125.6 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.982 0.913 . . . . 0.0 109.327 -170.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.91 139.73 22.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.842 2.057 . . . . 0.0 109.111 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 119.86 12.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.174 1.79 . . . . 0.0 109.088 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -147.62 150.99 35.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.924 1.69 . . . . 0.0 110.097 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 -17.78 6.88 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.77 -23.49 63.31 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.001 1.32 . . . . 0.0 114.083 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.4 p -150.05 -45.06 0.13 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.509 1.524 . . . . 0.0 113.65 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.35 138.37 94.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 111.4 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.15 178.36 4.26 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.223 2.615 . . . . 0.0 112.502 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -128.1 -35.63 2.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.65 1.18 . . . . 0.0 112.434 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -66.0 -17.7 64.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.534 1.934 . . . . 0.0 113.565 166.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -125.18 145.1 50.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.698 1.599 . . . . 0.0 109.055 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 p -128.42 167.63 16.75 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.879 1.672 . . . . 0.0 110.114 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 9.7 p -144.97 147.71 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.288 -0.882 . . . . 0.0 110.614 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 99.9 m -127.68 130.33 48.71 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.252 1.021 . . . . 0.0 109.386 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.03 103.4 7.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.517 0.727 . . . . 0.0 110.108 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.13 -45.3 34.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 122.001 -0.437 . . . . 0.0 111.235 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -145.51 -175.15 4.61 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.17 1.788 . . . . 0.0 111.766 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -56.4 -25.32 49.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.8 m -149.7 49.01 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.667 1.187 . . . . 0.0 108.14 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 58.8 m -151.76 110.45 3.82 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.31 2.244 . . . . 0.0 109.507 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 138.04 54.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.388 1.075 . . . . 0.0 110.382 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 tt -133.83 108.78 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.148 0.975 . . . . 0.0 110.005 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . 0.45 ' CD1' ' HE1' ' A' ' 117' ' ' MET . 38.8 m-85 -90.54 133.98 34.69 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.707 1.603 . . . . 0.0 110.214 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -127.32 121.33 30.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.724 1.21 . . . . 0.0 109.381 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.55 101.15 13.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.337 0.655 . . . . 0.0 110.898 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.91 -18.28 29.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.624 1.97 . . . . 0.0 114.464 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.5 m -152.86 140.89 20.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.065 2.546 . . . . 0.0 109.02 170.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.9 -46.2 82.09 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 119.937 1.244 . . . . 0.0 112.413 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.649 1.979 . . . . 0.0 111.932 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.9 140.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.802 0.841 . . . . 0.0 110.535 168.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.57 142.44 56.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.329 0.652 . . . . 0.0 110.076 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.6 -17.35 54.82 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.673 -1.267 . . . . 0.0 113.042 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.51 3.75 11.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.919 1.688 . . . . 0.0 113.193 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -146.68 170.84 16.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.291 2.236 . . . . 0.0 109.061 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.77 162.26 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.82 -0.55 . . . . 0.0 110.487 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.14 143.94 28.63 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.801 -0.562 . . . . 0.0 110.98 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.3 147.07 38.32 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.449 1.099 . . . . 0.0 108.465 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.65 118.94 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 123.181 1.467 . . . . 0.0 110.241 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.78 48.73 1.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.969 1.307 . . . . 0.0 110.516 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.4 144.71 5.95 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.856 1.694 . . . . 0.0 111.074 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -55.91 137.53 50.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.09 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 72.56 40.14 0.66 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.349 1.46 . . . . 0.0 113.964 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.342 27.5 p 47.41 56.82 6.49 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.436 1.894 . . . . 0.0 114.582 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.7 p -123.74 -174.78 3.06 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.45 1.5 . . . . 0.0 112.213 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.05 -109.74 2.91 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.931 1.253 . . . . 0.0 112.683 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -107.36 163.59 12.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.663 0.785 . . . . 0.0 110.876 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 p -130.31 144.4 51.36 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.971 0.909 . . . . 0.0 111.425 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -141.74 151.14 42.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.204 1.402 . . . . 0.0 110.069 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.97 147.84 49.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.929 0.892 . . . . 0.0 111.681 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -140.96 137.57 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.077 0.951 . . . . 0.0 111.643 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.63 151.03 30.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.755 1.222 . . . . 0.0 109.584 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -63.73 150.45 44.47 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.529 -0.732 . . . . 0.0 111.157 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.23 50.34 57.07 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 122.115 -0.366 . . . . 0.0 113.862 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -137.16 141.25 42.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.202 1.401 . . . . 0.0 110.912 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.2 m -123.99 130.72 53.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.062 0.945 . . . . 0.0 109.577 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.84 117.21 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 100.61 7.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -80.1 162.5 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.734 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -106.54 152.25 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.318 0.647 . . . . 0.0 109.965 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -17.07 53.58 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.66 82.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.314 0.959 . . . . 0.0 114.312 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -84.73 108.34 17.38 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.196 0.998 . . . . 0.0 110.042 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.95 -23.06 52.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.031 -1.043 . . . . 0.0 112.757 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -60.09 -22.91 63.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.814 1.646 . . . . 0.0 112.226 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -65.76 -56.06 14.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.454 1.101 . . . . 0.0 112.422 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.32 -15.89 58.7 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.171 0.989 . . . . 0.0 113.65 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -23.36 65.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.629 1.572 . . . . 0.0 113.695 173.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -46.38 129.3 10.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 111.57 166.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmt -149.65 -31.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.294 1.038 . . . . 0.0 113.58 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -144.68 165.77 27.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.61 1.964 . . . . 0.0 110.682 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.61 168.32 23.67 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.347 -0.846 . . . . 0.0 110.867 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.01 128.5 20.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.906 0.882 . . . . 0.0 109.621 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.02 129.17 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 109.005 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.79 -98.1 0.01 OUTLIER Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.022 1.772 . . . . 0.0 116.617 -170.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.9 p -168.17 -25.68 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.681 1.192 . . . . 0.0 112.817 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -115.8 29.6 7.88 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.12 1.368 . . . . 0.0 111.266 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.24 116.38 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.838 1.655 . . . . 0.0 110.135 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -79.43 152.93 30.04 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.306 -0.871 . . . . 0.0 109.456 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 138.19 45.46 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.599 1.159 . . . . 0.0 109.242 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.92 119.48 23.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.7 pt -118.42 118.11 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.199 0.999 . . . . 0.0 111.298 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -124.15 142.63 51.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.771 1.628 . . . . 0.0 108.887 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.92 -44.22 3.05 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.965 0.906 . . . . 0.0 111.363 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -119.18 140.28 50.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.466 0.651 . . . . 0.0 111.025 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -140.97 120.29 13.04 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.826 1.25 . . . . 0.0 109.057 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -158.62 163.41 36.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.177 0.991 . . . . 0.0 111.046 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt -147.68 51.31 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.206 1.403 . . . . 0.0 111.065 -167.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -177.48 -31.64 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.961 2.105 . . . . 0.0 110.722 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -58.9 137.95 87.31 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.221 1.008 . . . . 0.0 112.994 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.01 -23.09 5.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.523 2.149 . . . . 0.0 113.578 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 t -76.0 120.26 80.86 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 119.015 0.825 . . . . 0.0 111.138 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.47 114.97 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.279 1.32 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.89 156.61 32.34 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.405 1.003 . . . . 0.0 113.592 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -65.4 123.9 20.83 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.305 1.052 . . . . 0.0 111.717 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -140.87 143.47 34.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.47 2.308 . . . . 0.0 108.822 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 125.97 6.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.345 1.069 . . . . 0.0 110.406 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.63 105.64 11.08 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.137 0.97 . . . . 0.0 109.904 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tp -63.18 121.24 13.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.613 0.765 . . . . 0.0 109.068 171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.52 141.28 16.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.628 1.171 . . . . 0.0 112.398 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -59.78 -15.06 17.56 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.45 118.81 0.91 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.606 1.098 . . . . 0.0 111.444 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.37 169.33 1.05 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.264 1.826 . . . . 0.0 111.646 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.1 m -105.22 144.51 31.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.873 1.269 . . . . 0.0 110.455 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -124.33 98.31 5.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.373 1.069 . . . . 0.0 108.636 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.48 -35.94 7.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.324 1.049 . . . . 0.0 112.823 -164.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -143.96 112.09 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.405 1.482 . . . . 0.0 108.915 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 26.04 2.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.501 1.52 . . . . 0.0 111.006 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -51.39 -33.46 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.304 1.042 . . . . 0.0 112.574 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -58.18 -21.46 47.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.89 -9.27 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.326 1.45 . . . . 0.0 112.598 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 82.29 39.97 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.409 2.283 . . . . 0.0 112.266 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.16 -133.59 31.13 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.337 -1.477 . . . . 0.0 110.76 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.3 tp -146.81 160.89 41.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.938 1.369 . . . . 0.0 110.875 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 p -144.58 -35.96 0.33 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.86 0.864 . . . . 0.0 113.141 155.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -129.14 139.66 51.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.905 0.882 . . . . 0.0 110.635 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.66 135.64 48.75 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.121 0.969 . . . . 0.0 110.591 173.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -129.21 130.46 46.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.881 0.873 . . . . 0.0 109.401 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.82 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.378 1.471 . . . . 0.0 107.539 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.21 142.11 33.02 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.612 0.765 . . . . 0.0 110.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.95 32.0 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.862 3.041 . . . . 0.0 114.794 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.34 60.17 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.862 1.22 . . . . 0.0 113.763 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.73 -25.13 2.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.396 1.478 . . . . 0.0 112.768 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -118.13 141.71 48.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.684 1.594 . . . . 0.0 108.15 177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -79.59 -33.68 41.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.383 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -149.01 174.44 12.29 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.582 1.953 . . . . 0.0 109.053 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.89 23.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.993 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -137.94 130.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.097 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.36 131.25 34.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.858 0.863 . . . . 0.0 110.11 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 m -133.04 142.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.402 1.081 . . . . 0.0 110.289 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -144.95 144.16 30.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.97 0.908 . . . . 0.0 110.545 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 pt -87.65 153.71 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.8 120.48 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.18 1.392 . . . . 0.0 108.335 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -58.96 103.08 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.96 1.304 . . . . 0.0 112.196 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 16.94 22.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.507 1.123 . . . . 0.0 111.359 168.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.82 -35.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.618 1.567 . . . . 0.0 113.035 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -96.8 170.88 8.87 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.6 1.16 . . . . 0.0 111.649 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -109.71 -45.56 3.64 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.47 -0.769 . . . . 0.0 113.044 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.6 m -71.48 -31.22 66.88 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.505 1.122 . . . . 0.0 112.528 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.93 -44.38 0.56 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.114 2.166 . . . . 0.0 114.117 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.04 42.06 0.36 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.014 2.245 . . . . 0.0 115.017 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.7 p -129.74 -1.16 4.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.861 2.064 . . . . 0.0 112.005 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -118.63 150.37 39.81 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.185 1.394 . . . . 0.0 111.653 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.96 127.67 29.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.762 1.225 . . . . 0.0 109.971 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.7 ttm -102.89 122.55 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.761 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.4 m -116.0 117.69 30.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.5 pt -122.66 142.15 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.76 0.79 . . . . 0.0 112.277 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 78.7 m -135.23 85.84 32.22 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.283 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.47 167.66 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.43 2.087 . . . . 0.0 111.766 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -33.9 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.64 2.376 . . . . 0.0 114.538 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 39.68 51.12 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.538 1.935 . . . . 0.0 114.528 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.13 148.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.901 1.68 . . . . 0.0 110.436 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -51.35 111.89 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.665 1.186 . . . . 0.0 111.36 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.29 134.62 39.47 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.516 0.726 . . . . 0.0 110.735 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.84 127.53 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.39 114.58 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.226 1.011 . . . . 0.0 109.061 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.28 146.02 46.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.42 0.688 . . . . 0.0 110.956 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -117.76 170.59 8.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.831 0.852 . . . . 0.0 110.552 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.3 69.93 1.63 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.62 1.2 . . . . 0.0 112.135 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.03 0.08 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.001 1.762 . . . . 0.0 111.309 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.52 161.93 36.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.698 1.199 . . . . 0.0 111.585 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.56 55.16 1.65 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.999 1.32 . . . . 0.0 111.935 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 60.33 93.1 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.225 2.21 . . . . 0.0 112.722 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.99 139.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.344 0.658 . . . . 0.0 111.645 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -97.94 123.6 42.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.874 0.869 . . . . 0.0 110.336 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 127.51 37.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.454 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.53 128.31 9.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.487 2.125 . . . . 0.0 110.999 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.5 mm -128.15 125.56 23.44 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.518 0.727 . . . . 0.0 109.619 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.44 178.02 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.419 2.079 . . . . 0.0 111.534 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -14.28 43.75 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.867 -1.145 . . . . 0.0 113.577 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp 55.21 -175.42 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.428 1.891 . . . . 0.0 112.319 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.7 t -153.63 106.3 2.54 Favored Pre-proline 0 C--O 1.241 0.606 0 O-C-N 121.265 -0.897 . . . . 0.0 111.282 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.26 165.14 69.22 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 119.386 0.816 . . . . 0.0 113.142 -9.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.64 -30.98 41.6 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.211 1.941 . . . . 0.0 114.082 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.98 2.09 13.59 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -73.69 144.51 45.76 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.992 -1.068 . . . . 0.0 112.004 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -70.28 157.97 36.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 113.117 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tt -125.94 122.48 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.649 1.18 . . . . 0.0 109.445 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.28 132.71 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 110.414 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -138.7 122.2 17.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.651 0.781 . . . . 0.0 110.758 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -82.29 134.38 35.27 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 171.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.04 119.59 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 109.557 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.1 p -124.16 113.38 18.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.338 1.055 . . . . 0.0 109.033 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 t -104.39 125.02 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -140.44 151.44 44.89 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.629 1.572 . . . . 0.0 109.115 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -67.26 141.55 57.2 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.81 -0.556 . . . . 0.0 111.979 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.9 p -67.9 -24.71 65.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.02 0.928 . . . . 0.0 113.16 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -144.34 179.67 7.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.716 2.006 . . . . 0.0 110.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.6 t -41.55 136.55 1.89 Allowed Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.216 1.806 . . . . 0.0 113.863 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.22 8.68 31.0 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 N-CA-C 114.683 0.994 . . . . 0.0 114.683 5.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.63 27.56 16.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.166 1.387 . . . . 0.0 112.719 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.77 151.11 36.11 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.25 -1.531 . . . . 0.0 113.157 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -78.57 128.43 33.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.999 1.32 . . . . 0.0 111.401 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.7 -38.41 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.431 1.493 . . . . 0.0 111.602 -175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.58 138.5 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.76 1.224 . . . . 0.0 108.557 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -150.12 76.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.23 1.012 . . . . 0.0 108.905 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.09 -168.56 14.85 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.715 1.626 . . . . 0.0 111.938 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -133.32 160.48 37.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.291 -1.123 . . . . 0.0 112.593 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.41 147.35 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.272 1.429 . . . . 0.0 108.124 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.2 131.38 52.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.377 0.608 . . . . 0.0 109.592 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -110.06 153.29 24.85 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -163.04 148.35 11.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -120.44 151.51 39.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.378 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 73.7 m -90.39 110.78 43.31 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.039 0.936 . . . . 0.0 108.66 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.45 52.3 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 124.993 3.796 . . . . 0.0 112.298 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.2 m -130.08 -40.22 1.33 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.792 2.037 . . . . 0.0 111.687 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 t -149.22 30.03 0.78 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.93 1.292 . . . . 0.0 111.408 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.19 35.87 43.25 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.86 -1.15 . . . . 0.0 113.151 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.59 118.2 18.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.905 0.882 . . . . 0.0 109.169 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.4 139.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.572 0.749 . . . . 0.0 109.917 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 49.5 m -143.36 158.36 43.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.599 1.56 . . . . 0.0 110.571 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.49 129.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.711 0.804 . . . . 0.0 110.904 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.04 129.89 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 107.979 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -140.45 122.85 16.01 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.835 1.254 . . . . 0.0 108.605 -171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -150.22 146.49 26.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -55.83 -18.02 7.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 113.811 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -59.2 -25.62 64.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.64 1.976 . . . . 0.0 114.207 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.1 p -145.12 -43.14 0.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.528 1.531 . . . . 0.0 113.096 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -60.58 135.58 92.1 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.065 1.746 . . . . 0.0 111.889 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.09 -172.44 1.54 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.022 2.482 . . . . 0.0 111.341 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.82 31.85 3.3 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.964 1.306 . . . . 0.0 113.593 -166.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -148.31 -32.41 0.25 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.228 1.811 . . . . 0.0 113.737 -164.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.3 ttt -125.1 140.04 53.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.272 2.229 . . . . 0.0 107.928 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.9 p -127.49 159.38 34.73 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.388 0.675 . . . . 0.0 109.864 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.03 131.28 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 t -116.58 147.77 41.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.134 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -85.45 83.68 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.669 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.42 -29.74 69.18 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.718 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.07 174.05 15.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.905 1.682 . . . . 0.0 111.171 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.77 140.58 57.54 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.989 -1.694 . . . . 0.0 110.333 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p 53.66 12.68 0.42 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.224 2.209 . . . . 0.0 114.836 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.3 t -133.91 105.25 6.66 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.595 1.158 . . . . 0.0 111.664 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -108.03 148.37 29.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.276 1.03 . . . . 0.0 111.833 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.8 tt -134.11 116.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.734 0.778 . . . . 0.0 109.252 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.3 125.11 37.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.998 1.319 . . . . 0.0 109.727 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -109.48 123.71 49.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.106 0.962 . . . . 0.0 109.187 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.49 96.57 6.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 111.077 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -87.57 -25.99 23.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.282 1.033 . . . . 0.0 112.329 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.2 t -90.56 176.34 6.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.733 1.213 . . . . 0.0 113.002 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.48 57.44 0.94 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.722 1.209 . . . . 0.0 110.06 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 116.99 -1.481 . . . . 0.0 113.371 173.091 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.545 0.212 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.42 154.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.892 1.277 . . . . 0.0 109.302 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.98 143.88 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.475 0.71 . . . . 0.0 110.983 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.0 -20.38 23.67 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.54 15.41 22.95 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.389 2.276 . . . . 0.0 113.348 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -140.26 169.33 17.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.462 -1.399 . . . . 0.0 110.033 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.49 145.66 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.837 0.855 . . . . 0.0 109.968 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.0 144.79 49.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.056 1.342 . . . . 0.0 109.201 -174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -132.85 120.27 21.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.1 1.36 . . . . 0.0 109.601 -171.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.17 125.93 42.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.261 1.424 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.17 43.12 0.43 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.511 1.924 . . . . 0.0 112.602 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.1 137.91 2.49 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.758 2.123 . . . . 0.0 110.601 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -51.84 159.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.831 0.852 . . . . 0.0 111.289 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 t30 64.83 22.78 12.58 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m 54.84 57.16 5.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.34 1.456 . . . . 0.0 113.126 -173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.6 p -131.82 -177.92 4.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.737 1.215 . . . . 0.0 112.393 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.54 -119.08 4.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.283 0.944 . . . . 0.0 111.772 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.72 -178.22 3.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.241 1.416 . . . . 0.0 110.834 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p -136.6 153.81 50.85 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.794 -1.191 . . . . 0.0 111.387 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.27 155.19 41.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.105 1.362 . . . . 0.0 110.451 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.64 138.31 51.14 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 109.945 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -134.21 144.52 48.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.195 1.398 . . . . 0.0 110.705 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -79.99 149.17 30.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.535 1.134 . . . . 0.0 111.128 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -63.24 157.48 22.55 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.323 1.049 . . . . 0.0 111.688 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.3 39.54 97.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.387 0.518 . . . . 0.0 113.019 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.51 160.81 32.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.578 1.551 . . . . 0.0 109.758 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.4 p -138.96 151.15 46.64 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.276 -1.515 . . . . 0.0 109.099 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.84 116.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.306 1.051 . . . . 0.0 108.628 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 mtm105 -125.91 92.52 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 108.684 -164.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.34 153.0 21.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.418 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -95.83 147.05 24.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.419 0.687 . . . . 0.0 110.763 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -67.61 2.23 1.96 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.69 80.99 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.265 1.412 . . . . 0.0 114.736 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -133.9 120.56 20.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.934 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -13.18 2.15 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -57.16 -20.6 27.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.562 1.545 . . . . 0.0 112.49 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -65.16 -54.79 24.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.043 0.838 . . . . 0.0 111.749 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.65 -22.8 57.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.122 1.369 . . . . 0.0 113.251 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 42' ' ' MET . 63.9 mmtt -51.36 -42.07 61.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.964 1.306 . . . . 0.0 113.541 171.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -67.0 31.19 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 126.575 1.95 . . . . 0.0 114.042 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -64.01 -38.11 89.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.561 2.345 . . . . 0.0 113.917 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -112.22 151.9 29.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.749 1.159 . . . . 0.0 110.754 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.1 p -169.03 167.38 10.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 123.046 1.403 . . . . 0.0 113.154 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.84 125.56 14.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.126 1.37 . . . . 0.0 108.405 -172.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.8 133.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.225 1.81 . . . . 0.0 108.306 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.85 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.634 1.588 . . . . 0.0 115.886 -168.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -156.47 -22.63 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.239 1.416 . . . . 0.0 113.77 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.94 16.26 12.55 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.732 1.613 . . . . 0.0 111.801 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -145.36 152.36 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.412 1.885 . . . . 0.0 110.216 -173.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -116.99 156.78 26.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.687 1.195 . . . . 0.0 110.041 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.2 t -127.05 131.03 51.03 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.005 0.922 . . . . 0.0 108.725 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -112.87 140.14 47.91 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.143 1.377 . . . . 0.0 107.584 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -129.39 137.96 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.194 0.998 . . . . 0.0 109.363 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.1 120.24 8.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.269 1.428 . . . . 0.0 111.263 -161.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -95.27 -63.02 1.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.107 -0.995 . . . . 0.0 112.7 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.21 142.46 37.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.581 1.153 . . . . 0.0 109.54 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -134.42 105.7 6.7 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.921 -1.112 . . . . 0.0 109.431 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -142.0 152.44 43.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.209 1.404 . . . . 0.0 110.38 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.4 45.72 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.19 1.796 . . . . 0.0 111.012 -166.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -169.82 -26.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.476 2.31 . . . . 0.0 111.945 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -60.52 137.27 92.48 Favored Pre-proline 0 CA--C 1.543 0.712 0 C-N-CA 125.39 1.476 . . . . 0.0 112.673 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.61 -23.89 9.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.28 2.653 . . . . 0.0 112.937 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -99.61 117.29 63.95 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 124.744 1.217 . . . . 0.0 109.127 171.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.46 155.14 64.25 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.257 1.305 . . . . 0.0 110.033 168.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.6 -136.55 0.71 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.032 0.825 . . . . 0.0 112.947 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -122.76 137.93 54.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.234 1.016 . . . . 0.0 112.921 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.72 167.78 23.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.13 2.172 . . . . 0.0 109.797 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -157.19 142.28 17.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 111.339 170.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -94.85 98.59 10.84 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.733 1.213 . . . . 0.0 110.734 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.89 124.15 18.23 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.998 -1.063 . . . . 0.0 108.668 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.81 153.35 3.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.034 0.934 . . . . 0.0 112.849 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.24 -10.16 2.71 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.93 112.26 0.52 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.424 1.012 . . . . 0.0 111.859 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.05 159.67 2.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.343 1.857 . . . . 0.0 111.983 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 m -104.31 140.12 38.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.538 1.135 . . . . 0.0 110.066 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -130.95 121.06 24.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.658 1.583 . . . . 0.0 108.556 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.98 -22.9 2.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -66.12 0.8 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.733 1.213 . . . . 0.0 110.771 171.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 mp 41.01 34.87 0.31 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.043 2.137 . . . . 0.0 113.381 -170.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -62.85 -31.19 72.16 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.765 -1.209 . . . . 0.0 112.406 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -63.19 -28.39 70.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.831 0.852 . . . . 0.0 113.284 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.71 -35.22 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.409 1.484 . . . . 0.0 110.978 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 54.38 55.07 8.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.148 1.379 . . . . 0.0 113.475 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.14 -152.99 16.86 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.448 1.499 . . . . 0.0 111.862 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -153.91 146.05 23.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.684 1.193 . . . . 0.0 111.525 166.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.25 -63.77 1.13 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 153.09 50.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.386 1.475 . . . . 0.0 110.809 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.38 147.68 22.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.908 0.861 . . . . 0.0 111.883 -170.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -139.02 120.97 15.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.48 1.512 . . . . 0.0 109.58 -168.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.11 118.51 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.253 0.621 . . . . 0.0 109.465 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.3 mt -125.64 126.81 24.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.554 1.142 . . . . 0.0 109.898 -164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.9 162.63 23.67 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.611 2.207 . . . . 0.0 112.185 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.29 -5.23 15.07 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.765 1.174 . . . . 0.0 115.644 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.7 -19.76 32.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.276 1.43 . . . . 0.0 113.606 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.53 165.63 24.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.746 1.618 . . . . 0.0 110.03 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.95 -46.81 3.69 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.955 -1.091 . . . . 0.0 111.634 -173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.27 148.05 47.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.68 1.592 . . . . 0.0 107.903 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.84 157.57 42.53 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.45 149.42 24.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.014 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 144.43 26.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.99 139.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.429 1.091 . . . . 0.0 109.596 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -143.15 157.97 44.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.562 1.145 . . . . 0.0 110.681 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.45 145.91 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.072 0.949 . . . . 0.0 112.181 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.44 105.02 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.519 1.928 . . . . 0.0 109.534 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.86 89.49 4.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 112.532 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.54 -32.0 36.86 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.182 -0.949 . . . . 0.0 112.477 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.44 -46.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.9 -24.6 35.58 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.469 0.577 . . . . 0.0 111.485 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t 65.72 -42.82 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.379 3.071 . . . . 0.0 115.437 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -57.42 -37.69 73.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.775 1.63 . . . . 0.0 112.833 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.69 176.11 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.928 1.691 . . . . 0.0 113.993 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.72 28.17 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.921 1.248 . . . . 0.0 114.639 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -140.78 30.58 1.86 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -162.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -120.16 147.52 44.79 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.79 1.636 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.95 126.21 33.5 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.966 1.306 . . . . 0.0 109.409 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 63.1 ttp -126.09 132.43 51.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.884 1.274 . . . . 0.0 110.148 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.9 m -123.09 106.76 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.337 1.455 . . . . 0.0 108.615 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.85 125.37 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.2 t -144.93 123.47 6.69 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.87 170.15 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.962 3.108 . . . . 0.0 113.004 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -42.46 106.43 0.06 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.391 1.876 . . . . 0.0 113.371 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? 47.07 57.03 6.08 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.801 1.64 . . . . 0.0 113.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -126.18 159.32 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.588 1.955 . . . . 0.0 109.919 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -55.23 109.67 0.57 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.152 0.981 . . . . 0.0 111.455 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.81 152.03 20.05 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.442 0.697 . . . . 0.0 111.518 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.61 150.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.262 1.025 . . . . 0.0 110.141 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.69 103.63 10.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 109.42 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.97 146.22 30.83 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.422 0.689 . . . . 0.0 109.61 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -133.82 144.02 48.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.204 1.002 . . . . 0.0 110.546 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.94 108.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.022 2.129 . . . . 0.0 111.025 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.54 -17.03 14.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.445 1.021 . . . . 0.0 114.49 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.0 136.48 57.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.823 1.311 . . . . 0.0 109.927 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -74.59 57.9 0.76 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.076 1.751 . . . . 0.0 112.51 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 63.37 90.49 0.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.858 2.463 . . . . 0.0 111.152 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.97 149.96 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 120.918 -1.114 . . . . 0.0 111.478 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 137.7 32.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.93 96.16 40.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.491 1.916 . . . . 0.0 108.143 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.1 138.5 30.93 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.546 2.164 . . . . 0.0 111.099 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.7 mt -128.36 129.9 23.57 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 108.812 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.47 169.96 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.53 2.82 . . . . 0.0 112.109 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -57.13 134.85 56.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.838 -0.539 . . . . 0.0 111.574 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 pp -144.41 150.3 37.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 110.184 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -142.61 136.63 14.64 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.168 0.987 . . . . 0.0 112.102 -171.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.96 154.0 73.1 Favored 'Cis proline' 0 CA--C 1.544 0.991 0 CA-C-N 119.381 0.815 . . . . 0.0 111.706 -6.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.45 -35.89 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.281 1.988 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.6 0.09 5.95 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.622 1.569 . . . . 0.0 114.225 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 p -68.37 133.58 48.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.162 1.346 . . . . 0.0 110.869 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.53 120.84 15.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.075 167.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.3 tt -104.48 116.8 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.053 1.741 . . . . 0.0 109.086 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.49 139.64 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.057 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.8 m -133.52 134.09 42.98 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.518 1.127 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.43 146.74 36.36 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.693 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.2 111.11 8.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 109.465 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 132.68 49.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.091 0.956 . . . . 0.0 109.382 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.54 136.18 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.153 0.981 . . . . 0.0 109.681 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.72 150.84 37.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.548 1.139 . . . . 0.0 111.668 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.98 140.38 57.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.198 0.599 . . . . 0.0 111.507 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.3 p -80.24 -7.31 58.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.64 177.46 9.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.71 2.004 . . . . 0.0 111.241 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -39.79 133.77 1.37 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.887 1.675 . . . . 0.0 114.205 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.29 8.49 17.56 Favored 'Cis proline' 0 CA--C 1.547 1.135 0 N-CA-C 115.044 1.132 . . . . 0.0 115.044 3.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.06 10.34 2.82 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.321 1.848 . . . . 0.0 114.454 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.22 162.07 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.408 1.483 . . . . 0.0 112.653 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -58.23 151.82 18.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.85 1.26 . . . . 0.0 111.755 170.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.37 -22.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.744 1.218 . . . . 0.0 113.193 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -151.94 142.89 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.608 1.963 . . . . 0.0 109.036 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -142.27 117.39 10.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.587 1.155 . . . . 0.0 108.923 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.68 -147.87 6.18 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.637 1.113 . . . . 0.0 112.097 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.51 172.42 15.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.048 1.339 . . . . 0.0 110.141 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.35 149.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.751 1.62 . . . . 0.0 107.854 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.5 130.8 54.81 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.938 -1.101 . . . . 0.0 109.113 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -111.91 158.27 19.66 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.113 -0.992 . . . . 0.0 110.849 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -163.18 146.16 10.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.908 1.683 . . . . 0.0 108.968 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -111.79 156.58 21.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.257 1.023 . . . . 0.0 110.811 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.6 m -126.81 101.37 26.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.76 1.624 . . . . 0.0 110.329 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -68.32 -10.11 27.96 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.911 3.074 . . . . 0.0 113.785 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.0 m -40.09 -43.5 1.61 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.835 2.054 . . . . 0.0 112.748 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -156.28 28.52 0.35 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.904 0.859 . . . . 0.0 112.941 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 55.98 55.25 30.1 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.115 -1.616 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -129.73 130.75 45.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.299 1.44 . . . . 0.0 109.222 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.7 159.39 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 121.565 -0.709 . . . . 0.0 110.407 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 87.1 m -148.29 111.51 4.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.085 0.954 . . . . 0.0 110.067 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.83 138.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.482 0.658 . . . . 0.0 109.966 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.33 129.03 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.524 1.93 . . . . 0.0 107.195 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 139.62 37.5 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.217 1.007 . . . . 0.0 109.695 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -160.02 164.43 33.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.156 1.382 . . . . 0.0 109.779 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -16.06 5.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.301 1.44 . . . . 0.0 114.001 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.158 1.783 . . . . 0.0 114.058 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 42.1 p -142.91 -47.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.344 1.458 . . . . 0.0 112.432 -170.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.434 ' CE2' ' HA ' ' A' ' 196' ' ' THR . 0.0 OUTLIER -76.58 143.12 71.49 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.985 1.714 . . . . 0.0 111.533 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.36 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.855 2.37 . . . . 0.0 110.736 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -179.68 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 128.266 2.626 . . . . 0.0 111.708 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -58.08 -40.76 81.91 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.92 1.688 . . . . 0.0 112.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.5 ttt -104.67 140.13 38.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.767 1.627 . . . . 0.0 108.627 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.434 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 65.9 p -136.82 158.93 43.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.924 0.49 . . . . 0.0 110.961 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.0 p -124.62 139.02 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.968 0.907 . . . . 0.0 110.741 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 97.9 m -126.33 143.04 51.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.426 1.09 . . . . 0.0 109.404 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -73.05 79.1 1.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.338 1.455 . . . . 0.0 111.482 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -54.51 -33.62 60.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.034 1.734 . . . . 0.0 112.699 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.12 -179.67 8.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.854 1.662 . . . . 0.0 111.367 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -44.14 -42.46 6.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.916 2.087 . . . . 0.0 114.295 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.1 p -130.61 12.92 5.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.086 1.755 . . . . 0.0 112.907 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -103.88 126.02 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.387 -0.82 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -123.23 138.5 54.62 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.852 1.261 . . . . 0.0 110.977 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.28 116.99 44.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.747 0.819 . . . . 0.0 110.007 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.56 112.2 24.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.767 1.627 . . . . 0.0 108.612 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -94.06 142.73 27.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.439 -0.788 . . . . 0.0 109.684 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.49 122.26 30.78 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.115 0.966 . . . . 0.0 111.948 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -115.27 13.83 16.75 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.704 1.602 . . . . 0.0 112.312 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.7 t -154.17 165.11 37.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.515 1.526 . . . . 0.0 111.522 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.05 2.03 9.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.797 1.239 . . . . 0.0 113.418 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.539 1.936 . . . . 0.0 115.226 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.07 150.6 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.56 0.744 . . . . 0.0 111.581 172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -95.25 150.6 20.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.505 0.722 . . . . 0.0 109.624 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.2 34.84 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.847 -1.158 . . . . 0.0 113.201 170.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -106.19 7.55 31.61 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.189 1.796 . . . . 0.0 113.426 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -142.76 -179.36 6.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.074 1.35 . . . . 0.0 111.379 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.24 152.25 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.407 1.483 . . . . 0.0 111.253 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.86 153.26 46.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.862 1.265 . . . . 0.0 110.701 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -136.88 117.12 13.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.382 1.073 . . . . 0.0 109.835 -169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -95.24 122.45 37.94 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.163 1.385 . . . . 0.0 111.229 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.88 59.04 1.55 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.781 1.232 . . . . 0.0 111.993 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.55 130.94 1.3 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.171 0.891 . . . . 0.0 111.11 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.13 146.12 9.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.876 0.87 . . . . 0.0 110.656 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 70.44 20.94 5.81 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.288 1.435 . . . . 0.0 114.705 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.84 58.41 2.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.681 1.192 . . . . 0.0 112.718 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 p -133.22 -174.54 3.52 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.301 1.44 . . . . 0.0 112.009 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.02 -142.98 40.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.905 0.764 . . . . 0.0 112.81 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -74.76 176.02 7.42 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.694 0.798 . . . . 0.0 112.451 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -136.21 157.24 47.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.562 1.145 . . . . 0.0 111.833 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.47 155.45 43.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.274 1.83 . . . . 0.0 110.118 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.45 143.93 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.544 1.138 . . . . 0.0 110.403 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -132.11 128.44 38.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.958 1.303 . . . . 0.0 109.012 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.36 148.81 30.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.814 0.845 . . . . 0.0 110.363 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -62.86 142.28 58.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.065 0.546 . . . . 0.0 111.449 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.61 66.63 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 122.211 -0.305 . . . . 0.0 112.486 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 152.67 39.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.49 1.116 . . . . 0.0 110.538 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -135.53 120.32 18.45 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 108.096 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.12 141.17 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.016 0.926 . . . . 0.0 109.413 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -135.35 133.45 38.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.244 1.018 . . . . 0.0 109.189 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.39 175.16 5.54 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.028 1.731 . . . . 0.0 109.595 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -123.41 133.99 54.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.682 0.793 . . . . 0.0 108.958 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.62 -14.28 12.96 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.279 1.032 . . . . 0.0 113.627 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.76 -25.54 52.02 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.961 1.267 . . . . 0.0 114.682 166.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -119.2 121.29 39.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.058 1.343 . . . . 0.0 109.852 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -12.48 6.22 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -63.68 -9.83 16.06 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.276 1.43 . . . . 0.0 112.959 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -70.39 -52.22 23.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.673 1.189 . . . . 0.0 112.037 164.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.61 -15.05 16.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.93 1.692 . . . . 0.0 113.513 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -40.79 -45.1 2.38 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.627 2.371 . . . . 0.0 113.069 169.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.98 50.32 0.59 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.429 1.492 . . . . 0.0 113.033 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -73.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.662 0.785 . . . . 0.0 111.219 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -93.36 160.11 14.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.192 0.997 . . . . 0.0 110.655 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -168.75 169.63 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.293 1.037 . . . . 0.0 112.374 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 156.01 41.94 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.334 1.064 . . . . 0.0 112.303 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.65 139.04 53.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 124.872 1.269 . . . . 0.0 109.282 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.16 -96.71 0.01 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.958 1.742 . . . . 0.0 116.073 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -166.95 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 113.243 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -123.99 26.36 7.59 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.644 1.977 . . . . 0.0 111.899 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.42 153.69 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.456 1.902 . . . . 0.0 109.023 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -125.41 149.48 48.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.614 1.566 . . . . 0.0 108.857 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.8 m -123.26 151.22 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 110.508 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.31 130.23 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.52 142.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.027 0.931 . . . . 0.0 109.637 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -137.25 127.41 26.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.159 1.384 . . . . 0.0 109.089 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -100.66 -53.32 3.11 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 111.379 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -101.6 98.51 8.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.858 0.863 . . . . 0.0 111.418 -172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.08 96.75 5.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.421 1.089 . . . . 0.0 112.828 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -156.14 164.53 38.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 112.27 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 6.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.26 2.224 . . . . 0.0 113.068 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.38 49.11 2.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.388 1.875 . . . . 0.0 112.122 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -148.59 145.44 20.11 Favored Pre-proline 0 N--CA 1.478 0.956 0 O-C-N 120.77 -1.206 . . . . 0.0 112.365 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.42 -14.15 20.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.922 2.415 . . . . 0.0 113.16 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -67.75 121.24 78.63 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 119.239 0.927 . . . . 0.0 109.956 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.56 95.66 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.199 1.933 . . . . 0.0 108.687 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.57 138.8 28.22 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.457 1.027 . . . . 0.0 112.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 115.42 2.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.714 0.757 . . . . 0.0 111.212 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CD2' ' HA ' ' A' ' 179' ' ' THR . 2.3 t80 -138.48 143.15 39.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.218 2.207 . . . . 0.0 109.48 -174.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.98 139.94 24.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.307 1.051 . . . . 0.0 109.614 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -100.11 103.61 15.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.08 1.352 . . . . 0.0 107.643 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.98 121.53 12.64 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.48 150.84 6.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.322 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -58.55 -15.5 11.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.16 124.73 1.6 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.644 152.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.05 158.36 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.657 2.383 . . . . 0.0 111.546 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -94.23 143.57 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.436 1.094 . . . . 0.0 110.829 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -128.1 102.04 6.55 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.507 1.923 . . . . 0.0 108.553 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -123.65 6.65 8.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.633 1.573 . . . . 0.0 112.772 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -140.35 45.03 1.86 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.896 1.679 . . . . 0.0 111.461 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 mp -75.26 30.67 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.079 1.351 . . . . 0.0 112.588 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.1 m -61.43 -35.65 78.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.753 1.621 . . . . 0.0 112.485 174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -61.11 -24.06 65.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.719 0.808 . . . . 0.0 112.715 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.4 mm -88.06 -25.58 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.655 1.982 . . . . 0.0 113.198 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 54.75 52.68 11.69 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.52 1.528 . . . . 0.0 113.372 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.32 -179.62 19.93 Favored Glycine 0 CA--C 1.538 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 112.567 -170.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 -178.88 6.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.574 -1.545 . . . . 0.0 112.054 -169.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -148.13 -36.94 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.14 1.776 . . . . 0.0 113.164 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.91 147.03 47.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.762 1.225 . . . . 0.0 111.445 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -135.96 119.69 17.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.326 1.85 . . . . 0.0 108.416 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -115.05 138.93 50.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.37 0.668 . . . . 0.0 109.404 170.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.83 119.27 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.757 1.623 . . . . 0.0 107.411 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt -127.55 126.79 24.1 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 124.672 1.189 . . . . 0.0 109.467 -172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.88 161.41 33.23 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 121.74 1.627 . . . . 0.0 111.752 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.34 -3.15 17.56 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.09 45.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.004 1.322 . . . . 0.0 113.86 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -130.78 151.1 51.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.045 1.338 . . . . 0.0 110.507 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -82.09 -49.3 10.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.518 -0.739 . . . . 0.0 111.378 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -154.52 161.23 41.76 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.773 1.629 . . . . 0.0 110.589 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -131.21 154.41 48.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.108 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.44 137.16 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.945 1.298 . . . . 0.0 109.733 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.07 123.83 36.6 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.192 0.997 . . . . 0.0 108.986 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.88 132.26 71.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.651 1.58 . . . . 0.0 108.692 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -125.15 145.25 50.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.916 0.887 . . . . 0.0 110.185 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.71 128.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.05 143.17 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 122.069 0.938 . . . . 0.0 109.814 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.62 140.34 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.536 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 7.24 2.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.832 1.253 . . . . 0.0 112.168 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.52 -33.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.069 1.748 . . . . 0.0 112.907 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.44 172.61 12.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.789 1.236 . . . . 0.0 111.835 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.3 p -105.71 14.24 28.59 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.28 1.432 . . . . 0.0 112.944 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.4 m -107.0 31.03 5.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.787 2.435 . . . . 0.0 110.169 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.38 145.76 17.35 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.839 -1.163 . . . . 0.0 112.252 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.46 25.1 6.78 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.696 1.141 . . . . 0.0 112.956 -171.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.8 p -147.57 9.51 0.92 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.075 1.75 . . . . 0.0 114.033 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -127.28 143.74 51.18 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 110.784 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -131.03 130.87 43.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.074 1.349 . . . . 0.0 108.717 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -122.02 131.58 54.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.618 1.567 . . . . 0.0 110.365 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 m -95.52 133.86 39.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.856 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.57 110.78 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.801 1.64 . . . . 0.0 109.135 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -129.99 128.31 22.84 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.385 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.19 -91.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.142 2.561 . . . . 0.0 111.35 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 124' ' ' VAL . 0.2 OUTLIER -71.14 -171.76 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.032 0.92 . . . . 0.0 112.685 174.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -65.09 26.8 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 126.682 1.993 . . . . 0.0 113.786 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' TYR . 7.7 p -76.2 165.63 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.549 1.94 . . . . 0.0 110.831 172.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -56.05 114.77 2.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.331 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -58.61 147.98 30.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.741 0.816 . . . . 0.0 111.909 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -110.14 145.07 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.862 1.265 . . . . 0.0 110.274 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.81 117.21 32.81 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.858 1.263 . . . . 0.0 109.594 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.8 m -125.47 118.53 26.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.523 1.129 . . . . 0.0 108.646 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.36 138.59 49.23 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.09 1.356 . . . . 0.0 112.008 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.51 127.4 17.63 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.308 0.575 . . . . 0.0 111.978 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.57 -18.6 22.5 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.576 1.084 . . . . 0.0 113.67 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -57.75 137.14 56.83 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.865 1.333 . . . . 0.0 112.945 169.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.53 72.15 5.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.018 0.927 . . . . 0.0 110.526 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 61.83 85.73 0.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.516 1.926 . . . . 0.0 112.449 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.18 134.81 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.775 -1.203 . . . . 0.0 110.883 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -93.43 127.29 38.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.278 0.561 . . . . 0.0 110.944 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.4 tp -107.67 95.48 14.37 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.412 1.885 . . . . 0.0 107.995 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.37 146.47 40.0 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.958 1.772 . . . . 0.0 111.484 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.46 125.1 27.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.997 1.719 . . . . 0.0 108.496 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.67 -37.96 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.04 2.493 . . . . 0.0 113.125 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 168.4 7.76 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.298 2.639 . . . . 0.0 109.995 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 pp -163.44 37.8 0.09 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.163 1.385 . . . . 0.0 113.868 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.0 t -50.63 139.77 20.37 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.704 1.201 . . . . 0.0 114.211 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.35 142.08 67.63 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.979 1.028 . . . . 0.0 111.867 -6.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.24 -23.31 45.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.309 2.006 . . . . 0.0 113.051 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -75.86 -5.93 48.36 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.041 1.336 . . . . 0.0 114.548 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 161.73 16.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.584 1.084 . . . . 0.0 112.862 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -70.67 168.95 15.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.81 0.814 . . . . 0.0 113.097 167.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.38 135.72 53.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.536 1.535 . . . . 0.0 110.441 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.21 149.03 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.716 0.806 . . . . 0.0 109.231 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.3 t -150.43 155.16 39.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.079 . . . . 0.0 110.414 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -123.99 129.69 51.34 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.514 1.126 . . . . 0.0 109.798 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 tt -113.83 121.44 44.01 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.943 1.697 . . . . 0.0 109.463 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -139.61 114.75 9.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.622 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.7 p -108.63 141.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.631 1.173 . . . . 0.0 109.517 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -144.7 148.19 33.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.321 1.448 . . . . 0.0 110.009 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.29 128.9 37.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.196 0.598 . . . . 0.0 110.174 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.7 p -79.44 -2.32 41.39 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -132.97 151.14 52.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.772 2.029 . . . . 0.0 110.08 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.2 t -66.85 141.38 96.75 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.499 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.27 128.95 13.98 Favored 'Cis proline' 0 C--N 1.352 0.761 0 CA-C-N 120.565 1.238 . . . . 0.0 111.616 -7.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.43 41.22 0.14 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.95 1.7 . . . . 0.0 112.236 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -62.5 143.59 56.99 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 111.491 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -59.55 122.45 14.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.782 -0.574 . . . . 0.0 110.366 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 65.9 t -80.68 -56.91 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.6 155.22 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 170.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -142.11 76.8 1.55 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.792 1.237 . . . . 0.0 108.695 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.19 -165.72 12.74 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.614 2.054 . . . . 0.0 111.608 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.98 170.72 16.06 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.831 -1.393 . . . . 0.0 111.12 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -153.46 157.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.715 -1.241 . . . . 0.0 108.033 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -112.83 128.84 56.55 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.925 -1.109 . . . . 0.0 108.445 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.61 155.48 17.57 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.89 0.876 . . . . 0.0 109.88 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -157.96 158.02 34.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.207 1.403 . . . . 0.0 109.579 174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.38 150.35 49.89 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.713 1.605 . . . . 0.0 108.708 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 75.6 m -105.75 110.37 64.11 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.47 50.74 2.04 Favored 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 125.221 3.948 . . . . 0.0 112.765 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.6 m -137.3 -53.97 0.69 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.989 1.716 . . . . 0.0 111.439 -172.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.486 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 63.5 p -127.29 21.9 6.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.317 1.047 . . . . 0.0 112.791 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.79 31.74 64.72 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.19 -0.944 . . . . 0.0 113.205 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -78.22 150.51 33.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.453 0.701 . . . . 0.0 110.787 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.8 t -128.65 137.57 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.5 m -142.12 129.32 20.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.644 1.577 . . . . 0.0 109.124 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.51 141.36 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.225 1.01 . . . . 0.0 110.133 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.04 127.34 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 127.079 2.151 . . . . 0.0 107.986 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -137.68 116.49 12.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.297 1.439 . . . . 0.0 108.546 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.52 156.46 36.71 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.875 1.27 . . . . 0.0 110.706 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.48 -14.41 7.81 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.14 -24.51 66.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.84 1.656 . . . . 0.0 114.005 169.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.6 p -146.7 -56.11 0.26 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.96 1.704 . . . . 0.0 111.692 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.16 138.92 97.56 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 0.0 111.841 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.02 -88.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.579 2.186 . . . . 0.0 111.625 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? 158.23 -33.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 129.561 3.145 . . . . 0.0 112.674 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -54.19 -36.91 63.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 113.459 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 15.5 ttm -103.67 151.48 22.92 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.939 1.295 . . . . 0.0 109.181 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.7 p -134.39 153.93 51.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.089 1.356 . . . . 0.0 110.287 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.34 110.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.3 m -93.47 130.7 39.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.831 0.852 . . . . 0.0 108.869 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -76.27 82.35 3.05 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.75 1.22 . . . . 0.0 109.634 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.93 -44.72 96.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.041 0.936 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -147.6 -178.52 6.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.769 2.028 . . . . 0.0 110.106 166.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -53.55 141.96 23.96 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.664 -1.272 . . . . 0.0 110.836 158.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.8 p 50.66 10.69 0.07 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.258 2.223 . . . . 0.0 116.142 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.23 95.65 4.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.983 1.713 . . . . 0.0 108.711 -169.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -105.16 149.57 25.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.7 tt -134.61 123.28 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.99 109.27 22.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.731 1.612 . . . . 0.0 108.598 -170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.62 116.86 32.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.169 1.388 . . . . 0.0 108.92 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.79 99.14 9.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.176 0.59 . . . . 0.0 110.967 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -88.27 -15.71 35.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.228 2.211 . . . . 0.0 114.295 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.24 165.36 24.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.614 1.166 . . . . 0.0 111.995 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -128.0 54.06 1.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.952 1.701 . . . . 0.0 110.365 -170.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.151 1.78 . . . . 0.0 114.798 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.002 0.43 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.57 141.99 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 171.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.95 151.35 30.13 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.805 -0.559 . . . . 0.0 110.034 173.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.66 -17.26 46.39 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.59 -1.319 . . . . 0.0 113.48 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -115.17 17.83 16.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.986 1.714 . . . . 0.0 113.668 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -139.55 172.58 12.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.564 1.545 . . . . 0.0 110.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -145.42 144.77 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.792 0.837 . . . . 0.0 110.628 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -127.58 145.94 50.7 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.148 0.975 . . . . 0.0 111.222 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -128.06 124.49 37.2 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.477 1.511 . . . . 0.0 107.497 -164.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 122.16 42.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 123.94 1.829 . . . . 0.0 111.052 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -93.18 42.58 1.1 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.477 1.911 . . . . 0.0 111.504 -167.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.86 155.2 12.5 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.575 2.036 . . . . 0.0 111.499 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -60.8 141.52 56.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.372 0.586 . . . . 0.0 110.135 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.4 t30 46.66 43.21 12.46 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.832 1.253 . . . . 0.0 114.238 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.304 30.9 p 49.18 36.42 9.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.257 2.223 . . . . 0.0 116.054 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -88.16 -24.95 23.2 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.51 -91.93 1.0 Allowed Glycine 0 N--CA 1.476 1.362 0 CA-C-N 119.559 1.072 . . . . 0.0 113.585 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.13 176.7 6.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 110.333 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -138.56 157.76 45.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.449 1.099 . . . . 0.0 112.336 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.78 152.18 39.96 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.186 1.794 . . . . 0.0 110.152 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -124.41 122.25 37.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.508 1.523 . . . . 0.0 108.972 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.04 148.51 43.49 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.294 1.438 . . . . 0.0 109.482 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -101.02 153.1 19.83 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.339 0.656 . . . . 0.0 109.949 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 147.53 23.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.975 -0.453 . . . . 0.0 112.163 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.38 41.55 90.88 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -129.19 130.83 46.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.833 1.253 . . . . 0.0 111.106 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -114.69 129.96 56.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.224 1.01 . . . . 0.0 108.836 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.79 109.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.662 1.585 . . . . 0.0 109.069 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -101.7 101.12 11.58 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.257 1.023 . . . . 0.0 109.11 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -70.45 -179.15 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.884 0.85 . . . . 0.0 111.226 165.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -127.06 157.17 40.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.547 1.139 . . . . 0.0 109.328 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.99 -12.17 59.04 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.016 -1.053 . . . . 0.0 113.496 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.14 97.71 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.615 1.102 . . . . 0.0 114.248 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.1 118.34 27.61 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.406 1.103 . . . . 0.0 110.482 170.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -18.91 62.33 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.949 -1.094 . . . . 0.0 112.458 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -61.49 -20.64 63.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.433 1.893 . . . . 0.0 112.357 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -60.89 -51.95 67.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.797 1.639 . . . . 0.0 112.367 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -70.13 -14.82 62.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.388 1.475 . . . . 0.0 113.286 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.9 -22.95 64.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.558 1.943 . . . . 0.0 113.731 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -46.92 121.22 3.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.669 1.187 . . . . 0.0 110.941 162.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.1 tpt -152.41 -19.95 0.17 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.842 . . . . 0.0 111.921 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -146.69 154.38 41.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.846 2.059 . . . . 0.0 108.856 172.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 p -172.54 155.22 3.32 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.574 1.55 . . . . 0.0 109.697 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 150.66 43.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.939 1.352 . . . . 0.0 112.399 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.83 135.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.776 1.63 . . . . 0.0 108.199 -168.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -98.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.446 1.498 . . . . 0.0 115.81 -171.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -160.29 -23.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.105 1.762 . . . . 0.0 112.473 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.56 25.63 8.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.714 1.605 . . . . 0.0 111.565 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.12 140.47 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 128.151 2.58 . . . . 0.0 108.831 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.64 153.12 29.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.448 0.699 . . . . 0.0 109.947 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.8 m -136.39 136.17 39.38 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.286 0.635 . . . . 0.0 109.732 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -125.79 130.63 51.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.72 131.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.454 1.501 . . . . 0.0 109.7 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -141.31 118.67 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.38 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -103.85 -39.46 6.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.643 0.777 . . . . 0.0 111.837 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -92.57 158.82 15.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.278 1.031 . . . . 0.0 111.098 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -159.59 128.72 5.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.639 1.176 . . . . 0.0 111.505 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -162.17 -21.91 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.273 0.6 OUTLIER 50.01 37.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 127.143 2.177 . . . . 0.0 114.234 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.57 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.1 1.76 . . . . 0.0 111.924 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -51.79 124.63 27.84 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.619 1.168 . . . . 0.0 113.467 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.42 -14.72 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.881 2.387 . . . . 0.0 113.008 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t -90.18 119.66 69.23 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 119.008 0.822 . . . . 0.0 109.804 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.84 117.71 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.219 1.279 . . . . 0.0 108.977 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.0 -152.86 3.34 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -85.46 104.36 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.602 -0.94 . . . . 0.0 109.958 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -140.08 155.21 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.827 1.651 . . . . 0.0 109.582 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.4 172.19 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.617 1.167 . . . . 0.0 110.777 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -119.59 94.36 4.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.458 1.503 . . . . 0.0 107.495 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -52.83 118.71 3.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.565 1.546 . . . . 0.0 109.063 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.45 149.26 10.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.588 0.755 . . . . 0.0 112.998 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.65 -13.8 11.18 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.8 118.99 0.87 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.343 0.973 . . . . 0.0 111.777 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.48 161.64 4.1 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.871 2.068 . . . . 0.0 111.207 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 m -115.45 131.4 56.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.082 1.353 . . . . 0.0 110.067 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -131.58 136.0 47.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.508 1.123 . . . . 0.0 110.104 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -138.47 10.75 2.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.467 1.107 . . . . 0.0 112.901 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.64 52.15 0.58 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.548 1.539 . . . . 0.0 109.94 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -74.13 39.16 0.11 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.922 1.289 . . . . 0.0 112.928 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -55.99 -30.67 62.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.002 1.721 . . . . 0.0 113.047 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -64.34 -18.24 64.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.6 mm -90.26 -23.42 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.627 1.571 . . . . 0.0 111.964 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 45.05 74.51 0.13 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.079 2.152 . . . . 0.0 114.537 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.4 -160.33 36.14 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.555 0.598 . . . . 0.0 112.096 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 87' ' ' SER . 0.4 OUTLIER -143.44 177.89 8.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.917 0.887 . . . . 0.0 110.861 172.15 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.409 ' H ' ' CD2' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -152.15 -46.3 0.11 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.216 1.007 . . . . 0.0 111.825 164.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.498 ' HE3' ' CG2' ' A' ' 203' ' ' THR . 2.0 ptmm? -140.7 156.22 46.27 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.95 140.42 34.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.148 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -129.08 125.01 36.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.39 131.36 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.353 1.461 . . . . 0.0 108.702 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.76 143.81 41.12 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.344 1.458 . . . . 0.0 109.97 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.12 26.27 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.15 3.9 . . . . 0.0 115.452 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.82 26.9 61.07 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.585 1.088 . . . . 0.0 113.582 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.1 -42.15 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 111.297 -168.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.72 146.55 32.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 109.983 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -88.69 -39.94 13.63 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.814 0.816 . . . . 0.0 111.637 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -152.0 158.77 43.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 107.191 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.25 174.06 7.53 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.916 -0.49 . . . . 0.0 109.981 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.08 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 111.185 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -71.71 131.83 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.76 139.78 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.693 1.197 . . . . 0.0 109.839 170.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -139.65 142.58 36.99 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.547 -0.721 . . . . 0.0 110.025 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 pt -91.95 144.28 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 122.91 0.484 . . . . 0.0 110.254 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.3 t -133.0 109.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.137 1.375 . . . . 0.0 108.686 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.07 118.18 17.73 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.679 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.87 -12.82 14.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.95 0.9 . . . . 0.0 113.002 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.49 -51.96 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.856 1.262 . . . . 0.0 111.681 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -92.7 110.72 22.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.088 0.955 . . . . 0.0 109.233 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 t -75.25 39.32 0.15 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.134 1.374 . . . . 0.0 114.013 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 m -140.48 -39.18 0.43 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.591 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.52 -160.49 0.07 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.585 1.154 . . . . 0.0 113.34 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.78 7.43 61.69 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 120.398 -1.439 . . . . 0.0 116.136 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.9 p -144.82 28.96 1.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.759 1.78 . . . . 0.0 114.663 -159.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -133.66 145.29 49.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.681 1.593 . . . . 0.0 109.193 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -132.79 112.2 11.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.149 0.98 . . . . 0.0 110.376 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.0 ttp -111.09 105.96 14.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.414 2.286 . . . . 0.0 110.544 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.8 m -92.21 126.55 37.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.569 0.699 . . . . 0.0 109.173 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.03 132.05 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.105 1.362 . . . . 0.0 108.933 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -137.04 89.33 16.83 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 123.62 0.768 . . . . 0.0 109.269 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.38 167.1 17.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.978 2.452 . . . . 0.0 112.668 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -37.57 98.36 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.437 2.295 . . . . 0.0 113.611 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.268 19.4 pt20 43.01 52.82 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.065 1.746 . . . . 0.0 114.87 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.61 148.0 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.162 1.785 . . . . 0.0 110.942 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -51.85 112.37 0.76 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.057 1.343 . . . . 0.0 111.067 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 152.79 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.323 1.049 . . . . 0.0 111.993 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.43 141.09 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.758 -0.589 . . . . 0.0 111.936 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.88 91.3 3.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.704 1.602 . . . . 0.0 109.896 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 42.3 t -74.06 131.65 41.55 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 121.785 -0.572 . . . . 0.0 109.691 169.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.77 139.39 48.91 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.86 128.98 39.81 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.932 -0.48 . . . . 0.0 110.303 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.47 -11.03 59.71 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.98 1.276 . . . . 0.0 115.189 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 145.47 41.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.695 1.748 . . . . 0.0 111.95 169.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.67 55.45 0.37 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.934 1.694 . . . . 0.0 112.957 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 57.88 95.72 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.737 2.415 . . . . 0.0 112.197 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.8 t -51.97 130.22 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.156 0.982 . . . . 0.0 112.225 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -80.09 122.28 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.793 0.837 . . . . 0.0 111.251 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.6 101.84 11.44 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.262 163.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.6 121.99 6.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.742 1.628 . . . . 0.0 110.534 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.87 121.44 43.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.816 0.846 . . . . 0.0 108.901 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.53 168.36 23.82 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.262 2.642 . . . . 0.0 111.75 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 131.79 51.45 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.698 -0.626 . . . . 0.0 110.792 174.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.99 149.27 33.84 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.777 1.631 . . . . 0.0 110.047 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.1 m -138.27 135.18 18.13 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 0.0 110.559 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.17 150.0 82.08 Favored 'Cis proline' 0 CA--C 1.544 1.022 0 CA-C-N 119.252 0.769 . . . . 0.0 112.001 -5.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.52 -24.24 49.2 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.027 1.818 . . . . 0.0 113.092 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.83 1.78 29.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -69.89 156.25 39.36 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.357 1.075 . . . . 0.0 112.843 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -83.67 135.67 34.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.284 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.4 tt -115.73 116.58 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.941 1.696 . . . . 0.0 108.401 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.49 142.9 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.921 -0.487 . . . . 0.0 110.749 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.0 p -142.91 140.56 31.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 122.088 0.946 . . . . 0.0 111.994 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -90.16 140.18 29.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.387 0.675 . . . . 0.0 110.148 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.17 113.94 18.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.732 1.613 . . . . 0.0 108.736 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 98.56 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.31 1.044 . . . . 0.0 109.517 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 3.9 p -115.4 145.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.541 1.136 . . . . 0.0 110.056 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.54 160.84 39.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.186 1.395 . . . . 0.0 112.454 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.56 146.63 46.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.017 1.327 . . . . 0.0 111.335 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.6 p -85.33 -12.22 52.79 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.34 171.79 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.813 1.245 . . . . 0.0 110.884 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -60.56 145.37 87.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 120.965 -1.085 . . . . 0.0 112.315 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.65 12.06 26.2 Favored 'Cis proline' 0 CA--C 1.55 1.287 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 3.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.22 13.53 8.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.869 1.668 . . . . 0.0 113.683 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.07 152.82 32.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 112.338 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -52.3 139.11 25.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.922 0.889 . . . . 0.0 112.92 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.56 -20.39 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.406 1.482 . . . . 0.0 111.937 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.403 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 95.0 t -152.66 131.78 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 126.776 2.03 . . . . 0.0 108.329 168.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -122.79 129.65 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.236 1.415 . . . . 0.0 109.084 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 176.63 -165.37 35.58 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.903 0.724 . . . . 0.0 112.695 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.39 156.01 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.183 0.992 . . . . 0.0 110.738 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 156.46 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.49 1.916 . . . . 0.0 108.246 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.56 134.59 54.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.83 157.88 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.65 154.14 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 107.64 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -118.85 160.5 21.8 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.441 1.096 . . . . 0.0 108.608 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.4 m -121.54 106.63 37.38 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 121.235 -0.915 . . . . 0.0 108.598 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.77 53.83 2.88 Favored 'Trans proline' 0 CA--C 1.542 0.92 1 C-N-CA 125.506 4.137 . . . . 0.0 112.545 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -126.66 -44.71 1.66 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.754 2.022 . . . . 0.0 110.713 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 82.4 p -144.91 6.55 1.19 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.521 1.128 . . . . 0.0 113.843 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.17 34.77 40.31 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.576 -1.327 . . . . 0.0 113.171 -171.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 149.81 35.86 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.884 -0.774 . . . . 0.0 110.752 173.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.21 132.2 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.681 1.192 . . . . 0.0 108.121 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 99.5 m -135.55 125.57 25.96 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.893 1.277 . . . . 0.0 109.307 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.56 130.0 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.334 1.054 . . . . 0.0 110.64 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 mt -108.83 141.33 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.275 2.23 . . . . 0.0 107.634 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 136.49 24.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.501 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -134.36 134.46 41.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.015 -170.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -58.39 -14.11 6.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.561 1.144 . . . . 0.0 113.955 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.07 -23.67 65.64 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.306 1.442 . . . . 0.0 114.492 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 p -145.28 -34.86 0.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.024 1.73 . . . . 0.0 113.646 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.25 129.99 89.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.775 0.83 . . . . 0.0 110.69 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.35 173.3 14.46 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.443 2.762 . . . . 0.0 112.069 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 5.97 32.32 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.214 1.406 . . . . 0.0 113.299 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -89.86 -37.2 14.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.968 1.707 . . . . 0.0 112.231 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.0 ttt -113.83 152.13 31.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.49 1.516 . . . . 0.0 109.279 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.5 p -133.21 144.31 49.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 0.0 110.756 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.88 119.94 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 88.5 m -115.42 114.51 25.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.036 1.334 . . . . 0.0 109.419 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.39 129.87 39.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.934 0.894 . . . . 0.0 110.972 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -31.89 3.78 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.326 1.05 . . . . 0.0 112.508 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -146.71 169.23 19.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.847 2.059 . . . . 0.0 109.702 171.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -59.19 -2.09 0.25 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.498 ' CG2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 t -156.64 32.62 0.31 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.586 2.354 . . . . 0.0 110.543 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -143.94 117.27 9.04 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.291 -1.506 . . . . 0.0 111.853 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 135.02 53.87 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.251 1.421 . . . . 0.0 110.616 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -118.15 117.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -97.69 91.72 5.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -75.51 127.08 32.32 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.231 0.612 . . . . 0.0 109.587 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.4 tp -111.18 110.56 21.12 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 111.679 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -107.78 17.35 22.63 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.986 2.114 . . . . 0.0 112.866 -173.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 t -152.16 155.15 37.25 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.343 1.457 . . . . 0.0 111.723 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -9.73 15.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.107 0.963 . . . . 0.0 113.044 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.79 139.93 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.34 1.456 . . . . 0.0 110.643 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.81 149.56 37.88 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.714 -0.616 . . . . 0.0 110.918 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.55 -24.44 47.05 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 113.324 170.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -111.58 12.51 21.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.0 1.72 . . . . 0.0 112.962 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -146.4 173.34 12.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.63 1.572 . . . . 0.0 111.145 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.7 158.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.074 0.949 . . . . 0.0 110.788 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.9 149.45 48.98 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.187 0.995 . . . . 0.0 110.665 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -127.2 132.01 50.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.133 1.373 . . . . 0.0 108.184 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -126.55 123.21 37.2 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.245 1.498 . . . . 0.0 110.443 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -83.59 33.52 0.47 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.644 1.578 . . . . 0.0 112.574 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.53 148.56 11.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.972 1.748 . . . . 0.0 111.993 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.34 147.91 9.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.335 1.454 . . . . 0.0 112.025 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 49.62 42.67 23.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.323 1.049 . . . . 0.0 113.46 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m 56.38 65.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.873 1.669 . . . . 0.0 113.914 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -130.62 -179.88 5.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.883 1.273 . . . . 0.0 112.529 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 -95.09 1.23 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.01 1.291 . . . . 0.0 113.335 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.64 169.23 15.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.516 1.527 . . . . 0.0 110.36 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.9 p -135.07 149.72 50.14 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.048 0.939 . . . . 0.0 112.16 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 156.36 44.72 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.534 1.934 . . . . 0.0 110.271 -174.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.55 132.49 48.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.853 1.261 . . . . 0.0 109.642 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.25 122.0 30.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.077 1.351 . . . . 0.0 108.928 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -74.56 158.76 33.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.332 0.653 . . . . 0.0 110.926 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -64.98 154.78 36.63 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.505 -0.747 . . . . 0.0 111.622 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.15 45.51 96.38 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.367 0.508 . . . . 0.0 112.582 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -121.78 148.96 43.98 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.703 1.201 . . . . 0.0 110.319 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -136.95 119.3 15.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.32 117.81 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 109.664 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.558 ' HG3' ' HZ2' ' A' ' 88' ' ' LYS . 6.1 tmm_? -106.05 100.04 9.6 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.78 -176.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.79 162.33 26.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.239 170.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -107.91 162.91 13.59 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -67.02 -15.3 63.64 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.029 -1.045 . . . . 0.0 113.35 170.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.32 -20.55 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.308 0.956 . . . . 0.0 114.449 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -80.99 109.55 15.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.563 1.182 . . . . 0.0 111.01 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.14 66.72 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.531 -1.355 . . . . 0.0 112.623 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -57.42 -28.28 63.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.904 2.082 . . . . 0.0 113.514 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -73.26 -52.07 15.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.55 1.14 . . . . 0.0 111.742 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.74 -15.22 61.25 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.104 0.962 . . . . 0.0 112.989 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.88 0.93 4.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.102 2.561 . . . . 0.0 114.73 168.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -44.07 135.2 4.38 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.693 1.133 . . . . 0.0 110.222 164.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.76 -54.56 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.4 p -146.46 164.22 33.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.662 0.744 . . . . 0.0 112.004 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 p -161.68 159.68 27.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.226 -0.922 . . . . 0.0 110.423 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mp -123.87 132.07 53.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.337 1.055 . . . . 0.0 108.499 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -123.49 127.01 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 124.752 1.221 . . . . 0.0 109.512 -177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.548 2.023 . . . . 0.0 115.844 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -171.71 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.256 1.422 . . . . 0.0 114.0 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -120.93 29.49 7.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.928 1.691 . . . . 0.0 111.751 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.93 138.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.296 1.439 . . . . 0.0 110.776 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -115.45 132.87 56.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.684 1.194 . . . . 0.0 109.316 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.26 143.49 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -123.05 131.45 53.7 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.732 1.613 . . . . 0.0 108.749 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 pt -137.56 118.37 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.822 1.249 . . . . 0.0 111.037 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.08 138.03 53.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 110.311 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.4 -46.03 4.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.501 0.72 . . . . 0.0 112.917 -164.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -151.93 131.62 13.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.821 1.248 . . . . 0.0 108.684 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -146.56 138.48 24.74 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.263 1.425 . . . . 0.0 107.86 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.32 9.72 0.56 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.247 0.619 . . . . 0.0 111.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt 43.47 27.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 129.655 3.182 . . . . 0.0 116.259 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -173.39 -23.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.294 2.238 . . . . 0.0 111.429 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -46.98 136.71 8.06 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.125 1.37 . . . . 0.0 113.241 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.38 -5.38 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.294 2.662 . . . . 0.0 113.01 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 90.54 50.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 109.808 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.24 109.97 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.835 1.69 . . . . 0.0 108.092 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.37 159.1 20.99 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 153.62 18.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.454 1.121 . . . . 0.0 111.191 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -148.55 144.69 27.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.664 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.4 166.64 27.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.474 1.131 . . . . 0.0 111.071 170.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -126.34 111.63 14.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.055 1.342 . . . . 0.0 109.32 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.08 136.13 57.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.819 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.02 144.26 9.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 112.665 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.45 -10.82 8.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.46 109.62 0.41 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.04 1.781 . . . . 0.0 111.829 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.79 168.87 0.52 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.431 2.292 . . . . 0.0 111.331 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.1 m -111.21 142.38 43.49 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.527 1.131 . . . . 0.0 109.49 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -129.6 120.45 25.29 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.833 1.253 . . . . 0.0 108.095 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -128.7 -18.28 3.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.63 -80.42 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 109.419 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp 44.77 22.34 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.927 1.691 . . . . 0.0 113.762 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -78.29 -36.22 46.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.434 1.494 . . . . 0.0 110.055 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.6 t -69.07 -30.44 68.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.551 1.14 . . . . 0.0 112.859 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.39 -27.24 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.234 1.414 . . . . 0.0 112.105 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 57.02 45.57 20.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.491 1.516 . . . . 0.0 112.304 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.62 -167.94 43.87 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.533 1.063 . . . . 0.0 113.94 -172.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -173.55 4.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.071 1.349 . . . . 0.0 111.246 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 85.6 p -149.19 -34.63 0.19 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.843 1.257 . . . . 0.0 112.819 167.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.558 ' HZ2' ' HG3' ' A' ' 30' ' ' ARG . 7.4 mttp -99.29 127.28 45.28 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.293 1.037 . . . . 0.0 110.093 173.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.35 136.37 54.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.184 1.393 . . . . 0.0 108.796 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -143.89 153.55 42.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.408 0.683 . . . . 0.0 109.265 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.69 114.42 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 124.75 1.22 . . . . 0.0 108.707 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.63 115.27 31.02 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.492 0.717 . . . . 0.0 110.636 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 95' ' ' ALA . 60.2 Cg_endo -71.73 166.22 30.12 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.938 2.425 . . . . 0.0 112.633 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.1 33.65 0.19 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.158 2.313 . . . . 0.0 114.831 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 93' ' ' PRO . . . -117.71 -27.11 6.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.055 2.542 . . . . 0.0 110.986 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -140.41 161.23 38.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.038 1.735 . . . . 0.0 110.749 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -104.21 -45.64 4.65 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.095 -1.003 . . . . 0.0 112.501 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.34 165.18 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.186 1.794 . . . . 0.0 108.333 174.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.74 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.252 0.549 . . . . 0.0 109.753 169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.06 139.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.978 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -97.2 121.44 39.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.943 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 167.46 29.36 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.689 1.196 . . . . 0.0 109.623 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.34 148.63 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 125.38 1.472 . . . . 0.0 109.678 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.61 114.08 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.964 0.906 . . . . 0.0 109.149 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.93 88.72 2.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 111.92 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.41 19.48 20.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.86 1.264 . . . . 0.0 112.028 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.71 -66.08 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.544 1.538 . . . . 0.0 111.458 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -85.16 -19.59 31.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.949 1.3 . . . . 0.0 111.989 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t 62.51 39.46 11.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.651 1.981 . . . . 0.0 113.358 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.8 m -131.43 -38.36 1.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.762 1.225 . . . . 0.0 113.915 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.04 -177.86 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.163 1.385 . . . . 0.0 114.338 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.74 20.46 39.85 Favored Glycine 0 CA--C 1.54 1.653 0 O-C-N 120.618 -1.301 . . . . 0.0 115.037 -171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.6 p -139.63 17.66 2.53 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.772 1.629 . . . . 0.0 113.327 -166.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.38 132.45 27.89 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.404 1.882 . . . . 0.0 109.385 -170.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -117.23 121.89 42.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.541 1.136 . . . . 0.0 110.163 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttt -115.8 122.37 45.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.706 1.203 . . . . 0.0 109.637 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -119.41 116.22 25.72 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.02 1.328 . . . . 0.0 108.373 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.09 138.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.266 1.426 . . . . 0.0 108.818 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 t -154.67 99.2 2.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.405 0.682 . . . . 0.0 110.842 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.38 168.26 16.63 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.346 2.697 . . . . 0.0 112.905 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -34.99 95.0 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.138 2.175 . . . . 0.0 114.884 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 37.55 65.85 0.5 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.892 2.077 . . . . 0.0 115.099 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.2 155.26 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.663 . . . . 0.0 110.41 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.01 100.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.352 1.461 . . . . 0.0 111.811 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -59.01 151.39 22.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.444 0.64 . . . . 0.0 110.327 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.72 124.0 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.13 107.83 15.4 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.673 1.589 . . . . 0.0 108.802 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.88 160.49 24.64 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 160.72 16.19 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.197 0.599 . . . . 0.0 110.848 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.54 53.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.842 2.457 . . . . 0.0 114.727 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.01 -21.81 0.07 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.74 2.591 . . . . 0.0 113.776 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.21 156.96 23.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.156 1.478 . . . . 0.0 111.808 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.7 -16.64 29.93 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.302 -0.874 . . . . 0.0 112.793 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -176.66 115.97 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.78 2.832 . . . . 0.0 108.253 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.56 126.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.238 -1.539 . . . . 0.0 109.559 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 127.98 33.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.922 0.489 . . . . 0.0 110.87 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.23 109.55 54.15 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.161 1.384 . . . . 0.0 109.817 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.59 138.87 33.08 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.429 2.086 . . . . 0.0 110.556 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.62 123.76 18.57 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.733 1.213 . . . . 0.0 109.199 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.68 164.51 35.18 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.831 2.354 . . . . 0.0 112.055 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 134.02 55.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.29 0.567 . . . . 0.0 111.735 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.15 146.59 40.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.921 1.688 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.8 m -142.55 136.05 14.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 124.603 1.161 . . . . 0.0 109.874 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.7 154.95 75.72 Favored 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 119.844 0.98 . . . . 0.0 113.006 -4.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -64.33 -32.2 61.7 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.064 1.843 . . . . 0.0 112.509 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.59 -12.48 58.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.662 1.585 . . . . 0.0 114.168 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.32 174.75 6.07 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.161 0.981 . . . . 0.0 112.89 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.81 149.23 45.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.994 1.317 . . . . 0.0 111.574 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.28 122.76 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.964 1.706 . . . . 0.0 109.139 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.84 140.69 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.411 0.624 . . . . 0.0 110.722 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.6 t -141.14 137.93 33.1 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.87 1.268 . . . . 0.0 110.885 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -91.15 139.81 30.4 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -130.48 116.72 18.61 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.869 1.268 . . . . 0.0 108.47 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.29 124.81 37.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.67 133.25 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.719 1.208 . . . . 0.0 110.559 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.81 145.3 56.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.426 0.631 . . . . 0.0 111.585 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.7 p -81.68 -5.24 57.92 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.113 1.365 . . . . 0.0 113.076 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -135.56 166.55 22.95 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.087 1.755 . . . . 0.0 111.194 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 t -80.39 142.87 54.82 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.623 0.769 . . . . 0.0 112.671 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.36 132.3 21.32 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.117 1.077 . . . . 0.0 110.993 -9.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -75.08 36.26 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.627 1.571 . . . . 0.0 112.171 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.93 132.29 41.8 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.701 1.2 . . . . 0.0 109.565 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -52.36 148.44 6.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.221 -0.299 . . . . 0.0 110.96 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.57 -29.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.292 1.037 . . . . 0.0 112.404 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.96 143.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.935 1.694 . . . . 0.0 109.306 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.95 122.0 14.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.366 1.467 . . . . 0.0 109.035 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.21 -165.25 31.67 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 121.906 0.725 . . . . 0.0 114.262 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.36 144.96 34.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.426 1.09 . . . . 0.0 110.256 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.86 155.58 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.215 1.806 . . . . 0.0 108.934 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -125.32 126.05 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.406 -0.809 . . . . 0.0 108.867 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -95.98 139.38 32.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -133.24 150.39 51.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.376 1.87 . . . . 0.0 108.414 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -122.94 150.57 42.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.005 0.922 . . . . 0.0 109.417 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.25 105.89 56.14 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.676 0.79 . . . . 0.0 109.326 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.9 51.42 1.97 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.354 4.036 . . . . 0.0 113.614 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.7 m -132.57 -41.24 0.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.72 2.008 . . . . 0.0 111.703 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.8 t -145.92 23.68 1.37 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 123.078 1.418 . . . . 0.0 112.098 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.15 46.41 56.52 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.595 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -83.5 156.13 23.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.479 1.112 . . . . 0.0 110.423 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.23 134.82 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.9 m -124.83 150.26 46.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.855 2.062 . . . . 0.0 108.421 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 123.77 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.226 1.011 . . . . 0.0 109.155 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.11 133.5 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.3 1.44 . . . . 0.0 107.338 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.32 138.9 25.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.639 1.576 . . . . 0.0 107.635 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 147.68 50.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.786 1.235 . . . . 0.0 108.494 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.17 -17.84 59.19 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.311 -0.868 . . . . 0.0 112.593 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.35 -12.68 61.23 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.307 2.243 . . . . 0.0 114.013 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.4 p -137.02 -44.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.583 1.553 . . . . 0.0 111.872 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -68.68 160.97 74.51 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.107 1.763 . . . . 0.0 111.324 169.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -76.72 -2.16 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.848 3.032 . . . . 0.0 113.859 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 53.69 15.56 0.81 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.709 2.404 . . . . 0.0 115.113 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.39 -0.67 8.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.867 1.667 . . . . 0.0 113.398 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.7 ttt -125.62 148.61 48.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.817 2.047 . . . . 0.0 107.507 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -133.75 156.97 47.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.724 0.81 . . . . 0.0 109.846 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.9 t -117.58 125.31 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.251 0.621 . . . . 0.0 109.563 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 41.5 m -110.61 110.35 21.01 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.602 1.961 . . . . 0.0 108.229 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.09 103.97 5.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.086 0.955 . . . . 0.0 110.543 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.8 -34.55 19.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.317 0.647 . . . . 0.0 111.257 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -142.44 -177.62 5.36 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.301 1.84 . . . . 0.0 112.739 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -66.97 -17.39 64.9 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.9 p -138.68 10.37 2.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 112.644 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.4 m -125.18 114.13 18.59 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.279 1.032 . . . . 0.0 110.975 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.59 138.1 52.8 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.433 1.493 . . . . 0.0 109.258 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 48.8 mt -119.79 122.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.36 104.79 16.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.981 1.312 . . . . 0.0 109.094 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -87.23 126.88 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.774 0.83 . . . . 0.0 109.019 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.46 118.99 31.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.702 0.801 . . . . 0.0 109.981 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -110.86 -27.16 8.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.877 1.271 . . . . 0.0 113.374 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.7 m -103.8 177.88 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 112.209 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -134.3 72.97 1.47 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.248 1.419 . . . . 0.0 109.644 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.341 1.056 . . . . 0.0 113.672 178.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.369 0.604 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.66 152.27 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.363 1.465 . . . . 0.0 111.213 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 139.94 51.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.594 1.158 . . . . 0.0 111.082 171.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.6 -17.74 60.76 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.684 -1.26 . . . . 0.0 113.568 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.31 3.53 12.58 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.284 1.834 . . . . 0.0 113.837 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -149.1 173.19 13.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.076 2.55 . . . . 0.0 109.399 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.63 161.5 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.729 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -145.48 142.3 29.12 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.335 0.654 . . . . 0.0 110.341 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.51 138.04 54.04 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.413 1.485 . . . . 0.0 108.71 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.47 127.27 42.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.141 0.972 . . . . 0.0 110.365 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -80.49 58.24 3.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.145 1.378 . . . . 0.0 111.19 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.9 139.32 3.94 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.587 -0.696 . . . . 0.0 112.278 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.922 0.889 . . . . 0.0 108.831 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 75.99 34.02 0.56 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.789 1.636 . . . . 0.0 112.874 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.7 t 62.89 63.96 0.92 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.622 1.569 . . . . 0.0 112.831 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.6 p -137.28 -178.53 5.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.253 1.821 . . . . 0.0 112.99 -172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.84 -95.39 0.63 Allowed Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.63 1.586 . . . . 0.0 114.317 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -123.37 164.23 19.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.99 1.316 . . . . 0.0 110.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.7 p -132.92 149.32 52.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.72 1.208 . . . . 0.0 112.036 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.95 148.42 29.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.523 1.529 . . . . 0.0 109.603 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -126.93 146.31 50.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.106 0.962 . . . . 0.0 110.258 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.42 132.31 31.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.875 1.322 . . . . 0.0 111.721 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.7 146.75 49.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.964 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -62.66 142.62 58.0 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.415 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 52.45 34.75 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.083 0.401 . . . . 0.0 113.428 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 158.1 45.05 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.841 0.856 . . . . 0.0 112.101 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -138.6 135.33 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.69 119.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.321 1.048 . . . . 0.0 109.29 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -99.9 103.5 15.09 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.25 155.2 23.79 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.605 1.162 . . . . 0.0 110.663 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -103.48 137.22 41.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.445 0.698 . . . . 0.0 110.029 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -59.78 -17.37 35.04 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.77 -25.41 63.64 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.424 1.012 . . . . 0.0 114.342 170.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.01 119.18 38.54 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.534 1.167 . . . . 0.0 109.975 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -12.5 3.44 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 170.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -58.2 -25.82 62.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.196 1.398 . . . . 0.0 112.22 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.12 -56.03 10.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.098 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.07 -15.24 21.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.962 1.705 . . . . 0.0 113.771 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -28.52 44.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.807 1.643 . . . . 0.0 113.522 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -47.36 122.22 4.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.229 0.538 . . . . 0.0 111.575 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.9 tpt -149.23 -31.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 111.918 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.6 p -145.32 162.06 38.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 111.684 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.1 p -156.05 149.16 24.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.322 1.449 . . . . 0.0 110.407 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.27 136.23 53.19 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.56 129.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.232 1.413 . . . . 0.0 109.563 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.36 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.574 2.035 . . . . 0.0 116.11 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -166.36 -20.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 113.267 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -119.92 22.92 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.01 1.724 . . . . 0.0 111.607 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.21 143.25 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.93 2.092 . . . . 0.0 109.508 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -120.94 145.66 47.46 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.91 1.284 . . . . 0.0 109.807 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.4 m -112.29 142.89 44.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.606 1.194 . . . . 0.0 109.957 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -132.33 130.79 41.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.44 123.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.105 . . . . 0.0 109.639 -172.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -131.92 134.31 45.53 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.094 1.358 . . . . 0.0 110.549 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.58 -34.22 7.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.05 0.94 . . . . 0.0 112.935 -168.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.42 157.27 46.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.593 1.957 . . . . 0.0 107.223 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -142.39 131.79 23.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.111 0.964 . . . . 0.0 109.743 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.53 162.68 0.7 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.105 1.762 . . . . 0.0 110.68 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.34 15.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 112.556 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.14 28.82 1.1 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.04 2.136 . . . . 0.0 111.147 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 t -99.53 139.96 21.26 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.929 1.291 . . . . 0.0 112.456 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.39 -16.69 11.91 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.45 2.767 . . . . 0.0 114.281 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 t -124.92 137.59 29.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.73 150.32 83.53 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.43 -161.29 5.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.426 1.014 . . . . 0.0 112.241 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.16 134.8 51.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 108.59 167.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -159.43 155.66 27.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.568 1.547 . . . . 0.0 110.482 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -158.61 147.32 18.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.732 1.253 . . . . 0.0 113.027 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.73 95.26 9.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.848 2.059 . . . . 0.0 109.676 168.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.6 134.14 55.89 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.22 151.46 15.67 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.89 -8.61 7.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.46 89.93 0.11 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.236 -0.915 . . . . 0.0 112.644 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.1 p -162.42 169.41 20.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.355 1.074 . . . . 0.0 112.851 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -104.54 133.34 49.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.584 1.554 . . . . 0.0 109.107 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -128.67 115.4 17.97 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.084 0.954 . . . . 0.0 109.682 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -141.53 15.56 2.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 112.257 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -153.71 50.57 0.68 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.932 1.293 . . . . 0.0 109.96 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.01 42.25 0.39 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.649 1.18 . . . . 0.0 110.841 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -66.31 -30.08 70.42 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 119.971 -1.706 . . . . 0.0 112.385 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -63.26 -23.94 67.65 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.196 0.998 . . . . 0.0 112.88 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.24 -34.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.674 1.99 . . . . 0.0 111.421 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.92 40.83 22.1 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.898 1.679 . . . . 0.0 113.24 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 168.89 33.95 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.668 1.128 . . . . 0.0 112.287 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.44 -173.91 3.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.409 1.484 . . . . 0.0 112.39 -170.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 84.8 p -145.83 -28.18 0.43 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.36 139.26 51.64 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.501 1.52 . . . . 0.0 110.03 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.79 127.39 40.25 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.023 1.329 . . . . 0.0 107.673 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -136.91 130.44 31.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.703 0.801 . . . . 0.0 109.11 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.61 118.77 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.218 1.407 . . . . 0.0 107.541 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.84 123.27 27.46 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.473 1.109 . . . . 0.0 109.061 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.54 160.48 41.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.999 2.466 . . . . 0.0 111.107 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.17 24.6 0.2 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 125.831 1.682 . . . . 0.0 116.01 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.13 -20.94 6.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.236 2.215 . . . . 0.0 112.816 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.06 158.93 32.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.821 1.648 . . . . 0.0 109.399 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.13 -38.8 7.98 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.252 -0.905 . . . . 0.0 112.826 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 -149.98 155.52 40.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.101 1.361 . . . . 0.0 108.878 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.78 146.06 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.03 0.532 . . . . 0.0 110.072 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.02 134.55 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.253 1.021 . . . . 0.0 110.539 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -84.72 126.18 33.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.1 m -124.89 140.0 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.555 0.742 . . . . 0.0 109.548 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.29 161.83 30.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.295 1.038 . . . . 0.0 110.716 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.01 134.94 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.984 0.913 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.7 t -127.4 108.27 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -76.21 118.31 18.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.735 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -102.33 -21.69 14.26 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.319 1.047 . . . . 0.0 112.466 170.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.21 -67.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.192 0.997 . . . . 0.0 111.971 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -85.2 97.62 10.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.852 1.261 . . . . 0.0 110.393 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -70.17 47.84 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.26 1.824 . . . . 0.0 114.417 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.8 m -144.68 -36.16 0.32 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.123 2.569 . . . . 0.0 111.82 -171.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.29 -153.58 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 53.03 25.18 23.5 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 120.224 1.375 . . . . 0.0 116.203 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 m -143.82 5.66 1.36 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.974 1.71 . . . . 0.0 114.935 -167.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -133.58 120.3 20.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.431 1.493 . . . . 0.0 111.855 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.26 137.99 32.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.315 1.046 . . . . 0.0 109.916 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 119.38 34.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.261 2.224 . . . . 0.0 108.662 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 m -119.07 119.5 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.41 128.83 73.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -117.49 89.11 31.12 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.233 1.413 . . . . 0.0 109.226 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.07 160.36 49.01 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.668 2.912 . . . . 0.0 112.035 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -42.94 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.288 2.635 . . . . 0.0 116.084 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 44.48 39.7 3.39 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.836 1.654 . . . . 0.0 113.948 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.25 154.92 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.734 2.014 . . . . 0.0 109.683 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -45.95 98.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 112.752 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 151.06 36.17 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 0.0 111.046 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.46 125.41 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.882 0.873 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.17 105.45 17.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.012 1.325 . . . . 0.0 108.638 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.4 p -103.06 164.99 11.28 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.053 0.941 . . . . 0.0 110.796 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -142.46 159.9 41.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.764 0.825 . . . . 0.0 110.65 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -60.54 81.85 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 126.339 1.856 . . . . 0.0 114.526 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.22 0.18 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.939 1.733 . . . . 0.0 112.159 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.12 131.43 49.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.978 0.894 . . . . 0.0 111.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -74.95 70.52 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.32 1.448 . . . . 0.0 112.466 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 63.3 84.3 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.23 2.212 . . . . 0.0 110.919 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.61 147.96 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.603 -0.686 . . . . 0.0 110.599 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.1 146.06 24.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.886 0.474 . . . . 0.0 111.199 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.66 97.09 44.82 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.195 1.398 . . . . 0.0 108.106 166.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.51 137.51 27.99 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.542 2.161 . . . . 0.0 111.072 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.68 127.62 23.52 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.508 1.123 . . . . 0.0 107.997 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.22 -178.7 3.77 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.326 3.35 . . . . 0.0 111.327 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 149.41 47.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.84 0.829 . . . . 0.0 112.358 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.02 143.39 21.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.432 1.893 . . . . 0.0 109.46 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.8 m -125.83 130.62 23.98 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 124.275 1.03 . . . . 0.0 109.534 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.1 150.78 79.37 Favored 'Cis proline' 0 CA--C 1.545 1.038 0 CA-C-N 119.368 0.81 . . . . 0.0 112.435 -3.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.27 -22.69 39.76 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.76 1.64 . . . . 0.0 112.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.01 4.87 15.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.543 1.537 . . . . 0.0 114.548 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 148.71 46.68 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.727 -1.233 . . . . 0.0 111.992 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 155.57 36.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 112.182 168.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 tt -132.99 114.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 109.155 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 138.91 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.331 0.652 . . . . 0.0 109.844 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.1 p -142.57 145.99 34.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.033 0.921 . . . . 0.0 111.221 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -86.49 145.72 26.69 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 tt -134.6 122.49 22.39 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.993 0.917 . . . . 0.0 110.035 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 t -131.14 138.31 49.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.434 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.02 134.11 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.72 50.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.89 0.876 . . . . 0.0 109.885 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.26 129.46 40.04 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.156 -0.34 . . . . 0.0 110.253 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.9 p -77.41 -10.37 59.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.81 0.844 . . . . 0.0 112.855 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.74 164.43 17.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.085 2.154 . . . . 0.0 111.301 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.9 t -75.17 141.29 74.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.63 -0.669 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.35 129.58 15.45 Favored 'Cis proline' 0 C--N 1.354 0.861 0 CA-C-N 120.279 1.135 . . . . 0.0 111.091 -9.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -73.73 34.38 0.08 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.978 1.711 . . . . 0.0 113.546 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.23 151.17 23.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 113.039 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.21 102.62 2.14 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.916 0.886 . . . . 0.0 110.381 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.94 -39.1 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.82 2.048 . . . . 0.0 111.495 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.53 143.76 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.2 1.4 . . . . 0.0 108.252 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -148.77 74.46 1.27 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.962 0.905 . . . . 0.0 109.273 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -140.69 -156.13 6.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.424 1.488 . . . . 0.0 112.039 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 55.2 m -141.69 164.73 29.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.95 0.9 . . . . 0.0 110.434 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.73 156.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.444 1.498 . . . . 0.0 108.176 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.01 134.39 53.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.141 -0.974 . . . . 0.0 108.65 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.05 160.08 16.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.486 1.115 . . . . 0.0 109.609 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -159.22 154.31 25.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.269 1.428 . . . . 0.0 109.262 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -128.94 142.83 50.81 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.937 1.295 . . . . 0.0 109.168 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.6 m -101.86 109.66 60.21 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.376 0.67 . . . . 0.0 109.197 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.63 47.65 1.71 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 125.227 3.952 . . . . 0.0 113.098 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -130.27 -49.73 1.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.105 1.762 . . . . 0.0 110.462 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.2 p -138.46 24.71 2.68 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.196 1.398 . . . . 0.0 112.609 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.99 23.75 64.08 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.306 0.955 . . . . 0.0 114.154 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 158.73 35.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.327 1.051 . . . . 0.0 111.318 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.19 143.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.705 1.602 . . . . 0.0 107.819 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 59.4 m -139.49 128.73 23.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.841 1.256 . . . . 0.0 108.587 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.07 126.61 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.866 0.866 . . . . 0.0 110.233 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.71 130.18 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.902 1.281 . . . . 0.0 108.224 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -140.03 125.86 19.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.198 1.799 . . . . 0.0 108.468 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 158.56 42.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.164 1.386 . . . . 0.0 109.943 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.59 -18.36 19.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.648 1.179 . . . . 0.0 113.274 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.78 -24.88 64.45 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.967 1.707 . . . . 0.0 114.609 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.0 p -150.15 -44.17 0.13 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.756 1.223 . . . . 0.0 114.1 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.86 144.28 51.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.895 1.278 . . . . 0.0 110.072 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.47 -78.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 121.268 1.312 . . . . 0.0 113.437 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 156.06 -44.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 130.262 3.425 . . . . 0.0 112.003 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -57.97 -25.18 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.058 1.743 . . . . 0.0 113.533 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -119.46 131.85 55.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.737 1.615 . . . . 0.0 107.433 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -132.09 149.68 52.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 110.174 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.69 131.23 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.3 t -120.08 153.76 35.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.882 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -105.04 114.4 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.731 0.812 . . . . 0.0 109.897 -176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.48 -33.62 60.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -134.42 -175.6 3.93 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.352 1.061 . . . . 0.0 112.968 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.85 -30.91 68.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.361 1.064 . . . . 0.0 113.319 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.1 p -139.81 13.72 2.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.47 1.908 . . . . 0.0 112.591 -168.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 t -129.07 123.57 32.6 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.668 1.187 . . . . 0.0 110.958 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -130.04 146.63 51.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.812 1.645 . . . . 0.0 109.819 -171.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.63 119.2 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.81 107.76 19.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.737 . . . . 0.0 109.685 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.25 140.69 29.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.842 1.657 . . . . 0.0 109.998 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.39 110.49 12.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.913 0.885 . . . . 0.0 110.569 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.5 13.06 13.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.567 1.947 . . . . 0.0 113.861 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.13 135.4 3.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.1 1.76 . . . . 0.0 109.849 166.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.91 -4.44 35.05 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.651 0 C-N-CA 126.206 1.802 . . . . 0.0 115.332 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -96.75 129.67 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.406 1.483 . . . . 0.0 110.122 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.74 148.31 49.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.24 -21.55 24.27 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.666 -1.271 . . . . 0.0 113.098 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -112.71 11.65 19.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.474 1.91 . . . . 0.0 113.729 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -144.08 172.65 12.6 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.912 2.085 . . . . 0.0 110.402 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.26 156.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.237 -0.914 . . . . 0.0 110.692 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 134.25 26.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.817 0.847 . . . . 0.0 110.783 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -118.5 154.46 32.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.425 1.09 . . . . 0.0 110.281 -168.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -138.15 126.12 22.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.782 1.277 . . . . 0.0 110.984 -166.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -96.92 44.01 1.06 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.287 1.041 . . . . 0.0 112.647 -165.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.57 137.6 3.84 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.72 1.628 . . . . 0.0 110.778 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -61.32 133.93 56.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.925 0.89 . . . . 0.0 109.6 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 83.94 27.5 0.09 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.913 2.085 . . . . 0.0 113.058 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.79 59.0 4.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.242 1.417 . . . . 0.0 113.154 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.3 p -128.05 -174.06 3.1 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.98 1.712 . . . . 0.0 112.032 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.6 -98.62 1.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.861 1.219 . . . . 0.0 112.634 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.2 175.97 8.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.205 1.402 . . . . 0.0 110.753 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -133.42 158.61 42.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 111.228 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.58 152.33 37.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.963 1.305 . . . . 0.0 110.491 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.49 140.96 52.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.768 0.827 . . . . 0.0 111.731 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -137.9 134.24 34.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.255 1.422 . . . . 0.0 110.393 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.71 159.37 20.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.727 0.811 . . . . 0.0 111.577 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 155.27 13.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.036 -0.415 . . . . 0.0 112.051 168.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.57 93.95 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.736 0.684 . . . . 0.0 113.254 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -125.16 124.34 41.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.448 1.099 . . . . 0.0 110.731 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -122.62 124.18 42.88 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 108.481 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.74 133.52 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.521 1.153 . . . . 0.0 109.858 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -114.51 83.69 1.93 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.649 1.98 . . . . 0.0 107.922 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.2 167.35 14.41 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.999 0.904 . . . . 0.0 111.382 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -117.96 159.81 22.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 109.807 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -17.97 63.63 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -36.24 73.55 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.052 1.31 . . . . 0.0 114.191 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -76.96 110.73 11.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.496 1.148 . . . . 0.0 109.345 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -24.31 66.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.182 -1.574 . . . . 0.0 112.563 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -61.47 -21.66 64.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.734 1.614 . . . . 0.0 112.363 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -71.88 -53.93 11.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.642 1.177 . . . . 0.0 112.243 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -24.29 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -55.05 -27.62 46.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.023 1.729 . . . . 0.0 114.467 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -51.2 108.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.435 1.016 . . . . 0.0 111.707 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.9 tpt -132.35 -29.03 1.62 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.028 0.931 . . . . 0.0 112.663 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.9 m -139.33 164.24 30.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.643 2.377 . . . . 0.0 109.438 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.5 163.26 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.43 1.092 . . . . 0.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pp -146.75 148.86 32.39 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 123.17 1.462 . . . . 0.0 111.326 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.04 133.33 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.086 1.754 . . . . 0.0 107.803 -167.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.44 -92.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.181 1.372 . . . . 0.0 116.002 -168.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -170.25 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.111 1.364 . . . . 0.0 113.772 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -122.11 28.17 7.65 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.679 1.992 . . . . 0.0 111.841 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -145.24 146.75 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.874 2.07 . . . . 0.0 109.375 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.43 149.78 38.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 109.138 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.1 144.85 44.22 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.958 0.903 . . . . 0.0 110.49 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -122.38 135.5 54.71 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.672 1.189 . . . . 0.0 109.27 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.5 mt -118.39 126.4 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.153 1.381 . . . . 0.0 108.475 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -131.59 124.74 30.61 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.062 0.945 . . . . 0.0 110.572 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -26.59 11.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.863 1.265 . . . . 0.0 111.809 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.38 150.68 34.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.828 1.251 . . . . 0.0 110.759 174.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -142.77 103.6 4.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.842 1.257 . . . . 0.0 109.027 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.73 155.29 19.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.286 1.434 . . . . 0.0 109.88 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.34 27.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.525 1.53 . . . . 0.0 111.764 -168.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.2 -29.68 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.92 2.088 . . . . 0.0 111.37 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 t -54.44 122.19 36.69 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.027 0.931 . . . . 0.0 112.566 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.97 -15.26 10.6 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.791 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 t -82.77 113.2 43.5 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.11 0.868 . . . . 0.0 110.174 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.8 127.53 14.69 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.107 1.204 . . . . 0.0 109.055 174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.08 -113.91 0.62 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.67 115.02 18.1 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 109.621 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.17 143.29 34.14 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.337 2.255 . . . . 0.0 107.882 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -158.64 166.71 31.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.608 1.163 . . . . 0.0 110.015 166.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -126.72 104.99 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 108.48 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.73 124.89 21.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.58 153.86 2.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.88 -18.77 14.4 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.62 126.49 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 160.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.14 164.32 0.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.927 2.091 . . . . 0.0 111.364 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.8 m -112.69 131.54 55.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 0.0 109.036 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -124.71 98.73 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.764 1.625 . . . . 0.0 107.571 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -112.39 17.57 19.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.246 1.018 . . . . 0.0 111.886 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -156.69 66.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.838 1.655 . . . . 0.0 110.803 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.0 mp -92.0 31.22 1.28 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.161 -0.962 . . . . 0.0 111.874 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.3 m -56.58 -28.39 60.16 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 119.995 -1.691 . . . . 0.0 113.038 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -60.28 -26.66 66.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.711 -1.243 . . . . 0.0 114.106 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.63 -23.32 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.786 1.234 . . . . 0.0 112.484 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 55.41 50.42 14.83 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.672 1.989 . . . . 0.0 113.464 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.22 -170.49 44.69 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.529 -0.732 . . . . 0.0 111.31 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -175.0 5.16 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.66 -1.494 . . . . 0.0 111.987 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -135.02 -27.93 1.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.35 135.28 46.06 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.536 -0.728 . . . . 0.0 110.006 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.86 131.24 52.42 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.503 1.521 . . . . 0.0 108.945 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.31 137.78 54.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.397 0.618 . . . . 0.0 109.635 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.81 116.65 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 125.637 1.575 . . . . 0.0 106.879 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.69 130.39 24.48 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 109.352 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.12 162.07 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.753 1.636 . . . . 0.0 112.871 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.16 2.09 4.36 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.803 1.668 . . . . 0.0 116.029 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.28 -18.41 32.1 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.238 1.415 . . . . 0.0 113.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -132.75 161.05 35.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.763 1.625 . . . . 0.0 110.153 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -93.55 -55.19 3.36 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -139.99 164.34 30.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.615 1.566 . . . . 0.0 109.145 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 163.63 32.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.524 0.73 . . . . 0.0 109.4 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.407 HG21 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -135.5 142.59 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.151 0.58 . . . . 0.0 109.505 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.92 139.27 33.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.271 0.558 . . . . 0.0 110.479 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.55 137.14 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.479 1.111 . . . . 0.0 109.773 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' HE3' ' CZ ' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -136.79 153.93 50.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.787 0.835 . . . . 0.0 111.111 -178.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.83 137.75 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 108.789 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -109.87 119.16 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.625 1.17 . . . . 0.0 109.346 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -63.62 89.67 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.433 1.893 . . . . 0.0 112.877 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.84 10.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.454 1.101 . . . . 0.0 112.987 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -80.69 -70.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.133 1.373 . . . . 0.0 110.508 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.23 169.42 8.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.477 1.511 . . . . 0.0 110.729 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.6 t -83.99 -47.45 10.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.957 0.503 . . . . 0.0 112.347 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -61.32 -39.13 89.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 41.44 -148.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.123 1.369 . . . . 0.0 112.271 -170.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.91 26.52 55.12 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 120.927 -1.108 . . . . 0.0 114.137 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.0 m -138.19 15.64 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.468 1.507 . . . . 0.0 114.622 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -133.71 114.26 13.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.542 1.537 . . . . 0.0 110.624 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -111.12 114.43 27.69 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.606 0.762 . . . . 0.0 110.495 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -107.47 117.98 35.53 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.786 2.034 . . . . 0.0 110.161 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -108.13 126.43 52.75 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.1 pt -118.19 140.3 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 110.056 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 m -145.24 93.98 5.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.188 0.995 . . . . 0.0 109.107 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.94 168.49 18.66 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.372 2.048 . . . . 0.0 112.627 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -35.91 101.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.771 2.428 . . . . 0.0 113.65 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.306 2.7 pp0? 42.15 42.08 2.31 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.619 2.367 . . . . 0.0 116.61 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.45 156.8 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.021 1.729 . . . . 0.0 112.099 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -52.33 119.88 4.92 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.219 1.808 . . . . 0.0 112.62 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 142.87 56.37 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.592 0.757 . . . . 0.0 111.513 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.14 117.66 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.624 1.17 . . . . 0.0 110.615 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.73 102.18 13.41 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.209 1.004 . . . . 0.0 110.059 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 3.9 t -93.5 152.16 19.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.51 0.724 . . . . 0.0 110.333 170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -143.49 146.88 33.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.511 1.124 . . . . 0.0 109.289 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -54.9 85.57 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.106 . . . . 0.0 114.052 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.63 -21.44 1.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.547 1.546 . . . . 0.0 113.463 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.66 135.45 56.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.32 1.06 . . . . 0.0 110.602 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.15 64.02 3.22 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.213 1.005 . . . . 0.0 111.725 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.41 ' CZ ' ' HE3' ' A' ' 103' ' ' LYS . 6.5 m-85 60.54 81.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.0 2.12 . . . . 0.0 111.423 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.79 131.97 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.15 -0.969 . . . . 0.0 110.403 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 136.89 32.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 110.515 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.12 98.64 48.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.573 1.949 . . . . 0.0 108.873 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -71.63 138.34 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.717 2.278 . . . . 0.0 111.409 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.49 126.93 22.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 108.541 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.86 167.18 23.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.723 2.949 . . . . 0.0 111.942 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -61.71 122.04 14.34 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.572 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.06 153.02 47.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.351 2.261 . . . . 0.0 109.438 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 t -137.86 136.05 19.48 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.575 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.76 150.41 65.26 Favored 'Cis proline' 0 CA--C 1.548 1.18 0 CA-C-N 119.771 0.954 . . . . 0.0 112.471 -7.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.47 -29.09 62.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.295 1.996 . . . . 0.0 112.494 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.47 3.75 15.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.266 1.427 . . . . 0.0 113.786 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.7 p -67.97 147.7 52.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.138 1.335 . . . . 0.0 112.198 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.15 121.09 16.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.889 0.875 . . . . 0.0 110.829 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.0 tt -109.54 116.51 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.819 0.848 . . . . 0.0 110.668 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.15 142.68 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.0 0.52 . . . . 0.0 109.808 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.6 t -144.63 137.83 26.96 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.982 0.913 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -99.85 139.19 35.88 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.232 0.539 . . . . 0.0 109.55 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.27 124.41 47.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.842 2.057 . . . . 0.0 107.643 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 113.77 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.401 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 2.0 p -124.23 140.64 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.181 1.392 . . . . 0.0 108.969 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -139.84 156.45 46.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.056 0.942 . . . . 0.0 111.524 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -65.24 134.34 53.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.2 p -71.96 -8.55 55.13 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.94 10.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.35 2.26 . . . . 0.0 110.383 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.9 t -40.09 134.59 1.43 Allowed Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 125.729 1.612 . . . . 0.0 114.212 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.65 2.36 21.03 Favored 'Cis proline' 0 CA--C 1.546 1.105 0 N-CA-C 114.854 1.059 . . . . 0.0 114.854 3.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 6.89 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.84 2.056 . . . . 0.0 114.243 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.13 156.41 38.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.911 1.285 . . . . 0.0 111.735 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -55.21 143.29 28.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.908 0.883 . . . . 0.0 111.802 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.75 -23.01 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.487 1.515 . . . . 0.0 112.205 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.431 ' CG2' HD22 ' A' ' 194' ' ' ASN . 75.2 t -155.89 141.82 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.75 1.62 . . . . 0.0 108.324 171.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -136.81 113.68 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.676 1.99 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.19 -179.11 39.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.139 0.876 . . . . 0.0 111.993 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.49 149.0 44.96 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.921 -0.752 . . . . 0.0 110.934 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.0 p -138.81 159.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.087 1.355 . . . . 0.0 109.133 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -115.43 130.73 56.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 109.917 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -104.91 152.31 22.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 0.0 109.521 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -149.86 162.86 39.49 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.759 2.024 . . . . 0.0 110.578 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -133.7 123.52 25.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.574 1.55 . . . . 0.0 108.93 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.8 m -77.82 112.51 25.32 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.367 0.667 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.4 54.05 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.542 3.494 . . . . 0.0 112.072 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.3 m -136.92 -52.65 0.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.262 1.425 . . . . 0.0 111.273 -170.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 32.1 p -130.26 12.91 5.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.235 1.414 . . . . 0.0 112.551 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.66 28.81 72.89 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.084 1.326 . . . . 0.0 113.626 -171.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -68.34 156.37 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.476 -1.014 . . . . 0.0 111.141 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -136.02 131.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.8 m -135.53 132.17 36.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.206 1.403 . . . . 0.0 109.23 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.02 117.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.26 1.024 . . . . 0.0 110.255 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -88.64 128.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 134.94 25.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.973 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -148.78 143.91 26.67 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.77 1.628 . . . . 0.0 109.678 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.17 -14.93 4.61 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.11 1.364 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -52.31 -30.43 28.27 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.324 1.85 . . . . 0.0 114.409 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 16.7 p -149.49 -34.72 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.705 1.602 . . . . 0.0 113.623 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -72.88 133.43 82.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 111.608 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.68 130.2 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.545 2.83 . . . . 0.0 111.546 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -73.56 -20.09 60.72 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.431 HD22 ' CG2' ' A' ' 167' ' ' VAL . 0.8 OUTLIER -74.86 -13.04 60.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.29 1.036 . . . . 0.0 113.493 177.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.8 mtp -112.53 150.91 30.63 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.515 1.526 . . . . 0.0 108.828 167.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.1 p -142.21 118.28 10.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.238 0.615 . . . . 0.0 109.614 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.17 107.92 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.486 0.66 . . . . 0.0 109.708 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 95.2 m -88.11 143.82 26.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.555 0.693 . . . . 0.0 109.753 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.26 71.14 10.66 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.72 1.208 . . . . 0.0 110.408 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.43 -42.78 64.4 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.301 1.44 . . . . 0.0 113.259 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.08 -177.38 6.54 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.076 1.75 . . . . 0.0 110.991 163.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -50.91 143.45 10.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.256 -1.528 . . . . 0.0 109.574 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 29.9 p 53.13 14.96 0.54 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 t -139.88 108.92 6.03 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.865 1.666 . . . . 0.0 110.958 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.407 ' CE2' HG21 ' A' ' 100' ' ' VAL . 22.3 m-85 -120.76 147.62 45.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.177 0.991 . . . . 0.0 111.128 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . 0.272 9.8 tt -133.84 99.08 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 122.51 1.148 . . . . 0.0 110.513 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -73.36 109.91 7.25 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.305 1.842 . . . . 0.0 110.11 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -81.04 138.21 36.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.9 tp -132.07 111.65 11.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.37 1.068 . . . . 0.0 108.667 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -120.73 -3.38 9.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.432 1.493 . . . . 0.0 114.609 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -141.18 -178.55 5.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.012 1.325 . . . . 0.0 111.502 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.1 46.67 0.99 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.082 0.944 . . . . 0.0 113.181 -170.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt . . . . . 0 C--O 1.258 1.531 0 C-N-CA 128.214 2.606 . . . . 0.0 116.986 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.79 138.51 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.724 1.209 . . . . 0.0 110.291 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.58 140.57 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.15 -16.4 32.27 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.845 -1.159 . . . . 0.0 113.109 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.77 9.89 11.49 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 112.45 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -148.17 171.72 15.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.622 1.969 . . . . 0.0 110.738 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.27 150.99 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 O-C-N 121.035 -1.041 . . . . 0.0 112.412 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -149.64 151.14 33.25 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.807 -0.558 . . . . 0.0 109.631 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.6 159.4 42.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.741 -0.6 . . . . 0.0 110.877 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -130.86 136.46 48.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.223 1.009 . . . . 0.0 111.054 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.63 63.35 3.4 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.732 1.613 . . . . 0.0 111.287 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.47 135.72 1.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.686 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -58.58 126.73 28.82 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 90.28 22.7 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.735 2.414 . . . . 0.0 112.268 -174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.39 55.1 0.86 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.254 1.421 . . . . 0.0 111.408 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.8 p -129.24 -178.78 4.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.682 1.593 . . . . 0.0 112.367 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.95 -107.31 2.15 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.651 1.12 . . . . 0.0 113.773 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.0 167.87 9.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.9 p -133.7 152.22 51.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.835 0.854 . . . . 0.0 112.589 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.49 150.48 29.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -141.97 140.75 32.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.082 0.953 . . . . 0.0 110.734 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -145.52 142.5 29.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.364 1.066 . . . . 0.0 109.277 -173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.97 163.89 26.6 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.749 -1.219 . . . . 0.0 112.09 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.11 161.31 28.95 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.196 -0.94 . . . . 0.0 111.326 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.22 43.65 70.12 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 114.644 0.617 . . . . 0.0 114.644 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 169.88 19.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.438 1.495 . . . . 0.0 111.616 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.4 p -138.95 143.44 38.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.976 0.91 . . . . 0.0 111.502 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.59 129.15 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.149 0.979 . . . . 0.0 110.556 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.21 90.53 3.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.756 1.223 . . . . 0.0 108.921 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.42 166.42 14.62 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.973 0.892 . . . . 0.0 111.346 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -111.8 153.42 26.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.6 0.76 . . . . 0.0 110.163 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.92 57.43 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.65 73.59 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.815 1.198 . . . . 0.0 114.411 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -91.91 112.49 24.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.863 0.831 . . . . 0.0 109.381 167.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -21.75 33.9 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.529 -0.732 . . . . 0.0 111.494 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -61.32 -11.65 10.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.358 1.463 . . . . 0.0 112.533 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -67.32 -52.05 45.12 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.444 -1.41 . . . . 0.0 111.392 167.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.09 -10.7 55.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.509 1.524 . . . . 0.0 112.883 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.97 -27.09 63.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.838 1.655 . . . . 0.0 113.313 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -58.43 104.66 0.23 Allowed 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.63 -1.294 . . . . 0.0 111.671 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -27.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.917 1.687 . . . . 0.0 112.438 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 t -142.12 137.17 30.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.474 1.91 . . . . 0.0 111.173 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.73 120.06 13.04 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.462 1.125 . . . . 0.0 112.178 -173.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.46 112.97 24.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.894 1.678 . . . . 0.0 109.839 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.93 140.62 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.724 1.209 . . . . 0.0 109.429 173.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.05 -116.78 0.03 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.02 1.295 . . . . 0.0 114.552 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.7 m -147.08 -13.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.666 1.186 . . . . 0.0 113.024 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 36.03 3.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.493 1.517 . . . . 0.0 110.392 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.22 118.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.7 1.6 . . . . 0.0 110.959 -168.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -95.77 140.53 30.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.55 1.14 . . . . 0.0 110.652 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 51.6 m -125.79 112.93 16.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 108.916 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -109.25 134.6 51.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.45 144.04 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.437 0.637 . . . . 0.0 111.839 -171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -142.14 142.06 32.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.37 -166.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -118.62 -29.53 5.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.779 0.832 . . . . 0.0 111.588 -170.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.11 130.59 25.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.411 1.484 . . . . 0.0 111.85 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.93 121.53 41.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.192 0.597 . . . . 0.0 110.967 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -165.81 170.32 14.02 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 0.0 110.953 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.82 21.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.172 1.389 . . . . 0.0 111.539 -169.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.75 -17.19 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.808 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.2 t -41.81 138.88 1.7 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.427 1.491 . . . . 0.0 114.908 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.56 -9.05 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.445 2.763 . . . . 0.0 112.71 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -143.79 115.08 5.58 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.533 1.133 . . . . 0.0 111.52 172.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 49.62 1.92 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.388 2.726 . . . . 0.0 112.033 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 31.66 -107.41 0.02 OUTLIER Glycine 0 CA--C 1.527 0.827 0 C-N-CA 129.008 3.194 . . . . 0.0 114.548 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -123.44 144.64 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.016 0.926 . . . . 0.0 110.252 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.56 153.98 40.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.96 1.704 . . . . 0.0 110.259 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -161.86 153.99 19.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.734 0.814 . . . . 0.0 110.86 167.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.1 93.75 4.25 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.942 1.297 . . . . 0.0 109.172 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.74 134.81 57.45 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 176.3 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.54 -18.65 65.48 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.535 -1.353 . . . . 0.0 113.113 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 111.71 0.5 Allowed Glycine 0 CA--C 1.536 1.36 0 CA-C-N 119.028 0.831 . . . . 0.0 113.357 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 175.46 162.47 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.728 2.411 . . . . 0.0 111.023 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -109.28 142.53 40.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.018 1.327 . . . . 0.0 110.743 171.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -134.18 136.29 43.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.698 1.199 . . . . 0.0 108.676 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -150.24 -50.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.929 0.892 . . . . 0.0 111.374 -170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -81.23 46.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.981 1.312 . . . . 0.0 113.413 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.01 42.61 0.09 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.216 1.406 . . . . 0.0 113.433 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -60.29 -34.69 74.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 112.713 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -65.91 -26.42 67.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.6 mm -72.6 -38.91 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.397 1.079 . . . . 0.0 110.262 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.82 32.6 22.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.714 1.606 . . . . 0.0 113.297 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.14 39.8 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.216 1.389 . . . . 0.0 113.411 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -176.29 3.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 112.399 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -140.53 -31.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.0 136.77 37.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.194 0.998 . . . . 0.0 110.153 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.44 133.86 21.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.78 0.8 . . . . 0.0 110.093 -168.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.32 138.54 53.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.72 -170.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.78 121.92 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.33 135.57 27.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.143 0.577 . . . . 0.0 110.313 -166.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.44 152.59 34.39 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.04 1.827 . . . . 0.0 111.021 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.37 29.13 0.21 Allowed Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.851 1.691 . . . . 0.0 116.121 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.69 -18.23 3.92 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.605 1.962 . . . . 0.0 112.654 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -119.25 156.24 30.29 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.941 0.897 . . . . 0.0 110.167 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -88.24 -41.91 12.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.491 -0.755 . . . . 0.0 111.966 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -150.14 167.64 26.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.143 2.177 . . . . 0.0 108.561 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.63 166.55 23.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.668 -0.645 . . . . 0.0 110.72 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.92 149.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.238 0.615 . . . . 0.0 111.579 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.95 118.17 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.54 130.32 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.803 0.841 . . . . 0.0 111.326 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -127.6 145.58 50.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.39 1.076 . . . . 0.0 110.65 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.14 147.46 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 123.808 0.692 . . . . 0.0 111.651 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.69 127.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.312 1.054 . . . . 0.0 110.132 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -64.03 125.54 24.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.561 1.544 . . . . 0.0 112.242 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -35.14 2.48 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.63 -35.86 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.492 1.117 . . . . 0.0 113.383 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -120.33 139.96 51.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.039 1.336 . . . . 0.0 109.05 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -87.15 6.81 30.98 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.955 -1.091 . . . . 0.0 113.181 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -88.66 -33.65 17.52 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 48.44 -167.35 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.37 17.13 55.95 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 p -141.25 5.95 1.9 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.43 1.115 . . . . 0.0 113.247 -162.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -113.32 152.01 30.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.242 1.017 . . . . 0.0 112.7 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -127.81 134.76 49.47 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.248 1.419 . . . . 0.0 109.454 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -124.37 139.83 53.53 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.817 -0.552 . . . . 0.0 110.94 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -135.63 119.26 17.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.971 1.309 . . . . 0.0 109.404 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.91 115.15 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 108.968 -170.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.8 m -122.96 92.18 49.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.019 0.528 . . . . 0.0 112.123 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.48 169.52 21.57 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.232 2.621 . . . . 0.0 113.249 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.2 57.71 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.135 1.774 . . . . 0.0 115.269 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.82 -53.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 161.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.0 158.86 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.33 1.052 . . . . 0.0 111.716 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -154.52 -165.2 2.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.239 1.415 . . . . 0.0 110.182 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 56.88 58.79 3.83 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.68 122.52 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.562 1.945 . . . . 0.0 109.957 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.45 112.43 11.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.631 0.772 . . . . 0.0 110.069 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.7 t -97.48 137.55 36.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.682 0.393 . . . . 0.0 110.278 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -104.11 143.34 33.05 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.181 0.992 . . . . 0.0 109.932 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -56.19 131.62 48.31 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 121.962 -0.461 . . . . 0.0 110.984 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.84 8.66 44.9 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.823 1.202 . . . . 0.0 115.356 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.17 155.74 19.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.127 0.963 . . . . 0.0 112.354 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.44 49.55 1.17 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.51 1.124 . . . . 0.0 113.199 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 60.48 104.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.362 2.265 . . . . 0.0 112.44 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.28 141.0 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 134.25 35.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.745 0.784 . . . . 0.0 112.104 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.47 102.13 50.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 169.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.63 121.22 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.046 1.83 . . . . 0.0 111.827 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.8 mm -99.76 123.04 49.07 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.368 1.067 . . . . 0.0 110.106 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.99 178.47 7.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.811 2.341 . . . . 0.0 111.97 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 139.8 43.71 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.966 -1.084 . . . . 0.0 113.227 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.16 152.11 29.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.441 1.497 . . . . 0.0 111.724 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -145.14 135.69 12.1 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.215 1.406 . . . . 0.0 110.396 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.03 146.33 68.11 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 120.045 1.052 . . . . 0.0 110.782 -7.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.68 -31.05 33.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.502 2.135 . . . . 0.0 111.393 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.72 5.86 4.51 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.744 1.618 . . . . 0.0 114.979 168.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.5 t -77.1 149.16 35.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.104 0.866 . . . . 0.0 111.74 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.434 0.694 . . . . 0.0 111.374 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 tt -106.0 121.72 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.441 1.096 . . . . 0.0 110.912 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.75 135.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.068 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.4 p -143.2 127.75 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.548 0.689 . . . . 0.0 111.485 169.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 140.77 42.2 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.49 111.12 11.99 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.652 1.215 . . . . 0.0 109.425 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 p -109.06 144.09 37.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.634 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.34 133.57 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -138.9 147.8 42.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.755 1.222 . . . . 0.0 109.23 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -67.14 115.14 6.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.453 -0.78 . . . . 0.0 110.006 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.3 t -65.08 -16.78 63.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.339 1.056 . . . . 0.0 112.528 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -114.37 156.7 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 110.794 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 t -69.83 138.99 88.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.491 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.66 129.11 16.51 Favored 'Cis proline' 0 C--N 1.355 0.912 0 CA-C-N 120.721 1.293 . . . . 0.0 110.374 -5.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -76.0 36.68 0.14 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.174 1.39 . . . . 0.0 113.457 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 146.83 52.95 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.046 -1.659 . . . . 0.0 113.158 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -69.62 127.25 32.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.435 0.694 . . . . 0.0 111.01 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 -50.49 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 112.205 -171.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 24.4 m -146.57 139.18 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.884 1.274 . . . . 0.0 109.574 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -130.39 98.29 4.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.465 1.506 . . . . 0.0 108.019 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.05 11.46 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.326 1.441 . . . . 0.0 113.193 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.8 m -135.41 153.72 51.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.801 0.84 . . . . 0.0 111.502 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.51 165.09 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.682 1.593 . . . . 0.0 108.849 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.5 126.89 38.01 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.03 150.89 23.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.456 -0.777 . . . . 0.0 110.414 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -145.31 162.34 37.44 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 125.185 1.394 . . . . 0.0 108.344 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 170.11 19.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 169.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 178' ' ' THR . 71.5 m -133.64 105.52 11.86 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.63 0.772 . . . . 0.0 109.026 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 18.77 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.26 3.306 . . . . 0.0 113.037 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 176' ' ' SER . 84.8 m -63.65 -34.06 77.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.008 1.723 . . . . 0.0 112.5 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 t -164.3 26.83 0.07 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 123.176 1.465 . . . . 0.0 112.4 -173.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 60.59 27.99 67.01 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 119.259 -2.151 . . . . 0.0 113.778 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -79.07 142.89 36.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.69 0.745 . . . . 0.0 111.191 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.49 160.67 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.061 0.545 . . . . 0.0 111.414 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.4 m -148.99 129.98 14.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.901 1.28 . . . . 0.0 111.118 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.91 128.07 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.392 0.542 . . . . 0.0 110.433 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.41 130.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.361 1.077 . . . . 0.0 108.612 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.67 135.94 22.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 109.044 -176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -144.43 145.08 31.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.311 1.444 . . . . 0.0 109.693 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.57 -16.7 6.53 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.331 1.452 . . . . 0.0 113.786 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.4 -24.03 64.83 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.9 p -144.7 -30.2 0.45 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.121 1.369 . . . . 0.0 113.727 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -79.42 144.51 61.83 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.895 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.78 158.84 52.24 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.04 1.827 . . . . 0.0 112.284 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -93.65 -2.08 54.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -109.48 -16.47 13.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.135 1.374 . . . . 0.0 113.517 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.1 ttt -134.34 134.13 41.45 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.797 1.239 . . . . 0.0 107.966 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.3 p -136.73 153.36 50.88 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.86 138.61 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.039 0.536 . . . . 0.0 111.039 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 52.2 m -127.12 143.73 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.803 1.241 . . . . 0.0 109.4 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -75.03 85.42 2.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.468 0.652 . . . . 0.0 110.943 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.28 -42.69 82.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.984 1.314 . . . . 0.0 112.136 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -152.26 178.5 9.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.625 1.57 . . . . 0.0 109.696 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.45 135.3 54.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.668 -1.895 . . . . 0.0 110.944 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 m 58.61 23.21 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.558 1.143 . . . . 0.0 113.054 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.13 110.91 6.2 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.591 -0.693 . . . . 0.0 110.829 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.25 145.22 42.02 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.935 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.86 116.69 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.88 0.848 . . . . 0.0 110.663 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -96.7 117.1 30.29 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.267 1.427 . . . . 0.0 110.516 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -100.01 131.89 45.69 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.594 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.49 114.42 20.67 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.89 0.768 . . . . 0.0 112.943 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -117.09 25.4 10.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.734 1.214 . . . . 0.0 113.339 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.0 m -143.74 166.81 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 52.39 1.18 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.023 2.129 . . . . 0.0 110.86 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt . . . . . 0 C--O 1.294 3.401 0 CA-C-O 115.565 -2.16 . . . . 0.0 111.186 177.519 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.191 0.519 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.91 137.97 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.97 0.908 . . . . 0.0 111.365 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.57 147.93 29.38 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.736 -0.602 . . . . 0.0 110.488 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.12 -20.31 52.42 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.839 -1.163 . . . . 0.0 113.835 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -111.2 7.93 21.4 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.501 1.92 . . . . 0.0 113.636 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -143.92 -176.09 4.85 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 110.6 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -145.57 154.03 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.596 0.758 . . . . 0.0 112.733 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 144.41 49.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.902 1.281 . . . . 0.0 110.309 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -132.48 129.66 39.47 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.765 1.626 . . . . 0.0 107.465 -165.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -128.29 121.43 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 123.796 1.76 . . . . 0.0 109.872 -170.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.34 59.26 5.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.735 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.57 149.19 5.78 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.592 1.568 . . . . 0.0 111.357 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.59 151.55 5.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.562 1.145 . . . . 0.0 111.957 175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 49.74 41.54 22.27 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m 50.43 63.19 2.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.465 1.506 . . . . 0.0 113.636 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 18' ' ' GLY . 3.0 m -130.25 -178.21 4.65 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.876 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 17' ' ' THR . . . 74.02 -118.83 6.13 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.078 1.323 . . . . 0.0 111.972 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.11 166.41 11.26 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 117.685 0.742 . . . . 0.0 111.509 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -126.17 146.49 49.94 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.685 1.194 . . . . 0.0 110.965 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.74 155.8 41.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.78 1.232 . . . . 0.0 110.072 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -128.28 142.3 51.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -125.63 125.14 42.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.359 1.064 . . . . 0.0 109.312 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.61 129.01 34.29 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.955 0.902 . . . . 0.0 109.509 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 144.68 25.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.475 1.11 . . . . 0.0 112.875 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.02 41.45 9.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.062 0.839 . . . . 0.0 112.939 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.13 153.45 42.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.954 1.301 . . . . 0.0 111.698 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -129.39 131.08 46.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.958 1.303 . . . . 0.0 109.037 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.48 128.23 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 122.579 1.18 . . . . 0.0 109.753 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.6 mtm105 -124.36 89.46 3.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.817 1.247 . . . . 0.0 109.112 -171.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -78.22 168.69 19.45 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.821 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -116.18 157.85 24.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.632 1.173 . . . . 0.0 110.096 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.63 -19.68 65.06 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.263 -0.898 . . . . 0.0 113.073 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.93 -24.05 66.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.221 1.391 . . . . 0.0 114.464 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -98.67 105.14 17.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.283 1.041 . . . . 0.0 109.244 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -21.5 60.48 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.618 -1.301 . . . . 0.0 112.625 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -61.15 -24.21 66.12 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.64 1.976 . . . . 0.0 112.399 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -64.54 -56.14 15.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.693 1.597 . . . . 0.0 111.1 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.5 -18.55 65.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.424 1.49 . . . . 0.0 113.251 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -29.62 69.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.899 2.08 . . . . 0.0 113.222 172.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -53.27 118.62 3.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.784 0.72 . . . . 0.0 110.259 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 mmm -146.12 -16.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.126 0.97 . . . . 0.0 113.435 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.7 m -136.9 151.79 49.48 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 110.783 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.55 155.77 22.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.641 1.176 . . . . 0.0 110.743 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.7 121.7 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -92.23 136.69 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.352 0.661 . . . . 0.0 110.137 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -106.02 0.01 OUTLIER Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.85 2.166 . . . . 0.0 115.823 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -161.27 -21.78 0.05 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.794 1.638 . . . . 0.0 112.866 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.14 33.14 4.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.622 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.8 121.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.111 1.765 . . . . 0.0 110.109 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -84.69 145.63 27.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.856 -1.153 . . . . 0.0 109.558 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 58.5 m -126.65 147.82 49.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.594 -0.692 . . . . 0.0 110.771 173.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.85 140.09 52.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.667 0.787 . . . . 0.0 109.451 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.1 mt -122.44 138.14 53.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.454 1.102 . . . . 0.0 109.362 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -152.7 120.49 6.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.663 0.785 . . . . 0.0 112.379 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -83.51 -60.95 1.97 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.7 175.02 5.64 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.543 -0.723 . . . . 0.0 110.986 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -153.92 134.48 13.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.927 0.891 . . . . 0.0 110.31 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -164.8 155.09 14.01 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.314 1.445 . . . . 0.0 110.461 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.35 41.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 111.177 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.09 -34.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.148 1.779 . . . . 0.0 111.606 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 t -56.08 134.5 74.4 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.597 1.159 . . . . 0.0 113.251 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.1 -18.96 9.73 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.095 2.53 . . . . 0.0 113.312 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 t -101.74 130.64 24.14 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.503 1.121 . . . . 0.0 110.637 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.04 174.67 11.61 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.356 2.038 . . . . 0.0 111.657 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.89 -151.64 19.73 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 124.576 1.084 . . . . 0.0 112.558 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 109.01 18.91 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.057 0.543 . . . . 0.0 110.329 168.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.7 148.71 41.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.988 1.315 . . . . 0.0 110.169 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -162.49 137.65 6.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.753 0.821 . . . . 0.0 109.51 168.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -87.91 110.36 20.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 165.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.74 125.7 26.67 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.366 -0.834 . . . . 0.0 109.016 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.85 150.2 5.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.798 1.239 . . . . 0.0 112.181 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -15.49 6.35 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.18 104.86 0.26 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 112.143 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.47 160.62 3.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.98 1.712 . . . . 0.0 111.993 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.7 m -113.98 143.66 44.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.013 1.325 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -141.44 112.54 7.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.606 1.163 . . . . 0.0 109.928 -164.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -126.44 -32.72 2.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.48 1.112 . . . . 0.0 112.379 -170.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -96.58 59.33 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.276 2.63 . . . . 0.0 109.621 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.72 52.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.186 1.394 . . . . 0.0 111.629 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.8 m -62.33 -42.54 99.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.176 -1.578 . . . . 0.0 111.547 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -59.46 -28.21 66.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.004 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -128.95 54.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.418 1.887 . . . . 0.0 108.513 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -65.0 -15.63 62.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.685 1.194 . . . . 0.0 113.401 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.38 20.1 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.014 1.292 . . . . 0.0 109.881 155.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.07 150.28 43.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.205 1.802 . . . . 0.0 108.452 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -118.53 -42.59 2.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.303 0.641 . . . . 0.0 112.635 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.06 156.36 46.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.893 1.277 . . . . 0.0 111.73 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 52' ' ' CYS . 8.4 t80 -145.97 150.54 36.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.33 1.052 . . . . 0.0 111.458 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.35 129.67 27.43 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.403 1.081 . . . . 0.0 110.949 172.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.93 125.18 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.096 1.358 . . . . 0.0 109.209 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.93 147.67 57.38 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.06 1.344 . . . . 0.0 110.644 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -67.99 -177.03 1.16 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.261 3.307 . . . . 0.0 113.997 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.91 14.88 4.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.022 1.772 . . . . 0.0 114.144 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.7 -47.98 2.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.562 1.945 . . . . 0.0 110.34 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -91.44 157.9 16.8 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.49 1.116 . . . . 0.0 111.146 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -127.66 -37.06 2.0 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.948 1.299 . . . . 0.0 111.958 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -141.64 167.13 22.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.882 2.073 . . . . 0.0 108.066 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.7 159.6 41.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 109.793 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.65 130.05 59.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.082 0.953 . . . . 0.0 109.237 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -82.89 127.68 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.873 0.869 . . . . 0.0 108.816 172.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -119.58 144.6 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.747 0.819 . . . . 0.0 109.296 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -144.41 133.85 23.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.677 0.791 . . . . 0.0 109.826 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.0 pt -78.81 148.75 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.726 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -141.94 120.49 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.593 1.957 . . . . 0.0 107.542 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.15 110.93 4.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.471 0.708 . . . . 0.0 110.57 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 19.29 20.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.49 1.116 . . . . 0.0 112.379 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.8 t -126.45 -69.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.145 1.378 . . . . 0.0 111.597 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -89.08 134.61 33.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.442 0.697 . . . . 0.0 109.425 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -79.77 34.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.825 -1.172 . . . . 0.0 112.573 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 m -138.54 52.85 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.063 2.545 . . . . 0.0 108.536 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.23 144.35 41.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 166.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.09 6.34 4.91 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.362 1.458 . . . . 0.0 114.343 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.5 m -141.55 25.52 2.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.605 1.562 . . . . 0.0 113.388 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -128.82 136.72 50.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.278 1.831 . . . . 0.0 109.149 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.63 121.76 43.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.772 1.229 . . . . 0.0 109.683 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -105.23 144.9 31.38 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.0 0.92 . . . . 0.0 110.245 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -137.82 106.8 5.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.093 1.357 . . . . 0.0 107.348 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.4 tt -103.81 131.45 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 109.507 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.7 m -129.95 86.7 53.97 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.958 1.703 . . . . 0.0 109.043 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.28 163.95 35.95 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.422 2.748 . . . . 0.0 112.265 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -31.67 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.715 2.406 . . . . 0.0 114.39 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 34.01 36.15 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.693 2.397 . . . . 0.0 116.37 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -104.26 155.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.69 1.596 . . . . 0.0 109.999 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -48.9 100.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.852 1.661 . . . . 0.0 111.996 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -59.18 165.2 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.255 1.026 . . . . 0.0 111.435 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.2 136.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.101 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.64 123.6 42.31 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.19 168.02 20.6 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.438 0.695 . . . . 0.0 111.111 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -132.46 155.64 48.17 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.34 1.056 . . . . 0.0 110.323 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.56 116.54 1.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.41 . . . . 0.0 111.79 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.69 15.86 19.31 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -171.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.03 160.62 14.7 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.51 1.124 . . . . 0.0 113.712 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.57 50.02 1.89 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.262 1.425 . . . . 0.0 112.325 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 59.81 78.66 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.186 1.794 . . . . 0.0 111.823 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.1 t -40.92 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.068 1.747 . . . . 0.0 112.452 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -81.99 95.84 7.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 111.72 31.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.98 137.29 13.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.586 2.191 . . . . 0.0 112.008 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.5 mt -128.65 128.47 23.53 Favored Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 121.654 -0.654 . . . . 0.0 110.242 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.91 174.78 11.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.431 2.754 . . . . 0.0 113.38 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -60.33 134.98 57.58 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.737 -0.602 . . . . 0.0 109.951 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.39 146.15 49.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.176 1.39 . . . . 0.0 108.567 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.2 m -131.29 126.8 21.55 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 123.942 0.897 . . . . 0.0 110.216 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.44 155.82 81.93 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 119.008 0.681 . . . . 0.0 111.447 -5.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.0 -24.82 32.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.468 1.445 . . . . 0.0 113.364 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -72.22 -5.94 39.36 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 168.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 160.13 33.11 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.742 1.258 . . . . 0.0 112.935 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -103.14 162.68 12.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.15 1.38 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tt -129.1 132.26 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.638 1.975 . . . . 0.0 109.193 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.56 136.08 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.038 0.935 . . . . 0.0 111.126 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.3 t -143.72 150.11 38.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -112.29 136.69 51.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.019 1.328 . . . . 0.0 109.32 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.55 118.83 22.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.297 1.039 . . . . 0.0 109.166 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 t -125.64 123.04 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.233 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.03 140.4 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.027 1.331 . . . . 0.0 108.635 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -148.52 153.09 37.95 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.955 1.302 . . . . 0.0 110.379 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.65 135.71 56.2 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.058 0.543 . . . . 0.0 110.449 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -72.49 -12.85 61.26 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.458 1.103 . . . . 0.0 113.83 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -141.61 -179.09 5.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.98 2.512 . . . . 0.0 110.034 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 p -52.9 146.79 17.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.763 1.225 . . . . 0.0 113.459 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.94 3.58 17.33 Favored 'Cis proline' 0 CA--C 1.545 1.058 0 N-CA-C 114.878 1.068 . . . . 0.0 114.878 1.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.27 27.0 15.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.144 1.378 . . . . 0.0 113.026 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -80.86 139.34 36.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.054 1.342 . . . . 0.0 110.738 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -55.9 100.22 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.474 1.109 . . . . 0.0 112.232 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.49 -51.82 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.823 1.249 . . . . 0.0 110.443 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.4 t -145.36 126.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.742 1.217 . . . . 0.0 108.177 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.83 91.21 2.87 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.621 1.168 . . . . 0.0 108.361 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -150.79 -152.03 5.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.008 1.289 . . . . 0.0 111.103 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 m -143.05 170.15 16.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.749 0.785 . . . . 0.0 111.049 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.63 146.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.338 1.455 . . . . 0.0 108.52 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -101.37 143.02 31.92 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.01 154.17 33.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.331 1.052 . . . . 0.0 109.402 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -157.44 158.77 36.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.594 1.558 . . . . 0.0 108.261 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -128.36 145.32 51.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.525 0.73 . . . . 0.0 109.818 166.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.6 m -91.73 117.24 67.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 -10.07 27.76 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 2.747 . . . . 0.0 113.129 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.7 p -45.62 -38.47 6.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.088 2.155 . . . . 0.0 113.061 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.8 t -158.89 14.73 0.17 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.007 1.323 . . . . 0.0 112.933 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.39 29.91 76.37 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 119.793 -1.817 . . . . 0.0 112.882 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 160.35 31.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.705 1.202 . . . . 0.0 110.703 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.65 130.95 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.278 -0.889 . . . . 0.0 111.069 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.5 m -145.6 121.45 10.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.475 1.51 . . . . 0.0 110.13 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 1.8 m -86.71 142.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.487 0.66 . . . . 0.0 111.153 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 139.8 29.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.515 1.526 . . . . 0.0 107.927 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 123.04 18.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.788 1.235 . . . . 0.0 109.273 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -149.59 152.32 35.27 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.873 1.669 . . . . 0.0 110.046 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -17.01 5.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.98 1.312 . . . . 0.0 114.449 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.79 -26.6 58.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.665 1.586 . . . . 0.0 114.63 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.6 p -147.81 -38.8 0.19 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.623 1.569 . . . . 0.0 112.984 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -60.95 124.21 78.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.047 1.339 . . . . 0.0 110.827 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.8 -7.93 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.519 2.813 . . . . 0.0 113.554 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 65.39 -16.34 0.1 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 127.914 2.485 . . . . 0.0 115.461 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -73.52 -45.86 51.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.391 2.276 . . . . 0.0 112.716 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.7 ttt -114.17 135.78 53.66 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.219 1.008 . . . . 0.0 108.38 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -116.58 171.46 7.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.551 0.74 . . . . 0.0 109.323 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.07 131.38 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.385 -0.822 . . . . 0.0 109.689 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.4 m -109.2 132.72 53.86 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.571 1.148 . . . . 0.0 109.352 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -75.11 69.91 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.188 1.795 . . . . 0.0 110.624 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -53.96 -42.95 69.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.954 1.302 . . . . 0.0 111.848 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -160.37 178.36 9.67 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.469 1.907 . . . . 0.0 110.967 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -51.82 142.57 14.89 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.51 -1.369 . . . . 0.0 110.476 164.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.9 p 46.17 27.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.526 1.53 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.1 t -146.9 101.06 3.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.52 1.128 . . . . 0.0 111.369 -171.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -116.52 133.73 55.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.31 93.96 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -69.44 125.3 26.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.454 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -121.45 115.05 22.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.844 1.258 . . . . 0.0 111.606 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.77 108.94 7.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.366 1.466 . . . . 0.0 110.523 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -89.95 -15.37 32.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 -174.52 3.02 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.124 1.37 . . . . 0.0 111.511 171.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.99 41.04 0.65 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.632 0.254 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.11 142.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.247 1.019 . . . . 0.0 110.474 167.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.3 143.07 57.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.49 0.716 . . . . 0.0 109.944 173.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.74 -14.56 62.71 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.435 -1.416 . . . . 0.0 113.126 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -119.01 6.02 11.33 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.273 2.229 . . . . 0.0 113.384 -171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -146.9 175.05 10.95 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.127 2.171 . . . . 0.0 109.042 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.18 154.63 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.229 1.012 . . . . 0.0 110.587 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.49 143.8 31.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.18 131.74 51.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.977 1.311 . . . . 0.0 108.782 -165.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -114.8 135.02 54.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.116 1.436 . . . . 0.0 109.872 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.93 39.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.878 1.671 . . . . 0.0 111.235 -168.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.92 143.12 6.87 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.944 1.259 . . . . 0.0 111.866 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -55.46 147.65 17.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.15 0.98 . . . . 0.0 110.955 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.45 27.52 15.62 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.9 m 61.51 68.88 0.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.091 1.756 . . . . 0.0 113.101 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.1 p -131.66 -173.58 3.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.35 1.86 . . . . 0.0 111.514 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.91 -121.29 9.25 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.887 -1.133 . . . . 0.0 112.39 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.27 172.67 6.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 111.415 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.4 p -134.96 146.97 49.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 111.515 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.88 154.33 45.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.244 1.818 . . . . 0.0 109.255 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -129.98 150.73 51.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.829 0.823 . . . . 0.0 111.754 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -138.49 122.55 17.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.848 1.659 . . . . 0.0 110.341 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -68.76 128.63 37.34 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.934 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -52.41 139.63 24.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.979 0.912 . . . . 0.0 111.406 171.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.1 48.47 4.35 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.043 0.83 . . . . 0.0 112.896 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 177.42 9.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.113 0.965 . . . . 0.0 112.745 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 m -138.75 135.65 34.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.821 1.649 . . . . 0.0 109.155 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.28 120.65 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.265 1.826 . . . . 0.0 109.926 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -117.55 100.4 7.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.57 1.148 . . . . 0.0 108.883 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.51 173.49 7.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.28 1.032 . . . . 0.0 110.364 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -119.15 154.47 33.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -17.56 29.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.647 1.179 . . . . 0.0 113.429 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.84 -35.4 61.85 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.505 1.526 . . . . 0.0 114.477 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.43 119.84 18.22 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.795 1.298 . . . . 0.0 109.677 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.56 67.58 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.088 -1.632 . . . . 0.0 112.374 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -62.89 -25.22 68.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.541 1.536 . . . . 0.0 112.578 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.5 -56.5 10.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.524 1.53 . . . . 0.0 110.87 169.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.9 -21.51 66.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.012 1.325 . . . . 0.0 113.344 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -5.48 3.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.755 2.022 . . . . 0.0 115.336 170.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.2 139.25 1.44 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.883 0.765 . . . . 0.0 110.131 158.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tpt -160.53 -41.34 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.1 p -155.46 169.09 25.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.839 1.256 . . . . 0.0 111.386 171.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -159.54 172.71 17.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 110.814 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 141.95 50.5 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.365 1.466 . . . . 0.0 109.129 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.36 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.507 1.523 . . . . 0.0 109.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.02 -110.87 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.688 2.089 . . . . 0.0 115.42 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.5 m -152.92 -28.31 0.15 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.953 1.301 . . . . 0.0 112.9 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -113.94 31.56 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.516 1.926 . . . . 0.0 110.723 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.4 m -144.76 133.22 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.447 1.499 . . . . 0.0 109.548 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 154.01 21.17 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.47 -0.769 . . . . 0.0 109.858 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 104.33 6.54 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 0.0 109.365 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.98 130.47 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.806 0.843 . . . . 0.0 109.216 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 11.3 tt -124.44 134.18 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 109.611 -169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.37 137.15 37.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 111.256 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.97 -47.27 4.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.801 1.241 . . . . 0.0 113.124 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -129.12 132.52 47.38 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.814 0.846 . . . . 0.0 109.296 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -129.65 96.42 4.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.064 1.346 . . . . 0.0 110.531 -165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.87 165.5 25.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.689 1.196 . . . . 0.0 111.658 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.34 17.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.092 1.357 . . . . 0.0 113.049 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -147.9 39.22 0.93 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.09 1.356 . . . . 0.0 111.277 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -125.94 136.63 28.72 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.68 1.192 . . . . 0.0 111.742 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.38 -18.24 16.02 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.774 2.316 . . . . 0.0 112.776 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -75.3 118.61 72.0 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.852 0.861 . . . . 0.0 109.453 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.14 86.78 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.87 2.38 . . . . 0.0 109.485 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -44.32 128.26 6.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.529 1.538 . . . . 0.0 112.852 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -57.92 125.96 25.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.69 0.757 . . . . 0.0 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -142.78 149.52 38.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.182 1.393 . . . . 0.0 108.569 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.53 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.028 0.918 . . . . 0.0 109.957 169.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.36 82.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.328 1.051 . . . . 0.0 109.046 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -43.43 125.29 3.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.326 1.45 . . . . 0.0 109.303 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.01 146.09 11.77 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.106 0.962 . . . . 0.0 112.18 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -57.82 -14.15 5.49 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.93 116.07 0.77 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.858 1.218 . . . . 0.0 111.598 160.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.34 168.85 2.76 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.298 1.839 . . . . 0.0 112.151 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.9 m -103.34 141.12 36.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.015 0.926 . . . . 0.0 109.477 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -119.35 89.27 3.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.818 1.247 . . . . 0.0 107.759 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.13 -0.64 14.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.366 1.466 . . . . 0.0 113.322 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -144.78 69.92 1.27 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.882 1.673 . . . . 0.0 109.779 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mp -92.86 10.36 31.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.6 m -52.68 -30.8 33.99 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.66 -1.275 . . . . 0.0 112.78 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -58.91 -27.45 65.27 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.9 -25.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.13 0.972 . . . . 0.0 111.424 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.7 t30 68.0 39.89 2.4 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 126.152 1.781 . . . . 0.0 113.986 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.18 153.92 30.62 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.07 -1.019 . . . . 0.0 110.932 -169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.58 148.6 31.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.033 1.333 . . . . 0.0 108.317 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.44 -40.79 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.738 1.215 . . . . 0.0 113.019 171.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -130.97 140.82 50.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.292 1.037 . . . . 0.0 110.404 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.24 142.08 50.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.911 1.285 . . . . 0.0 110.55 172.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -135.37 126.17 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.135 1.374 . . . . 0.0 107.991 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.46 107.7 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 122.487 1.137 . . . . 0.0 109.468 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.97 150.62 42.18 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.253 1.021 . . . . 0.0 109.357 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.66 27.45 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.614 3.543 . . . . 0.0 115.601 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.72 34.7 65.13 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.073 1.32 . . . . 0.0 113.792 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.46 -44.51 0.19 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.156 1.782 . . . . 0.0 110.063 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.415 ' CD2' ' CB ' ' A' ' 139' ' ' PRO . 5.0 m-85 -83.1 153.1 25.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.168 1.387 . . . . 0.0 110.546 168.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -90.45 -41.12 11.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.529 1.132 . . . . 0.0 111.01 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -155.99 177.89 10.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.363 2.265 . . . . 0.0 108.784 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.47 159.43 43.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.674 0.79 . . . . 0.0 109.713 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.9 p -120.8 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.75 125.9 30.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.285 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.27 137.76 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 108.666 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -132.21 159.09 40.04 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.494 -0.754 . . . . 0.0 109.562 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.79 136.3 56.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.087 1.755 . . . . 0.0 109.009 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.43 135.61 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.718 1.207 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -91.6 117.92 30.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.659 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -109.19 4.51 22.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.622 1.169 . . . . 0.0 113.082 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.5 t -116.89 -60.98 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.299 1.44 . . . . 0.0 110.933 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.42 -20.61 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.338 1.055 . . . . 0.0 110.841 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.7 m 48.47 31.94 3.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.675 1.99 . . . . 0.0 113.846 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -127.83 31.43 5.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.123 1.769 . . . . 0.0 111.331 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -37.95 104.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.123 2.569 . . . . 0.0 113.293 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.24 10.76 0.05 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.9 p -149.36 14.87 0.89 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.306 1.442 . . . . 0.0 114.136 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -115.86 139.71 49.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.575 1.55 . . . . 0.0 108.064 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -115.12 140.75 48.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 109.067 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.45 ' HE1' ' CD1' ' A' ' 207' ' ' PHE . 1.3 ttp -134.46 127.66 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.797 0.839 . . . . 0.0 110.272 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.1 m -117.84 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.392 1.077 . . . . 0.0 109.124 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.77 122.9 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.361 1.864 . . . . 0.0 108.753 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.1 m -130.21 99.71 19.32 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.153 1.381 . . . . 0.0 110.175 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.85 169.59 18.67 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.969 3.113 . . . . 0.0 112.39 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -25.23 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.655 2.782 . . . . 0.0 113.724 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 41.53 48.9 3.53 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.97 1.708 . . . . 0.0 115.203 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.7 160.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.918 2.087 . . . . 0.0 111.362 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.85 129.12 9.31 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.762 1.625 . . . . 0.0 112.495 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -64.65 157.06 28.21 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.278 0.561 . . . . 0.0 111.505 169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.08 149.33 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 126.699 1.999 . . . . 0.0 109.701 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.44 91.79 3.72 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.978 0.911 . . . . 0.0 110.887 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.5 t -67.14 139.47 57.49 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -134.32 133.02 40.22 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.519 1.127 . . . . 0.0 108.692 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.59 129.06 40.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.412 0.685 . . . . 0.0 111.296 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.44 18.84 12.21 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.711 1.148 . . . . 0.0 114.867 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.03 156.16 16.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.203 1.401 . . . . 0.0 112.178 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.16 57.54 0.66 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.611 1.564 . . . . 0.0 111.84 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 57.21 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.204 2.201 . . . . 0.0 112.156 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.13 149.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.062 -1.024 . . . . 0.0 111.469 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -114.92 97.87 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.5 tp -75.05 116.39 53.75 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.415 ' CB ' ' CD2' ' A' ' 96' ' ' PHE . 65.9 Cg_endo -73.46 144.56 36.46 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.175 1.917 . . . . 0.0 112.694 172.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 mm -130.85 130.38 22.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.225 1.41 . . . . 0.0 109.063 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 178.76 4.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.751 2.301 . . . . 0.0 111.895 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 54.8 0.08 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.099 1.76 . . . . 0.0 113.6 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 pp -45.73 134.72 7.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.154 1.382 . . . . 0.0 111.164 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -139.68 133.81 15.83 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.989 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.02 150.04 78.26 Favored 'Cis proline' 0 CA--C 1.545 1.05 0 CA-C-N 119.216 0.756 . . . . 0.0 112.113 -5.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.08 -34.76 45.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.946 1.764 . . . . 0.0 112.431 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -63.77 -10.03 17.72 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 161.41 24.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.244 1.018 . . . . 0.0 112.654 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -84.73 161.28 20.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.976 . . . . 0.0 112.012 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.5 119.47 39.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 109.051 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.94 136.01 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.671 174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 p -134.42 142.39 47.12 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.985 0.914 . . . . 0.0 110.319 170.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -101.81 136.87 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.41 152.29 50.79 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 123.137 1.446 . . . . 0.0 112.946 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.32 132.78 28.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.777 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 t -104.93 129.27 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -144.13 133.75 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.4 156.26 23.05 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.707 -0.621 . . . . 0.0 112.048 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.0 p -89.76 -27.13 20.24 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.46 169.03 9.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.962 2.105 . . . . 0.0 111.267 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -52.65 150.74 8.94 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.98 9.24 15.48 Favored 'Cis proline' 0 CA--C 1.547 1.146 0 N-CA-C 115.818 1.43 . . . . 0.0 115.818 2.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.28 30.07 17.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.256 1.022 . . . . 0.0 112.482 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 148.69 31.84 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.502 -1.374 . . . . 0.0 112.161 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.94 106.66 2.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.52 1.128 . . . . 0.0 111.539 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.63 -59.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.656 1.582 . . . . 0.0 109.956 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.9 t -125.53 143.07 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.103 -1.623 . . . . 0.0 108.957 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 101.21 3.64 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.085 1.354 . . . . 0.0 107.391 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.23 -164.81 15.93 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.461 1.029 . . . . 0.0 111.567 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.33 151.39 37.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.398 -1.06 . . . . 0.0 111.644 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.3 142.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.817 1.647 . . . . 0.0 109.285 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -107.51 105.36 15.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.607 -0.683 . . . . 0.0 109.162 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -84.11 160.9 20.81 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.726 0.774 . . . . 0.0 110.012 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -158.95 161.34 36.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.832 2.053 . . . . 0.0 108.197 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.76 141.46 50.37 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.884 0.874 . . . . 0.0 109.256 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.0 m -96.42 110.24 51.73 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.104 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.11 53.29 3.34 Favored 'Trans proline' 0 CA--C 1.541 0.85 1 C-N-CA 125.492 4.128 . . . . 0.0 112.704 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -134.86 -43.33 0.74 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 111.187 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.7 p -146.7 19.33 1.31 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.455 1.502 . . . . 0.0 113.584 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.41 31.7 63.06 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 120.414 -1.428 . . . . 0.0 113.584 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -85.64 146.7 26.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.582 1.153 . . . . 0.0 111.097 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.1 t -127.03 85.78 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.469 1.508 . . . . 0.0 110.218 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -81.98 163.15 22.34 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.92 -1.112 . . . . 0.0 111.638 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.84 125.6 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.982 0.913 . . . . 0.0 109.327 -170.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.91 139.73 22.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.842 2.057 . . . . 0.0 109.111 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 119.86 12.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.174 1.79 . . . . 0.0 109.088 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -147.62 150.99 35.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.924 1.69 . . . . 0.0 110.097 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 -17.78 6.88 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.77 -23.49 63.31 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.001 1.32 . . . . 0.0 114.083 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.4 p -150.05 -45.06 0.13 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.509 1.524 . . . . 0.0 113.65 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -61.35 138.37 94.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 111.4 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.15 178.36 4.26 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.223 2.615 . . . . 0.0 112.502 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -128.1 -35.63 2.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.65 1.18 . . . . 0.0 112.434 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -66.0 -17.7 64.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.534 1.934 . . . . 0.0 113.565 166.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -125.18 145.1 50.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.698 1.599 . . . . 0.0 109.055 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 p -128.42 167.63 16.75 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.879 1.672 . . . . 0.0 110.114 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 9.7 p -144.97 147.71 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.288 -0.882 . . . . 0.0 110.614 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 99.9 m -127.68 130.33 48.71 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.252 1.021 . . . . 0.0 109.386 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.03 103.4 7.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.517 0.727 . . . . 0.0 110.108 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.13 -45.3 34.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 122.001 -0.437 . . . . 0.0 111.235 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -145.51 -175.15 4.61 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.17 1.788 . . . . 0.0 111.766 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -56.4 -25.32 49.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.8 m -149.7 49.01 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.667 1.187 . . . . 0.0 108.14 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 58.8 m -151.76 110.45 3.82 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.31 2.244 . . . . 0.0 109.507 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 138.04 54.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.388 1.075 . . . . 0.0 110.382 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 tt -133.83 108.78 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.148 0.975 . . . . 0.0 110.005 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . 0.45 ' CD1' ' HE1' ' A' ' 117' ' ' MET . 38.8 m-85 -90.54 133.98 34.69 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.707 1.603 . . . . 0.0 110.214 -178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -127.32 121.33 30.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.724 1.21 . . . . 0.0 109.381 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.55 101.15 13.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.337 0.655 . . . . 0.0 110.898 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.91 -18.28 29.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.624 1.97 . . . . 0.0 114.464 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.5 m -152.86 140.89 20.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.065 2.546 . . . . 0.0 109.02 170.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.9 -46.2 82.09 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 119.937 1.244 . . . . 0.0 112.413 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.649 1.979 . . . . 0.0 111.932 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.9 140.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.802 0.841 . . . . 0.0 110.535 168.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.57 142.44 56.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.329 0.652 . . . . 0.0 110.076 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.6 -17.35 54.82 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.673 -1.267 . . . . 0.0 113.042 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.51 3.75 11.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.919 1.688 . . . . 0.0 113.193 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -146.68 170.84 16.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.291 2.236 . . . . 0.0 109.061 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 23' ' ' TYR . 17.2 m -132.77 162.26 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.82 -0.55 . . . . 0.0 110.487 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.14 143.94 28.63 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.801 -0.562 . . . . 0.0 110.98 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.3 147.07 38.32 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.449 1.099 . . . . 0.0 108.465 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.65 118.94 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 123.181 1.467 . . . . 0.0 110.241 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.78 48.73 1.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.969 1.307 . . . . 0.0 110.516 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.4 144.71 5.95 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.856 1.694 . . . . 0.0 111.074 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -55.91 137.53 50.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.09 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 72.56 40.14 0.66 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.349 1.46 . . . . 0.0 113.964 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.342 27.5 p 47.41 56.82 6.49 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.436 1.894 . . . . 0.0 114.582 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.7 p -123.74 -174.78 3.06 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.45 1.5 . . . . 0.0 112.213 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.05 -109.74 2.91 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.931 1.253 . . . . 0.0 112.683 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -107.36 163.59 12.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.663 0.785 . . . . 0.0 110.876 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 p -130.31 144.4 51.36 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.971 0.909 . . . . 0.0 111.425 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -141.74 151.14 42.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.204 1.402 . . . . 0.0 110.069 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.97 147.84 49.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.929 0.892 . . . . 0.0 111.681 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB2' HG23 ' A' ' 8' ' ' VAL . 22.7 m-85 -140.96 137.57 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.077 0.951 . . . . 0.0 111.643 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.63 151.03 30.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.755 1.222 . . . . 0.0 109.584 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -63.73 150.45 44.47 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.529 -0.732 . . . . 0.0 111.157 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.23 50.34 57.07 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 122.115 -0.366 . . . . 0.0 113.862 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -137.16 141.25 42.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.202 1.401 . . . . 0.0 110.912 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.2 m -123.99 130.72 53.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.062 0.945 . . . . 0.0 109.577 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.84 117.21 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 100.61 7.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -80.1 162.5 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.734 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -106.54 152.25 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.318 0.647 . . . . 0.0 109.965 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -17.07 53.58 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.66 82.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.314 0.959 . . . . 0.0 114.312 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -84.73 108.34 17.38 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.196 0.998 . . . . 0.0 110.042 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.95 -23.06 52.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.031 -1.043 . . . . 0.0 112.757 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -60.09 -22.91 63.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.814 1.646 . . . . 0.0 112.226 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -65.76 -56.06 14.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.454 1.101 . . . . 0.0 112.422 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.32 -15.89 58.7 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.171 0.989 . . . . 0.0 113.65 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -61.25 -23.36 65.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.629 1.572 . . . . 0.0 113.695 173.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -46.38 129.3 10.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 111.57 166.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmt -149.65 -31.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.294 1.038 . . . . 0.0 113.58 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -144.68 165.77 27.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.61 1.964 . . . . 0.0 110.682 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.61 168.32 23.67 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.347 -0.846 . . . . 0.0 110.867 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.01 128.5 20.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.906 0.882 . . . . 0.0 109.621 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.02 129.17 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 109.005 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.79 -98.1 0.01 OUTLIER Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.022 1.772 . . . . 0.0 116.617 -170.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.9 p -168.17 -25.68 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.681 1.192 . . . . 0.0 112.817 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -115.8 29.6 7.88 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.12 1.368 . . . . 0.0 111.266 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.24 116.38 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.838 1.655 . . . . 0.0 110.135 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -79.43 152.93 30.04 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.306 -0.871 . . . . 0.0 109.456 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 138.19 45.46 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.599 1.159 . . . . 0.0 109.242 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.92 119.48 23.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 71' ' ' LEU . 11.7 pt -118.42 118.11 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.199 0.999 . . . . 0.0 111.298 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -124.15 142.63 51.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.771 1.628 . . . . 0.0 108.887 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.92 -44.22 3.05 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.965 0.906 . . . . 0.0 111.363 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -119.18 140.28 50.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.466 0.651 . . . . 0.0 111.025 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -140.97 120.29 13.04 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.826 1.25 . . . . 0.0 109.057 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -158.62 163.41 36.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.177 0.991 . . . . 0.0 111.046 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt -147.68 51.31 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.206 1.403 . . . . 0.0 111.065 -167.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -177.48 -31.64 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.961 2.105 . . . . 0.0 110.722 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -58.9 137.95 87.31 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.221 1.008 . . . . 0.0 112.994 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.01 -23.09 5.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.523 2.149 . . . . 0.0 113.578 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 t -76.0 120.26 80.86 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 119.015 0.825 . . . . 0.0 111.138 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.47 114.97 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.279 1.32 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.89 156.61 32.34 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.405 1.003 . . . . 0.0 113.592 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -65.4 123.9 20.83 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.305 1.052 . . . . 0.0 111.717 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -140.87 143.47 34.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.47 2.308 . . . . 0.0 108.822 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 125.97 6.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.345 1.069 . . . . 0.0 110.406 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.63 105.64 11.08 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.137 0.97 . . . . 0.0 109.904 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 54' ' ' ILE . 1.7 tp -63.18 121.24 13.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.613 0.765 . . . . 0.0 109.068 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.52 141.28 16.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.628 1.171 . . . . 0.0 112.398 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -59.78 -15.06 17.56 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.45 118.81 0.91 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.606 1.098 . . . . 0.0 111.444 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.37 169.33 1.05 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.264 1.826 . . . . 0.0 111.646 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.1 m -105.22 144.51 31.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.873 1.269 . . . . 0.0 110.455 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -124.33 98.31 5.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.373 1.069 . . . . 0.0 108.636 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.48 -35.94 7.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.324 1.049 . . . . 0.0 112.823 -164.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -143.96 112.09 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.405 1.482 . . . . 0.0 108.915 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 26.04 2.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.501 1.52 . . . . 0.0 111.006 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -51.39 -33.46 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.304 1.042 . . . . 0.0 112.574 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -58.18 -21.46 47.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.89 -9.27 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.326 1.45 . . . . 0.0 112.598 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 82.29 39.97 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.409 2.283 . . . . 0.0 112.266 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.16 -133.59 31.13 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.337 -1.477 . . . . 0.0 110.76 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.3 tp -146.81 160.89 41.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.938 1.369 . . . . 0.0 110.875 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 p -144.58 -35.96 0.33 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.86 0.864 . . . . 0.0 113.141 155.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -129.14 139.66 51.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.905 0.882 . . . . 0.0 110.635 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.66 135.64 48.75 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.121 0.969 . . . . 0.0 110.591 173.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -129.21 130.46 46.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.881 0.873 . . . . 0.0 109.401 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.82 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.378 1.471 . . . . 0.0 107.539 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.21 142.11 33.02 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.612 0.765 . . . . 0.0 110.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.95 32.0 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.862 3.041 . . . . 0.0 114.794 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.34 60.17 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.862 1.22 . . . . 0.0 113.763 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.73 -25.13 2.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.396 1.478 . . . . 0.0 112.768 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 139' ' ' PRO . 1.3 m-85 -118.13 141.71 48.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.684 1.594 . . . . 0.0 108.15 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -79.59 -33.68 41.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.383 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.461 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 18.8 p-90 -149.01 174.44 12.29 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.582 1.953 . . . . 0.0 109.053 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.89 23.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.993 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -137.94 130.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.097 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.36 131.25 34.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.858 0.863 . . . . 0.0 110.11 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 m -133.04 142.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.402 1.081 . . . . 0.0 110.289 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -144.95 144.16 30.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.97 0.908 . . . . 0.0 110.545 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 pt -87.65 153.71 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.8 120.48 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.18 1.392 . . . . 0.0 108.335 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -58.96 103.08 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.96 1.304 . . . . 0.0 112.196 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 16.94 22.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.507 1.123 . . . . 0.0 111.359 168.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.82 -35.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.618 1.567 . . . . 0.0 113.035 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -96.8 170.88 8.87 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.6 1.16 . . . . 0.0 111.649 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -109.71 -45.56 3.64 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.47 -0.769 . . . . 0.0 113.044 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.6 m -71.48 -31.22 66.88 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.505 1.122 . . . . 0.0 112.528 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.93 -44.38 0.56 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.114 2.166 . . . . 0.0 114.117 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.04 42.06 0.36 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.014 2.245 . . . . 0.0 115.017 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.7 p -129.74 -1.16 4.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.861 2.064 . . . . 0.0 112.005 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -118.63 150.37 39.81 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.185 1.394 . . . . 0.0 111.653 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.96 127.67 29.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.762 1.225 . . . . 0.0 109.971 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.7 ttm -102.89 122.55 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.761 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.4 m -116.0 117.69 30.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 26.5 pt -122.66 142.15 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.76 0.79 . . . . 0.0 112.277 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 78.7 m -135.23 85.84 32.22 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.283 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.47 167.66 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.43 2.087 . . . . 0.0 111.766 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -33.9 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.64 2.376 . . . . 0.0 114.538 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 39.68 51.12 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.538 1.935 . . . . 0.0 114.528 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.13 148.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.901 1.68 . . . . 0.0 110.436 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -51.35 111.89 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.665 1.186 . . . . 0.0 111.36 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.29 134.62 39.47 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.516 0.726 . . . . 0.0 110.735 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.84 127.53 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.39 114.58 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.226 1.011 . . . . 0.0 109.061 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.28 146.02 46.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.42 0.688 . . . . 0.0 110.956 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -117.76 170.59 8.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.831 0.852 . . . . 0.0 110.552 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.3 69.93 1.63 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.62 1.2 . . . . 0.0 112.135 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.03 0.08 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.001 1.762 . . . . 0.0 111.309 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.52 161.93 36.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.698 1.199 . . . . 0.0 111.585 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.56 55.16 1.65 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.999 1.32 . . . . 0.0 111.935 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 60.33 93.1 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.225 2.21 . . . . 0.0 112.722 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.99 139.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.344 0.658 . . . . 0.0 111.645 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -97.94 123.6 42.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.874 0.869 . . . . 0.0 110.336 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 127.51 37.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.454 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 86.1 Cg_endo -77.53 128.31 9.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.487 2.125 . . . . 0.0 110.999 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.461 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 6.5 mm -128.15 125.56 23.44 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.518 0.727 . . . . 0.0 109.619 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.44 178.02 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.419 2.079 . . . . 0.0 111.534 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -14.28 43.75 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.867 -1.145 . . . . 0.0 113.577 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp 55.21 -175.42 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.428 1.891 . . . . 0.0 112.319 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.7 t -153.63 106.3 2.54 Favored Pre-proline 0 C--O 1.241 0.606 0 O-C-N 121.265 -0.897 . . . . 0.0 111.282 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.26 165.14 69.22 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 119.386 0.816 . . . . 0.0 113.142 -9.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.64 -30.98 41.6 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.211 1.941 . . . . 0.0 114.082 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.98 2.09 13.59 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -73.69 144.51 45.76 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.992 -1.068 . . . . 0.0 112.004 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -70.28 157.97 36.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 113.117 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tt -125.94 122.48 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.649 1.18 . . . . 0.0 109.445 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.28 132.71 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 110.414 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -138.7 122.2 17.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.651 0.781 . . . . 0.0 110.758 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -82.29 134.38 35.27 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 171.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.04 119.59 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 109.557 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.1 p -124.16 113.38 18.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.338 1.055 . . . . 0.0 109.033 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 t -104.39 125.02 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -140.44 151.44 44.89 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.629 1.572 . . . . 0.0 109.115 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -67.26 141.55 57.2 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.81 -0.556 . . . . 0.0 111.979 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.9 p -67.9 -24.71 65.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.02 0.928 . . . . 0.0 113.16 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -144.34 179.67 7.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.716 2.006 . . . . 0.0 110.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.6 t -41.55 136.55 1.89 Allowed Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.216 1.806 . . . . 0.0 113.863 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.22 8.68 31.0 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 N-CA-C 114.683 0.994 . . . . 0.0 114.683 5.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.63 27.56 16.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.166 1.387 . . . . 0.0 112.719 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.77 151.11 36.11 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.25 -1.531 . . . . 0.0 113.157 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -78.57 128.43 33.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.999 1.32 . . . . 0.0 111.401 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.7 -38.41 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.431 1.493 . . . . 0.0 111.602 -175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.58 138.5 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.76 1.224 . . . . 0.0 108.557 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -150.12 76.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.23 1.012 . . . . 0.0 108.905 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.09 -168.56 14.85 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.715 1.626 . . . . 0.0 111.938 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -133.32 160.48 37.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.291 -1.123 . . . . 0.0 112.593 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.41 147.35 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.272 1.429 . . . . 0.0 108.124 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.2 131.38 52.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.377 0.608 . . . . 0.0 109.592 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -110.06 153.29 24.85 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -163.04 148.35 11.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -120.44 151.51 39.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.378 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 73.7 m -90.39 110.78 43.31 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.039 0.936 . . . . 0.0 108.66 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.45 52.3 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 124.993 3.796 . . . . 0.0 112.298 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.2 m -130.08 -40.22 1.33 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.792 2.037 . . . . 0.0 111.687 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 t -149.22 30.03 0.78 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.93 1.292 . . . . 0.0 111.408 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.19 35.87 43.25 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.86 -1.15 . . . . 0.0 113.151 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.59 118.2 18.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.905 0.882 . . . . 0.0 109.169 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.4 139.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.572 0.749 . . . . 0.0 109.917 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 49.5 m -143.36 158.36 43.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.599 1.56 . . . . 0.0 110.571 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -128.49 129.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.711 0.804 . . . . 0.0 110.904 174.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.04 129.89 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 107.979 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.409 ' HE2' HG23 ' A' ' 184' ' ' VAL . 8.1 mtmt -140.45 122.85 16.01 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.835 1.254 . . . . 0.0 108.605 -171.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -150.22 146.49 26.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -55.83 -18.02 7.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 113.811 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -59.2 -25.62 64.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.64 1.976 . . . . 0.0 114.207 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.1 p -145.12 -43.14 0.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.528 1.531 . . . . 0.0 113.096 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.413 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 66.1 t80 -60.58 135.58 92.1 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.065 1.746 . . . . 0.0 111.889 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 38.0 Cg_endo -79.09 -172.44 1.54 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.022 2.482 . . . . 0.0 111.341 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.82 31.85 3.3 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.964 1.306 . . . . 0.0 113.593 -166.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -148.31 -32.41 0.25 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.228 1.811 . . . . 0.0 113.737 -164.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.3 ttt -125.1 140.04 53.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.272 2.229 . . . . 0.0 107.928 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.9 p -127.49 159.38 34.73 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.388 0.675 . . . . 0.0 109.864 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.03 131.28 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 t -116.58 147.77 41.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.134 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -85.45 83.68 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.669 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.42 -29.74 69.18 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.718 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.07 174.05 15.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.905 1.682 . . . . 0.0 111.171 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.77 140.58 57.54 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.989 -1.694 . . . . 0.0 110.333 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p 53.66 12.68 0.42 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.224 2.209 . . . . 0.0 114.836 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.3 t -133.91 105.25 6.66 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.595 1.158 . . . . 0.0 111.664 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 184' ' ' VAL . 20.7 m-85 -108.03 148.37 29.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.276 1.03 . . . . 0.0 111.833 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.8 tt -134.11 116.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.734 0.778 . . . . 0.0 109.252 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.3 125.11 37.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.998 1.319 . . . . 0.0 109.727 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -109.48 123.71 49.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.106 0.962 . . . . 0.0 109.187 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.49 96.57 6.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 111.077 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -87.57 -25.99 23.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.282 1.033 . . . . 0.0 112.329 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.2 t -90.56 176.34 6.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.733 1.213 . . . . 0.0 113.002 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.48 57.44 0.94 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.722 1.209 . . . . 0.0 110.06 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 116.99 -1.481 . . . . 0.0 113.371 173.091 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.545 0.212 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.42 154.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.892 1.277 . . . . 0.0 109.302 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.98 143.88 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.475 0.71 . . . . 0.0 110.983 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.0 -20.38 23.67 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.54 15.41 22.95 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.389 2.276 . . . . 0.0 113.348 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -140.26 169.33 17.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.462 -1.399 . . . . 0.0 110.033 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 23' ' ' TYR . 25.4 m -136.49 145.66 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.837 0.855 . . . . 0.0 109.968 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.0 144.79 49.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.056 1.342 . . . . 0.0 109.201 -174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 44' ' ' CYS . 1.2 m-85 -132.85 120.27 21.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.1 1.36 . . . . 0.0 109.601 -171.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.17 125.93 42.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.261 1.424 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.17 43.12 0.43 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.511 1.924 . . . . 0.0 112.602 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.1 137.91 2.49 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.758 2.123 . . . . 0.0 110.601 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -51.84 159.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.831 0.852 . . . . 0.0 111.289 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 t30 64.83 22.78 12.58 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m 54.84 57.16 5.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.34 1.456 . . . . 0.0 113.126 -173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.6 p -131.82 -177.92 4.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.737 1.215 . . . . 0.0 112.393 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.54 -119.08 4.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.283 0.944 . . . . 0.0 111.772 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.72 -178.22 3.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.241 1.416 . . . . 0.0 110.834 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p -136.6 153.81 50.85 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.794 -1.191 . . . . 0.0 111.387 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.27 155.19 41.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.105 1.362 . . . . 0.0 110.451 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.64 138.31 51.14 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 109.945 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 8' ' ' VAL . 33.2 m-85 -134.21 144.52 48.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.195 1.398 . . . . 0.0 110.705 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -79.99 149.17 30.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.535 1.134 . . . . 0.0 111.128 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -63.24 157.48 22.55 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.323 1.049 . . . . 0.0 111.688 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.3 39.54 97.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.387 0.518 . . . . 0.0 113.019 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.51 160.81 32.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.578 1.551 . . . . 0.0 109.758 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.4 p -138.96 151.15 46.64 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.276 -1.515 . . . . 0.0 109.099 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.84 116.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.306 1.051 . . . . 0.0 108.628 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 mtm105 -125.91 92.52 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 108.684 -164.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.34 153.0 21.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.418 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -95.83 147.05 24.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.419 0.687 . . . . 0.0 110.763 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -67.61 2.23 1.96 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.69 80.99 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.265 1.412 . . . . 0.0 114.736 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -133.9 120.56 20.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.934 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -13.18 2.15 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -57.16 -20.6 27.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.562 1.545 . . . . 0.0 112.49 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -65.16 -54.79 24.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.043 0.838 . . . . 0.0 111.749 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.65 -22.8 57.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.122 1.369 . . . . 0.0 113.251 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -51.36 -42.07 61.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.964 1.306 . . . . 0.0 113.541 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -67.0 31.19 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 126.575 1.95 . . . . 0.0 114.042 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.01 -38.11 89.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.561 2.345 . . . . 0.0 113.917 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -112.22 151.9 29.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.749 1.159 . . . . 0.0 110.754 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 10' ' ' PHE . 6.1 p -169.03 167.38 10.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 123.046 1.403 . . . . 0.0 113.154 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.84 125.56 14.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.126 1.37 . . . . 0.0 108.405 -172.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.8 133.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.225 1.81 . . . . 0.0 108.306 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.85 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.634 1.588 . . . . 0.0 115.886 -168.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -156.47 -22.63 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.239 1.416 . . . . 0.0 113.77 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.94 16.26 12.55 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.732 1.613 . . . . 0.0 111.801 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -145.36 152.36 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.412 1.885 . . . . 0.0 110.216 -173.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -116.99 156.78 26.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.687 1.195 . . . . 0.0 110.041 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.2 t -127.05 131.03 51.03 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.005 0.922 . . . . 0.0 108.725 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -112.87 140.14 47.91 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.143 1.377 . . . . 0.0 107.584 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' CG1' HD23 ' A' ' 86' ' ' LEU . 5.3 tt -129.39 137.96 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.194 0.998 . . . . 0.0 109.363 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.1 120.24 8.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.269 1.428 . . . . 0.0 111.263 -161.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -95.27 -63.02 1.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.107 -0.995 . . . . 0.0 112.7 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.21 142.46 37.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.581 1.153 . . . . 0.0 109.54 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.42 105.7 6.7 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.921 -1.112 . . . . 0.0 109.431 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -142.0 152.44 43.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.209 1.404 . . . . 0.0 110.38 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.4 45.72 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.19 1.796 . . . . 0.0 111.012 -166.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -169.82 -26.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.476 2.31 . . . . 0.0 111.945 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -60.52 137.27 92.48 Favored Pre-proline 0 CA--C 1.543 0.712 0 C-N-CA 125.39 1.476 . . . . 0.0 112.673 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.61 -23.89 9.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.28 2.653 . . . . 0.0 112.937 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -99.61 117.29 63.95 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 124.744 1.217 . . . . 0.0 109.127 171.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.46 155.14 64.25 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.257 1.305 . . . . 0.0 110.033 168.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.6 -136.55 0.71 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.032 0.825 . . . . 0.0 112.947 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -122.76 137.93 54.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.234 1.016 . . . . 0.0 112.921 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.72 167.78 23.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.13 2.172 . . . . 0.0 109.797 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -157.19 142.28 17.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 111.339 170.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -94.85 98.59 10.84 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.733 1.213 . . . . 0.0 110.734 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.89 124.15 18.23 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.998 -1.063 . . . . 0.0 108.668 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.81 153.35 3.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.034 0.934 . . . . 0.0 112.849 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.24 -10.16 2.71 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.93 112.26 0.52 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.424 1.012 . . . . 0.0 111.859 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.05 159.67 2.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.343 1.857 . . . . 0.0 111.983 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 m -104.31 140.12 38.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.538 1.135 . . . . 0.0 110.066 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.504 ' HB3' HD11 ' A' ' 80' ' ' LEU . 12.7 m-80 -130.95 121.06 24.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.658 1.583 . . . . 0.0 108.556 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.98 -22.9 2.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -66.12 0.8 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.733 1.213 . . . . 0.0 110.771 171.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 42' ' ' MET . 4.0 mp 41.01 34.87 0.31 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.043 2.137 . . . . 0.0 113.381 -170.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -62.85 -31.19 72.16 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.765 -1.209 . . . . 0.0 112.406 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -63.19 -28.39 70.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.831 0.852 . . . . 0.0 113.284 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.71 -35.22 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.409 1.484 . . . . 0.0 110.978 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 54.38 55.07 8.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.148 1.379 . . . . 0.0 113.475 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.14 -152.99 16.86 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.448 1.499 . . . . 0.0 111.862 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 87' ' ' SER . 2.1 tm? -153.91 146.05 23.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.684 1.193 . . . . 0.0 111.525 166.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.494 ' H ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -125.25 -63.77 1.13 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.354 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 153.09 50.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.386 1.475 . . . . 0.0 110.809 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.38 147.68 22.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.908 0.861 . . . . 0.0 111.883 -170.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -139.02 120.97 15.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.48 1.512 . . . . 0.0 109.58 -168.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.11 118.51 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.253 0.621 . . . . 0.0 109.465 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.3 mt -125.64 126.81 24.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.554 1.142 . . . . 0.0 109.898 -164.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.9 162.63 23.67 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.611 2.207 . . . . 0.0 112.185 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.29 -5.23 15.07 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.765 1.174 . . . . 0.0 115.644 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.7 -19.76 32.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.276 1.43 . . . . 0.0 113.606 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.53 165.63 24.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.746 1.618 . . . . 0.0 110.03 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.95 -46.81 3.69 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.955 -1.091 . . . . 0.0 111.634 -173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.27 148.05 47.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.68 1.592 . . . . 0.0 107.903 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.84 157.57 42.53 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.45 149.42 24.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.014 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 144.43 26.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.99 139.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.429 1.091 . . . . 0.0 109.596 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -143.15 157.97 44.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.562 1.145 . . . . 0.0 110.681 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.45 145.91 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.072 0.949 . . . . 0.0 112.181 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.44 105.02 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.519 1.928 . . . . 0.0 109.534 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.86 89.49 4.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 112.532 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.54 -32.0 36.86 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.182 -0.949 . . . . 0.0 112.477 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.44 -46.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.9 -24.6 35.58 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.469 0.577 . . . . 0.0 111.485 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t 65.72 -42.82 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.379 3.071 . . . . 0.0 115.437 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -57.42 -37.69 73.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.775 1.63 . . . . 0.0 112.833 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.69 176.11 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.928 1.691 . . . . 0.0 113.993 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.72 28.17 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.921 1.248 . . . . 0.0 114.639 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -140.78 30.58 1.86 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -162.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -120.16 147.52 44.79 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.79 1.636 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.95 126.21 33.5 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.966 1.306 . . . . 0.0 109.409 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 63.1 ttp -126.09 132.43 51.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.884 1.274 . . . . 0.0 110.148 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.9 m -123.09 106.76 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.337 1.455 . . . . 0.0 108.615 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.85 125.37 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.2 t -144.93 123.47 6.69 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.87 170.15 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.962 3.108 . . . . 0.0 113.004 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -42.46 106.43 0.06 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.391 1.876 . . . . 0.0 113.371 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? 47.07 57.03 6.08 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.801 1.64 . . . . 0.0 113.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -126.18 159.32 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.588 1.955 . . . . 0.0 109.919 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -55.23 109.67 0.57 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.152 0.981 . . . . 0.0 111.455 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.81 152.03 20.05 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.442 0.697 . . . . 0.0 111.518 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.61 150.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.262 1.025 . . . . 0.0 110.141 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.69 103.63 10.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 109.42 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.97 146.22 30.83 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.422 0.689 . . . . 0.0 109.61 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -133.82 144.02 48.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.204 1.002 . . . . 0.0 110.546 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.94 108.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.022 2.129 . . . . 0.0 111.025 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.54 -17.03 14.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.445 1.021 . . . . 0.0 114.49 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.0 136.48 57.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.823 1.311 . . . . 0.0 109.927 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -74.59 57.9 0.76 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.076 1.751 . . . . 0.0 112.51 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 63.37 90.49 0.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.858 2.463 . . . . 0.0 111.152 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.97 149.96 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 120.918 -1.114 . . . . 0.0 111.478 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 137.7 32.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.93 96.16 40.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.491 1.916 . . . . 0.0 108.143 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.1 138.5 30.93 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.546 2.164 . . . . 0.0 111.099 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.7 mt -128.36 129.9 23.57 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 108.812 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.47 169.96 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.53 2.82 . . . . 0.0 112.109 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -57.13 134.85 56.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.838 -0.539 . . . . 0.0 111.574 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 pp -144.41 150.3 37.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 110.184 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -142.61 136.63 14.64 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.168 0.987 . . . . 0.0 112.102 -171.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.96 154.0 73.1 Favored 'Cis proline' 0 CA--C 1.544 0.991 0 CA-C-N 119.381 0.815 . . . . 0.0 111.706 -6.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.45 -35.89 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.281 1.988 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.6 0.09 5.95 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.622 1.569 . . . . 0.0 114.225 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 p -68.37 133.58 48.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.162 1.346 . . . . 0.0 110.869 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.53 120.84 15.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.075 167.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.3 tt -104.48 116.8 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.053 1.741 . . . . 0.0 109.086 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.49 139.64 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.057 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.8 m -133.52 134.09 42.98 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.518 1.127 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.43 146.74 36.36 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.693 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.2 111.11 8.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 109.465 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 132.68 49.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.091 0.956 . . . . 0.0 109.382 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.54 136.18 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.153 0.981 . . . . 0.0 109.681 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.72 150.84 37.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.548 1.139 . . . . 0.0 111.668 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.98 140.38 57.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.198 0.599 . . . . 0.0 111.507 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.3 p -80.24 -7.31 58.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.64 177.46 9.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.71 2.004 . . . . 0.0 111.241 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -39.79 133.77 1.37 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.887 1.675 . . . . 0.0 114.205 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.29 8.49 17.56 Favored 'Cis proline' 0 CA--C 1.547 1.135 0 N-CA-C 115.044 1.132 . . . . 0.0 115.044 3.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.06 10.34 2.82 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.321 1.848 . . . . 0.0 114.454 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.22 162.07 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.408 1.483 . . . . 0.0 112.653 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -58.23 151.82 18.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.85 1.26 . . . . 0.0 111.755 170.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.37 -22.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.744 1.218 . . . . 0.0 113.193 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -151.94 142.89 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.608 1.963 . . . . 0.0 109.036 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -142.27 117.39 10.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.587 1.155 . . . . 0.0 108.923 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.68 -147.87 6.18 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.637 1.113 . . . . 0.0 112.097 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.51 172.42 15.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.048 1.339 . . . . 0.0 110.141 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.35 149.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.751 1.62 . . . . 0.0 107.854 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.5 130.8 54.81 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.938 -1.101 . . . . 0.0 109.113 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -111.91 158.27 19.66 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.113 -0.992 . . . . 0.0 110.849 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -163.18 146.16 10.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.908 1.683 . . . . 0.0 108.968 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -111.79 156.58 21.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.257 1.023 . . . . 0.0 110.811 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.6 m -126.81 101.37 26.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.76 1.624 . . . . 0.0 110.329 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -68.32 -10.11 27.96 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.911 3.074 . . . . 0.0 113.785 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.0 m -40.09 -43.5 1.61 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.835 2.054 . . . . 0.0 112.748 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -156.28 28.52 0.35 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.904 0.859 . . . . 0.0 112.941 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 55.98 55.25 30.1 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.115 -1.616 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -129.73 130.75 45.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.299 1.44 . . . . 0.0 109.222 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.7 159.39 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 121.565 -0.709 . . . . 0.0 110.407 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 87.1 m -148.29 111.51 4.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.085 0.954 . . . . 0.0 110.067 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 205' ' ' PHE . 3.1 p -80.83 138.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.482 0.658 . . . . 0.0 109.966 172.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.33 129.03 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.524 1.93 . . . . 0.0 107.195 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 139.62 37.5 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.217 1.007 . . . . 0.0 109.695 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -160.02 164.43 33.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.156 1.382 . . . . 0.0 109.779 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -16.06 5.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.301 1.44 . . . . 0.0 114.001 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.158 1.783 . . . . 0.0 114.058 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 42.1 p -142.91 -47.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.344 1.458 . . . . 0.0 112.432 -170.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 196' ' ' THR . 0.0 OUTLIER -76.58 143.12 71.49 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.985 1.714 . . . . 0.0 111.533 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.36 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.855 2.37 . . . . 0.0 110.736 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -179.68 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 128.266 2.626 . . . . 0.0 111.708 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -58.08 -40.76 81.91 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.92 1.688 . . . . 0.0 112.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.5 ttt -104.67 140.13 38.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.767 1.627 . . . . 0.0 108.627 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 65.9 p -136.82 158.93 43.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.924 0.49 . . . . 0.0 110.961 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.0 p -124.62 139.02 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.968 0.907 . . . . 0.0 110.741 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 97.9 m -126.33 143.04 51.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.426 1.09 . . . . 0.0 109.404 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -73.05 79.1 1.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.338 1.455 . . . . 0.0 111.482 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -54.51 -33.62 60.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.034 1.734 . . . . 0.0 112.699 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.12 -179.67 8.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.854 1.662 . . . . 0.0 111.367 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -44.14 -42.46 6.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.916 2.087 . . . . 0.0 114.295 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.1 p -130.61 12.92 5.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.086 1.755 . . . . 0.0 112.907 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -103.88 126.02 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.387 -0.82 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 184' ' ' VAL . 43.5 m-85 -123.23 138.5 54.62 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.852 1.261 . . . . 0.0 110.977 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.28 116.99 44.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.747 0.819 . . . . 0.0 110.007 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.56 112.2 24.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.767 1.627 . . . . 0.0 108.612 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -94.06 142.73 27.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.439 -0.788 . . . . 0.0 109.684 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.49 122.26 30.78 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.115 0.966 . . . . 0.0 111.948 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -115.27 13.83 16.75 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.704 1.602 . . . . 0.0 112.312 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.7 t -154.17 165.11 37.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.515 1.526 . . . . 0.0 111.522 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.05 2.03 9.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.797 1.239 . . . . 0.0 113.418 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.539 1.936 . . . . 0.0 115.226 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 45' ' ' LEU . 2.5 p -73.07 150.6 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.56 0.744 . . . . 0.0 111.581 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -95.25 150.6 20.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.505 0.722 . . . . 0.0 109.624 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.2 34.84 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.847 -1.158 . . . . 0.0 113.201 170.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -106.19 7.55 31.61 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.189 1.796 . . . . 0.0 113.426 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -142.76 -179.36 6.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.074 1.35 . . . . 0.0 111.379 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 152.25 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.407 1.483 . . . . 0.0 111.253 -175.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.86 153.26 46.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.862 1.265 . . . . 0.0 110.701 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 44' ' ' CYS . 21.3 m-85 -136.88 117.12 13.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.382 1.073 . . . . 0.0 109.835 -169.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -95.24 122.45 37.94 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.163 1.385 . . . . 0.0 111.229 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.88 59.04 1.55 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.781 1.232 . . . . 0.0 111.993 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.55 130.94 1.3 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.171 0.891 . . . . 0.0 111.11 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.13 146.12 9.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.876 0.87 . . . . 0.0 110.656 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 70.44 20.94 5.81 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.288 1.435 . . . . 0.0 114.705 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.84 58.41 2.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.681 1.192 . . . . 0.0 112.718 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 p -133.22 -174.54 3.52 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.301 1.44 . . . . 0.0 112.009 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.02 -142.98 40.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.905 0.764 . . . . 0.0 112.81 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -74.76 176.02 7.42 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.694 0.798 . . . . 0.0 112.451 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -136.21 157.24 47.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.562 1.145 . . . . 0.0 111.833 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.47 155.45 43.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.274 1.83 . . . . 0.0 110.118 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.45 143.93 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.544 1.138 . . . . 0.0 110.403 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -132.11 128.44 38.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.958 1.303 . . . . 0.0 109.012 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.36 148.81 30.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.814 0.845 . . . . 0.0 110.363 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -62.86 142.28 58.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.065 0.546 . . . . 0.0 111.449 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.61 66.63 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 122.211 -0.305 . . . . 0.0 112.486 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 152.67 39.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.49 1.116 . . . . 0.0 110.538 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -135.53 120.32 18.45 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 108.096 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.12 141.17 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.016 0.926 . . . . 0.0 109.413 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -135.35 133.45 38.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.244 1.018 . . . . 0.0 109.189 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.39 175.16 5.54 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.028 1.731 . . . . 0.0 109.595 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -123.41 133.99 54.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.682 0.793 . . . . 0.0 108.958 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.62 -14.28 12.96 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.279 1.032 . . . . 0.0 113.627 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.76 -25.54 52.02 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.961 1.267 . . . . 0.0 114.682 166.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -119.2 121.29 39.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.058 1.343 . . . . 0.0 109.852 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -12.48 6.22 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -63.68 -9.83 16.06 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.276 1.43 . . . . 0.0 112.959 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -70.39 -52.22 23.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.673 1.189 . . . . 0.0 112.037 164.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.61 -15.05 16.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.93 1.692 . . . . 0.0 113.513 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -40.79 -45.1 2.38 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.627 2.371 . . . . 0.0 113.069 169.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.98 50.32 0.59 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.429 1.492 . . . . 0.0 113.033 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -73.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.662 0.785 . . . . 0.0 111.219 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -93.36 160.11 14.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.192 0.997 . . . . 0.0 110.655 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HB3' ' CD2' ' A' ' 10' ' ' PHE . 5.8 p -168.75 169.63 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.293 1.037 . . . . 0.0 112.374 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.454 HD23 ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -148.42 156.01 41.94 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.334 1.064 . . . . 0.0 112.303 177.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 8' ' ' VAL . 38.5 t -127.65 139.04 53.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 124.872 1.269 . . . . 0.0 109.282 -171.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.16 -96.71 0.01 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.958 1.742 . . . . 0.0 116.073 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -166.95 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 113.243 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -123.99 26.36 7.59 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.644 1.977 . . . . 0.0 111.899 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.42 153.69 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.456 1.902 . . . . 0.0 109.023 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -125.41 149.48 48.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.614 1.566 . . . . 0.0 108.857 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.454 ' SG ' HG11 ' A' ' 8' ' ' VAL . 2.8 m -123.26 151.22 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 110.508 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.31 130.23 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.52 142.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.027 0.931 . . . . 0.0 109.637 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -137.25 127.41 26.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.159 1.384 . . . . 0.0 109.089 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -100.66 -53.32 3.11 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 111.379 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -101.6 98.51 8.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.858 0.863 . . . . 0.0 111.418 -172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.08 96.75 5.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.421 1.089 . . . . 0.0 112.828 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -156.14 164.53 38.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 112.27 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 6.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.26 2.224 . . . . 0.0 113.068 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.38 49.11 2.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.388 1.875 . . . . 0.0 112.122 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -148.59 145.44 20.11 Favored Pre-proline 0 N--CA 1.478 0.956 0 O-C-N 120.77 -1.206 . . . . 0.0 112.365 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.42 -14.15 20.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.922 2.415 . . . . 0.0 113.16 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -67.75 121.24 78.63 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 119.239 0.927 . . . . 0.0 109.956 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.56 95.66 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.199 1.933 . . . . 0.0 108.687 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.57 138.8 28.22 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.457 1.027 . . . . 0.0 112.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 115.42 2.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.714 0.757 . . . . 0.0 111.212 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 179' ' ' THR . 2.3 t80 -138.48 143.15 39.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.218 2.207 . . . . 0.0 109.48 -174.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.98 139.94 24.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.307 1.051 . . . . 0.0 109.614 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -100.11 103.61 15.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.08 1.352 . . . . 0.0 107.643 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp -60.98 121.53 12.64 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.48 150.84 6.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.322 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -58.55 -15.5 11.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.16 124.73 1.6 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.644 152.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.05 158.36 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.657 2.383 . . . . 0.0 111.546 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -94.23 143.57 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.436 1.094 . . . . 0.0 110.829 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -128.1 102.04 6.55 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.507 1.923 . . . . 0.0 108.553 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -123.65 6.65 8.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.633 1.573 . . . . 0.0 112.772 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -140.35 45.03 1.86 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.896 1.679 . . . . 0.0 111.461 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 80' ' ' LEU . 3.2 mp -75.26 30.67 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.079 1.351 . . . . 0.0 112.588 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.1 m -61.43 -35.65 78.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.753 1.621 . . . . 0.0 112.485 174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -61.11 -24.06 65.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.719 0.808 . . . . 0.0 112.715 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.4 mm -88.06 -25.58 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.655 1.982 . . . . 0.0 113.198 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 54.75 52.68 11.69 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.52 1.528 . . . . 0.0 113.372 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.32 -179.62 19.93 Favored Glycine 0 CA--C 1.538 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 112.567 -170.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -150.38 -178.88 6.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.574 -1.545 . . . . 0.0 112.054 -169.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -148.13 -36.94 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.14 1.776 . . . . 0.0 113.164 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.91 147.03 47.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.762 1.225 . . . . 0.0 111.445 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -135.96 119.69 17.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.326 1.85 . . . . 0.0 108.416 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -115.05 138.93 50.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.37 0.668 . . . . 0.0 109.404 170.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.83 119.27 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.757 1.623 . . . . 0.0 107.411 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.557 HD13 ' HA ' ' A' ' 98' ' ' TRP . 99.2 mt -127.55 126.79 24.1 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 124.672 1.189 . . . . 0.0 109.467 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.88 161.41 33.23 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 121.74 1.627 . . . . 0.0 111.752 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.34 -3.15 17.56 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.09 45.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.004 1.322 . . . . 0.0 113.86 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -130.78 151.1 51.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.045 1.338 . . . . 0.0 110.507 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -82.09 -49.3 10.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.518 -0.739 . . . . 0.0 111.378 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.557 ' HA ' HD13 ' A' ' 92' ' ' LEU . 58.3 p-90 -154.52 161.23 41.76 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.773 1.629 . . . . 0.0 110.589 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -131.21 154.41 48.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.108 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.44 137.16 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.945 1.298 . . . . 0.0 109.733 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.07 123.83 36.6 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.192 0.997 . . . . 0.0 108.986 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.88 132.26 71.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.651 1.58 . . . . 0.0 108.692 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -125.15 145.25 50.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.916 0.887 . . . . 0.0 110.185 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.71 128.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.05 143.17 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 122.069 0.938 . . . . 0.0 109.814 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.62 140.34 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.536 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 7.24 2.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.832 1.253 . . . . 0.0 112.168 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.52 -33.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.069 1.748 . . . . 0.0 112.907 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.44 172.61 12.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.789 1.236 . . . . 0.0 111.835 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.3 p -105.71 14.24 28.59 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.28 1.432 . . . . 0.0 112.944 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.4 m -107.0 31.03 5.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.787 2.435 . . . . 0.0 110.169 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.38 145.76 17.35 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.839 -1.163 . . . . 0.0 112.252 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.46 25.1 6.78 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.696 1.141 . . . . 0.0 112.956 -171.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.8 p -147.57 9.51 0.92 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.075 1.75 . . . . 0.0 114.033 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -127.28 143.74 51.18 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 110.784 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -131.03 130.87 43.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.074 1.349 . . . . 0.0 108.717 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -122.02 131.58 54.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.618 1.567 . . . . 0.0 110.365 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 m -95.52 133.86 39.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.856 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.57 110.78 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.801 1.64 . . . . 0.0 109.135 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -129.99 128.31 22.84 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.385 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.19 -91.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.142 2.561 . . . . 0.0 111.35 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -171.76 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.032 0.92 . . . . 0.0 112.685 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -65.09 26.8 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 126.682 1.993 . . . . 0.0 113.786 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.2 165.63 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.549 1.94 . . . . 0.0 110.831 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -56.05 114.77 2.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.331 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -58.61 147.98 30.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.741 0.816 . . . . 0.0 111.909 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -110.14 145.07 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.862 1.265 . . . . 0.0 110.274 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.81 117.21 32.81 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.858 1.263 . . . . 0.0 109.594 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.8 m -125.47 118.53 26.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.523 1.129 . . . . 0.0 108.646 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.36 138.59 49.23 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.09 1.356 . . . . 0.0 112.008 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.51 127.4 17.63 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.308 0.575 . . . . 0.0 111.978 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.57 -18.6 22.5 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.576 1.084 . . . . 0.0 113.67 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -57.75 137.14 56.83 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.865 1.333 . . . . 0.0 112.945 169.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.53 72.15 5.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.018 0.927 . . . . 0.0 110.526 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 61.83 85.73 0.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.516 1.926 . . . . 0.0 112.449 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.18 134.81 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.775 -1.203 . . . . 0.0 110.883 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -93.43 127.29 38.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.278 0.561 . . . . 0.0 110.944 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.4 tp -107.67 95.48 14.37 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.412 1.885 . . . . 0.0 107.995 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.37 146.47 40.0 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.958 1.772 . . . . 0.0 111.484 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.46 125.1 27.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.997 1.719 . . . . 0.0 108.496 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.67 -37.96 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.04 2.493 . . . . 0.0 113.125 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 168.4 7.76 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.298 2.639 . . . . 0.0 109.995 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 pp -163.44 37.8 0.09 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.163 1.385 . . . . 0.0 113.868 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.0 t -50.63 139.77 20.37 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.704 1.201 . . . . 0.0 114.211 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.35 142.08 67.63 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.979 1.028 . . . . 0.0 111.867 -6.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.24 -23.31 45.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.309 2.006 . . . . 0.0 113.051 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -75.86 -5.93 48.36 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.041 1.336 . . . . 0.0 114.548 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 161.73 16.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.584 1.084 . . . . 0.0 112.862 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -70.67 168.95 15.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.81 0.814 . . . . 0.0 113.097 167.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.38 135.72 53.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.536 1.535 . . . . 0.0 110.441 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.21 149.03 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.716 0.806 . . . . 0.0 109.231 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.3 t -150.43 155.16 39.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.079 . . . . 0.0 110.414 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -123.99 129.69 51.34 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.514 1.126 . . . . 0.0 109.798 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 tt -113.83 121.44 44.01 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.943 1.697 . . . . 0.0 109.463 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -139.61 114.75 9.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.622 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 167' ' ' VAL . 1.7 p -108.63 141.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.631 1.173 . . . . 0.0 109.517 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -144.7 148.19 33.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.321 1.448 . . . . 0.0 110.009 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.29 128.9 37.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.196 0.598 . . . . 0.0 110.174 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.7 p -79.44 -2.32 41.39 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -132.97 151.14 52.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.772 2.029 . . . . 0.0 110.08 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.2 t -66.85 141.38 96.75 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.499 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.27 128.95 13.98 Favored 'Cis proline' 0 C--N 1.352 0.761 0 CA-C-N 120.565 1.238 . . . . 0.0 111.616 -7.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.43 41.22 0.14 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.95 1.7 . . . . 0.0 112.236 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -62.5 143.59 56.99 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 111.491 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -59.55 122.45 14.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.782 -0.574 . . . . 0.0 110.366 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 65.9 t -80.68 -56.91 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 156' ' ' VAL . 0.4 OUTLIER -149.6 155.22 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 170.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -142.11 76.8 1.55 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.792 1.237 . . . . 0.0 108.695 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.19 -165.72 12.74 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.614 2.054 . . . . 0.0 111.608 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.98 170.72 16.06 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.831 -1.393 . . . . 0.0 111.12 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -153.46 157.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.715 -1.241 . . . . 0.0 108.033 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -112.83 128.84 56.55 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.925 -1.109 . . . . 0.0 108.445 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.61 155.48 17.57 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.89 0.876 . . . . 0.0 109.88 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -157.96 158.02 34.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.207 1.403 . . . . 0.0 109.579 174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.38 150.35 49.89 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.713 1.605 . . . . 0.0 108.708 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 75.6 m -105.75 110.37 64.11 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.47 50.74 2.04 Favored 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 125.221 3.948 . . . . 0.0 112.765 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.6 m -137.3 -53.97 0.69 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.989 1.716 . . . . 0.0 111.439 -172.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 63.5 p -127.29 21.9 6.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.317 1.047 . . . . 0.0 112.791 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.79 31.74 64.72 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.19 -0.944 . . . . 0.0 113.205 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -78.22 150.51 33.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.453 0.701 . . . . 0.0 110.787 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.8 t -128.65 137.57 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.5 m -142.12 129.32 20.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.644 1.577 . . . . 0.0 109.124 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.51 141.36 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.225 1.01 . . . . 0.0 110.133 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.04 127.34 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 127.079 2.151 . . . . 0.0 107.986 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -137.68 116.49 12.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.297 1.439 . . . . 0.0 108.546 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.52 156.46 36.71 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.875 1.27 . . . . 0.0 110.706 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.48 -14.41 7.81 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.14 -24.51 66.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.84 1.656 . . . . 0.0 114.005 169.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.6 p -146.7 -56.11 0.26 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.96 1.704 . . . . 0.0 111.692 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.16 138.92 97.56 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 0.0 111.841 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.02 -88.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.579 2.186 . . . . 0.0 111.625 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? 158.23 -33.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 129.561 3.145 . . . . 0.0 112.674 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -54.19 -36.91 63.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 113.459 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 15.5 ttm -103.67 151.48 22.92 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.939 1.295 . . . . 0.0 109.181 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.7 p -134.39 153.93 51.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.089 1.356 . . . . 0.0 110.287 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 ' CE1' ' A' ' 207' ' ' PHE . 2.5 t -112.34 110.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.3 m -93.47 130.7 39.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.831 0.852 . . . . 0.0 108.869 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -76.27 82.35 3.05 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.75 1.22 . . . . 0.0 109.634 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.93 -44.72 96.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.041 0.936 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 204' ' ' SER . 8.3 m-20 -147.6 -178.52 6.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.769 2.028 . . . . 0.0 110.106 166.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -53.55 141.96 23.96 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.664 -1.272 . . . . 0.0 110.836 158.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.8 p 50.66 10.69 0.07 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.258 2.223 . . . . 0.0 116.142 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -129.23 95.65 4.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.983 1.713 . . . . 0.0 108.711 -169.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -105.16 149.57 25.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.7 tt -134.61 123.28 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.406 ' CE1' HG22 ' A' ' 197' ' ' VAL . 8.4 m-85 -98.99 109.27 22.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.731 1.612 . . . . 0.0 108.598 -170.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.62 116.86 32.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.169 1.388 . . . . 0.0 108.92 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.79 99.14 9.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.176 0.59 . . . . 0.0 110.967 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -88.27 -15.71 35.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.228 2.211 . . . . 0.0 114.295 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.24 165.36 24.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.614 1.166 . . . . 0.0 111.995 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -128.0 54.06 1.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.952 1.701 . . . . 0.0 110.365 -170.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.151 1.78 . . . . 0.0 114.798 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.002 0.43 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.57 141.99 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 171.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.95 151.35 30.13 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.805 -0.559 . . . . 0.0 110.034 173.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.66 -17.26 46.39 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.59 -1.319 . . . . 0.0 113.48 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -115.17 17.83 16.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.986 1.714 . . . . 0.0 113.668 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -139.55 172.58 12.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.564 1.545 . . . . 0.0 110.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 46' ' ' VAL . 14.7 m -145.42 144.77 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.792 0.837 . . . . 0.0 110.628 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -127.58 145.94 50.7 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.148 0.975 . . . . 0.0 111.222 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -128.06 124.49 37.2 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.477 1.511 . . . . 0.0 107.497 -164.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 122.16 42.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 123.94 1.829 . . . . 0.0 111.052 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -93.18 42.58 1.1 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.477 1.911 . . . . 0.0 111.504 -167.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.86 155.2 12.5 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.575 2.036 . . . . 0.0 111.499 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -60.8 141.52 56.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.372 0.586 . . . . 0.0 110.135 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.4 t30 46.66 43.21 12.46 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.832 1.253 . . . . 0.0 114.238 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.304 30.9 p 49.18 36.42 9.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.257 2.223 . . . . 0.0 116.054 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -88.16 -24.95 23.2 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.51 -91.93 1.0 Allowed Glycine 0 N--CA 1.476 1.362 0 CA-C-N 119.559 1.072 . . . . 0.0 113.585 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.13 176.7 6.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 110.333 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -138.56 157.76 45.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.449 1.099 . . . . 0.0 112.336 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.78 152.18 39.96 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.186 1.794 . . . . 0.0 110.152 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -124.41 122.25 37.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.508 1.523 . . . . 0.0 108.972 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.04 148.51 43.49 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.294 1.438 . . . . 0.0 109.482 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -101.02 153.1 19.83 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.339 0.656 . . . . 0.0 109.949 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 147.53 23.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.975 -0.453 . . . . 0.0 112.163 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.38 41.55 90.88 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -129.19 130.83 46.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.833 1.253 . . . . 0.0 111.106 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -114.69 129.96 56.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.224 1.01 . . . . 0.0 108.836 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.79 109.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.662 1.585 . . . . 0.0 109.069 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -101.7 101.12 11.58 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.257 1.023 . . . . 0.0 109.11 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -70.45 -179.15 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.884 0.85 . . . . 0.0 111.226 165.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -127.06 157.17 40.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.547 1.139 . . . . 0.0 109.328 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.99 -12.17 59.04 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.016 -1.053 . . . . 0.0 113.496 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.14 97.71 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.615 1.102 . . . . 0.0 114.248 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.1 118.34 27.61 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.406 1.103 . . . . 0.0 110.482 170.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -18.91 62.33 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.949 -1.094 . . . . 0.0 112.458 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -61.49 -20.64 63.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.433 1.893 . . . . 0.0 112.357 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -60.89 -51.95 67.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.797 1.639 . . . . 0.0 112.367 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -70.13 -14.82 62.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.388 1.475 . . . . 0.0 113.286 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.9 -22.95 64.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.558 1.943 . . . . 0.0 113.731 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -46.92 121.22 3.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.669 1.187 . . . . 0.0 110.941 162.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.1 tpt -152.41 -19.95 0.17 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.842 . . . . 0.0 111.921 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -146.69 154.38 41.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.846 2.059 . . . . 0.0 108.856 172.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 p -172.54 155.22 3.32 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.574 1.55 . . . . 0.0 109.697 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 150.66 43.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.939 1.352 . . . . 0.0 112.399 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 8' ' ' VAL . 47.6 t -127.83 135.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.776 1.63 . . . . 0.0 108.199 -168.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -98.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.446 1.498 . . . . 0.0 115.81 -171.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -160.29 -23.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.105 1.762 . . . . 0.0 112.473 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.56 25.63 8.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.714 1.605 . . . . 0.0 111.565 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.12 140.47 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 128.151 2.58 . . . . 0.0 108.831 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.64 153.12 29.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.448 0.699 . . . . 0.0 109.947 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.8 m -136.39 136.17 39.38 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.286 0.635 . . . . 0.0 109.732 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -125.79 130.63 51.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.72 131.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.454 1.501 . . . . 0.0 109.7 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -141.31 118.67 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.38 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -103.85 -39.46 6.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.643 0.777 . . . . 0.0 111.837 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -92.57 158.82 15.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.278 1.031 . . . . 0.0 111.098 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -159.59 128.72 5.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.639 1.176 . . . . 0.0 111.505 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -162.17 -21.91 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.273 0.6 OUTLIER 50.01 37.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 127.143 2.177 . . . . 0.0 114.234 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.57 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.1 1.76 . . . . 0.0 111.924 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -51.79 124.63 27.84 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.619 1.168 . . . . 0.0 113.467 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.42 -14.72 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.881 2.387 . . . . 0.0 113.008 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t -90.18 119.66 69.23 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 119.008 0.822 . . . . 0.0 109.804 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.84 117.71 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.219 1.279 . . . . 0.0 108.977 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.0 -152.86 3.34 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -85.46 104.36 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.602 -0.94 . . . . 0.0 109.958 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -140.08 155.21 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.827 1.651 . . . . 0.0 109.582 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.4 172.19 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.617 1.167 . . . . 0.0 110.777 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -119.59 94.36 4.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.458 1.503 . . . . 0.0 107.495 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -52.83 118.71 3.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.565 1.546 . . . . 0.0 109.063 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.45 149.26 10.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.588 0.755 . . . . 0.0 112.998 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.65 -13.8 11.18 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.8 118.99 0.87 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.343 0.973 . . . . 0.0 111.777 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.48 161.64 4.1 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.871 2.068 . . . . 0.0 111.207 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 m -115.45 131.4 56.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.082 1.353 . . . . 0.0 110.067 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -131.58 136.0 47.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.508 1.123 . . . . 0.0 110.104 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -138.47 10.75 2.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.467 1.107 . . . . 0.0 112.901 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.64 52.15 0.58 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.548 1.539 . . . . 0.0 109.94 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -74.13 39.16 0.11 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.922 1.289 . . . . 0.0 112.928 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -55.99 -30.67 62.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.002 1.721 . . . . 0.0 113.047 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -64.34 -18.24 64.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.6 mm -90.26 -23.42 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.627 1.571 . . . . 0.0 111.964 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 45.05 74.51 0.13 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.079 2.152 . . . . 0.0 114.537 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.4 -160.33 36.14 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.555 0.598 . . . . 0.0 112.096 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 177.89 8.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.917 0.887 . . . . 0.0 110.861 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.15 -46.3 0.11 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.216 1.007 . . . . 0.0 111.825 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HE3' ' CG2' ' A' ' 203' ' ' THR . 2.0 ptmm? -140.7 156.22 46.27 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.95 140.42 34.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.148 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -129.08 125.01 36.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.39 131.36 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.353 1.461 . . . . 0.0 108.702 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.76 143.81 41.12 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.344 1.458 . . . . 0.0 109.97 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.12 26.27 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.15 3.9 . . . . 0.0 115.452 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.82 26.9 61.07 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.585 1.088 . . . . 0.0 113.582 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.1 -42.15 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 111.297 -168.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.72 146.55 32.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 109.983 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -88.69 -39.94 13.63 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.814 0.816 . . . . 0.0 111.637 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -152.0 158.77 43.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 107.191 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.25 174.06 7.53 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.916 -0.49 . . . . 0.0 109.981 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.08 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 111.185 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -71.71 131.83 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.76 139.78 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.693 1.197 . . . . 0.0 109.839 170.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -139.65 142.58 36.99 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.547 -0.721 . . . . 0.0 110.025 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 pt -91.95 144.28 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 122.91 0.484 . . . . 0.0 110.254 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.3 t -133.0 109.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.137 1.375 . . . . 0.0 108.686 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.07 118.18 17.73 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.679 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.87 -12.82 14.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.95 0.9 . . . . 0.0 113.002 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.49 -51.96 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.856 1.262 . . . . 0.0 111.681 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -92.7 110.72 22.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.088 0.955 . . . . 0.0 109.233 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 t -75.25 39.32 0.15 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.134 1.374 . . . . 0.0 114.013 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 m -140.48 -39.18 0.43 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.591 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.52 -160.49 0.07 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.585 1.154 . . . . 0.0 113.34 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.78 7.43 61.69 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 120.398 -1.439 . . . . 0.0 116.136 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.9 p -144.82 28.96 1.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.759 1.78 . . . . 0.0 114.663 -159.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -133.66 145.29 49.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.681 1.593 . . . . 0.0 109.193 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -132.79 112.2 11.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.149 0.98 . . . . 0.0 110.376 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.0 ttp -111.09 105.96 14.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.414 2.286 . . . . 0.0 110.544 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.8 m -92.21 126.55 37.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.569 0.699 . . . . 0.0 109.173 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.03 132.05 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.105 1.362 . . . . 0.0 108.933 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -137.04 89.33 16.83 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 123.62 0.768 . . . . 0.0 109.269 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.38 167.1 17.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.978 2.452 . . . . 0.0 112.668 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -37.57 98.36 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.437 2.295 . . . . 0.0 113.611 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.268 19.4 pt20 43.01 52.82 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.065 1.746 . . . . 0.0 114.87 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.61 148.0 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.162 1.785 . . . . 0.0 110.942 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -51.85 112.37 0.76 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.057 1.343 . . . . 0.0 111.067 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 152.79 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.323 1.049 . . . . 0.0 111.993 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.43 141.09 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.758 -0.589 . . . . 0.0 111.936 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.88 91.3 3.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.704 1.602 . . . . 0.0 109.896 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.717 ' HA ' HG21 ' A' ' 136' ' ' VAL . 42.3 t -74.06 131.65 41.55 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 121.785 -0.572 . . . . 0.0 109.691 169.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.77 139.39 48.91 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.86 128.98 39.81 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.932 -0.48 . . . . 0.0 110.303 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.47 -11.03 59.71 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.98 1.276 . . . . 0.0 115.189 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 145.47 41.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.695 1.748 . . . . 0.0 111.95 169.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.67 55.45 0.37 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.934 1.694 . . . . 0.0 112.957 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 57.88 95.72 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.737 2.415 . . . . 0.0 112.197 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' A' ' 129' ' ' CYS . 10.8 t -51.97 130.22 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.156 0.982 . . . . 0.0 112.225 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -80.09 122.28 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.793 0.837 . . . . 0.0 111.251 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.6 101.84 11.44 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.262 163.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.6 121.99 6.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.742 1.628 . . . . 0.0 110.534 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.87 121.44 43.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.816 0.846 . . . . 0.0 108.901 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.53 168.36 23.82 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.262 2.642 . . . . 0.0 111.75 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 131.79 51.45 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.698 -0.626 . . . . 0.0 110.792 174.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.99 149.27 33.84 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.777 1.631 . . . . 0.0 110.047 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.1 m -138.27 135.18 18.13 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 0.0 110.559 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.17 150.0 82.08 Favored 'Cis proline' 0 CA--C 1.544 1.022 0 CA-C-N 119.252 0.769 . . . . 0.0 112.001 -5.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.52 -24.24 49.2 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.027 1.818 . . . . 0.0 113.092 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.83 1.78 29.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -69.89 156.25 39.36 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.357 1.075 . . . . 0.0 112.843 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -83.67 135.67 34.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.284 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.4 tt -115.73 116.58 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.941 1.696 . . . . 0.0 108.401 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.49 142.9 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.921 -0.487 . . . . 0.0 110.749 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.0 p -142.91 140.56 31.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 122.088 0.946 . . . . 0.0 111.994 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -90.16 140.18 29.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.387 0.675 . . . . 0.0 110.148 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.17 113.94 18.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.732 1.613 . . . . 0.0 108.736 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 98.56 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.31 1.044 . . . . 0.0 109.517 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 3.9 p -115.4 145.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.541 1.136 . . . . 0.0 110.056 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.54 160.84 39.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.186 1.395 . . . . 0.0 112.454 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.56 146.63 46.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.017 1.327 . . . . 0.0 111.335 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.6 p -85.33 -12.22 52.79 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.34 171.79 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.813 1.245 . . . . 0.0 110.884 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -60.56 145.37 87.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 120.965 -1.085 . . . . 0.0 112.315 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.65 12.06 26.2 Favored 'Cis proline' 0 CA--C 1.55 1.287 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 3.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.22 13.53 8.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.869 1.668 . . . . 0.0 113.683 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.07 152.82 32.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 112.338 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -52.3 139.11 25.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.922 0.889 . . . . 0.0 112.92 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.56 -20.39 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.406 1.482 . . . . 0.0 111.937 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 95.0 t -152.66 131.78 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 126.776 2.03 . . . . 0.0 108.329 168.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -122.79 129.65 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.236 1.415 . . . . 0.0 109.084 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 176.63 -165.37 35.58 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.903 0.724 . . . . 0.0 112.695 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.39 156.01 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.183 0.992 . . . . 0.0 110.738 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 156.46 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.49 1.916 . . . . 0.0 108.246 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.56 134.59 54.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.83 157.88 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.65 154.14 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 107.64 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -118.85 160.5 21.8 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.441 1.096 . . . . 0.0 108.608 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.4 m -121.54 106.63 37.38 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 121.235 -0.915 . . . . 0.0 108.598 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.77 53.83 2.88 Favored 'Trans proline' 0 CA--C 1.542 0.92 1 C-N-CA 125.506 4.137 . . . . 0.0 112.545 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -126.66 -44.71 1.66 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.754 2.022 . . . . 0.0 110.713 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 82.4 p -144.91 6.55 1.19 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.521 1.128 . . . . 0.0 113.843 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.17 34.77 40.31 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.576 -1.327 . . . . 0.0 113.171 -171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 149.81 35.86 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.884 -0.774 . . . . 0.0 110.752 173.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.21 132.2 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.681 1.192 . . . . 0.0 108.121 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 99.5 m -135.55 125.57 25.96 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.893 1.277 . . . . 0.0 109.307 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.56 130.0 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.334 1.054 . . . . 0.0 110.64 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 mt -108.83 141.33 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.275 2.23 . . . . 0.0 107.634 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 136.49 24.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.501 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -134.36 134.46 41.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.015 -170.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -58.39 -14.11 6.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.561 1.144 . . . . 0.0 113.955 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.07 -23.67 65.64 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.306 1.442 . . . . 0.0 114.492 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 p -145.28 -34.86 0.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.024 1.73 . . . . 0.0 113.646 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.25 129.99 89.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.775 0.83 . . . . 0.0 110.69 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.35 173.3 14.46 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.443 2.762 . . . . 0.0 112.069 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 5.97 32.32 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.214 1.406 . . . . 0.0 113.299 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -89.86 -37.2 14.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.968 1.707 . . . . 0.0 112.231 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.0 ttt -113.83 152.13 31.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.49 1.516 . . . . 0.0 109.279 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.5 p -133.21 144.31 49.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 0.0 110.756 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.88 119.94 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 88.5 m -115.42 114.51 25.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.036 1.334 . . . . 0.0 109.419 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.39 129.87 39.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.934 0.894 . . . . 0.0 110.972 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -31.89 3.78 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.326 1.05 . . . . 0.0 112.508 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -146.71 169.23 19.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.847 2.059 . . . . 0.0 109.702 171.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -59.19 -2.09 0.25 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.503 ' CG2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 t -156.64 32.62 0.31 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.586 2.354 . . . . 0.0 110.543 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -143.94 117.27 9.04 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.291 -1.506 . . . . 0.0 111.853 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 135.02 53.87 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.251 1.421 . . . . 0.0 110.616 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -118.15 117.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -97.69 91.72 5.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -75.51 127.08 32.32 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.231 0.612 . . . . 0.0 109.587 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.4 tp -111.18 110.56 21.12 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 111.679 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -107.78 17.35 22.63 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.986 2.114 . . . . 0.0 112.866 -173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 t -152.16 155.15 37.25 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.343 1.457 . . . . 0.0 111.723 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -9.73 15.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.107 0.963 . . . . 0.0 113.044 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.79 139.93 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.34 1.456 . . . . 0.0 110.643 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.81 149.56 37.88 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.714 -0.616 . . . . 0.0 110.918 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.55 -24.44 47.05 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 113.324 170.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -111.58 12.51 21.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.0 1.72 . . . . 0.0 112.962 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -146.4 173.34 12.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.63 1.572 . . . . 0.0 111.145 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -133.7 158.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.074 0.949 . . . . 0.0 110.788 -177.258 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.9 149.45 48.98 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.187 0.995 . . . . 0.0 110.665 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -127.2 132.01 50.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.133 1.373 . . . . 0.0 108.184 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -126.55 123.21 37.2 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.245 1.498 . . . . 0.0 110.443 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -83.59 33.52 0.47 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.644 1.578 . . . . 0.0 112.574 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.53 148.56 11.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.972 1.748 . . . . 0.0 111.993 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.34 147.91 9.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.335 1.454 . . . . 0.0 112.025 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 49.62 42.67 23.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.323 1.049 . . . . 0.0 113.46 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m 56.38 65.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.873 1.669 . . . . 0.0 113.914 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -130.62 -179.88 5.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.883 1.273 . . . . 0.0 112.529 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 -95.09 1.23 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.01 1.291 . . . . 0.0 113.335 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.64 169.23 15.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.516 1.527 . . . . 0.0 110.36 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.9 p -135.07 149.72 50.14 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.048 0.939 . . . . 0.0 112.16 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 156.36 44.72 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.534 1.934 . . . . 0.0 110.271 -174.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.55 132.49 48.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.853 1.261 . . . . 0.0 109.642 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.25 122.0 30.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.077 1.351 . . . . 0.0 108.928 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -74.56 158.76 33.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.332 0.653 . . . . 0.0 110.926 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -64.98 154.78 36.63 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.505 -0.747 . . . . 0.0 111.622 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.15 45.51 96.38 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.367 0.508 . . . . 0.0 112.582 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -121.78 148.96 43.98 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.703 1.201 . . . . 0.0 110.319 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -136.95 119.3 15.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.32 117.81 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 109.664 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.05 100.04 9.6 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.78 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.79 162.33 26.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.239 170.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -107.91 162.91 13.59 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -67.02 -15.3 63.64 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.029 -1.045 . . . . 0.0 113.35 170.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.32 -20.55 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.308 0.956 . . . . 0.0 114.449 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -80.99 109.55 15.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.563 1.182 . . . . 0.0 111.01 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.14 66.72 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.531 -1.355 . . . . 0.0 112.623 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -57.42 -28.28 63.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.904 2.082 . . . . 0.0 113.514 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -73.26 -52.07 15.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.55 1.14 . . . . 0.0 111.742 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.74 -15.22 61.25 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.104 0.962 . . . . 0.0 112.989 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.88 0.93 4.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.102 2.561 . . . . 0.0 114.73 168.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -44.07 135.2 4.38 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.693 1.133 . . . . 0.0 110.222 164.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.76 -54.56 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.4 p -146.46 164.22 33.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.662 0.744 . . . . 0.0 112.004 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 p -161.68 159.68 27.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.226 -0.922 . . . . 0.0 110.423 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mp -123.87 132.07 53.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.337 1.055 . . . . 0.0 108.499 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 74.4 t -123.49 127.01 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 124.752 1.221 . . . . 0.0 109.512 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.548 2.023 . . . . 0.0 115.844 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -171.71 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.256 1.422 . . . . 0.0 114.0 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -120.93 29.49 7.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.928 1.691 . . . . 0.0 111.751 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.93 138.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.296 1.439 . . . . 0.0 110.776 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -115.45 132.87 56.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.684 1.194 . . . . 0.0 109.316 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.26 143.49 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -123.05 131.45 53.7 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.732 1.613 . . . . 0.0 108.749 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 pt -137.56 118.37 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.822 1.249 . . . . 0.0 111.037 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.08 138.03 53.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 110.311 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.4 -46.03 4.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.501 0.72 . . . . 0.0 112.917 -164.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -151.93 131.62 13.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.821 1.248 . . . . 0.0 108.684 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -146.56 138.48 24.74 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.263 1.425 . . . . 0.0 107.86 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.32 9.72 0.56 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.247 0.619 . . . . 0.0 111.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt 43.47 27.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 129.655 3.182 . . . . 0.0 116.259 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -173.39 -23.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.294 2.238 . . . . 0.0 111.429 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -46.98 136.71 8.06 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.125 1.37 . . . . 0.0 113.241 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.38 -5.38 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.294 2.662 . . . . 0.0 113.01 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 90.54 50.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 109.808 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.24 109.97 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.835 1.69 . . . . 0.0 108.092 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.37 159.1 20.99 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 153.62 18.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.454 1.121 . . . . 0.0 111.191 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -148.55 144.69 27.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.664 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.4 166.64 27.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.474 1.131 . . . . 0.0 111.071 170.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -126.34 111.63 14.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.055 1.342 . . . . 0.0 109.32 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.08 136.13 57.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.819 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.02 144.26 9.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 112.665 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.45 -10.82 8.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.46 109.62 0.41 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.04 1.781 . . . . 0.0 111.829 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.79 168.87 0.52 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.431 2.292 . . . . 0.0 111.331 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.1 m -111.21 142.38 43.49 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.527 1.131 . . . . 0.0 109.49 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -129.6 120.45 25.29 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.833 1.253 . . . . 0.0 108.095 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -128.7 -18.28 3.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.63 -80.42 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 109.419 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp 44.77 22.34 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.927 1.691 . . . . 0.0 113.762 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -78.29 -36.22 46.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.434 1.494 . . . . 0.0 110.055 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.6 t -69.07 -30.44 68.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.551 1.14 . . . . 0.0 112.859 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.39 -27.24 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.234 1.414 . . . . 0.0 112.105 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 57.02 45.57 20.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.491 1.516 . . . . 0.0 112.304 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.62 -167.94 43.87 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.533 1.063 . . . . 0.0 113.94 -172.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -173.55 4.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.071 1.349 . . . . 0.0 111.246 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 85.6 p -149.19 -34.63 0.19 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.843 1.257 . . . . 0.0 112.819 167.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -99.29 127.28 45.28 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.293 1.037 . . . . 0.0 110.093 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.35 136.37 54.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.184 1.393 . . . . 0.0 108.796 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -143.89 153.55 42.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.408 0.683 . . . . 0.0 109.265 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.69 114.42 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 124.75 1.22 . . . . 0.0 108.707 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.63 115.27 31.02 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.492 0.717 . . . . 0.0 110.636 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.73 166.22 30.12 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.938 2.425 . . . . 0.0 112.633 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.1 33.65 0.19 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.158 2.313 . . . . 0.0 114.831 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.71 -27.11 6.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.055 2.542 . . . . 0.0 110.986 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -140.41 161.23 38.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.038 1.735 . . . . 0.0 110.749 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -104.21 -45.64 4.65 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.095 -1.003 . . . . 0.0 112.501 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.34 165.18 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.186 1.794 . . . . 0.0 108.333 174.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.74 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.252 0.549 . . . . 0.0 109.753 169.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.06 139.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.978 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -97.2 121.44 39.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.943 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 167.46 29.36 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.689 1.196 . . . . 0.0 109.623 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.34 148.63 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 125.38 1.472 . . . . 0.0 109.678 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.61 114.08 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.964 0.906 . . . . 0.0 109.149 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.93 88.72 2.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 111.92 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.41 19.48 20.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.86 1.264 . . . . 0.0 112.028 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.71 -66.08 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.544 1.538 . . . . 0.0 111.458 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -85.16 -19.59 31.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.949 1.3 . . . . 0.0 111.989 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t 62.51 39.46 11.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.651 1.981 . . . . 0.0 113.358 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.8 m -131.43 -38.36 1.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.762 1.225 . . . . 0.0 113.915 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.04 -177.86 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.163 1.385 . . . . 0.0 114.338 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.74 20.46 39.85 Favored Glycine 0 CA--C 1.54 1.653 0 O-C-N 120.618 -1.301 . . . . 0.0 115.037 -171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.6 p -139.63 17.66 2.53 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.772 1.629 . . . . 0.0 113.327 -166.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.38 132.45 27.89 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.404 1.882 . . . . 0.0 109.385 -170.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -117.23 121.89 42.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.541 1.136 . . . . 0.0 110.163 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttt -115.8 122.37 45.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.706 1.203 . . . . 0.0 109.637 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -119.41 116.22 25.72 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.02 1.328 . . . . 0.0 108.373 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.09 138.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.266 1.426 . . . . 0.0 108.818 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 t -154.67 99.2 2.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.405 0.682 . . . . 0.0 110.842 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 9.8 Cg_endo -66.38 168.26 16.63 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.346 2.697 . . . . 0.0 112.905 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -34.99 95.0 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.138 2.175 . . . . 0.0 114.884 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 37.55 65.85 0.5 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.892 2.077 . . . . 0.0 115.099 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.2 155.26 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.663 . . . . 0.0 110.41 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.01 100.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.352 1.461 . . . . 0.0 111.811 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -59.01 151.39 22.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.444 0.64 . . . . 0.0 110.327 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.72 124.0 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.13 107.83 15.4 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.673 1.589 . . . . 0.0 108.802 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.88 160.49 24.64 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 160.72 16.19 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.197 0.599 . . . . 0.0 110.848 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.54 53.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.842 2.457 . . . . 0.0 114.727 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.01 -21.81 0.07 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.74 2.591 . . . . 0.0 113.776 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.21 156.96 23.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.156 1.478 . . . . 0.0 111.808 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.7 -16.64 29.93 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.302 -0.874 . . . . 0.0 112.793 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -176.66 115.97 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.78 2.832 . . . . 0.0 108.253 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.56 126.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.238 -1.539 . . . . 0.0 109.559 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 127.98 33.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.922 0.489 . . . . 0.0 110.87 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.23 109.55 54.15 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.161 1.384 . . . . 0.0 109.817 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.59 138.87 33.08 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.429 2.086 . . . . 0.0 110.556 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.62 123.76 18.57 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.733 1.213 . . . . 0.0 109.199 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.68 164.51 35.18 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.831 2.354 . . . . 0.0 112.055 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 134.02 55.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.29 0.567 . . . . 0.0 111.735 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.15 146.59 40.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.921 1.688 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.8 m -142.55 136.05 14.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 124.603 1.161 . . . . 0.0 109.874 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.7 154.95 75.72 Favored 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 119.844 0.98 . . . . 0.0 113.006 -4.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -64.33 -32.2 61.7 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.064 1.843 . . . . 0.0 112.509 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.59 -12.48 58.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.662 1.585 . . . . 0.0 114.168 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.32 174.75 6.07 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.161 0.981 . . . . 0.0 112.89 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.81 149.23 45.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.994 1.317 . . . . 0.0 111.574 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.28 122.76 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.964 1.706 . . . . 0.0 109.139 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.84 140.69 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.411 0.624 . . . . 0.0 110.722 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 121' ' ' PRO . 36.6 t -141.14 137.93 33.1 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.87 1.268 . . . . 0.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -91.15 139.81 30.4 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -130.48 116.72 18.61 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.869 1.268 . . . . 0.0 108.47 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.29 124.81 37.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.67 133.25 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.719 1.208 . . . . 0.0 110.559 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.81 145.3 56.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.426 0.631 . . . . 0.0 111.585 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.7 p -81.68 -5.24 57.92 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.113 1.365 . . . . 0.0 113.076 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -135.56 166.55 22.95 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.087 1.755 . . . . 0.0 111.194 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 t -80.39 142.87 54.82 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.623 0.769 . . . . 0.0 112.671 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.36 132.3 21.32 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.117 1.077 . . . . 0.0 110.993 -9.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -75.08 36.26 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.627 1.571 . . . . 0.0 112.171 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.93 132.29 41.8 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.701 1.2 . . . . 0.0 109.565 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -52.36 148.44 6.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.221 -0.299 . . . . 0.0 110.96 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.57 -29.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.292 1.037 . . . . 0.0 112.404 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.96 143.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.935 1.694 . . . . 0.0 109.306 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.95 122.0 14.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.366 1.467 . . . . 0.0 109.035 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.21 -165.25 31.67 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 121.906 0.725 . . . . 0.0 114.262 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.36 144.96 34.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.426 1.09 . . . . 0.0 110.256 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.86 155.58 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.215 1.806 . . . . 0.0 108.934 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -125.32 126.05 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.406 -0.809 . . . . 0.0 108.867 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -95.98 139.38 32.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -133.24 150.39 51.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.376 1.87 . . . . 0.0 108.414 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -122.94 150.57 42.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.005 0.922 . . . . 0.0 109.417 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.25 105.89 56.14 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.676 0.79 . . . . 0.0 109.326 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.9 51.42 1.97 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.354 4.036 . . . . 0.0 113.614 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.7 m -132.57 -41.24 0.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.72 2.008 . . . . 0.0 111.703 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.8 t -145.92 23.68 1.37 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 123.078 1.418 . . . . 0.0 112.098 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.15 46.41 56.52 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.595 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -83.5 156.13 23.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.479 1.112 . . . . 0.0 110.423 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.23 134.82 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.9 m -124.83 150.26 46.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.855 2.062 . . . . 0.0 108.421 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 123.77 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.226 1.011 . . . . 0.0 109.155 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.11 133.5 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.3 1.44 . . . . 0.0 107.338 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.32 138.9 25.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.639 1.576 . . . . 0.0 107.635 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 147.68 50.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.786 1.235 . . . . 0.0 108.494 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.17 -17.84 59.19 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.311 -0.868 . . . . 0.0 112.593 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.35 -12.68 61.23 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.307 2.243 . . . . 0.0 114.013 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.4 p -137.02 -44.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.583 1.553 . . . . 0.0 111.872 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.504 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -68.68 160.97 74.51 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.107 1.763 . . . . 0.0 111.324 169.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.504 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 59.6 Cg_endo -76.72 -2.16 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.848 3.032 . . . . 0.0 113.859 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 53.69 15.56 0.81 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.709 2.404 . . . . 0.0 115.113 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.39 -0.67 8.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.867 1.667 . . . . 0.0 113.398 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.7 ttt -125.62 148.61 48.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.817 2.047 . . . . 0.0 107.507 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -133.75 156.97 47.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.724 0.81 . . . . 0.0 109.846 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.9 t -117.58 125.31 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.251 0.621 . . . . 0.0 109.563 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 41.5 m -110.61 110.35 21.01 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.602 1.961 . . . . 0.0 108.229 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.09 103.97 5.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.086 0.955 . . . . 0.0 110.543 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.8 -34.55 19.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.317 0.647 . . . . 0.0 111.257 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -142.44 -177.62 5.36 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.301 1.84 . . . . 0.0 112.739 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -66.97 -17.39 64.9 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.9 p -138.68 10.37 2.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 112.644 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.4 m -125.18 114.13 18.59 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.279 1.032 . . . . 0.0 110.975 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.59 138.1 52.8 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.433 1.493 . . . . 0.0 109.258 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 48.8 mt -119.79 122.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.36 104.79 16.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.981 1.312 . . . . 0.0 109.094 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -87.23 126.88 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.774 0.83 . . . . 0.0 109.019 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.46 118.99 31.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.702 0.801 . . . . 0.0 109.981 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -110.86 -27.16 8.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.877 1.271 . . . . 0.0 113.374 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.7 m -103.8 177.88 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 112.209 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -134.3 72.97 1.47 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.248 1.419 . . . . 0.0 109.644 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.341 1.056 . . . . 0.0 113.672 178.848 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.369 0.604 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.66 152.27 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.363 1.465 . . . . 0.0 111.213 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 139.94 51.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.594 1.158 . . . . 0.0 111.082 171.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.6 -17.74 60.76 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.684 -1.26 . . . . 0.0 113.568 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.31 3.53 12.58 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.284 1.834 . . . . 0.0 113.837 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -149.1 173.19 13.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.076 2.55 . . . . 0.0 109.399 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.63 161.5 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.729 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -145.48 142.3 29.12 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.335 0.654 . . . . 0.0 110.341 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.51 138.04 54.04 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.413 1.485 . . . . 0.0 108.71 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.47 127.27 42.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.141 0.972 . . . . 0.0 110.365 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -80.49 58.24 3.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.145 1.378 . . . . 0.0 111.19 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.9 139.32 3.94 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.587 -0.696 . . . . 0.0 112.278 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.922 0.889 . . . . 0.0 108.831 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 75.99 34.02 0.56 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.789 1.636 . . . . 0.0 112.874 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.7 t 62.89 63.96 0.92 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.622 1.569 . . . . 0.0 112.831 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.6 p -137.28 -178.53 5.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.253 1.821 . . . . 0.0 112.99 -172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.84 -95.39 0.63 Allowed Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.63 1.586 . . . . 0.0 114.317 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -123.37 164.23 19.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.99 1.316 . . . . 0.0 110.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.7 p -132.92 149.32 52.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.72 1.208 . . . . 0.0 112.036 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.95 148.42 29.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.523 1.529 . . . . 0.0 109.603 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -126.93 146.31 50.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.106 0.962 . . . . 0.0 110.258 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.42 132.31 31.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.875 1.322 . . . . 0.0 111.721 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.7 146.75 49.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.964 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -62.66 142.62 58.0 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.415 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 52.45 34.75 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.083 0.401 . . . . 0.0 113.428 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 158.1 45.05 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.841 0.856 . . . . 0.0 112.101 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -138.6 135.33 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.69 119.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.321 1.048 . . . . 0.0 109.29 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -99.9 103.5 15.09 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.25 155.2 23.79 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.605 1.162 . . . . 0.0 110.663 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -103.48 137.22 41.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.445 0.698 . . . . 0.0 110.029 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -59.78 -17.37 35.04 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.77 -25.41 63.64 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.424 1.012 . . . . 0.0 114.342 170.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.01 119.18 38.54 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.534 1.167 . . . . 0.0 109.975 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -12.5 3.44 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 170.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -58.2 -25.82 62.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.196 1.398 . . . . 0.0 112.22 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.12 -56.03 10.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.098 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.07 -15.24 21.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.962 1.705 . . . . 0.0 113.771 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -28.52 44.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.807 1.643 . . . . 0.0 113.522 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -47.36 122.22 4.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.229 0.538 . . . . 0.0 111.575 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.9 tpt -149.23 -31.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 111.918 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.6 p -145.32 162.06 38.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 111.684 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.1 p -156.05 149.16 24.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.322 1.449 . . . . 0.0 110.407 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.27 136.23 53.19 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.56 129.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.232 1.413 . . . . 0.0 109.563 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.36 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.574 2.035 . . . . 0.0 116.11 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -166.36 -20.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 113.267 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -119.92 22.92 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.01 1.724 . . . . 0.0 111.607 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.21 143.25 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.93 2.092 . . . . 0.0 109.508 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -120.94 145.66 47.46 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.91 1.284 . . . . 0.0 109.807 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.4 m -112.29 142.89 44.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.606 1.194 . . . . 0.0 109.957 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 4.6 m120 -132.33 130.79 41.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.44 123.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.105 . . . . 0.0 109.639 -172.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -131.92 134.31 45.53 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.094 1.358 . . . . 0.0 110.549 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.58 -34.22 7.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.05 0.94 . . . . 0.0 112.935 -168.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.42 157.27 46.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.593 1.957 . . . . 0.0 107.223 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -142.39 131.79 23.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.111 0.964 . . . . 0.0 109.743 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.53 162.68 0.7 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.105 1.762 . . . . 0.0 110.68 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.34 15.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 112.556 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.14 28.82 1.1 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.04 2.136 . . . . 0.0 111.147 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 t -99.53 139.96 21.26 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.929 1.291 . . . . 0.0 112.456 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.39 -16.69 11.91 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.45 2.767 . . . . 0.0 114.281 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 t -124.92 137.59 29.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.73 150.32 83.53 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.43 -161.29 5.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.426 1.014 . . . . 0.0 112.241 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.16 134.8 51.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 108.59 167.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -159.43 155.66 27.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.568 1.547 . . . . 0.0 110.482 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -158.61 147.32 18.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.732 1.253 . . . . 0.0 113.027 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.73 95.26 9.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.848 2.059 . . . . 0.0 109.676 168.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.6 134.14 55.89 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.22 151.46 15.67 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.89 -8.61 7.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.46 89.93 0.11 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.236 -0.915 . . . . 0.0 112.644 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.1 p -162.42 169.41 20.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.355 1.074 . . . . 0.0 112.851 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -104.54 133.34 49.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.584 1.554 . . . . 0.0 109.107 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -128.67 115.4 17.97 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.084 0.954 . . . . 0.0 109.682 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -141.53 15.56 2.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 112.257 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -153.71 50.57 0.68 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.932 1.293 . . . . 0.0 109.96 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.01 42.25 0.39 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.649 1.18 . . . . 0.0 110.841 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -66.31 -30.08 70.42 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 119.971 -1.706 . . . . 0.0 112.385 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -63.26 -23.94 67.65 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.196 0.998 . . . . 0.0 112.88 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.24 -34.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.674 1.99 . . . . 0.0 111.421 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.92 40.83 22.1 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.898 1.679 . . . . 0.0 113.24 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 168.89 33.95 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.668 1.128 . . . . 0.0 112.287 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.44 -173.91 3.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.409 1.484 . . . . 0.0 112.39 -170.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 84.8 p -145.83 -28.18 0.43 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.36 139.26 51.64 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.501 1.52 . . . . 0.0 110.03 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.79 127.39 40.25 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.023 1.329 . . . . 0.0 107.673 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 53' ' ' ASN . 1.5 pm0 -136.91 130.44 31.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.703 0.801 . . . . 0.0 109.11 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.61 118.77 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.218 1.407 . . . . 0.0 107.541 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.84 123.27 27.46 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.473 1.109 . . . . 0.0 109.061 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.54 160.48 41.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.999 2.466 . . . . 0.0 111.107 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.17 24.6 0.2 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 125.831 1.682 . . . . 0.0 116.01 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.13 -20.94 6.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.236 2.215 . . . . 0.0 112.816 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.06 158.93 32.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.821 1.648 . . . . 0.0 109.399 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.13 -38.8 7.98 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.252 -0.905 . . . . 0.0 112.826 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 -149.98 155.52 40.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.101 1.361 . . . . 0.0 108.878 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.78 146.06 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.03 0.532 . . . . 0.0 110.072 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.02 134.55 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.253 1.021 . . . . 0.0 110.539 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -84.72 126.18 33.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.1 m -124.89 140.0 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.555 0.742 . . . . 0.0 109.548 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.29 161.83 30.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.295 1.038 . . . . 0.0 110.716 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.01 134.94 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.984 0.913 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.7 t -127.4 108.27 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.21 118.31 18.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.735 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -102.33 -21.69 14.26 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.319 1.047 . . . . 0.0 112.466 170.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.21 -67.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.192 0.997 . . . . 0.0 111.971 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -85.2 97.62 10.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.852 1.261 . . . . 0.0 110.393 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -70.17 47.84 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.26 1.824 . . . . 0.0 114.417 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.8 m -144.68 -36.16 0.32 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.123 2.569 . . . . 0.0 111.82 -171.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.29 -153.58 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 53.03 25.18 23.5 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 120.224 1.375 . . . . 0.0 116.203 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 m -143.82 5.66 1.36 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.974 1.71 . . . . 0.0 114.935 -167.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -133.58 120.3 20.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.431 1.493 . . . . 0.0 111.855 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.26 137.99 32.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.315 1.046 . . . . 0.0 109.916 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 119.38 34.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.261 2.224 . . . . 0.0 108.662 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 m -119.07 119.5 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.41 128.83 73.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -117.49 89.11 31.12 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.233 1.413 . . . . 0.0 109.226 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.07 160.36 49.01 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.668 2.912 . . . . 0.0 112.035 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -42.94 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.288 2.635 . . . . 0.0 116.084 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 44.48 39.7 3.39 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.836 1.654 . . . . 0.0 113.948 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.25 154.92 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.734 2.014 . . . . 0.0 109.683 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -45.95 98.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 112.752 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 151.06 36.17 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 0.0 111.046 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.46 125.41 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.882 0.873 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.17 105.45 17.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.012 1.325 . . . . 0.0 108.638 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.4 p -103.06 164.99 11.28 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.053 0.941 . . . . 0.0 110.796 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -142.46 159.9 41.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.764 0.825 . . . . 0.0 110.65 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -60.54 81.85 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 126.339 1.856 . . . . 0.0 114.526 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.22 0.18 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.939 1.733 . . . . 0.0 112.159 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.12 131.43 49.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.978 0.894 . . . . 0.0 111.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -74.95 70.52 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.32 1.448 . . . . 0.0 112.466 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 63.3 84.3 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.23 2.212 . . . . 0.0 110.919 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.61 147.96 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.603 -0.686 . . . . 0.0 110.599 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.1 146.06 24.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.886 0.474 . . . . 0.0 111.199 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.66 97.09 44.82 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.195 1.398 . . . . 0.0 108.106 166.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.51 137.51 27.99 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.542 2.161 . . . . 0.0 111.072 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.68 127.62 23.52 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.508 1.123 . . . . 0.0 107.997 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.22 -178.7 3.77 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.326 3.35 . . . . 0.0 111.327 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 149.41 47.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.84 0.829 . . . . 0.0 112.358 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.02 143.39 21.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.432 1.893 . . . . 0.0 109.46 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.8 m -125.83 130.62 23.98 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 124.275 1.03 . . . . 0.0 109.534 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.1 150.78 79.37 Favored 'Cis proline' 0 CA--C 1.545 1.038 0 CA-C-N 119.368 0.81 . . . . 0.0 112.435 -3.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.27 -22.69 39.76 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.76 1.64 . . . . 0.0 112.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.01 4.87 15.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.543 1.537 . . . . 0.0 114.548 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 148.71 46.68 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.727 -1.233 . . . . 0.0 111.992 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 155.57 36.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 112.182 168.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 tt -132.99 114.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 109.155 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 138.91 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.331 0.652 . . . . 0.0 109.844 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.1 p -142.57 145.99 34.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.033 0.921 . . . . 0.0 111.221 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -86.49 145.72 26.69 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 tt -134.6 122.49 22.39 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.993 0.917 . . . . 0.0 110.035 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 t -131.14 138.31 49.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.434 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.02 134.11 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.72 50.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.89 0.876 . . . . 0.0 109.885 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.26 129.46 40.04 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.156 -0.34 . . . . 0.0 110.253 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.9 p -77.41 -10.37 59.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.81 0.844 . . . . 0.0 112.855 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.74 164.43 17.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.085 2.154 . . . . 0.0 111.301 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.9 t -75.17 141.29 74.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.63 -0.669 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.35 129.58 15.45 Favored 'Cis proline' 0 C--N 1.354 0.861 0 CA-C-N 120.279 1.135 . . . . 0.0 111.091 -9.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -73.73 34.38 0.08 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.978 1.711 . . . . 0.0 113.546 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.23 151.17 23.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 113.039 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.21 102.62 2.14 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.916 0.886 . . . . 0.0 110.381 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.94 -39.1 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.82 2.048 . . . . 0.0 111.495 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.53 143.76 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.2 1.4 . . . . 0.0 108.252 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -148.77 74.46 1.27 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.962 0.905 . . . . 0.0 109.273 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -140.69 -156.13 6.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.424 1.488 . . . . 0.0 112.039 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 55.2 m -141.69 164.73 29.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.95 0.9 . . . . 0.0 110.434 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.73 156.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.444 1.498 . . . . 0.0 108.176 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.01 134.39 53.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.141 -0.974 . . . . 0.0 108.65 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.05 160.08 16.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.486 1.115 . . . . 0.0 109.609 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -159.22 154.31 25.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.269 1.428 . . . . 0.0 109.262 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -128.94 142.83 50.81 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.937 1.295 . . . . 0.0 109.168 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.6 m -101.86 109.66 60.21 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.376 0.67 . . . . 0.0 109.197 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.63 47.65 1.71 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 125.227 3.952 . . . . 0.0 113.098 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -130.27 -49.73 1.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.105 1.762 . . . . 0.0 110.462 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.2 p -138.46 24.71 2.68 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.196 1.398 . . . . 0.0 112.609 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.99 23.75 64.08 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.306 0.955 . . . . 0.0 114.154 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 158.73 35.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.327 1.051 . . . . 0.0 111.318 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.19 143.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.705 1.602 . . . . 0.0 107.819 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 59.4 m -139.49 128.73 23.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.841 1.256 . . . . 0.0 108.587 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.567 HG23 ' HE2' ' A' ' 186' ' ' LYS . 0.9 OUTLIER -102.07 126.61 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.866 0.866 . . . . 0.0 110.233 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.71 130.18 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.902 1.281 . . . . 0.0 108.224 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 184' ' ' VAL . 14.8 mtmt -140.03 125.86 19.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.198 1.799 . . . . 0.0 108.468 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 158.56 42.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.164 1.386 . . . . 0.0 109.943 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.59 -18.36 19.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.648 1.179 . . . . 0.0 113.274 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.78 -24.88 64.45 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.967 1.707 . . . . 0.0 114.609 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.0 p -150.15 -44.17 0.13 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.756 1.223 . . . . 0.0 114.1 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.86 144.28 51.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.895 1.278 . . . . 0.0 110.072 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.47 -78.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 121.268 1.312 . . . . 0.0 113.437 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 156.06 -44.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 130.262 3.425 . . . . 0.0 112.003 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -57.97 -25.18 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.058 1.743 . . . . 0.0 113.533 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -119.46 131.85 55.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.737 1.615 . . . . 0.0 107.433 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -132.09 149.68 52.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 110.174 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.69 131.23 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.3 t -120.08 153.76 35.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.882 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.432 ' HB3' ' CE2' ' A' ' 205' ' ' PHE . 11.3 pt20 -105.04 114.4 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.731 0.812 . . . . 0.0 109.897 -176.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.48 -33.62 60.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -134.42 -175.6 3.93 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.352 1.061 . . . . 0.0 112.968 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.85 -30.91 68.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.361 1.064 . . . . 0.0 113.319 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.1 p -139.81 13.72 2.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.47 1.908 . . . . 0.0 112.591 -168.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 t -129.07 123.57 32.6 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.668 1.187 . . . . 0.0 110.958 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 199' ' ' GLN . 94.4 m-85 -130.04 146.63 51.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.812 1.645 . . . . 0.0 109.819 -171.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.63 119.2 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.81 107.76 19.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.737 . . . . 0.0 109.685 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.25 140.69 29.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.842 1.657 . . . . 0.0 109.998 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.39 110.49 12.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.913 0.885 . . . . 0.0 110.569 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.5 13.06 13.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.567 1.947 . . . . 0.0 113.861 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.13 135.4 3.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.1 1.76 . . . . 0.0 109.849 166.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.91 -4.44 35.05 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.651 0 C-N-CA 126.206 1.802 . . . . 0.0 115.332 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -96.75 129.67 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.406 1.483 . . . . 0.0 110.122 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.74 148.31 49.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.24 -21.55 24.27 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.666 -1.271 . . . . 0.0 113.098 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -112.71 11.65 19.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.474 1.91 . . . . 0.0 113.729 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -144.08 172.65 12.6 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.912 2.085 . . . . 0.0 110.402 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.26 156.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.237 -0.914 . . . . 0.0 110.692 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 134.25 26.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.817 0.847 . . . . 0.0 110.783 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -118.5 154.46 32.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.425 1.09 . . . . 0.0 110.281 -168.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -138.15 126.12 22.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.782 1.277 . . . . 0.0 110.984 -166.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -96.92 44.01 1.06 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.287 1.041 . . . . 0.0 112.647 -165.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.57 137.6 3.84 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.72 1.628 . . . . 0.0 110.778 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -61.32 133.93 56.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.925 0.89 . . . . 0.0 109.6 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 83.94 27.5 0.09 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.913 2.085 . . . . 0.0 113.058 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.79 59.0 4.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.242 1.417 . . . . 0.0 113.154 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.3 p -128.05 -174.06 3.1 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.98 1.712 . . . . 0.0 112.032 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.6 -98.62 1.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.861 1.219 . . . . 0.0 112.634 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.2 175.97 8.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.205 1.402 . . . . 0.0 110.753 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -133.42 158.61 42.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 111.228 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.58 152.33 37.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.963 1.305 . . . . 0.0 110.491 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.49 140.96 52.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.768 0.827 . . . . 0.0 111.731 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -137.9 134.24 34.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.255 1.422 . . . . 0.0 110.393 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.71 159.37 20.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.727 0.811 . . . . 0.0 111.577 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 155.27 13.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.036 -0.415 . . . . 0.0 112.051 168.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.57 93.95 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.736 0.684 . . . . 0.0 113.254 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -125.16 124.34 41.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.448 1.099 . . . . 0.0 110.731 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -122.62 124.18 42.88 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 108.481 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.74 133.52 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.521 1.153 . . . . 0.0 109.858 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -114.51 83.69 1.93 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.649 1.98 . . . . 0.0 107.922 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.2 167.35 14.41 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.999 0.904 . . . . 0.0 111.382 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -117.96 159.81 22.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 109.807 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -17.97 63.63 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -36.24 73.55 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.052 1.31 . . . . 0.0 114.191 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -76.96 110.73 11.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.496 1.148 . . . . 0.0 109.345 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -24.31 66.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.182 -1.574 . . . . 0.0 112.563 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -61.47 -21.66 64.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.734 1.614 . . . . 0.0 112.363 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -71.88 -53.93 11.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.642 1.177 . . . . 0.0 112.243 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -24.29 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -55.05 -27.62 46.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.023 1.729 . . . . 0.0 114.467 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -51.2 108.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.435 1.016 . . . . 0.0 111.707 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.9 tpt -132.35 -29.03 1.62 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.028 0.931 . . . . 0.0 112.663 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.9 m -139.33 164.24 30.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.643 2.377 . . . . 0.0 109.438 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.5 163.26 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.43 1.092 . . . . 0.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pp -146.75 148.86 32.39 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 123.17 1.462 . . . . 0.0 111.326 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.04 133.33 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.086 1.754 . . . . 0.0 107.803 -167.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.44 -92.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.181 1.372 . . . . 0.0 116.002 -168.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -170.25 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.111 1.364 . . . . 0.0 113.772 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -122.11 28.17 7.65 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.679 1.992 . . . . 0.0 111.841 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -145.24 146.75 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.874 2.07 . . . . 0.0 109.375 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.43 149.78 38.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 109.138 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.1 144.85 44.22 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.958 0.903 . . . . 0.0 110.49 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -122.38 135.5 54.71 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.672 1.189 . . . . 0.0 109.27 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.5 mt -118.39 126.4 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.153 1.381 . . . . 0.0 108.475 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -131.59 124.74 30.61 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.062 0.945 . . . . 0.0 110.572 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -26.59 11.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.863 1.265 . . . . 0.0 111.809 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -114.38 150.68 34.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.828 1.251 . . . . 0.0 110.759 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -142.77 103.6 4.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.842 1.257 . . . . 0.0 109.027 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.73 155.29 19.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.286 1.434 . . . . 0.0 109.88 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.34 27.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.525 1.53 . . . . 0.0 111.764 -168.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.2 -29.68 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.92 2.088 . . . . 0.0 111.37 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 t -54.44 122.19 36.69 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.027 0.931 . . . . 0.0 112.566 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.97 -15.26 10.6 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.791 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 t -82.77 113.2 43.5 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.11 0.868 . . . . 0.0 110.174 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.8 127.53 14.69 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.107 1.204 . . . . 0.0 109.055 174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.08 -113.91 0.62 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.67 115.02 18.1 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 109.621 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.17 143.29 34.14 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.337 2.255 . . . . 0.0 107.882 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -158.64 166.71 31.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.608 1.163 . . . . 0.0 110.015 166.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -126.72 104.99 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 108.48 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.73 124.89 21.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.58 153.86 2.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.88 -18.77 14.4 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.62 126.49 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 160.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.14 164.32 0.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.927 2.091 . . . . 0.0 111.364 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.8 m -112.69 131.54 55.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 0.0 109.036 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -124.71 98.73 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.764 1.625 . . . . 0.0 107.571 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -112.39 17.57 19.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.246 1.018 . . . . 0.0 111.886 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -156.69 66.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.838 1.655 . . . . 0.0 110.803 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB3' HG22 ' A' ' 83' ' ' ILE . 4.0 mp -92.0 31.22 1.28 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.161 -0.962 . . . . 0.0 111.874 176.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.3 m -56.58 -28.39 60.16 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 119.995 -1.691 . . . . 0.0 113.038 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -60.28 -26.66 66.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.711 -1.243 . . . . 0.0 114.106 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.404 HG22 ' HB3' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -97.63 -23.32 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.786 1.234 . . . . 0.0 112.484 176.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 55.41 50.42 14.83 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.672 1.989 . . . . 0.0 113.464 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.22 -170.49 44.69 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.529 -0.732 . . . . 0.0 111.31 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -175.0 5.16 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.66 -1.494 . . . . 0.0 111.987 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -135.02 -27.93 1.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.35 135.28 46.06 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.536 -0.728 . . . . 0.0 110.006 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.86 131.24 52.42 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.503 1.521 . . . . 0.0 108.945 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -122.31 137.78 54.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.397 0.618 . . . . 0.0 109.635 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.81 116.65 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 125.637 1.575 . . . . 0.0 106.879 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.69 130.39 24.48 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 109.352 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.12 162.07 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.753 1.636 . . . . 0.0 112.871 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.16 2.09 4.36 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.803 1.668 . . . . 0.0 116.029 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.28 -18.41 32.1 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.238 1.415 . . . . 0.0 113.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -132.75 161.05 35.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.763 1.625 . . . . 0.0 110.153 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -93.55 -55.19 3.36 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -139.99 164.34 30.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.615 1.566 . . . . 0.0 109.145 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 163.63 32.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.524 0.73 . . . . 0.0 109.4 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.445 HG21 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -135.5 142.59 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.151 0.58 . . . . 0.0 109.505 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.92 139.27 33.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.271 0.558 . . . . 0.0 110.479 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.55 137.14 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.479 1.111 . . . . 0.0 109.773 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -136.79 153.93 50.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.787 0.835 . . . . 0.0 111.111 -178.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.83 137.75 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 108.789 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -109.87 119.16 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.625 1.17 . . . . 0.0 109.346 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -63.62 89.67 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.433 1.893 . . . . 0.0 112.877 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.84 10.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.454 1.101 . . . . 0.0 112.987 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -80.69 -70.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.133 1.373 . . . . 0.0 110.508 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.42 8.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.477 1.511 . . . . 0.0 110.729 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.6 t -83.99 -47.45 10.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.957 0.503 . . . . 0.0 112.347 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -61.32 -39.13 89.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 41.44 -148.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.123 1.369 . . . . 0.0 112.271 -170.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.91 26.52 55.12 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 120.927 -1.108 . . . . 0.0 114.137 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.0 m -138.19 15.64 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.468 1.507 . . . . 0.0 114.622 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -133.71 114.26 13.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.542 1.537 . . . . 0.0 110.624 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -111.12 114.43 27.69 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.606 0.762 . . . . 0.0 110.495 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -107.47 117.98 35.53 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.786 2.034 . . . . 0.0 110.161 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -108.13 126.43 52.75 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.1 pt -118.19 140.3 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 110.056 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 m -145.24 93.98 5.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.188 0.995 . . . . 0.0 109.107 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.94 168.49 18.66 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.372 2.048 . . . . 0.0 112.627 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -35.91 101.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.771 2.428 . . . . 0.0 113.65 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.306 2.7 pp0? 42.15 42.08 2.31 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.619 2.367 . . . . 0.0 116.61 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.45 156.8 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.021 1.729 . . . . 0.0 112.099 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -52.33 119.88 4.92 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.219 1.808 . . . . 0.0 112.62 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 142.87 56.37 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.592 0.757 . . . . 0.0 111.513 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.14 117.66 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.624 1.17 . . . . 0.0 110.615 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.73 102.18 13.41 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.209 1.004 . . . . 0.0 110.059 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 3.9 t -93.5 152.16 19.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.51 0.724 . . . . 0.0 110.333 170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -143.49 146.88 33.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.511 1.124 . . . . 0.0 109.289 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -54.9 85.57 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.106 . . . . 0.0 114.052 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.63 -21.44 1.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.547 1.546 . . . . 0.0 113.463 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.66 135.45 56.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.32 1.06 . . . . 0.0 110.602 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.15 64.02 3.22 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.213 1.005 . . . . 0.0 111.725 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 6.5 m-85 60.54 81.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.0 2.12 . . . . 0.0 111.423 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.79 131.97 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.15 -0.969 . . . . 0.0 110.403 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 136.89 32.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 110.515 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.12 98.64 48.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.573 1.949 . . . . 0.0 108.873 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -71.63 138.34 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.717 2.278 . . . . 0.0 111.409 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.49 126.93 22.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 108.541 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.86 167.18 23.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.723 2.949 . . . . 0.0 111.942 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -61.71 122.04 14.34 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.572 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.06 153.02 47.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.351 2.261 . . . . 0.0 109.438 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 t -137.86 136.05 19.48 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.575 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.76 150.41 65.26 Favored 'Cis proline' 0 CA--C 1.548 1.18 0 CA-C-N 119.771 0.954 . . . . 0.0 112.471 -7.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.47 -29.09 62.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.295 1.996 . . . . 0.0 112.494 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.47 3.75 15.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.266 1.427 . . . . 0.0 113.786 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.7 p -67.97 147.7 52.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.138 1.335 . . . . 0.0 112.198 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.15 121.09 16.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.889 0.875 . . . . 0.0 110.829 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.0 tt -109.54 116.51 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.819 0.848 . . . . 0.0 110.668 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.15 142.68 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.0 0.52 . . . . 0.0 109.808 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.6 t -144.63 137.83 26.96 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.982 0.913 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -99.85 139.19 35.88 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.232 0.539 . . . . 0.0 109.55 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.27 124.41 47.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.842 2.057 . . . . 0.0 107.643 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 113.77 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 2.0 p -124.23 140.64 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.181 1.392 . . . . 0.0 108.969 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -139.84 156.45 46.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.056 0.942 . . . . 0.0 111.524 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -65.24 134.34 53.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.2 p -71.96 -8.55 55.13 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.94 10.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.35 2.26 . . . . 0.0 110.383 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.9 t -40.09 134.59 1.43 Allowed Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 125.729 1.612 . . . . 0.0 114.212 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.65 2.36 21.03 Favored 'Cis proline' 0 CA--C 1.546 1.105 0 N-CA-C 114.854 1.059 . . . . 0.0 114.854 3.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 6.89 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.84 2.056 . . . . 0.0 114.243 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.13 156.41 38.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.911 1.285 . . . . 0.0 111.735 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -55.21 143.29 28.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.908 0.883 . . . . 0.0 111.802 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.75 -23.01 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.487 1.515 . . . . 0.0 112.205 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 75.2 t -155.89 141.82 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.75 1.62 . . . . 0.0 108.324 171.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -136.81 113.68 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.676 1.99 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.19 -179.11 39.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.139 0.876 . . . . 0.0 111.993 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.49 149.0 44.96 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.921 -0.752 . . . . 0.0 110.934 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.0 p -138.81 159.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.087 1.355 . . . . 0.0 109.133 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -115.43 130.73 56.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 109.917 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -104.91 152.31 22.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 0.0 109.521 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -149.86 162.86 39.49 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.759 2.024 . . . . 0.0 110.578 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -133.7 123.52 25.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.574 1.55 . . . . 0.0 108.93 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.8 m -77.82 112.51 25.32 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.367 0.667 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.4 54.05 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.542 3.494 . . . . 0.0 112.072 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.3 m -136.92 -52.65 0.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.262 1.425 . . . . 0.0 111.273 -170.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 32.1 p -130.26 12.91 5.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.235 1.414 . . . . 0.0 112.551 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.66 28.81 72.89 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.084 1.326 . . . . 0.0 113.626 -171.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -68.34 156.37 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.476 -1.014 . . . . 0.0 111.141 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -136.02 131.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.8 m -135.53 132.17 36.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.206 1.403 . . . . 0.0 109.23 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.513 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -105.02 117.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.26 1.024 . . . . 0.0 110.255 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -88.64 128.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 134.94 25.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.973 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -148.78 143.91 26.67 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.77 1.628 . . . . 0.0 109.678 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.17 -14.93 4.61 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.11 1.364 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -52.31 -30.43 28.27 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.324 1.85 . . . . 0.0 114.409 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 16.7 p -149.49 -34.72 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.705 1.602 . . . . 0.0 113.623 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -72.88 133.43 82.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 111.608 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.68 130.2 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.545 2.83 . . . . 0.0 111.546 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -73.56 -20.09 60.72 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 167' ' ' VAL . 0.8 OUTLIER -74.86 -13.04 60.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.29 1.036 . . . . 0.0 113.493 177.01 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.8 mtp -112.53 150.91 30.63 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.515 1.526 . . . . 0.0 108.828 167.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.1 p -142.21 118.28 10.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.238 0.615 . . . . 0.0 109.614 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.17 107.92 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.486 0.66 . . . . 0.0 109.708 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 95.2 m -88.11 143.82 26.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.555 0.693 . . . . 0.0 109.753 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.26 71.14 10.66 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.72 1.208 . . . . 0.0 110.408 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.43 -42.78 64.4 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.301 1.44 . . . . 0.0 113.259 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.08 -177.38 6.54 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.076 1.75 . . . . 0.0 110.991 163.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -50.91 143.45 10.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.256 -1.528 . . . . 0.0 109.574 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 29.9 p 53.13 14.96 0.54 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 t -139.88 108.92 6.03 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.865 1.666 . . . . 0.0 110.958 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 184' ' ' VAL . 22.3 m-85 -120.76 147.62 45.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.177 0.991 . . . . 0.0 111.128 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . 0.272 9.8 tt -133.84 99.08 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 122.51 1.148 . . . . 0.0 110.513 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -73.36 109.91 7.25 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.305 1.842 . . . . 0.0 110.11 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -81.04 138.21 36.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.9 tp -132.07 111.65 11.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.37 1.068 . . . . 0.0 108.667 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -120.73 -3.38 9.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.432 1.493 . . . . 0.0 114.609 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -141.18 -178.55 5.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.012 1.325 . . . . 0.0 111.502 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.1 46.67 0.99 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.082 0.944 . . . . 0.0 113.181 -170.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt . . . . . 0 C--O 1.258 1.531 0 C-N-CA 128.214 2.606 . . . . 0.0 116.986 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.79 138.51 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.724 1.209 . . . . 0.0 110.291 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.58 140.57 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.15 -16.4 32.27 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.845 -1.159 . . . . 0.0 113.109 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.77 9.89 11.49 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 112.45 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -148.17 171.72 15.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.622 1.969 . . . . 0.0 110.738 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 23' ' ' TYR . 2.1 m -141.27 150.99 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 O-C-N 121.035 -1.041 . . . . 0.0 112.412 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -149.64 151.14 33.25 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.807 -0.558 . . . . 0.0 109.631 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.6 159.4 42.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.741 -0.6 . . . . 0.0 110.877 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -130.86 136.46 48.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.223 1.009 . . . . 0.0 111.054 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.63 63.35 3.4 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.732 1.613 . . . . 0.0 111.287 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.47 135.72 1.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.686 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -58.58 126.73 28.82 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 90.28 22.7 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.735 2.414 . . . . 0.0 112.268 -174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.39 55.1 0.86 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.254 1.421 . . . . 0.0 111.408 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.8 p -129.24 -178.78 4.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.682 1.593 . . . . 0.0 112.367 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.95 -107.31 2.15 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.651 1.12 . . . . 0.0 113.773 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.0 167.87 9.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.9 p -133.7 152.22 51.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.835 0.854 . . . . 0.0 112.589 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.49 150.48 29.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -141.97 140.75 32.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.082 0.953 . . . . 0.0 110.734 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 8' ' ' VAL . 1.7 p90 -145.52 142.5 29.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.364 1.066 . . . . 0.0 109.277 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.97 163.89 26.6 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.749 -1.219 . . . . 0.0 112.09 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -76.11 161.31 28.95 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.196 -0.94 . . . . 0.0 111.326 171.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.22 43.65 70.12 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 114.644 0.617 . . . . 0.0 114.644 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 169.88 19.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.438 1.495 . . . . 0.0 111.616 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.4 p -138.95 143.44 38.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.976 0.91 . . . . 0.0 111.502 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -135.59 129.15 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.149 0.979 . . . . 0.0 110.556 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.21 90.53 3.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.756 1.223 . . . . 0.0 108.921 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.42 166.42 14.62 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.973 0.892 . . . . 0.0 111.346 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -111.8 153.42 26.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.6 0.76 . . . . 0.0 110.163 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.92 57.43 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.65 73.59 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.815 1.198 . . . . 0.0 114.411 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -91.91 112.49 24.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.863 0.831 . . . . 0.0 109.381 167.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -21.75 33.9 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.529 -0.732 . . . . 0.0 111.494 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -61.32 -11.65 10.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.358 1.463 . . . . 0.0 112.533 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -67.32 -52.05 45.12 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.444 -1.41 . . . . 0.0 111.392 167.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.09 -10.7 55.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.509 1.524 . . . . 0.0 112.883 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.97 -27.09 63.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.838 1.655 . . . . 0.0 113.313 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -58.43 104.66 0.23 Allowed 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.63 -1.294 . . . . 0.0 111.671 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -27.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.917 1.687 . . . . 0.0 112.438 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 t -142.12 137.17 30.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.474 1.91 . . . . 0.0 111.173 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.73 120.06 13.04 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.462 1.125 . . . . 0.0 112.178 -173.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.46 112.97 24.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.894 1.678 . . . . 0.0 109.839 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 75' ' ' SER . 0.9 OUTLIER -98.93 140.62 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.724 1.209 . . . . 0.0 109.429 173.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.05 -116.78 0.03 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.02 1.295 . . . . 0.0 114.552 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.7 m -147.08 -13.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.666 1.186 . . . . 0.0 113.024 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 36.03 3.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.493 1.517 . . . . 0.0 110.392 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.22 118.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.7 1.6 . . . . 0.0 110.959 -168.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -95.77 140.53 30.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.55 1.14 . . . . 0.0 110.652 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 51.6 m -125.79 112.93 16.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 108.916 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -109.25 134.6 51.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.45 144.04 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.437 0.637 . . . . 0.0 111.839 -171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -142.14 142.06 32.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.37 -166.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -118.62 -29.53 5.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.779 0.832 . . . . 0.0 111.588 -170.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.11 130.59 25.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.411 1.484 . . . . 0.0 111.85 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.93 121.53 41.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.192 0.597 . . . . 0.0 110.967 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -165.81 170.32 14.02 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 0.0 110.953 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.82 21.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.172 1.389 . . . . 0.0 111.539 -169.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.75 -17.19 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.808 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.2 t -41.81 138.88 1.7 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.427 1.491 . . . . 0.0 114.908 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.56 -9.05 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.445 2.763 . . . . 0.0 112.71 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -143.79 115.08 5.58 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.533 1.133 . . . . 0.0 111.52 172.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 49.62 1.92 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.388 2.726 . . . . 0.0 112.033 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 31.66 -107.41 0.02 OUTLIER Glycine 0 CA--C 1.527 0.827 0 C-N-CA 129.008 3.194 . . . . 0.0 114.548 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -123.44 144.64 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.016 0.926 . . . . 0.0 110.252 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.56 153.98 40.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.96 1.704 . . . . 0.0 110.259 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -161.86 153.99 19.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.734 0.814 . . . . 0.0 110.86 167.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.1 93.75 4.25 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.942 1.297 . . . . 0.0 109.172 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.74 134.81 57.45 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 176.3 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.54 -18.65 65.48 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.535 -1.353 . . . . 0.0 113.113 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 111.71 0.5 Allowed Glycine 0 CA--C 1.536 1.36 0 CA-C-N 119.028 0.831 . . . . 0.0 113.357 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER 175.46 162.47 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.728 2.411 . . . . 0.0 111.023 179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -109.28 142.53 40.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.018 1.327 . . . . 0.0 110.743 171.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -134.18 136.29 43.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.698 1.199 . . . . 0.0 108.676 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -150.24 -50.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.929 0.892 . . . . 0.0 111.374 -170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -81.23 46.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.981 1.312 . . . . 0.0 113.413 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.01 42.61 0.09 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.216 1.406 . . . . 0.0 113.433 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -60.29 -34.69 74.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 112.713 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -65.91 -26.42 67.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.6 mm -72.6 -38.91 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.397 1.079 . . . . 0.0 110.262 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.82 32.6 22.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.714 1.606 . . . . 0.0 113.297 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.14 39.8 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.216 1.389 . . . . 0.0 113.411 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -176.29 3.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 112.399 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -140.53 -31.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.0 136.77 37.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.194 0.998 . . . . 0.0 110.153 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.402 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -145.44 133.86 21.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.78 0.8 . . . . 0.0 110.093 -168.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.32 138.54 53.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.72 -170.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.78 121.92 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.33 135.57 27.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.143 0.577 . . . . 0.0 110.313 -166.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.424 ' CB ' ' HE2' ' A' ' 25' ' ' LYS . 61.4 Cg_endo -76.44 152.59 34.39 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.04 1.827 . . . . 0.0 111.021 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.37 29.13 0.21 Allowed Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.851 1.691 . . . . 0.0 116.121 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.69 -18.23 3.92 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.605 1.962 . . . . 0.0 112.654 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -119.25 156.24 30.29 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.941 0.897 . . . . 0.0 110.167 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -88.24 -41.91 12.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.491 -0.755 . . . . 0.0 111.966 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -150.14 167.64 26.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.143 2.177 . . . . 0.0 108.561 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.63 166.55 23.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.668 -0.645 . . . . 0.0 110.72 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.92 149.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.238 0.615 . . . . 0.0 111.579 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.95 118.17 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.54 130.32 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.803 0.841 . . . . 0.0 111.326 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -127.6 145.58 50.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.39 1.076 . . . . 0.0 110.65 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.14 147.46 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 123.808 0.692 . . . . 0.0 111.651 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.69 127.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.312 1.054 . . . . 0.0 110.132 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -64.03 125.54 24.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.561 1.544 . . . . 0.0 112.242 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -35.14 2.48 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.63 -35.86 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.492 1.117 . . . . 0.0 113.383 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -120.33 139.96 51.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.039 1.336 . . . . 0.0 109.05 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -87.15 6.81 30.98 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.955 -1.091 . . . . 0.0 113.181 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -88.66 -33.65 17.52 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 48.44 -167.35 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.37 17.13 55.95 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 p -141.25 5.95 1.9 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.43 1.115 . . . . 0.0 113.247 -162.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -113.32 152.01 30.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.242 1.017 . . . . 0.0 112.7 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 159' ' ' THR . 3.5 tt0 -127.81 134.76 49.47 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.248 1.419 . . . . 0.0 109.454 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -124.37 139.83 53.53 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.817 -0.552 . . . . 0.0 110.94 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -135.63 119.26 17.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.971 1.309 . . . . 0.0 109.404 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.91 115.15 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 108.968 -170.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.8 m -122.96 92.18 49.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.019 0.528 . . . . 0.0 112.123 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.48 169.52 21.57 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.232 2.621 . . . . 0.0 113.249 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.2 57.71 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.135 1.774 . . . . 0.0 115.269 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.82 -53.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 161.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.0 158.86 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.33 1.052 . . . . 0.0 111.716 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -154.52 -165.2 2.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.239 1.415 . . . . 0.0 110.182 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 56.88 58.79 3.83 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.68 122.52 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.562 1.945 . . . . 0.0 109.957 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.45 112.43 11.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.631 0.772 . . . . 0.0 110.069 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.7 t -97.48 137.55 36.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.682 0.393 . . . . 0.0 110.278 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -104.11 143.34 33.05 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.181 0.992 . . . . 0.0 109.932 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -56.19 131.62 48.31 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 121.962 -0.461 . . . . 0.0 110.984 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.84 8.66 44.9 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.823 1.202 . . . . 0.0 115.356 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.17 155.74 19.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.127 0.963 . . . . 0.0 112.354 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.44 49.55 1.17 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.51 1.124 . . . . 0.0 113.199 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 60.48 104.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.362 2.265 . . . . 0.0 112.44 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.28 141.0 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 134.25 35.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.745 0.784 . . . . 0.0 112.104 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -118.47 102.13 50.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 169.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.63 121.22 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.046 1.83 . . . . 0.0 111.827 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.8 mm -99.76 123.04 49.07 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.368 1.067 . . . . 0.0 110.106 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.99 178.47 7.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.811 2.341 . . . . 0.0 111.97 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 139.8 43.71 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.966 -1.084 . . . . 0.0 113.227 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.16 152.11 29.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.441 1.497 . . . . 0.0 111.724 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -145.14 135.69 12.1 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.215 1.406 . . . . 0.0 110.396 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.03 146.33 68.11 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 120.045 1.052 . . . . 0.0 110.782 -7.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.68 -31.05 33.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.502 2.135 . . . . 0.0 111.393 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.72 5.86 4.51 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.744 1.618 . . . . 0.0 114.979 168.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.5 t -77.1 149.16 35.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.104 0.866 . . . . 0.0 111.74 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.434 0.694 . . . . 0.0 111.374 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 tt -106.0 121.72 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.441 1.096 . . . . 0.0 110.912 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.75 135.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.068 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.4 p -143.2 127.75 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.548 0.689 . . . . 0.0 111.485 169.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 140.77 42.2 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.49 111.12 11.99 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.652 1.215 . . . . 0.0 109.425 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 p -109.06 144.09 37.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.634 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.34 133.57 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -138.9 147.8 42.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.755 1.222 . . . . 0.0 109.23 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -67.14 115.14 6.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.453 -0.78 . . . . 0.0 110.006 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.3 t -65.08 -16.78 63.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.339 1.056 . . . . 0.0 112.528 173.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -114.37 156.7 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 110.794 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 t -69.83 138.99 88.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.491 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.66 129.11 16.51 Favored 'Cis proline' 0 C--N 1.355 0.912 0 CA-C-N 120.721 1.293 . . . . 0.0 110.374 -5.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -76.0 36.68 0.14 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.174 1.39 . . . . 0.0 113.457 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 146.83 52.95 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.046 -1.659 . . . . 0.0 113.158 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -69.62 127.25 32.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.435 0.694 . . . . 0.0 111.01 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 -50.49 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 112.205 -171.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 24.4 m -146.57 139.18 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.884 1.274 . . . . 0.0 109.574 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -130.39 98.29 4.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.465 1.506 . . . . 0.0 108.019 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.05 11.46 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.326 1.441 . . . . 0.0 113.193 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.8 m -135.41 153.72 51.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.801 0.84 . . . . 0.0 111.502 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.51 165.09 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.682 1.593 . . . . 0.0 108.849 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.5 126.89 38.01 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.03 150.89 23.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.456 -0.777 . . . . 0.0 110.414 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -145.31 162.34 37.44 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 125.185 1.394 . . . . 0.0 108.344 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 170.11 19.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 169.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.5 m -133.64 105.52 11.86 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.63 0.772 . . . . 0.0 109.026 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 18.77 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.26 3.306 . . . . 0.0 113.037 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -63.65 -34.06 77.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.008 1.723 . . . . 0.0 112.5 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 t -164.3 26.83 0.07 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 123.176 1.465 . . . . 0.0 112.4 -173.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 60.59 27.99 67.01 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 119.259 -2.151 . . . . 0.0 113.778 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -79.07 142.89 36.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.69 0.745 . . . . 0.0 111.191 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.49 160.67 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.061 0.545 . . . . 0.0 111.414 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.4 m -148.99 129.98 14.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.901 1.28 . . . . 0.0 111.118 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.91 128.07 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.392 0.542 . . . . 0.0 110.433 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.41 130.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.361 1.077 . . . . 0.0 108.612 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.67 135.94 22.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 109.044 -176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -144.43 145.08 31.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.311 1.444 . . . . 0.0 109.693 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.57 -16.7 6.53 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.331 1.452 . . . . 0.0 113.786 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.4 -24.03 64.83 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.9 p -144.7 -30.2 0.45 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.121 1.369 . . . . 0.0 113.727 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -79.42 144.51 61.83 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.895 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.78 158.84 52.24 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.04 1.827 . . . . 0.0 112.284 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -93.65 -2.08 54.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -109.48 -16.47 13.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.135 1.374 . . . . 0.0 113.517 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.1 ttt -134.34 134.13 41.45 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.797 1.239 . . . . 0.0 107.966 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.3 p -136.73 153.36 50.88 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.86 138.61 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.039 0.536 . . . . 0.0 111.039 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 52.2 m -127.12 143.73 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.803 1.241 . . . . 0.0 109.4 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -75.03 85.42 2.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.468 0.652 . . . . 0.0 110.943 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.28 -42.69 82.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.984 1.314 . . . . 0.0 112.136 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -152.26 178.5 9.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.625 1.57 . . . . 0.0 109.696 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.45 135.3 54.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.668 -1.895 . . . . 0.0 110.944 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 m 58.61 23.21 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.558 1.143 . . . . 0.0 113.054 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.13 110.91 6.2 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.591 -0.693 . . . . 0.0 110.829 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.25 145.22 42.02 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.935 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.86 116.69 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.88 0.848 . . . . 0.0 110.663 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -96.7 117.1 30.29 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.267 1.427 . . . . 0.0 110.516 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -100.01 131.89 45.69 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.594 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.49 114.42 20.67 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.89 0.768 . . . . 0.0 112.943 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -117.09 25.4 10.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.734 1.214 . . . . 0.0 113.339 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.0 m -143.74 166.81 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 52.39 1.18 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.023 2.129 . . . . 0.0 110.86 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt . . . . . 0 C--O 1.294 3.401 0 CA-C-O 115.565 -2.16 . . . . 0.0 111.186 177.519 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.191 0.519 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.91 137.97 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.97 0.908 . . . . 0.0 111.365 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.57 147.93 29.38 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.736 -0.602 . . . . 0.0 110.488 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.12 -20.31 52.42 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.839 -1.163 . . . . 0.0 113.835 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -111.2 7.93 21.4 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.501 1.92 . . . . 0.0 113.636 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -143.92 -176.09 4.85 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 110.6 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -145.57 154.03 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.596 0.758 . . . . 0.0 112.733 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 144.41 49.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.902 1.281 . . . . 0.0 110.309 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.414 ' HZ ' ' CE1' ' A' ' 89' ' ' PHE . 14.6 m-85 -132.48 129.66 39.47 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.765 1.626 . . . . 0.0 107.465 -165.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -128.29 121.43 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 123.796 1.76 . . . . 0.0 109.872 -170.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.34 59.26 5.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.735 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.57 149.19 5.78 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.592 1.568 . . . . 0.0 111.357 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.59 151.55 5.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.562 1.145 . . . . 0.0 111.957 175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 49.74 41.54 22.27 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m 50.43 63.19 2.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.465 1.506 . . . . 0.0 113.636 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 18' ' ' GLY . 3.0 m -130.25 -178.21 4.65 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.876 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 17' ' ' THR . . . 74.02 -118.83 6.13 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.078 1.323 . . . . 0.0 111.972 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.11 166.41 11.26 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 117.685 0.742 . . . . 0.0 111.509 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -126.17 146.49 49.94 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.685 1.194 . . . . 0.0 110.965 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.74 155.8 41.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.78 1.232 . . . . 0.0 110.072 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -128.28 142.3 51.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -125.63 125.14 42.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.359 1.064 . . . . 0.0 109.312 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.61 129.01 34.29 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.955 0.902 . . . . 0.0 109.509 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.48 144.68 25.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.475 1.11 . . . . 0.0 112.875 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.02 41.45 9.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.062 0.839 . . . . 0.0 112.939 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.13 153.45 42.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.954 1.301 . . . . 0.0 111.698 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -129.39 131.08 46.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.958 1.303 . . . . 0.0 109.037 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.48 128.23 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 122.579 1.18 . . . . 0.0 109.753 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.6 mtm105 -124.36 89.46 3.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.817 1.247 . . . . 0.0 109.112 -171.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -78.22 168.69 19.45 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.821 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -116.18 157.85 24.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.632 1.173 . . . . 0.0 110.096 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.63 -19.68 65.06 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.263 -0.898 . . . . 0.0 113.073 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.93 -24.05 66.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.221 1.391 . . . . 0.0 114.464 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -98.67 105.14 17.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.283 1.041 . . . . 0.0 109.244 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -21.5 60.48 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.618 -1.301 . . . . 0.0 112.625 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -61.15 -24.21 66.12 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.64 1.976 . . . . 0.0 112.399 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -64.54 -56.14 15.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.693 1.597 . . . . 0.0 111.1 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.5 -18.55 65.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.424 1.49 . . . . 0.0 113.251 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -29.62 69.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.899 2.08 . . . . 0.0 113.222 172.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 86' ' ' LEU . 38.4 t80 -53.27 118.62 3.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.784 0.72 . . . . 0.0 110.259 169.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 mmm -146.12 -16.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.126 0.97 . . . . 0.0 113.435 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.7 m -136.9 151.79 49.48 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 110.783 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.55 155.77 22.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.641 1.176 . . . . 0.0 110.743 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.7 121.7 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 8' ' ' VAL . 62.7 t -92.23 136.69 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.352 0.661 . . . . 0.0 110.137 172.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -106.02 0.01 OUTLIER Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.85 2.166 . . . . 0.0 115.823 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -161.27 -21.78 0.05 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.794 1.638 . . . . 0.0 112.866 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.14 33.14 4.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.622 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.8 121.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.111 1.765 . . . . 0.0 110.109 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -84.69 145.63 27.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.856 -1.153 . . . . 0.0 109.558 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 58.5 m -126.65 147.82 49.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.594 -0.692 . . . . 0.0 110.771 173.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.85 140.09 52.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.667 0.787 . . . . 0.0 109.451 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.512 HG23 HD12 ' A' ' 86' ' ' LEU . 9.1 mt -122.44 138.14 53.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.454 1.102 . . . . 0.0 109.362 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -152.7 120.49 6.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.663 0.785 . . . . 0.0 112.379 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -83.51 -60.95 1.97 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.7 175.02 5.64 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.543 -0.723 . . . . 0.0 110.986 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 202' ' ' ASN . 3.1 p30 -153.92 134.48 13.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.927 0.891 . . . . 0.0 110.31 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -164.8 155.09 14.01 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.314 1.445 . . . . 0.0 110.461 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.35 41.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 111.177 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.09 -34.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.148 1.779 . . . . 0.0 111.606 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 t -56.08 134.5 74.4 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.597 1.159 . . . . 0.0 113.251 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.1 -18.96 9.73 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.095 2.53 . . . . 0.0 113.312 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 t -101.74 130.64 24.14 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.503 1.121 . . . . 0.0 110.637 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.04 174.67 11.61 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.356 2.038 . . . . 0.0 111.657 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.89 -151.64 19.73 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 124.576 1.084 . . . . 0.0 112.558 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 109.01 18.91 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.057 0.543 . . . . 0.0 110.329 168.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.7 148.71 41.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.988 1.315 . . . . 0.0 110.169 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -162.49 137.65 6.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.753 0.821 . . . . 0.0 109.51 168.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -87.91 110.36 20.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 165.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.74 125.7 26.67 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.366 -0.834 . . . . 0.0 109.016 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.85 150.2 5.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.798 1.239 . . . . 0.0 112.181 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -15.49 6.35 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.18 104.86 0.26 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 112.143 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.47 160.62 3.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.98 1.712 . . . . 0.0 111.993 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.7 m -113.98 143.66 44.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.013 1.325 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -141.44 112.54 7.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.606 1.163 . . . . 0.0 109.928 -164.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -126.44 -32.72 2.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.48 1.112 . . . . 0.0 112.379 -170.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -96.58 59.33 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.276 2.63 . . . . 0.0 109.621 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.72 52.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.186 1.394 . . . . 0.0 111.629 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.8 m -62.33 -42.54 99.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.176 -1.578 . . . . 0.0 111.547 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -59.46 -28.21 66.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.004 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -128.95 54.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.418 1.887 . . . . 0.0 108.513 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -65.0 -15.63 62.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.685 1.194 . . . . 0.0 113.401 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.38 20.1 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.014 1.292 . . . . 0.0 109.881 155.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -123.07 150.28 43.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.205 1.802 . . . . 0.0 108.452 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -118.53 -42.59 2.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.303 0.641 . . . . 0.0 112.635 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.06 156.36 46.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.893 1.277 . . . . 0.0 111.73 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 52' ' ' CYS . 8.4 t80 -145.97 150.54 36.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.33 1.052 . . . . 0.0 111.458 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.35 129.67 27.43 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.403 1.081 . . . . 0.0 110.949 172.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 25' ' ' LYS . 2.6 p -106.93 125.18 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.096 1.358 . . . . 0.0 109.209 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.93 147.67 57.38 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.06 1.344 . . . . 0.0 110.644 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 29.6 Cg_endo -67.99 -177.03 1.16 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.261 3.307 . . . . 0.0 113.997 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.91 14.88 4.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.022 1.772 . . . . 0.0 114.144 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.7 -47.98 2.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.562 1.945 . . . . 0.0 110.34 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 139' ' ' PRO . 1.3 m-85 -91.44 157.9 16.8 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.49 1.116 . . . . 0.0 111.146 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -127.66 -37.06 2.0 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.948 1.299 . . . . 0.0 111.958 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -141.64 167.13 22.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.882 2.073 . . . . 0.0 108.066 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.7 159.6 41.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 109.793 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.65 130.05 59.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.082 0.953 . . . . 0.0 109.237 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -82.89 127.68 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.873 0.869 . . . . 0.0 108.816 172.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -119.58 144.6 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.747 0.819 . . . . 0.0 109.296 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -144.41 133.85 23.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.677 0.791 . . . . 0.0 109.826 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.0 pt -78.81 148.75 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.726 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -141.94 120.49 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.593 1.957 . . . . 0.0 107.542 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.15 110.93 4.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.471 0.708 . . . . 0.0 110.57 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 19.29 20.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.49 1.116 . . . . 0.0 112.379 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.8 t -126.45 -69.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.145 1.378 . . . . 0.0 111.597 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -89.08 134.61 33.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.442 0.697 . . . . 0.0 109.425 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -79.77 34.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.825 -1.172 . . . . 0.0 112.573 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 m -138.54 52.85 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.063 2.545 . . . . 0.0 108.536 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.23 144.35 41.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 166.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.09 6.34 4.91 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.362 1.458 . . . . 0.0 114.343 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.5 m -141.55 25.52 2.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.605 1.562 . . . . 0.0 113.388 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -128.82 136.72 50.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.278 1.831 . . . . 0.0 109.149 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.63 121.76 43.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.772 1.229 . . . . 0.0 109.683 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -105.23 144.9 31.38 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.0 0.92 . . . . 0.0 110.245 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -137.82 106.8 5.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.093 1.357 . . . . 0.0 107.348 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.4 tt -103.81 131.45 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 109.507 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.7 m -129.95 86.7 53.97 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.958 1.703 . . . . 0.0 109.043 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.28 163.95 35.95 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.422 2.748 . . . . 0.0 112.265 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -31.67 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.715 2.406 . . . . 0.0 114.39 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 34.01 36.15 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.693 2.397 . . . . 0.0 116.37 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -104.26 155.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.69 1.596 . . . . 0.0 109.999 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -48.9 100.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.852 1.661 . . . . 0.0 111.996 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -59.18 165.2 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.255 1.026 . . . . 0.0 111.435 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.2 136.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.101 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.64 123.6 42.31 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.19 168.02 20.6 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.438 0.695 . . . . 0.0 111.111 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -132.46 155.64 48.17 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.34 1.056 . . . . 0.0 110.323 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.56 116.54 1.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.41 . . . . 0.0 111.79 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.69 15.86 19.31 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -171.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.03 160.62 14.7 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.51 1.124 . . . . 0.0 113.712 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.57 50.02 1.89 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.262 1.425 . . . . 0.0 112.325 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 59.81 78.66 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.186 1.794 . . . . 0.0 111.823 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.1 t -40.92 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.068 1.747 . . . . 0.0 112.452 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -81.99 95.84 7.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 111.72 31.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 96' ' ' PHE . 57.7 Cg_endo -78.98 137.29 13.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.586 2.191 . . . . 0.0 112.008 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.5 mt -128.65 128.47 23.53 Favored Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 121.654 -0.654 . . . . 0.0 110.242 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.91 174.78 11.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.431 2.754 . . . . 0.0 113.38 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -60.33 134.98 57.58 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.737 -0.602 . . . . 0.0 109.951 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.39 146.15 49.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.176 1.39 . . . . 0.0 108.567 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.2 m -131.29 126.8 21.55 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 123.942 0.897 . . . . 0.0 110.216 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.44 155.82 81.93 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 119.008 0.681 . . . . 0.0 111.447 -5.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.0 -24.82 32.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.468 1.445 . . . . 0.0 113.364 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -72.22 -5.94 39.36 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 168.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 160.13 33.11 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.742 1.258 . . . . 0.0 112.935 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -103.14 162.68 12.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.15 1.38 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tt -129.1 132.26 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.638 1.975 . . . . 0.0 109.193 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.56 136.08 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.038 0.935 . . . . 0.0 111.126 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.3 t -143.72 150.11 38.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -112.29 136.69 51.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.019 1.328 . . . . 0.0 109.32 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.55 118.83 22.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.297 1.039 . . . . 0.0 109.166 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 t -125.64 123.04 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.233 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.03 140.4 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.027 1.331 . . . . 0.0 108.635 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -148.52 153.09 37.95 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.955 1.302 . . . . 0.0 110.379 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.65 135.71 56.2 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.058 0.543 . . . . 0.0 110.449 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -72.49 -12.85 61.26 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.458 1.103 . . . . 0.0 113.83 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -141.61 -179.09 5.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.98 2.512 . . . . 0.0 110.034 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 p -52.9 146.79 17.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.763 1.225 . . . . 0.0 113.459 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.94 3.58 17.33 Favored 'Cis proline' 0 CA--C 1.545 1.058 0 N-CA-C 114.878 1.068 . . . . 0.0 114.878 1.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.27 27.0 15.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.144 1.378 . . . . 0.0 113.026 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -80.86 139.34 36.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.054 1.342 . . . . 0.0 110.738 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -55.9 100.22 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.474 1.109 . . . . 0.0 112.232 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.49 -51.82 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.823 1.249 . . . . 0.0 110.443 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.4 t -145.36 126.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.742 1.217 . . . . 0.0 108.177 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.83 91.21 2.87 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.621 1.168 . . . . 0.0 108.361 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -150.79 -152.03 5.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.008 1.289 . . . . 0.0 111.103 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 m -143.05 170.15 16.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.749 0.785 . . . . 0.0 111.049 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.63 146.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.338 1.455 . . . . 0.0 108.52 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -101.37 143.02 31.92 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.01 154.17 33.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.331 1.052 . . . . 0.0 109.402 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -157.44 158.77 36.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.594 1.558 . . . . 0.0 108.261 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -128.36 145.32 51.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.525 0.73 . . . . 0.0 109.818 166.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.6 m -91.73 117.24 67.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 -10.07 27.76 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 2.747 . . . . 0.0 113.129 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.7 p -45.62 -38.47 6.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.088 2.155 . . . . 0.0 113.061 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.8 t -158.89 14.73 0.17 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.007 1.323 . . . . 0.0 112.933 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.39 29.91 76.37 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 119.793 -1.817 . . . . 0.0 112.882 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 160.35 31.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.705 1.202 . . . . 0.0 110.703 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.65 130.95 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.278 -0.889 . . . . 0.0 111.069 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.5 m -145.6 121.45 10.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.475 1.51 . . . . 0.0 110.13 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.8 m -86.71 142.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.487 0.66 . . . . 0.0 111.153 171.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 139.8 29.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.515 1.526 . . . . 0.0 107.927 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 123.04 18.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.788 1.235 . . . . 0.0 109.273 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -149.59 152.32 35.27 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.873 1.669 . . . . 0.0 110.046 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -17.01 5.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.98 1.312 . . . . 0.0 114.449 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.79 -26.6 58.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.665 1.586 . . . . 0.0 114.63 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.6 p -147.81 -38.8 0.19 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.623 1.569 . . . . 0.0 112.984 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -60.95 124.21 78.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.047 1.339 . . . . 0.0 110.827 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.8 -7.93 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.519 2.813 . . . . 0.0 113.554 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 65.39 -16.34 0.1 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 127.914 2.485 . . . . 0.0 115.461 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -73.52 -45.86 51.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.391 2.276 . . . . 0.0 112.716 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.7 ttt -114.17 135.78 53.66 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.219 1.008 . . . . 0.0 108.38 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -116.58 171.46 7.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.551 0.74 . . . . 0.0 109.323 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.07 131.38 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.385 -0.822 . . . . 0.0 109.689 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.4 m -109.2 132.72 53.86 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.571 1.148 . . . . 0.0 109.352 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -75.11 69.91 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.188 1.795 . . . . 0.0 110.624 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -53.96 -42.95 69.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.954 1.302 . . . . 0.0 111.848 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -160.37 178.36 9.67 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.469 1.907 . . . . 0.0 110.967 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.4 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 4.3 m-20 -51.82 142.57 14.89 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.51 -1.369 . . . . 0.0 110.476 164.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.9 p 46.17 27.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.526 1.53 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.1 t -146.9 101.06 3.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.52 1.128 . . . . 0.0 111.369 -171.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.426 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.6 m-85 -116.52 133.73 55.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.31 93.96 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -69.44 125.3 26.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.454 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -121.45 115.05 22.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.844 1.258 . . . . 0.0 111.606 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.77 108.94 7.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.366 1.466 . . . . 0.0 110.523 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -89.95 -15.37 32.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 -174.52 3.02 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.124 1.37 . . . . 0.0 111.511 171.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.99 41.04 0.65 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.76 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.632 0.254 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.11 142.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.247 1.019 . . . . 0.0 110.474 167.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.3 143.07 57.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.49 0.716 . . . . 0.0 109.944 173.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.74 -14.56 62.71 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.435 -1.416 . . . . 0.0 113.126 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -119.01 6.02 11.33 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.273 2.229 . . . . 0.0 113.384 -171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -146.9 175.05 10.95 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.127 2.171 . . . . 0.0 109.042 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.18 154.63 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.229 1.012 . . . . 0.0 110.587 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.49 143.8 31.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.18 131.74 51.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.977 1.311 . . . . 0.0 108.782 -165.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -114.8 135.02 54.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.116 1.436 . . . . 0.0 109.872 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.93 39.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.878 1.671 . . . . 0.0 111.235 -168.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.92 143.12 6.87 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.944 1.259 . . . . 0.0 111.866 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -55.46 147.65 17.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.15 0.98 . . . . 0.0 110.955 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.45 27.52 15.62 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.9 m 61.51 68.88 0.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.091 1.756 . . . . 0.0 113.101 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.1 p -131.66 -173.58 3.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.35 1.86 . . . . 0.0 111.514 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.91 -121.29 9.25 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.887 -1.133 . . . . 0.0 112.39 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.27 172.67 6.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 111.415 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.4 p -134.96 146.97 49.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 111.515 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.88 154.33 45.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.244 1.818 . . . . 0.0 109.255 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -129.98 150.73 51.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.829 0.823 . . . . 0.0 111.754 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -138.49 122.55 17.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.848 1.659 . . . . 0.0 110.341 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -68.76 128.63 37.34 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.934 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG3' HG12 ' A' ' 50' ' ' VAL . 2.9 ttmm -52.41 139.63 24.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.979 0.912 . . . . 0.0 111.406 171.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.1 48.47 4.35 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.043 0.83 . . . . 0.0 112.896 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 177.42 9.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.113 0.965 . . . . 0.0 112.745 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 m -138.75 135.65 34.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.821 1.649 . . . . 0.0 109.155 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.28 120.65 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.265 1.826 . . . . 0.0 109.926 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -117.55 100.4 7.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.57 1.148 . . . . 0.0 108.883 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.51 173.49 7.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.28 1.032 . . . . 0.0 110.364 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -119.15 154.47 33.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -17.56 29.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.647 1.179 . . . . 0.0 113.429 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.84 -35.4 61.85 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.505 1.526 . . . . 0.0 114.477 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.43 119.84 18.22 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.795 1.298 . . . . 0.0 109.677 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.56 67.58 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.088 -1.632 . . . . 0.0 112.374 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -62.89 -25.22 68.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.541 1.536 . . . . 0.0 112.578 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.5 -56.5 10.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.524 1.53 . . . . 0.0 110.87 169.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.9 -21.51 66.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.012 1.325 . . . . 0.0 113.344 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -5.48 3.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.755 2.022 . . . . 0.0 115.336 170.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.2 139.25 1.44 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.883 0.765 . . . . 0.0 110.131 158.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tpt -160.53 -41.34 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.1 p -155.46 169.09 25.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.839 1.256 . . . . 0.0 111.386 171.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -159.54 172.71 17.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 110.814 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 141.95 50.5 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.365 1.466 . . . . 0.0 109.129 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.36 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.507 1.523 . . . . 0.0 109.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.02 -110.87 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.688 2.089 . . . . 0.0 115.42 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.5 m -152.92 -28.31 0.15 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.953 1.301 . . . . 0.0 112.9 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -113.94 31.56 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.516 1.926 . . . . 0.0 110.723 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG12 ' HG3' ' A' ' 25' ' ' LYS . 34.4 m -144.76 133.22 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.447 1.499 . . . . 0.0 109.548 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 154.01 21.17 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.47 -0.769 . . . . 0.0 109.858 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 104.33 6.54 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 0.0 109.365 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.98 130.47 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.806 0.843 . . . . 0.0 109.216 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 89' ' ' PHE . 11.3 tt -124.44 134.18 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 109.611 -169.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.37 137.15 37.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 111.256 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.97 -47.27 4.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.801 1.241 . . . . 0.0 113.124 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -129.12 132.52 47.38 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.814 0.846 . . . . 0.0 109.296 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -129.65 96.42 4.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.064 1.346 . . . . 0.0 110.531 -165.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.87 165.5 25.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.689 1.196 . . . . 0.0 111.658 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.34 17.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.092 1.357 . . . . 0.0 113.049 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -147.9 39.22 0.93 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.09 1.356 . . . . 0.0 111.277 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -125.94 136.63 28.72 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.68 1.192 . . . . 0.0 111.742 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.38 -18.24 16.02 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.774 2.316 . . . . 0.0 112.776 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -75.3 118.61 72.0 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.852 0.861 . . . . 0.0 109.453 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.14 86.78 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.87 2.38 . . . . 0.0 109.485 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -44.32 128.26 6.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.529 1.538 . . . . 0.0 112.852 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -57.92 125.96 25.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.69 0.757 . . . . 0.0 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -142.78 149.52 38.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.182 1.393 . . . . 0.0 108.569 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.53 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.028 0.918 . . . . 0.0 109.957 169.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.36 82.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.328 1.051 . . . . 0.0 109.046 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 71' ' ' LEU . 3.1 mm? -43.43 125.29 3.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.326 1.45 . . . . 0.0 109.303 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.01 146.09 11.77 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.106 0.962 . . . . 0.0 112.18 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -57.82 -14.15 5.49 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.93 116.07 0.77 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.858 1.218 . . . . 0.0 111.598 160.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.34 168.85 2.76 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.298 1.839 . . . . 0.0 112.151 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.9 m -103.34 141.12 36.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.015 0.926 . . . . 0.0 109.477 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -119.35 89.27 3.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.818 1.247 . . . . 0.0 107.759 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.13 -0.64 14.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.366 1.466 . . . . 0.0 113.322 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -144.78 69.92 1.27 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.882 1.673 . . . . 0.0 109.779 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mp -92.86 10.36 31.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.6 m -52.68 -30.8 33.99 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.66 -1.275 . . . . 0.0 112.78 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -58.91 -27.45 65.27 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.9 -25.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.13 0.972 . . . . 0.0 111.424 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.7 t30 68.0 39.89 2.4 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 126.152 1.781 . . . . 0.0 113.986 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.18 153.92 30.62 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.07 -1.019 . . . . 0.0 110.932 -169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -110.58 148.6 31.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.033 1.333 . . . . 0.0 108.317 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -128.44 -40.79 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.738 1.215 . . . . 0.0 113.019 171.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -130.97 140.82 50.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.292 1.037 . . . . 0.0 110.404 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -129.24 142.08 50.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.911 1.285 . . . . 0.0 110.55 172.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -135.37 126.17 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.135 1.374 . . . . 0.0 107.991 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.46 107.7 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 122.487 1.137 . . . . 0.0 109.468 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.97 150.62 42.18 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.253 1.021 . . . . 0.0 109.357 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.66 27.45 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.614 3.543 . . . . 0.0 115.601 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.72 34.7 65.13 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.073 1.32 . . . . 0.0 113.792 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.46 -44.51 0.19 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.156 1.782 . . . . 0.0 110.063 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 5.0 m-85 -83.1 153.1 25.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.168 1.387 . . . . 0.0 110.546 168.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -90.45 -41.12 11.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.529 1.132 . . . . 0.0 111.01 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -155.99 177.89 10.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.363 2.265 . . . . 0.0 108.784 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.47 159.43 43.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.674 0.79 . . . . 0.0 109.713 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 173' ' ' PHE . 10.9 p -120.8 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.75 125.9 30.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.285 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.27 137.76 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 108.666 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -132.21 159.09 40.04 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.494 -0.754 . . . . 0.0 109.562 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.79 136.3 56.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.087 1.755 . . . . 0.0 109.009 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.43 135.61 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.718 1.207 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -91.6 117.92 30.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.659 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -109.19 4.51 22.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.622 1.169 . . . . 0.0 113.082 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.5 t -116.89 -60.98 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.299 1.44 . . . . 0.0 110.933 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.42 -20.61 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.338 1.055 . . . . 0.0 110.841 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.7 m 48.47 31.94 3.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.675 1.99 . . . . 0.0 113.846 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -127.83 31.43 5.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.123 1.769 . . . . 0.0 111.331 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -37.95 104.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.123 2.569 . . . . 0.0 113.293 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.24 10.76 0.05 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.9 p -149.36 14.87 0.89 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.306 1.442 . . . . 0.0 114.136 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -115.86 139.71 49.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.575 1.55 . . . . 0.0 108.064 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -115.12 140.75 48.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 109.067 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttp -134.46 127.66 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.797 0.839 . . . . 0.0 110.272 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.1 m -117.84 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.392 1.077 . . . . 0.0 109.124 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.77 122.9 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.361 1.864 . . . . 0.0 108.753 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.1 m -130.21 99.71 19.32 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.153 1.381 . . . . 0.0 110.175 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.85 169.59 18.67 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.969 3.113 . . . . 0.0 112.39 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -25.23 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.655 2.782 . . . . 0.0 113.724 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 41.53 48.9 3.53 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.97 1.708 . . . . 0.0 115.203 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.7 160.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.918 2.087 . . . . 0.0 111.362 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.85 129.12 9.31 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.762 1.625 . . . . 0.0 112.495 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -64.65 157.06 28.21 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.278 0.561 . . . . 0.0 111.505 169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.08 149.33 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 126.699 1.999 . . . . 0.0 109.701 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.44 91.79 3.72 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.978 0.911 . . . . 0.0 110.887 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.5 t -67.14 139.47 57.49 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -134.32 133.02 40.22 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.519 1.127 . . . . 0.0 108.692 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.59 129.06 40.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.412 0.685 . . . . 0.0 111.296 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.44 18.84 12.21 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.711 1.148 . . . . 0.0 114.867 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.03 156.16 16.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.203 1.401 . . . . 0.0 112.178 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.16 57.54 0.66 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.611 1.564 . . . . 0.0 111.84 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 57.21 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.204 2.201 . . . . 0.0 112.156 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.13 149.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.062 -1.024 . . . . 0.0 111.469 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -114.92 97.87 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.5 tp -75.05 116.39 53.75 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 65.9 Cg_endo -73.46 144.56 36.46 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.175 1.917 . . . . 0.0 112.694 172.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 mm -130.85 130.38 22.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.225 1.41 . . . . 0.0 109.063 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 178.76 4.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.751 2.301 . . . . 0.0 111.895 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 54.8 0.08 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.099 1.76 . . . . 0.0 113.6 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 pp -45.73 134.72 7.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.154 1.382 . . . . 0.0 111.164 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -139.68 133.81 15.83 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.989 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.02 150.04 78.26 Favored 'Cis proline' 0 CA--C 1.545 1.05 0 CA-C-N 119.216 0.756 . . . . 0.0 112.113 -5.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.08 -34.76 45.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.946 1.764 . . . . 0.0 112.431 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -63.77 -10.03 17.72 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 161.41 24.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.244 1.018 . . . . 0.0 112.654 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -84.73 161.28 20.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.976 . . . . 0.0 112.012 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.5 119.47 39.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 109.051 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 172' ' ' TYR . 23.1 m -67.94 136.01 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.671 174.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 p -134.42 142.39 47.12 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.985 0.914 . . . . 0.0 110.319 170.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -101.81 136.87 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.41 152.29 50.79 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 123.137 1.446 . . . . 0.0 112.946 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.32 132.78 28.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.777 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 t -104.93 129.27 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -144.13 133.75 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.4 156.26 23.05 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.707 -0.621 . . . . 0.0 112.048 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.0 p -89.76 -27.13 20.24 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.46 169.03 9.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.962 2.105 . . . . 0.0 111.267 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -52.65 150.74 8.94 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.98 9.24 15.48 Favored 'Cis proline' 0 CA--C 1.547 1.146 0 N-CA-C 115.818 1.43 . . . . 0.0 115.818 2.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.28 30.07 17.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.256 1.022 . . . . 0.0 112.482 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 148.69 31.84 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.502 -1.374 . . . . 0.0 112.161 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.94 106.66 2.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.52 1.128 . . . . 0.0 111.539 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.63 -59.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.656 1.582 . . . . 0.0 109.956 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 194' ' ' ASN . 41.9 t -125.53 143.07 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.103 -1.623 . . . . 0.0 108.957 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 101.21 3.64 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.085 1.354 . . . . 0.0 107.391 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.23 -164.81 15.93 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.461 1.029 . . . . 0.0 111.567 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.33 151.39 37.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.398 -1.06 . . . . 0.0 111.644 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.3 142.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.817 1.647 . . . . 0.0 109.285 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 151' ' ' VAL . 10.0 m-30 -107.51 105.36 15.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.607 -0.683 . . . . 0.0 109.162 -171.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 100' ' ' VAL . 64.9 m-85 -84.11 160.9 20.81 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.726 0.774 . . . . 0.0 110.012 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -158.95 161.34 36.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.832 2.053 . . . . 0.0 108.197 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.76 141.46 50.37 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.884 0.874 . . . . 0.0 109.256 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.0 m -96.42 110.24 51.73 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.104 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.11 53.29 3.34 Favored 'Trans proline' 0 CA--C 1.541 0.85 1 C-N-CA 125.492 4.128 . . . . 0.0 112.704 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -134.86 -43.33 0.74 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 111.187 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.7 p -146.7 19.33 1.31 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.455 1.502 . . . . 0.0 113.584 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.41 31.7 63.06 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 120.414 -1.428 . . . . 0.0 113.584 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -85.64 146.7 26.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.582 1.153 . . . . 0.0 111.097 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.1 t -127.03 85.78 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.469 1.508 . . . . 0.0 110.218 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -81.98 163.15 22.34 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.92 -1.112 . . . . 0.0 111.638 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.84 125.6 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.982 0.913 . . . . 0.0 109.327 -170.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.91 139.73 22.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.842 2.057 . . . . 0.0 109.111 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 119.86 12.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.174 1.79 . . . . 0.0 109.088 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -147.62 150.99 35.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.924 1.69 . . . . 0.0 110.097 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 -17.78 6.88 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.77 -23.49 63.31 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.001 1.32 . . . . 0.0 114.083 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.4 p -150.05 -45.06 0.13 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.509 1.524 . . . . 0.0 113.65 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.409 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 36.8 t80 -61.35 138.37 94.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 111.4 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 73.6 Cg_endo -69.15 178.36 4.26 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.223 2.615 . . . . 0.0 112.502 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -128.1 -35.63 2.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.65 1.18 . . . . 0.0 112.434 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . 0.497 HD21 HG22 ' A' ' 167' ' ' VAL . 15.9 p-10 -66.0 -17.7 64.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.534 1.934 . . . . 0.0 113.565 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -125.18 145.1 50.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.698 1.599 . . . . 0.0 109.055 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 p -128.42 167.63 16.75 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.879 1.672 . . . . 0.0 110.114 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 9.7 p -144.97 147.71 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.288 -0.882 . . . . 0.0 110.614 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 99.9 m -127.68 130.33 48.71 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.252 1.021 . . . . 0.0 109.386 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.03 103.4 7.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.517 0.727 . . . . 0.0 110.108 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.13 -45.3 34.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 122.001 -0.437 . . . . 0.0 111.235 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -145.51 -175.15 4.61 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.17 1.788 . . . . 0.0 111.766 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -56.4 -25.32 49.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.8 m -149.7 49.01 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.667 1.187 . . . . 0.0 108.14 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 58.8 m -151.76 110.45 3.82 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.31 2.244 . . . . 0.0 109.507 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 138.04 54.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.388 1.075 . . . . 0.0 110.382 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 tt -133.83 108.78 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.148 0.975 . . . . 0.0 110.005 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -90.54 133.98 34.69 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.707 1.603 . . . . 0.0 110.214 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -127.32 121.33 30.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.724 1.21 . . . . 0.0 109.381 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.55 101.15 13.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.337 0.655 . . . . 0.0 110.898 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.91 -18.28 29.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.624 1.97 . . . . 0.0 114.464 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.5 m -152.86 140.89 20.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.065 2.546 . . . . 0.0 109.02 170.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.9 -46.2 82.09 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 119.937 1.244 . . . . 0.0 112.413 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.649 1.979 . . . . 0.0 111.932 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.9 140.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.802 0.841 . . . . 0.0 110.535 168.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.57 142.44 56.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.329 0.652 . . . . 0.0 110.076 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.6 -17.35 54.82 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.673 -1.267 . . . . 0.0 113.042 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.51 3.75 11.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.919 1.688 . . . . 0.0 113.193 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -146.68 170.84 16.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.291 2.236 . . . . 0.0 109.061 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 23' ' ' TYR . 17.2 m -132.77 162.26 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.82 -0.55 . . . . 0.0 110.487 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.14 143.94 28.63 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.801 -0.562 . . . . 0.0 110.98 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.3 147.07 38.32 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.449 1.099 . . . . 0.0 108.465 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.65 118.94 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 123.181 1.467 . . . . 0.0 110.241 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.78 48.73 1.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.969 1.307 . . . . 0.0 110.516 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.4 144.71 5.95 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.856 1.694 . . . . 0.0 111.074 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -55.91 137.53 50.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.09 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 72.56 40.14 0.66 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.349 1.46 . . . . 0.0 113.964 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.342 27.5 p 47.41 56.82 6.49 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.436 1.894 . . . . 0.0 114.582 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.7 p -123.74 -174.78 3.06 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.45 1.5 . . . . 0.0 112.213 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.05 -109.74 2.91 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.931 1.253 . . . . 0.0 112.683 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -107.36 163.59 12.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.663 0.785 . . . . 0.0 110.876 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 p -130.31 144.4 51.36 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.971 0.909 . . . . 0.0 111.425 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -141.74 151.14 42.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.204 1.402 . . . . 0.0 110.069 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.97 147.84 49.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.929 0.892 . . . . 0.0 111.681 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB2' HG23 ' A' ' 8' ' ' VAL . 22.7 m-85 -140.96 137.57 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.077 0.951 . . . . 0.0 111.643 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.63 151.03 30.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.755 1.222 . . . . 0.0 109.584 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -63.73 150.45 44.47 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.529 -0.732 . . . . 0.0 111.157 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.23 50.34 57.07 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 122.115 -0.366 . . . . 0.0 113.862 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -137.16 141.25 42.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.202 1.401 . . . . 0.0 110.912 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.2 m -123.99 130.72 53.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.062 0.945 . . . . 0.0 109.577 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.84 117.21 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 100.61 7.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -80.1 162.5 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.734 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -106.54 152.25 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.318 0.647 . . . . 0.0 109.965 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -17.07 53.58 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.66 82.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.314 0.959 . . . . 0.0 114.312 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -84.73 108.34 17.38 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.196 0.998 . . . . 0.0 110.042 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.95 -23.06 52.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.031 -1.043 . . . . 0.0 112.757 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -60.09 -22.91 63.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.814 1.646 . . . . 0.0 112.226 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -65.76 -56.06 14.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.454 1.101 . . . . 0.0 112.422 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.32 -15.89 58.7 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.171 0.989 . . . . 0.0 113.65 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -61.25 -23.36 65.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.629 1.572 . . . . 0.0 113.695 173.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -46.38 129.3 10.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 111.57 166.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmt -149.65 -31.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.294 1.038 . . . . 0.0 113.58 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -144.68 165.77 27.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.61 1.964 . . . . 0.0 110.682 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.61 168.32 23.67 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.347 -0.846 . . . . 0.0 110.867 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.01 128.5 20.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.906 0.882 . . . . 0.0 109.621 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.02 129.17 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 109.005 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.79 -98.1 0.01 OUTLIER Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.022 1.772 . . . . 0.0 116.617 -170.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.9 p -168.17 -25.68 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.681 1.192 . . . . 0.0 112.817 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -115.8 29.6 7.88 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.12 1.368 . . . . 0.0 111.266 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.24 116.38 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.838 1.655 . . . . 0.0 110.135 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -79.43 152.93 30.04 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.306 -0.871 . . . . 0.0 109.456 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 138.19 45.46 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.599 1.159 . . . . 0.0 109.242 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.92 119.48 23.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 71' ' ' LEU . 11.7 pt -118.42 118.11 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.199 0.999 . . . . 0.0 111.298 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -124.15 142.63 51.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.771 1.628 . . . . 0.0 108.887 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.92 -44.22 3.05 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.965 0.906 . . . . 0.0 111.363 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -119.18 140.28 50.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.466 0.651 . . . . 0.0 111.025 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -140.97 120.29 13.04 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.826 1.25 . . . . 0.0 109.057 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -158.62 163.41 36.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.177 0.991 . . . . 0.0 111.046 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt -147.68 51.31 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.206 1.403 . . . . 0.0 111.065 -167.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -177.48 -31.64 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.961 2.105 . . . . 0.0 110.722 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -58.9 137.95 87.31 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.221 1.008 . . . . 0.0 112.994 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.01 -23.09 5.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.523 2.149 . . . . 0.0 113.578 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 t -76.0 120.26 80.86 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 119.015 0.825 . . . . 0.0 111.138 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.47 114.97 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.279 1.32 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.89 156.61 32.34 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.405 1.003 . . . . 0.0 113.592 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -65.4 123.9 20.83 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.305 1.052 . . . . 0.0 111.717 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -140.87 143.47 34.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.47 2.308 . . . . 0.0 108.822 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 125.97 6.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.345 1.069 . . . . 0.0 110.406 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.63 105.64 11.08 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.137 0.97 . . . . 0.0 109.904 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 54' ' ' ILE . 1.7 tp -63.18 121.24 13.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.613 0.765 . . . . 0.0 109.068 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.52 141.28 16.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.628 1.171 . . . . 0.0 112.398 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -59.78 -15.06 17.56 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.45 118.81 0.91 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.606 1.098 . . . . 0.0 111.444 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.37 169.33 1.05 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.264 1.826 . . . . 0.0 111.646 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.1 m -105.22 144.51 31.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.873 1.269 . . . . 0.0 110.455 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -124.33 98.31 5.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.373 1.069 . . . . 0.0 108.636 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.48 -35.94 7.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.324 1.049 . . . . 0.0 112.823 -164.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -143.96 112.09 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.405 1.482 . . . . 0.0 108.915 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 26.04 2.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.501 1.52 . . . . 0.0 111.006 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -51.39 -33.46 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.304 1.042 . . . . 0.0 112.574 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -58.18 -21.46 47.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.89 -9.27 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.326 1.45 . . . . 0.0 112.598 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 82.29 39.97 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.409 2.283 . . . . 0.0 112.266 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.16 -133.59 31.13 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.337 -1.477 . . . . 0.0 110.76 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.3 tp -146.81 160.89 41.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.938 1.369 . . . . 0.0 110.875 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 p -144.58 -35.96 0.33 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.86 0.864 . . . . 0.0 113.141 155.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -129.14 139.66 51.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.905 0.882 . . . . 0.0 110.635 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.66 135.64 48.75 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.121 0.969 . . . . 0.0 110.591 173.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -129.21 130.46 46.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.881 0.873 . . . . 0.0 109.401 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.82 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.378 1.471 . . . . 0.0 107.539 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.21 142.11 33.02 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.612 0.765 . . . . 0.0 110.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.95 32.0 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.862 3.041 . . . . 0.0 114.794 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.34 60.17 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.862 1.22 . . . . 0.0 113.763 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.73 -25.13 2.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.396 1.478 . . . . 0.0 112.768 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 139' ' ' PRO . 1.3 m-85 -118.13 141.71 48.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.684 1.594 . . . . 0.0 108.15 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -79.59 -33.68 41.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.383 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.461 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 18.8 p-90 -149.01 174.44 12.29 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.582 1.953 . . . . 0.0 109.053 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.89 23.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.993 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -137.94 130.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.097 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.36 131.25 34.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.858 0.863 . . . . 0.0 110.11 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 m -133.04 142.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.402 1.081 . . . . 0.0 110.289 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -144.95 144.16 30.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.97 0.908 . . . . 0.0 110.545 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 pt -87.65 153.71 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.8 120.48 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.18 1.392 . . . . 0.0 108.335 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -58.96 103.08 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.96 1.304 . . . . 0.0 112.196 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 16.94 22.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.507 1.123 . . . . 0.0 111.359 168.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.82 -35.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.618 1.567 . . . . 0.0 113.035 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -96.8 170.88 8.87 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.6 1.16 . . . . 0.0 111.649 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -109.71 -45.56 3.64 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.47 -0.769 . . . . 0.0 113.044 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.6 m -71.48 -31.22 66.88 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.505 1.122 . . . . 0.0 112.528 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.93 -44.38 0.56 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.114 2.166 . . . . 0.0 114.117 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.04 42.06 0.36 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.014 2.245 . . . . 0.0 115.017 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.7 p -129.74 -1.16 4.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.861 2.064 . . . . 0.0 112.005 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -118.63 150.37 39.81 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.185 1.394 . . . . 0.0 111.653 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.96 127.67 29.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.762 1.225 . . . . 0.0 109.971 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.7 ttm -102.89 122.55 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.761 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.4 m -116.0 117.69 30.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 26.5 pt -122.66 142.15 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.76 0.79 . . . . 0.0 112.277 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 78.7 m -135.23 85.84 32.22 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.283 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.47 167.66 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.43 2.087 . . . . 0.0 111.766 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -33.9 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.64 2.376 . . . . 0.0 114.538 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 39.68 51.12 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.538 1.935 . . . . 0.0 114.528 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.13 148.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.901 1.68 . . . . 0.0 110.436 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -51.35 111.89 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.665 1.186 . . . . 0.0 111.36 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.29 134.62 39.47 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.516 0.726 . . . . 0.0 110.735 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.84 127.53 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.39 114.58 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.226 1.011 . . . . 0.0 109.061 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.28 146.02 46.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.42 0.688 . . . . 0.0 110.956 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -117.76 170.59 8.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.831 0.852 . . . . 0.0 110.552 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.3 69.93 1.63 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.62 1.2 . . . . 0.0 112.135 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.03 0.08 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.001 1.762 . . . . 0.0 111.309 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.52 161.93 36.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.698 1.199 . . . . 0.0 111.585 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.56 55.16 1.65 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.999 1.32 . . . . 0.0 111.935 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 60.33 93.1 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.225 2.21 . . . . 0.0 112.722 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.99 139.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.344 0.658 . . . . 0.0 111.645 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -97.94 123.6 42.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.874 0.869 . . . . 0.0 110.336 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 127.51 37.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.454 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 86.1 Cg_endo -77.53 128.31 9.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.487 2.125 . . . . 0.0 110.999 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.461 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 6.5 mm -128.15 125.56 23.44 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.518 0.727 . . . . 0.0 109.619 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.44 178.02 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.419 2.079 . . . . 0.0 111.534 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -14.28 43.75 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.867 -1.145 . . . . 0.0 113.577 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp 55.21 -175.42 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.428 1.891 . . . . 0.0 112.319 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.7 t -153.63 106.3 2.54 Favored Pre-proline 0 C--O 1.241 0.606 0 O-C-N 121.265 -0.897 . . . . 0.0 111.282 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.26 165.14 69.22 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 119.386 0.816 . . . . 0.0 113.142 -9.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.64 -30.98 41.6 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.211 1.941 . . . . 0.0 114.082 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.98 2.09 13.59 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -73.69 144.51 45.76 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.992 -1.068 . . . . 0.0 112.004 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -70.28 157.97 36.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 113.117 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tt -125.94 122.48 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.649 1.18 . . . . 0.0 109.445 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.28 132.71 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 110.414 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -138.7 122.2 17.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.651 0.781 . . . . 0.0 110.758 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -82.29 134.38 35.27 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 171.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.04 119.59 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 109.557 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.1 p -124.16 113.38 18.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.338 1.055 . . . . 0.0 109.033 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 t -104.39 125.02 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -140.44 151.44 44.89 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.629 1.572 . . . . 0.0 109.115 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -67.26 141.55 57.2 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.81 -0.556 . . . . 0.0 111.979 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.9 p -67.9 -24.71 65.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.02 0.928 . . . . 0.0 113.16 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -144.34 179.67 7.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.716 2.006 . . . . 0.0 110.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.6 t -41.55 136.55 1.89 Allowed Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.216 1.806 . . . . 0.0 113.863 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.22 8.68 31.0 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 N-CA-C 114.683 0.994 . . . . 0.0 114.683 5.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.63 27.56 16.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.166 1.387 . . . . 0.0 112.719 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.77 151.11 36.11 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.25 -1.531 . . . . 0.0 113.157 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -78.57 128.43 33.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.999 1.32 . . . . 0.0 111.401 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.7 -38.41 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.431 1.493 . . . . 0.0 111.602 -175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.58 138.5 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.76 1.224 . . . . 0.0 108.557 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -150.12 76.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.23 1.012 . . . . 0.0 108.905 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.09 -168.56 14.85 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.715 1.626 . . . . 0.0 111.938 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -133.32 160.48 37.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.291 -1.123 . . . . 0.0 112.593 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.41 147.35 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.272 1.429 . . . . 0.0 108.124 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.2 131.38 52.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.377 0.608 . . . . 0.0 109.592 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -110.06 153.29 24.85 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -163.04 148.35 11.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -120.44 151.51 39.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.378 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 73.7 m -90.39 110.78 43.31 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.039 0.936 . . . . 0.0 108.66 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.45 52.3 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 124.993 3.796 . . . . 0.0 112.298 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.2 m -130.08 -40.22 1.33 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.792 2.037 . . . . 0.0 111.687 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 t -149.22 30.03 0.78 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.93 1.292 . . . . 0.0 111.408 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.19 35.87 43.25 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.86 -1.15 . . . . 0.0 113.151 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.59 118.2 18.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.905 0.882 . . . . 0.0 109.169 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.4 139.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.572 0.749 . . . . 0.0 109.917 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 49.5 m -143.36 158.36 43.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.599 1.56 . . . . 0.0 110.571 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -128.49 129.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.711 0.804 . . . . 0.0 110.904 174.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.04 129.89 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 107.979 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.409 ' HE2' HG23 ' A' ' 184' ' ' VAL . 8.1 mtmt -140.45 122.85 16.01 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.835 1.254 . . . . 0.0 108.605 -171.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -150.22 146.49 26.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -55.83 -18.02 7.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 113.811 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -59.2 -25.62 64.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.64 1.976 . . . . 0.0 114.207 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.1 p -145.12 -43.14 0.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.528 1.531 . . . . 0.0 113.096 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.413 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 66.1 t80 -60.58 135.58 92.1 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.065 1.746 . . . . 0.0 111.889 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 38.0 Cg_endo -79.09 -172.44 1.54 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.022 2.482 . . . . 0.0 111.341 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.82 31.85 3.3 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.964 1.306 . . . . 0.0 113.593 -166.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -148.31 -32.41 0.25 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.228 1.811 . . . . 0.0 113.737 -164.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.3 ttt -125.1 140.04 53.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.272 2.229 . . . . 0.0 107.928 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.9 p -127.49 159.38 34.73 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.388 0.675 . . . . 0.0 109.864 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.03 131.28 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 t -116.58 147.77 41.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.134 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -85.45 83.68 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.669 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.42 -29.74 69.18 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.718 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.07 174.05 15.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.905 1.682 . . . . 0.0 111.171 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.77 140.58 57.54 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.989 -1.694 . . . . 0.0 110.333 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p 53.66 12.68 0.42 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.224 2.209 . . . . 0.0 114.836 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.3 t -133.91 105.25 6.66 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.595 1.158 . . . . 0.0 111.664 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 184' ' ' VAL . 20.7 m-85 -108.03 148.37 29.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.276 1.03 . . . . 0.0 111.833 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.8 tt -134.11 116.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.734 0.778 . . . . 0.0 109.252 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.3 125.11 37.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.998 1.319 . . . . 0.0 109.727 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -109.48 123.71 49.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.106 0.962 . . . . 0.0 109.187 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.49 96.57 6.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 111.077 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -87.57 -25.99 23.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.282 1.033 . . . . 0.0 112.329 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.2 t -90.56 176.34 6.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.733 1.213 . . . . 0.0 113.002 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.48 57.44 0.94 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.722 1.209 . . . . 0.0 110.06 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 116.99 -1.481 . . . . 0.0 113.371 173.091 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.545 0.212 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.42 154.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.892 1.277 . . . . 0.0 109.302 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.98 143.88 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.475 0.71 . . . . 0.0 110.983 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.0 -20.38 23.67 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.54 15.41 22.95 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.389 2.276 . . . . 0.0 113.348 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -140.26 169.33 17.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.462 -1.399 . . . . 0.0 110.033 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 23' ' ' TYR . 25.4 m -136.49 145.66 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.837 0.855 . . . . 0.0 109.968 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.0 144.79 49.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.056 1.342 . . . . 0.0 109.201 -174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 44' ' ' CYS . 1.2 m-85 -132.85 120.27 21.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.1 1.36 . . . . 0.0 109.601 -171.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.17 125.93 42.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.261 1.424 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.17 43.12 0.43 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.511 1.924 . . . . 0.0 112.602 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.1 137.91 2.49 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.758 2.123 . . . . 0.0 110.601 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -51.84 159.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.831 0.852 . . . . 0.0 111.289 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 t30 64.83 22.78 12.58 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m 54.84 57.16 5.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.34 1.456 . . . . 0.0 113.126 -173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.6 p -131.82 -177.92 4.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.737 1.215 . . . . 0.0 112.393 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.54 -119.08 4.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.283 0.944 . . . . 0.0 111.772 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.72 -178.22 3.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.241 1.416 . . . . 0.0 110.834 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p -136.6 153.81 50.85 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.794 -1.191 . . . . 0.0 111.387 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.27 155.19 41.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.105 1.362 . . . . 0.0 110.451 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.64 138.31 51.14 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 109.945 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 8' ' ' VAL . 33.2 m-85 -134.21 144.52 48.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.195 1.398 . . . . 0.0 110.705 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -79.99 149.17 30.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.535 1.134 . . . . 0.0 111.128 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -63.24 157.48 22.55 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.323 1.049 . . . . 0.0 111.688 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.3 39.54 97.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.387 0.518 . . . . 0.0 113.019 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.51 160.81 32.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.578 1.551 . . . . 0.0 109.758 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.4 p -138.96 151.15 46.64 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.276 -1.515 . . . . 0.0 109.099 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.84 116.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.306 1.051 . . . . 0.0 108.628 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 mtm105 -125.91 92.52 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 108.684 -164.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.34 153.0 21.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.418 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -95.83 147.05 24.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.419 0.687 . . . . 0.0 110.763 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -67.61 2.23 1.96 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.69 80.99 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.265 1.412 . . . . 0.0 114.736 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -133.9 120.56 20.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.934 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -13.18 2.15 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -57.16 -20.6 27.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.562 1.545 . . . . 0.0 112.49 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -65.16 -54.79 24.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.043 0.838 . . . . 0.0 111.749 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.65 -22.8 57.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.122 1.369 . . . . 0.0 113.251 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -51.36 -42.07 61.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.964 1.306 . . . . 0.0 113.541 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -67.0 31.19 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 126.575 1.95 . . . . 0.0 114.042 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.01 -38.11 89.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.561 2.345 . . . . 0.0 113.917 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -112.22 151.9 29.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.749 1.159 . . . . 0.0 110.754 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 10' ' ' PHE . 6.1 p -169.03 167.38 10.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 123.046 1.403 . . . . 0.0 113.154 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.84 125.56 14.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.126 1.37 . . . . 0.0 108.405 -172.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.8 133.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.225 1.81 . . . . 0.0 108.306 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.85 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.634 1.588 . . . . 0.0 115.886 -168.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -156.47 -22.63 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.239 1.416 . . . . 0.0 113.77 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.94 16.26 12.55 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.732 1.613 . . . . 0.0 111.801 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -145.36 152.36 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.412 1.885 . . . . 0.0 110.216 -173.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -116.99 156.78 26.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.687 1.195 . . . . 0.0 110.041 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.2 t -127.05 131.03 51.03 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.005 0.922 . . . . 0.0 108.725 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -112.87 140.14 47.91 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.143 1.377 . . . . 0.0 107.584 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' CG1' HD23 ' A' ' 86' ' ' LEU . 5.3 tt -129.39 137.96 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.194 0.998 . . . . 0.0 109.363 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.1 120.24 8.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.269 1.428 . . . . 0.0 111.263 -161.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -95.27 -63.02 1.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.107 -0.995 . . . . 0.0 112.7 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.21 142.46 37.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.581 1.153 . . . . 0.0 109.54 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.42 105.7 6.7 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.921 -1.112 . . . . 0.0 109.431 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -142.0 152.44 43.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.209 1.404 . . . . 0.0 110.38 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.4 45.72 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.19 1.796 . . . . 0.0 111.012 -166.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -169.82 -26.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.476 2.31 . . . . 0.0 111.945 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -60.52 137.27 92.48 Favored Pre-proline 0 CA--C 1.543 0.712 0 C-N-CA 125.39 1.476 . . . . 0.0 112.673 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.61 -23.89 9.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.28 2.653 . . . . 0.0 112.937 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -99.61 117.29 63.95 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 124.744 1.217 . . . . 0.0 109.127 171.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.46 155.14 64.25 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.257 1.305 . . . . 0.0 110.033 168.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.6 -136.55 0.71 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.032 0.825 . . . . 0.0 112.947 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -122.76 137.93 54.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.234 1.016 . . . . 0.0 112.921 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.72 167.78 23.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.13 2.172 . . . . 0.0 109.797 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -157.19 142.28 17.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 111.339 170.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -94.85 98.59 10.84 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.733 1.213 . . . . 0.0 110.734 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.89 124.15 18.23 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.998 -1.063 . . . . 0.0 108.668 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.81 153.35 3.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.034 0.934 . . . . 0.0 112.849 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.24 -10.16 2.71 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.93 112.26 0.52 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.424 1.012 . . . . 0.0 111.859 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.05 159.67 2.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.343 1.857 . . . . 0.0 111.983 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 m -104.31 140.12 38.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.538 1.135 . . . . 0.0 110.066 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.504 ' HB3' HD11 ' A' ' 80' ' ' LEU . 12.7 m-80 -130.95 121.06 24.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.658 1.583 . . . . 0.0 108.556 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.98 -22.9 2.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -66.12 0.8 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.733 1.213 . . . . 0.0 110.771 171.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 42' ' ' MET . 4.0 mp 41.01 34.87 0.31 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.043 2.137 . . . . 0.0 113.381 -170.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -62.85 -31.19 72.16 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.765 -1.209 . . . . 0.0 112.406 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -63.19 -28.39 70.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.831 0.852 . . . . 0.0 113.284 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.71 -35.22 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.409 1.484 . . . . 0.0 110.978 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 54.38 55.07 8.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.148 1.379 . . . . 0.0 113.475 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.14 -152.99 16.86 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.448 1.499 . . . . 0.0 111.862 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 87' ' ' SER . 2.1 tm? -153.91 146.05 23.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.684 1.193 . . . . 0.0 111.525 166.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.494 ' H ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -125.25 -63.77 1.13 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 153.09 50.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.386 1.475 . . . . 0.0 110.809 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.38 147.68 22.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.908 0.861 . . . . 0.0 111.883 -170.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -139.02 120.97 15.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.48 1.512 . . . . 0.0 109.58 -168.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.11 118.51 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.253 0.621 . . . . 0.0 109.465 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.3 mt -125.64 126.81 24.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.554 1.142 . . . . 0.0 109.898 -164.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.9 162.63 23.67 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.611 2.207 . . . . 0.0 112.185 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.29 -5.23 15.07 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.765 1.174 . . . . 0.0 115.644 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.7 -19.76 32.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.276 1.43 . . . . 0.0 113.606 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.53 165.63 24.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.746 1.618 . . . . 0.0 110.03 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.95 -46.81 3.69 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.955 -1.091 . . . . 0.0 111.634 -173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.27 148.05 47.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.68 1.592 . . . . 0.0 107.903 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.84 157.57 42.53 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.45 149.42 24.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.014 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 144.43 26.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.99 139.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.429 1.091 . . . . 0.0 109.596 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -143.15 157.97 44.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.562 1.145 . . . . 0.0 110.681 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.45 145.91 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.072 0.949 . . . . 0.0 112.181 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.44 105.02 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.519 1.928 . . . . 0.0 109.534 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.86 89.49 4.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 112.532 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.54 -32.0 36.86 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.182 -0.949 . . . . 0.0 112.477 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.44 -46.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.9 -24.6 35.58 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.469 0.577 . . . . 0.0 111.485 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t 65.72 -42.82 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.379 3.071 . . . . 0.0 115.437 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -57.42 -37.69 73.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.775 1.63 . . . . 0.0 112.833 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.69 176.11 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.928 1.691 . . . . 0.0 113.993 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.72 28.17 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.921 1.248 . . . . 0.0 114.639 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -140.78 30.58 1.86 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -162.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -120.16 147.52 44.79 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.79 1.636 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.95 126.21 33.5 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.966 1.306 . . . . 0.0 109.409 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 63.1 ttp -126.09 132.43 51.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.884 1.274 . . . . 0.0 110.148 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.9 m -123.09 106.76 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.337 1.455 . . . . 0.0 108.615 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.85 125.37 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.2 t -144.93 123.47 6.69 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.87 170.15 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.962 3.108 . . . . 0.0 113.004 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -42.46 106.43 0.06 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.391 1.876 . . . . 0.0 113.371 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? 47.07 57.03 6.08 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.801 1.64 . . . . 0.0 113.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -126.18 159.32 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.588 1.955 . . . . 0.0 109.919 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -55.23 109.67 0.57 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.152 0.981 . . . . 0.0 111.455 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.81 152.03 20.05 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.442 0.697 . . . . 0.0 111.518 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.61 150.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.262 1.025 . . . . 0.0 110.141 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.69 103.63 10.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 109.42 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.97 146.22 30.83 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.422 0.689 . . . . 0.0 109.61 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -133.82 144.02 48.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.204 1.002 . . . . 0.0 110.546 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.94 108.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.022 2.129 . . . . 0.0 111.025 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.54 -17.03 14.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.445 1.021 . . . . 0.0 114.49 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.0 136.48 57.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.823 1.311 . . . . 0.0 109.927 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -74.59 57.9 0.76 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.076 1.751 . . . . 0.0 112.51 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 63.37 90.49 0.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.858 2.463 . . . . 0.0 111.152 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.97 149.96 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 120.918 -1.114 . . . . 0.0 111.478 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 137.7 32.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.93 96.16 40.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.491 1.916 . . . . 0.0 108.143 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.1 138.5 30.93 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.546 2.164 . . . . 0.0 111.099 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.7 mt -128.36 129.9 23.57 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 108.812 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.47 169.96 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.53 2.82 . . . . 0.0 112.109 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -57.13 134.85 56.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.838 -0.539 . . . . 0.0 111.574 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 pp -144.41 150.3 37.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 110.184 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -142.61 136.63 14.64 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.168 0.987 . . . . 0.0 112.102 -171.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.96 154.0 73.1 Favored 'Cis proline' 0 CA--C 1.544 0.991 0 CA-C-N 119.381 0.815 . . . . 0.0 111.706 -6.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.45 -35.89 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.281 1.988 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.6 0.09 5.95 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.622 1.569 . . . . 0.0 114.225 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 p -68.37 133.58 48.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.162 1.346 . . . . 0.0 110.869 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.53 120.84 15.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.075 167.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.3 tt -104.48 116.8 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.053 1.741 . . . . 0.0 109.086 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.49 139.64 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.057 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.8 m -133.52 134.09 42.98 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.518 1.127 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.43 146.74 36.36 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.693 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.2 111.11 8.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 109.465 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 132.68 49.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.091 0.956 . . . . 0.0 109.382 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.54 136.18 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.153 0.981 . . . . 0.0 109.681 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.72 150.84 37.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.548 1.139 . . . . 0.0 111.668 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.98 140.38 57.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.198 0.599 . . . . 0.0 111.507 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.3 p -80.24 -7.31 58.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.64 177.46 9.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.71 2.004 . . . . 0.0 111.241 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -39.79 133.77 1.37 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.887 1.675 . . . . 0.0 114.205 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.29 8.49 17.56 Favored 'Cis proline' 0 CA--C 1.547 1.135 0 N-CA-C 115.044 1.132 . . . . 0.0 115.044 3.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.06 10.34 2.82 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.321 1.848 . . . . 0.0 114.454 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.22 162.07 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.408 1.483 . . . . 0.0 112.653 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -58.23 151.82 18.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.85 1.26 . . . . 0.0 111.755 170.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.37 -22.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.744 1.218 . . . . 0.0 113.193 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -151.94 142.89 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.608 1.963 . . . . 0.0 109.036 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -142.27 117.39 10.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.587 1.155 . . . . 0.0 108.923 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.68 -147.87 6.18 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.637 1.113 . . . . 0.0 112.097 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.51 172.42 15.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.048 1.339 . . . . 0.0 110.141 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.35 149.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.751 1.62 . . . . 0.0 107.854 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.5 130.8 54.81 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.938 -1.101 . . . . 0.0 109.113 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -111.91 158.27 19.66 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.113 -0.992 . . . . 0.0 110.849 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -163.18 146.16 10.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.908 1.683 . . . . 0.0 108.968 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -111.79 156.58 21.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.257 1.023 . . . . 0.0 110.811 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.6 m -126.81 101.37 26.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.76 1.624 . . . . 0.0 110.329 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -68.32 -10.11 27.96 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.911 3.074 . . . . 0.0 113.785 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.0 m -40.09 -43.5 1.61 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.835 2.054 . . . . 0.0 112.748 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -156.28 28.52 0.35 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.904 0.859 . . . . 0.0 112.941 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 55.98 55.25 30.1 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.115 -1.616 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -129.73 130.75 45.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.299 1.44 . . . . 0.0 109.222 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.7 159.39 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 121.565 -0.709 . . . . 0.0 110.407 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 87.1 m -148.29 111.51 4.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.085 0.954 . . . . 0.0 110.067 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 205' ' ' PHE . 3.1 p -80.83 138.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.482 0.658 . . . . 0.0 109.966 172.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.33 129.03 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.524 1.93 . . . . 0.0 107.195 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 139.62 37.5 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.217 1.007 . . . . 0.0 109.695 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -160.02 164.43 33.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.156 1.382 . . . . 0.0 109.779 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -16.06 5.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.301 1.44 . . . . 0.0 114.001 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.158 1.783 . . . . 0.0 114.058 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 42.1 p -142.91 -47.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.344 1.458 . . . . 0.0 112.432 -170.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 196' ' ' THR . 0.0 OUTLIER -76.58 143.12 71.49 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.985 1.714 . . . . 0.0 111.533 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.36 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.855 2.37 . . . . 0.0 110.736 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -179.68 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 128.266 2.626 . . . . 0.0 111.708 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -58.08 -40.76 81.91 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.92 1.688 . . . . 0.0 112.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.5 ttt -104.67 140.13 38.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.767 1.627 . . . . 0.0 108.627 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 65.9 p -136.82 158.93 43.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.924 0.49 . . . . 0.0 110.961 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.0 p -124.62 139.02 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.968 0.907 . . . . 0.0 110.741 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 97.9 m -126.33 143.04 51.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.426 1.09 . . . . 0.0 109.404 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -73.05 79.1 1.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.338 1.455 . . . . 0.0 111.482 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -54.51 -33.62 60.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.034 1.734 . . . . 0.0 112.699 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.12 -179.67 8.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.854 1.662 . . . . 0.0 111.367 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -44.14 -42.46 6.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.916 2.087 . . . . 0.0 114.295 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.1 p -130.61 12.92 5.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.086 1.755 . . . . 0.0 112.907 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -103.88 126.02 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.387 -0.82 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 184' ' ' VAL . 43.5 m-85 -123.23 138.5 54.62 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.852 1.261 . . . . 0.0 110.977 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.28 116.99 44.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.747 0.819 . . . . 0.0 110.007 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.56 112.2 24.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.767 1.627 . . . . 0.0 108.612 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -94.06 142.73 27.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.439 -0.788 . . . . 0.0 109.684 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.49 122.26 30.78 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.115 0.966 . . . . 0.0 111.948 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -115.27 13.83 16.75 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.704 1.602 . . . . 0.0 112.312 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.7 t -154.17 165.11 37.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.515 1.526 . . . . 0.0 111.522 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.05 2.03 9.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.797 1.239 . . . . 0.0 113.418 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.539 1.936 . . . . 0.0 115.226 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 45' ' ' LEU . 2.5 p -73.07 150.6 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.56 0.744 . . . . 0.0 111.581 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -95.25 150.6 20.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.505 0.722 . . . . 0.0 109.624 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.2 34.84 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.847 -1.158 . . . . 0.0 113.201 170.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -106.19 7.55 31.61 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.189 1.796 . . . . 0.0 113.426 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -142.76 -179.36 6.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.074 1.35 . . . . 0.0 111.379 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 152.25 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.407 1.483 . . . . 0.0 111.253 -175.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.86 153.26 46.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.862 1.265 . . . . 0.0 110.701 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 44' ' ' CYS . 21.3 m-85 -136.88 117.12 13.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.382 1.073 . . . . 0.0 109.835 -169.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -95.24 122.45 37.94 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.163 1.385 . . . . 0.0 111.229 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.88 59.04 1.55 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.781 1.232 . . . . 0.0 111.993 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.55 130.94 1.3 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.171 0.891 . . . . 0.0 111.11 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.13 146.12 9.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.876 0.87 . . . . 0.0 110.656 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 70.44 20.94 5.81 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.288 1.435 . . . . 0.0 114.705 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.84 58.41 2.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.681 1.192 . . . . 0.0 112.718 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 p -133.22 -174.54 3.52 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.301 1.44 . . . . 0.0 112.009 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.02 -142.98 40.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.905 0.764 . . . . 0.0 112.81 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -74.76 176.02 7.42 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.694 0.798 . . . . 0.0 112.451 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -136.21 157.24 47.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.562 1.145 . . . . 0.0 111.833 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.47 155.45 43.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.274 1.83 . . . . 0.0 110.118 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.45 143.93 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.544 1.138 . . . . 0.0 110.403 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -132.11 128.44 38.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.958 1.303 . . . . 0.0 109.012 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.36 148.81 30.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.814 0.845 . . . . 0.0 110.363 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -62.86 142.28 58.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.065 0.546 . . . . 0.0 111.449 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.61 66.63 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 122.211 -0.305 . . . . 0.0 112.486 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 152.67 39.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.49 1.116 . . . . 0.0 110.538 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -135.53 120.32 18.45 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 108.096 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.12 141.17 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.016 0.926 . . . . 0.0 109.413 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -135.35 133.45 38.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.244 1.018 . . . . 0.0 109.189 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.39 175.16 5.54 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.028 1.731 . . . . 0.0 109.595 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -123.41 133.99 54.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.682 0.793 . . . . 0.0 108.958 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.62 -14.28 12.96 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.279 1.032 . . . . 0.0 113.627 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.76 -25.54 52.02 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.961 1.267 . . . . 0.0 114.682 166.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -119.2 121.29 39.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.058 1.343 . . . . 0.0 109.852 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -12.48 6.22 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -63.68 -9.83 16.06 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.276 1.43 . . . . 0.0 112.959 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -70.39 -52.22 23.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.673 1.189 . . . . 0.0 112.037 164.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.61 -15.05 16.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.93 1.692 . . . . 0.0 113.513 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -40.79 -45.1 2.38 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.627 2.371 . . . . 0.0 113.069 169.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.98 50.32 0.59 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.429 1.492 . . . . 0.0 113.033 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -73.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.662 0.785 . . . . 0.0 111.219 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -93.36 160.11 14.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.192 0.997 . . . . 0.0 110.655 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HB3' ' CD2' ' A' ' 10' ' ' PHE . 5.8 p -168.75 169.63 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.293 1.037 . . . . 0.0 112.374 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.454 HD23 ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -148.42 156.01 41.94 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.334 1.064 . . . . 0.0 112.303 177.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 8' ' ' VAL . 38.5 t -127.65 139.04 53.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 124.872 1.269 . . . . 0.0 109.282 -171.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.16 -96.71 0.01 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.958 1.742 . . . . 0.0 116.073 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -166.95 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 113.243 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -123.99 26.36 7.59 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.644 1.977 . . . . 0.0 111.899 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.42 153.69 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.456 1.902 . . . . 0.0 109.023 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -125.41 149.48 48.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.614 1.566 . . . . 0.0 108.857 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.454 ' SG ' HG11 ' A' ' 8' ' ' VAL . 2.8 m -123.26 151.22 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 110.508 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.31 130.23 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.52 142.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.027 0.931 . . . . 0.0 109.637 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -137.25 127.41 26.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.159 1.384 . . . . 0.0 109.089 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -100.66 -53.32 3.11 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 111.379 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -101.6 98.51 8.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.858 0.863 . . . . 0.0 111.418 -172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.08 96.75 5.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.421 1.089 . . . . 0.0 112.828 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -156.14 164.53 38.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 112.27 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 6.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.26 2.224 . . . . 0.0 113.068 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.38 49.11 2.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.388 1.875 . . . . 0.0 112.122 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -148.59 145.44 20.11 Favored Pre-proline 0 N--CA 1.478 0.956 0 O-C-N 120.77 -1.206 . . . . 0.0 112.365 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.42 -14.15 20.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.922 2.415 . . . . 0.0 113.16 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -67.75 121.24 78.63 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 119.239 0.927 . . . . 0.0 109.956 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.56 95.66 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.199 1.933 . . . . 0.0 108.687 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.57 138.8 28.22 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.457 1.027 . . . . 0.0 112.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 115.42 2.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.714 0.757 . . . . 0.0 111.212 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 179' ' ' THR . 2.3 t80 -138.48 143.15 39.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.218 2.207 . . . . 0.0 109.48 -174.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.98 139.94 24.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.307 1.051 . . . . 0.0 109.614 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -100.11 103.61 15.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.08 1.352 . . . . 0.0 107.643 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp -60.98 121.53 12.64 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.48 150.84 6.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.322 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -58.55 -15.5 11.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.16 124.73 1.6 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.644 152.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.05 158.36 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.657 2.383 . . . . 0.0 111.546 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -94.23 143.57 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.436 1.094 . . . . 0.0 110.829 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -128.1 102.04 6.55 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.507 1.923 . . . . 0.0 108.553 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -123.65 6.65 8.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.633 1.573 . . . . 0.0 112.772 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -140.35 45.03 1.86 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.896 1.679 . . . . 0.0 111.461 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 80' ' ' LEU . 3.2 mp -75.26 30.67 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.079 1.351 . . . . 0.0 112.588 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.1 m -61.43 -35.65 78.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.753 1.621 . . . . 0.0 112.485 174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -61.11 -24.06 65.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.719 0.808 . . . . 0.0 112.715 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.4 mm -88.06 -25.58 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.655 1.982 . . . . 0.0 113.198 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 54.75 52.68 11.69 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.52 1.528 . . . . 0.0 113.372 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.32 -179.62 19.93 Favored Glycine 0 CA--C 1.538 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 112.567 -170.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -150.38 -178.88 6.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.574 -1.545 . . . . 0.0 112.054 -169.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -148.13 -36.94 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.14 1.776 . . . . 0.0 113.164 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.91 147.03 47.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.762 1.225 . . . . 0.0 111.445 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -135.96 119.69 17.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.326 1.85 . . . . 0.0 108.416 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -115.05 138.93 50.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.37 0.668 . . . . 0.0 109.404 170.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.83 119.27 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.757 1.623 . . . . 0.0 107.411 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.557 HD13 ' HA ' ' A' ' 98' ' ' TRP . 99.2 mt -127.55 126.79 24.1 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 124.672 1.189 . . . . 0.0 109.467 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.88 161.41 33.23 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 121.74 1.627 . . . . 0.0 111.752 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.34 -3.15 17.56 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.09 45.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.004 1.322 . . . . 0.0 113.86 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -130.78 151.1 51.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.045 1.338 . . . . 0.0 110.507 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -82.09 -49.3 10.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.518 -0.739 . . . . 0.0 111.378 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.557 ' HA ' HD13 ' A' ' 92' ' ' LEU . 58.3 p-90 -154.52 161.23 41.76 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.773 1.629 . . . . 0.0 110.589 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -131.21 154.41 48.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.108 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.44 137.16 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.945 1.298 . . . . 0.0 109.733 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.07 123.83 36.6 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.192 0.997 . . . . 0.0 108.986 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.88 132.26 71.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.651 1.58 . . . . 0.0 108.692 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -125.15 145.25 50.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.916 0.887 . . . . 0.0 110.185 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.71 128.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.05 143.17 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 122.069 0.938 . . . . 0.0 109.814 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.62 140.34 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.536 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 7.24 2.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.832 1.253 . . . . 0.0 112.168 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.52 -33.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.069 1.748 . . . . 0.0 112.907 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.44 172.61 12.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.789 1.236 . . . . 0.0 111.835 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.3 p -105.71 14.24 28.59 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.28 1.432 . . . . 0.0 112.944 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.4 m -107.0 31.03 5.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.787 2.435 . . . . 0.0 110.169 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.38 145.76 17.35 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.839 -1.163 . . . . 0.0 112.252 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.46 25.1 6.78 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.696 1.141 . . . . 0.0 112.956 -171.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.8 p -147.57 9.51 0.92 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.075 1.75 . . . . 0.0 114.033 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -127.28 143.74 51.18 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 110.784 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -131.03 130.87 43.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.074 1.349 . . . . 0.0 108.717 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -122.02 131.58 54.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.618 1.567 . . . . 0.0 110.365 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 m -95.52 133.86 39.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.856 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.57 110.78 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.801 1.64 . . . . 0.0 109.135 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -129.99 128.31 22.84 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.385 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.19 -91.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.142 2.561 . . . . 0.0 111.35 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -171.76 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.032 0.92 . . . . 0.0 112.685 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -65.09 26.8 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 126.682 1.993 . . . . 0.0 113.786 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.2 165.63 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.549 1.94 . . . . 0.0 110.831 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -56.05 114.77 2.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.331 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -58.61 147.98 30.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.741 0.816 . . . . 0.0 111.909 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -110.14 145.07 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.862 1.265 . . . . 0.0 110.274 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.81 117.21 32.81 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.858 1.263 . . . . 0.0 109.594 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.8 m -125.47 118.53 26.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.523 1.129 . . . . 0.0 108.646 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.36 138.59 49.23 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.09 1.356 . . . . 0.0 112.008 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.51 127.4 17.63 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.308 0.575 . . . . 0.0 111.978 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.57 -18.6 22.5 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.576 1.084 . . . . 0.0 113.67 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -57.75 137.14 56.83 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.865 1.333 . . . . 0.0 112.945 169.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.53 72.15 5.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.018 0.927 . . . . 0.0 110.526 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 61.83 85.73 0.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.516 1.926 . . . . 0.0 112.449 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.18 134.81 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.775 -1.203 . . . . 0.0 110.883 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -93.43 127.29 38.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.278 0.561 . . . . 0.0 110.944 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.4 tp -107.67 95.48 14.37 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.412 1.885 . . . . 0.0 107.995 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.37 146.47 40.0 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.958 1.772 . . . . 0.0 111.484 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.46 125.1 27.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.997 1.719 . . . . 0.0 108.496 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.67 -37.96 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.04 2.493 . . . . 0.0 113.125 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 168.4 7.76 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.298 2.639 . . . . 0.0 109.995 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 pp -163.44 37.8 0.09 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.163 1.385 . . . . 0.0 113.868 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.0 t -50.63 139.77 20.37 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.704 1.201 . . . . 0.0 114.211 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.35 142.08 67.63 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.979 1.028 . . . . 0.0 111.867 -6.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.24 -23.31 45.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.309 2.006 . . . . 0.0 113.051 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -75.86 -5.93 48.36 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.041 1.336 . . . . 0.0 114.548 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 161.73 16.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.584 1.084 . . . . 0.0 112.862 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -70.67 168.95 15.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.81 0.814 . . . . 0.0 113.097 167.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.38 135.72 53.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.536 1.535 . . . . 0.0 110.441 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.21 149.03 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.716 0.806 . . . . 0.0 109.231 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.3 t -150.43 155.16 39.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.079 . . . . 0.0 110.414 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -123.99 129.69 51.34 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.514 1.126 . . . . 0.0 109.798 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 tt -113.83 121.44 44.01 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.943 1.697 . . . . 0.0 109.463 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -139.61 114.75 9.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.622 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 167' ' ' VAL . 1.7 p -108.63 141.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.631 1.173 . . . . 0.0 109.517 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -144.7 148.19 33.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.321 1.448 . . . . 0.0 110.009 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.29 128.9 37.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.196 0.598 . . . . 0.0 110.174 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.7 p -79.44 -2.32 41.39 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -132.97 151.14 52.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.772 2.029 . . . . 0.0 110.08 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.2 t -66.85 141.38 96.75 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.499 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.27 128.95 13.98 Favored 'Cis proline' 0 C--N 1.352 0.761 0 CA-C-N 120.565 1.238 . . . . 0.0 111.616 -7.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.43 41.22 0.14 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.95 1.7 . . . . 0.0 112.236 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -62.5 143.59 56.99 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 111.491 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -59.55 122.45 14.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.782 -0.574 . . . . 0.0 110.366 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 65.9 t -80.68 -56.91 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 156' ' ' VAL . 0.4 OUTLIER -149.6 155.22 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 170.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -142.11 76.8 1.55 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.792 1.237 . . . . 0.0 108.695 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.19 -165.72 12.74 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.614 2.054 . . . . 0.0 111.608 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.98 170.72 16.06 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.831 -1.393 . . . . 0.0 111.12 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -153.46 157.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.715 -1.241 . . . . 0.0 108.033 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -112.83 128.84 56.55 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.925 -1.109 . . . . 0.0 108.445 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.61 155.48 17.57 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.89 0.876 . . . . 0.0 109.88 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -157.96 158.02 34.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.207 1.403 . . . . 0.0 109.579 174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.38 150.35 49.89 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.713 1.605 . . . . 0.0 108.708 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 75.6 m -105.75 110.37 64.11 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.47 50.74 2.04 Favored 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 125.221 3.948 . . . . 0.0 112.765 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.6 m -137.3 -53.97 0.69 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.989 1.716 . . . . 0.0 111.439 -172.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 63.5 p -127.29 21.9 6.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.317 1.047 . . . . 0.0 112.791 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.79 31.74 64.72 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.19 -0.944 . . . . 0.0 113.205 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -78.22 150.51 33.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.453 0.701 . . . . 0.0 110.787 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.8 t -128.65 137.57 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.5 m -142.12 129.32 20.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.644 1.577 . . . . 0.0 109.124 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.51 141.36 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.225 1.01 . . . . 0.0 110.133 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.04 127.34 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 127.079 2.151 . . . . 0.0 107.986 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -137.68 116.49 12.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.297 1.439 . . . . 0.0 108.546 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.52 156.46 36.71 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.875 1.27 . . . . 0.0 110.706 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.48 -14.41 7.81 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.14 -24.51 66.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.84 1.656 . . . . 0.0 114.005 169.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.6 p -146.7 -56.11 0.26 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.96 1.704 . . . . 0.0 111.692 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.16 138.92 97.56 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 0.0 111.841 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.02 -88.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.579 2.186 . . . . 0.0 111.625 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? 158.23 -33.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 129.561 3.145 . . . . 0.0 112.674 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -54.19 -36.91 63.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 113.459 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 15.5 ttm -103.67 151.48 22.92 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.939 1.295 . . . . 0.0 109.181 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.7 p -134.39 153.93 51.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.089 1.356 . . . . 0.0 110.287 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 ' CE1' ' A' ' 207' ' ' PHE . 2.5 t -112.34 110.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.3 m -93.47 130.7 39.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.831 0.852 . . . . 0.0 108.869 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -76.27 82.35 3.05 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.75 1.22 . . . . 0.0 109.634 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.93 -44.72 96.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.041 0.936 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 204' ' ' SER . 8.3 m-20 -147.6 -178.52 6.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.769 2.028 . . . . 0.0 110.106 166.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -53.55 141.96 23.96 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.664 -1.272 . . . . 0.0 110.836 158.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.8 p 50.66 10.69 0.07 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.258 2.223 . . . . 0.0 116.142 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -129.23 95.65 4.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.983 1.713 . . . . 0.0 108.711 -169.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -105.16 149.57 25.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.7 tt -134.61 123.28 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.406 ' CE1' HG22 ' A' ' 197' ' ' VAL . 8.4 m-85 -98.99 109.27 22.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.731 1.612 . . . . 0.0 108.598 -170.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.62 116.86 32.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.169 1.388 . . . . 0.0 108.92 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.79 99.14 9.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.176 0.59 . . . . 0.0 110.967 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -88.27 -15.71 35.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.228 2.211 . . . . 0.0 114.295 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.24 165.36 24.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.614 1.166 . . . . 0.0 111.995 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -128.0 54.06 1.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.952 1.701 . . . . 0.0 110.365 -170.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.151 1.78 . . . . 0.0 114.798 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.002 0.43 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.57 141.99 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 171.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.95 151.35 30.13 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.805 -0.559 . . . . 0.0 110.034 173.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.66 -17.26 46.39 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.59 -1.319 . . . . 0.0 113.48 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -115.17 17.83 16.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.986 1.714 . . . . 0.0 113.668 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -139.55 172.58 12.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.564 1.545 . . . . 0.0 110.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 46' ' ' VAL . 14.7 m -145.42 144.77 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.792 0.837 . . . . 0.0 110.628 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -127.58 145.94 50.7 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.148 0.975 . . . . 0.0 111.222 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -128.06 124.49 37.2 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.477 1.511 . . . . 0.0 107.497 -164.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 122.16 42.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 123.94 1.829 . . . . 0.0 111.052 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -93.18 42.58 1.1 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.477 1.911 . . . . 0.0 111.504 -167.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.86 155.2 12.5 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.575 2.036 . . . . 0.0 111.499 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -60.8 141.52 56.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.372 0.586 . . . . 0.0 110.135 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.4 t30 46.66 43.21 12.46 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.832 1.253 . . . . 0.0 114.238 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.304 30.9 p 49.18 36.42 9.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.257 2.223 . . . . 0.0 116.054 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -88.16 -24.95 23.2 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.51 -91.93 1.0 Allowed Glycine 0 N--CA 1.476 1.362 0 CA-C-N 119.559 1.072 . . . . 0.0 113.585 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.13 176.7 6.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 110.333 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -138.56 157.76 45.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.449 1.099 . . . . 0.0 112.336 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.78 152.18 39.96 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.186 1.794 . . . . 0.0 110.152 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -124.41 122.25 37.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.508 1.523 . . . . 0.0 108.972 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.04 148.51 43.49 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.294 1.438 . . . . 0.0 109.482 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -101.02 153.1 19.83 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.339 0.656 . . . . 0.0 109.949 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 147.53 23.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.975 -0.453 . . . . 0.0 112.163 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.38 41.55 90.88 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -129.19 130.83 46.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.833 1.253 . . . . 0.0 111.106 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -114.69 129.96 56.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.224 1.01 . . . . 0.0 108.836 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.79 109.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.662 1.585 . . . . 0.0 109.069 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -101.7 101.12 11.58 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.257 1.023 . . . . 0.0 109.11 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -70.45 -179.15 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.884 0.85 . . . . 0.0 111.226 165.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -127.06 157.17 40.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.547 1.139 . . . . 0.0 109.328 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.99 -12.17 59.04 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.016 -1.053 . . . . 0.0 113.496 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.14 97.71 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.615 1.102 . . . . 0.0 114.248 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.1 118.34 27.61 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.406 1.103 . . . . 0.0 110.482 170.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -18.91 62.33 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.949 -1.094 . . . . 0.0 112.458 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -61.49 -20.64 63.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.433 1.893 . . . . 0.0 112.357 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -60.89 -51.95 67.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.797 1.639 . . . . 0.0 112.367 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -70.13 -14.82 62.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.388 1.475 . . . . 0.0 113.286 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.9 -22.95 64.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.558 1.943 . . . . 0.0 113.731 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -46.92 121.22 3.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.669 1.187 . . . . 0.0 110.941 162.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.1 tpt -152.41 -19.95 0.17 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.842 . . . . 0.0 111.921 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -146.69 154.38 41.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.846 2.059 . . . . 0.0 108.856 172.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 p -172.54 155.22 3.32 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.574 1.55 . . . . 0.0 109.697 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 150.66 43.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.939 1.352 . . . . 0.0 112.399 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 8' ' ' VAL . 47.6 t -127.83 135.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.776 1.63 . . . . 0.0 108.199 -168.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -98.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.446 1.498 . . . . 0.0 115.81 -171.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -160.29 -23.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.105 1.762 . . . . 0.0 112.473 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.56 25.63 8.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.714 1.605 . . . . 0.0 111.565 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.12 140.47 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 128.151 2.58 . . . . 0.0 108.831 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.64 153.12 29.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.448 0.699 . . . . 0.0 109.947 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.8 m -136.39 136.17 39.38 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.286 0.635 . . . . 0.0 109.732 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -125.79 130.63 51.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.72 131.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.454 1.501 . . . . 0.0 109.7 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -141.31 118.67 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.38 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -103.85 -39.46 6.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.643 0.777 . . . . 0.0 111.837 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -92.57 158.82 15.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.278 1.031 . . . . 0.0 111.098 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -159.59 128.72 5.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.639 1.176 . . . . 0.0 111.505 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -162.17 -21.91 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.273 0.6 OUTLIER 50.01 37.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 127.143 2.177 . . . . 0.0 114.234 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.57 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.1 1.76 . . . . 0.0 111.924 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -51.79 124.63 27.84 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.619 1.168 . . . . 0.0 113.467 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.42 -14.72 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.881 2.387 . . . . 0.0 113.008 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t -90.18 119.66 69.23 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 119.008 0.822 . . . . 0.0 109.804 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.84 117.71 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.219 1.279 . . . . 0.0 108.977 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.0 -152.86 3.34 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -85.46 104.36 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.602 -0.94 . . . . 0.0 109.958 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -140.08 155.21 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.827 1.651 . . . . 0.0 109.582 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.4 172.19 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.617 1.167 . . . . 0.0 110.777 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -119.59 94.36 4.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.458 1.503 . . . . 0.0 107.495 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -52.83 118.71 3.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.565 1.546 . . . . 0.0 109.063 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.45 149.26 10.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.588 0.755 . . . . 0.0 112.998 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.65 -13.8 11.18 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.8 118.99 0.87 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.343 0.973 . . . . 0.0 111.777 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.48 161.64 4.1 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.871 2.068 . . . . 0.0 111.207 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 m -115.45 131.4 56.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.082 1.353 . . . . 0.0 110.067 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -131.58 136.0 47.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.508 1.123 . . . . 0.0 110.104 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -138.47 10.75 2.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.467 1.107 . . . . 0.0 112.901 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.64 52.15 0.58 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.548 1.539 . . . . 0.0 109.94 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -74.13 39.16 0.11 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.922 1.289 . . . . 0.0 112.928 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -55.99 -30.67 62.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.002 1.721 . . . . 0.0 113.047 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -64.34 -18.24 64.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.6 mm -90.26 -23.42 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.627 1.571 . . . . 0.0 111.964 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 45.05 74.51 0.13 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.079 2.152 . . . . 0.0 114.537 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.4 -160.33 36.14 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.555 0.598 . . . . 0.0 112.096 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 177.89 8.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.917 0.887 . . . . 0.0 110.861 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.15 -46.3 0.11 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.216 1.007 . . . . 0.0 111.825 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HE3' ' CG2' ' A' ' 203' ' ' THR . 2.0 ptmm? -140.7 156.22 46.27 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.95 140.42 34.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.148 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -129.08 125.01 36.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.39 131.36 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.353 1.461 . . . . 0.0 108.702 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.76 143.81 41.12 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.344 1.458 . . . . 0.0 109.97 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.12 26.27 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.15 3.9 . . . . 0.0 115.452 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.82 26.9 61.07 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.585 1.088 . . . . 0.0 113.582 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.1 -42.15 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 111.297 -168.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.72 146.55 32.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 109.983 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -88.69 -39.94 13.63 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.814 0.816 . . . . 0.0 111.637 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -152.0 158.77 43.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 107.191 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.25 174.06 7.53 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.916 -0.49 . . . . 0.0 109.981 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.08 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 111.185 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -71.71 131.83 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.76 139.78 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.693 1.197 . . . . 0.0 109.839 170.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -139.65 142.58 36.99 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.547 -0.721 . . . . 0.0 110.025 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 pt -91.95 144.28 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 122.91 0.484 . . . . 0.0 110.254 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.3 t -133.0 109.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.137 1.375 . . . . 0.0 108.686 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.07 118.18 17.73 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.679 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.87 -12.82 14.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.95 0.9 . . . . 0.0 113.002 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.49 -51.96 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.856 1.262 . . . . 0.0 111.681 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -92.7 110.72 22.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.088 0.955 . . . . 0.0 109.233 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 t -75.25 39.32 0.15 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.134 1.374 . . . . 0.0 114.013 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 m -140.48 -39.18 0.43 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.591 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.52 -160.49 0.07 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.585 1.154 . . . . 0.0 113.34 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.78 7.43 61.69 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 120.398 -1.439 . . . . 0.0 116.136 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.9 p -144.82 28.96 1.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.759 1.78 . . . . 0.0 114.663 -159.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -133.66 145.29 49.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.681 1.593 . . . . 0.0 109.193 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -132.79 112.2 11.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.149 0.98 . . . . 0.0 110.376 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.0 ttp -111.09 105.96 14.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.414 2.286 . . . . 0.0 110.544 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.8 m -92.21 126.55 37.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.569 0.699 . . . . 0.0 109.173 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.03 132.05 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.105 1.362 . . . . 0.0 108.933 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -137.04 89.33 16.83 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 123.62 0.768 . . . . 0.0 109.269 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.38 167.1 17.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.978 2.452 . . . . 0.0 112.668 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -37.57 98.36 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.437 2.295 . . . . 0.0 113.611 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.268 19.4 pt20 43.01 52.82 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.065 1.746 . . . . 0.0 114.87 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.61 148.0 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.162 1.785 . . . . 0.0 110.942 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -51.85 112.37 0.76 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.057 1.343 . . . . 0.0 111.067 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 152.79 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.323 1.049 . . . . 0.0 111.993 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.43 141.09 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.758 -0.589 . . . . 0.0 111.936 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.88 91.3 3.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.704 1.602 . . . . 0.0 109.896 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.717 ' HA ' HG21 ' A' ' 136' ' ' VAL . 42.3 t -74.06 131.65 41.55 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 121.785 -0.572 . . . . 0.0 109.691 169.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.77 139.39 48.91 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.86 128.98 39.81 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.932 -0.48 . . . . 0.0 110.303 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.47 -11.03 59.71 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.98 1.276 . . . . 0.0 115.189 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 145.47 41.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.695 1.748 . . . . 0.0 111.95 169.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.67 55.45 0.37 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.934 1.694 . . . . 0.0 112.957 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 57.88 95.72 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.737 2.415 . . . . 0.0 112.197 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' A' ' 129' ' ' CYS . 10.8 t -51.97 130.22 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.156 0.982 . . . . 0.0 112.225 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -80.09 122.28 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.793 0.837 . . . . 0.0 111.251 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.6 101.84 11.44 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.262 163.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.6 121.99 6.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.742 1.628 . . . . 0.0 110.534 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.87 121.44 43.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.816 0.846 . . . . 0.0 108.901 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.53 168.36 23.82 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.262 2.642 . . . . 0.0 111.75 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 131.79 51.45 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.698 -0.626 . . . . 0.0 110.792 174.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.99 149.27 33.84 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.777 1.631 . . . . 0.0 110.047 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.1 m -138.27 135.18 18.13 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 0.0 110.559 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.17 150.0 82.08 Favored 'Cis proline' 0 CA--C 1.544 1.022 0 CA-C-N 119.252 0.769 . . . . 0.0 112.001 -5.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.52 -24.24 49.2 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.027 1.818 . . . . 0.0 113.092 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.83 1.78 29.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -69.89 156.25 39.36 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.357 1.075 . . . . 0.0 112.843 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -83.67 135.67 34.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.284 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.4 tt -115.73 116.58 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.941 1.696 . . . . 0.0 108.401 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.49 142.9 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.921 -0.487 . . . . 0.0 110.749 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.0 p -142.91 140.56 31.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 122.088 0.946 . . . . 0.0 111.994 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -90.16 140.18 29.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.387 0.675 . . . . 0.0 110.148 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.17 113.94 18.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.732 1.613 . . . . 0.0 108.736 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 98.56 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.31 1.044 . . . . 0.0 109.517 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 3.9 p -115.4 145.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.541 1.136 . . . . 0.0 110.056 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.54 160.84 39.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.186 1.395 . . . . 0.0 112.454 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.56 146.63 46.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.017 1.327 . . . . 0.0 111.335 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.6 p -85.33 -12.22 52.79 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.34 171.79 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.813 1.245 . . . . 0.0 110.884 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -60.56 145.37 87.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 120.965 -1.085 . . . . 0.0 112.315 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.65 12.06 26.2 Favored 'Cis proline' 0 CA--C 1.55 1.287 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 3.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.22 13.53 8.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.869 1.668 . . . . 0.0 113.683 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.07 152.82 32.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 112.338 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -52.3 139.11 25.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.922 0.889 . . . . 0.0 112.92 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.56 -20.39 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.406 1.482 . . . . 0.0 111.937 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 95.0 t -152.66 131.78 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 126.776 2.03 . . . . 0.0 108.329 168.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -122.79 129.65 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.236 1.415 . . . . 0.0 109.084 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 176.63 -165.37 35.58 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.903 0.724 . . . . 0.0 112.695 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.39 156.01 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.183 0.992 . . . . 0.0 110.738 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 156.46 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.49 1.916 . . . . 0.0 108.246 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.56 134.59 54.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.83 157.88 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.65 154.14 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 107.64 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -118.85 160.5 21.8 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.441 1.096 . . . . 0.0 108.608 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.4 m -121.54 106.63 37.38 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 121.235 -0.915 . . . . 0.0 108.598 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.77 53.83 2.88 Favored 'Trans proline' 0 CA--C 1.542 0.92 1 C-N-CA 125.506 4.137 . . . . 0.0 112.545 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -126.66 -44.71 1.66 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.754 2.022 . . . . 0.0 110.713 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 82.4 p -144.91 6.55 1.19 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.521 1.128 . . . . 0.0 113.843 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.17 34.77 40.31 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.576 -1.327 . . . . 0.0 113.171 -171.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 149.81 35.86 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.884 -0.774 . . . . 0.0 110.752 173.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.21 132.2 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.681 1.192 . . . . 0.0 108.121 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 99.5 m -135.55 125.57 25.96 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.893 1.277 . . . . 0.0 109.307 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.56 130.0 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.334 1.054 . . . . 0.0 110.64 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 mt -108.83 141.33 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.275 2.23 . . . . 0.0 107.634 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 136.49 24.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.501 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -134.36 134.46 41.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.015 -170.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -58.39 -14.11 6.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.561 1.144 . . . . 0.0 113.955 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.07 -23.67 65.64 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.306 1.442 . . . . 0.0 114.492 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 p -145.28 -34.86 0.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.024 1.73 . . . . 0.0 113.646 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.25 129.99 89.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.775 0.83 . . . . 0.0 110.69 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.35 173.3 14.46 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.443 2.762 . . . . 0.0 112.069 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 5.97 32.32 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.214 1.406 . . . . 0.0 113.299 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -89.86 -37.2 14.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.968 1.707 . . . . 0.0 112.231 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.0 ttt -113.83 152.13 31.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.49 1.516 . . . . 0.0 109.279 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.5 p -133.21 144.31 49.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 0.0 110.756 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.88 119.94 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 88.5 m -115.42 114.51 25.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.036 1.334 . . . . 0.0 109.419 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.39 129.87 39.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.934 0.894 . . . . 0.0 110.972 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -31.89 3.78 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.326 1.05 . . . . 0.0 112.508 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -146.71 169.23 19.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.847 2.059 . . . . 0.0 109.702 171.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -59.19 -2.09 0.25 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.503 ' CG2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 t -156.64 32.62 0.31 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.586 2.354 . . . . 0.0 110.543 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -143.94 117.27 9.04 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.291 -1.506 . . . . 0.0 111.853 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 135.02 53.87 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.251 1.421 . . . . 0.0 110.616 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -118.15 117.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -97.69 91.72 5.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -75.51 127.08 32.32 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.231 0.612 . . . . 0.0 109.587 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.4 tp -111.18 110.56 21.12 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 111.679 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -107.78 17.35 22.63 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.986 2.114 . . . . 0.0 112.866 -173.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 t -152.16 155.15 37.25 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.343 1.457 . . . . 0.0 111.723 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -9.73 15.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.107 0.963 . . . . 0.0 113.044 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.79 139.93 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.34 1.456 . . . . 0.0 110.643 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.81 149.56 37.88 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.714 -0.616 . . . . 0.0 110.918 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.55 -24.44 47.05 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 113.324 170.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -111.58 12.51 21.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.0 1.72 . . . . 0.0 112.962 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -146.4 173.34 12.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.63 1.572 . . . . 0.0 111.145 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -133.7 158.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.074 0.949 . . . . 0.0 110.788 -177.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.9 149.45 48.98 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.187 0.995 . . . . 0.0 110.665 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -127.2 132.01 50.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.133 1.373 . . . . 0.0 108.184 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -126.55 123.21 37.2 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.245 1.498 . . . . 0.0 110.443 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -83.59 33.52 0.47 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.644 1.578 . . . . 0.0 112.574 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.53 148.56 11.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.972 1.748 . . . . 0.0 111.993 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.34 147.91 9.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.335 1.454 . . . . 0.0 112.025 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 49.62 42.67 23.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.323 1.049 . . . . 0.0 113.46 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m 56.38 65.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.873 1.669 . . . . 0.0 113.914 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -130.62 -179.88 5.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.883 1.273 . . . . 0.0 112.529 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 -95.09 1.23 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.01 1.291 . . . . 0.0 113.335 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.64 169.23 15.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.516 1.527 . . . . 0.0 110.36 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.9 p -135.07 149.72 50.14 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.048 0.939 . . . . 0.0 112.16 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 156.36 44.72 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.534 1.934 . . . . 0.0 110.271 -174.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.55 132.49 48.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.853 1.261 . . . . 0.0 109.642 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.25 122.0 30.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.077 1.351 . . . . 0.0 108.928 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -74.56 158.76 33.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.332 0.653 . . . . 0.0 110.926 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -64.98 154.78 36.63 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.505 -0.747 . . . . 0.0 111.622 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.15 45.51 96.38 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.367 0.508 . . . . 0.0 112.582 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -121.78 148.96 43.98 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.703 1.201 . . . . 0.0 110.319 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -136.95 119.3 15.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.32 117.81 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 109.664 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.05 100.04 9.6 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.78 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.79 162.33 26.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.239 170.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -107.91 162.91 13.59 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -67.02 -15.3 63.64 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.029 -1.045 . . . . 0.0 113.35 170.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.32 -20.55 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.308 0.956 . . . . 0.0 114.449 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -80.99 109.55 15.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.563 1.182 . . . . 0.0 111.01 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.14 66.72 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.531 -1.355 . . . . 0.0 112.623 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -57.42 -28.28 63.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.904 2.082 . . . . 0.0 113.514 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -73.26 -52.07 15.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.55 1.14 . . . . 0.0 111.742 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.74 -15.22 61.25 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.104 0.962 . . . . 0.0 112.989 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.88 0.93 4.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.102 2.561 . . . . 0.0 114.73 168.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -44.07 135.2 4.38 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.693 1.133 . . . . 0.0 110.222 164.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.76 -54.56 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.4 p -146.46 164.22 33.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.662 0.744 . . . . 0.0 112.004 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 p -161.68 159.68 27.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.226 -0.922 . . . . 0.0 110.423 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mp -123.87 132.07 53.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.337 1.055 . . . . 0.0 108.499 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 74.4 t -123.49 127.01 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 124.752 1.221 . . . . 0.0 109.512 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.548 2.023 . . . . 0.0 115.844 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -171.71 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.256 1.422 . . . . 0.0 114.0 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -120.93 29.49 7.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.928 1.691 . . . . 0.0 111.751 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.93 138.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.296 1.439 . . . . 0.0 110.776 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -115.45 132.87 56.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.684 1.194 . . . . 0.0 109.316 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.26 143.49 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -123.05 131.45 53.7 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.732 1.613 . . . . 0.0 108.749 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 pt -137.56 118.37 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.822 1.249 . . . . 0.0 111.037 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.08 138.03 53.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 110.311 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.4 -46.03 4.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.501 0.72 . . . . 0.0 112.917 -164.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -151.93 131.62 13.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.821 1.248 . . . . 0.0 108.684 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -146.56 138.48 24.74 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.263 1.425 . . . . 0.0 107.86 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.32 9.72 0.56 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.247 0.619 . . . . 0.0 111.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt 43.47 27.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 129.655 3.182 . . . . 0.0 116.259 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -173.39 -23.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.294 2.238 . . . . 0.0 111.429 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -46.98 136.71 8.06 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.125 1.37 . . . . 0.0 113.241 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.38 -5.38 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.294 2.662 . . . . 0.0 113.01 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 90.54 50.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 109.808 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.24 109.97 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.835 1.69 . . . . 0.0 108.092 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.37 159.1 20.99 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 153.62 18.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.454 1.121 . . . . 0.0 111.191 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -148.55 144.69 27.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.664 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.4 166.64 27.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.474 1.131 . . . . 0.0 111.071 170.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -126.34 111.63 14.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.055 1.342 . . . . 0.0 109.32 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.08 136.13 57.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.819 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.02 144.26 9.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 112.665 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.45 -10.82 8.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.46 109.62 0.41 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.04 1.781 . . . . 0.0 111.829 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.79 168.87 0.52 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.431 2.292 . . . . 0.0 111.331 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.1 m -111.21 142.38 43.49 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.527 1.131 . . . . 0.0 109.49 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -129.6 120.45 25.29 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.833 1.253 . . . . 0.0 108.095 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -128.7 -18.28 3.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.63 -80.42 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 109.419 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp 44.77 22.34 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.927 1.691 . . . . 0.0 113.762 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -78.29 -36.22 46.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.434 1.494 . . . . 0.0 110.055 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.6 t -69.07 -30.44 68.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.551 1.14 . . . . 0.0 112.859 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.39 -27.24 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.234 1.414 . . . . 0.0 112.105 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 57.02 45.57 20.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.491 1.516 . . . . 0.0 112.304 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.62 -167.94 43.87 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.533 1.063 . . . . 0.0 113.94 -172.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -173.55 4.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.071 1.349 . . . . 0.0 111.246 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 85.6 p -149.19 -34.63 0.19 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.843 1.257 . . . . 0.0 112.819 167.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -99.29 127.28 45.28 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.293 1.037 . . . . 0.0 110.093 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.35 136.37 54.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.184 1.393 . . . . 0.0 108.796 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -143.89 153.55 42.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.408 0.683 . . . . 0.0 109.265 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.69 114.42 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 124.75 1.22 . . . . 0.0 108.707 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.63 115.27 31.02 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.492 0.717 . . . . 0.0 110.636 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.73 166.22 30.12 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.938 2.425 . . . . 0.0 112.633 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.1 33.65 0.19 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.158 2.313 . . . . 0.0 114.831 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.71 -27.11 6.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.055 2.542 . . . . 0.0 110.986 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -140.41 161.23 38.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.038 1.735 . . . . 0.0 110.749 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -104.21 -45.64 4.65 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.095 -1.003 . . . . 0.0 112.501 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.34 165.18 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.186 1.794 . . . . 0.0 108.333 174.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.74 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.252 0.549 . . . . 0.0 109.753 169.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.06 139.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.978 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -97.2 121.44 39.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.943 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 167.46 29.36 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.689 1.196 . . . . 0.0 109.623 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.34 148.63 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 125.38 1.472 . . . . 0.0 109.678 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.61 114.08 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.964 0.906 . . . . 0.0 109.149 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.93 88.72 2.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 111.92 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.41 19.48 20.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.86 1.264 . . . . 0.0 112.028 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.71 -66.08 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.544 1.538 . . . . 0.0 111.458 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -85.16 -19.59 31.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.949 1.3 . . . . 0.0 111.989 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t 62.51 39.46 11.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.651 1.981 . . . . 0.0 113.358 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.8 m -131.43 -38.36 1.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.762 1.225 . . . . 0.0 113.915 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.04 -177.86 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.163 1.385 . . . . 0.0 114.338 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.74 20.46 39.85 Favored Glycine 0 CA--C 1.54 1.653 0 O-C-N 120.618 -1.301 . . . . 0.0 115.037 -171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.6 p -139.63 17.66 2.53 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.772 1.629 . . . . 0.0 113.327 -166.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.38 132.45 27.89 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.404 1.882 . . . . 0.0 109.385 -170.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -117.23 121.89 42.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.541 1.136 . . . . 0.0 110.163 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttt -115.8 122.37 45.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.706 1.203 . . . . 0.0 109.637 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -119.41 116.22 25.72 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.02 1.328 . . . . 0.0 108.373 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.09 138.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.266 1.426 . . . . 0.0 108.818 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 t -154.67 99.2 2.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.405 0.682 . . . . 0.0 110.842 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 9.8 Cg_endo -66.38 168.26 16.63 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.346 2.697 . . . . 0.0 112.905 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -34.99 95.0 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.138 2.175 . . . . 0.0 114.884 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 37.55 65.85 0.5 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.892 2.077 . . . . 0.0 115.099 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.2 155.26 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.663 . . . . 0.0 110.41 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.01 100.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.352 1.461 . . . . 0.0 111.811 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -59.01 151.39 22.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.444 0.64 . . . . 0.0 110.327 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.72 124.0 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.13 107.83 15.4 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.673 1.589 . . . . 0.0 108.802 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.88 160.49 24.64 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 160.72 16.19 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.197 0.599 . . . . 0.0 110.848 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.54 53.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.842 2.457 . . . . 0.0 114.727 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.01 -21.81 0.07 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.74 2.591 . . . . 0.0 113.776 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.21 156.96 23.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.156 1.478 . . . . 0.0 111.808 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.7 -16.64 29.93 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.302 -0.874 . . . . 0.0 112.793 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -176.66 115.97 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.78 2.832 . . . . 0.0 108.253 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.56 126.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.238 -1.539 . . . . 0.0 109.559 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 127.98 33.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.922 0.489 . . . . 0.0 110.87 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.23 109.55 54.15 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.161 1.384 . . . . 0.0 109.817 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.59 138.87 33.08 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.429 2.086 . . . . 0.0 110.556 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.62 123.76 18.57 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.733 1.213 . . . . 0.0 109.199 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.68 164.51 35.18 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.831 2.354 . . . . 0.0 112.055 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 134.02 55.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.29 0.567 . . . . 0.0 111.735 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.15 146.59 40.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.921 1.688 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.8 m -142.55 136.05 14.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 124.603 1.161 . . . . 0.0 109.874 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.7 154.95 75.72 Favored 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 119.844 0.98 . . . . 0.0 113.006 -4.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -64.33 -32.2 61.7 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.064 1.843 . . . . 0.0 112.509 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.59 -12.48 58.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.662 1.585 . . . . 0.0 114.168 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.32 174.75 6.07 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.161 0.981 . . . . 0.0 112.89 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.81 149.23 45.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.994 1.317 . . . . 0.0 111.574 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.28 122.76 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.964 1.706 . . . . 0.0 109.139 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.84 140.69 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.411 0.624 . . . . 0.0 110.722 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 121' ' ' PRO . 36.6 t -141.14 137.93 33.1 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.87 1.268 . . . . 0.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -91.15 139.81 30.4 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -130.48 116.72 18.61 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.869 1.268 . . . . 0.0 108.47 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.29 124.81 37.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.67 133.25 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.719 1.208 . . . . 0.0 110.559 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.81 145.3 56.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.426 0.631 . . . . 0.0 111.585 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.7 p -81.68 -5.24 57.92 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.113 1.365 . . . . 0.0 113.076 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -135.56 166.55 22.95 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.087 1.755 . . . . 0.0 111.194 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 t -80.39 142.87 54.82 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.623 0.769 . . . . 0.0 112.671 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.36 132.3 21.32 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.117 1.077 . . . . 0.0 110.993 -9.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -75.08 36.26 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.627 1.571 . . . . 0.0 112.171 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.93 132.29 41.8 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.701 1.2 . . . . 0.0 109.565 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -52.36 148.44 6.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.221 -0.299 . . . . 0.0 110.96 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.57 -29.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.292 1.037 . . . . 0.0 112.404 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.96 143.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.935 1.694 . . . . 0.0 109.306 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.95 122.0 14.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.366 1.467 . . . . 0.0 109.035 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.21 -165.25 31.67 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 121.906 0.725 . . . . 0.0 114.262 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.36 144.96 34.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.426 1.09 . . . . 0.0 110.256 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.86 155.58 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.215 1.806 . . . . 0.0 108.934 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -125.32 126.05 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.406 -0.809 . . . . 0.0 108.867 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -95.98 139.38 32.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -133.24 150.39 51.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.376 1.87 . . . . 0.0 108.414 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -122.94 150.57 42.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.005 0.922 . . . . 0.0 109.417 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.25 105.89 56.14 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.676 0.79 . . . . 0.0 109.326 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.9 51.42 1.97 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.354 4.036 . . . . 0.0 113.614 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.7 m -132.57 -41.24 0.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.72 2.008 . . . . 0.0 111.703 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.8 t -145.92 23.68 1.37 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 123.078 1.418 . . . . 0.0 112.098 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.15 46.41 56.52 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.595 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -83.5 156.13 23.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.479 1.112 . . . . 0.0 110.423 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.23 134.82 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.9 m -124.83 150.26 46.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.855 2.062 . . . . 0.0 108.421 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 123.77 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.226 1.011 . . . . 0.0 109.155 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.11 133.5 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.3 1.44 . . . . 0.0 107.338 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.32 138.9 25.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.639 1.576 . . . . 0.0 107.635 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 147.68 50.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.786 1.235 . . . . 0.0 108.494 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.17 -17.84 59.19 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.311 -0.868 . . . . 0.0 112.593 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.35 -12.68 61.23 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.307 2.243 . . . . 0.0 114.013 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.4 p -137.02 -44.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.583 1.553 . . . . 0.0 111.872 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.504 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -68.68 160.97 74.51 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.107 1.763 . . . . 0.0 111.324 169.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.504 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 59.6 Cg_endo -76.72 -2.16 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.848 3.032 . . . . 0.0 113.859 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 53.69 15.56 0.81 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.709 2.404 . . . . 0.0 115.113 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.39 -0.67 8.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.867 1.667 . . . . 0.0 113.398 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.7 ttt -125.62 148.61 48.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.817 2.047 . . . . 0.0 107.507 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -133.75 156.97 47.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.724 0.81 . . . . 0.0 109.846 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.9 t -117.58 125.31 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.251 0.621 . . . . 0.0 109.563 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 41.5 m -110.61 110.35 21.01 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.602 1.961 . . . . 0.0 108.229 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.09 103.97 5.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.086 0.955 . . . . 0.0 110.543 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.8 -34.55 19.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.317 0.647 . . . . 0.0 111.257 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -142.44 -177.62 5.36 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.301 1.84 . . . . 0.0 112.739 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -66.97 -17.39 64.9 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.9 p -138.68 10.37 2.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 112.644 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.4 m -125.18 114.13 18.59 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.279 1.032 . . . . 0.0 110.975 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.59 138.1 52.8 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.433 1.493 . . . . 0.0 109.258 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 48.8 mt -119.79 122.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.36 104.79 16.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.981 1.312 . . . . 0.0 109.094 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -87.23 126.88 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.774 0.83 . . . . 0.0 109.019 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.46 118.99 31.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.702 0.801 . . . . 0.0 109.981 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -110.86 -27.16 8.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.877 1.271 . . . . 0.0 113.374 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.7 m -103.8 177.88 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 112.209 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -134.3 72.97 1.47 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.248 1.419 . . . . 0.0 109.644 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.341 1.056 . . . . 0.0 113.672 178.848 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.369 0.604 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.66 152.27 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.363 1.465 . . . . 0.0 111.213 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 139.94 51.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.594 1.158 . . . . 0.0 111.082 171.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.6 -17.74 60.76 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.684 -1.26 . . . . 0.0 113.568 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.31 3.53 12.58 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.284 1.834 . . . . 0.0 113.837 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -149.1 173.19 13.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.076 2.55 . . . . 0.0 109.399 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.63 161.5 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.729 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -145.48 142.3 29.12 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.335 0.654 . . . . 0.0 110.341 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.51 138.04 54.04 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.413 1.485 . . . . 0.0 108.71 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.47 127.27 42.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.141 0.972 . . . . 0.0 110.365 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -80.49 58.24 3.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.145 1.378 . . . . 0.0 111.19 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.9 139.32 3.94 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.587 -0.696 . . . . 0.0 112.278 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.922 0.889 . . . . 0.0 108.831 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 75.99 34.02 0.56 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.789 1.636 . . . . 0.0 112.874 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.7 t 62.89 63.96 0.92 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.622 1.569 . . . . 0.0 112.831 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.6 p -137.28 -178.53 5.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.253 1.821 . . . . 0.0 112.99 -172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.84 -95.39 0.63 Allowed Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.63 1.586 . . . . 0.0 114.317 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -123.37 164.23 19.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.99 1.316 . . . . 0.0 110.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.7 p -132.92 149.32 52.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.72 1.208 . . . . 0.0 112.036 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.95 148.42 29.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.523 1.529 . . . . 0.0 109.603 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -126.93 146.31 50.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.106 0.962 . . . . 0.0 110.258 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.42 132.31 31.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.875 1.322 . . . . 0.0 111.721 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.7 146.75 49.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.964 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -62.66 142.62 58.0 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.415 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 52.45 34.75 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.083 0.401 . . . . 0.0 113.428 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 158.1 45.05 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.841 0.856 . . . . 0.0 112.101 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -138.6 135.33 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.69 119.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.321 1.048 . . . . 0.0 109.29 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -99.9 103.5 15.09 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.25 155.2 23.79 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.605 1.162 . . . . 0.0 110.663 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -103.48 137.22 41.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.445 0.698 . . . . 0.0 110.029 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -59.78 -17.37 35.04 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.77 -25.41 63.64 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.424 1.012 . . . . 0.0 114.342 170.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.01 119.18 38.54 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.534 1.167 . . . . 0.0 109.975 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -12.5 3.44 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 170.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -58.2 -25.82 62.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.196 1.398 . . . . 0.0 112.22 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.12 -56.03 10.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.098 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.07 -15.24 21.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.962 1.705 . . . . 0.0 113.771 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -28.52 44.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.807 1.643 . . . . 0.0 113.522 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -47.36 122.22 4.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.229 0.538 . . . . 0.0 111.575 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.9 tpt -149.23 -31.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 111.918 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.6 p -145.32 162.06 38.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 111.684 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.1 p -156.05 149.16 24.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.322 1.449 . . . . 0.0 110.407 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.27 136.23 53.19 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.56 129.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.232 1.413 . . . . 0.0 109.563 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.36 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.574 2.035 . . . . 0.0 116.11 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -166.36 -20.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 113.267 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -119.92 22.92 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.01 1.724 . . . . 0.0 111.607 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.21 143.25 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.93 2.092 . . . . 0.0 109.508 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -120.94 145.66 47.46 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.91 1.284 . . . . 0.0 109.807 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.4 m -112.29 142.89 44.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.606 1.194 . . . . 0.0 109.957 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 4.6 m120 -132.33 130.79 41.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.44 123.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.105 . . . . 0.0 109.639 -172.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -131.92 134.31 45.53 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.094 1.358 . . . . 0.0 110.549 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.58 -34.22 7.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.05 0.94 . . . . 0.0 112.935 -168.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.42 157.27 46.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.593 1.957 . . . . 0.0 107.223 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -142.39 131.79 23.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.111 0.964 . . . . 0.0 109.743 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.53 162.68 0.7 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.105 1.762 . . . . 0.0 110.68 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.34 15.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 112.556 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.14 28.82 1.1 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.04 2.136 . . . . 0.0 111.147 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 t -99.53 139.96 21.26 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.929 1.291 . . . . 0.0 112.456 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.39 -16.69 11.91 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.45 2.767 . . . . 0.0 114.281 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 t -124.92 137.59 29.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.73 150.32 83.53 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.43 -161.29 5.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.426 1.014 . . . . 0.0 112.241 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.16 134.8 51.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 108.59 167.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -159.43 155.66 27.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.568 1.547 . . . . 0.0 110.482 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -158.61 147.32 18.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.732 1.253 . . . . 0.0 113.027 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.73 95.26 9.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.848 2.059 . . . . 0.0 109.676 168.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.6 134.14 55.89 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.22 151.46 15.67 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.89 -8.61 7.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.46 89.93 0.11 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.236 -0.915 . . . . 0.0 112.644 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.1 p -162.42 169.41 20.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.355 1.074 . . . . 0.0 112.851 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -104.54 133.34 49.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.584 1.554 . . . . 0.0 109.107 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -128.67 115.4 17.97 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.084 0.954 . . . . 0.0 109.682 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -141.53 15.56 2.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 112.257 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -153.71 50.57 0.68 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.932 1.293 . . . . 0.0 109.96 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.01 42.25 0.39 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.649 1.18 . . . . 0.0 110.841 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -66.31 -30.08 70.42 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 119.971 -1.706 . . . . 0.0 112.385 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -63.26 -23.94 67.65 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.196 0.998 . . . . 0.0 112.88 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.24 -34.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.674 1.99 . . . . 0.0 111.421 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.92 40.83 22.1 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.898 1.679 . . . . 0.0 113.24 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 168.89 33.95 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.668 1.128 . . . . 0.0 112.287 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.44 -173.91 3.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.409 1.484 . . . . 0.0 112.39 -170.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 84.8 p -145.83 -28.18 0.43 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.36 139.26 51.64 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.501 1.52 . . . . 0.0 110.03 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.79 127.39 40.25 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.023 1.329 . . . . 0.0 107.673 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 53' ' ' ASN . 1.5 pm0 -136.91 130.44 31.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.703 0.801 . . . . 0.0 109.11 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.61 118.77 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.218 1.407 . . . . 0.0 107.541 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.84 123.27 27.46 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.473 1.109 . . . . 0.0 109.061 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.54 160.48 41.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.999 2.466 . . . . 0.0 111.107 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.17 24.6 0.2 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 125.831 1.682 . . . . 0.0 116.01 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.13 -20.94 6.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.236 2.215 . . . . 0.0 112.816 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.06 158.93 32.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.821 1.648 . . . . 0.0 109.399 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.13 -38.8 7.98 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.252 -0.905 . . . . 0.0 112.826 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 -149.98 155.52 40.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.101 1.361 . . . . 0.0 108.878 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.78 146.06 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.03 0.532 . . . . 0.0 110.072 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.02 134.55 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.253 1.021 . . . . 0.0 110.539 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -84.72 126.18 33.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.1 m -124.89 140.0 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.555 0.742 . . . . 0.0 109.548 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.29 161.83 30.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.295 1.038 . . . . 0.0 110.716 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.01 134.94 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.984 0.913 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.7 t -127.4 108.27 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -76.21 118.31 18.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.735 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -102.33 -21.69 14.26 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.319 1.047 . . . . 0.0 112.466 170.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.21 -67.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.192 0.997 . . . . 0.0 111.971 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -85.2 97.62 10.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.852 1.261 . . . . 0.0 110.393 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -70.17 47.84 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.26 1.824 . . . . 0.0 114.417 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.8 m -144.68 -36.16 0.32 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.123 2.569 . . . . 0.0 111.82 -171.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.29 -153.58 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 53.03 25.18 23.5 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 120.224 1.375 . . . . 0.0 116.203 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 m -143.82 5.66 1.36 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.974 1.71 . . . . 0.0 114.935 -167.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -133.58 120.3 20.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.431 1.493 . . . . 0.0 111.855 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.26 137.99 32.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.315 1.046 . . . . 0.0 109.916 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 119.38 34.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.261 2.224 . . . . 0.0 108.662 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 m -119.07 119.5 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.41 128.83 73.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -117.49 89.11 31.12 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.233 1.413 . . . . 0.0 109.226 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.07 160.36 49.01 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.668 2.912 . . . . 0.0 112.035 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -42.94 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.288 2.635 . . . . 0.0 116.084 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 44.48 39.7 3.39 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.836 1.654 . . . . 0.0 113.948 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.25 154.92 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.734 2.014 . . . . 0.0 109.683 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -45.95 98.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 112.752 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 151.06 36.17 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 0.0 111.046 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.46 125.41 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.882 0.873 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.17 105.45 17.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.012 1.325 . . . . 0.0 108.638 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.4 p -103.06 164.99 11.28 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.053 0.941 . . . . 0.0 110.796 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -142.46 159.9 41.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.764 0.825 . . . . 0.0 110.65 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -60.54 81.85 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 126.339 1.856 . . . . 0.0 114.526 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.22 0.18 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.939 1.733 . . . . 0.0 112.159 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.12 131.43 49.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.978 0.894 . . . . 0.0 111.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -74.95 70.52 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.32 1.448 . . . . 0.0 112.466 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 63.3 84.3 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.23 2.212 . . . . 0.0 110.919 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.61 147.96 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.603 -0.686 . . . . 0.0 110.599 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.1 146.06 24.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.886 0.474 . . . . 0.0 111.199 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.66 97.09 44.82 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.195 1.398 . . . . 0.0 108.106 166.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.51 137.51 27.99 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.542 2.161 . . . . 0.0 111.072 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.68 127.62 23.52 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.508 1.123 . . . . 0.0 107.997 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.22 -178.7 3.77 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.326 3.35 . . . . 0.0 111.327 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 149.41 47.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.84 0.829 . . . . 0.0 112.358 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.02 143.39 21.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.432 1.893 . . . . 0.0 109.46 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.8 m -125.83 130.62 23.98 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 124.275 1.03 . . . . 0.0 109.534 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.1 150.78 79.37 Favored 'Cis proline' 0 CA--C 1.545 1.038 0 CA-C-N 119.368 0.81 . . . . 0.0 112.435 -3.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.27 -22.69 39.76 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.76 1.64 . . . . 0.0 112.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.01 4.87 15.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.543 1.537 . . . . 0.0 114.548 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 148.71 46.68 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.727 -1.233 . . . . 0.0 111.992 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 155.57 36.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 112.182 168.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 tt -132.99 114.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 109.155 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 138.91 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.331 0.652 . . . . 0.0 109.844 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.1 p -142.57 145.99 34.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.033 0.921 . . . . 0.0 111.221 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -86.49 145.72 26.69 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 tt -134.6 122.49 22.39 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.993 0.917 . . . . 0.0 110.035 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 t -131.14 138.31 49.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.434 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.02 134.11 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.72 50.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.89 0.876 . . . . 0.0 109.885 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.26 129.46 40.04 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.156 -0.34 . . . . 0.0 110.253 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.9 p -77.41 -10.37 59.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.81 0.844 . . . . 0.0 112.855 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.74 164.43 17.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.085 2.154 . . . . 0.0 111.301 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.9 t -75.17 141.29 74.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.63 -0.669 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.35 129.58 15.45 Favored 'Cis proline' 0 C--N 1.354 0.861 0 CA-C-N 120.279 1.135 . . . . 0.0 111.091 -9.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -73.73 34.38 0.08 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.978 1.711 . . . . 0.0 113.546 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.23 151.17 23.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 113.039 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.21 102.62 2.14 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.916 0.886 . . . . 0.0 110.381 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.94 -39.1 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.82 2.048 . . . . 0.0 111.495 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.53 143.76 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.2 1.4 . . . . 0.0 108.252 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -148.77 74.46 1.27 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.962 0.905 . . . . 0.0 109.273 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -140.69 -156.13 6.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.424 1.488 . . . . 0.0 112.039 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 55.2 m -141.69 164.73 29.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.95 0.9 . . . . 0.0 110.434 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.73 156.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.444 1.498 . . . . 0.0 108.176 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.01 134.39 53.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.141 -0.974 . . . . 0.0 108.65 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.05 160.08 16.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.486 1.115 . . . . 0.0 109.609 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -159.22 154.31 25.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.269 1.428 . . . . 0.0 109.262 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -128.94 142.83 50.81 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.937 1.295 . . . . 0.0 109.168 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.6 m -101.86 109.66 60.21 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.376 0.67 . . . . 0.0 109.197 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.63 47.65 1.71 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 125.227 3.952 . . . . 0.0 113.098 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -130.27 -49.73 1.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.105 1.762 . . . . 0.0 110.462 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.2 p -138.46 24.71 2.68 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.196 1.398 . . . . 0.0 112.609 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.99 23.75 64.08 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.306 0.955 . . . . 0.0 114.154 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 158.73 35.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.327 1.051 . . . . 0.0 111.318 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.19 143.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.705 1.602 . . . . 0.0 107.819 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 59.4 m -139.49 128.73 23.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.841 1.256 . . . . 0.0 108.587 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.567 HG23 ' HE2' ' A' ' 186' ' ' LYS . 0.9 OUTLIER -102.07 126.61 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.866 0.866 . . . . 0.0 110.233 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.71 130.18 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.902 1.281 . . . . 0.0 108.224 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 184' ' ' VAL . 14.8 mtmt -140.03 125.86 19.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.198 1.799 . . . . 0.0 108.468 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 158.56 42.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.164 1.386 . . . . 0.0 109.943 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.59 -18.36 19.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.648 1.179 . . . . 0.0 113.274 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.78 -24.88 64.45 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.967 1.707 . . . . 0.0 114.609 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.0 p -150.15 -44.17 0.13 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.756 1.223 . . . . 0.0 114.1 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.86 144.28 51.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.895 1.278 . . . . 0.0 110.072 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.47 -78.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 121.268 1.312 . . . . 0.0 113.437 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 156.06 -44.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 130.262 3.425 . . . . 0.0 112.003 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -57.97 -25.18 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.058 1.743 . . . . 0.0 113.533 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -119.46 131.85 55.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.737 1.615 . . . . 0.0 107.433 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -132.09 149.68 52.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 110.174 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.69 131.23 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.3 t -120.08 153.76 35.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.882 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.432 ' HB3' ' CE2' ' A' ' 205' ' ' PHE . 11.3 pt20 -105.04 114.4 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.731 0.812 . . . . 0.0 109.897 -176.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.48 -33.62 60.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -134.42 -175.6 3.93 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.352 1.061 . . . . 0.0 112.968 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.85 -30.91 68.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.361 1.064 . . . . 0.0 113.319 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.1 p -139.81 13.72 2.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.47 1.908 . . . . 0.0 112.591 -168.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 t -129.07 123.57 32.6 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.668 1.187 . . . . 0.0 110.958 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 199' ' ' GLN . 94.4 m-85 -130.04 146.63 51.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.812 1.645 . . . . 0.0 109.819 -171.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.63 119.2 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.81 107.76 19.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.737 . . . . 0.0 109.685 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.25 140.69 29.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.842 1.657 . . . . 0.0 109.998 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.39 110.49 12.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.913 0.885 . . . . 0.0 110.569 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.5 13.06 13.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.567 1.947 . . . . 0.0 113.861 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.13 135.4 3.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.1 1.76 . . . . 0.0 109.849 166.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.91 -4.44 35.05 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.651 0 C-N-CA 126.206 1.802 . . . . 0.0 115.332 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -96.75 129.67 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.406 1.483 . . . . 0.0 110.122 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.74 148.31 49.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.24 -21.55 24.27 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.666 -1.271 . . . . 0.0 113.098 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -112.71 11.65 19.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.474 1.91 . . . . 0.0 113.729 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -144.08 172.65 12.6 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.912 2.085 . . . . 0.0 110.402 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.26 156.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.237 -0.914 . . . . 0.0 110.692 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 134.25 26.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.817 0.847 . . . . 0.0 110.783 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -118.5 154.46 32.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.425 1.09 . . . . 0.0 110.281 -168.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -138.15 126.12 22.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.782 1.277 . . . . 0.0 110.984 -166.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -96.92 44.01 1.06 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.287 1.041 . . . . 0.0 112.647 -165.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.57 137.6 3.84 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.72 1.628 . . . . 0.0 110.778 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -61.32 133.93 56.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.925 0.89 . . . . 0.0 109.6 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 83.94 27.5 0.09 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.913 2.085 . . . . 0.0 113.058 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.79 59.0 4.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.242 1.417 . . . . 0.0 113.154 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.3 p -128.05 -174.06 3.1 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.98 1.712 . . . . 0.0 112.032 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.6 -98.62 1.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.861 1.219 . . . . 0.0 112.634 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.2 175.97 8.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.205 1.402 . . . . 0.0 110.753 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -133.42 158.61 42.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 111.228 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.58 152.33 37.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.963 1.305 . . . . 0.0 110.491 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.49 140.96 52.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.768 0.827 . . . . 0.0 111.731 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -137.9 134.24 34.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.255 1.422 . . . . 0.0 110.393 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.71 159.37 20.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.727 0.811 . . . . 0.0 111.577 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 155.27 13.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.036 -0.415 . . . . 0.0 112.051 168.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.57 93.95 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.736 0.684 . . . . 0.0 113.254 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -125.16 124.34 41.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.448 1.099 . . . . 0.0 110.731 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -122.62 124.18 42.88 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 108.481 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.74 133.52 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.521 1.153 . . . . 0.0 109.858 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -114.51 83.69 1.93 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.649 1.98 . . . . 0.0 107.922 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.2 167.35 14.41 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.999 0.904 . . . . 0.0 111.382 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -117.96 159.81 22.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 109.807 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -17.97 63.63 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -36.24 73.55 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.052 1.31 . . . . 0.0 114.191 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -76.96 110.73 11.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.496 1.148 . . . . 0.0 109.345 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -24.31 66.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.182 -1.574 . . . . 0.0 112.563 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -61.47 -21.66 64.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.734 1.614 . . . . 0.0 112.363 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -71.88 -53.93 11.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.642 1.177 . . . . 0.0 112.243 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -24.29 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -55.05 -27.62 46.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.023 1.729 . . . . 0.0 114.467 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -51.2 108.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.435 1.016 . . . . 0.0 111.707 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.9 tpt -132.35 -29.03 1.62 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.028 0.931 . . . . 0.0 112.663 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.9 m -139.33 164.24 30.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.643 2.377 . . . . 0.0 109.438 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.5 163.26 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.43 1.092 . . . . 0.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pp -146.75 148.86 32.39 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 123.17 1.462 . . . . 0.0 111.326 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.04 133.33 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.086 1.754 . . . . 0.0 107.803 -167.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.44 -92.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.181 1.372 . . . . 0.0 116.002 -168.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -170.25 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.111 1.364 . . . . 0.0 113.772 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -122.11 28.17 7.65 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.679 1.992 . . . . 0.0 111.841 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -145.24 146.75 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.874 2.07 . . . . 0.0 109.375 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.43 149.78 38.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 109.138 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.1 144.85 44.22 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.958 0.903 . . . . 0.0 110.49 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -122.38 135.5 54.71 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.672 1.189 . . . . 0.0 109.27 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.5 mt -118.39 126.4 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.153 1.381 . . . . 0.0 108.475 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -131.59 124.74 30.61 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.062 0.945 . . . . 0.0 110.572 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -26.59 11.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.863 1.265 . . . . 0.0 111.809 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -114.38 150.68 34.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.828 1.251 . . . . 0.0 110.759 174.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -142.77 103.6 4.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.842 1.257 . . . . 0.0 109.027 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.73 155.29 19.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.286 1.434 . . . . 0.0 109.88 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.34 27.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.525 1.53 . . . . 0.0 111.764 -168.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.2 -29.68 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.92 2.088 . . . . 0.0 111.37 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 t -54.44 122.19 36.69 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.027 0.931 . . . . 0.0 112.566 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.97 -15.26 10.6 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.791 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 t -82.77 113.2 43.5 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.11 0.868 . . . . 0.0 110.174 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.8 127.53 14.69 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.107 1.204 . . . . 0.0 109.055 174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.08 -113.91 0.62 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.67 115.02 18.1 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 109.621 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.17 143.29 34.14 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.337 2.255 . . . . 0.0 107.882 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -158.64 166.71 31.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.608 1.163 . . . . 0.0 110.015 166.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -126.72 104.99 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 108.48 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.73 124.89 21.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.58 153.86 2.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.88 -18.77 14.4 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.62 126.49 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 160.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.14 164.32 0.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.927 2.091 . . . . 0.0 111.364 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.8 m -112.69 131.54 55.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 0.0 109.036 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -124.71 98.73 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.764 1.625 . . . . 0.0 107.571 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -112.39 17.57 19.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.246 1.018 . . . . 0.0 111.886 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -156.69 66.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.838 1.655 . . . . 0.0 110.803 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB3' HG22 ' A' ' 83' ' ' ILE . 4.0 mp -92.0 31.22 1.28 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.161 -0.962 . . . . 0.0 111.874 176.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.3 m -56.58 -28.39 60.16 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 119.995 -1.691 . . . . 0.0 113.038 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -60.28 -26.66 66.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.711 -1.243 . . . . 0.0 114.106 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.404 HG22 ' HB3' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -97.63 -23.32 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.786 1.234 . . . . 0.0 112.484 176.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 55.41 50.42 14.83 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.672 1.989 . . . . 0.0 113.464 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.22 -170.49 44.69 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.529 -0.732 . . . . 0.0 111.31 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -175.0 5.16 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.66 -1.494 . . . . 0.0 111.987 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -135.02 -27.93 1.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.35 135.28 46.06 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.536 -0.728 . . . . 0.0 110.006 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.86 131.24 52.42 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.503 1.521 . . . . 0.0 108.945 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -122.31 137.78 54.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.397 0.618 . . . . 0.0 109.635 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.81 116.65 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 125.637 1.575 . . . . 0.0 106.879 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.69 130.39 24.48 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 109.352 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.12 162.07 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.753 1.636 . . . . 0.0 112.871 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.16 2.09 4.36 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.803 1.668 . . . . 0.0 116.029 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.28 -18.41 32.1 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.238 1.415 . . . . 0.0 113.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -132.75 161.05 35.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.763 1.625 . . . . 0.0 110.153 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -93.55 -55.19 3.36 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -139.99 164.34 30.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.615 1.566 . . . . 0.0 109.145 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 163.63 32.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.524 0.73 . . . . 0.0 109.4 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.445 HG21 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -135.5 142.59 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.151 0.58 . . . . 0.0 109.505 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.92 139.27 33.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.271 0.558 . . . . 0.0 110.479 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.55 137.14 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.479 1.111 . . . . 0.0 109.773 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -136.79 153.93 50.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.787 0.835 . . . . 0.0 111.111 -178.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.83 137.75 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 108.789 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -109.87 119.16 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.625 1.17 . . . . 0.0 109.346 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -63.62 89.67 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.433 1.893 . . . . 0.0 112.877 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.84 10.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.454 1.101 . . . . 0.0 112.987 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -80.69 -70.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.133 1.373 . . . . 0.0 110.508 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.23 169.42 8.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.477 1.511 . . . . 0.0 110.729 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.6 t -83.99 -47.45 10.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.957 0.503 . . . . 0.0 112.347 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -61.32 -39.13 89.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 41.44 -148.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.123 1.369 . . . . 0.0 112.271 -170.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.91 26.52 55.12 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 120.927 -1.108 . . . . 0.0 114.137 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.0 m -138.19 15.64 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.468 1.507 . . . . 0.0 114.622 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -133.71 114.26 13.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.542 1.537 . . . . 0.0 110.624 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -111.12 114.43 27.69 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.606 0.762 . . . . 0.0 110.495 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -107.47 117.98 35.53 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.786 2.034 . . . . 0.0 110.161 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -108.13 126.43 52.75 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.1 pt -118.19 140.3 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 110.056 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 m -145.24 93.98 5.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.188 0.995 . . . . 0.0 109.107 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.94 168.49 18.66 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.372 2.048 . . . . 0.0 112.627 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -35.91 101.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.771 2.428 . . . . 0.0 113.65 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.306 2.7 pp0? 42.15 42.08 2.31 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.619 2.367 . . . . 0.0 116.61 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.45 156.8 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.021 1.729 . . . . 0.0 112.099 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -52.33 119.88 4.92 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.219 1.808 . . . . 0.0 112.62 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 142.87 56.37 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.592 0.757 . . . . 0.0 111.513 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.14 117.66 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.624 1.17 . . . . 0.0 110.615 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.73 102.18 13.41 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.209 1.004 . . . . 0.0 110.059 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 3.9 t -93.5 152.16 19.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.51 0.724 . . . . 0.0 110.333 170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -143.49 146.88 33.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.511 1.124 . . . . 0.0 109.289 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -54.9 85.57 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.106 . . . . 0.0 114.052 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.63 -21.44 1.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.547 1.546 . . . . 0.0 113.463 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.66 135.45 56.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.32 1.06 . . . . 0.0 110.602 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.15 64.02 3.22 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.213 1.005 . . . . 0.0 111.725 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 6.5 m-85 60.54 81.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.0 2.12 . . . . 0.0 111.423 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.79 131.97 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.15 -0.969 . . . . 0.0 110.403 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 136.89 32.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 110.515 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.12 98.64 48.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.573 1.949 . . . . 0.0 108.873 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -71.63 138.34 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.717 2.278 . . . . 0.0 111.409 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.49 126.93 22.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 108.541 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.86 167.18 23.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.723 2.949 . . . . 0.0 111.942 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -61.71 122.04 14.34 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.572 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.06 153.02 47.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.351 2.261 . . . . 0.0 109.438 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 t -137.86 136.05 19.48 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.575 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.76 150.41 65.26 Favored 'Cis proline' 0 CA--C 1.548 1.18 0 CA-C-N 119.771 0.954 . . . . 0.0 112.471 -7.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.47 -29.09 62.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.295 1.996 . . . . 0.0 112.494 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.47 3.75 15.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.266 1.427 . . . . 0.0 113.786 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.7 p -67.97 147.7 52.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.138 1.335 . . . . 0.0 112.198 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.15 121.09 16.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.889 0.875 . . . . 0.0 110.829 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.0 tt -109.54 116.51 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.819 0.848 . . . . 0.0 110.668 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.15 142.68 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.0 0.52 . . . . 0.0 109.808 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.6 t -144.63 137.83 26.96 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.982 0.913 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -99.85 139.19 35.88 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.232 0.539 . . . . 0.0 109.55 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.27 124.41 47.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.842 2.057 . . . . 0.0 107.643 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 113.77 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 2.0 p -124.23 140.64 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.181 1.392 . . . . 0.0 108.969 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -139.84 156.45 46.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.056 0.942 . . . . 0.0 111.524 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -65.24 134.34 53.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.2 p -71.96 -8.55 55.13 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.94 10.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.35 2.26 . . . . 0.0 110.383 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.9 t -40.09 134.59 1.43 Allowed Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 125.729 1.612 . . . . 0.0 114.212 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.65 2.36 21.03 Favored 'Cis proline' 0 CA--C 1.546 1.105 0 N-CA-C 114.854 1.059 . . . . 0.0 114.854 3.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 6.89 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.84 2.056 . . . . 0.0 114.243 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.13 156.41 38.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.911 1.285 . . . . 0.0 111.735 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -55.21 143.29 28.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.908 0.883 . . . . 0.0 111.802 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.75 -23.01 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.487 1.515 . . . . 0.0 112.205 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 75.2 t -155.89 141.82 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.75 1.62 . . . . 0.0 108.324 171.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -136.81 113.68 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.676 1.99 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.19 -179.11 39.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.139 0.876 . . . . 0.0 111.993 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.49 149.0 44.96 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.921 -0.752 . . . . 0.0 110.934 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.0 p -138.81 159.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.087 1.355 . . . . 0.0 109.133 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -115.43 130.73 56.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 109.917 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -104.91 152.31 22.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 0.0 109.521 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -149.86 162.86 39.49 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.759 2.024 . . . . 0.0 110.578 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -133.7 123.52 25.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.574 1.55 . . . . 0.0 108.93 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.8 m -77.82 112.51 25.32 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.367 0.667 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.4 54.05 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.542 3.494 . . . . 0.0 112.072 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.3 m -136.92 -52.65 0.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.262 1.425 . . . . 0.0 111.273 -170.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 32.1 p -130.26 12.91 5.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.235 1.414 . . . . 0.0 112.551 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.66 28.81 72.89 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.084 1.326 . . . . 0.0 113.626 -171.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -68.34 156.37 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.476 -1.014 . . . . 0.0 111.141 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -136.02 131.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.8 m -135.53 132.17 36.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.206 1.403 . . . . 0.0 109.23 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.513 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -105.02 117.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.26 1.024 . . . . 0.0 110.255 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -88.64 128.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 134.94 25.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.973 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -148.78 143.91 26.67 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.77 1.628 . . . . 0.0 109.678 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.17 -14.93 4.61 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.11 1.364 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -52.31 -30.43 28.27 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.324 1.85 . . . . 0.0 114.409 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 16.7 p -149.49 -34.72 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.705 1.602 . . . . 0.0 113.623 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -72.88 133.43 82.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 111.608 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.68 130.2 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.545 2.83 . . . . 0.0 111.546 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -73.56 -20.09 60.72 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 167' ' ' VAL . 0.8 OUTLIER -74.86 -13.04 60.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.29 1.036 . . . . 0.0 113.493 177.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.8 mtp -112.53 150.91 30.63 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.515 1.526 . . . . 0.0 108.828 167.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.1 p -142.21 118.28 10.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.238 0.615 . . . . 0.0 109.614 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.17 107.92 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.486 0.66 . . . . 0.0 109.708 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 95.2 m -88.11 143.82 26.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.555 0.693 . . . . 0.0 109.753 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.26 71.14 10.66 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.72 1.208 . . . . 0.0 110.408 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.43 -42.78 64.4 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.301 1.44 . . . . 0.0 113.259 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.08 -177.38 6.54 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.076 1.75 . . . . 0.0 110.991 163.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -50.91 143.45 10.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.256 -1.528 . . . . 0.0 109.574 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 29.9 p 53.13 14.96 0.54 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 t -139.88 108.92 6.03 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.865 1.666 . . . . 0.0 110.958 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 184' ' ' VAL . 22.3 m-85 -120.76 147.62 45.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.177 0.991 . . . . 0.0 111.128 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . 0.272 9.8 tt -133.84 99.08 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 122.51 1.148 . . . . 0.0 110.513 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -73.36 109.91 7.25 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.305 1.842 . . . . 0.0 110.11 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -81.04 138.21 36.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.9 tp -132.07 111.65 11.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.37 1.068 . . . . 0.0 108.667 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -120.73 -3.38 9.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.432 1.493 . . . . 0.0 114.609 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -141.18 -178.55 5.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.012 1.325 . . . . 0.0 111.502 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.1 46.67 0.99 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.082 0.944 . . . . 0.0 113.181 -170.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt . . . . . 0 C--O 1.258 1.531 0 C-N-CA 128.214 2.606 . . . . 0.0 116.986 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.79 138.51 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.724 1.209 . . . . 0.0 110.291 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.58 140.57 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.15 -16.4 32.27 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.845 -1.159 . . . . 0.0 113.109 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.77 9.89 11.49 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 112.45 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -148.17 171.72 15.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.622 1.969 . . . . 0.0 110.738 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 23' ' ' TYR . 2.1 m -141.27 150.99 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 O-C-N 121.035 -1.041 . . . . 0.0 112.412 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -149.64 151.14 33.25 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.807 -0.558 . . . . 0.0 109.631 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.6 159.4 42.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.741 -0.6 . . . . 0.0 110.877 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -130.86 136.46 48.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.223 1.009 . . . . 0.0 111.054 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.63 63.35 3.4 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.732 1.613 . . . . 0.0 111.287 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.47 135.72 1.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.686 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -58.58 126.73 28.82 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 90.28 22.7 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.735 2.414 . . . . 0.0 112.268 -174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.39 55.1 0.86 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.254 1.421 . . . . 0.0 111.408 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.8 p -129.24 -178.78 4.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.682 1.593 . . . . 0.0 112.367 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.95 -107.31 2.15 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.651 1.12 . . . . 0.0 113.773 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.0 167.87 9.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.9 p -133.7 152.22 51.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.835 0.854 . . . . 0.0 112.589 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.49 150.48 29.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -141.97 140.75 32.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.082 0.953 . . . . 0.0 110.734 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 8' ' ' VAL . 1.7 p90 -145.52 142.5 29.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.364 1.066 . . . . 0.0 109.277 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.97 163.89 26.6 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.749 -1.219 . . . . 0.0 112.09 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -76.11 161.31 28.95 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.196 -0.94 . . . . 0.0 111.326 171.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.22 43.65 70.12 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 114.644 0.617 . . . . 0.0 114.644 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 169.88 19.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.438 1.495 . . . . 0.0 111.616 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.4 p -138.95 143.44 38.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.976 0.91 . . . . 0.0 111.502 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -135.59 129.15 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.149 0.979 . . . . 0.0 110.556 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.21 90.53 3.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.756 1.223 . . . . 0.0 108.921 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.42 166.42 14.62 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.973 0.892 . . . . 0.0 111.346 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -111.8 153.42 26.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.6 0.76 . . . . 0.0 110.163 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.92 57.43 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.65 73.59 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.815 1.198 . . . . 0.0 114.411 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -91.91 112.49 24.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.863 0.831 . . . . 0.0 109.381 167.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -21.75 33.9 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.529 -0.732 . . . . 0.0 111.494 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -61.32 -11.65 10.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.358 1.463 . . . . 0.0 112.533 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -67.32 -52.05 45.12 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.444 -1.41 . . . . 0.0 111.392 167.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.09 -10.7 55.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.509 1.524 . . . . 0.0 112.883 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.97 -27.09 63.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.838 1.655 . . . . 0.0 113.313 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -58.43 104.66 0.23 Allowed 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.63 -1.294 . . . . 0.0 111.671 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -27.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.917 1.687 . . . . 0.0 112.438 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 t -142.12 137.17 30.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.474 1.91 . . . . 0.0 111.173 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.73 120.06 13.04 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.462 1.125 . . . . 0.0 112.178 -173.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.46 112.97 24.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.894 1.678 . . . . 0.0 109.839 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 75' ' ' SER . 0.9 OUTLIER -98.93 140.62 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.724 1.209 . . . . 0.0 109.429 173.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.05 -116.78 0.03 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.02 1.295 . . . . 0.0 114.552 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.7 m -147.08 -13.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.666 1.186 . . . . 0.0 113.024 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 36.03 3.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.493 1.517 . . . . 0.0 110.392 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.22 118.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.7 1.6 . . . . 0.0 110.959 -168.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -95.77 140.53 30.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.55 1.14 . . . . 0.0 110.652 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 51.6 m -125.79 112.93 16.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 108.916 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -109.25 134.6 51.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.45 144.04 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.437 0.637 . . . . 0.0 111.839 -171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -142.14 142.06 32.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.37 -166.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -118.62 -29.53 5.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.779 0.832 . . . . 0.0 111.588 -170.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.11 130.59 25.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.411 1.484 . . . . 0.0 111.85 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.93 121.53 41.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.192 0.597 . . . . 0.0 110.967 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -165.81 170.32 14.02 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 0.0 110.953 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.82 21.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.172 1.389 . . . . 0.0 111.539 -169.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.75 -17.19 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.808 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.2 t -41.81 138.88 1.7 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.427 1.491 . . . . 0.0 114.908 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.56 -9.05 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.445 2.763 . . . . 0.0 112.71 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -143.79 115.08 5.58 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.533 1.133 . . . . 0.0 111.52 172.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 49.62 1.92 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.388 2.726 . . . . 0.0 112.033 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 31.66 -107.41 0.02 OUTLIER Glycine 0 CA--C 1.527 0.827 0 C-N-CA 129.008 3.194 . . . . 0.0 114.548 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -123.44 144.64 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.016 0.926 . . . . 0.0 110.252 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.56 153.98 40.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.96 1.704 . . . . 0.0 110.259 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -161.86 153.99 19.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.734 0.814 . . . . 0.0 110.86 167.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.1 93.75 4.25 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.942 1.297 . . . . 0.0 109.172 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.74 134.81 57.45 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 176.3 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.54 -18.65 65.48 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.535 -1.353 . . . . 0.0 113.113 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 111.71 0.5 Allowed Glycine 0 CA--C 1.536 1.36 0 CA-C-N 119.028 0.831 . . . . 0.0 113.357 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER 175.46 162.47 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.728 2.411 . . . . 0.0 111.023 179.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -109.28 142.53 40.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.018 1.327 . . . . 0.0 110.743 171.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -134.18 136.29 43.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.698 1.199 . . . . 0.0 108.676 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -150.24 -50.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.929 0.892 . . . . 0.0 111.374 -170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -81.23 46.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.981 1.312 . . . . 0.0 113.413 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.01 42.61 0.09 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.216 1.406 . . . . 0.0 113.433 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -60.29 -34.69 74.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 112.713 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -65.91 -26.42 67.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.6 mm -72.6 -38.91 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.397 1.079 . . . . 0.0 110.262 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.82 32.6 22.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.714 1.606 . . . . 0.0 113.297 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.14 39.8 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.216 1.389 . . . . 0.0 113.411 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -176.29 3.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 112.399 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -140.53 -31.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.0 136.77 37.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.194 0.998 . . . . 0.0 110.153 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.402 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -145.44 133.86 21.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.78 0.8 . . . . 0.0 110.093 -168.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.32 138.54 53.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.72 -170.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.78 121.92 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.33 135.57 27.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.143 0.577 . . . . 0.0 110.313 -166.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.424 ' CB ' ' HE2' ' A' ' 25' ' ' LYS . 61.4 Cg_endo -76.44 152.59 34.39 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.04 1.827 . . . . 0.0 111.021 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.37 29.13 0.21 Allowed Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.851 1.691 . . . . 0.0 116.121 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.69 -18.23 3.92 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.605 1.962 . . . . 0.0 112.654 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -119.25 156.24 30.29 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.941 0.897 . . . . 0.0 110.167 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -88.24 -41.91 12.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.491 -0.755 . . . . 0.0 111.966 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -150.14 167.64 26.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.143 2.177 . . . . 0.0 108.561 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.63 166.55 23.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.668 -0.645 . . . . 0.0 110.72 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.92 149.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.238 0.615 . . . . 0.0 111.579 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.95 118.17 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.54 130.32 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.803 0.841 . . . . 0.0 111.326 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -127.6 145.58 50.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.39 1.076 . . . . 0.0 110.65 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.14 147.46 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 123.808 0.692 . . . . 0.0 111.651 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.69 127.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.312 1.054 . . . . 0.0 110.132 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -64.03 125.54 24.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.561 1.544 . . . . 0.0 112.242 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -35.14 2.48 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.63 -35.86 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.492 1.117 . . . . 0.0 113.383 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -120.33 139.96 51.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.039 1.336 . . . . 0.0 109.05 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -87.15 6.81 30.98 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.955 -1.091 . . . . 0.0 113.181 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -88.66 -33.65 17.52 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 48.44 -167.35 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.37 17.13 55.95 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 p -141.25 5.95 1.9 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.43 1.115 . . . . 0.0 113.247 -162.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -113.32 152.01 30.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.242 1.017 . . . . 0.0 112.7 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 159' ' ' THR . 3.5 tt0 -127.81 134.76 49.47 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.248 1.419 . . . . 0.0 109.454 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -124.37 139.83 53.53 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.817 -0.552 . . . . 0.0 110.94 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -135.63 119.26 17.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.971 1.309 . . . . 0.0 109.404 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.91 115.15 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 108.968 -170.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.8 m -122.96 92.18 49.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.019 0.528 . . . . 0.0 112.123 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.48 169.52 21.57 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.232 2.621 . . . . 0.0 113.249 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.2 57.71 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.135 1.774 . . . . 0.0 115.269 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.82 -53.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 161.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.0 158.86 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.33 1.052 . . . . 0.0 111.716 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -154.52 -165.2 2.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.239 1.415 . . . . 0.0 110.182 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 56.88 58.79 3.83 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.68 122.52 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.562 1.945 . . . . 0.0 109.957 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.45 112.43 11.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.631 0.772 . . . . 0.0 110.069 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.7 t -97.48 137.55 36.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.682 0.393 . . . . 0.0 110.278 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -104.11 143.34 33.05 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.181 0.992 . . . . 0.0 109.932 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -56.19 131.62 48.31 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 121.962 -0.461 . . . . 0.0 110.984 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.84 8.66 44.9 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.823 1.202 . . . . 0.0 115.356 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.17 155.74 19.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.127 0.963 . . . . 0.0 112.354 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.44 49.55 1.17 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.51 1.124 . . . . 0.0 113.199 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 60.48 104.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.362 2.265 . . . . 0.0 112.44 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.28 141.0 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 134.25 35.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.745 0.784 . . . . 0.0 112.104 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -118.47 102.13 50.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 169.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.63 121.22 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.046 1.83 . . . . 0.0 111.827 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.8 mm -99.76 123.04 49.07 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.368 1.067 . . . . 0.0 110.106 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.99 178.47 7.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.811 2.341 . . . . 0.0 111.97 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 139.8 43.71 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.966 -1.084 . . . . 0.0 113.227 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.16 152.11 29.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.441 1.497 . . . . 0.0 111.724 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -145.14 135.69 12.1 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.215 1.406 . . . . 0.0 110.396 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.03 146.33 68.11 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 120.045 1.052 . . . . 0.0 110.782 -7.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.68 -31.05 33.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.502 2.135 . . . . 0.0 111.393 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.72 5.86 4.51 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.744 1.618 . . . . 0.0 114.979 168.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.5 t -77.1 149.16 35.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.104 0.866 . . . . 0.0 111.74 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.434 0.694 . . . . 0.0 111.374 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 tt -106.0 121.72 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.441 1.096 . . . . 0.0 110.912 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.75 135.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.068 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.4 p -143.2 127.75 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.548 0.689 . . . . 0.0 111.485 169.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 140.77 42.2 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.49 111.12 11.99 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.652 1.215 . . . . 0.0 109.425 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 p -109.06 144.09 37.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.634 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.34 133.57 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -138.9 147.8 42.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.755 1.222 . . . . 0.0 109.23 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -67.14 115.14 6.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.453 -0.78 . . . . 0.0 110.006 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.3 t -65.08 -16.78 63.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.339 1.056 . . . . 0.0 112.528 173.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -114.37 156.7 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 110.794 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 t -69.83 138.99 88.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.491 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.66 129.11 16.51 Favored 'Cis proline' 0 C--N 1.355 0.912 0 CA-C-N 120.721 1.293 . . . . 0.0 110.374 -5.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -76.0 36.68 0.14 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.174 1.39 . . . . 0.0 113.457 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 146.83 52.95 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.046 -1.659 . . . . 0.0 113.158 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -69.62 127.25 32.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.435 0.694 . . . . 0.0 111.01 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 -50.49 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 112.205 -171.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 24.4 m -146.57 139.18 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.884 1.274 . . . . 0.0 109.574 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -130.39 98.29 4.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.465 1.506 . . . . 0.0 108.019 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.05 11.46 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.326 1.441 . . . . 0.0 113.193 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.8 m -135.41 153.72 51.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.801 0.84 . . . . 0.0 111.502 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.51 165.09 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.682 1.593 . . . . 0.0 108.849 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.5 126.89 38.01 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.03 150.89 23.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.456 -0.777 . . . . 0.0 110.414 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -145.31 162.34 37.44 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 125.185 1.394 . . . . 0.0 108.344 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 170.11 19.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 169.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.5 m -133.64 105.52 11.86 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.63 0.772 . . . . 0.0 109.026 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 18.77 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.26 3.306 . . . . 0.0 113.037 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -63.65 -34.06 77.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.008 1.723 . . . . 0.0 112.5 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 t -164.3 26.83 0.07 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 123.176 1.465 . . . . 0.0 112.4 -173.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 60.59 27.99 67.01 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 119.259 -2.151 . . . . 0.0 113.778 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -79.07 142.89 36.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.69 0.745 . . . . 0.0 111.191 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.49 160.67 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.061 0.545 . . . . 0.0 111.414 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.4 m -148.99 129.98 14.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.901 1.28 . . . . 0.0 111.118 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.91 128.07 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.392 0.542 . . . . 0.0 110.433 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.41 130.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.361 1.077 . . . . 0.0 108.612 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.67 135.94 22.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 109.044 -176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -144.43 145.08 31.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.311 1.444 . . . . 0.0 109.693 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.57 -16.7 6.53 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.331 1.452 . . . . 0.0 113.786 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.4 -24.03 64.83 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.9 p -144.7 -30.2 0.45 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.121 1.369 . . . . 0.0 113.727 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -79.42 144.51 61.83 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.895 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.78 158.84 52.24 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.04 1.827 . . . . 0.0 112.284 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -93.65 -2.08 54.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -109.48 -16.47 13.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.135 1.374 . . . . 0.0 113.517 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.1 ttt -134.34 134.13 41.45 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.797 1.239 . . . . 0.0 107.966 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.3 p -136.73 153.36 50.88 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.86 138.61 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.039 0.536 . . . . 0.0 111.039 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 52.2 m -127.12 143.73 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.803 1.241 . . . . 0.0 109.4 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -75.03 85.42 2.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.468 0.652 . . . . 0.0 110.943 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.28 -42.69 82.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.984 1.314 . . . . 0.0 112.136 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -152.26 178.5 9.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.625 1.57 . . . . 0.0 109.696 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.45 135.3 54.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.668 -1.895 . . . . 0.0 110.944 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 m 58.61 23.21 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.558 1.143 . . . . 0.0 113.054 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.13 110.91 6.2 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.591 -0.693 . . . . 0.0 110.829 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.25 145.22 42.02 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.935 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.86 116.69 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.88 0.848 . . . . 0.0 110.663 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -96.7 117.1 30.29 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.267 1.427 . . . . 0.0 110.516 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -100.01 131.89 45.69 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.594 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.49 114.42 20.67 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.89 0.768 . . . . 0.0 112.943 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -117.09 25.4 10.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.734 1.214 . . . . 0.0 113.339 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.0 m -143.74 166.81 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 52.39 1.18 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.023 2.129 . . . . 0.0 110.86 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt . . . . . 0 C--O 1.294 3.401 0 CA-C-O 115.565 -2.16 . . . . 0.0 111.186 177.519 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.191 0.519 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.91 137.97 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.97 0.908 . . . . 0.0 111.365 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.57 147.93 29.38 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.736 -0.602 . . . . 0.0 110.488 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.12 -20.31 52.42 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.839 -1.163 . . . . 0.0 113.835 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -111.2 7.93 21.4 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.501 1.92 . . . . 0.0 113.636 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -143.92 -176.09 4.85 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 110.6 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -145.57 154.03 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.596 0.758 . . . . 0.0 112.733 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 144.41 49.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.902 1.281 . . . . 0.0 110.309 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.414 ' HZ ' ' CE1' ' A' ' 89' ' ' PHE . 14.6 m-85 -132.48 129.66 39.47 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.765 1.626 . . . . 0.0 107.465 -165.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -128.29 121.43 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 123.796 1.76 . . . . 0.0 109.872 -170.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.34 59.26 5.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.735 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.57 149.19 5.78 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.592 1.568 . . . . 0.0 111.357 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.59 151.55 5.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.562 1.145 . . . . 0.0 111.957 175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 49.74 41.54 22.27 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m 50.43 63.19 2.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.465 1.506 . . . . 0.0 113.636 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 18' ' ' GLY . 3.0 m -130.25 -178.21 4.65 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.876 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 17' ' ' THR . . . 74.02 -118.83 6.13 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.078 1.323 . . . . 0.0 111.972 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.11 166.41 11.26 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 117.685 0.742 . . . . 0.0 111.509 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -126.17 146.49 49.94 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.685 1.194 . . . . 0.0 110.965 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.74 155.8 41.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.78 1.232 . . . . 0.0 110.072 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -128.28 142.3 51.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -125.63 125.14 42.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.359 1.064 . . . . 0.0 109.312 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.61 129.01 34.29 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.955 0.902 . . . . 0.0 109.509 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.48 144.68 25.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.475 1.11 . . . . 0.0 112.875 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.02 41.45 9.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.062 0.839 . . . . 0.0 112.939 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.13 153.45 42.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.954 1.301 . . . . 0.0 111.698 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -129.39 131.08 46.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.958 1.303 . . . . 0.0 109.037 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.48 128.23 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 122.579 1.18 . . . . 0.0 109.753 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.6 mtm105 -124.36 89.46 3.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.817 1.247 . . . . 0.0 109.112 -171.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -78.22 168.69 19.45 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.821 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -116.18 157.85 24.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.632 1.173 . . . . 0.0 110.096 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.63 -19.68 65.06 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.263 -0.898 . . . . 0.0 113.073 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.93 -24.05 66.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.221 1.391 . . . . 0.0 114.464 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -98.67 105.14 17.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.283 1.041 . . . . 0.0 109.244 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -21.5 60.48 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.618 -1.301 . . . . 0.0 112.625 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -61.15 -24.21 66.12 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.64 1.976 . . . . 0.0 112.399 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -64.54 -56.14 15.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.693 1.597 . . . . 0.0 111.1 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.5 -18.55 65.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.424 1.49 . . . . 0.0 113.251 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -29.62 69.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.899 2.08 . . . . 0.0 113.222 172.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 86' ' ' LEU . 38.4 t80 -53.27 118.62 3.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.784 0.72 . . . . 0.0 110.259 169.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 mmm -146.12 -16.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.126 0.97 . . . . 0.0 113.435 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.7 m -136.9 151.79 49.48 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 110.783 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.55 155.77 22.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.641 1.176 . . . . 0.0 110.743 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.7 121.7 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 8' ' ' VAL . 62.7 t -92.23 136.69 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.352 0.661 . . . . 0.0 110.137 172.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -106.02 0.01 OUTLIER Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.85 2.166 . . . . 0.0 115.823 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -161.27 -21.78 0.05 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.794 1.638 . . . . 0.0 112.866 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.14 33.14 4.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.622 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.8 121.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.111 1.765 . . . . 0.0 110.109 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -84.69 145.63 27.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.856 -1.153 . . . . 0.0 109.558 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 58.5 m -126.65 147.82 49.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.594 -0.692 . . . . 0.0 110.771 173.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.85 140.09 52.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.667 0.787 . . . . 0.0 109.451 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.512 HG23 HD12 ' A' ' 86' ' ' LEU . 9.1 mt -122.44 138.14 53.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.454 1.102 . . . . 0.0 109.362 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -152.7 120.49 6.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.663 0.785 . . . . 0.0 112.379 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -83.51 -60.95 1.97 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.7 175.02 5.64 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.543 -0.723 . . . . 0.0 110.986 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 202' ' ' ASN . 3.1 p30 -153.92 134.48 13.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.927 0.891 . . . . 0.0 110.31 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -164.8 155.09 14.01 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.314 1.445 . . . . 0.0 110.461 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.35 41.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 111.177 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.09 -34.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.148 1.779 . . . . 0.0 111.606 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 t -56.08 134.5 74.4 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.597 1.159 . . . . 0.0 113.251 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.1 -18.96 9.73 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.095 2.53 . . . . 0.0 113.312 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 t -101.74 130.64 24.14 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.503 1.121 . . . . 0.0 110.637 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.04 174.67 11.61 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.356 2.038 . . . . 0.0 111.657 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.89 -151.64 19.73 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 124.576 1.084 . . . . 0.0 112.558 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 109.01 18.91 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.057 0.543 . . . . 0.0 110.329 168.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.7 148.71 41.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.988 1.315 . . . . 0.0 110.169 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -162.49 137.65 6.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.753 0.821 . . . . 0.0 109.51 168.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -87.91 110.36 20.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 165.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.74 125.7 26.67 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.366 -0.834 . . . . 0.0 109.016 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.85 150.2 5.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.798 1.239 . . . . 0.0 112.181 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -15.49 6.35 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.18 104.86 0.26 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 112.143 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.47 160.62 3.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.98 1.712 . . . . 0.0 111.993 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.7 m -113.98 143.66 44.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.013 1.325 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -141.44 112.54 7.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.606 1.163 . . . . 0.0 109.928 -164.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -126.44 -32.72 2.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.48 1.112 . . . . 0.0 112.379 -170.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -96.58 59.33 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.276 2.63 . . . . 0.0 109.621 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.72 52.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.186 1.394 . . . . 0.0 111.629 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.8 m -62.33 -42.54 99.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.176 -1.578 . . . . 0.0 111.547 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -59.46 -28.21 66.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.004 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -128.95 54.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.418 1.887 . . . . 0.0 108.513 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -65.0 -15.63 62.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.685 1.194 . . . . 0.0 113.401 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.38 20.1 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.014 1.292 . . . . 0.0 109.881 155.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -123.07 150.28 43.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.205 1.802 . . . . 0.0 108.452 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -118.53 -42.59 2.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.303 0.641 . . . . 0.0 112.635 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.06 156.36 46.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.893 1.277 . . . . 0.0 111.73 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 52' ' ' CYS . 8.4 t80 -145.97 150.54 36.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.33 1.052 . . . . 0.0 111.458 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.35 129.67 27.43 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.403 1.081 . . . . 0.0 110.949 172.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 25' ' ' LYS . 2.6 p -106.93 125.18 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.096 1.358 . . . . 0.0 109.209 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.93 147.67 57.38 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.06 1.344 . . . . 0.0 110.644 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 29.6 Cg_endo -67.99 -177.03 1.16 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.261 3.307 . . . . 0.0 113.997 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.91 14.88 4.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.022 1.772 . . . . 0.0 114.144 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.7 -47.98 2.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.562 1.945 . . . . 0.0 110.34 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 139' ' ' PRO . 1.3 m-85 -91.44 157.9 16.8 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.49 1.116 . . . . 0.0 111.146 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -127.66 -37.06 2.0 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.948 1.299 . . . . 0.0 111.958 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -141.64 167.13 22.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.882 2.073 . . . . 0.0 108.066 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.7 159.6 41.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 109.793 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.65 130.05 59.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.082 0.953 . . . . 0.0 109.237 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -82.89 127.68 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.873 0.869 . . . . 0.0 108.816 172.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -119.58 144.6 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.747 0.819 . . . . 0.0 109.296 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -144.41 133.85 23.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.677 0.791 . . . . 0.0 109.826 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.0 pt -78.81 148.75 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.726 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -141.94 120.49 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.593 1.957 . . . . 0.0 107.542 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.15 110.93 4.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.471 0.708 . . . . 0.0 110.57 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 19.29 20.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.49 1.116 . . . . 0.0 112.379 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.8 t -126.45 -69.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.145 1.378 . . . . 0.0 111.597 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -89.08 134.61 33.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.442 0.697 . . . . 0.0 109.425 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -79.77 34.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.825 -1.172 . . . . 0.0 112.573 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 m -138.54 52.85 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.063 2.545 . . . . 0.0 108.536 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.23 144.35 41.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 166.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.09 6.34 4.91 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.362 1.458 . . . . 0.0 114.343 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.5 m -141.55 25.52 2.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.605 1.562 . . . . 0.0 113.388 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -128.82 136.72 50.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.278 1.831 . . . . 0.0 109.149 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.63 121.76 43.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.772 1.229 . . . . 0.0 109.683 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -105.23 144.9 31.38 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.0 0.92 . . . . 0.0 110.245 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -137.82 106.8 5.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.093 1.357 . . . . 0.0 107.348 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.4 tt -103.81 131.45 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 109.507 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.7 m -129.95 86.7 53.97 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.958 1.703 . . . . 0.0 109.043 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.28 163.95 35.95 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.422 2.748 . . . . 0.0 112.265 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -31.67 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.715 2.406 . . . . 0.0 114.39 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 34.01 36.15 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.693 2.397 . . . . 0.0 116.37 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -104.26 155.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.69 1.596 . . . . 0.0 109.999 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -48.9 100.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.852 1.661 . . . . 0.0 111.996 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -59.18 165.2 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.255 1.026 . . . . 0.0 111.435 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.2 136.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.101 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.64 123.6 42.31 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.19 168.02 20.6 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.438 0.695 . . . . 0.0 111.111 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -132.46 155.64 48.17 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.34 1.056 . . . . 0.0 110.323 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.56 116.54 1.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.41 . . . . 0.0 111.79 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.69 15.86 19.31 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -171.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.03 160.62 14.7 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.51 1.124 . . . . 0.0 113.712 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.57 50.02 1.89 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.262 1.425 . . . . 0.0 112.325 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 59.81 78.66 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.186 1.794 . . . . 0.0 111.823 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.1 t -40.92 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.068 1.747 . . . . 0.0 112.452 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -81.99 95.84 7.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 111.72 31.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 96' ' ' PHE . 57.7 Cg_endo -78.98 137.29 13.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.586 2.191 . . . . 0.0 112.008 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.5 mt -128.65 128.47 23.53 Favored Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 121.654 -0.654 . . . . 0.0 110.242 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.91 174.78 11.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.431 2.754 . . . . 0.0 113.38 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -60.33 134.98 57.58 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.737 -0.602 . . . . 0.0 109.951 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.39 146.15 49.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.176 1.39 . . . . 0.0 108.567 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.2 m -131.29 126.8 21.55 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 123.942 0.897 . . . . 0.0 110.216 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.44 155.82 81.93 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 119.008 0.681 . . . . 0.0 111.447 -5.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.0 -24.82 32.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.468 1.445 . . . . 0.0 113.364 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -72.22 -5.94 39.36 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 168.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 160.13 33.11 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.742 1.258 . . . . 0.0 112.935 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -103.14 162.68 12.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.15 1.38 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tt -129.1 132.26 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.638 1.975 . . . . 0.0 109.193 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.56 136.08 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.038 0.935 . . . . 0.0 111.126 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.3 t -143.72 150.11 38.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -112.29 136.69 51.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.019 1.328 . . . . 0.0 109.32 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.55 118.83 22.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.297 1.039 . . . . 0.0 109.166 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 t -125.64 123.04 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.233 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.03 140.4 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.027 1.331 . . . . 0.0 108.635 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -148.52 153.09 37.95 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.955 1.302 . . . . 0.0 110.379 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.65 135.71 56.2 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.058 0.543 . . . . 0.0 110.449 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -72.49 -12.85 61.26 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.458 1.103 . . . . 0.0 113.83 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -141.61 -179.09 5.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.98 2.512 . . . . 0.0 110.034 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 p -52.9 146.79 17.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.763 1.225 . . . . 0.0 113.459 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.94 3.58 17.33 Favored 'Cis proline' 0 CA--C 1.545 1.058 0 N-CA-C 114.878 1.068 . . . . 0.0 114.878 1.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.27 27.0 15.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.144 1.378 . . . . 0.0 113.026 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -80.86 139.34 36.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.054 1.342 . . . . 0.0 110.738 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -55.9 100.22 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.474 1.109 . . . . 0.0 112.232 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.49 -51.82 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.823 1.249 . . . . 0.0 110.443 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.4 t -145.36 126.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.742 1.217 . . . . 0.0 108.177 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.83 91.21 2.87 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.621 1.168 . . . . 0.0 108.361 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -150.79 -152.03 5.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.008 1.289 . . . . 0.0 111.103 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 m -143.05 170.15 16.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.749 0.785 . . . . 0.0 111.049 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.63 146.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.338 1.455 . . . . 0.0 108.52 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -101.37 143.02 31.92 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.01 154.17 33.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.331 1.052 . . . . 0.0 109.402 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -157.44 158.77 36.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.594 1.558 . . . . 0.0 108.261 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -128.36 145.32 51.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.525 0.73 . . . . 0.0 109.818 166.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.6 m -91.73 117.24 67.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 -10.07 27.76 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 2.747 . . . . 0.0 113.129 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.7 p -45.62 -38.47 6.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.088 2.155 . . . . 0.0 113.061 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.8 t -158.89 14.73 0.17 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.007 1.323 . . . . 0.0 112.933 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.39 29.91 76.37 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 119.793 -1.817 . . . . 0.0 112.882 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 160.35 31.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.705 1.202 . . . . 0.0 110.703 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.65 130.95 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.278 -0.889 . . . . 0.0 111.069 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.5 m -145.6 121.45 10.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.475 1.51 . . . . 0.0 110.13 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.8 m -86.71 142.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.487 0.66 . . . . 0.0 111.153 171.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 139.8 29.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.515 1.526 . . . . 0.0 107.927 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 123.04 18.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.788 1.235 . . . . 0.0 109.273 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -149.59 152.32 35.27 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.873 1.669 . . . . 0.0 110.046 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -17.01 5.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.98 1.312 . . . . 0.0 114.449 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.79 -26.6 58.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.665 1.586 . . . . 0.0 114.63 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.6 p -147.81 -38.8 0.19 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.623 1.569 . . . . 0.0 112.984 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -60.95 124.21 78.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.047 1.339 . . . . 0.0 110.827 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.8 -7.93 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.519 2.813 . . . . 0.0 113.554 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 65.39 -16.34 0.1 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 127.914 2.485 . . . . 0.0 115.461 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -73.52 -45.86 51.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.391 2.276 . . . . 0.0 112.716 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.7 ttt -114.17 135.78 53.66 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.219 1.008 . . . . 0.0 108.38 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -116.58 171.46 7.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.551 0.74 . . . . 0.0 109.323 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.07 131.38 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.385 -0.822 . . . . 0.0 109.689 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.4 m -109.2 132.72 53.86 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.571 1.148 . . . . 0.0 109.352 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -75.11 69.91 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.188 1.795 . . . . 0.0 110.624 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -53.96 -42.95 69.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.954 1.302 . . . . 0.0 111.848 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -160.37 178.36 9.67 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.469 1.907 . . . . 0.0 110.967 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.4 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 4.3 m-20 -51.82 142.57 14.89 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.51 -1.369 . . . . 0.0 110.476 164.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.9 p 46.17 27.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.526 1.53 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.1 t -146.9 101.06 3.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.52 1.128 . . . . 0.0 111.369 -171.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.426 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.6 m-85 -116.52 133.73 55.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.31 93.96 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -69.44 125.3 26.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.454 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -121.45 115.05 22.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.844 1.258 . . . . 0.0 111.606 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.77 108.94 7.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.366 1.466 . . . . 0.0 110.523 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -89.95 -15.37 32.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 -174.52 3.02 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.124 1.37 . . . . 0.0 111.511 171.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.99 41.04 0.65 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.76 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.632 0.254 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.11 142.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.247 1.019 . . . . 0.0 110.474 167.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.3 143.07 57.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.49 0.716 . . . . 0.0 109.944 173.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.74 -14.56 62.71 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.435 -1.416 . . . . 0.0 113.126 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -119.01 6.02 11.33 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.273 2.229 . . . . 0.0 113.384 -171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -146.9 175.05 10.95 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.127 2.171 . . . . 0.0 109.042 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.18 154.63 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.229 1.012 . . . . 0.0 110.587 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.49 143.8 31.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.18 131.74 51.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.977 1.311 . . . . 0.0 108.782 -165.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -114.8 135.02 54.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.116 1.436 . . . . 0.0 109.872 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.93 39.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.878 1.671 . . . . 0.0 111.235 -168.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.92 143.12 6.87 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.944 1.259 . . . . 0.0 111.866 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -55.46 147.65 17.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.15 0.98 . . . . 0.0 110.955 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.45 27.52 15.62 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.9 m 61.51 68.88 0.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.091 1.756 . . . . 0.0 113.101 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.1 p -131.66 -173.58 3.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.35 1.86 . . . . 0.0 111.514 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.91 -121.29 9.25 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.887 -1.133 . . . . 0.0 112.39 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.27 172.67 6.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 111.415 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.4 p -134.96 146.97 49.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 111.515 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.88 154.33 45.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.244 1.818 . . . . 0.0 109.255 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -129.98 150.73 51.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.829 0.823 . . . . 0.0 111.754 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -138.49 122.55 17.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.848 1.659 . . . . 0.0 110.341 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -68.76 128.63 37.34 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.934 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG3' HG12 ' A' ' 50' ' ' VAL . 2.9 ttmm -52.41 139.63 24.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.979 0.912 . . . . 0.0 111.406 171.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.1 48.47 4.35 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.043 0.83 . . . . 0.0 112.896 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 177.42 9.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.113 0.965 . . . . 0.0 112.745 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 m -138.75 135.65 34.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.821 1.649 . . . . 0.0 109.155 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.28 120.65 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.265 1.826 . . . . 0.0 109.926 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -117.55 100.4 7.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.57 1.148 . . . . 0.0 108.883 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.51 173.49 7.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.28 1.032 . . . . 0.0 110.364 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -119.15 154.47 33.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -17.56 29.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.647 1.179 . . . . 0.0 113.429 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.84 -35.4 61.85 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.505 1.526 . . . . 0.0 114.477 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.43 119.84 18.22 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.795 1.298 . . . . 0.0 109.677 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.56 67.58 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.088 -1.632 . . . . 0.0 112.374 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -62.89 -25.22 68.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.541 1.536 . . . . 0.0 112.578 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.5 -56.5 10.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.524 1.53 . . . . 0.0 110.87 169.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.9 -21.51 66.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.012 1.325 . . . . 0.0 113.344 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -5.48 3.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.755 2.022 . . . . 0.0 115.336 170.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.2 139.25 1.44 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.883 0.765 . . . . 0.0 110.131 158.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tpt -160.53 -41.34 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.1 p -155.46 169.09 25.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.839 1.256 . . . . 0.0 111.386 171.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -159.54 172.71 17.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 110.814 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 141.95 50.5 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.365 1.466 . . . . 0.0 109.129 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.36 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.507 1.523 . . . . 0.0 109.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.02 -110.87 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.688 2.089 . . . . 0.0 115.42 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.5 m -152.92 -28.31 0.15 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.953 1.301 . . . . 0.0 112.9 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -113.94 31.56 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.516 1.926 . . . . 0.0 110.723 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG12 ' HG3' ' A' ' 25' ' ' LYS . 34.4 m -144.76 133.22 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.447 1.499 . . . . 0.0 109.548 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 154.01 21.17 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.47 -0.769 . . . . 0.0 109.858 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 104.33 6.54 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 0.0 109.365 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.98 130.47 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.806 0.843 . . . . 0.0 109.216 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 89' ' ' PHE . 11.3 tt -124.44 134.18 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 109.611 -169.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.37 137.15 37.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 111.256 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.97 -47.27 4.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.801 1.241 . . . . 0.0 113.124 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -129.12 132.52 47.38 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.814 0.846 . . . . 0.0 109.296 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -129.65 96.42 4.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.064 1.346 . . . . 0.0 110.531 -165.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.87 165.5 25.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.689 1.196 . . . . 0.0 111.658 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.34 17.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.092 1.357 . . . . 0.0 113.049 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -147.9 39.22 0.93 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.09 1.356 . . . . 0.0 111.277 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -125.94 136.63 28.72 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.68 1.192 . . . . 0.0 111.742 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.38 -18.24 16.02 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.774 2.316 . . . . 0.0 112.776 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -75.3 118.61 72.0 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.852 0.861 . . . . 0.0 109.453 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.14 86.78 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.87 2.38 . . . . 0.0 109.485 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -44.32 128.26 6.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.529 1.538 . . . . 0.0 112.852 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -57.92 125.96 25.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.69 0.757 . . . . 0.0 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -142.78 149.52 38.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.182 1.393 . . . . 0.0 108.569 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.53 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.028 0.918 . . . . 0.0 109.957 169.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.36 82.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.328 1.051 . . . . 0.0 109.046 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 71' ' ' LEU . 3.1 mm? -43.43 125.29 3.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.326 1.45 . . . . 0.0 109.303 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.01 146.09 11.77 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.106 0.962 . . . . 0.0 112.18 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -57.82 -14.15 5.49 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.93 116.07 0.77 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.858 1.218 . . . . 0.0 111.598 160.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.34 168.85 2.76 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.298 1.839 . . . . 0.0 112.151 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.9 m -103.34 141.12 36.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.015 0.926 . . . . 0.0 109.477 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -119.35 89.27 3.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.818 1.247 . . . . 0.0 107.759 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.13 -0.64 14.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.366 1.466 . . . . 0.0 113.322 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -144.78 69.92 1.27 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.882 1.673 . . . . 0.0 109.779 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mp -92.86 10.36 31.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.6 m -52.68 -30.8 33.99 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.66 -1.275 . . . . 0.0 112.78 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -58.91 -27.45 65.27 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.9 -25.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.13 0.972 . . . . 0.0 111.424 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.7 t30 68.0 39.89 2.4 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 126.152 1.781 . . . . 0.0 113.986 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.18 153.92 30.62 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.07 -1.019 . . . . 0.0 110.932 -169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -110.58 148.6 31.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.033 1.333 . . . . 0.0 108.317 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -128.44 -40.79 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.738 1.215 . . . . 0.0 113.019 171.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -130.97 140.82 50.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.292 1.037 . . . . 0.0 110.404 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -129.24 142.08 50.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.911 1.285 . . . . 0.0 110.55 172.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -135.37 126.17 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.135 1.374 . . . . 0.0 107.991 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.46 107.7 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 122.487 1.137 . . . . 0.0 109.468 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.97 150.62 42.18 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.253 1.021 . . . . 0.0 109.357 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.66 27.45 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.614 3.543 . . . . 0.0 115.601 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.72 34.7 65.13 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.073 1.32 . . . . 0.0 113.792 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.46 -44.51 0.19 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.156 1.782 . . . . 0.0 110.063 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 5.0 m-85 -83.1 153.1 25.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.168 1.387 . . . . 0.0 110.546 168.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -90.45 -41.12 11.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.529 1.132 . . . . 0.0 111.01 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -155.99 177.89 10.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.363 2.265 . . . . 0.0 108.784 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.47 159.43 43.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.674 0.79 . . . . 0.0 109.713 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 173' ' ' PHE . 10.9 p -120.8 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.75 125.9 30.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.285 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.27 137.76 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 108.666 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -132.21 159.09 40.04 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.494 -0.754 . . . . 0.0 109.562 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.79 136.3 56.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.087 1.755 . . . . 0.0 109.009 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.43 135.61 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.718 1.207 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -91.6 117.92 30.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.659 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -109.19 4.51 22.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.622 1.169 . . . . 0.0 113.082 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.5 t -116.89 -60.98 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.299 1.44 . . . . 0.0 110.933 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.42 -20.61 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.338 1.055 . . . . 0.0 110.841 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.7 m 48.47 31.94 3.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.675 1.99 . . . . 0.0 113.846 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -127.83 31.43 5.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.123 1.769 . . . . 0.0 111.331 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -37.95 104.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.123 2.569 . . . . 0.0 113.293 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.24 10.76 0.05 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.9 p -149.36 14.87 0.89 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.306 1.442 . . . . 0.0 114.136 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -115.86 139.71 49.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.575 1.55 . . . . 0.0 108.064 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -115.12 140.75 48.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 109.067 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttp -134.46 127.66 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.797 0.839 . . . . 0.0 110.272 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.1 m -117.84 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.392 1.077 . . . . 0.0 109.124 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.77 122.9 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.361 1.864 . . . . 0.0 108.753 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.1 m -130.21 99.71 19.32 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.153 1.381 . . . . 0.0 110.175 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.85 169.59 18.67 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.969 3.113 . . . . 0.0 112.39 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -25.23 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.655 2.782 . . . . 0.0 113.724 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 41.53 48.9 3.53 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.97 1.708 . . . . 0.0 115.203 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.7 160.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.918 2.087 . . . . 0.0 111.362 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.85 129.12 9.31 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.762 1.625 . . . . 0.0 112.495 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -64.65 157.06 28.21 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.278 0.561 . . . . 0.0 111.505 169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.08 149.33 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 126.699 1.999 . . . . 0.0 109.701 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.44 91.79 3.72 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.978 0.911 . . . . 0.0 110.887 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.5 t -67.14 139.47 57.49 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -134.32 133.02 40.22 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.519 1.127 . . . . 0.0 108.692 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.59 129.06 40.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.412 0.685 . . . . 0.0 111.296 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.44 18.84 12.21 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.711 1.148 . . . . 0.0 114.867 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.03 156.16 16.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.203 1.401 . . . . 0.0 112.178 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.16 57.54 0.66 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.611 1.564 . . . . 0.0 111.84 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 57.21 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.204 2.201 . . . . 0.0 112.156 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.13 149.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.062 -1.024 . . . . 0.0 111.469 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -114.92 97.87 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.5 tp -75.05 116.39 53.75 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 65.9 Cg_endo -73.46 144.56 36.46 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.175 1.917 . . . . 0.0 112.694 172.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 mm -130.85 130.38 22.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.225 1.41 . . . . 0.0 109.063 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 178.76 4.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.751 2.301 . . . . 0.0 111.895 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 54.8 0.08 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.099 1.76 . . . . 0.0 113.6 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 pp -45.73 134.72 7.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.154 1.382 . . . . 0.0 111.164 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -139.68 133.81 15.83 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.989 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.02 150.04 78.26 Favored 'Cis proline' 0 CA--C 1.545 1.05 0 CA-C-N 119.216 0.756 . . . . 0.0 112.113 -5.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.08 -34.76 45.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.946 1.764 . . . . 0.0 112.431 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -63.77 -10.03 17.72 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 161.41 24.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.244 1.018 . . . . 0.0 112.654 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -84.73 161.28 20.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.976 . . . . 0.0 112.012 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.5 119.47 39.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 109.051 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 172' ' ' TYR . 23.1 m -67.94 136.01 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.671 174.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 p -134.42 142.39 47.12 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.985 0.914 . . . . 0.0 110.319 170.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -101.81 136.87 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.41 152.29 50.79 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 123.137 1.446 . . . . 0.0 112.946 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.32 132.78 28.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.777 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 t -104.93 129.27 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -144.13 133.75 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.4 156.26 23.05 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.707 -0.621 . . . . 0.0 112.048 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.0 p -89.76 -27.13 20.24 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.46 169.03 9.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.962 2.105 . . . . 0.0 111.267 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -52.65 150.74 8.94 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.98 9.24 15.48 Favored 'Cis proline' 0 CA--C 1.547 1.146 0 N-CA-C 115.818 1.43 . . . . 0.0 115.818 2.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.28 30.07 17.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.256 1.022 . . . . 0.0 112.482 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 148.69 31.84 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.502 -1.374 . . . . 0.0 112.161 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.94 106.66 2.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.52 1.128 . . . . 0.0 111.539 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.63 -59.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.656 1.582 . . . . 0.0 109.956 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 194' ' ' ASN . 41.9 t -125.53 143.07 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.103 -1.623 . . . . 0.0 108.957 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 101.21 3.64 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.085 1.354 . . . . 0.0 107.391 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.23 -164.81 15.93 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.461 1.029 . . . . 0.0 111.567 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.33 151.39 37.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.398 -1.06 . . . . 0.0 111.644 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.3 142.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.817 1.647 . . . . 0.0 109.285 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 151' ' ' VAL . 10.0 m-30 -107.51 105.36 15.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.607 -0.683 . . . . 0.0 109.162 -171.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 100' ' ' VAL . 64.9 m-85 -84.11 160.9 20.81 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.726 0.774 . . . . 0.0 110.012 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -158.95 161.34 36.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.832 2.053 . . . . 0.0 108.197 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.76 141.46 50.37 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.884 0.874 . . . . 0.0 109.256 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.0 m -96.42 110.24 51.73 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.104 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.11 53.29 3.34 Favored 'Trans proline' 0 CA--C 1.541 0.85 1 C-N-CA 125.492 4.128 . . . . 0.0 112.704 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -134.86 -43.33 0.74 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 111.187 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.7 p -146.7 19.33 1.31 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.455 1.502 . . . . 0.0 113.584 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.41 31.7 63.06 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 120.414 -1.428 . . . . 0.0 113.584 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -85.64 146.7 26.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.582 1.153 . . . . 0.0 111.097 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.1 t -127.03 85.78 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.469 1.508 . . . . 0.0 110.218 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -81.98 163.15 22.34 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.92 -1.112 . . . . 0.0 111.638 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.84 125.6 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.982 0.913 . . . . 0.0 109.327 -170.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.91 139.73 22.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.842 2.057 . . . . 0.0 109.111 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 119.86 12.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.174 1.79 . . . . 0.0 109.088 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -147.62 150.99 35.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.924 1.69 . . . . 0.0 110.097 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 -17.78 6.88 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.77 -23.49 63.31 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.001 1.32 . . . . 0.0 114.083 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.4 p -150.05 -45.06 0.13 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.509 1.524 . . . . 0.0 113.65 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.409 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 36.8 t80 -61.35 138.37 94.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 111.4 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 73.6 Cg_endo -69.15 178.36 4.26 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.223 2.615 . . . . 0.0 112.502 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -128.1 -35.63 2.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.65 1.18 . . . . 0.0 112.434 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.497 HD21 HG22 ' A' ' 167' ' ' VAL . 15.9 p-10 -66.0 -17.7 64.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.534 1.934 . . . . 0.0 113.565 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -125.18 145.1 50.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.698 1.599 . . . . 0.0 109.055 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 p -128.42 167.63 16.75 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.879 1.672 . . . . 0.0 110.114 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 9.7 p -144.97 147.71 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.288 -0.882 . . . . 0.0 110.614 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 99.9 m -127.68 130.33 48.71 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.252 1.021 . . . . 0.0 109.386 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.03 103.4 7.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.517 0.727 . . . . 0.0 110.108 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.13 -45.3 34.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 122.001 -0.437 . . . . 0.0 111.235 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -145.51 -175.15 4.61 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.17 1.788 . . . . 0.0 111.766 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -56.4 -25.32 49.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.8 m -149.7 49.01 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.667 1.187 . . . . 0.0 108.14 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 58.8 m -151.76 110.45 3.82 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.31 2.244 . . . . 0.0 109.507 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 138.04 54.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.388 1.075 . . . . 0.0 110.382 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 tt -133.83 108.78 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.148 0.975 . . . . 0.0 110.005 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -90.54 133.98 34.69 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.707 1.603 . . . . 0.0 110.214 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -127.32 121.33 30.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.724 1.21 . . . . 0.0 109.381 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.55 101.15 13.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.337 0.655 . . . . 0.0 110.898 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.91 -18.28 29.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.624 1.97 . . . . 0.0 114.464 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.5 m -152.86 140.89 20.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.065 2.546 . . . . 0.0 109.02 170.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.9 -46.2 82.09 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 119.937 1.244 . . . . 0.0 112.413 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.649 1.979 . . . . 0.0 111.932 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.9 140.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.802 0.841 . . . . 0.0 110.535 168.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.57 142.44 56.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.329 0.652 . . . . 0.0 110.076 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.6 -17.35 54.82 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.673 -1.267 . . . . 0.0 113.042 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.51 3.75 11.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.919 1.688 . . . . 0.0 113.193 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -146.68 170.84 16.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.291 2.236 . . . . 0.0 109.061 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 23' ' ' TYR . 17.2 m -132.77 162.26 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.82 -0.55 . . . . 0.0 110.487 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.14 143.94 28.63 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.801 -0.562 . . . . 0.0 110.98 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.3 147.07 38.32 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.449 1.099 . . . . 0.0 108.465 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.65 118.94 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 123.181 1.467 . . . . 0.0 110.241 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.78 48.73 1.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.969 1.307 . . . . 0.0 110.516 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.4 144.71 5.95 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.856 1.694 . . . . 0.0 111.074 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -55.91 137.53 50.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.09 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 72.56 40.14 0.66 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.349 1.46 . . . . 0.0 113.964 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.342 27.5 p 47.41 56.82 6.49 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.436 1.894 . . . . 0.0 114.582 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.7 p -123.74 -174.78 3.06 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.45 1.5 . . . . 0.0 112.213 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.05 -109.74 2.91 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.931 1.253 . . . . 0.0 112.683 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -107.36 163.59 12.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.663 0.785 . . . . 0.0 110.876 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 p -130.31 144.4 51.36 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.971 0.909 . . . . 0.0 111.425 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -141.74 151.14 42.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.204 1.402 . . . . 0.0 110.069 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.97 147.84 49.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.929 0.892 . . . . 0.0 111.681 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB2' HG23 ' A' ' 8' ' ' VAL . 22.7 m-85 -140.96 137.57 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.077 0.951 . . . . 0.0 111.643 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.63 151.03 30.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.755 1.222 . . . . 0.0 109.584 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -63.73 150.45 44.47 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.529 -0.732 . . . . 0.0 111.157 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.23 50.34 57.07 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 122.115 -0.366 . . . . 0.0 113.862 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -137.16 141.25 42.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.202 1.401 . . . . 0.0 110.912 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.2 m -123.99 130.72 53.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.062 0.945 . . . . 0.0 109.577 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.84 117.21 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 100.61 7.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -80.1 162.5 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.734 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -106.54 152.25 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.318 0.647 . . . . 0.0 109.965 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -17.07 53.58 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.66 82.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.314 0.959 . . . . 0.0 114.312 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -84.73 108.34 17.38 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.196 0.998 . . . . 0.0 110.042 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.95 -23.06 52.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.031 -1.043 . . . . 0.0 112.757 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -60.09 -22.91 63.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.814 1.646 . . . . 0.0 112.226 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -65.76 -56.06 14.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.454 1.101 . . . . 0.0 112.422 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.32 -15.89 58.7 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.171 0.989 . . . . 0.0 113.65 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -61.25 -23.36 65.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.629 1.572 . . . . 0.0 113.695 173.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -46.38 129.3 10.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 111.57 166.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmt -149.65 -31.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.294 1.038 . . . . 0.0 113.58 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -144.68 165.77 27.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.61 1.964 . . . . 0.0 110.682 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.61 168.32 23.67 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.347 -0.846 . . . . 0.0 110.867 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.01 128.5 20.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.906 0.882 . . . . 0.0 109.621 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.02 129.17 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 109.005 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.79 -98.1 0.01 OUTLIER Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.022 1.772 . . . . 0.0 116.617 -170.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.9 p -168.17 -25.68 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.681 1.192 . . . . 0.0 112.817 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -115.8 29.6 7.88 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.12 1.368 . . . . 0.0 111.266 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.24 116.38 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.838 1.655 . . . . 0.0 110.135 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -79.43 152.93 30.04 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.306 -0.871 . . . . 0.0 109.456 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 138.19 45.46 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.599 1.159 . . . . 0.0 109.242 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.92 119.48 23.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 71' ' ' LEU . 11.7 pt -118.42 118.11 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.199 0.999 . . . . 0.0 111.298 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -124.15 142.63 51.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.771 1.628 . . . . 0.0 108.887 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.92 -44.22 3.05 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.965 0.906 . . . . 0.0 111.363 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -119.18 140.28 50.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.466 0.651 . . . . 0.0 111.025 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -140.97 120.29 13.04 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.826 1.25 . . . . 0.0 109.057 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -158.62 163.41 36.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.177 0.991 . . . . 0.0 111.046 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt -147.68 51.31 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.206 1.403 . . . . 0.0 111.065 -167.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -177.48 -31.64 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.961 2.105 . . . . 0.0 110.722 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -58.9 137.95 87.31 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.221 1.008 . . . . 0.0 112.994 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.01 -23.09 5.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.523 2.149 . . . . 0.0 113.578 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 t -76.0 120.26 80.86 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 119.015 0.825 . . . . 0.0 111.138 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.47 114.97 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.279 1.32 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.89 156.61 32.34 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.405 1.003 . . . . 0.0 113.592 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -65.4 123.9 20.83 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.305 1.052 . . . . 0.0 111.717 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -140.87 143.47 34.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.47 2.308 . . . . 0.0 108.822 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 125.97 6.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.345 1.069 . . . . 0.0 110.406 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.63 105.64 11.08 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.137 0.97 . . . . 0.0 109.904 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 54' ' ' ILE . 1.7 tp -63.18 121.24 13.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.613 0.765 . . . . 0.0 109.068 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.52 141.28 16.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.628 1.171 . . . . 0.0 112.398 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -59.78 -15.06 17.56 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.45 118.81 0.91 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.606 1.098 . . . . 0.0 111.444 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.37 169.33 1.05 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.264 1.826 . . . . 0.0 111.646 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.1 m -105.22 144.51 31.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.873 1.269 . . . . 0.0 110.455 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -124.33 98.31 5.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.373 1.069 . . . . 0.0 108.636 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.48 -35.94 7.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.324 1.049 . . . . 0.0 112.823 -164.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -143.96 112.09 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.405 1.482 . . . . 0.0 108.915 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 26.04 2.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.501 1.52 . . . . 0.0 111.006 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -51.39 -33.46 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.304 1.042 . . . . 0.0 112.574 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -58.18 -21.46 47.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.89 -9.27 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.326 1.45 . . . . 0.0 112.598 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 82.29 39.97 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.409 2.283 . . . . 0.0 112.266 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.16 -133.59 31.13 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.337 -1.477 . . . . 0.0 110.76 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.3 tp -146.81 160.89 41.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.938 1.369 . . . . 0.0 110.875 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 p -144.58 -35.96 0.33 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.86 0.864 . . . . 0.0 113.141 155.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -129.14 139.66 51.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.905 0.882 . . . . 0.0 110.635 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.66 135.64 48.75 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.121 0.969 . . . . 0.0 110.591 173.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -129.21 130.46 46.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.881 0.873 . . . . 0.0 109.401 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.82 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.378 1.471 . . . . 0.0 107.539 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.21 142.11 33.02 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.612 0.765 . . . . 0.0 110.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.95 32.0 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.862 3.041 . . . . 0.0 114.794 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.34 60.17 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.862 1.22 . . . . 0.0 113.763 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.73 -25.13 2.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.396 1.478 . . . . 0.0 112.768 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 139' ' ' PRO . 1.3 m-85 -118.13 141.71 48.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.684 1.594 . . . . 0.0 108.15 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -79.59 -33.68 41.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.383 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.461 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 18.8 p-90 -149.01 174.44 12.29 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.582 1.953 . . . . 0.0 109.053 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.89 23.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.993 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -137.94 130.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.097 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.36 131.25 34.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.858 0.863 . . . . 0.0 110.11 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 m -133.04 142.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.402 1.081 . . . . 0.0 110.289 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -144.95 144.16 30.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.97 0.908 . . . . 0.0 110.545 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 pt -87.65 153.71 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.8 120.48 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.18 1.392 . . . . 0.0 108.335 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -58.96 103.08 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.96 1.304 . . . . 0.0 112.196 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 16.94 22.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.507 1.123 . . . . 0.0 111.359 168.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.82 -35.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.618 1.567 . . . . 0.0 113.035 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -96.8 170.88 8.87 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.6 1.16 . . . . 0.0 111.649 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -109.71 -45.56 3.64 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.47 -0.769 . . . . 0.0 113.044 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.6 m -71.48 -31.22 66.88 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.505 1.122 . . . . 0.0 112.528 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.93 -44.38 0.56 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.114 2.166 . . . . 0.0 114.117 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.04 42.06 0.36 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.014 2.245 . . . . 0.0 115.017 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.7 p -129.74 -1.16 4.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.861 2.064 . . . . 0.0 112.005 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -118.63 150.37 39.81 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.185 1.394 . . . . 0.0 111.653 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.96 127.67 29.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.762 1.225 . . . . 0.0 109.971 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.7 ttm -102.89 122.55 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.761 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.4 m -116.0 117.69 30.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 26.5 pt -122.66 142.15 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.76 0.79 . . . . 0.0 112.277 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 78.7 m -135.23 85.84 32.22 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.283 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.47 167.66 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.43 2.087 . . . . 0.0 111.766 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -33.9 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.64 2.376 . . . . 0.0 114.538 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 39.68 51.12 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.538 1.935 . . . . 0.0 114.528 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.13 148.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.901 1.68 . . . . 0.0 110.436 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -51.35 111.89 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.665 1.186 . . . . 0.0 111.36 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.29 134.62 39.47 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.516 0.726 . . . . 0.0 110.735 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.84 127.53 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.39 114.58 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.226 1.011 . . . . 0.0 109.061 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.28 146.02 46.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.42 0.688 . . . . 0.0 110.956 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -117.76 170.59 8.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.831 0.852 . . . . 0.0 110.552 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.3 69.93 1.63 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.62 1.2 . . . . 0.0 112.135 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.03 0.08 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.001 1.762 . . . . 0.0 111.309 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.52 161.93 36.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.698 1.199 . . . . 0.0 111.585 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.56 55.16 1.65 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.999 1.32 . . . . 0.0 111.935 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 60.33 93.1 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.225 2.21 . . . . 0.0 112.722 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.99 139.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.344 0.658 . . . . 0.0 111.645 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -97.94 123.6 42.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.874 0.869 . . . . 0.0 110.336 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 127.51 37.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.454 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 86.1 Cg_endo -77.53 128.31 9.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.487 2.125 . . . . 0.0 110.999 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.461 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 6.5 mm -128.15 125.56 23.44 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.518 0.727 . . . . 0.0 109.619 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.44 178.02 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.419 2.079 . . . . 0.0 111.534 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -14.28 43.75 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.867 -1.145 . . . . 0.0 113.577 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp 55.21 -175.42 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.428 1.891 . . . . 0.0 112.319 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.7 t -153.63 106.3 2.54 Favored Pre-proline 0 C--O 1.241 0.606 0 O-C-N 121.265 -0.897 . . . . 0.0 111.282 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.26 165.14 69.22 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 119.386 0.816 . . . . 0.0 113.142 -9.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.64 -30.98 41.6 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.211 1.941 . . . . 0.0 114.082 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.98 2.09 13.59 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -73.69 144.51 45.76 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.992 -1.068 . . . . 0.0 112.004 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -70.28 157.97 36.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 113.117 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tt -125.94 122.48 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.649 1.18 . . . . 0.0 109.445 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.28 132.71 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 110.414 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -138.7 122.2 17.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.651 0.781 . . . . 0.0 110.758 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -82.29 134.38 35.27 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 171.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.04 119.59 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 109.557 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.1 p -124.16 113.38 18.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.338 1.055 . . . . 0.0 109.033 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 t -104.39 125.02 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -140.44 151.44 44.89 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.629 1.572 . . . . 0.0 109.115 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -67.26 141.55 57.2 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.81 -0.556 . . . . 0.0 111.979 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.9 p -67.9 -24.71 65.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.02 0.928 . . . . 0.0 113.16 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -144.34 179.67 7.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.716 2.006 . . . . 0.0 110.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.6 t -41.55 136.55 1.89 Allowed Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.216 1.806 . . . . 0.0 113.863 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.22 8.68 31.0 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 N-CA-C 114.683 0.994 . . . . 0.0 114.683 5.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.63 27.56 16.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.166 1.387 . . . . 0.0 112.719 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.77 151.11 36.11 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.25 -1.531 . . . . 0.0 113.157 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -78.57 128.43 33.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.999 1.32 . . . . 0.0 111.401 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.7 -38.41 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.431 1.493 . . . . 0.0 111.602 -175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.58 138.5 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.76 1.224 . . . . 0.0 108.557 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -150.12 76.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.23 1.012 . . . . 0.0 108.905 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.09 -168.56 14.85 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.715 1.626 . . . . 0.0 111.938 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -133.32 160.48 37.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.291 -1.123 . . . . 0.0 112.593 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.41 147.35 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.272 1.429 . . . . 0.0 108.124 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.2 131.38 52.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.377 0.608 . . . . 0.0 109.592 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -110.06 153.29 24.85 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -163.04 148.35 11.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -120.44 151.51 39.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.378 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 73.7 m -90.39 110.78 43.31 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.039 0.936 . . . . 0.0 108.66 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.45 52.3 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 124.993 3.796 . . . . 0.0 112.298 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.2 m -130.08 -40.22 1.33 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.792 2.037 . . . . 0.0 111.687 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 t -149.22 30.03 0.78 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.93 1.292 . . . . 0.0 111.408 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.19 35.87 43.25 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.86 -1.15 . . . . 0.0 113.151 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.59 118.2 18.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.905 0.882 . . . . 0.0 109.169 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.4 139.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.572 0.749 . . . . 0.0 109.917 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 49.5 m -143.36 158.36 43.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.599 1.56 . . . . 0.0 110.571 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -128.49 129.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.711 0.804 . . . . 0.0 110.904 174.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.04 129.89 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 107.979 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.409 ' HE2' HG23 ' A' ' 184' ' ' VAL . 8.1 mtmt -140.45 122.85 16.01 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.835 1.254 . . . . 0.0 108.605 -171.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -150.22 146.49 26.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -55.83 -18.02 7.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 113.811 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -59.2 -25.62 64.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.64 1.976 . . . . 0.0 114.207 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.1 p -145.12 -43.14 0.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.528 1.531 . . . . 0.0 113.096 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.413 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 66.1 t80 -60.58 135.58 92.1 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.065 1.746 . . . . 0.0 111.889 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 38.0 Cg_endo -79.09 -172.44 1.54 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.022 2.482 . . . . 0.0 111.341 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.82 31.85 3.3 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.964 1.306 . . . . 0.0 113.593 -166.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -148.31 -32.41 0.25 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.228 1.811 . . . . 0.0 113.737 -164.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.3 ttt -125.1 140.04 53.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.272 2.229 . . . . 0.0 107.928 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.9 p -127.49 159.38 34.73 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.388 0.675 . . . . 0.0 109.864 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.03 131.28 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 t -116.58 147.77 41.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.134 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -85.45 83.68 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.669 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.42 -29.74 69.18 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.718 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.07 174.05 15.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.905 1.682 . . . . 0.0 111.171 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.77 140.58 57.54 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.989 -1.694 . . . . 0.0 110.333 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p 53.66 12.68 0.42 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.224 2.209 . . . . 0.0 114.836 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.3 t -133.91 105.25 6.66 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.595 1.158 . . . . 0.0 111.664 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 184' ' ' VAL . 20.7 m-85 -108.03 148.37 29.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.276 1.03 . . . . 0.0 111.833 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.8 tt -134.11 116.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.734 0.778 . . . . 0.0 109.252 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.3 125.11 37.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.998 1.319 . . . . 0.0 109.727 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -109.48 123.71 49.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.106 0.962 . . . . 0.0 109.187 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.49 96.57 6.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 111.077 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -87.57 -25.99 23.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.282 1.033 . . . . 0.0 112.329 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.2 t -90.56 176.34 6.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.733 1.213 . . . . 0.0 113.002 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.48 57.44 0.94 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.722 1.209 . . . . 0.0 110.06 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 116.99 -1.481 . . . . 0.0 113.371 173.091 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.545 0.212 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.42 154.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.892 1.277 . . . . 0.0 109.302 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.98 143.88 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.475 0.71 . . . . 0.0 110.983 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.0 -20.38 23.67 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.54 15.41 22.95 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.389 2.276 . . . . 0.0 113.348 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -140.26 169.33 17.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.462 -1.399 . . . . 0.0 110.033 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 23' ' ' TYR . 25.4 m -136.49 145.66 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.837 0.855 . . . . 0.0 109.968 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.0 144.79 49.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.056 1.342 . . . . 0.0 109.201 -174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 44' ' ' CYS . 1.2 m-85 -132.85 120.27 21.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.1 1.36 . . . . 0.0 109.601 -171.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.17 125.93 42.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.261 1.424 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.17 43.12 0.43 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.511 1.924 . . . . 0.0 112.602 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.1 137.91 2.49 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.758 2.123 . . . . 0.0 110.601 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -51.84 159.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.831 0.852 . . . . 0.0 111.289 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 t30 64.83 22.78 12.58 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m 54.84 57.16 5.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.34 1.456 . . . . 0.0 113.126 -173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.6 p -131.82 -177.92 4.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.737 1.215 . . . . 0.0 112.393 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.54 -119.08 4.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.283 0.944 . . . . 0.0 111.772 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.72 -178.22 3.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.241 1.416 . . . . 0.0 110.834 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p -136.6 153.81 50.85 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.794 -1.191 . . . . 0.0 111.387 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.27 155.19 41.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.105 1.362 . . . . 0.0 110.451 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.64 138.31 51.14 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 109.945 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 8' ' ' VAL . 33.2 m-85 -134.21 144.52 48.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.195 1.398 . . . . 0.0 110.705 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -79.99 149.17 30.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.535 1.134 . . . . 0.0 111.128 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -63.24 157.48 22.55 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.323 1.049 . . . . 0.0 111.688 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.3 39.54 97.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.387 0.518 . . . . 0.0 113.019 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.51 160.81 32.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.578 1.551 . . . . 0.0 109.758 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.4 p -138.96 151.15 46.64 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.276 -1.515 . . . . 0.0 109.099 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.84 116.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.306 1.051 . . . . 0.0 108.628 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 mtm105 -125.91 92.52 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 108.684 -164.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.34 153.0 21.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.418 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -95.83 147.05 24.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.419 0.687 . . . . 0.0 110.763 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -67.61 2.23 1.96 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.69 80.99 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.265 1.412 . . . . 0.0 114.736 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -133.9 120.56 20.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.934 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -13.18 2.15 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -57.16 -20.6 27.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.562 1.545 . . . . 0.0 112.49 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -65.16 -54.79 24.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.043 0.838 . . . . 0.0 111.749 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.65 -22.8 57.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.122 1.369 . . . . 0.0 113.251 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -51.36 -42.07 61.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.964 1.306 . . . . 0.0 113.541 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -67.0 31.19 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 126.575 1.95 . . . . 0.0 114.042 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.01 -38.11 89.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.561 2.345 . . . . 0.0 113.917 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -112.22 151.9 29.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.749 1.159 . . . . 0.0 110.754 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 10' ' ' PHE . 6.1 p -169.03 167.38 10.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 123.046 1.403 . . . . 0.0 113.154 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.84 125.56 14.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.126 1.37 . . . . 0.0 108.405 -172.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.8 133.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.225 1.81 . . . . 0.0 108.306 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.85 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.634 1.588 . . . . 0.0 115.886 -168.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -156.47 -22.63 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.239 1.416 . . . . 0.0 113.77 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.94 16.26 12.55 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.732 1.613 . . . . 0.0 111.801 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -145.36 152.36 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.412 1.885 . . . . 0.0 110.216 -173.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -116.99 156.78 26.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.687 1.195 . . . . 0.0 110.041 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.2 t -127.05 131.03 51.03 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.005 0.922 . . . . 0.0 108.725 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -112.87 140.14 47.91 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.143 1.377 . . . . 0.0 107.584 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' CG1' HD23 ' A' ' 86' ' ' LEU . 5.3 tt -129.39 137.96 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.194 0.998 . . . . 0.0 109.363 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.1 120.24 8.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.269 1.428 . . . . 0.0 111.263 -161.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -95.27 -63.02 1.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.107 -0.995 . . . . 0.0 112.7 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.21 142.46 37.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.581 1.153 . . . . 0.0 109.54 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -134.42 105.7 6.7 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.921 -1.112 . . . . 0.0 109.431 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -142.0 152.44 43.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.209 1.404 . . . . 0.0 110.38 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.4 45.72 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.19 1.796 . . . . 0.0 111.012 -166.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -169.82 -26.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.476 2.31 . . . . 0.0 111.945 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -60.52 137.27 92.48 Favored Pre-proline 0 CA--C 1.543 0.712 0 C-N-CA 125.39 1.476 . . . . 0.0 112.673 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.61 -23.89 9.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.28 2.653 . . . . 0.0 112.937 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -99.61 117.29 63.95 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 124.744 1.217 . . . . 0.0 109.127 171.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.46 155.14 64.25 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.257 1.305 . . . . 0.0 110.033 168.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.6 -136.55 0.71 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.032 0.825 . . . . 0.0 112.947 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -122.76 137.93 54.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.234 1.016 . . . . 0.0 112.921 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.72 167.78 23.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.13 2.172 . . . . 0.0 109.797 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -157.19 142.28 17.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 111.339 170.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -94.85 98.59 10.84 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.733 1.213 . . . . 0.0 110.734 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.89 124.15 18.23 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.998 -1.063 . . . . 0.0 108.668 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.81 153.35 3.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.034 0.934 . . . . 0.0 112.849 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.24 -10.16 2.71 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.93 112.26 0.52 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.424 1.012 . . . . 0.0 111.859 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.05 159.67 2.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.343 1.857 . . . . 0.0 111.983 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 m -104.31 140.12 38.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.538 1.135 . . . . 0.0 110.066 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.504 ' HB3' HD11 ' A' ' 80' ' ' LEU . 12.7 m-80 -130.95 121.06 24.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.658 1.583 . . . . 0.0 108.556 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.98 -22.9 2.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -66.12 0.8 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.733 1.213 . . . . 0.0 110.771 171.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 42' ' ' MET . 4.0 mp 41.01 34.87 0.31 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.043 2.137 . . . . 0.0 113.381 -170.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -62.85 -31.19 72.16 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.765 -1.209 . . . . 0.0 112.406 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -63.19 -28.39 70.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.831 0.852 . . . . 0.0 113.284 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.71 -35.22 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.409 1.484 . . . . 0.0 110.978 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 54.38 55.07 8.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.148 1.379 . . . . 0.0 113.475 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.14 -152.99 16.86 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.448 1.499 . . . . 0.0 111.862 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 87' ' ' SER . 2.1 tm? -153.91 146.05 23.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.684 1.193 . . . . 0.0 111.525 166.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.494 ' H ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -125.25 -63.77 1.13 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 153.09 50.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.386 1.475 . . . . 0.0 110.809 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.38 147.68 22.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.908 0.861 . . . . 0.0 111.883 -170.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -139.02 120.97 15.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.48 1.512 . . . . 0.0 109.58 -168.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.11 118.51 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.253 0.621 . . . . 0.0 109.465 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.3 mt -125.64 126.81 24.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.554 1.142 . . . . 0.0 109.898 -164.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.9 162.63 23.67 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.611 2.207 . . . . 0.0 112.185 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.29 -5.23 15.07 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.765 1.174 . . . . 0.0 115.644 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.7 -19.76 32.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.276 1.43 . . . . 0.0 113.606 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.53 165.63 24.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.746 1.618 . . . . 0.0 110.03 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.95 -46.81 3.69 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.955 -1.091 . . . . 0.0 111.634 -173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.27 148.05 47.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.68 1.592 . . . . 0.0 107.903 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.84 157.57 42.53 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.45 149.42 24.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.014 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 144.43 26.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.99 139.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.429 1.091 . . . . 0.0 109.596 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -143.15 157.97 44.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.562 1.145 . . . . 0.0 110.681 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.45 145.91 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.072 0.949 . . . . 0.0 112.181 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.44 105.02 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.519 1.928 . . . . 0.0 109.534 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.86 89.49 4.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 112.532 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.54 -32.0 36.86 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.182 -0.949 . . . . 0.0 112.477 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.44 -46.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.9 -24.6 35.58 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.469 0.577 . . . . 0.0 111.485 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t 65.72 -42.82 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.379 3.071 . . . . 0.0 115.437 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -57.42 -37.69 73.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.775 1.63 . . . . 0.0 112.833 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.69 176.11 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.928 1.691 . . . . 0.0 113.993 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.72 28.17 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.921 1.248 . . . . 0.0 114.639 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -140.78 30.58 1.86 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -162.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -120.16 147.52 44.79 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.79 1.636 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.95 126.21 33.5 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.966 1.306 . . . . 0.0 109.409 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 63.1 ttp -126.09 132.43 51.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.884 1.274 . . . . 0.0 110.148 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.9 m -123.09 106.76 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.337 1.455 . . . . 0.0 108.615 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.85 125.37 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.2 t -144.93 123.47 6.69 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.87 170.15 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.962 3.108 . . . . 0.0 113.004 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -42.46 106.43 0.06 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.391 1.876 . . . . 0.0 113.371 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? 47.07 57.03 6.08 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.801 1.64 . . . . 0.0 113.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -126.18 159.32 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.588 1.955 . . . . 0.0 109.919 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -55.23 109.67 0.57 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.152 0.981 . . . . 0.0 111.455 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.81 152.03 20.05 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.442 0.697 . . . . 0.0 111.518 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.61 150.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.262 1.025 . . . . 0.0 110.141 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.69 103.63 10.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 109.42 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.97 146.22 30.83 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.422 0.689 . . . . 0.0 109.61 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -133.82 144.02 48.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.204 1.002 . . . . 0.0 110.546 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.94 108.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.022 2.129 . . . . 0.0 111.025 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.54 -17.03 14.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.445 1.021 . . . . 0.0 114.49 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.0 136.48 57.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.823 1.311 . . . . 0.0 109.927 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -74.59 57.9 0.76 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.076 1.751 . . . . 0.0 112.51 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 63.37 90.49 0.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.858 2.463 . . . . 0.0 111.152 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.97 149.96 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 120.918 -1.114 . . . . 0.0 111.478 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 137.7 32.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.93 96.16 40.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.491 1.916 . . . . 0.0 108.143 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.1 138.5 30.93 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.546 2.164 . . . . 0.0 111.099 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.7 mt -128.36 129.9 23.57 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 108.812 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.47 169.96 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.53 2.82 . . . . 0.0 112.109 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -57.13 134.85 56.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.838 -0.539 . . . . 0.0 111.574 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 pp -144.41 150.3 37.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 110.184 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -142.61 136.63 14.64 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.168 0.987 . . . . 0.0 112.102 -171.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.96 154.0 73.1 Favored 'Cis proline' 0 CA--C 1.544 0.991 0 CA-C-N 119.381 0.815 . . . . 0.0 111.706 -6.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.45 -35.89 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.281 1.988 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.6 0.09 5.95 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.622 1.569 . . . . 0.0 114.225 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 p -68.37 133.58 48.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.162 1.346 . . . . 0.0 110.869 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.53 120.84 15.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.075 167.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.3 tt -104.48 116.8 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.053 1.741 . . . . 0.0 109.086 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.49 139.64 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.057 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.8 m -133.52 134.09 42.98 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.518 1.127 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.43 146.74 36.36 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.693 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.2 111.11 8.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 109.465 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 132.68 49.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.091 0.956 . . . . 0.0 109.382 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.54 136.18 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.153 0.981 . . . . 0.0 109.681 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.72 150.84 37.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.548 1.139 . . . . 0.0 111.668 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.98 140.38 57.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.198 0.599 . . . . 0.0 111.507 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.3 p -80.24 -7.31 58.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.64 177.46 9.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.71 2.004 . . . . 0.0 111.241 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -39.79 133.77 1.37 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.887 1.675 . . . . 0.0 114.205 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.29 8.49 17.56 Favored 'Cis proline' 0 CA--C 1.547 1.135 0 N-CA-C 115.044 1.132 . . . . 0.0 115.044 3.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.06 10.34 2.82 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.321 1.848 . . . . 0.0 114.454 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.22 162.07 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.408 1.483 . . . . 0.0 112.653 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -58.23 151.82 18.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.85 1.26 . . . . 0.0 111.755 170.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.37 -22.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.744 1.218 . . . . 0.0 113.193 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -151.94 142.89 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.608 1.963 . . . . 0.0 109.036 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -142.27 117.39 10.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.587 1.155 . . . . 0.0 108.923 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.68 -147.87 6.18 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.637 1.113 . . . . 0.0 112.097 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.51 172.42 15.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.048 1.339 . . . . 0.0 110.141 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.35 149.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.751 1.62 . . . . 0.0 107.854 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.5 130.8 54.81 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.938 -1.101 . . . . 0.0 109.113 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -111.91 158.27 19.66 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.113 -0.992 . . . . 0.0 110.849 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -163.18 146.16 10.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.908 1.683 . . . . 0.0 108.968 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -111.79 156.58 21.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.257 1.023 . . . . 0.0 110.811 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.6 m -126.81 101.37 26.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.76 1.624 . . . . 0.0 110.329 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -68.32 -10.11 27.96 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.911 3.074 . . . . 0.0 113.785 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.0 m -40.09 -43.5 1.61 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.835 2.054 . . . . 0.0 112.748 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -156.28 28.52 0.35 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.904 0.859 . . . . 0.0 112.941 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 55.98 55.25 30.1 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.115 -1.616 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -129.73 130.75 45.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.299 1.44 . . . . 0.0 109.222 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.7 159.39 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 121.565 -0.709 . . . . 0.0 110.407 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 87.1 m -148.29 111.51 4.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.085 0.954 . . . . 0.0 110.067 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 205' ' ' PHE . 3.1 p -80.83 138.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.482 0.658 . . . . 0.0 109.966 172.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.33 129.03 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.524 1.93 . . . . 0.0 107.195 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 139.62 37.5 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.217 1.007 . . . . 0.0 109.695 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -160.02 164.43 33.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.156 1.382 . . . . 0.0 109.779 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -16.06 5.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.301 1.44 . . . . 0.0 114.001 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.158 1.783 . . . . 0.0 114.058 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 42.1 p -142.91 -47.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.344 1.458 . . . . 0.0 112.432 -170.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 196' ' ' THR . 0.0 OUTLIER -76.58 143.12 71.49 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.985 1.714 . . . . 0.0 111.533 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.36 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.855 2.37 . . . . 0.0 110.736 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -179.68 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 128.266 2.626 . . . . 0.0 111.708 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -58.08 -40.76 81.91 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.92 1.688 . . . . 0.0 112.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.5 ttt -104.67 140.13 38.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.767 1.627 . . . . 0.0 108.627 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 65.9 p -136.82 158.93 43.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.924 0.49 . . . . 0.0 110.961 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.0 p -124.62 139.02 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.968 0.907 . . . . 0.0 110.741 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 97.9 m -126.33 143.04 51.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.426 1.09 . . . . 0.0 109.404 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -73.05 79.1 1.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.338 1.455 . . . . 0.0 111.482 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -54.51 -33.62 60.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.034 1.734 . . . . 0.0 112.699 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.12 -179.67 8.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.854 1.662 . . . . 0.0 111.367 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -44.14 -42.46 6.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.916 2.087 . . . . 0.0 114.295 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.1 p -130.61 12.92 5.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.086 1.755 . . . . 0.0 112.907 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -103.88 126.02 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.387 -0.82 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 184' ' ' VAL . 43.5 m-85 -123.23 138.5 54.62 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.852 1.261 . . . . 0.0 110.977 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.28 116.99 44.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.747 0.819 . . . . 0.0 110.007 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.56 112.2 24.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.767 1.627 . . . . 0.0 108.612 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -94.06 142.73 27.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.439 -0.788 . . . . 0.0 109.684 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.49 122.26 30.78 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.115 0.966 . . . . 0.0 111.948 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -115.27 13.83 16.75 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.704 1.602 . . . . 0.0 112.312 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.7 t -154.17 165.11 37.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.515 1.526 . . . . 0.0 111.522 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.05 2.03 9.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.797 1.239 . . . . 0.0 113.418 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.539 1.936 . . . . 0.0 115.226 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 45' ' ' LEU . 2.5 p -73.07 150.6 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.56 0.744 . . . . 0.0 111.581 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -95.25 150.6 20.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.505 0.722 . . . . 0.0 109.624 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.2 34.84 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.847 -1.158 . . . . 0.0 113.201 170.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -106.19 7.55 31.61 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.189 1.796 . . . . 0.0 113.426 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -142.76 -179.36 6.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.074 1.35 . . . . 0.0 111.379 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 152.25 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.407 1.483 . . . . 0.0 111.253 -175.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.86 153.26 46.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.862 1.265 . . . . 0.0 110.701 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 44' ' ' CYS . 21.3 m-85 -136.88 117.12 13.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.382 1.073 . . . . 0.0 109.835 -169.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -95.24 122.45 37.94 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.163 1.385 . . . . 0.0 111.229 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.88 59.04 1.55 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.781 1.232 . . . . 0.0 111.993 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.55 130.94 1.3 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.171 0.891 . . . . 0.0 111.11 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.13 146.12 9.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.876 0.87 . . . . 0.0 110.656 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 70.44 20.94 5.81 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.288 1.435 . . . . 0.0 114.705 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.84 58.41 2.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.681 1.192 . . . . 0.0 112.718 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 p -133.22 -174.54 3.52 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.301 1.44 . . . . 0.0 112.009 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.02 -142.98 40.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.905 0.764 . . . . 0.0 112.81 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -74.76 176.02 7.42 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.694 0.798 . . . . 0.0 112.451 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -136.21 157.24 47.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.562 1.145 . . . . 0.0 111.833 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.47 155.45 43.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.274 1.83 . . . . 0.0 110.118 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.45 143.93 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.544 1.138 . . . . 0.0 110.403 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -132.11 128.44 38.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.958 1.303 . . . . 0.0 109.012 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.36 148.81 30.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.814 0.845 . . . . 0.0 110.363 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -62.86 142.28 58.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.065 0.546 . . . . 0.0 111.449 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.61 66.63 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 122.211 -0.305 . . . . 0.0 112.486 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 152.67 39.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.49 1.116 . . . . 0.0 110.538 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -135.53 120.32 18.45 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 108.096 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.12 141.17 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.016 0.926 . . . . 0.0 109.413 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -135.35 133.45 38.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.244 1.018 . . . . 0.0 109.189 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.39 175.16 5.54 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.028 1.731 . . . . 0.0 109.595 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -123.41 133.99 54.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.682 0.793 . . . . 0.0 108.958 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.62 -14.28 12.96 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.279 1.032 . . . . 0.0 113.627 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.76 -25.54 52.02 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.961 1.267 . . . . 0.0 114.682 166.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -119.2 121.29 39.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.058 1.343 . . . . 0.0 109.852 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -12.48 6.22 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -63.68 -9.83 16.06 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.276 1.43 . . . . 0.0 112.959 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -70.39 -52.22 23.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.673 1.189 . . . . 0.0 112.037 164.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.61 -15.05 16.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.93 1.692 . . . . 0.0 113.513 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -40.79 -45.1 2.38 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.627 2.371 . . . . 0.0 113.069 169.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.98 50.32 0.59 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.429 1.492 . . . . 0.0 113.033 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -73.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.662 0.785 . . . . 0.0 111.219 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -93.36 160.11 14.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.192 0.997 . . . . 0.0 110.655 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HB3' ' CD2' ' A' ' 10' ' ' PHE . 5.8 p -168.75 169.63 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.293 1.037 . . . . 0.0 112.374 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.454 HD23 ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -148.42 156.01 41.94 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.334 1.064 . . . . 0.0 112.303 177.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 8' ' ' VAL . 38.5 t -127.65 139.04 53.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 124.872 1.269 . . . . 0.0 109.282 -171.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.16 -96.71 0.01 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.958 1.742 . . . . 0.0 116.073 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -166.95 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 113.243 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -123.99 26.36 7.59 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.644 1.977 . . . . 0.0 111.899 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.42 153.69 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.456 1.902 . . . . 0.0 109.023 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -125.41 149.48 48.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.614 1.566 . . . . 0.0 108.857 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.454 ' SG ' HG11 ' A' ' 8' ' ' VAL . 2.8 m -123.26 151.22 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 110.508 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.31 130.23 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.52 142.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.027 0.931 . . . . 0.0 109.637 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -137.25 127.41 26.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.159 1.384 . . . . 0.0 109.089 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -100.66 -53.32 3.11 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 111.379 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -101.6 98.51 8.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.858 0.863 . . . . 0.0 111.418 -172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.08 96.75 5.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.421 1.089 . . . . 0.0 112.828 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -156.14 164.53 38.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 112.27 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 6.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.26 2.224 . . . . 0.0 113.068 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.38 49.11 2.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.388 1.875 . . . . 0.0 112.122 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -148.59 145.44 20.11 Favored Pre-proline 0 N--CA 1.478 0.956 0 O-C-N 120.77 -1.206 . . . . 0.0 112.365 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.42 -14.15 20.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.922 2.415 . . . . 0.0 113.16 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -67.75 121.24 78.63 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 119.239 0.927 . . . . 0.0 109.956 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.56 95.66 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.199 1.933 . . . . 0.0 108.687 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.57 138.8 28.22 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.457 1.027 . . . . 0.0 112.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 115.42 2.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.714 0.757 . . . . 0.0 111.212 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 179' ' ' THR . 2.3 t80 -138.48 143.15 39.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.218 2.207 . . . . 0.0 109.48 -174.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.98 139.94 24.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.307 1.051 . . . . 0.0 109.614 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -100.11 103.61 15.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.08 1.352 . . . . 0.0 107.643 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp -60.98 121.53 12.64 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.48 150.84 6.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.322 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -58.55 -15.5 11.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.16 124.73 1.6 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.644 152.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.05 158.36 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.657 2.383 . . . . 0.0 111.546 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -94.23 143.57 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.436 1.094 . . . . 0.0 110.829 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -128.1 102.04 6.55 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.507 1.923 . . . . 0.0 108.553 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -123.65 6.65 8.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.633 1.573 . . . . 0.0 112.772 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -140.35 45.03 1.86 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.896 1.679 . . . . 0.0 111.461 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 80' ' ' LEU . 3.2 mp -75.26 30.67 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.079 1.351 . . . . 0.0 112.588 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.1 m -61.43 -35.65 78.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.753 1.621 . . . . 0.0 112.485 174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -61.11 -24.06 65.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.719 0.808 . . . . 0.0 112.715 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.4 mm -88.06 -25.58 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.655 1.982 . . . . 0.0 113.198 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 54.75 52.68 11.69 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.52 1.528 . . . . 0.0 113.372 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.32 -179.62 19.93 Favored Glycine 0 CA--C 1.538 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 112.567 -170.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -150.38 -178.88 6.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.574 -1.545 . . . . 0.0 112.054 -169.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -148.13 -36.94 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.14 1.776 . . . . 0.0 113.164 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.91 147.03 47.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.762 1.225 . . . . 0.0 111.445 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -135.96 119.69 17.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.326 1.85 . . . . 0.0 108.416 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -115.05 138.93 50.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.37 0.668 . . . . 0.0 109.404 170.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.83 119.27 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.757 1.623 . . . . 0.0 107.411 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.557 HD13 ' HA ' ' A' ' 98' ' ' TRP . 99.2 mt -127.55 126.79 24.1 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 124.672 1.189 . . . . 0.0 109.467 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.88 161.41 33.23 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 121.74 1.627 . . . . 0.0 111.752 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.34 -3.15 17.56 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.09 45.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.004 1.322 . . . . 0.0 113.86 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -130.78 151.1 51.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.045 1.338 . . . . 0.0 110.507 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -82.09 -49.3 10.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.518 -0.739 . . . . 0.0 111.378 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.557 ' HA ' HD13 ' A' ' 92' ' ' LEU . 58.3 p-90 -154.52 161.23 41.76 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.773 1.629 . . . . 0.0 110.589 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -131.21 154.41 48.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.108 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.44 137.16 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.945 1.298 . . . . 0.0 109.733 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.07 123.83 36.6 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.192 0.997 . . . . 0.0 108.986 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.88 132.26 71.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.651 1.58 . . . . 0.0 108.692 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -125.15 145.25 50.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.916 0.887 . . . . 0.0 110.185 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.71 128.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.05 143.17 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 122.069 0.938 . . . . 0.0 109.814 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.62 140.34 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.536 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 7.24 2.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.832 1.253 . . . . 0.0 112.168 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.52 -33.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.069 1.748 . . . . 0.0 112.907 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.44 172.61 12.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.789 1.236 . . . . 0.0 111.835 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.3 p -105.71 14.24 28.59 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.28 1.432 . . . . 0.0 112.944 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.4 m -107.0 31.03 5.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.787 2.435 . . . . 0.0 110.169 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.38 145.76 17.35 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.839 -1.163 . . . . 0.0 112.252 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.46 25.1 6.78 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.696 1.141 . . . . 0.0 112.956 -171.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.8 p -147.57 9.51 0.92 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.075 1.75 . . . . 0.0 114.033 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -127.28 143.74 51.18 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 110.784 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -131.03 130.87 43.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.074 1.349 . . . . 0.0 108.717 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -122.02 131.58 54.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.618 1.567 . . . . 0.0 110.365 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 m -95.52 133.86 39.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.856 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.57 110.78 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.801 1.64 . . . . 0.0 109.135 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -129.99 128.31 22.84 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.385 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.19 -91.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.142 2.561 . . . . 0.0 111.35 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -171.76 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.032 0.92 . . . . 0.0 112.685 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -65.09 26.8 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 126.682 1.993 . . . . 0.0 113.786 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.2 165.63 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.549 1.94 . . . . 0.0 110.831 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -56.05 114.77 2.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.331 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -58.61 147.98 30.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.741 0.816 . . . . 0.0 111.909 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -110.14 145.07 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.862 1.265 . . . . 0.0 110.274 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.81 117.21 32.81 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.858 1.263 . . . . 0.0 109.594 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.8 m -125.47 118.53 26.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.523 1.129 . . . . 0.0 108.646 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.36 138.59 49.23 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.09 1.356 . . . . 0.0 112.008 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.51 127.4 17.63 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.308 0.575 . . . . 0.0 111.978 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.57 -18.6 22.5 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.576 1.084 . . . . 0.0 113.67 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -57.75 137.14 56.83 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.865 1.333 . . . . 0.0 112.945 169.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.53 72.15 5.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.018 0.927 . . . . 0.0 110.526 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 61.83 85.73 0.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.516 1.926 . . . . 0.0 112.449 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.18 134.81 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.775 -1.203 . . . . 0.0 110.883 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -93.43 127.29 38.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.278 0.561 . . . . 0.0 110.944 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.4 tp -107.67 95.48 14.37 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.412 1.885 . . . . 0.0 107.995 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.37 146.47 40.0 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.958 1.772 . . . . 0.0 111.484 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.46 125.1 27.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.997 1.719 . . . . 0.0 108.496 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.67 -37.96 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.04 2.493 . . . . 0.0 113.125 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 168.4 7.76 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.298 2.639 . . . . 0.0 109.995 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 pp -163.44 37.8 0.09 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.163 1.385 . . . . 0.0 113.868 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.0 t -50.63 139.77 20.37 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.704 1.201 . . . . 0.0 114.211 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.35 142.08 67.63 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.979 1.028 . . . . 0.0 111.867 -6.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.24 -23.31 45.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.309 2.006 . . . . 0.0 113.051 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -75.86 -5.93 48.36 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.041 1.336 . . . . 0.0 114.548 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 161.73 16.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.584 1.084 . . . . 0.0 112.862 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -70.67 168.95 15.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.81 0.814 . . . . 0.0 113.097 167.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.38 135.72 53.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.536 1.535 . . . . 0.0 110.441 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.21 149.03 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.716 0.806 . . . . 0.0 109.231 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.3 t -150.43 155.16 39.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.079 . . . . 0.0 110.414 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -123.99 129.69 51.34 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.514 1.126 . . . . 0.0 109.798 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 tt -113.83 121.44 44.01 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.943 1.697 . . . . 0.0 109.463 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -139.61 114.75 9.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.622 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 167' ' ' VAL . 1.7 p -108.63 141.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.631 1.173 . . . . 0.0 109.517 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -144.7 148.19 33.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.321 1.448 . . . . 0.0 110.009 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.29 128.9 37.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.196 0.598 . . . . 0.0 110.174 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.7 p -79.44 -2.32 41.39 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -132.97 151.14 52.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.772 2.029 . . . . 0.0 110.08 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.2 t -66.85 141.38 96.75 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.499 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.27 128.95 13.98 Favored 'Cis proline' 0 C--N 1.352 0.761 0 CA-C-N 120.565 1.238 . . . . 0.0 111.616 -7.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.43 41.22 0.14 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.95 1.7 . . . . 0.0 112.236 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -62.5 143.59 56.99 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 111.491 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -59.55 122.45 14.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.782 -0.574 . . . . 0.0 110.366 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 65.9 t -80.68 -56.91 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 156' ' ' VAL . 0.4 OUTLIER -149.6 155.22 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 170.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -142.11 76.8 1.55 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.792 1.237 . . . . 0.0 108.695 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.19 -165.72 12.74 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.614 2.054 . . . . 0.0 111.608 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.98 170.72 16.06 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.831 -1.393 . . . . 0.0 111.12 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -153.46 157.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.715 -1.241 . . . . 0.0 108.033 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -112.83 128.84 56.55 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.925 -1.109 . . . . 0.0 108.445 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.61 155.48 17.57 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.89 0.876 . . . . 0.0 109.88 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -157.96 158.02 34.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.207 1.403 . . . . 0.0 109.579 174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.38 150.35 49.89 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.713 1.605 . . . . 0.0 108.708 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 75.6 m -105.75 110.37 64.11 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.47 50.74 2.04 Favored 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 125.221 3.948 . . . . 0.0 112.765 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.6 m -137.3 -53.97 0.69 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.989 1.716 . . . . 0.0 111.439 -172.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 63.5 p -127.29 21.9 6.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.317 1.047 . . . . 0.0 112.791 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.79 31.74 64.72 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.19 -0.944 . . . . 0.0 113.205 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -78.22 150.51 33.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.453 0.701 . . . . 0.0 110.787 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.8 t -128.65 137.57 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.5 m -142.12 129.32 20.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.644 1.577 . . . . 0.0 109.124 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.51 141.36 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.225 1.01 . . . . 0.0 110.133 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.04 127.34 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 127.079 2.151 . . . . 0.0 107.986 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -137.68 116.49 12.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.297 1.439 . . . . 0.0 108.546 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.52 156.46 36.71 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.875 1.27 . . . . 0.0 110.706 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.48 -14.41 7.81 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.14 -24.51 66.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.84 1.656 . . . . 0.0 114.005 169.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.6 p -146.7 -56.11 0.26 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.96 1.704 . . . . 0.0 111.692 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.16 138.92 97.56 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 0.0 111.841 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.02 -88.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.579 2.186 . . . . 0.0 111.625 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? 158.23 -33.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 129.561 3.145 . . . . 0.0 112.674 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -54.19 -36.91 63.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 113.459 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 15.5 ttm -103.67 151.48 22.92 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.939 1.295 . . . . 0.0 109.181 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.7 p -134.39 153.93 51.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.089 1.356 . . . . 0.0 110.287 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 ' CE1' ' A' ' 207' ' ' PHE . 2.5 t -112.34 110.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.3 m -93.47 130.7 39.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.831 0.852 . . . . 0.0 108.869 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -76.27 82.35 3.05 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.75 1.22 . . . . 0.0 109.634 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.93 -44.72 96.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.041 0.936 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 204' ' ' SER . 8.3 m-20 -147.6 -178.52 6.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.769 2.028 . . . . 0.0 110.106 166.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -53.55 141.96 23.96 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.664 -1.272 . . . . 0.0 110.836 158.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.8 p 50.66 10.69 0.07 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.258 2.223 . . . . 0.0 116.142 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -129.23 95.65 4.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.983 1.713 . . . . 0.0 108.711 -169.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -105.16 149.57 25.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.7 tt -134.61 123.28 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.406 ' CE1' HG22 ' A' ' 197' ' ' VAL . 8.4 m-85 -98.99 109.27 22.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.731 1.612 . . . . 0.0 108.598 -170.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.62 116.86 32.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.169 1.388 . . . . 0.0 108.92 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.79 99.14 9.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.176 0.59 . . . . 0.0 110.967 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -88.27 -15.71 35.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.228 2.211 . . . . 0.0 114.295 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.24 165.36 24.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.614 1.166 . . . . 0.0 111.995 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -128.0 54.06 1.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.952 1.701 . . . . 0.0 110.365 -170.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.151 1.78 . . . . 0.0 114.798 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.002 0.43 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.57 141.99 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 171.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.95 151.35 30.13 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.805 -0.559 . . . . 0.0 110.034 173.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.66 -17.26 46.39 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.59 -1.319 . . . . 0.0 113.48 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -115.17 17.83 16.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.986 1.714 . . . . 0.0 113.668 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -139.55 172.58 12.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.564 1.545 . . . . 0.0 110.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 46' ' ' VAL . 14.7 m -145.42 144.77 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.792 0.837 . . . . 0.0 110.628 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -127.58 145.94 50.7 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.148 0.975 . . . . 0.0 111.222 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -128.06 124.49 37.2 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.477 1.511 . . . . 0.0 107.497 -164.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 122.16 42.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 123.94 1.829 . . . . 0.0 111.052 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -93.18 42.58 1.1 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.477 1.911 . . . . 0.0 111.504 -167.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.86 155.2 12.5 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.575 2.036 . . . . 0.0 111.499 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -60.8 141.52 56.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.372 0.586 . . . . 0.0 110.135 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.4 t30 46.66 43.21 12.46 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.832 1.253 . . . . 0.0 114.238 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.304 30.9 p 49.18 36.42 9.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.257 2.223 . . . . 0.0 116.054 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -88.16 -24.95 23.2 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.51 -91.93 1.0 Allowed Glycine 0 N--CA 1.476 1.362 0 CA-C-N 119.559 1.072 . . . . 0.0 113.585 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.13 176.7 6.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 110.333 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -138.56 157.76 45.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.449 1.099 . . . . 0.0 112.336 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.78 152.18 39.96 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.186 1.794 . . . . 0.0 110.152 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -124.41 122.25 37.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.508 1.523 . . . . 0.0 108.972 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.04 148.51 43.49 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.294 1.438 . . . . 0.0 109.482 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -101.02 153.1 19.83 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.339 0.656 . . . . 0.0 109.949 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 147.53 23.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.975 -0.453 . . . . 0.0 112.163 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.38 41.55 90.88 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -129.19 130.83 46.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.833 1.253 . . . . 0.0 111.106 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -114.69 129.96 56.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.224 1.01 . . . . 0.0 108.836 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.79 109.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.662 1.585 . . . . 0.0 109.069 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -101.7 101.12 11.58 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.257 1.023 . . . . 0.0 109.11 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -70.45 -179.15 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.884 0.85 . . . . 0.0 111.226 165.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -127.06 157.17 40.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.547 1.139 . . . . 0.0 109.328 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.99 -12.17 59.04 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.016 -1.053 . . . . 0.0 113.496 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.14 97.71 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.615 1.102 . . . . 0.0 114.248 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.1 118.34 27.61 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.406 1.103 . . . . 0.0 110.482 170.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -18.91 62.33 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.949 -1.094 . . . . 0.0 112.458 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -61.49 -20.64 63.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.433 1.893 . . . . 0.0 112.357 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -60.89 -51.95 67.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.797 1.639 . . . . 0.0 112.367 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -70.13 -14.82 62.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.388 1.475 . . . . 0.0 113.286 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.9 -22.95 64.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.558 1.943 . . . . 0.0 113.731 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -46.92 121.22 3.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.669 1.187 . . . . 0.0 110.941 162.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.1 tpt -152.41 -19.95 0.17 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.842 . . . . 0.0 111.921 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -146.69 154.38 41.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.846 2.059 . . . . 0.0 108.856 172.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 p -172.54 155.22 3.32 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.574 1.55 . . . . 0.0 109.697 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 150.66 43.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.939 1.352 . . . . 0.0 112.399 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 8' ' ' VAL . 47.6 t -127.83 135.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.776 1.63 . . . . 0.0 108.199 -168.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -98.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.446 1.498 . . . . 0.0 115.81 -171.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -160.29 -23.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.105 1.762 . . . . 0.0 112.473 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.56 25.63 8.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.714 1.605 . . . . 0.0 111.565 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.12 140.47 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 128.151 2.58 . . . . 0.0 108.831 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.64 153.12 29.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.448 0.699 . . . . 0.0 109.947 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.8 m -136.39 136.17 39.38 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.286 0.635 . . . . 0.0 109.732 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -125.79 130.63 51.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.72 131.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.454 1.501 . . . . 0.0 109.7 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -141.31 118.67 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.38 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -103.85 -39.46 6.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.643 0.777 . . . . 0.0 111.837 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -92.57 158.82 15.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.278 1.031 . . . . 0.0 111.098 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -159.59 128.72 5.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.639 1.176 . . . . 0.0 111.505 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -162.17 -21.91 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.273 0.6 OUTLIER 50.01 37.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 127.143 2.177 . . . . 0.0 114.234 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.57 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.1 1.76 . . . . 0.0 111.924 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -51.79 124.63 27.84 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.619 1.168 . . . . 0.0 113.467 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.42 -14.72 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.881 2.387 . . . . 0.0 113.008 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t -90.18 119.66 69.23 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 119.008 0.822 . . . . 0.0 109.804 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.84 117.71 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.219 1.279 . . . . 0.0 108.977 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.0 -152.86 3.34 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -85.46 104.36 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.602 -0.94 . . . . 0.0 109.958 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -140.08 155.21 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.827 1.651 . . . . 0.0 109.582 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.4 172.19 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.617 1.167 . . . . 0.0 110.777 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -119.59 94.36 4.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.458 1.503 . . . . 0.0 107.495 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -52.83 118.71 3.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.565 1.546 . . . . 0.0 109.063 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.45 149.26 10.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.588 0.755 . . . . 0.0 112.998 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.65 -13.8 11.18 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.8 118.99 0.87 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.343 0.973 . . . . 0.0 111.777 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.48 161.64 4.1 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.871 2.068 . . . . 0.0 111.207 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 m -115.45 131.4 56.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.082 1.353 . . . . 0.0 110.067 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -131.58 136.0 47.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.508 1.123 . . . . 0.0 110.104 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -138.47 10.75 2.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.467 1.107 . . . . 0.0 112.901 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.64 52.15 0.58 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.548 1.539 . . . . 0.0 109.94 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -74.13 39.16 0.11 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.922 1.289 . . . . 0.0 112.928 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -55.99 -30.67 62.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.002 1.721 . . . . 0.0 113.047 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -64.34 -18.24 64.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.6 mm -90.26 -23.42 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.627 1.571 . . . . 0.0 111.964 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 45.05 74.51 0.13 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.079 2.152 . . . . 0.0 114.537 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.4 -160.33 36.14 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.555 0.598 . . . . 0.0 112.096 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 177.89 8.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.917 0.887 . . . . 0.0 110.861 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.15 -46.3 0.11 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.216 1.007 . . . . 0.0 111.825 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HE3' ' CG2' ' A' ' 203' ' ' THR . 2.0 ptmm? -140.7 156.22 46.27 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.95 140.42 34.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.148 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -129.08 125.01 36.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.39 131.36 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.353 1.461 . . . . 0.0 108.702 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.76 143.81 41.12 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.344 1.458 . . . . 0.0 109.97 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.12 26.27 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.15 3.9 . . . . 0.0 115.452 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.82 26.9 61.07 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.585 1.088 . . . . 0.0 113.582 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.1 -42.15 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 111.297 -168.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.72 146.55 32.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 109.983 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -88.69 -39.94 13.63 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.814 0.816 . . . . 0.0 111.637 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -152.0 158.77 43.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 107.191 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.25 174.06 7.53 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.916 -0.49 . . . . 0.0 109.981 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.08 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 111.185 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -71.71 131.83 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.76 139.78 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.693 1.197 . . . . 0.0 109.839 170.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -139.65 142.58 36.99 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.547 -0.721 . . . . 0.0 110.025 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 pt -91.95 144.28 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 122.91 0.484 . . . . 0.0 110.254 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.3 t -133.0 109.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.137 1.375 . . . . 0.0 108.686 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.07 118.18 17.73 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.679 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.87 -12.82 14.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.95 0.9 . . . . 0.0 113.002 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.49 -51.96 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.856 1.262 . . . . 0.0 111.681 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -92.7 110.72 22.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.088 0.955 . . . . 0.0 109.233 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 t -75.25 39.32 0.15 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.134 1.374 . . . . 0.0 114.013 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 m -140.48 -39.18 0.43 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.591 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.52 -160.49 0.07 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.585 1.154 . . . . 0.0 113.34 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.78 7.43 61.69 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 120.398 -1.439 . . . . 0.0 116.136 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.9 p -144.82 28.96 1.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.759 1.78 . . . . 0.0 114.663 -159.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -133.66 145.29 49.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.681 1.593 . . . . 0.0 109.193 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -132.79 112.2 11.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.149 0.98 . . . . 0.0 110.376 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.0 ttp -111.09 105.96 14.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.414 2.286 . . . . 0.0 110.544 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.8 m -92.21 126.55 37.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.569 0.699 . . . . 0.0 109.173 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.03 132.05 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.105 1.362 . . . . 0.0 108.933 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -137.04 89.33 16.83 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 123.62 0.768 . . . . 0.0 109.269 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.38 167.1 17.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.978 2.452 . . . . 0.0 112.668 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -37.57 98.36 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.437 2.295 . . . . 0.0 113.611 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.268 19.4 pt20 43.01 52.82 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.065 1.746 . . . . 0.0 114.87 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.61 148.0 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.162 1.785 . . . . 0.0 110.942 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -51.85 112.37 0.76 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.057 1.343 . . . . 0.0 111.067 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 152.79 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.323 1.049 . . . . 0.0 111.993 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.43 141.09 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.758 -0.589 . . . . 0.0 111.936 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.88 91.3 3.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.704 1.602 . . . . 0.0 109.896 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.717 ' HA ' HG21 ' A' ' 136' ' ' VAL . 42.3 t -74.06 131.65 41.55 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 121.785 -0.572 . . . . 0.0 109.691 169.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.77 139.39 48.91 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.86 128.98 39.81 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.932 -0.48 . . . . 0.0 110.303 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.47 -11.03 59.71 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.98 1.276 . . . . 0.0 115.189 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 145.47 41.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.695 1.748 . . . . 0.0 111.95 169.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.67 55.45 0.37 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.934 1.694 . . . . 0.0 112.957 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 57.88 95.72 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.737 2.415 . . . . 0.0 112.197 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' A' ' 129' ' ' CYS . 10.8 t -51.97 130.22 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.156 0.982 . . . . 0.0 112.225 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -80.09 122.28 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.793 0.837 . . . . 0.0 111.251 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.6 101.84 11.44 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.262 163.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.6 121.99 6.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.742 1.628 . . . . 0.0 110.534 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.87 121.44 43.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.816 0.846 . . . . 0.0 108.901 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.53 168.36 23.82 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.262 2.642 . . . . 0.0 111.75 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 131.79 51.45 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.698 -0.626 . . . . 0.0 110.792 174.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.99 149.27 33.84 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.777 1.631 . . . . 0.0 110.047 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.1 m -138.27 135.18 18.13 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 0.0 110.559 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.17 150.0 82.08 Favored 'Cis proline' 0 CA--C 1.544 1.022 0 CA-C-N 119.252 0.769 . . . . 0.0 112.001 -5.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.52 -24.24 49.2 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.027 1.818 . . . . 0.0 113.092 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.83 1.78 29.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -69.89 156.25 39.36 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.357 1.075 . . . . 0.0 112.843 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -83.67 135.67 34.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.284 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.4 tt -115.73 116.58 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.941 1.696 . . . . 0.0 108.401 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.49 142.9 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.921 -0.487 . . . . 0.0 110.749 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.0 p -142.91 140.56 31.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 122.088 0.946 . . . . 0.0 111.994 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -90.16 140.18 29.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.387 0.675 . . . . 0.0 110.148 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.17 113.94 18.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.732 1.613 . . . . 0.0 108.736 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 98.56 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.31 1.044 . . . . 0.0 109.517 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 3.9 p -115.4 145.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.541 1.136 . . . . 0.0 110.056 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.54 160.84 39.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.186 1.395 . . . . 0.0 112.454 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.56 146.63 46.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.017 1.327 . . . . 0.0 111.335 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.6 p -85.33 -12.22 52.79 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.34 171.79 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.813 1.245 . . . . 0.0 110.884 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -60.56 145.37 87.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 120.965 -1.085 . . . . 0.0 112.315 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.65 12.06 26.2 Favored 'Cis proline' 0 CA--C 1.55 1.287 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 3.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.22 13.53 8.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.869 1.668 . . . . 0.0 113.683 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.07 152.82 32.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 112.338 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -52.3 139.11 25.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.922 0.889 . . . . 0.0 112.92 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.56 -20.39 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.406 1.482 . . . . 0.0 111.937 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 95.0 t -152.66 131.78 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 126.776 2.03 . . . . 0.0 108.329 168.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -122.79 129.65 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.236 1.415 . . . . 0.0 109.084 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 176.63 -165.37 35.58 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.903 0.724 . . . . 0.0 112.695 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.39 156.01 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.183 0.992 . . . . 0.0 110.738 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 156.46 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.49 1.916 . . . . 0.0 108.246 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.56 134.59 54.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.83 157.88 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.65 154.14 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 107.64 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -118.85 160.5 21.8 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.441 1.096 . . . . 0.0 108.608 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.4 m -121.54 106.63 37.38 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 121.235 -0.915 . . . . 0.0 108.598 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.77 53.83 2.88 Favored 'Trans proline' 0 CA--C 1.542 0.92 1 C-N-CA 125.506 4.137 . . . . 0.0 112.545 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -126.66 -44.71 1.66 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.754 2.022 . . . . 0.0 110.713 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 82.4 p -144.91 6.55 1.19 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.521 1.128 . . . . 0.0 113.843 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.17 34.77 40.31 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.576 -1.327 . . . . 0.0 113.171 -171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 149.81 35.86 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.884 -0.774 . . . . 0.0 110.752 173.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.21 132.2 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.681 1.192 . . . . 0.0 108.121 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 99.5 m -135.55 125.57 25.96 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.893 1.277 . . . . 0.0 109.307 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.56 130.0 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.334 1.054 . . . . 0.0 110.64 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 mt -108.83 141.33 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.275 2.23 . . . . 0.0 107.634 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 136.49 24.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.501 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -134.36 134.46 41.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.015 -170.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -58.39 -14.11 6.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.561 1.144 . . . . 0.0 113.955 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.07 -23.67 65.64 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.306 1.442 . . . . 0.0 114.492 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 p -145.28 -34.86 0.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.024 1.73 . . . . 0.0 113.646 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.25 129.99 89.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.775 0.83 . . . . 0.0 110.69 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.35 173.3 14.46 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.443 2.762 . . . . 0.0 112.069 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 5.97 32.32 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.214 1.406 . . . . 0.0 113.299 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -89.86 -37.2 14.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.968 1.707 . . . . 0.0 112.231 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.0 ttt -113.83 152.13 31.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.49 1.516 . . . . 0.0 109.279 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.5 p -133.21 144.31 49.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 0.0 110.756 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.88 119.94 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 88.5 m -115.42 114.51 25.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.036 1.334 . . . . 0.0 109.419 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.39 129.87 39.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.934 0.894 . . . . 0.0 110.972 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -31.89 3.78 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.326 1.05 . . . . 0.0 112.508 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -146.71 169.23 19.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.847 2.059 . . . . 0.0 109.702 171.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -59.19 -2.09 0.25 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.503 ' CG2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 t -156.64 32.62 0.31 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.586 2.354 . . . . 0.0 110.543 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -143.94 117.27 9.04 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.291 -1.506 . . . . 0.0 111.853 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 135.02 53.87 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.251 1.421 . . . . 0.0 110.616 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -118.15 117.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -97.69 91.72 5.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -75.51 127.08 32.32 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.231 0.612 . . . . 0.0 109.587 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.4 tp -111.18 110.56 21.12 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 111.679 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -107.78 17.35 22.63 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.986 2.114 . . . . 0.0 112.866 -173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 t -152.16 155.15 37.25 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.343 1.457 . . . . 0.0 111.723 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -9.73 15.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.107 0.963 . . . . 0.0 113.044 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.79 139.93 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.34 1.456 . . . . 0.0 110.643 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.81 149.56 37.88 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.714 -0.616 . . . . 0.0 110.918 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.55 -24.44 47.05 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 113.324 170.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -111.58 12.51 21.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.0 1.72 . . . . 0.0 112.962 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -146.4 173.34 12.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.63 1.572 . . . . 0.0 111.145 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -133.7 158.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.074 0.949 . . . . 0.0 110.788 -177.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.9 149.45 48.98 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.187 0.995 . . . . 0.0 110.665 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -127.2 132.01 50.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.133 1.373 . . . . 0.0 108.184 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -126.55 123.21 37.2 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.245 1.498 . . . . 0.0 110.443 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -83.59 33.52 0.47 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.644 1.578 . . . . 0.0 112.574 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.53 148.56 11.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.972 1.748 . . . . 0.0 111.993 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.34 147.91 9.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.335 1.454 . . . . 0.0 112.025 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 49.62 42.67 23.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.323 1.049 . . . . 0.0 113.46 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m 56.38 65.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.873 1.669 . . . . 0.0 113.914 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -130.62 -179.88 5.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.883 1.273 . . . . 0.0 112.529 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 -95.09 1.23 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.01 1.291 . . . . 0.0 113.335 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.64 169.23 15.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.516 1.527 . . . . 0.0 110.36 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.9 p -135.07 149.72 50.14 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.048 0.939 . . . . 0.0 112.16 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 156.36 44.72 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.534 1.934 . . . . 0.0 110.271 -174.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.55 132.49 48.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.853 1.261 . . . . 0.0 109.642 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.25 122.0 30.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.077 1.351 . . . . 0.0 108.928 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -74.56 158.76 33.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.332 0.653 . . . . 0.0 110.926 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -64.98 154.78 36.63 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.505 -0.747 . . . . 0.0 111.622 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.15 45.51 96.38 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.367 0.508 . . . . 0.0 112.582 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -121.78 148.96 43.98 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.703 1.201 . . . . 0.0 110.319 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -136.95 119.3 15.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.32 117.81 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 109.664 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.05 100.04 9.6 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.78 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.79 162.33 26.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.239 170.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -107.91 162.91 13.59 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -67.02 -15.3 63.64 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.029 -1.045 . . . . 0.0 113.35 170.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.32 -20.55 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.308 0.956 . . . . 0.0 114.449 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -80.99 109.55 15.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.563 1.182 . . . . 0.0 111.01 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.14 66.72 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.531 -1.355 . . . . 0.0 112.623 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -57.42 -28.28 63.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.904 2.082 . . . . 0.0 113.514 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -73.26 -52.07 15.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.55 1.14 . . . . 0.0 111.742 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.74 -15.22 61.25 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.104 0.962 . . . . 0.0 112.989 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.88 0.93 4.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.102 2.561 . . . . 0.0 114.73 168.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -44.07 135.2 4.38 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.693 1.133 . . . . 0.0 110.222 164.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.76 -54.56 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.4 p -146.46 164.22 33.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.662 0.744 . . . . 0.0 112.004 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 p -161.68 159.68 27.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.226 -0.922 . . . . 0.0 110.423 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mp -123.87 132.07 53.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.337 1.055 . . . . 0.0 108.499 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 74.4 t -123.49 127.01 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 124.752 1.221 . . . . 0.0 109.512 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.548 2.023 . . . . 0.0 115.844 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -171.71 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.256 1.422 . . . . 0.0 114.0 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -120.93 29.49 7.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.928 1.691 . . . . 0.0 111.751 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.93 138.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.296 1.439 . . . . 0.0 110.776 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -115.45 132.87 56.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.684 1.194 . . . . 0.0 109.316 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.26 143.49 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -123.05 131.45 53.7 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.732 1.613 . . . . 0.0 108.749 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 pt -137.56 118.37 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.822 1.249 . . . . 0.0 111.037 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.08 138.03 53.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 110.311 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.4 -46.03 4.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.501 0.72 . . . . 0.0 112.917 -164.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -151.93 131.62 13.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.821 1.248 . . . . 0.0 108.684 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -146.56 138.48 24.74 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.263 1.425 . . . . 0.0 107.86 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.32 9.72 0.56 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.247 0.619 . . . . 0.0 111.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt 43.47 27.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 129.655 3.182 . . . . 0.0 116.259 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -173.39 -23.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.294 2.238 . . . . 0.0 111.429 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -46.98 136.71 8.06 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.125 1.37 . . . . 0.0 113.241 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.38 -5.38 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.294 2.662 . . . . 0.0 113.01 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 90.54 50.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 109.808 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.24 109.97 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.835 1.69 . . . . 0.0 108.092 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.37 159.1 20.99 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 153.62 18.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.454 1.121 . . . . 0.0 111.191 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -148.55 144.69 27.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.664 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.4 166.64 27.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.474 1.131 . . . . 0.0 111.071 170.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -126.34 111.63 14.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.055 1.342 . . . . 0.0 109.32 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.08 136.13 57.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.819 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.02 144.26 9.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 112.665 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.45 -10.82 8.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.46 109.62 0.41 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.04 1.781 . . . . 0.0 111.829 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.79 168.87 0.52 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.431 2.292 . . . . 0.0 111.331 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.1 m -111.21 142.38 43.49 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.527 1.131 . . . . 0.0 109.49 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -129.6 120.45 25.29 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.833 1.253 . . . . 0.0 108.095 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -128.7 -18.28 3.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.63 -80.42 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 109.419 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp 44.77 22.34 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.927 1.691 . . . . 0.0 113.762 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -78.29 -36.22 46.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.434 1.494 . . . . 0.0 110.055 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.6 t -69.07 -30.44 68.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.551 1.14 . . . . 0.0 112.859 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.39 -27.24 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.234 1.414 . . . . 0.0 112.105 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 57.02 45.57 20.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.491 1.516 . . . . 0.0 112.304 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.62 -167.94 43.87 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.533 1.063 . . . . 0.0 113.94 -172.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -173.55 4.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.071 1.349 . . . . 0.0 111.246 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 85.6 p -149.19 -34.63 0.19 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.843 1.257 . . . . 0.0 112.819 167.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -99.29 127.28 45.28 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.293 1.037 . . . . 0.0 110.093 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.35 136.37 54.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.184 1.393 . . . . 0.0 108.796 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -143.89 153.55 42.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.408 0.683 . . . . 0.0 109.265 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.69 114.42 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 124.75 1.22 . . . . 0.0 108.707 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.63 115.27 31.02 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.492 0.717 . . . . 0.0 110.636 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.73 166.22 30.12 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.938 2.425 . . . . 0.0 112.633 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.1 33.65 0.19 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.158 2.313 . . . . 0.0 114.831 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.71 -27.11 6.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.055 2.542 . . . . 0.0 110.986 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -140.41 161.23 38.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.038 1.735 . . . . 0.0 110.749 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -104.21 -45.64 4.65 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.095 -1.003 . . . . 0.0 112.501 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.34 165.18 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.186 1.794 . . . . 0.0 108.333 174.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.74 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.252 0.549 . . . . 0.0 109.753 169.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.06 139.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.978 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -97.2 121.44 39.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.943 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 167.46 29.36 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.689 1.196 . . . . 0.0 109.623 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.34 148.63 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 125.38 1.472 . . . . 0.0 109.678 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.61 114.08 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.964 0.906 . . . . 0.0 109.149 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.93 88.72 2.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 111.92 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.41 19.48 20.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.86 1.264 . . . . 0.0 112.028 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.71 -66.08 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.544 1.538 . . . . 0.0 111.458 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -85.16 -19.59 31.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.949 1.3 . . . . 0.0 111.989 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t 62.51 39.46 11.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.651 1.981 . . . . 0.0 113.358 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.8 m -131.43 -38.36 1.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.762 1.225 . . . . 0.0 113.915 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.04 -177.86 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.163 1.385 . . . . 0.0 114.338 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.74 20.46 39.85 Favored Glycine 0 CA--C 1.54 1.653 0 O-C-N 120.618 -1.301 . . . . 0.0 115.037 -171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.6 p -139.63 17.66 2.53 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.772 1.629 . . . . 0.0 113.327 -166.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.38 132.45 27.89 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.404 1.882 . . . . 0.0 109.385 -170.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -117.23 121.89 42.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.541 1.136 . . . . 0.0 110.163 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttt -115.8 122.37 45.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.706 1.203 . . . . 0.0 109.637 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -119.41 116.22 25.72 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.02 1.328 . . . . 0.0 108.373 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.09 138.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.266 1.426 . . . . 0.0 108.818 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 t -154.67 99.2 2.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.405 0.682 . . . . 0.0 110.842 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 9.8 Cg_endo -66.38 168.26 16.63 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.346 2.697 . . . . 0.0 112.905 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -34.99 95.0 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.138 2.175 . . . . 0.0 114.884 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 37.55 65.85 0.5 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.892 2.077 . . . . 0.0 115.099 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.2 155.26 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.663 . . . . 0.0 110.41 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.01 100.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.352 1.461 . . . . 0.0 111.811 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -59.01 151.39 22.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.444 0.64 . . . . 0.0 110.327 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.72 124.0 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.13 107.83 15.4 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.673 1.589 . . . . 0.0 108.802 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.88 160.49 24.64 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 160.72 16.19 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.197 0.599 . . . . 0.0 110.848 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.54 53.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.842 2.457 . . . . 0.0 114.727 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.01 -21.81 0.07 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.74 2.591 . . . . 0.0 113.776 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.21 156.96 23.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.156 1.478 . . . . 0.0 111.808 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.7 -16.64 29.93 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.302 -0.874 . . . . 0.0 112.793 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -176.66 115.97 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.78 2.832 . . . . 0.0 108.253 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.56 126.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.238 -1.539 . . . . 0.0 109.559 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 127.98 33.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.922 0.489 . . . . 0.0 110.87 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.23 109.55 54.15 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.161 1.384 . . . . 0.0 109.817 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.59 138.87 33.08 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.429 2.086 . . . . 0.0 110.556 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.62 123.76 18.57 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.733 1.213 . . . . 0.0 109.199 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.68 164.51 35.18 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.831 2.354 . . . . 0.0 112.055 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 134.02 55.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.29 0.567 . . . . 0.0 111.735 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.15 146.59 40.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.921 1.688 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.8 m -142.55 136.05 14.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 124.603 1.161 . . . . 0.0 109.874 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.7 154.95 75.72 Favored 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 119.844 0.98 . . . . 0.0 113.006 -4.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -64.33 -32.2 61.7 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.064 1.843 . . . . 0.0 112.509 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.59 -12.48 58.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.662 1.585 . . . . 0.0 114.168 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.32 174.75 6.07 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.161 0.981 . . . . 0.0 112.89 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.81 149.23 45.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.994 1.317 . . . . 0.0 111.574 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.28 122.76 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.964 1.706 . . . . 0.0 109.139 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.84 140.69 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.411 0.624 . . . . 0.0 110.722 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 121' ' ' PRO . 36.6 t -141.14 137.93 33.1 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.87 1.268 . . . . 0.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -91.15 139.81 30.4 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -130.48 116.72 18.61 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.869 1.268 . . . . 0.0 108.47 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.29 124.81 37.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.67 133.25 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.719 1.208 . . . . 0.0 110.559 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.81 145.3 56.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.426 0.631 . . . . 0.0 111.585 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.7 p -81.68 -5.24 57.92 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.113 1.365 . . . . 0.0 113.076 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -135.56 166.55 22.95 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.087 1.755 . . . . 0.0 111.194 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 t -80.39 142.87 54.82 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.623 0.769 . . . . 0.0 112.671 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.36 132.3 21.32 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.117 1.077 . . . . 0.0 110.993 -9.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -75.08 36.26 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.627 1.571 . . . . 0.0 112.171 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.93 132.29 41.8 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.701 1.2 . . . . 0.0 109.565 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -52.36 148.44 6.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.221 -0.299 . . . . 0.0 110.96 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.57 -29.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.292 1.037 . . . . 0.0 112.404 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.96 143.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.935 1.694 . . . . 0.0 109.306 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.95 122.0 14.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.366 1.467 . . . . 0.0 109.035 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.21 -165.25 31.67 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 121.906 0.725 . . . . 0.0 114.262 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.36 144.96 34.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.426 1.09 . . . . 0.0 110.256 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.86 155.58 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.215 1.806 . . . . 0.0 108.934 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -125.32 126.05 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.406 -0.809 . . . . 0.0 108.867 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -95.98 139.38 32.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -133.24 150.39 51.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.376 1.87 . . . . 0.0 108.414 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -122.94 150.57 42.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.005 0.922 . . . . 0.0 109.417 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.25 105.89 56.14 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.676 0.79 . . . . 0.0 109.326 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.9 51.42 1.97 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.354 4.036 . . . . 0.0 113.614 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.7 m -132.57 -41.24 0.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.72 2.008 . . . . 0.0 111.703 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.8 t -145.92 23.68 1.37 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 123.078 1.418 . . . . 0.0 112.098 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.15 46.41 56.52 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.595 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -83.5 156.13 23.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.479 1.112 . . . . 0.0 110.423 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.23 134.82 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.9 m -124.83 150.26 46.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.855 2.062 . . . . 0.0 108.421 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 123.77 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.226 1.011 . . . . 0.0 109.155 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.11 133.5 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.3 1.44 . . . . 0.0 107.338 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.32 138.9 25.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.639 1.576 . . . . 0.0 107.635 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 147.68 50.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.786 1.235 . . . . 0.0 108.494 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.17 -17.84 59.19 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.311 -0.868 . . . . 0.0 112.593 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.35 -12.68 61.23 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.307 2.243 . . . . 0.0 114.013 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.4 p -137.02 -44.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.583 1.553 . . . . 0.0 111.872 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.504 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -68.68 160.97 74.51 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.107 1.763 . . . . 0.0 111.324 169.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.504 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 59.6 Cg_endo -76.72 -2.16 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.848 3.032 . . . . 0.0 113.859 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 53.69 15.56 0.81 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.709 2.404 . . . . 0.0 115.113 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.39 -0.67 8.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.867 1.667 . . . . 0.0 113.398 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.7 ttt -125.62 148.61 48.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.817 2.047 . . . . 0.0 107.507 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -133.75 156.97 47.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.724 0.81 . . . . 0.0 109.846 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.9 t -117.58 125.31 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.251 0.621 . . . . 0.0 109.563 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 41.5 m -110.61 110.35 21.01 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.602 1.961 . . . . 0.0 108.229 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.09 103.97 5.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.086 0.955 . . . . 0.0 110.543 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.8 -34.55 19.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.317 0.647 . . . . 0.0 111.257 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -142.44 -177.62 5.36 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.301 1.84 . . . . 0.0 112.739 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -66.97 -17.39 64.9 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.9 p -138.68 10.37 2.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 112.644 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.4 m -125.18 114.13 18.59 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.279 1.032 . . . . 0.0 110.975 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.59 138.1 52.8 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.433 1.493 . . . . 0.0 109.258 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 48.8 mt -119.79 122.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.36 104.79 16.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.981 1.312 . . . . 0.0 109.094 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -87.23 126.88 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.774 0.83 . . . . 0.0 109.019 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.46 118.99 31.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.702 0.801 . . . . 0.0 109.981 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -110.86 -27.16 8.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.877 1.271 . . . . 0.0 113.374 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.7 m -103.8 177.88 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 112.209 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -134.3 72.97 1.47 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.248 1.419 . . . . 0.0 109.644 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.341 1.056 . . . . 0.0 113.672 178.848 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.369 0.604 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.66 152.27 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.363 1.465 . . . . 0.0 111.213 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 139.94 51.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.594 1.158 . . . . 0.0 111.082 171.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.6 -17.74 60.76 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.684 -1.26 . . . . 0.0 113.568 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.31 3.53 12.58 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.284 1.834 . . . . 0.0 113.837 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -149.1 173.19 13.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.076 2.55 . . . . 0.0 109.399 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.63 161.5 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.729 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -145.48 142.3 29.12 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.335 0.654 . . . . 0.0 110.341 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.51 138.04 54.04 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.413 1.485 . . . . 0.0 108.71 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.47 127.27 42.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.141 0.972 . . . . 0.0 110.365 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -80.49 58.24 3.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.145 1.378 . . . . 0.0 111.19 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.9 139.32 3.94 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.587 -0.696 . . . . 0.0 112.278 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.922 0.889 . . . . 0.0 108.831 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 75.99 34.02 0.56 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.789 1.636 . . . . 0.0 112.874 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.7 t 62.89 63.96 0.92 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.622 1.569 . . . . 0.0 112.831 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.6 p -137.28 -178.53 5.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.253 1.821 . . . . 0.0 112.99 -172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.84 -95.39 0.63 Allowed Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.63 1.586 . . . . 0.0 114.317 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -123.37 164.23 19.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.99 1.316 . . . . 0.0 110.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.7 p -132.92 149.32 52.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.72 1.208 . . . . 0.0 112.036 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.95 148.42 29.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.523 1.529 . . . . 0.0 109.603 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -126.93 146.31 50.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.106 0.962 . . . . 0.0 110.258 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.42 132.31 31.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.875 1.322 . . . . 0.0 111.721 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.7 146.75 49.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.964 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -62.66 142.62 58.0 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.415 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 52.45 34.75 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.083 0.401 . . . . 0.0 113.428 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 158.1 45.05 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.841 0.856 . . . . 0.0 112.101 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -138.6 135.33 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.69 119.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.321 1.048 . . . . 0.0 109.29 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -99.9 103.5 15.09 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.25 155.2 23.79 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.605 1.162 . . . . 0.0 110.663 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -103.48 137.22 41.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.445 0.698 . . . . 0.0 110.029 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -59.78 -17.37 35.04 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.77 -25.41 63.64 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.424 1.012 . . . . 0.0 114.342 170.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.01 119.18 38.54 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.534 1.167 . . . . 0.0 109.975 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -12.5 3.44 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 170.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -58.2 -25.82 62.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.196 1.398 . . . . 0.0 112.22 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.12 -56.03 10.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.098 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.07 -15.24 21.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.962 1.705 . . . . 0.0 113.771 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -28.52 44.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.807 1.643 . . . . 0.0 113.522 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -47.36 122.22 4.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.229 0.538 . . . . 0.0 111.575 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.9 tpt -149.23 -31.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 111.918 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.6 p -145.32 162.06 38.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 111.684 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.1 p -156.05 149.16 24.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.322 1.449 . . . . 0.0 110.407 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.27 136.23 53.19 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.56 129.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.232 1.413 . . . . 0.0 109.563 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.36 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.574 2.035 . . . . 0.0 116.11 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -166.36 -20.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 113.267 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -119.92 22.92 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.01 1.724 . . . . 0.0 111.607 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.21 143.25 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.93 2.092 . . . . 0.0 109.508 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -120.94 145.66 47.46 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.91 1.284 . . . . 0.0 109.807 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.4 m -112.29 142.89 44.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.606 1.194 . . . . 0.0 109.957 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 4.6 m120 -132.33 130.79 41.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.44 123.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.105 . . . . 0.0 109.639 -172.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -131.92 134.31 45.53 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.094 1.358 . . . . 0.0 110.549 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.58 -34.22 7.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.05 0.94 . . . . 0.0 112.935 -168.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.42 157.27 46.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.593 1.957 . . . . 0.0 107.223 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -142.39 131.79 23.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.111 0.964 . . . . 0.0 109.743 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.53 162.68 0.7 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.105 1.762 . . . . 0.0 110.68 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.34 15.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 112.556 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.14 28.82 1.1 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.04 2.136 . . . . 0.0 111.147 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 t -99.53 139.96 21.26 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.929 1.291 . . . . 0.0 112.456 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.39 -16.69 11.91 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.45 2.767 . . . . 0.0 114.281 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 t -124.92 137.59 29.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.73 150.32 83.53 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.43 -161.29 5.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.426 1.014 . . . . 0.0 112.241 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.16 134.8 51.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 108.59 167.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -159.43 155.66 27.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.568 1.547 . . . . 0.0 110.482 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -158.61 147.32 18.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.732 1.253 . . . . 0.0 113.027 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.73 95.26 9.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.848 2.059 . . . . 0.0 109.676 168.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.6 134.14 55.89 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.22 151.46 15.67 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.89 -8.61 7.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.46 89.93 0.11 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.236 -0.915 . . . . 0.0 112.644 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.1 p -162.42 169.41 20.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.355 1.074 . . . . 0.0 112.851 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -104.54 133.34 49.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.584 1.554 . . . . 0.0 109.107 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -128.67 115.4 17.97 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.084 0.954 . . . . 0.0 109.682 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -141.53 15.56 2.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 112.257 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -153.71 50.57 0.68 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.932 1.293 . . . . 0.0 109.96 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.01 42.25 0.39 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.649 1.18 . . . . 0.0 110.841 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -66.31 -30.08 70.42 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 119.971 -1.706 . . . . 0.0 112.385 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -63.26 -23.94 67.65 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.196 0.998 . . . . 0.0 112.88 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.24 -34.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.674 1.99 . . . . 0.0 111.421 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.92 40.83 22.1 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.898 1.679 . . . . 0.0 113.24 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 168.89 33.95 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.668 1.128 . . . . 0.0 112.287 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.44 -173.91 3.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.409 1.484 . . . . 0.0 112.39 -170.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 84.8 p -145.83 -28.18 0.43 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.36 139.26 51.64 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.501 1.52 . . . . 0.0 110.03 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.79 127.39 40.25 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.023 1.329 . . . . 0.0 107.673 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 53' ' ' ASN . 1.5 pm0 -136.91 130.44 31.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.703 0.801 . . . . 0.0 109.11 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.61 118.77 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.218 1.407 . . . . 0.0 107.541 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.84 123.27 27.46 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.473 1.109 . . . . 0.0 109.061 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.54 160.48 41.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.999 2.466 . . . . 0.0 111.107 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.17 24.6 0.2 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 125.831 1.682 . . . . 0.0 116.01 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.13 -20.94 6.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.236 2.215 . . . . 0.0 112.816 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.06 158.93 32.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.821 1.648 . . . . 0.0 109.399 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.13 -38.8 7.98 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.252 -0.905 . . . . 0.0 112.826 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 -149.98 155.52 40.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.101 1.361 . . . . 0.0 108.878 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.78 146.06 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.03 0.532 . . . . 0.0 110.072 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.02 134.55 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.253 1.021 . . . . 0.0 110.539 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -84.72 126.18 33.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.1 m -124.89 140.0 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.555 0.742 . . . . 0.0 109.548 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.29 161.83 30.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.295 1.038 . . . . 0.0 110.716 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.01 134.94 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.984 0.913 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.7 t -127.4 108.27 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -76.21 118.31 18.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.735 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -102.33 -21.69 14.26 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.319 1.047 . . . . 0.0 112.466 170.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.21 -67.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.192 0.997 . . . . 0.0 111.971 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -85.2 97.62 10.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.852 1.261 . . . . 0.0 110.393 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -70.17 47.84 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.26 1.824 . . . . 0.0 114.417 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.8 m -144.68 -36.16 0.32 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.123 2.569 . . . . 0.0 111.82 -171.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.29 -153.58 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 53.03 25.18 23.5 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 120.224 1.375 . . . . 0.0 116.203 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 m -143.82 5.66 1.36 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.974 1.71 . . . . 0.0 114.935 -167.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -133.58 120.3 20.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.431 1.493 . . . . 0.0 111.855 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.26 137.99 32.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.315 1.046 . . . . 0.0 109.916 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 119.38 34.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.261 2.224 . . . . 0.0 108.662 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 m -119.07 119.5 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.41 128.83 73.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -117.49 89.11 31.12 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.233 1.413 . . . . 0.0 109.226 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.07 160.36 49.01 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.668 2.912 . . . . 0.0 112.035 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -42.94 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.288 2.635 . . . . 0.0 116.084 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 44.48 39.7 3.39 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.836 1.654 . . . . 0.0 113.948 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.25 154.92 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.734 2.014 . . . . 0.0 109.683 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -45.95 98.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 112.752 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 151.06 36.17 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 0.0 111.046 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.46 125.41 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.882 0.873 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.17 105.45 17.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.012 1.325 . . . . 0.0 108.638 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.4 p -103.06 164.99 11.28 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.053 0.941 . . . . 0.0 110.796 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -142.46 159.9 41.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.764 0.825 . . . . 0.0 110.65 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -60.54 81.85 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 126.339 1.856 . . . . 0.0 114.526 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.22 0.18 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.939 1.733 . . . . 0.0 112.159 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.12 131.43 49.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.978 0.894 . . . . 0.0 111.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -74.95 70.52 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.32 1.448 . . . . 0.0 112.466 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 63.3 84.3 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.23 2.212 . . . . 0.0 110.919 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.61 147.96 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.603 -0.686 . . . . 0.0 110.599 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.1 146.06 24.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.886 0.474 . . . . 0.0 111.199 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.66 97.09 44.82 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.195 1.398 . . . . 0.0 108.106 166.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.51 137.51 27.99 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.542 2.161 . . . . 0.0 111.072 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.68 127.62 23.52 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.508 1.123 . . . . 0.0 107.997 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.22 -178.7 3.77 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.326 3.35 . . . . 0.0 111.327 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 149.41 47.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.84 0.829 . . . . 0.0 112.358 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.02 143.39 21.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.432 1.893 . . . . 0.0 109.46 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.8 m -125.83 130.62 23.98 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 124.275 1.03 . . . . 0.0 109.534 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.1 150.78 79.37 Favored 'Cis proline' 0 CA--C 1.545 1.038 0 CA-C-N 119.368 0.81 . . . . 0.0 112.435 -3.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.27 -22.69 39.76 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.76 1.64 . . . . 0.0 112.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.01 4.87 15.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.543 1.537 . . . . 0.0 114.548 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 148.71 46.68 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.727 -1.233 . . . . 0.0 111.992 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 155.57 36.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 112.182 168.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 tt -132.99 114.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 109.155 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 138.91 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.331 0.652 . . . . 0.0 109.844 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.1 p -142.57 145.99 34.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.033 0.921 . . . . 0.0 111.221 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -86.49 145.72 26.69 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 tt -134.6 122.49 22.39 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.993 0.917 . . . . 0.0 110.035 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 t -131.14 138.31 49.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.434 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.02 134.11 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.72 50.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.89 0.876 . . . . 0.0 109.885 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.26 129.46 40.04 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.156 -0.34 . . . . 0.0 110.253 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.9 p -77.41 -10.37 59.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.81 0.844 . . . . 0.0 112.855 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.74 164.43 17.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.085 2.154 . . . . 0.0 111.301 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.9 t -75.17 141.29 74.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.63 -0.669 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.35 129.58 15.45 Favored 'Cis proline' 0 C--N 1.354 0.861 0 CA-C-N 120.279 1.135 . . . . 0.0 111.091 -9.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -73.73 34.38 0.08 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.978 1.711 . . . . 0.0 113.546 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.23 151.17 23.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 113.039 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.21 102.62 2.14 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.916 0.886 . . . . 0.0 110.381 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.94 -39.1 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.82 2.048 . . . . 0.0 111.495 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.53 143.76 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.2 1.4 . . . . 0.0 108.252 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -148.77 74.46 1.27 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.962 0.905 . . . . 0.0 109.273 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -140.69 -156.13 6.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.424 1.488 . . . . 0.0 112.039 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 55.2 m -141.69 164.73 29.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.95 0.9 . . . . 0.0 110.434 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.73 156.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.444 1.498 . . . . 0.0 108.176 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.01 134.39 53.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.141 -0.974 . . . . 0.0 108.65 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.05 160.08 16.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.486 1.115 . . . . 0.0 109.609 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -159.22 154.31 25.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.269 1.428 . . . . 0.0 109.262 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -128.94 142.83 50.81 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.937 1.295 . . . . 0.0 109.168 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.6 m -101.86 109.66 60.21 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.376 0.67 . . . . 0.0 109.197 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.63 47.65 1.71 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 125.227 3.952 . . . . 0.0 113.098 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -130.27 -49.73 1.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.105 1.762 . . . . 0.0 110.462 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.2 p -138.46 24.71 2.68 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.196 1.398 . . . . 0.0 112.609 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.99 23.75 64.08 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.306 0.955 . . . . 0.0 114.154 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 158.73 35.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.327 1.051 . . . . 0.0 111.318 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.19 143.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.705 1.602 . . . . 0.0 107.819 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 59.4 m -139.49 128.73 23.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.841 1.256 . . . . 0.0 108.587 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.567 HG23 ' HE2' ' A' ' 186' ' ' LYS . 0.9 OUTLIER -102.07 126.61 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.866 0.866 . . . . 0.0 110.233 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.71 130.18 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.902 1.281 . . . . 0.0 108.224 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 184' ' ' VAL . 14.8 mtmt -140.03 125.86 19.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.198 1.799 . . . . 0.0 108.468 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 158.56 42.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.164 1.386 . . . . 0.0 109.943 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.59 -18.36 19.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.648 1.179 . . . . 0.0 113.274 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.78 -24.88 64.45 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.967 1.707 . . . . 0.0 114.609 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.0 p -150.15 -44.17 0.13 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.756 1.223 . . . . 0.0 114.1 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.86 144.28 51.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.895 1.278 . . . . 0.0 110.072 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.47 -78.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 121.268 1.312 . . . . 0.0 113.437 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 156.06 -44.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 130.262 3.425 . . . . 0.0 112.003 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -57.97 -25.18 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.058 1.743 . . . . 0.0 113.533 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -119.46 131.85 55.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.737 1.615 . . . . 0.0 107.433 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -132.09 149.68 52.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 110.174 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.69 131.23 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.3 t -120.08 153.76 35.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.882 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.432 ' HB3' ' CE2' ' A' ' 205' ' ' PHE . 11.3 pt20 -105.04 114.4 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.731 0.812 . . . . 0.0 109.897 -176.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.48 -33.62 60.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -134.42 -175.6 3.93 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.352 1.061 . . . . 0.0 112.968 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.85 -30.91 68.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.361 1.064 . . . . 0.0 113.319 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.1 p -139.81 13.72 2.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.47 1.908 . . . . 0.0 112.591 -168.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 t -129.07 123.57 32.6 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.668 1.187 . . . . 0.0 110.958 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 199' ' ' GLN . 94.4 m-85 -130.04 146.63 51.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.812 1.645 . . . . 0.0 109.819 -171.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.63 119.2 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.81 107.76 19.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.737 . . . . 0.0 109.685 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.25 140.69 29.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.842 1.657 . . . . 0.0 109.998 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.39 110.49 12.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.913 0.885 . . . . 0.0 110.569 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.5 13.06 13.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.567 1.947 . . . . 0.0 113.861 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.13 135.4 3.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.1 1.76 . . . . 0.0 109.849 166.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.91 -4.44 35.05 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.651 0 C-N-CA 126.206 1.802 . . . . 0.0 115.332 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -96.75 129.67 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.406 1.483 . . . . 0.0 110.122 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.74 148.31 49.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.24 -21.55 24.27 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.666 -1.271 . . . . 0.0 113.098 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -112.71 11.65 19.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.474 1.91 . . . . 0.0 113.729 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -144.08 172.65 12.6 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.912 2.085 . . . . 0.0 110.402 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.26 156.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.237 -0.914 . . . . 0.0 110.692 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 134.25 26.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.817 0.847 . . . . 0.0 110.783 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -118.5 154.46 32.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.425 1.09 . . . . 0.0 110.281 -168.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -138.15 126.12 22.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.782 1.277 . . . . 0.0 110.984 -166.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -96.92 44.01 1.06 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.287 1.041 . . . . 0.0 112.647 -165.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.57 137.6 3.84 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.72 1.628 . . . . 0.0 110.778 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -61.32 133.93 56.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.925 0.89 . . . . 0.0 109.6 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 83.94 27.5 0.09 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.913 2.085 . . . . 0.0 113.058 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.79 59.0 4.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.242 1.417 . . . . 0.0 113.154 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.3 p -128.05 -174.06 3.1 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.98 1.712 . . . . 0.0 112.032 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.6 -98.62 1.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.861 1.219 . . . . 0.0 112.634 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.2 175.97 8.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.205 1.402 . . . . 0.0 110.753 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -133.42 158.61 42.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 111.228 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.58 152.33 37.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.963 1.305 . . . . 0.0 110.491 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.49 140.96 52.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.768 0.827 . . . . 0.0 111.731 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -137.9 134.24 34.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.255 1.422 . . . . 0.0 110.393 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.71 159.37 20.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.727 0.811 . . . . 0.0 111.577 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 155.27 13.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.036 -0.415 . . . . 0.0 112.051 168.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.57 93.95 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.736 0.684 . . . . 0.0 113.254 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -125.16 124.34 41.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.448 1.099 . . . . 0.0 110.731 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -122.62 124.18 42.88 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 108.481 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.74 133.52 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.521 1.153 . . . . 0.0 109.858 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -114.51 83.69 1.93 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.649 1.98 . . . . 0.0 107.922 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.2 167.35 14.41 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.999 0.904 . . . . 0.0 111.382 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -117.96 159.81 22.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 109.807 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -17.97 63.63 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -36.24 73.55 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.052 1.31 . . . . 0.0 114.191 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -76.96 110.73 11.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.496 1.148 . . . . 0.0 109.345 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -24.31 66.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.182 -1.574 . . . . 0.0 112.563 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -61.47 -21.66 64.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.734 1.614 . . . . 0.0 112.363 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -71.88 -53.93 11.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.642 1.177 . . . . 0.0 112.243 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -24.29 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -55.05 -27.62 46.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.023 1.729 . . . . 0.0 114.467 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -51.2 108.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.435 1.016 . . . . 0.0 111.707 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.9 tpt -132.35 -29.03 1.62 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.028 0.931 . . . . 0.0 112.663 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.9 m -139.33 164.24 30.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.643 2.377 . . . . 0.0 109.438 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.5 163.26 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.43 1.092 . . . . 0.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pp -146.75 148.86 32.39 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 123.17 1.462 . . . . 0.0 111.326 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.04 133.33 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.086 1.754 . . . . 0.0 107.803 -167.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.44 -92.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.181 1.372 . . . . 0.0 116.002 -168.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -170.25 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.111 1.364 . . . . 0.0 113.772 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -122.11 28.17 7.65 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.679 1.992 . . . . 0.0 111.841 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -145.24 146.75 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.874 2.07 . . . . 0.0 109.375 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.43 149.78 38.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 109.138 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.1 144.85 44.22 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.958 0.903 . . . . 0.0 110.49 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -122.38 135.5 54.71 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.672 1.189 . . . . 0.0 109.27 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.5 mt -118.39 126.4 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.153 1.381 . . . . 0.0 108.475 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -131.59 124.74 30.61 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.062 0.945 . . . . 0.0 110.572 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -26.59 11.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.863 1.265 . . . . 0.0 111.809 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.406 ' CE1' ' H ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -114.38 150.68 34.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.828 1.251 . . . . 0.0 110.759 174.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -142.77 103.6 4.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.842 1.257 . . . . 0.0 109.027 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.73 155.29 19.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.286 1.434 . . . . 0.0 109.88 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.34 27.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.525 1.53 . . . . 0.0 111.764 -168.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.2 -29.68 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.92 2.088 . . . . 0.0 111.37 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 t -54.44 122.19 36.69 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.027 0.931 . . . . 0.0 112.566 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.97 -15.26 10.6 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.791 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 t -82.77 113.2 43.5 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.11 0.868 . . . . 0.0 110.174 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.8 127.53 14.69 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.107 1.204 . . . . 0.0 109.055 174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.406 ' H ' ' CE1' ' A' ' 57' ' ' HIS . . . -84.08 -113.91 0.62 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 175.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.67 115.02 18.1 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 109.621 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.17 143.29 34.14 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.337 2.255 . . . . 0.0 107.882 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -158.64 166.71 31.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.608 1.163 . . . . 0.0 110.015 166.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -126.72 104.99 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 108.48 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.73 124.89 21.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.58 153.86 2.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.88 -18.77 14.4 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.62 126.49 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 160.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.14 164.32 0.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.927 2.091 . . . . 0.0 111.364 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.8 m -112.69 131.54 55.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 0.0 109.036 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -124.71 98.73 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.764 1.625 . . . . 0.0 107.571 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -112.39 17.57 19.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.246 1.018 . . . . 0.0 111.886 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -156.69 66.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.838 1.655 . . . . 0.0 110.803 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB3' HG22 ' A' ' 83' ' ' ILE . 4.0 mp -92.0 31.22 1.28 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.161 -0.962 . . . . 0.0 111.874 176.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.3 m -56.58 -28.39 60.16 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 119.995 -1.691 . . . . 0.0 113.038 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -60.28 -26.66 66.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.711 -1.243 . . . . 0.0 114.106 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.404 HG22 ' HB3' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -97.63 -23.32 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.786 1.234 . . . . 0.0 112.484 176.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 55.41 50.42 14.83 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.672 1.989 . . . . 0.0 113.464 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.22 -170.49 44.69 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.529 -0.732 . . . . 0.0 111.31 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -175.0 5.16 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.66 -1.494 . . . . 0.0 111.987 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -135.02 -27.93 1.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.35 135.28 46.06 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.536 -0.728 . . . . 0.0 110.006 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.86 131.24 52.42 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.503 1.521 . . . . 0.0 108.945 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.31 137.78 54.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.397 0.618 . . . . 0.0 109.635 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.81 116.65 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 125.637 1.575 . . . . 0.0 106.879 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.69 130.39 24.48 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 109.352 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.12 162.07 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.753 1.636 . . . . 0.0 112.871 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.16 2.09 4.36 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.803 1.668 . . . . 0.0 116.029 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.28 -18.41 32.1 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.238 1.415 . . . . 0.0 113.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -132.75 161.05 35.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.763 1.625 . . . . 0.0 110.153 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -93.55 -55.19 3.36 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -139.99 164.34 30.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.615 1.566 . . . . 0.0 109.145 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 163.63 32.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.524 0.73 . . . . 0.0 109.4 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.445 HG21 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -135.5 142.59 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.151 0.58 . . . . 0.0 109.505 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.92 139.27 33.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.271 0.558 . . . . 0.0 110.479 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.55 137.14 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.479 1.111 . . . . 0.0 109.773 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -136.79 153.93 50.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.787 0.835 . . . . 0.0 111.111 -178.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.83 137.75 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 108.789 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -109.87 119.16 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.625 1.17 . . . . 0.0 109.346 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -63.62 89.67 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.433 1.893 . . . . 0.0 112.877 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.84 10.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.454 1.101 . . . . 0.0 112.987 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -80.69 -70.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.133 1.373 . . . . 0.0 110.508 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.23 169.42 8.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.477 1.511 . . . . 0.0 110.729 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.6 t -83.99 -47.45 10.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.957 0.503 . . . . 0.0 112.347 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -61.32 -39.13 89.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 41.44 -148.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.123 1.369 . . . . 0.0 112.271 -170.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.91 26.52 55.12 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 120.927 -1.108 . . . . 0.0 114.137 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.0 m -138.19 15.64 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.468 1.507 . . . . 0.0 114.622 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -133.71 114.26 13.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.542 1.537 . . . . 0.0 110.624 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -111.12 114.43 27.69 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.606 0.762 . . . . 0.0 110.495 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -107.47 117.98 35.53 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.786 2.034 . . . . 0.0 110.161 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -108.13 126.43 52.75 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.1 pt -118.19 140.3 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 110.056 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 m -145.24 93.98 5.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.188 0.995 . . . . 0.0 109.107 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.94 168.49 18.66 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.372 2.048 . . . . 0.0 112.627 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -35.91 101.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.771 2.428 . . . . 0.0 113.65 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.306 2.7 pp0? 42.15 42.08 2.31 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.619 2.367 . . . . 0.0 116.61 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.45 156.8 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.021 1.729 . . . . 0.0 112.099 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -52.33 119.88 4.92 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.219 1.808 . . . . 0.0 112.62 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 142.87 56.37 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.592 0.757 . . . . 0.0 111.513 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.14 117.66 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.624 1.17 . . . . 0.0 110.615 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.73 102.18 13.41 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.209 1.004 . . . . 0.0 110.059 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 3.9 t -93.5 152.16 19.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.51 0.724 . . . . 0.0 110.333 170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -143.49 146.88 33.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.511 1.124 . . . . 0.0 109.289 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -54.9 85.57 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.106 . . . . 0.0 114.052 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.63 -21.44 1.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.547 1.546 . . . . 0.0 113.463 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.66 135.45 56.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.32 1.06 . . . . 0.0 110.602 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.15 64.02 3.22 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.213 1.005 . . . . 0.0 111.725 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 6.5 m-85 60.54 81.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.0 2.12 . . . . 0.0 111.423 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.79 131.97 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.15 -0.969 . . . . 0.0 110.403 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 136.89 32.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 110.515 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.12 98.64 48.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.573 1.949 . . . . 0.0 108.873 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -71.63 138.34 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.717 2.278 . . . . 0.0 111.409 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.49 126.93 22.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 108.541 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.86 167.18 23.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.723 2.949 . . . . 0.0 111.942 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -61.71 122.04 14.34 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.572 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.06 153.02 47.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.351 2.261 . . . . 0.0 109.438 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 t -137.86 136.05 19.48 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.575 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.76 150.41 65.26 Favored 'Cis proline' 0 CA--C 1.548 1.18 0 CA-C-N 119.771 0.954 . . . . 0.0 112.471 -7.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.47 -29.09 62.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.295 1.996 . . . . 0.0 112.494 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.47 3.75 15.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.266 1.427 . . . . 0.0 113.786 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.7 p -67.97 147.7 52.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.138 1.335 . . . . 0.0 112.198 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.15 121.09 16.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.889 0.875 . . . . 0.0 110.829 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.0 tt -109.54 116.51 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.819 0.848 . . . . 0.0 110.668 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.15 142.68 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.0 0.52 . . . . 0.0 109.808 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.6 t -144.63 137.83 26.96 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.982 0.913 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -99.85 139.19 35.88 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.232 0.539 . . . . 0.0 109.55 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.27 124.41 47.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.842 2.057 . . . . 0.0 107.643 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 113.77 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 2.0 p -124.23 140.64 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.181 1.392 . . . . 0.0 108.969 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -139.84 156.45 46.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.056 0.942 . . . . 0.0 111.524 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -65.24 134.34 53.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.2 p -71.96 -8.55 55.13 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.94 10.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.35 2.26 . . . . 0.0 110.383 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.9 t -40.09 134.59 1.43 Allowed Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 125.729 1.612 . . . . 0.0 114.212 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.65 2.36 21.03 Favored 'Cis proline' 0 CA--C 1.546 1.105 0 N-CA-C 114.854 1.059 . . . . 0.0 114.854 3.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 6.89 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.84 2.056 . . . . 0.0 114.243 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.13 156.41 38.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.911 1.285 . . . . 0.0 111.735 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -55.21 143.29 28.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.908 0.883 . . . . 0.0 111.802 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.75 -23.01 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.487 1.515 . . . . 0.0 112.205 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 75.2 t -155.89 141.82 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.75 1.62 . . . . 0.0 108.324 171.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -136.81 113.68 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.676 1.99 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.19 -179.11 39.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.139 0.876 . . . . 0.0 111.993 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.49 149.0 44.96 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.921 -0.752 . . . . 0.0 110.934 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.0 p -138.81 159.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.087 1.355 . . . . 0.0 109.133 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -115.43 130.73 56.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 109.917 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -104.91 152.31 22.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 0.0 109.521 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -149.86 162.86 39.49 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.759 2.024 . . . . 0.0 110.578 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -133.7 123.52 25.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.574 1.55 . . . . 0.0 108.93 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.8 m -77.82 112.51 25.32 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.367 0.667 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.4 54.05 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.542 3.494 . . . . 0.0 112.072 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.3 m -136.92 -52.65 0.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.262 1.425 . . . . 0.0 111.273 -170.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 32.1 p -130.26 12.91 5.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.235 1.414 . . . . 0.0 112.551 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.66 28.81 72.89 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.084 1.326 . . . . 0.0 113.626 -171.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -68.34 156.37 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.476 -1.014 . . . . 0.0 111.141 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -136.02 131.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.8 m -135.53 132.17 36.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.206 1.403 . . . . 0.0 109.23 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.513 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -105.02 117.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.26 1.024 . . . . 0.0 110.255 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -88.64 128.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 134.94 25.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.973 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -148.78 143.91 26.67 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.77 1.628 . . . . 0.0 109.678 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.17 -14.93 4.61 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.11 1.364 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -52.31 -30.43 28.27 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.324 1.85 . . . . 0.0 114.409 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 16.7 p -149.49 -34.72 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.705 1.602 . . . . 0.0 113.623 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -72.88 133.43 82.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 111.608 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.68 130.2 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.545 2.83 . . . . 0.0 111.546 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -73.56 -20.09 60.72 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 167' ' ' VAL . 0.8 OUTLIER -74.86 -13.04 60.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.29 1.036 . . . . 0.0 113.493 177.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.8 mtp -112.53 150.91 30.63 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.515 1.526 . . . . 0.0 108.828 167.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.1 p -142.21 118.28 10.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.238 0.615 . . . . 0.0 109.614 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.17 107.92 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.486 0.66 . . . . 0.0 109.708 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 95.2 m -88.11 143.82 26.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.555 0.693 . . . . 0.0 109.753 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.26 71.14 10.66 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.72 1.208 . . . . 0.0 110.408 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.43 -42.78 64.4 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.301 1.44 . . . . 0.0 113.259 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.08 -177.38 6.54 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.076 1.75 . . . . 0.0 110.991 163.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -50.91 143.45 10.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.256 -1.528 . . . . 0.0 109.574 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 29.9 p 53.13 14.96 0.54 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 t -139.88 108.92 6.03 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.865 1.666 . . . . 0.0 110.958 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 184' ' ' VAL . 22.3 m-85 -120.76 147.62 45.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.177 0.991 . . . . 0.0 111.128 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . 0.272 9.8 tt -133.84 99.08 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 122.51 1.148 . . . . 0.0 110.513 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -73.36 109.91 7.25 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.305 1.842 . . . . 0.0 110.11 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -81.04 138.21 36.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.9 tp -132.07 111.65 11.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.37 1.068 . . . . 0.0 108.667 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -120.73 -3.38 9.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.432 1.493 . . . . 0.0 114.609 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -141.18 -178.55 5.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.012 1.325 . . . . 0.0 111.502 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.1 46.67 0.99 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.082 0.944 . . . . 0.0 113.181 -170.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt . . . . . 0 C--O 1.258 1.531 0 C-N-CA 128.214 2.606 . . . . 0.0 116.986 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.79 138.51 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.724 1.209 . . . . 0.0 110.291 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.58 140.57 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.15 -16.4 32.27 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.845 -1.159 . . . . 0.0 113.109 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.77 9.89 11.49 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 112.45 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -148.17 171.72 15.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.622 1.969 . . . . 0.0 110.738 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 23' ' ' TYR . 2.1 m -141.27 150.99 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 O-C-N 121.035 -1.041 . . . . 0.0 112.412 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -149.64 151.14 33.25 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.807 -0.558 . . . . 0.0 109.631 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.6 159.4 42.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.741 -0.6 . . . . 0.0 110.877 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -130.86 136.46 48.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.223 1.009 . . . . 0.0 111.054 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.63 63.35 3.4 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.732 1.613 . . . . 0.0 111.287 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.47 135.72 1.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.686 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -58.58 126.73 28.82 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 90.28 22.7 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.735 2.414 . . . . 0.0 112.268 -174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.39 55.1 0.86 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.254 1.421 . . . . 0.0 111.408 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.8 p -129.24 -178.78 4.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.682 1.593 . . . . 0.0 112.367 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.95 -107.31 2.15 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.651 1.12 . . . . 0.0 113.773 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.0 167.87 9.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.9 p -133.7 152.22 51.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.835 0.854 . . . . 0.0 112.589 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.49 150.48 29.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -141.97 140.75 32.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.082 0.953 . . . . 0.0 110.734 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 8' ' ' VAL . 1.7 p90 -145.52 142.5 29.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.364 1.066 . . . . 0.0 109.277 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.97 163.89 26.6 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.749 -1.219 . . . . 0.0 112.09 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -76.11 161.31 28.95 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.196 -0.94 . . . . 0.0 111.326 171.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.22 43.65 70.12 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 114.644 0.617 . . . . 0.0 114.644 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 169.88 19.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.438 1.495 . . . . 0.0 111.616 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.4 p -138.95 143.44 38.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.976 0.91 . . . . 0.0 111.502 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -135.59 129.15 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.149 0.979 . . . . 0.0 110.556 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.21 90.53 3.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.756 1.223 . . . . 0.0 108.921 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.42 166.42 14.62 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.973 0.892 . . . . 0.0 111.346 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -111.8 153.42 26.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.6 0.76 . . . . 0.0 110.163 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.92 57.43 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.65 73.59 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.815 1.198 . . . . 0.0 114.411 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -91.91 112.49 24.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.863 0.831 . . . . 0.0 109.381 167.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -21.75 33.9 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.529 -0.732 . . . . 0.0 111.494 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -61.32 -11.65 10.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.358 1.463 . . . . 0.0 112.533 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -67.32 -52.05 45.12 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.444 -1.41 . . . . 0.0 111.392 167.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.09 -10.7 55.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.509 1.524 . . . . 0.0 112.883 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.97 -27.09 63.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.838 1.655 . . . . 0.0 113.313 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -58.43 104.66 0.23 Allowed 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.63 -1.294 . . . . 0.0 111.671 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -27.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.917 1.687 . . . . 0.0 112.438 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 t -142.12 137.17 30.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.474 1.91 . . . . 0.0 111.173 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.73 120.06 13.04 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.462 1.125 . . . . 0.0 112.178 -173.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.46 112.97 24.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.894 1.678 . . . . 0.0 109.839 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 75' ' ' SER . 0.9 OUTLIER -98.93 140.62 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.724 1.209 . . . . 0.0 109.429 173.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.05 -116.78 0.03 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.02 1.295 . . . . 0.0 114.552 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.7 m -147.08 -13.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.666 1.186 . . . . 0.0 113.024 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 36.03 3.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.493 1.517 . . . . 0.0 110.392 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.22 118.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.7 1.6 . . . . 0.0 110.959 -168.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -95.77 140.53 30.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.55 1.14 . . . . 0.0 110.652 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 51.6 m -125.79 112.93 16.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 108.916 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -109.25 134.6 51.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.45 144.04 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.437 0.637 . . . . 0.0 111.839 -171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -142.14 142.06 32.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.37 -166.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -118.62 -29.53 5.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.779 0.832 . . . . 0.0 111.588 -170.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.11 130.59 25.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.411 1.484 . . . . 0.0 111.85 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.93 121.53 41.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.192 0.597 . . . . 0.0 110.967 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -165.81 170.32 14.02 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 0.0 110.953 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.82 21.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.172 1.389 . . . . 0.0 111.539 -169.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.75 -17.19 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.808 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.2 t -41.81 138.88 1.7 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.427 1.491 . . . . 0.0 114.908 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.56 -9.05 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.445 2.763 . . . . 0.0 112.71 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -143.79 115.08 5.58 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.533 1.133 . . . . 0.0 111.52 172.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 49.62 1.92 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.388 2.726 . . . . 0.0 112.033 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 31.66 -107.41 0.02 OUTLIER Glycine 0 CA--C 1.527 0.827 0 C-N-CA 129.008 3.194 . . . . 0.0 114.548 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -123.44 144.64 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.016 0.926 . . . . 0.0 110.252 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.56 153.98 40.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.96 1.704 . . . . 0.0 110.259 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -161.86 153.99 19.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.734 0.814 . . . . 0.0 110.86 167.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.1 93.75 4.25 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.942 1.297 . . . . 0.0 109.172 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.74 134.81 57.45 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 176.3 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.54 -18.65 65.48 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.535 -1.353 . . . . 0.0 113.113 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 111.71 0.5 Allowed Glycine 0 CA--C 1.536 1.36 0 CA-C-N 119.028 0.831 . . . . 0.0 113.357 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER 175.46 162.47 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.728 2.411 . . . . 0.0 111.023 179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -109.28 142.53 40.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.018 1.327 . . . . 0.0 110.743 171.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -134.18 136.29 43.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.698 1.199 . . . . 0.0 108.676 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -150.24 -50.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.929 0.892 . . . . 0.0 111.374 -170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -81.23 46.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.981 1.312 . . . . 0.0 113.413 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.01 42.61 0.09 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.216 1.406 . . . . 0.0 113.433 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -60.29 -34.69 74.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 112.713 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -65.91 -26.42 67.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.6 mm -72.6 -38.91 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.397 1.079 . . . . 0.0 110.262 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.82 32.6 22.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.714 1.606 . . . . 0.0 113.297 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.14 39.8 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.216 1.389 . . . . 0.0 113.411 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -176.29 3.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 112.399 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -140.53 -31.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.0 136.77 37.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.194 0.998 . . . . 0.0 110.153 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.402 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -145.44 133.86 21.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.78 0.8 . . . . 0.0 110.093 -168.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.32 138.54 53.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.72 -170.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.78 121.92 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.33 135.57 27.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.143 0.577 . . . . 0.0 110.313 -166.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.424 ' CB ' ' HE2' ' A' ' 25' ' ' LYS . 61.4 Cg_endo -76.44 152.59 34.39 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.04 1.827 . . . . 0.0 111.021 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.37 29.13 0.21 Allowed Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.851 1.691 . . . . 0.0 116.121 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.69 -18.23 3.92 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.605 1.962 . . . . 0.0 112.654 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -119.25 156.24 30.29 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.941 0.897 . . . . 0.0 110.167 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -88.24 -41.91 12.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.491 -0.755 . . . . 0.0 111.966 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -150.14 167.64 26.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.143 2.177 . . . . 0.0 108.561 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.63 166.55 23.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.668 -0.645 . . . . 0.0 110.72 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.92 149.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.238 0.615 . . . . 0.0 111.579 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.95 118.17 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.54 130.32 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.803 0.841 . . . . 0.0 111.326 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -127.6 145.58 50.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.39 1.076 . . . . 0.0 110.65 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.14 147.46 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 123.808 0.692 . . . . 0.0 111.651 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.69 127.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.312 1.054 . . . . 0.0 110.132 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -64.03 125.54 24.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.561 1.544 . . . . 0.0 112.242 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -35.14 2.48 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.63 -35.86 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.492 1.117 . . . . 0.0 113.383 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -120.33 139.96 51.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.039 1.336 . . . . 0.0 109.05 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -87.15 6.81 30.98 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.955 -1.091 . . . . 0.0 113.181 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -88.66 -33.65 17.52 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 48.44 -167.35 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.37 17.13 55.95 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 p -141.25 5.95 1.9 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.43 1.115 . . . . 0.0 113.247 -162.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -113.32 152.01 30.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.242 1.017 . . . . 0.0 112.7 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 159' ' ' THR . 3.5 tt0 -127.81 134.76 49.47 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.248 1.419 . . . . 0.0 109.454 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -124.37 139.83 53.53 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.817 -0.552 . . . . 0.0 110.94 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -135.63 119.26 17.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.971 1.309 . . . . 0.0 109.404 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.91 115.15 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 108.968 -170.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.8 m -122.96 92.18 49.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.019 0.528 . . . . 0.0 112.123 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.48 169.52 21.57 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.232 2.621 . . . . 0.0 113.249 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.2 57.71 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.135 1.774 . . . . 0.0 115.269 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.82 -53.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 161.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.0 158.86 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.33 1.052 . . . . 0.0 111.716 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -154.52 -165.2 2.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.239 1.415 . . . . 0.0 110.182 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 56.88 58.79 3.83 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.68 122.52 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.562 1.945 . . . . 0.0 109.957 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.45 112.43 11.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.631 0.772 . . . . 0.0 110.069 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.7 t -97.48 137.55 36.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.682 0.393 . . . . 0.0 110.278 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -104.11 143.34 33.05 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.181 0.992 . . . . 0.0 109.932 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -56.19 131.62 48.31 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 121.962 -0.461 . . . . 0.0 110.984 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.84 8.66 44.9 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.823 1.202 . . . . 0.0 115.356 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.17 155.74 19.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.127 0.963 . . . . 0.0 112.354 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.44 49.55 1.17 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.51 1.124 . . . . 0.0 113.199 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 60.48 104.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.362 2.265 . . . . 0.0 112.44 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.28 141.0 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 134.25 35.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.745 0.784 . . . . 0.0 112.104 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -118.47 102.13 50.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 169.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.63 121.22 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.046 1.83 . . . . 0.0 111.827 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.8 mm -99.76 123.04 49.07 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.368 1.067 . . . . 0.0 110.106 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.99 178.47 7.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.811 2.341 . . . . 0.0 111.97 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 139.8 43.71 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.966 -1.084 . . . . 0.0 113.227 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.16 152.11 29.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.441 1.497 . . . . 0.0 111.724 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -145.14 135.69 12.1 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.215 1.406 . . . . 0.0 110.396 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.03 146.33 68.11 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 120.045 1.052 . . . . 0.0 110.782 -7.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.68 -31.05 33.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.502 2.135 . . . . 0.0 111.393 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.72 5.86 4.51 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.744 1.618 . . . . 0.0 114.979 168.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.5 t -77.1 149.16 35.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.104 0.866 . . . . 0.0 111.74 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.434 0.694 . . . . 0.0 111.374 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 tt -106.0 121.72 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.441 1.096 . . . . 0.0 110.912 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.75 135.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.068 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.4 p -143.2 127.75 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.548 0.689 . . . . 0.0 111.485 169.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 140.77 42.2 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.49 111.12 11.99 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.652 1.215 . . . . 0.0 109.425 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 p -109.06 144.09 37.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.634 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.34 133.57 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -138.9 147.8 42.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.755 1.222 . . . . 0.0 109.23 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -67.14 115.14 6.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.453 -0.78 . . . . 0.0 110.006 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.3 t -65.08 -16.78 63.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.339 1.056 . . . . 0.0 112.528 173.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -114.37 156.7 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 110.794 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 t -69.83 138.99 88.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.491 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.66 129.11 16.51 Favored 'Cis proline' 0 C--N 1.355 0.912 0 CA-C-N 120.721 1.293 . . . . 0.0 110.374 -5.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -76.0 36.68 0.14 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.174 1.39 . . . . 0.0 113.457 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 146.83 52.95 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.046 -1.659 . . . . 0.0 113.158 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -69.62 127.25 32.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.435 0.694 . . . . 0.0 111.01 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 -50.49 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 112.205 -171.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 24.4 m -146.57 139.18 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.884 1.274 . . . . 0.0 109.574 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -130.39 98.29 4.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.465 1.506 . . . . 0.0 108.019 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.05 11.46 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.326 1.441 . . . . 0.0 113.193 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.8 m -135.41 153.72 51.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.801 0.84 . . . . 0.0 111.502 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.51 165.09 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.682 1.593 . . . . 0.0 108.849 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.5 126.89 38.01 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.03 150.89 23.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.456 -0.777 . . . . 0.0 110.414 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -145.31 162.34 37.44 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 125.185 1.394 . . . . 0.0 108.344 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 170.11 19.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 169.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.5 m -133.64 105.52 11.86 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.63 0.772 . . . . 0.0 109.026 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 18.77 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.26 3.306 . . . . 0.0 113.037 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -63.65 -34.06 77.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.008 1.723 . . . . 0.0 112.5 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 t -164.3 26.83 0.07 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 123.176 1.465 . . . . 0.0 112.4 -173.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 60.59 27.99 67.01 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 119.259 -2.151 . . . . 0.0 113.778 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -79.07 142.89 36.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.69 0.745 . . . . 0.0 111.191 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.49 160.67 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.061 0.545 . . . . 0.0 111.414 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.4 m -148.99 129.98 14.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.901 1.28 . . . . 0.0 111.118 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.91 128.07 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.392 0.542 . . . . 0.0 110.433 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.41 130.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.361 1.077 . . . . 0.0 108.612 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.67 135.94 22.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 109.044 -176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -144.43 145.08 31.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.311 1.444 . . . . 0.0 109.693 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.57 -16.7 6.53 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.331 1.452 . . . . 0.0 113.786 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.4 -24.03 64.83 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.9 p -144.7 -30.2 0.45 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.121 1.369 . . . . 0.0 113.727 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -79.42 144.51 61.83 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.895 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.78 158.84 52.24 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.04 1.827 . . . . 0.0 112.284 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -93.65 -2.08 54.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -109.48 -16.47 13.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.135 1.374 . . . . 0.0 113.517 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.1 ttt -134.34 134.13 41.45 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.797 1.239 . . . . 0.0 107.966 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.3 p -136.73 153.36 50.88 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.86 138.61 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.039 0.536 . . . . 0.0 111.039 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 52.2 m -127.12 143.73 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.803 1.241 . . . . 0.0 109.4 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -75.03 85.42 2.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.468 0.652 . . . . 0.0 110.943 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.28 -42.69 82.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.984 1.314 . . . . 0.0 112.136 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -152.26 178.5 9.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.625 1.57 . . . . 0.0 109.696 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.45 135.3 54.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.668 -1.895 . . . . 0.0 110.944 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 m 58.61 23.21 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.558 1.143 . . . . 0.0 113.054 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.13 110.91 6.2 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.591 -0.693 . . . . 0.0 110.829 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.25 145.22 42.02 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.935 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.86 116.69 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.88 0.848 . . . . 0.0 110.663 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -96.7 117.1 30.29 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.267 1.427 . . . . 0.0 110.516 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -100.01 131.89 45.69 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.594 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.49 114.42 20.67 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.89 0.768 . . . . 0.0 112.943 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -117.09 25.4 10.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.734 1.214 . . . . 0.0 113.339 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.0 m -143.74 166.81 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 52.39 1.18 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.023 2.129 . . . . 0.0 110.86 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt . . . . . 0 C--O 1.294 3.401 0 CA-C-O 115.565 -2.16 . . . . 0.0 111.186 177.519 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.191 0.519 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.91 137.97 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.97 0.908 . . . . 0.0 111.365 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.57 147.93 29.38 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.736 -0.602 . . . . 0.0 110.488 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.12 -20.31 52.42 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.839 -1.163 . . . . 0.0 113.835 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -111.2 7.93 21.4 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.501 1.92 . . . . 0.0 113.636 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -143.92 -176.09 4.85 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 110.6 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -145.57 154.03 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.596 0.758 . . . . 0.0 112.733 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 144.41 49.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.902 1.281 . . . . 0.0 110.309 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.414 ' HZ ' ' CE1' ' A' ' 89' ' ' PHE . 14.6 m-85 -132.48 129.66 39.47 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.765 1.626 . . . . 0.0 107.465 -165.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -128.29 121.43 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 123.796 1.76 . . . . 0.0 109.872 -170.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.34 59.26 5.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.735 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.57 149.19 5.78 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.592 1.568 . . . . 0.0 111.357 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.59 151.55 5.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.562 1.145 . . . . 0.0 111.957 175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 49.74 41.54 22.27 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m 50.43 63.19 2.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.465 1.506 . . . . 0.0 113.636 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 18' ' ' GLY . 3.0 m -130.25 -178.21 4.65 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.876 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 17' ' ' THR . . . 74.02 -118.83 6.13 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.078 1.323 . . . . 0.0 111.972 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.11 166.41 11.26 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 117.685 0.742 . . . . 0.0 111.509 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -126.17 146.49 49.94 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.685 1.194 . . . . 0.0 110.965 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.74 155.8 41.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.78 1.232 . . . . 0.0 110.072 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -128.28 142.3 51.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -125.63 125.14 42.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.359 1.064 . . . . 0.0 109.312 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.61 129.01 34.29 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.955 0.902 . . . . 0.0 109.509 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.48 144.68 25.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.475 1.11 . . . . 0.0 112.875 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.02 41.45 9.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.062 0.839 . . . . 0.0 112.939 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.13 153.45 42.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.954 1.301 . . . . 0.0 111.698 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -129.39 131.08 46.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.958 1.303 . . . . 0.0 109.037 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.48 128.23 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 122.579 1.18 . . . . 0.0 109.753 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.6 mtm105 -124.36 89.46 3.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.817 1.247 . . . . 0.0 109.112 -171.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -78.22 168.69 19.45 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.821 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -116.18 157.85 24.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.632 1.173 . . . . 0.0 110.096 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.63 -19.68 65.06 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.263 -0.898 . . . . 0.0 113.073 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.93 -24.05 66.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.221 1.391 . . . . 0.0 114.464 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -98.67 105.14 17.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.283 1.041 . . . . 0.0 109.244 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -21.5 60.48 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.618 -1.301 . . . . 0.0 112.625 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -61.15 -24.21 66.12 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.64 1.976 . . . . 0.0 112.399 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -64.54 -56.14 15.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.693 1.597 . . . . 0.0 111.1 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.5 -18.55 65.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.424 1.49 . . . . 0.0 113.251 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -29.62 69.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.899 2.08 . . . . 0.0 113.222 172.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 86' ' ' LEU . 38.4 t80 -53.27 118.62 3.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.784 0.72 . . . . 0.0 110.259 169.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 mmm -146.12 -16.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.126 0.97 . . . . 0.0 113.435 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.7 m -136.9 151.79 49.48 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 110.783 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.55 155.77 22.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.641 1.176 . . . . 0.0 110.743 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.7 121.7 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 8' ' ' VAL . 62.7 t -92.23 136.69 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.352 0.661 . . . . 0.0 110.137 172.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -106.02 0.01 OUTLIER Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.85 2.166 . . . . 0.0 115.823 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -161.27 -21.78 0.05 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.794 1.638 . . . . 0.0 112.866 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.14 33.14 4.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.622 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.8 121.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.111 1.765 . . . . 0.0 110.109 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -84.69 145.63 27.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.856 -1.153 . . . . 0.0 109.558 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 58.5 m -126.65 147.82 49.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.594 -0.692 . . . . 0.0 110.771 173.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.85 140.09 52.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.667 0.787 . . . . 0.0 109.451 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.512 HG23 HD12 ' A' ' 86' ' ' LEU . 9.1 mt -122.44 138.14 53.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.454 1.102 . . . . 0.0 109.362 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -152.7 120.49 6.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.663 0.785 . . . . 0.0 112.379 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -83.51 -60.95 1.97 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.7 175.02 5.64 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.543 -0.723 . . . . 0.0 110.986 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 202' ' ' ASN . 3.1 p30 -153.92 134.48 13.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.927 0.891 . . . . 0.0 110.31 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -164.8 155.09 14.01 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.314 1.445 . . . . 0.0 110.461 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.35 41.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 111.177 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.09 -34.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.148 1.779 . . . . 0.0 111.606 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 t -56.08 134.5 74.4 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.597 1.159 . . . . 0.0 113.251 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.1 -18.96 9.73 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.095 2.53 . . . . 0.0 113.312 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 t -101.74 130.64 24.14 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.503 1.121 . . . . 0.0 110.637 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.04 174.67 11.61 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.356 2.038 . . . . 0.0 111.657 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.89 -151.64 19.73 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 124.576 1.084 . . . . 0.0 112.558 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 109.01 18.91 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.057 0.543 . . . . 0.0 110.329 168.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.7 148.71 41.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.988 1.315 . . . . 0.0 110.169 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -162.49 137.65 6.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.753 0.821 . . . . 0.0 109.51 168.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -87.91 110.36 20.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 165.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.74 125.7 26.67 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.366 -0.834 . . . . 0.0 109.016 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.85 150.2 5.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.798 1.239 . . . . 0.0 112.181 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -15.49 6.35 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.18 104.86 0.26 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 112.143 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.47 160.62 3.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.98 1.712 . . . . 0.0 111.993 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.7 m -113.98 143.66 44.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.013 1.325 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -141.44 112.54 7.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.606 1.163 . . . . 0.0 109.928 -164.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -126.44 -32.72 2.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.48 1.112 . . . . 0.0 112.379 -170.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -96.58 59.33 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.276 2.63 . . . . 0.0 109.621 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.72 52.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.186 1.394 . . . . 0.0 111.629 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.8 m -62.33 -42.54 99.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.176 -1.578 . . . . 0.0 111.547 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -59.46 -28.21 66.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.004 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -128.95 54.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.418 1.887 . . . . 0.0 108.513 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -65.0 -15.63 62.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.685 1.194 . . . . 0.0 113.401 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.38 20.1 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.014 1.292 . . . . 0.0 109.881 155.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -123.07 150.28 43.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.205 1.802 . . . . 0.0 108.452 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -118.53 -42.59 2.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.303 0.641 . . . . 0.0 112.635 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.06 156.36 46.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.893 1.277 . . . . 0.0 111.73 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 52' ' ' CYS . 8.4 t80 -145.97 150.54 36.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.33 1.052 . . . . 0.0 111.458 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.35 129.67 27.43 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.403 1.081 . . . . 0.0 110.949 172.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 25' ' ' LYS . 2.6 p -106.93 125.18 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.096 1.358 . . . . 0.0 109.209 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.93 147.67 57.38 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.06 1.344 . . . . 0.0 110.644 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 29.6 Cg_endo -67.99 -177.03 1.16 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.261 3.307 . . . . 0.0 113.997 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.91 14.88 4.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.022 1.772 . . . . 0.0 114.144 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.7 -47.98 2.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.562 1.945 . . . . 0.0 110.34 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 139' ' ' PRO . 1.3 m-85 -91.44 157.9 16.8 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.49 1.116 . . . . 0.0 111.146 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -127.66 -37.06 2.0 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.948 1.299 . . . . 0.0 111.958 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -141.64 167.13 22.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.882 2.073 . . . . 0.0 108.066 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.7 159.6 41.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 109.793 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.65 130.05 59.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.082 0.953 . . . . 0.0 109.237 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -82.89 127.68 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.873 0.869 . . . . 0.0 108.816 172.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -119.58 144.6 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.747 0.819 . . . . 0.0 109.296 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -144.41 133.85 23.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.677 0.791 . . . . 0.0 109.826 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.0 pt -78.81 148.75 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.726 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -141.94 120.49 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.593 1.957 . . . . 0.0 107.542 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.15 110.93 4.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.471 0.708 . . . . 0.0 110.57 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 19.29 20.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.49 1.116 . . . . 0.0 112.379 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.8 t -126.45 -69.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.145 1.378 . . . . 0.0 111.597 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -89.08 134.61 33.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.442 0.697 . . . . 0.0 109.425 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -79.77 34.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.825 -1.172 . . . . 0.0 112.573 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 m -138.54 52.85 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.063 2.545 . . . . 0.0 108.536 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.23 144.35 41.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 166.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.09 6.34 4.91 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.362 1.458 . . . . 0.0 114.343 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.5 m -141.55 25.52 2.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.605 1.562 . . . . 0.0 113.388 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -128.82 136.72 50.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.278 1.831 . . . . 0.0 109.149 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.63 121.76 43.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.772 1.229 . . . . 0.0 109.683 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -105.23 144.9 31.38 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.0 0.92 . . . . 0.0 110.245 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -137.82 106.8 5.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.093 1.357 . . . . 0.0 107.348 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.4 tt -103.81 131.45 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 109.507 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.7 m -129.95 86.7 53.97 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.958 1.703 . . . . 0.0 109.043 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.28 163.95 35.95 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.422 2.748 . . . . 0.0 112.265 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -31.67 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.715 2.406 . . . . 0.0 114.39 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 34.01 36.15 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.693 2.397 . . . . 0.0 116.37 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -104.26 155.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.69 1.596 . . . . 0.0 109.999 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -48.9 100.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.852 1.661 . . . . 0.0 111.996 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -59.18 165.2 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.255 1.026 . . . . 0.0 111.435 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.2 136.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.101 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.64 123.6 42.31 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.19 168.02 20.6 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.438 0.695 . . . . 0.0 111.111 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -132.46 155.64 48.17 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.34 1.056 . . . . 0.0 110.323 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.56 116.54 1.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.41 . . . . 0.0 111.79 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.69 15.86 19.31 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -171.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.03 160.62 14.7 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.51 1.124 . . . . 0.0 113.712 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.57 50.02 1.89 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.262 1.425 . . . . 0.0 112.325 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 59.81 78.66 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.186 1.794 . . . . 0.0 111.823 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.1 t -40.92 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.068 1.747 . . . . 0.0 112.452 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -81.99 95.84 7.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 111.72 31.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 96' ' ' PHE . 57.7 Cg_endo -78.98 137.29 13.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.586 2.191 . . . . 0.0 112.008 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.5 mt -128.65 128.47 23.53 Favored Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 121.654 -0.654 . . . . 0.0 110.242 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.91 174.78 11.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.431 2.754 . . . . 0.0 113.38 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -60.33 134.98 57.58 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.737 -0.602 . . . . 0.0 109.951 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.39 146.15 49.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.176 1.39 . . . . 0.0 108.567 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.2 m -131.29 126.8 21.55 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 123.942 0.897 . . . . 0.0 110.216 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.44 155.82 81.93 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 119.008 0.681 . . . . 0.0 111.447 -5.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.0 -24.82 32.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.468 1.445 . . . . 0.0 113.364 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -72.22 -5.94 39.36 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 168.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 160.13 33.11 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.742 1.258 . . . . 0.0 112.935 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -103.14 162.68 12.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.15 1.38 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tt -129.1 132.26 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.638 1.975 . . . . 0.0 109.193 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.56 136.08 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.038 0.935 . . . . 0.0 111.126 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.3 t -143.72 150.11 38.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -112.29 136.69 51.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.019 1.328 . . . . 0.0 109.32 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.55 118.83 22.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.297 1.039 . . . . 0.0 109.166 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 t -125.64 123.04 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.233 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.03 140.4 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.027 1.331 . . . . 0.0 108.635 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -148.52 153.09 37.95 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.955 1.302 . . . . 0.0 110.379 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.65 135.71 56.2 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.058 0.543 . . . . 0.0 110.449 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -72.49 -12.85 61.26 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.458 1.103 . . . . 0.0 113.83 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -141.61 -179.09 5.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.98 2.512 . . . . 0.0 110.034 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 p -52.9 146.79 17.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.763 1.225 . . . . 0.0 113.459 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.94 3.58 17.33 Favored 'Cis proline' 0 CA--C 1.545 1.058 0 N-CA-C 114.878 1.068 . . . . 0.0 114.878 1.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.27 27.0 15.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.144 1.378 . . . . 0.0 113.026 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -80.86 139.34 36.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.054 1.342 . . . . 0.0 110.738 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -55.9 100.22 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.474 1.109 . . . . 0.0 112.232 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.49 -51.82 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.823 1.249 . . . . 0.0 110.443 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.4 t -145.36 126.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.742 1.217 . . . . 0.0 108.177 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.83 91.21 2.87 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.621 1.168 . . . . 0.0 108.361 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -150.79 -152.03 5.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.008 1.289 . . . . 0.0 111.103 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 m -143.05 170.15 16.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.749 0.785 . . . . 0.0 111.049 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.63 146.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.338 1.455 . . . . 0.0 108.52 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -101.37 143.02 31.92 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.01 154.17 33.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.331 1.052 . . . . 0.0 109.402 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -157.44 158.77 36.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.594 1.558 . . . . 0.0 108.261 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -128.36 145.32 51.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.525 0.73 . . . . 0.0 109.818 166.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.6 m -91.73 117.24 67.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 -10.07 27.76 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 2.747 . . . . 0.0 113.129 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.7 p -45.62 -38.47 6.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.088 2.155 . . . . 0.0 113.061 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.8 t -158.89 14.73 0.17 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.007 1.323 . . . . 0.0 112.933 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.39 29.91 76.37 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 119.793 -1.817 . . . . 0.0 112.882 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 160.35 31.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.705 1.202 . . . . 0.0 110.703 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.65 130.95 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.278 -0.889 . . . . 0.0 111.069 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.5 m -145.6 121.45 10.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.475 1.51 . . . . 0.0 110.13 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.8 m -86.71 142.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.487 0.66 . . . . 0.0 111.153 171.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 139.8 29.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.515 1.526 . . . . 0.0 107.927 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 123.04 18.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.788 1.235 . . . . 0.0 109.273 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -149.59 152.32 35.27 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.873 1.669 . . . . 0.0 110.046 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -17.01 5.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.98 1.312 . . . . 0.0 114.449 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.79 -26.6 58.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.665 1.586 . . . . 0.0 114.63 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.6 p -147.81 -38.8 0.19 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.623 1.569 . . . . 0.0 112.984 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -60.95 124.21 78.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.047 1.339 . . . . 0.0 110.827 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.8 -7.93 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.519 2.813 . . . . 0.0 113.554 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 65.39 -16.34 0.1 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 127.914 2.485 . . . . 0.0 115.461 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -73.52 -45.86 51.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.391 2.276 . . . . 0.0 112.716 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.7 ttt -114.17 135.78 53.66 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.219 1.008 . . . . 0.0 108.38 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -116.58 171.46 7.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.551 0.74 . . . . 0.0 109.323 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.07 131.38 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.385 -0.822 . . . . 0.0 109.689 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.4 m -109.2 132.72 53.86 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.571 1.148 . . . . 0.0 109.352 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -75.11 69.91 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.188 1.795 . . . . 0.0 110.624 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -53.96 -42.95 69.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.954 1.302 . . . . 0.0 111.848 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -160.37 178.36 9.67 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.469 1.907 . . . . 0.0 110.967 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.4 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 4.3 m-20 -51.82 142.57 14.89 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.51 -1.369 . . . . 0.0 110.476 164.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.9 p 46.17 27.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.526 1.53 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.1 t -146.9 101.06 3.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.52 1.128 . . . . 0.0 111.369 -171.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.426 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.6 m-85 -116.52 133.73 55.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.31 93.96 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -69.44 125.3 26.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.454 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -121.45 115.05 22.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.844 1.258 . . . . 0.0 111.606 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.77 108.94 7.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.366 1.466 . . . . 0.0 110.523 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -89.95 -15.37 32.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 -174.52 3.02 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.124 1.37 . . . . 0.0 111.511 171.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.99 41.04 0.65 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.632 0.254 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.11 142.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.247 1.019 . . . . 0.0 110.474 167.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.3 143.07 57.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.49 0.716 . . . . 0.0 109.944 173.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.74 -14.56 62.71 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.435 -1.416 . . . . 0.0 113.126 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -119.01 6.02 11.33 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.273 2.229 . . . . 0.0 113.384 -171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -146.9 175.05 10.95 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.127 2.171 . . . . 0.0 109.042 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.18 154.63 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.229 1.012 . . . . 0.0 110.587 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.49 143.8 31.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.18 131.74 51.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.977 1.311 . . . . 0.0 108.782 -165.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -114.8 135.02 54.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.116 1.436 . . . . 0.0 109.872 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.93 39.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.878 1.671 . . . . 0.0 111.235 -168.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.92 143.12 6.87 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.944 1.259 . . . . 0.0 111.866 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -55.46 147.65 17.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.15 0.98 . . . . 0.0 110.955 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.45 27.52 15.62 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.9 m 61.51 68.88 0.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.091 1.756 . . . . 0.0 113.101 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.1 p -131.66 -173.58 3.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.35 1.86 . . . . 0.0 111.514 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.91 -121.29 9.25 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.887 -1.133 . . . . 0.0 112.39 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.27 172.67 6.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 111.415 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.4 p -134.96 146.97 49.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 111.515 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.88 154.33 45.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.244 1.818 . . . . 0.0 109.255 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -129.98 150.73 51.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.829 0.823 . . . . 0.0 111.754 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -138.49 122.55 17.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.848 1.659 . . . . 0.0 110.341 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -68.76 128.63 37.34 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.934 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG3' HG12 ' A' ' 50' ' ' VAL . 2.9 ttmm -52.41 139.63 24.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.979 0.912 . . . . 0.0 111.406 171.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.1 48.47 4.35 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.043 0.83 . . . . 0.0 112.896 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 177.42 9.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.113 0.965 . . . . 0.0 112.745 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 m -138.75 135.65 34.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.821 1.649 . . . . 0.0 109.155 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.28 120.65 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.265 1.826 . . . . 0.0 109.926 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -117.55 100.4 7.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.57 1.148 . . . . 0.0 108.883 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.51 173.49 7.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.28 1.032 . . . . 0.0 110.364 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -119.15 154.47 33.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -17.56 29.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.647 1.179 . . . . 0.0 113.429 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.84 -35.4 61.85 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.505 1.526 . . . . 0.0 114.477 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.43 119.84 18.22 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.795 1.298 . . . . 0.0 109.677 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.56 67.58 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.088 -1.632 . . . . 0.0 112.374 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -62.89 -25.22 68.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.541 1.536 . . . . 0.0 112.578 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.5 -56.5 10.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.524 1.53 . . . . 0.0 110.87 169.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.9 -21.51 66.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.012 1.325 . . . . 0.0 113.344 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -5.48 3.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.755 2.022 . . . . 0.0 115.336 170.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.2 139.25 1.44 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.883 0.765 . . . . 0.0 110.131 158.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tpt -160.53 -41.34 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.1 p -155.46 169.09 25.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.839 1.256 . . . . 0.0 111.386 171.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -159.54 172.71 17.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 110.814 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 141.95 50.5 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.365 1.466 . . . . 0.0 109.129 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.36 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.507 1.523 . . . . 0.0 109.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.02 -110.87 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.688 2.089 . . . . 0.0 115.42 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.5 m -152.92 -28.31 0.15 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.953 1.301 . . . . 0.0 112.9 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -113.94 31.56 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.516 1.926 . . . . 0.0 110.723 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG12 ' HG3' ' A' ' 25' ' ' LYS . 34.4 m -144.76 133.22 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.447 1.499 . . . . 0.0 109.548 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 154.01 21.17 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.47 -0.769 . . . . 0.0 109.858 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 104.33 6.54 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 0.0 109.365 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.98 130.47 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.806 0.843 . . . . 0.0 109.216 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 89' ' ' PHE . 11.3 tt -124.44 134.18 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 109.611 -169.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.37 137.15 37.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 111.256 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.97 -47.27 4.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.801 1.241 . . . . 0.0 113.124 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -129.12 132.52 47.38 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.814 0.846 . . . . 0.0 109.296 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -129.65 96.42 4.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.064 1.346 . . . . 0.0 110.531 -165.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.87 165.5 25.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.689 1.196 . . . . 0.0 111.658 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.34 17.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.092 1.357 . . . . 0.0 113.049 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -147.9 39.22 0.93 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.09 1.356 . . . . 0.0 111.277 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -125.94 136.63 28.72 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.68 1.192 . . . . 0.0 111.742 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.38 -18.24 16.02 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.774 2.316 . . . . 0.0 112.776 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -75.3 118.61 72.0 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.852 0.861 . . . . 0.0 109.453 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.14 86.78 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.87 2.38 . . . . 0.0 109.485 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -44.32 128.26 6.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.529 1.538 . . . . 0.0 112.852 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -57.92 125.96 25.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.69 0.757 . . . . 0.0 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -142.78 149.52 38.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.182 1.393 . . . . 0.0 108.569 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.53 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.028 0.918 . . . . 0.0 109.957 169.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.36 82.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.328 1.051 . . . . 0.0 109.046 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 71' ' ' LEU . 3.1 mm? -43.43 125.29 3.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.326 1.45 . . . . 0.0 109.303 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.01 146.09 11.77 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.106 0.962 . . . . 0.0 112.18 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -57.82 -14.15 5.49 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.93 116.07 0.77 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.858 1.218 . . . . 0.0 111.598 160.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.34 168.85 2.76 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.298 1.839 . . . . 0.0 112.151 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.9 m -103.34 141.12 36.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.015 0.926 . . . . 0.0 109.477 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -119.35 89.27 3.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.818 1.247 . . . . 0.0 107.759 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.13 -0.64 14.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.366 1.466 . . . . 0.0 113.322 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -144.78 69.92 1.27 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.882 1.673 . . . . 0.0 109.779 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mp -92.86 10.36 31.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.6 m -52.68 -30.8 33.99 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.66 -1.275 . . . . 0.0 112.78 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -58.91 -27.45 65.27 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.9 -25.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.13 0.972 . . . . 0.0 111.424 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.7 t30 68.0 39.89 2.4 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 126.152 1.781 . . . . 0.0 113.986 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.18 153.92 30.62 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.07 -1.019 . . . . 0.0 110.932 -169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -110.58 148.6 31.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.033 1.333 . . . . 0.0 108.317 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -128.44 -40.79 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.738 1.215 . . . . 0.0 113.019 171.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -130.97 140.82 50.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.292 1.037 . . . . 0.0 110.404 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -129.24 142.08 50.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.911 1.285 . . . . 0.0 110.55 172.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -135.37 126.17 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.135 1.374 . . . . 0.0 107.991 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.46 107.7 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 122.487 1.137 . . . . 0.0 109.468 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.97 150.62 42.18 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.253 1.021 . . . . 0.0 109.357 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.66 27.45 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.614 3.543 . . . . 0.0 115.601 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.72 34.7 65.13 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.073 1.32 . . . . 0.0 113.792 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.46 -44.51 0.19 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.156 1.782 . . . . 0.0 110.063 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 5.0 m-85 -83.1 153.1 25.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.168 1.387 . . . . 0.0 110.546 168.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -90.45 -41.12 11.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.529 1.132 . . . . 0.0 111.01 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -155.99 177.89 10.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.363 2.265 . . . . 0.0 108.784 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.47 159.43 43.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.674 0.79 . . . . 0.0 109.713 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 173' ' ' PHE . 10.9 p -120.8 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.75 125.9 30.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.285 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.27 137.76 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 108.666 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -132.21 159.09 40.04 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.494 -0.754 . . . . 0.0 109.562 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.79 136.3 56.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.087 1.755 . . . . 0.0 109.009 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.43 135.61 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.718 1.207 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -91.6 117.92 30.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.659 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -109.19 4.51 22.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.622 1.169 . . . . 0.0 113.082 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.5 t -116.89 -60.98 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.299 1.44 . . . . 0.0 110.933 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.42 -20.61 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.338 1.055 . . . . 0.0 110.841 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.7 m 48.47 31.94 3.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.675 1.99 . . . . 0.0 113.846 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -127.83 31.43 5.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.123 1.769 . . . . 0.0 111.331 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -37.95 104.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.123 2.569 . . . . 0.0 113.293 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.24 10.76 0.05 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.9 p -149.36 14.87 0.89 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.306 1.442 . . . . 0.0 114.136 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -115.86 139.71 49.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.575 1.55 . . . . 0.0 108.064 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -115.12 140.75 48.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 109.067 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttp -134.46 127.66 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.797 0.839 . . . . 0.0 110.272 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.1 m -117.84 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.392 1.077 . . . . 0.0 109.124 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.77 122.9 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.361 1.864 . . . . 0.0 108.753 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.1 m -130.21 99.71 19.32 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.153 1.381 . . . . 0.0 110.175 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.85 169.59 18.67 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.969 3.113 . . . . 0.0 112.39 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -25.23 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.655 2.782 . . . . 0.0 113.724 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 41.53 48.9 3.53 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.97 1.708 . . . . 0.0 115.203 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.7 160.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.918 2.087 . . . . 0.0 111.362 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.85 129.12 9.31 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.762 1.625 . . . . 0.0 112.495 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -64.65 157.06 28.21 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.278 0.561 . . . . 0.0 111.505 169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.08 149.33 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 126.699 1.999 . . . . 0.0 109.701 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.44 91.79 3.72 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.978 0.911 . . . . 0.0 110.887 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.5 t -67.14 139.47 57.49 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -134.32 133.02 40.22 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.519 1.127 . . . . 0.0 108.692 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.59 129.06 40.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.412 0.685 . . . . 0.0 111.296 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.44 18.84 12.21 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.711 1.148 . . . . 0.0 114.867 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.03 156.16 16.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.203 1.401 . . . . 0.0 112.178 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.16 57.54 0.66 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.611 1.564 . . . . 0.0 111.84 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 57.21 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.204 2.201 . . . . 0.0 112.156 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.13 149.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.062 -1.024 . . . . 0.0 111.469 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -114.92 97.87 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.5 tp -75.05 116.39 53.75 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 65.9 Cg_endo -73.46 144.56 36.46 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.175 1.917 . . . . 0.0 112.694 172.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 mm -130.85 130.38 22.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.225 1.41 . . . . 0.0 109.063 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 178.76 4.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.751 2.301 . . . . 0.0 111.895 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 54.8 0.08 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.099 1.76 . . . . 0.0 113.6 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 pp -45.73 134.72 7.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.154 1.382 . . . . 0.0 111.164 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -139.68 133.81 15.83 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.989 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.02 150.04 78.26 Favored 'Cis proline' 0 CA--C 1.545 1.05 0 CA-C-N 119.216 0.756 . . . . 0.0 112.113 -5.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.08 -34.76 45.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.946 1.764 . . . . 0.0 112.431 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -63.77 -10.03 17.72 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 161.41 24.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.244 1.018 . . . . 0.0 112.654 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -84.73 161.28 20.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.976 . . . . 0.0 112.012 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.5 119.47 39.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 109.051 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 172' ' ' TYR . 23.1 m -67.94 136.01 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.671 174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 p -134.42 142.39 47.12 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.985 0.914 . . . . 0.0 110.319 170.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -101.81 136.87 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.41 152.29 50.79 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 123.137 1.446 . . . . 0.0 112.946 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.32 132.78 28.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.777 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 t -104.93 129.27 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -144.13 133.75 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.4 156.26 23.05 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.707 -0.621 . . . . 0.0 112.048 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.0 p -89.76 -27.13 20.24 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.46 169.03 9.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.962 2.105 . . . . 0.0 111.267 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -52.65 150.74 8.94 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.98 9.24 15.48 Favored 'Cis proline' 0 CA--C 1.547 1.146 0 N-CA-C 115.818 1.43 . . . . 0.0 115.818 2.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.28 30.07 17.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.256 1.022 . . . . 0.0 112.482 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 148.69 31.84 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.502 -1.374 . . . . 0.0 112.161 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.94 106.66 2.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.52 1.128 . . . . 0.0 111.539 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.63 -59.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.656 1.582 . . . . 0.0 109.956 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 194' ' ' ASN . 41.9 t -125.53 143.07 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.103 -1.623 . . . . 0.0 108.957 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 101.21 3.64 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.085 1.354 . . . . 0.0 107.391 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.23 -164.81 15.93 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.461 1.029 . . . . 0.0 111.567 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.33 151.39 37.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.398 -1.06 . . . . 0.0 111.644 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.3 142.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.817 1.647 . . . . 0.0 109.285 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 151' ' ' VAL . 10.0 m-30 -107.51 105.36 15.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.607 -0.683 . . . . 0.0 109.162 -171.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 100' ' ' VAL . 64.9 m-85 -84.11 160.9 20.81 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.726 0.774 . . . . 0.0 110.012 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -158.95 161.34 36.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.832 2.053 . . . . 0.0 108.197 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.76 141.46 50.37 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.884 0.874 . . . . 0.0 109.256 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.0 m -96.42 110.24 51.73 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.104 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.11 53.29 3.34 Favored 'Trans proline' 0 CA--C 1.541 0.85 1 C-N-CA 125.492 4.128 . . . . 0.0 112.704 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -134.86 -43.33 0.74 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 111.187 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.7 p -146.7 19.33 1.31 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.455 1.502 . . . . 0.0 113.584 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.41 31.7 63.06 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 120.414 -1.428 . . . . 0.0 113.584 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -85.64 146.7 26.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.582 1.153 . . . . 0.0 111.097 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.1 t -127.03 85.78 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.469 1.508 . . . . 0.0 110.218 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -81.98 163.15 22.34 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.92 -1.112 . . . . 0.0 111.638 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.84 125.6 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.982 0.913 . . . . 0.0 109.327 -170.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.91 139.73 22.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.842 2.057 . . . . 0.0 109.111 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 119.86 12.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.174 1.79 . . . . 0.0 109.088 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -147.62 150.99 35.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.924 1.69 . . . . 0.0 110.097 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 -17.78 6.88 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.77 -23.49 63.31 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.001 1.32 . . . . 0.0 114.083 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.4 p -150.05 -45.06 0.13 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.509 1.524 . . . . 0.0 113.65 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.409 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 36.8 t80 -61.35 138.37 94.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 111.4 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 73.6 Cg_endo -69.15 178.36 4.26 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.223 2.615 . . . . 0.0 112.502 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -128.1 -35.63 2.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.65 1.18 . . . . 0.0 112.434 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.497 HD21 HG22 ' A' ' 167' ' ' VAL . 15.9 p-10 -66.0 -17.7 64.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.534 1.934 . . . . 0.0 113.565 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -125.18 145.1 50.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.698 1.599 . . . . 0.0 109.055 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 p -128.42 167.63 16.75 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.879 1.672 . . . . 0.0 110.114 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 9.7 p -144.97 147.71 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.288 -0.882 . . . . 0.0 110.614 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 99.9 m -127.68 130.33 48.71 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.252 1.021 . . . . 0.0 109.386 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.03 103.4 7.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.517 0.727 . . . . 0.0 110.108 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.13 -45.3 34.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 122.001 -0.437 . . . . 0.0 111.235 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -145.51 -175.15 4.61 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.17 1.788 . . . . 0.0 111.766 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -56.4 -25.32 49.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.8 m -149.7 49.01 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.667 1.187 . . . . 0.0 108.14 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 58.8 m -151.76 110.45 3.82 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.31 2.244 . . . . 0.0 109.507 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 138.04 54.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.388 1.075 . . . . 0.0 110.382 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 tt -133.83 108.78 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.148 0.975 . . . . 0.0 110.005 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -90.54 133.98 34.69 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.707 1.603 . . . . 0.0 110.214 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -127.32 121.33 30.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.724 1.21 . . . . 0.0 109.381 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.55 101.15 13.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.337 0.655 . . . . 0.0 110.898 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.91 -18.28 29.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.624 1.97 . . . . 0.0 114.464 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.5 m -152.86 140.89 20.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.065 2.546 . . . . 0.0 109.02 170.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.9 -46.2 82.09 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 119.937 1.244 . . . . 0.0 112.413 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.649 1.979 . . . . 0.0 111.932 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.9 140.62 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.802 0.841 . . . . 0.0 110.535 168.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.57 142.44 56.49 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.329 0.652 . . . . 0.0 110.076 172.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.6 -17.35 54.82 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.673 -1.267 . . . . 0.0 113.042 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -119.51 3.75 11.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.919 1.688 . . . . 0.0 113.193 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -146.68 170.84 16.13 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.291 2.236 . . . . 0.0 109.061 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 23' ' ' TYR . 17.2 m -132.77 162.26 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.82 -0.55 . . . . 0.0 110.487 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.14 143.94 28.63 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.801 -0.562 . . . . 0.0 110.98 -176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -113.3 147.07 38.32 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.449 1.099 . . . . 0.0 108.465 -169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.65 118.94 17.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 123.181 1.467 . . . . 0.0 110.241 -172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -93.78 48.73 1.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.969 1.307 . . . . 0.0 110.516 -169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.4 144.71 5.95 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.856 1.694 . . . . 0.0 111.074 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -55.91 137.53 50.33 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.62 0.768 . . . . 0.0 111.09 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 72.56 40.14 0.66 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.349 1.46 . . . . 0.0 113.964 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.342 27.5 p 47.41 56.82 6.49 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.436 1.894 . . . . 0.0 114.582 -174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.7 p -123.74 -174.78 3.06 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.45 1.5 . . . . 0.0 112.213 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.05 -109.74 2.91 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.931 1.253 . . . . 0.0 112.683 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -107.36 163.59 12.91 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.663 0.785 . . . . 0.0 110.876 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 63.8 p -130.31 144.4 51.36 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.971 0.909 . . . . 0.0 111.425 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -141.74 151.14 42.64 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.204 1.402 . . . . 0.0 110.069 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.97 147.84 49.41 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.929 0.892 . . . . 0.0 111.681 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB2' HG23 ' A' ' 8' ' ' VAL . 22.7 m-85 -140.96 137.57 33.16 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.077 0.951 . . . . 0.0 111.643 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.63 151.03 30.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.755 1.222 . . . . 0.0 109.584 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -63.73 150.45 44.47 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.529 -0.732 . . . . 0.0 111.157 166.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.23 50.34 57.07 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 122.115 -0.366 . . . . 0.0 113.862 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -137.16 141.25 42.21 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.202 1.401 . . . . 0.0 110.912 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.2 m -123.99 130.72 53.05 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.062 0.945 . . . . 0.0 109.577 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 m -132.84 117.21 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 125.22 1.408 . . . . 0.0 109.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.85 100.61 7.9 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -80.1 162.5 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.734 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -106.54 152.25 23.94 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.318 0.647 . . . . 0.0 109.965 174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -61.6 -17.07 53.58 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 173.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.39 -33.66 82.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.314 0.959 . . . . 0.0 114.312 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -84.73 108.34 17.38 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.196 0.998 . . . . 0.0 110.042 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -57.95 -23.06 52.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.031 -1.043 . . . . 0.0 112.757 175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -60.09 -22.91 63.34 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.814 1.646 . . . . 0.0 112.226 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -65.76 -56.06 14.0 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.454 1.101 . . . . 0.0 112.422 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -63.32 -15.89 58.7 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.171 0.989 . . . . 0.0 113.65 176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.402 ' HE2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -61.25 -23.36 65.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.629 1.572 . . . . 0.0 113.695 173.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -46.38 129.3 10.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.028 1.331 . . . . 0.0 111.57 166.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 9.0 mmt -149.65 -31.46 0.22 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.294 1.038 . . . . 0.0 113.58 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -144.68 165.77 27.11 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.61 1.964 . . . . 0.0 110.682 175.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -161.61 168.32 23.67 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.347 -0.846 . . . . 0.0 110.867 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.01 128.5 20.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.906 0.882 . . . . 0.0 109.621 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.02 129.17 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 109.005 -170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.79 -98.1 0.01 OUTLIER Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.022 1.772 . . . . 0.0 116.617 -170.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.9 p -168.17 -25.68 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.681 1.192 . . . . 0.0 112.817 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -115.8 29.6 7.88 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.12 1.368 . . . . 0.0 111.266 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.24 116.38 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.838 1.655 . . . . 0.0 110.135 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -79.43 152.93 30.04 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.306 -0.871 . . . . 0.0 109.456 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 138.19 45.46 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.599 1.159 . . . . 0.0 109.242 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.92 119.48 23.32 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -172.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.443 HD11 HD13 ' A' ' 71' ' ' LEU . 11.7 pt -118.42 118.11 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 122.199 0.999 . . . . 0.0 111.298 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -124.15 142.63 51.05 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.771 1.628 . . . . 0.0 108.887 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.92 -44.22 3.05 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.965 0.906 . . . . 0.0 111.363 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -119.18 140.28 50.45 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.466 0.651 . . . . 0.0 111.025 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -140.97 120.29 13.04 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.826 1.25 . . . . 0.0 109.057 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -158.62 163.41 36.97 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.177 0.991 . . . . 0.0 111.046 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 pt -147.68 51.31 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.206 1.403 . . . . 0.0 111.065 -167.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -177.48 -31.64 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.961 2.105 . . . . 0.0 110.722 173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -58.9 137.95 87.31 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.221 1.008 . . . . 0.0 112.994 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.01 -23.09 5.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.523 2.149 . . . . 0.0 113.578 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 t -76.0 120.26 80.86 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 119.015 0.825 . . . . 0.0 111.138 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.47 114.97 4.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.279 1.32 . . . . 0.0 109.067 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -60.89 156.61 32.34 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.405 1.003 . . . . 0.0 113.592 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -65.4 123.9 20.83 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 118.305 1.052 . . . . 0.0 111.717 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -140.87 143.47 34.72 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.47 2.308 . . . . 0.0 108.822 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 125.97 6.92 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.345 1.069 . . . . 0.0 110.406 170.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.63 105.64 11.08 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.137 0.97 . . . . 0.0 109.904 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.443 HD13 HD11 ' A' ' 54' ' ' ILE . 1.7 tp -63.18 121.24 13.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.613 0.765 . . . . 0.0 109.068 171.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.52 141.28 16.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.628 1.171 . . . . 0.0 112.398 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -59.78 -15.06 17.56 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -171.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.45 118.81 0.91 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.606 1.098 . . . . 0.0 111.444 163.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.37 169.33 1.05 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.264 1.826 . . . . 0.0 111.646 176.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 54.1 m -105.22 144.51 31.92 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.873 1.269 . . . . 0.0 110.455 173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -124.33 98.31 5.7 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.373 1.069 . . . . 0.0 108.636 -173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -105.48 -35.94 7.31 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.324 1.049 . . . . 0.0 112.823 -164.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -143.96 112.09 6.3 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.405 1.482 . . . . 0.0 108.915 170.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.3 26.04 2.21 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.501 1.52 . . . . 0.0 111.006 -173.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.3 m -51.39 -33.46 30.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.304 1.042 . . . . 0.0 112.574 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -58.18 -21.46 47.47 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.89 -9.27 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.326 1.45 . . . . 0.0 112.598 173.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 82.29 39.97 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.409 2.283 . . . . 0.0 112.266 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.16 -133.59 31.13 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.337 -1.477 . . . . 0.0 110.76 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.3 tp -146.81 160.89 41.72 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.938 1.369 . . . . 0.0 110.875 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.9 p -144.58 -35.96 0.33 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.86 0.864 . . . . 0.0 113.141 155.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -129.14 139.66 51.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.905 0.882 . . . . 0.0 110.635 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.66 135.64 48.75 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.121 0.969 . . . . 0.0 110.591 173.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -129.21 130.46 46.33 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.881 0.873 . . . . 0.0 109.401 171.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.6 t -112.82 128.7 69.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 125.378 1.471 . . . . 0.0 107.539 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.21 142.11 33.02 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 123.612 0.765 . . . . 0.0 110.108 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -78.95 32.0 0.46 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.862 3.041 . . . . 0.0 114.794 -170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 60.43 23.34 60.17 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.862 1.22 . . . . 0.0 113.763 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -130.73 -25.13 2.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.396 1.478 . . . . 0.0 112.768 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 139' ' ' PRO . 1.3 m-85 -118.13 141.71 48.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.684 1.594 . . . . 0.0 108.15 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -79.59 -33.68 41.41 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.285 0.564 . . . . 0.0 111.383 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.461 ' CZ2' HG21 ' A' ' 140' ' ' ILE . 18.8 p-90 -149.01 174.44 12.29 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.582 1.953 . . . . 0.0 109.053 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.89 23.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.993 170.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.7 p -137.94 130.47 40.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.097 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -87.36 131.25 34.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.858 0.863 . . . . 0.0 110.11 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.7 m -133.04 142.45 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.402 1.081 . . . . 0.0 110.289 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -144.95 144.16 30.91 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.97 0.908 . . . . 0.0 110.545 177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.6 pt -87.65 153.71 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 171.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.1 t -137.8 120.48 19.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.18 1.392 . . . . 0.0 108.335 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -58.96 103.08 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.96 1.304 . . . . 0.0 112.196 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 16.94 22.44 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.507 1.123 . . . . 0.0 111.359 168.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.82 -35.78 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.618 1.567 . . . . 0.0 113.035 176.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -96.8 170.88 8.87 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.6 1.16 . . . . 0.0 111.649 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -109.71 -45.56 3.64 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.47 -0.769 . . . . 0.0 113.044 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.6 m -71.48 -31.22 66.88 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.505 1.122 . . . . 0.0 112.528 175.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.93 -44.38 0.56 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.114 2.166 . . . . 0.0 114.117 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -69.04 42.06 0.36 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 127.014 2.245 . . . . 0.0 115.017 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.7 p -129.74 -1.16 4.83 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.861 2.064 . . . . 0.0 112.005 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -118.63 150.37 39.81 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.185 1.394 . . . . 0.0 111.653 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -135.96 127.67 29.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.762 1.225 . . . . 0.0 109.971 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.7 ttm -102.89 122.55 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.948 1.299 . . . . 0.0 108.761 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.4 m -116.0 117.69 30.84 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 119' ' ' ILE . 26.5 pt -122.66 142.15 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.76 0.79 . . . . 0.0 112.277 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 78.7 m -135.23 85.84 32.22 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.283 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.47 167.66 12.76 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.43 2.087 . . . . 0.0 111.766 170.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -33.9 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.64 2.376 . . . . 0.0 114.538 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 39.68 51.12 2.32 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.538 1.935 . . . . 0.0 114.528 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.13 148.92 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.901 1.68 . . . . 0.0 110.436 175.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -51.35 111.89 0.65 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.665 1.186 . . . . 0.0 111.36 171.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.29 134.62 39.47 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.516 0.726 . . . . 0.0 110.735 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.84 127.53 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.39 114.58 28.14 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.226 1.011 . . . . 0.0 109.061 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 14.7 p -120.28 146.02 46.5 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.42 0.688 . . . . 0.0 110.956 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -117.76 170.59 8.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.831 0.852 . . . . 0.0 110.552 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.3 69.93 1.63 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.62 1.2 . . . . 0.0 112.135 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.03 0.08 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.001 1.762 . . . . 0.0 111.309 -171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.52 161.93 36.72 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.698 1.199 . . . . 0.0 111.585 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -95.56 55.16 1.65 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.999 1.32 . . . . 0.0 111.935 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 60.33 93.1 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.225 2.21 . . . . 0.0 112.722 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.6 p -53.99 139.02 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.344 0.658 . . . . 0.0 111.645 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -97.94 123.6 42.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.874 0.869 . . . . 0.0 110.336 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.85 127.51 37.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.454 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 86.1 Cg_endo -77.53 128.31 9.43 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.487 2.125 . . . . 0.0 110.999 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.461 HG21 ' CZ2' ' A' ' 98' ' ' TRP . 6.5 mm -128.15 125.56 23.44 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.518 0.727 . . . . 0.0 109.619 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.44 178.02 6.07 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.419 2.079 . . . . 0.0 111.534 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -14.28 43.75 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.867 -1.145 . . . . 0.0 113.577 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mp 55.21 -175.42 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.428 1.891 . . . . 0.0 112.319 -169.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.7 t -153.63 106.3 2.54 Favored Pre-proline 0 C--O 1.241 0.606 0 O-C-N 121.265 -0.897 . . . . 0.0 111.282 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.26 165.14 69.22 Favored 'Cis proline' 0 CA--C 1.542 0.914 0 CA-C-N 119.386 0.816 . . . . 0.0 113.142 -9.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -66.64 -30.98 41.6 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.211 1.941 . . . . 0.0 114.082 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.98 2.09 13.59 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -73.69 144.51 45.76 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.992 -1.068 . . . . 0.0 112.004 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -70.28 157.97 36.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.329 1.052 . . . . 0.0 113.117 174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tt -125.94 122.48 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.649 1.18 . . . . 0.0 109.445 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.4 m -67.28 132.71 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 110.414 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -138.7 122.2 17.29 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.651 0.781 . . . . 0.0 110.758 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -82.29 134.38 35.27 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 171.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.04 119.59 34.71 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.683 1.593 . . . . 0.0 109.557 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.1 p -124.16 113.38 18.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.338 1.055 . . . . 0.0 109.033 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 t -104.39 125.02 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -140.44 151.44 44.89 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.629 1.572 . . . . 0.0 109.115 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -67.26 141.55 57.2 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.81 -0.556 . . . . 0.0 111.979 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 22.9 p -67.9 -24.71 65.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.02 0.928 . . . . 0.0 113.16 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -144.34 179.67 7.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.716 2.006 . . . . 0.0 110.675 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.6 t -41.55 136.55 1.89 Allowed Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 126.216 1.806 . . . . 0.0 113.863 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -80.22 8.68 31.0 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 N-CA-C 114.683 0.994 . . . . 0.0 114.683 5.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.63 27.56 16.97 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.166 1.387 . . . . 0.0 112.719 176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.77 151.11 36.11 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.25 -1.531 . . . . 0.0 113.157 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -78.57 128.43 33.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.999 1.32 . . . . 0.0 111.401 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -101.7 -38.41 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.431 1.493 . . . . 0.0 111.602 -175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.58 138.5 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.76 1.224 . . . . 0.0 108.557 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -150.12 76.52 1.28 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.23 1.012 . . . . 0.0 108.905 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.09 -168.56 14.85 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 125.715 1.626 . . . . 0.0 111.938 -170.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.6 p -133.32 160.48 37.2 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.291 -1.123 . . . . 0.0 112.593 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.41 147.35 20.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.272 1.429 . . . . 0.0 108.124 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -105.2 131.38 52.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.377 0.608 . . . . 0.0 109.592 177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -110.06 153.29 24.85 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -163.04 148.35 11.71 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -120.44 151.51 39.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.873 0.368 . . . . 0.0 111.378 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 73.7 m -90.39 110.78 43.31 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.039 0.936 . . . . 0.0 108.66 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -76.45 52.3 3.55 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 124.993 3.796 . . . . 0.0 112.298 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 74.2 m -130.08 -40.22 1.33 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.792 2.037 . . . . 0.0 111.687 -171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 12.8 t -149.22 30.03 0.78 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.93 1.292 . . . . 0.0 111.408 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.19 35.87 43.25 Favored Glycine 0 N--CA 1.474 1.192 0 O-C-N 120.86 -1.15 . . . . 0.0 113.151 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.59 118.2 18.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.905 0.882 . . . . 0.0 109.169 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.6 t -101.4 139.99 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.572 0.749 . . . . 0.0 109.917 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 49.5 m -143.36 158.36 43.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.599 1.56 . . . . 0.0 110.571 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -128.49 129.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.711 0.804 . . . . 0.0 110.904 174.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.04 129.89 50.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.725 1.61 . . . . 0.0 107.979 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.409 ' HE2' HG23 ' A' ' 184' ' ' VAL . 8.1 mtmt -140.45 122.85 16.01 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.835 1.254 . . . . 0.0 108.605 -171.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 4.4 tttm -150.22 146.49 26.86 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.87 0.868 . . . . 0.0 110.115 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -55.83 -18.02 7.65 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.668 1.187 . . . . 0.0 113.811 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -59.2 -25.62 64.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.64 1.976 . . . . 0.0 114.207 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 24.1 p -145.12 -43.14 0.23 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.528 1.531 . . . . 0.0 113.096 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.413 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 66.1 t80 -60.58 135.58 92.1 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.065 1.746 . . . . 0.0 111.889 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.413 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 38.0 Cg_endo -79.09 -172.44 1.54 Allowed 'Trans proline' 0 CA--C 1.549 1.248 0 C-N-CA 123.022 2.482 . . . . 0.0 111.341 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.82 31.85 3.3 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.964 1.306 . . . . 0.0 113.593 -166.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -148.31 -32.41 0.25 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.228 1.811 . . . . 0.0 113.737 -164.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.3 ttt -125.1 140.04 53.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.272 2.229 . . . . 0.0 107.928 172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 63.9 p -127.49 159.38 34.73 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.388 0.675 . . . . 0.0 109.864 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.03 131.28 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.154 0.502 . . . . 0.0 110.158 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 14.7 t -116.58 147.77 41.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.134 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -85.45 83.68 7.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.122 0.963 . . . . 0.0 110.669 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.42 -29.74 69.18 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.718 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.07 174.05 15.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.905 1.682 . . . . 0.0 111.171 169.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -60.77 140.58 57.54 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 119.989 -1.694 . . . . 0.0 110.333 165.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p 53.66 12.68 0.42 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.224 2.209 . . . . 0.0 114.836 -172.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.3 t -133.91 105.25 6.66 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.595 1.158 . . . . 0.0 111.664 -172.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 184' ' ' VAL . 20.7 m-85 -108.03 148.37 29.86 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.276 1.03 . . . . 0.0 111.833 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.8 tt -134.11 116.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.734 0.778 . . . . 0.0 109.252 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -93.3 125.11 37.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.998 1.319 . . . . 0.0 109.727 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -109.48 123.71 49.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.106 0.962 . . . . 0.0 109.187 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.49 96.57 6.6 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.468 0.707 . . . . 0.0 111.077 -176.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -87.57 -25.99 23.34 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.282 1.033 . . . . 0.0 112.329 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 6.2 t -90.56 176.34 6.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.733 1.213 . . . . 0.0 113.002 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.48 57.44 0.94 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.722 1.209 . . . . 0.0 110.06 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 116.99 -1.481 . . . . 0.0 113.371 173.091 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.545 0.212 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.42 154.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.892 1.277 . . . . 0.0 109.302 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -53.98 143.88 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.475 0.71 . . . . 0.0 110.983 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.0 -20.38 23.67 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -109.54 15.41 22.95 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 127.389 2.276 . . . . 0.0 113.348 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -140.26 169.33 17.89 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.462 -1.399 . . . . 0.0 110.033 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 23' ' ' TYR . 25.4 m -136.49 145.66 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.837 0.855 . . . . 0.0 109.968 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.0 144.79 49.61 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.056 1.342 . . . . 0.0 109.201 -174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 44' ' ' CYS . 1.2 m-85 -132.85 120.27 21.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.1 1.36 . . . . 0.0 109.601 -171.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -97.17 125.93 42.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.261 1.424 . . . . 0.0 109.676 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -78.17 43.12 0.43 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.511 1.924 . . . . 0.0 112.602 -174.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.1 137.91 2.49 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.758 2.123 . . . . 0.0 110.601 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -51.84 159.46 0.83 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.831 0.852 . . . . 0.0 111.289 171.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 t30 64.83 22.78 12.58 Favored 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.8 m 54.84 57.16 5.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.34 1.456 . . . . 0.0 113.126 -173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.6 p -131.82 -177.92 4.65 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.737 1.215 . . . . 0.0 112.393 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.54 -119.08 4.76 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.283 0.944 . . . . 0.0 111.772 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -112.72 -178.22 3.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.241 1.416 . . . . 0.0 110.834 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 78.7 p -136.6 153.81 50.85 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 120.794 -1.191 . . . . 0.0 111.387 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.27 155.19 41.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.105 1.362 . . . . 0.0 110.451 -173.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.64 138.31 51.14 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.671 1.189 . . . . 0.0 109.945 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' HG23 ' A' ' 8' ' ' VAL . 33.2 m-85 -134.21 144.52 48.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.195 1.398 . . . . 0.0 110.705 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -79.99 149.17 30.87 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.535 1.134 . . . . 0.0 111.128 169.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -63.24 157.48 22.55 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.323 1.049 . . . . 0.0 111.688 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.3 39.54 97.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.387 0.518 . . . . 0.0 113.019 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.51 160.81 32.04 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.578 1.551 . . . . 0.0 109.758 -177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.4 p -138.96 151.15 46.64 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.276 -1.515 . . . . 0.0 109.099 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.84 116.08 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 122.306 1.051 . . . . 0.0 108.628 -170.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 mtm105 -125.91 92.52 3.61 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.329 1.452 . . . . 0.0 108.684 -164.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.34 153.0 21.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.418 -177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -95.83 147.05 24.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.419 0.687 . . . . 0.0 110.763 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -67.61 2.23 1.96 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.69 80.99 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.265 1.412 . . . . 0.0 114.736 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -133.9 120.56 20.54 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.934 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -13.18 2.15 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -57.16 -20.6 27.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.562 1.545 . . . . 0.0 112.49 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -65.16 -54.79 24.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.043 0.838 . . . . 0.0 111.749 165.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -58.65 -22.8 57.74 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.122 1.369 . . . . 0.0 113.251 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -51.36 -42.07 61.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.964 1.306 . . . . 0.0 113.541 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -67.0 31.19 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 126.575 1.95 . . . . 0.0 114.042 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.504 ' O ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -64.01 -38.11 89.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.561 2.345 . . . . 0.0 113.917 178.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.6 t -112.22 151.9 29.04 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.749 1.159 . . . . 0.0 110.754 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HB3' ' CD1' ' A' ' 10' ' ' PHE . 6.1 p -169.03 167.38 10.66 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 123.046 1.403 . . . . 0.0 113.154 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.84 125.56 14.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.126 1.37 . . . . 0.0 108.405 -172.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.8 133.56 52.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.225 1.81 . . . . 0.0 108.306 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.85 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.634 1.588 . . . . 0.0 115.886 -168.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.5 m -156.47 -22.63 0.1 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.239 1.416 . . . . 0.0 113.77 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -119.94 16.26 12.55 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.732 1.613 . . . . 0.0 111.801 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.0 m -145.36 152.36 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.412 1.885 . . . . 0.0 110.216 -173.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -116.99 156.78 26.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.687 1.195 . . . . 0.0 110.041 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 41.2 t -127.05 131.03 51.03 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.005 0.922 . . . . 0.0 108.725 166.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -112.87 140.14 47.91 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.143 1.377 . . . . 0.0 107.584 174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' CG1' HD23 ' A' ' 86' ' ' LEU . 5.3 tt -129.39 137.96 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.194 0.998 . . . . 0.0 109.363 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.1 120.24 8.86 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.269 1.428 . . . . 0.0 111.263 -161.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -95.27 -63.02 1.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.107 -0.995 . . . . 0.0 112.7 -172.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.21 142.46 37.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.581 1.153 . . . . 0.0 109.54 172.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -134.42 105.7 6.7 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.921 -1.112 . . . . 0.0 109.431 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -142.0 152.44 43.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.209 1.404 . . . . 0.0 110.38 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.4 45.72 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.19 1.796 . . . . 0.0 111.012 -166.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -169.82 -26.0 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 127.476 2.31 . . . . 0.0 111.945 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -60.52 137.27 92.48 Favored Pre-proline 0 CA--C 1.543 0.712 0 C-N-CA 125.39 1.476 . . . . 0.0 112.673 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.61 -23.89 9.38 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.28 2.653 . . . . 0.0 112.937 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -99.61 117.29 63.95 Favored Pre-proline 0 N--CA 1.467 0.422 0 C-N-CA 124.744 1.217 . . . . 0.0 109.127 171.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.46 155.14 64.25 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.257 1.305 . . . . 0.0 110.033 168.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.6 -136.55 0.71 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.032 0.825 . . . . 0.0 112.947 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 pttp -122.76 137.93 54.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.234 1.016 . . . . 0.0 112.921 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -147.72 167.78 23.79 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.13 2.172 . . . . 0.0 109.797 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -157.19 142.28 17.07 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.55 0.691 . . . . 0.0 111.339 170.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -94.85 98.59 10.84 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.733 1.213 . . . . 0.0 110.734 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.89 124.15 18.23 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.998 -1.063 . . . . 0.0 108.668 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.81 153.35 3.32 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.034 0.934 . . . . 0.0 112.849 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.24 -10.16 2.71 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.93 112.26 0.52 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.424 1.012 . . . . 0.0 111.859 158.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.05 159.67 2.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.343 1.857 . . . . 0.0 111.983 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 m -104.31 140.12 38.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.538 1.135 . . . . 0.0 110.066 173.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.504 ' HB3' HD11 ' A' ' 80' ' ' LEU . 12.7 m-80 -130.95 121.06 24.45 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.658 1.583 . . . . 0.0 108.556 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -129.98 -22.9 2.83 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.13 -66.12 0.8 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.733 1.213 . . . . 0.0 110.771 171.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 42' ' ' MET . 4.0 mp 41.01 34.87 0.31 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.043 2.137 . . . . 0.0 113.381 -170.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.7 m -62.85 -31.19 72.16 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.765 -1.209 . . . . 0.0 112.406 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.0 m -63.19 -28.39 70.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.831 0.852 . . . . 0.0 113.284 168.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.71 -35.22 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.409 1.484 . . . . 0.0 110.978 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 54.38 55.07 8.54 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.148 1.379 . . . . 0.0 113.475 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.14 -152.99 16.86 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.448 1.499 . . . . 0.0 111.862 -174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD22 ' H ' ' A' ' 87' ' ' SER . 2.1 tm? -153.91 146.05 23.74 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.684 1.193 . . . . 0.0 111.525 166.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.494 ' H ' HD22 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -125.25 -63.77 1.13 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 169.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.34 153.09 50.3 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.386 1.475 . . . . 0.0 110.809 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -156.38 147.68 22.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.908 0.861 . . . . 0.0 111.883 -170.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -139.02 120.97 15.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.48 1.512 . . . . 0.0 109.58 -168.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.5 m -116.11 118.51 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.253 0.621 . . . . 0.0 109.465 -171.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.3 mt -125.64 126.81 24.96 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.554 1.142 . . . . 0.0 109.898 -164.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.9 162.63 23.67 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.611 2.207 . . . . 0.0 112.185 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.29 -5.23 15.07 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.765 1.174 . . . . 0.0 115.644 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.7 -19.76 32.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.276 1.43 . . . . 0.0 113.606 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -133.53 165.63 24.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.746 1.618 . . . . 0.0 110.03 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.95 -46.81 3.69 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 120.955 -1.091 . . . . 0.0 111.634 -173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.27 148.05 47.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.68 1.592 . . . . 0.0 107.903 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.84 157.57 42.53 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -138.45 149.42 24.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.014 -177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.74 144.43 26.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 175.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.99 139.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.429 1.091 . . . . 0.0 109.596 174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -143.15 157.97 44.03 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.562 1.145 . . . . 0.0 110.681 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.45 145.91 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.072 0.949 . . . . 0.0 112.181 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.8 t -137.44 105.02 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 126.519 1.928 . . . . 0.0 109.534 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.86 89.49 4.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.918 1.287 . . . . 0.0 112.532 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.9 mmtp -80.54 -32.0 36.86 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.182 -0.949 . . . . 0.0 112.477 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.44 -46.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -81.9 -24.6 35.58 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.469 0.577 . . . . 0.0 111.485 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 t 65.72 -42.82 0.36 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 129.379 3.071 . . . . 0.0 115.437 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 15.3 t -57.42 -37.69 73.15 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.775 1.63 . . . . 0.0 112.833 173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.69 176.11 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.928 1.691 . . . . 0.0 113.993 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.72 28.17 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.921 1.248 . . . . 0.0 114.639 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -140.78 30.58 1.86 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -162.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -120.16 147.52 44.79 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.79 1.636 . . . . 0.0 110.613 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -131.95 126.21 33.5 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.966 1.306 . . . . 0.0 109.409 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 63.1 ttp -126.09 132.43 51.91 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.884 1.274 . . . . 0.0 110.148 -173.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 30.9 m -123.09 106.76 11.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.337 1.455 . . . . 0.0 108.615 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.85 125.37 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.2 t -144.93 123.47 6.69 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.87 170.15 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.962 3.108 . . . . 0.0 113.004 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -42.46 106.43 0.06 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.391 1.876 . . . . 0.0 113.371 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? 47.07 57.03 6.08 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 125.801 1.64 . . . . 0.0 113.721 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 56.3 t -126.18 159.32 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.588 1.955 . . . . 0.0 109.919 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -55.23 109.67 0.57 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.152 0.981 . . . . 0.0 111.455 170.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.81 152.03 20.05 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.442 0.697 . . . . 0.0 111.518 173.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -125.61 150.66 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.262 1.025 . . . . 0.0 110.141 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.69 103.63 10.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 109.42 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.97 146.22 30.83 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.422 0.689 . . . . 0.0 109.61 168.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -133.82 144.02 48.72 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.204 1.002 . . . . 0.0 110.546 172.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.94 108.36 0.27 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.022 2.129 . . . . 0.0 111.025 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.54 -17.03 14.11 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.445 1.021 . . . . 0.0 114.49 -175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -58.0 136.48 57.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.823 1.311 . . . . 0.0 109.927 167.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -74.59 57.9 0.76 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.076 1.751 . . . . 0.0 112.51 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 63.37 90.49 0.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.858 2.463 . . . . 0.0 111.152 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.1 p -59.97 149.96 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 120.918 -1.114 . . . . 0.0 111.478 -177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.05 137.7 32.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 57.7 tp -113.93 96.16 40.51 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.491 1.916 . . . . 0.0 108.143 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.1 138.5 30.93 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.546 2.164 . . . . 0.0 111.099 171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.7 mt -128.36 129.9 23.57 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.351 1.46 . . . . 0.0 108.812 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -71.47 169.96 19.61 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.53 2.82 . . . . 0.0 112.109 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -57.13 134.85 56.23 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.838 -0.539 . . . . 0.0 111.574 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.2 pp -144.41 150.3 37.47 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.452 1.501 . . . . 0.0 110.184 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.9 t -142.61 136.63 14.64 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.168 0.987 . . . . 0.0 112.102 -171.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.96 154.0 73.1 Favored 'Cis proline' 0 CA--C 1.544 0.991 0 CA-C-N 119.381 0.815 . . . . 0.0 111.706 -6.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.45 -35.89 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.281 1.988 . . . . 0.0 111.861 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -69.6 0.09 5.95 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.622 1.569 . . . . 0.0 114.225 169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 p -68.37 133.58 48.94 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.162 1.346 . . . . 0.0 110.869 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.53 120.84 15.22 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.075 167.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.3 tt -104.48 116.8 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.053 1.741 . . . . 0.0 109.086 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.49 139.64 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.057 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.8 m -133.52 134.09 42.98 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.518 1.127 . . . . 0.0 110.325 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.43 146.74 36.36 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.693 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.2 111.11 8.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.743 1.217 . . . . 0.0 109.465 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 132.68 49.81 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.091 0.956 . . . . 0.0 109.382 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.54 136.18 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.153 0.981 . . . . 0.0 109.681 -174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.72 150.84 37.0 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.548 1.139 . . . . 0.0 111.668 -173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.98 140.38 57.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.198 0.599 . . . . 0.0 111.507 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 58.3 p -80.24 -7.31 58.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.64 177.46 9.74 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.71 2.004 . . . . 0.0 111.241 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.6 t -39.79 133.77 1.37 Allowed Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.887 1.675 . . . . 0.0 114.205 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.29 8.49 17.56 Favored 'Cis proline' 0 CA--C 1.547 1.135 0 N-CA-C 115.044 1.132 . . . . 0.0 115.044 3.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 61.06 10.34 2.82 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 126.321 1.848 . . . . 0.0 114.454 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.22 162.07 27.67 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.408 1.483 . . . . 0.0 112.653 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -58.23 151.82 18.5 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.85 1.26 . . . . 0.0 111.755 170.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.7 m -122.37 -22.74 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.744 1.218 . . . . 0.0 113.193 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -151.94 142.89 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.608 1.963 . . . . 0.0 109.036 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -142.27 117.39 10.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.587 1.155 . . . . 0.0 108.923 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -173.68 -147.87 6.18 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.637 1.113 . . . . 0.0 112.097 -173.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.51 172.42 15.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.048 1.339 . . . . 0.0 110.141 177.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.35 149.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.751 1.62 . . . . 0.0 107.854 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.5 130.8 54.81 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.938 -1.101 . . . . 0.0 109.113 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -111.91 158.27 19.66 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.113 -0.992 . . . . 0.0 110.849 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -163.18 146.16 10.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.908 1.683 . . . . 0.0 108.968 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -111.79 156.58 21.74 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.257 1.023 . . . . 0.0 110.811 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 74.6 m -126.81 101.37 26.64 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.76 1.624 . . . . 0.0 110.329 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -68.32 -10.11 27.96 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.911 3.074 . . . . 0.0 113.785 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 96.0 m -40.09 -43.5 1.61 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.835 2.054 . . . . 0.0 112.748 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -156.28 28.52 0.35 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.904 0.859 . . . . 0.0 112.941 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 55.98 55.25 30.1 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.115 -1.616 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -129.73 130.75 45.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.299 1.44 . . . . 0.0 109.222 -175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.7 159.39 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 121.565 -0.709 . . . . 0.0 110.407 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 87.1 m -148.29 111.51 4.92 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.085 0.954 . . . . 0.0 110.067 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.459 HG12 ' CE1' ' A' ' 205' ' ' PHE . 3.1 p -80.83 138.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.482 0.658 . . . . 0.0 109.966 172.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -116.33 129.03 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.524 1.93 . . . . 0.0 107.195 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 139.62 37.5 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.217 1.007 . . . . 0.0 109.695 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -160.02 164.43 33.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.156 1.382 . . . . 0.0 109.779 -176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -16.06 5.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.301 1.44 . . . . 0.0 114.001 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -61.44 -24.26 66.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.158 1.783 . . . . 0.0 114.058 170.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 42.1 p -142.91 -47.54 0.32 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.344 1.458 . . . . 0.0 112.432 -170.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 196' ' ' THR . 0.0 OUTLIER -76.58 143.12 71.49 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.985 1.714 . . . . 0.0 111.533 178.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.36 -96.87 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.855 2.37 . . . . 0.0 110.736 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -179.68 -36.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 128.266 2.626 . . . . 0.0 111.708 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -58.08 -40.76 81.91 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.92 1.688 . . . . 0.0 112.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.5 ttt -104.67 140.13 38.49 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.767 1.627 . . . . 0.0 108.627 170.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 191' ' ' PHE . 65.9 p -136.82 158.93 43.31 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.924 0.49 . . . . 0.0 110.961 168.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.0 p -124.62 139.02 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.968 0.907 . . . . 0.0 110.741 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 97.9 m -126.33 143.04 51.3 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.426 1.09 . . . . 0.0 109.404 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -73.05 79.1 1.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.338 1.455 . . . . 0.0 111.482 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -54.51 -33.62 60.25 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.034 1.734 . . . . 0.0 112.699 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -157.12 -179.67 8.42 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.854 1.662 . . . . 0.0 111.367 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -44.14 -42.46 6.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.916 2.087 . . . . 0.0 114.295 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 77.1 p -130.61 12.92 5.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.086 1.755 . . . . 0.0 112.907 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.2 t -103.88 126.02 50.71 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.387 -0.82 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 184' ' ' VAL . 43.5 m-85 -123.23 138.5 54.62 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.852 1.261 . . . . 0.0 110.977 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 17.3 tt -128.28 116.99 44.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.747 0.819 . . . . 0.0 110.007 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -96.56 112.2 24.04 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.767 1.627 . . . . 0.0 108.612 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -94.06 142.73 27.05 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.439 -0.788 . . . . 0.0 109.684 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.49 122.26 30.78 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.115 0.966 . . . . 0.0 111.948 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -115.27 13.83 16.75 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.704 1.602 . . . . 0.0 112.312 -168.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.7 t -154.17 165.11 37.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.515 1.526 . . . . 0.0 111.522 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.05 2.03 9.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.797 1.239 . . . . 0.0 113.418 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.539 1.936 . . . . 0.0 115.226 -174.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.891 0.377 . . . . 0.0 111.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 45' ' ' LEU . 2.5 p -73.07 150.6 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.56 0.744 . . . . 0.0 111.581 172.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -95.25 150.6 20.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.505 0.722 . . . . 0.0 109.624 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.48 -29.2 34.84 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.847 -1.158 . . . . 0.0 113.201 170.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -106.19 7.55 31.61 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.189 1.796 . . . . 0.0 113.426 -175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -142.76 -179.36 6.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.074 1.35 . . . . 0.0 111.379 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.542 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -142.24 152.25 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.407 1.483 . . . . 0.0 111.253 -175.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.86 153.26 46.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.862 1.265 . . . . 0.0 110.701 -177.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 44' ' ' CYS . 21.3 m-85 -136.88 117.12 13.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.382 1.073 . . . . 0.0 109.835 -169.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -95.24 122.45 37.94 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.163 1.385 . . . . 0.0 111.229 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.88 59.04 1.55 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.781 1.232 . . . . 0.0 111.993 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.55 130.94 1.3 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.171 0.891 . . . . 0.0 111.11 173.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.13 146.12 9.44 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.876 0.87 . . . . 0.0 110.656 171.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 70.44 20.94 5.81 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.288 1.435 . . . . 0.0 114.705 -171.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.84 58.41 2.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.681 1.192 . . . . 0.0 112.718 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.1 p -133.22 -174.54 3.52 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.301 1.44 . . . . 0.0 112.009 -176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.02 -142.98 40.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.905 0.764 . . . . 0.0 112.81 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -74.76 176.02 7.42 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.694 0.798 . . . . 0.0 112.451 176.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -136.21 157.24 47.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.562 1.145 . . . . 0.0 111.833 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.47 155.45 43.12 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.274 1.83 . . . . 0.0 110.118 -176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.45 143.93 51.02 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.544 1.138 . . . . 0.0 110.403 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -132.11 128.44 38.16 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.958 1.303 . . . . 0.0 109.012 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -80.36 148.81 30.48 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.814 0.845 . . . . 0.0 110.363 171.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -62.86 142.28 58.32 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.065 0.546 . . . . 0.0 111.449 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.61 66.63 2.22 Favored Glycine 0 CA--C 1.534 1.226 0 O-C-N 122.211 -0.305 . . . . 0.0 112.486 -177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 152.67 39.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.49 1.116 . . . . 0.0 110.538 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 99.7 m -135.53 120.32 18.45 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 108.096 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.12 141.17 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.016 0.926 . . . . 0.0 109.413 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -135.35 133.45 38.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.244 1.018 . . . . 0.0 109.189 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -110.39 175.16 5.54 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.028 1.731 . . . . 0.0 109.595 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -123.41 133.99 54.01 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.682 0.793 . . . . 0.0 108.958 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -59.62 -14.28 12.96 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.279 1.032 . . . . 0.0 113.627 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -56.76 -25.54 52.02 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.961 1.267 . . . . 0.0 114.682 166.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -119.2 121.29 39.37 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.058 1.343 . . . . 0.0 109.852 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -12.48 6.22 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 2.5 m0 -63.68 -9.83 16.06 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.276 1.43 . . . . 0.0 112.959 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -70.39 -52.22 23.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.673 1.189 . . . . 0.0 112.037 164.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.61 -15.05 16.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.93 1.692 . . . . 0.0 113.513 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -40.79 -45.1 2.38 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 127.627 2.371 . . . . 0.0 113.069 169.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -75.98 50.32 0.59 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.429 1.492 . . . . 0.0 113.033 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -73.76 0.1 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.662 0.785 . . . . 0.0 111.219 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -93.36 160.11 14.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.192 0.997 . . . . 0.0 110.655 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' HB3' ' CD2' ' A' ' 10' ' ' PHE . 5.8 p -168.75 169.63 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.293 1.037 . . . . 0.0 112.374 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.454 HD23 ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -148.42 156.01 41.94 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.334 1.064 . . . . 0.0 112.303 177.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HA ' HG12 ' A' ' 8' ' ' VAL . 38.5 t -127.65 139.04 53.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 124.872 1.269 . . . . 0.0 109.282 -171.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.16 -96.71 0.01 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.958 1.742 . . . . 0.0 116.073 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -166.95 -21.86 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 113.243 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -123.99 26.36 7.59 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.644 1.977 . . . . 0.0 111.899 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 m -145.42 153.69 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 126.456 1.902 . . . . 0.0 109.023 175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -125.41 149.48 48.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.614 1.566 . . . . 0.0 108.857 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.454 ' SG ' HG11 ' A' ' 8' ' ' VAL . 2.8 m -123.26 151.22 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.543 0.687 . . . . 0.0 110.508 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -135.31 130.23 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 pt -123.52 142.07 41.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 124.027 0.931 . . . . 0.0 109.637 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -137.25 127.41 26.15 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.159 1.384 . . . . 0.0 109.089 -173.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -100.66 -53.32 3.11 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.681 1.192 . . . . 0.0 111.379 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -101.6 98.51 8.8 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.858 0.863 . . . . 0.0 111.418 -172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -78.08 96.75 5.2 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.421 1.089 . . . . 0.0 112.828 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -156.14 164.53 38.27 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.66 1.184 . . . . 0.0 112.27 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 6.5 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.26 2.224 . . . . 0.0 113.068 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -133.38 49.11 2.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.388 1.875 . . . . 0.0 112.122 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -148.59 145.44 20.11 Favored Pre-proline 0 N--CA 1.478 0.956 0 O-C-N 120.77 -1.206 . . . . 0.0 112.365 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.42 -14.15 20.33 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.922 2.415 . . . . 0.0 113.16 171.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 p -67.75 121.24 78.63 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 119.239 0.927 . . . . 0.0 109.956 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.56 95.66 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.199 1.933 . . . . 0.0 108.687 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.57 138.8 28.22 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.457 1.027 . . . . 0.0 112.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 115.42 2.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.714 0.757 . . . . 0.0 111.212 -172.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 179' ' ' THR . 2.3 t80 -138.48 143.15 39.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.218 2.207 . . . . 0.0 109.48 -174.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -147.98 139.94 24.05 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.307 1.051 . . . . 0.0 109.614 169.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -100.11 103.61 15.12 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.08 1.352 . . . . 0.0 107.643 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' H ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp -60.98 121.53 12.64 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 173.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.48 150.84 6.24 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.117 0.967 . . . . 0.0 112.322 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -58.55 -15.5 11.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -170.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.16 124.73 1.6 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.94 -0.922 . . . . 0.0 111.644 152.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 176.05 158.36 0.26 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 127.657 2.383 . . . . 0.0 111.546 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.2 m -94.23 143.57 26.27 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.436 1.094 . . . . 0.0 110.829 171.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -128.1 102.04 6.55 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.507 1.923 . . . . 0.0 108.553 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -123.65 6.65 8.84 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.633 1.573 . . . . 0.0 112.772 -176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -140.35 45.03 1.86 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.896 1.679 . . . . 0.0 111.461 -173.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' H ' HD12 ' A' ' 80' ' ' LEU . 3.2 mp -75.26 30.67 0.1 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.079 1.351 . . . . 0.0 112.588 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.1 m -61.43 -35.65 78.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.753 1.621 . . . . 0.0 112.485 174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -61.11 -24.06 65.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.719 0.808 . . . . 0.0 112.715 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.4 mm -88.06 -25.58 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 126.655 1.982 . . . . 0.0 113.198 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 54.75 52.68 11.69 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.52 1.528 . . . . 0.0 113.372 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.32 -179.62 19.93 Favored Glycine 0 CA--C 1.538 1.511 0 O-C-N 121.529 -0.732 . . . . 0.0 112.567 -170.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -150.38 -178.88 6.78 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.574 -1.545 . . . . 0.0 112.054 -169.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 27.9 t -148.13 -36.94 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.14 1.776 . . . . 0.0 113.164 -173.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.91 147.03 47.06 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.762 1.225 . . . . 0.0 111.445 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -135.96 119.69 17.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.326 1.85 . . . . 0.0 108.416 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -115.05 138.93 50.3 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.37 0.668 . . . . 0.0 109.404 170.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.3 t -120.83 119.27 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 125.757 1.623 . . . . 0.0 107.411 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.557 HD13 ' HA ' ' A' ' 98' ' ' TRP . 99.2 mt -127.55 126.79 24.1 Favored Pre-proline 0 C--N 1.326 -0.444 0 C-N-CA 124.672 1.189 . . . . 0.0 109.467 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.88 161.41 33.23 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 121.74 1.627 . . . . 0.0 111.752 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.34 -3.15 17.56 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.755 1.062 . . . . 0.0 115.755 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.99 -14.09 45.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.004 1.322 . . . . 0.0 113.86 173.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -130.78 151.1 51.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.045 1.338 . . . . 0.0 110.507 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -82.09 -49.3 10.34 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.518 -0.739 . . . . 0.0 111.378 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.557 ' HA ' HD13 ' A' ' 92' ' ' LEU . 58.3 p-90 -154.52 161.23 41.76 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.773 1.629 . . . . 0.0 110.589 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -131.21 154.41 48.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.52 0.676 . . . . 0.0 111.108 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.44 137.16 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.945 1.298 . . . . 0.0 109.733 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.07 123.83 36.6 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.192 0.997 . . . . 0.0 108.986 174.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.88 132.26 71.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.651 1.58 . . . . 0.0 108.692 176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -125.15 145.25 50.04 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.916 0.887 . . . . 0.0 110.185 172.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.71 128.32 52.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.4 m -130.05 143.17 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 122.069 0.938 . . . . 0.0 109.814 174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.62 140.34 29.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.536 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 7.24 2.99 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.832 1.253 . . . . 0.0 112.168 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.52 -33.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 126.069 1.748 . . . . 0.0 112.907 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -142.44 172.61 12.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.789 1.236 . . . . 0.0 111.835 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.3 p -105.71 14.24 28.59 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.28 1.432 . . . . 0.0 112.944 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.4 m -107.0 31.03 5.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.787 2.435 . . . . 0.0 110.169 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.38 145.76 17.35 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.839 -1.163 . . . . 0.0 112.252 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.46 25.1 6.78 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.696 1.141 . . . . 0.0 112.956 -171.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 83.8 p -147.57 9.51 0.92 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.075 1.75 . . . . 0.0 114.033 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -127.28 143.74 51.18 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.905 1.282 . . . . 0.0 110.784 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -131.03 130.87 43.84 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.074 1.349 . . . . 0.0 108.717 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -122.02 131.58 54.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.618 1.567 . . . . 0.0 110.365 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 m -95.52 133.86 39.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.856 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.57 110.78 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.801 1.64 . . . . 0.0 109.135 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.3 t -129.99 128.31 22.84 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.385 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.19 -91.61 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.142 2.561 . . . . 0.0 111.35 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -171.76 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 122.032 0.92 . . . . 0.0 112.685 174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -65.09 26.8 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 126.682 1.993 . . . . 0.0 113.786 165.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.2 165.63 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.549 1.94 . . . . 0.0 110.831 172.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -56.05 114.77 2.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.026 0.93 . . . . 0.0 111.331 172.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -58.61 147.98 30.53 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.741 0.816 . . . . 0.0 111.909 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -110.14 145.07 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.862 1.265 . . . . 0.0 110.274 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.81 117.21 32.81 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.858 1.263 . . . . 0.0 109.594 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 11.8 m -125.47 118.53 26.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.523 1.129 . . . . 0.0 108.646 -169.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.36 138.59 49.23 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.09 1.356 . . . . 0.0 112.008 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.51 127.4 17.63 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.308 0.575 . . . . 0.0 111.978 -173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.57 -18.6 22.5 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.576 1.084 . . . . 0.0 113.67 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -57.75 137.14 56.83 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.865 1.333 . . . . 0.0 112.945 169.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.53 72.15 5.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.018 0.927 . . . . 0.0 110.526 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 61.83 85.73 0.12 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.516 1.926 . . . . 0.0 112.449 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -60.18 134.81 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.775 -1.203 . . . . 0.0 110.883 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -93.43 127.29 38.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.278 0.561 . . . . 0.0 110.944 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.4 tp -107.67 95.48 14.37 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.412 1.885 . . . . 0.0 107.995 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.37 146.47 40.0 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.958 1.772 . . . . 0.0 111.484 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.46 125.1 27.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.997 1.719 . . . . 0.0 108.496 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.67 -37.96 2.02 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.04 2.493 . . . . 0.0 113.125 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.5 168.4 7.76 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 128.298 2.639 . . . . 0.0 109.995 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.3 pp -163.44 37.8 0.09 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.163 1.385 . . . . 0.0 113.868 172.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 12.0 t -50.63 139.77 20.37 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.704 1.201 . . . . 0.0 114.211 -174.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -69.35 142.08 67.63 Favored 'Cis proline' 0 CA--C 1.542 0.92 0 CA-C-N 119.979 1.028 . . . . 0.0 111.867 -6.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.24 -23.31 45.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.309 2.006 . . . . 0.0 113.051 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -75.86 -5.93 48.36 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.041 1.336 . . . . 0.0 114.548 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.55 161.73 16.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.584 1.084 . . . . 0.0 112.862 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -70.67 168.95 15.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.81 0.814 . . . . 0.0 113.097 167.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 11.0 tt -134.38 135.72 53.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 125.536 1.535 . . . . 0.0 110.441 166.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.21 149.03 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.716 0.806 . . . . 0.0 109.231 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.3 t -150.43 155.16 39.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.399 1.079 . . . . 0.0 110.414 171.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -123.99 129.69 51.34 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.514 1.126 . . . . 0.0 109.798 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.5 tt -113.83 121.44 44.01 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.943 1.697 . . . . 0.0 109.463 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.2 t -139.61 114.75 9.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.622 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 167' ' ' VAL . 1.7 p -108.63 141.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.631 1.173 . . . . 0.0 109.517 176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -144.7 148.19 33.89 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.321 1.448 . . . . 0.0 110.009 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.29 128.9 37.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.196 0.598 . . . . 0.0 110.174 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.7 p -79.44 -2.32 41.39 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -132.97 151.14 52.1 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.772 2.029 . . . . 0.0 110.08 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.2 t -66.85 141.38 96.75 Favored Pre-proline 0 CA--C 1.55 0.943 0 CA-C-O 118.826 -0.607 . . . . 0.0 112.499 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.27 128.95 13.98 Favored 'Cis proline' 0 C--N 1.352 0.761 0 CA-C-N 120.565 1.238 . . . . 0.0 111.616 -7.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.43 41.22 0.14 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.95 1.7 . . . . 0.0 112.236 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -62.5 143.59 56.99 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.232 -1.543 . . . . 0.0 111.491 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -59.55 122.45 14.09 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.782 -0.574 . . . . 0.0 110.366 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 65.9 t -80.68 -56.91 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.424 HG12 HG12 ' A' ' 156' ' ' VAL . 0.4 OUTLIER -149.6 155.22 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 110.756 170.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -142.11 76.8 1.55 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.792 1.237 . . . . 0.0 108.695 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -121.19 -165.72 12.74 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.614 2.054 . . . . 0.0 111.608 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.98 170.72 16.06 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.831 -1.393 . . . . 0.0 111.12 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.6 p -153.46 157.26 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 120.715 -1.241 . . . . 0.0 108.033 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -112.83 128.84 56.55 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 120.925 -1.109 . . . . 0.0 108.445 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.61 155.48 17.57 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.89 0.876 . . . . 0.0 109.88 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -157.96 158.02 34.16 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.207 1.403 . . . . 0.0 109.579 174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.38 150.35 49.89 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 125.713 1.605 . . . . 0.0 108.708 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 75.6 m -105.75 110.37 64.11 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.47 50.74 2.04 Favored 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 125.221 3.948 . . . . 0.0 112.765 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 20.6 m -137.3 -53.97 0.69 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.989 1.716 . . . . 0.0 111.439 -172.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 68' ' ' PHE . 63.5 p -127.29 21.9 6.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.317 1.047 . . . . 0.0 112.791 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 57.79 31.74 64.72 Favored Glycine 0 CA--C 1.536 1.393 0 O-C-N 121.19 -0.944 . . . . 0.0 113.205 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -78.22 150.51 33.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.453 0.701 . . . . 0.0 110.787 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.8 t -128.65 137.57 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.5 m -142.12 129.32 20.99 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.644 1.577 . . . . 0.0 109.124 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.51 141.36 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.225 1.01 . . . . 0.0 110.133 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.2 mt -105.04 127.34 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 127.079 2.151 . . . . 0.0 107.986 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -137.68 116.49 12.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.297 1.439 . . . . 0.0 108.546 -172.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.52 156.46 36.71 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.875 1.27 . . . . 0.0 110.706 -174.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.48 -14.41 7.81 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.14 -24.51 66.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.84 1.656 . . . . 0.0 114.005 169.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.6 p -146.7 -56.11 0.26 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.96 1.704 . . . . 0.0 111.692 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -64.16 138.92 97.56 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 125.73 1.612 . . . . 0.0 111.841 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.02 -88.83 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 122.579 2.186 . . . . 0.0 111.625 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? 158.23 -33.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 129.561 3.145 . . . . 0.0 112.674 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -54.19 -36.91 63.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.907 1.283 . . . . 0.0 113.459 171.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 15.5 ttm -103.67 151.48 22.92 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.939 1.295 . . . . 0.0 109.181 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.7 p -134.39 153.93 51.64 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.089 1.356 . . . . 0.0 110.287 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 ' CE1' ' A' ' 207' ' ' PHE . 2.5 t -112.34 110.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 3.3 m -93.47 130.7 39.21 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.831 0.852 . . . . 0.0 108.869 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -76.27 82.35 3.05 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.75 1.22 . . . . 0.0 109.634 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.93 -44.72 96.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.041 0.936 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 204' ' ' SER . 8.3 m-20 -147.6 -178.52 6.29 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.769 2.028 . . . . 0.0 110.106 166.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -53.55 141.96 23.96 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.664 -1.272 . . . . 0.0 110.836 158.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 28.8 p 50.66 10.69 0.07 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.258 2.223 . . . . 0.0 116.142 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 201' ' ' ASP . 0.5 OUTLIER -129.23 95.65 4.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.983 1.713 . . . . 0.0 108.711 -169.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -105.16 149.57 25.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.7 tt -134.61 123.28 41.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.406 ' CE1' HG22 ' A' ' 197' ' ' VAL . 8.4 m-85 -98.99 109.27 22.05 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.731 1.612 . . . . 0.0 108.598 -170.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -104.62 116.86 32.8 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.169 1.388 . . . . 0.0 108.92 -171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.2 tp -99.79 99.14 9.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.176 0.59 . . . . 0.0 110.967 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -88.27 -15.71 35.08 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.228 2.211 . . . . 0.0 114.295 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.24 165.36 24.33 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.614 1.166 . . . . 0.0 111.995 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -128.0 54.06 1.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.952 1.701 . . . . 0.0 110.365 -170.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 C--O 1.255 1.362 0 C-N-CA 126.151 1.78 . . . . 0.0 114.798 179.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.002 0.43 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.1 p -80.57 141.99 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.365 -0.834 . . . . 0.0 110.776 171.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.95 151.35 30.13 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.805 -0.559 . . . . 0.0 110.034 173.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.66 -17.26 46.39 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.59 -1.319 . . . . 0.0 113.48 171.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -115.17 17.83 16.5 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.986 1.714 . . . . 0.0 113.668 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -139.55 172.58 12.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.564 1.545 . . . . 0.0 110.352 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 46' ' ' VAL . 14.7 m -145.42 144.77 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.792 0.837 . . . . 0.0 110.628 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -127.58 145.94 50.7 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.148 0.975 . . . . 0.0 111.222 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -128.06 124.49 37.2 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.477 1.511 . . . . 0.0 107.497 -164.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -117.56 122.16 42.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 123.94 1.829 . . . . 0.0 111.052 -169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -93.18 42.58 1.1 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.477 1.911 . . . . 0.0 111.504 -167.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 175.86 155.2 12.5 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.575 2.036 . . . . 0.0 111.499 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -60.8 141.52 56.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 117.372 0.586 . . . . 0.0 110.135 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.4 t30 46.66 43.21 12.46 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.832 1.253 . . . . 0.0 114.238 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . 0.304 30.9 p 49.18 36.42 9.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.257 2.223 . . . . 0.0 116.054 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.3 m -88.16 -24.95 23.2 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.51 -91.93 1.0 Allowed Glycine 0 N--CA 1.476 1.362 0 CA-C-N 119.559 1.072 . . . . 0.0 113.585 -173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -126.13 176.7 6.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.376 1.47 . . . . 0.0 110.333 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.3 p -138.56 157.76 45.54 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.449 1.099 . . . . 0.0 112.336 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.78 152.18 39.96 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.186 1.794 . . . . 0.0 110.152 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -124.41 122.25 37.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.508 1.523 . . . . 0.0 108.972 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.04 148.51 43.49 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.294 1.438 . . . . 0.0 109.482 -174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -101.02 153.1 19.83 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.339 0.656 . . . . 0.0 109.949 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 147.53 23.46 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.975 -0.453 . . . . 0.0 112.163 171.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.38 41.55 90.88 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -129.19 130.83 46.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.833 1.253 . . . . 0.0 111.106 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.5 m -114.69 129.96 56.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.224 1.01 . . . . 0.0 108.836 173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.79 109.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.662 1.585 . . . . 0.0 109.069 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.1 tmm_? -101.7 101.12 11.58 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.257 1.023 . . . . 0.0 109.11 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -70.45 -179.15 1.96 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.884 0.85 . . . . 0.0 111.226 165.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -127.06 157.17 40.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.547 1.139 . . . . 0.0 109.328 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.99 -12.17 59.04 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 121.016 -1.053 . . . . 0.0 113.496 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.79 -41.14 97.71 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.615 1.102 . . . . 0.0 114.248 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -88.1 118.34 27.61 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.406 1.103 . . . . 0.0 110.482 170.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -18.91 62.33 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 120.949 -1.094 . . . . 0.0 112.458 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -61.49 -20.64 63.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.433 1.893 . . . . 0.0 112.357 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -60.89 -51.95 67.12 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.797 1.639 . . . . 0.0 112.367 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -70.13 -14.82 62.82 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.388 1.475 . . . . 0.0 113.286 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -60.9 -22.95 64.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.558 1.943 . . . . 0.0 113.731 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -46.92 121.22 3.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.669 1.187 . . . . 0.0 110.941 162.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.1 tpt -152.41 -19.95 0.17 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.842 . . . . 0.0 111.921 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.9 t -146.69 154.38 41.37 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.846 2.059 . . . . 0.0 108.856 172.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 10.1 p -172.54 155.22 3.32 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.574 1.55 . . . . 0.0 109.697 174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 150.66 43.19 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.939 1.352 . . . . 0.0 112.399 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' HA ' HG12 ' A' ' 8' ' ' VAL . 47.6 t -127.83 135.03 64.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.776 1.63 . . . . 0.0 108.199 -168.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.42 -98.87 0.01 OUTLIER Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.446 1.498 . . . . 0.0 115.81 -171.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -160.29 -23.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.105 1.762 . . . . 0.0 112.473 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -123.56 25.63 8.12 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.714 1.605 . . . . 0.0 111.565 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.12 140.47 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 128.151 2.58 . . . . 0.0 108.831 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.64 153.12 29.41 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.448 0.699 . . . . 0.0 109.947 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.8 m -136.39 136.17 39.38 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.286 0.635 . . . . 0.0 109.732 -177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -125.79 130.63 51.81 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.72 131.18 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.454 1.501 . . . . 0.0 109.7 -176.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -141.31 118.67 11.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.38 -176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -103.85 -39.46 6.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.643 0.777 . . . . 0.0 111.837 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -92.57 158.82 15.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.278 1.031 . . . . 0.0 111.098 172.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -159.59 128.72 5.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.639 1.176 . . . . 0.0 111.505 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -162.17 -21.91 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . 0.273 0.6 OUTLIER 50.01 37.35 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 127.143 2.177 . . . . 0.0 114.234 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.57 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.1 1.76 . . . . 0.0 111.924 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -51.79 124.63 27.84 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 124.619 1.168 . . . . 0.0 113.467 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.42 -14.72 11.59 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.881 2.387 . . . . 0.0 113.008 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 t -90.18 119.66 69.23 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 119.008 0.822 . . . . 0.0 109.804 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.84 117.71 5.08 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.219 1.279 . . . . 0.0 108.977 171.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.0 -152.86 3.34 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 171.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -85.46 104.36 15.18 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.602 -0.94 . . . . 0.0 109.958 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -140.08 155.21 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.827 1.651 . . . . 0.0 109.582 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.4 172.19 9.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.617 1.167 . . . . 0.0 110.777 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -119.59 94.36 4.38 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.458 1.503 . . . . 0.0 107.495 176.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -52.83 118.71 3.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.565 1.546 . . . . 0.0 109.063 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.45 149.26 10.63 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.588 0.755 . . . . 0.0 112.998 -169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -59.65 -13.8 11.18 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.8 118.99 0.87 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.343 0.973 . . . . 0.0 111.777 159.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.48 161.64 4.1 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.871 2.068 . . . . 0.0 111.207 176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 m -115.45 131.4 56.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.082 1.353 . . . . 0.0 110.067 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -131.58 136.0 47.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.508 1.123 . . . . 0.0 110.104 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -138.47 10.75 2.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.467 1.107 . . . . 0.0 112.901 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -155.64 52.15 0.58 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.548 1.539 . . . . 0.0 109.94 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -74.13 39.16 0.11 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.922 1.289 . . . . 0.0 112.928 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -55.99 -30.67 62.16 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.002 1.721 . . . . 0.0 113.047 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -64.34 -18.24 64.46 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.6 mm -90.26 -23.42 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 125.627 1.571 . . . . 0.0 111.964 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 45.05 74.51 0.13 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.079 2.152 . . . . 0.0 114.537 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.4 -160.33 36.14 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 123.555 0.598 . . . . 0.0 112.096 -171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 177.89 8.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.917 0.887 . . . . 0.0 110.861 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.15 -46.3 0.11 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.216 1.007 . . . . 0.0 111.825 164.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HE3' ' CG2' ' A' ' 203' ' ' THR . 2.0 ptmm? -140.7 156.22 46.27 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -140.95 140.42 34.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.148 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -129.08 125.01 36.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.39 131.36 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.353 1.461 . . . . 0.0 108.702 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.6 mt -122.76 143.81 41.12 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.344 1.458 . . . . 0.0 109.97 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.12 26.27 0.22 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 125.15 3.9 . . . . 0.0 115.452 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 58.82 26.9 61.07 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.585 1.088 . . . . 0.0 113.582 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.1 -42.15 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.527 1.931 . . . . 0.0 111.297 -168.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -79.72 146.55 32.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.435 1.094 . . . . 0.0 109.983 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -88.69 -39.94 13.63 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.814 0.816 . . . . 0.0 111.637 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 -152.0 158.77 43.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 107.191 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -123.25 174.06 7.53 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.916 -0.49 . . . . 0.0 109.981 168.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.0 124.08 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 111.185 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -71.71 131.83 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 168.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.76 139.78 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 124.693 1.197 . . . . 0.0 109.839 170.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -139.65 142.58 36.99 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.547 -0.721 . . . . 0.0 110.025 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.8 pt -91.95 144.28 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 122.91 0.484 . . . . 0.0 110.254 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.3 t -133.0 109.71 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.137 1.375 . . . . 0.0 108.686 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.07 118.18 17.73 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.679 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -109.87 -12.82 14.54 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.95 0.9 . . . . 0.0 113.002 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.49 -51.96 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.856 1.262 . . . . 0.0 111.681 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -92.7 110.72 22.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.088 0.955 . . . . 0.0 109.233 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.5 t -75.25 39.32 0.15 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.134 1.374 . . . . 0.0 114.013 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.9 m -140.48 -39.18 0.43 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.591 -173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.52 -160.49 0.07 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.585 1.154 . . . . 0.0 113.34 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.78 7.43 61.69 Favored Glycine 0 CA--C 1.541 1.716 0 O-C-N 120.398 -1.439 . . . . 0.0 116.136 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.9 p -144.82 28.96 1.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.759 1.78 . . . . 0.0 114.663 -159.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -133.66 145.29 49.81 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.681 1.593 . . . . 0.0 109.193 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -132.79 112.2 11.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.149 0.98 . . . . 0.0 110.376 -173.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.0 ttp -111.09 105.96 14.85 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.414 2.286 . . . . 0.0 110.544 -173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.8 m -92.21 126.55 37.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.569 0.699 . . . . 0.0 109.173 171.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.03 132.05 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 125.105 1.362 . . . . 0.0 108.933 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.5 m -137.04 89.33 16.83 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 123.62 0.768 . . . . 0.0 109.269 -171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -65.38 167.1 17.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.978 2.452 . . . . 0.0 112.668 172.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -37.57 98.36 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.437 2.295 . . . . 0.0 113.611 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.268 19.4 pt20 43.01 52.82 5.25 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.065 1.746 . . . . 0.0 114.87 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.61 148.0 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.162 1.785 . . . . 0.0 110.942 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -51.85 112.37 0.76 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.057 1.343 . . . . 0.0 111.067 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.7 152.79 2.67 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.323 1.049 . . . . 0.0 111.993 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -144.43 141.09 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 O-C-N 121.758 -0.589 . . . . 0.0 111.936 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.88 91.3 3.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.704 1.602 . . . . 0.0 109.896 -176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.717 ' HA ' HG21 ' A' ' 136' ' ' VAL . 42.3 t -74.06 131.65 41.55 Favored 'General case' 0 C--N 1.334 -0.089 0 O-C-N 121.785 -0.572 . . . . 0.0 109.691 169.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.77 139.39 48.91 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.86 128.98 39.81 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.932 -0.48 . . . . 0.0 110.303 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.47 -11.03 59.71 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.98 1.276 . . . . 0.0 115.189 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.03 145.47 41.85 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 119.695 1.748 . . . . 0.0 111.95 169.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.67 55.45 0.37 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.934 1.694 . . . . 0.0 112.957 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 57.88 95.72 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.737 2.415 . . . . 0.0 112.197 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.717 HG21 ' HA ' ' A' ' 129' ' ' CYS . 10.8 t -51.97 130.22 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.156 0.982 . . . . 0.0 112.225 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -80.09 122.28 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.793 0.837 . . . . 0.0 111.251 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -97.6 101.84 11.44 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 124.384 1.074 . . . . 0.0 109.262 163.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.6 121.99 6.66 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.742 1.628 . . . . 0.0 110.534 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.87 121.44 43.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.816 0.846 . . . . 0.0 108.901 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.53 168.36 23.82 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.262 2.642 . . . . 0.0 111.75 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.9 131.79 51.45 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.698 -0.626 . . . . 0.0 110.792 174.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.99 149.27 33.84 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.777 1.631 . . . . 0.0 110.047 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.1 m -138.27 135.18 18.13 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.346 1.058 . . . . 0.0 110.559 -170.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.17 150.0 82.08 Favored 'Cis proline' 0 CA--C 1.544 1.022 0 CA-C-N 119.252 0.769 . . . . 0.0 112.001 -5.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -66.52 -24.24 49.2 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.027 1.818 . . . . 0.0 113.092 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.83 1.78 29.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -69.89 156.25 39.36 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.357 1.075 . . . . 0.0 112.843 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -83.67 135.67 34.5 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.122 0.969 . . . . 0.0 111.284 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.4 tt -115.73 116.58 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 125.941 1.696 . . . . 0.0 108.401 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.49 142.9 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.921 -0.487 . . . . 0.0 110.749 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 58.0 p -142.91 140.56 31.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 122.088 0.946 . . . . 0.0 111.994 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -90.16 140.18 29.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.387 0.675 . . . . 0.0 110.148 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.17 113.94 18.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.732 1.613 . . . . 0.0 108.736 -176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.72 98.56 4.22 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.31 1.044 . . . . 0.0 109.517 -175.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 3.9 p -115.4 145.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.541 1.136 . . . . 0.0 110.056 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.54 160.84 39.9 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.186 1.395 . . . . 0.0 112.454 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -72.56 146.63 46.59 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.017 1.327 . . . . 0.0 111.335 173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 78.6 p -85.33 -12.22 52.79 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -103.34 171.79 7.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.813 1.245 . . . . 0.0 110.884 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 35.8 p -60.56 145.37 87.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 120.965 -1.085 . . . . 0.0 112.315 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.65 12.06 26.2 Favored 'Cis proline' 0 CA--C 1.55 1.287 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 3.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.22 13.53 8.81 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.869 1.668 . . . . 0.0 113.683 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.07 152.82 32.73 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 112.338 -175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -52.3 139.11 25.04 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.922 0.889 . . . . 0.0 112.92 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.3 m -106.56 -20.39 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.406 1.482 . . . . 0.0 111.937 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 95.0 t -152.66 131.78 3.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 126.776 2.03 . . . . 0.0 108.329 168.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -122.79 129.65 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.236 1.415 . . . . 0.0 109.084 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 176.63 -165.37 35.58 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.903 0.724 . . . . 0.0 112.695 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.39 156.01 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.183 0.992 . . . . 0.0 110.738 172.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 156.46 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.49 1.916 . . . . 0.0 108.246 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -112.56 134.59 54.01 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.83 157.88 17.14 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -150.65 154.14 36.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.978 1.711 . . . . 0.0 107.64 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -118.85 160.5 21.8 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 124.441 1.096 . . . . 0.0 108.608 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.4 m -121.54 106.63 37.38 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 121.235 -0.915 . . . . 0.0 108.598 177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.77 53.83 2.88 Favored 'Trans proline' 0 CA--C 1.542 0.92 1 C-N-CA 125.506 4.137 . . . . 0.0 112.545 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -126.66 -44.71 1.66 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.754 2.022 . . . . 0.0 110.713 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 82.4 p -144.91 6.55 1.19 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.521 1.128 . . . . 0.0 113.843 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.17 34.77 40.31 Favored Glycine 0 CA--C 1.532 1.119 0 O-C-N 120.576 -1.327 . . . . 0.0 113.171 -171.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.01 149.81 35.86 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.884 -0.774 . . . . 0.0 110.752 173.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.21 132.2 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.681 1.192 . . . . 0.0 108.121 167.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 99.5 m -135.55 125.57 25.96 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.893 1.277 . . . . 0.0 109.307 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.56 130.0 45.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 124.334 1.054 . . . . 0.0 110.64 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 mt -108.83 141.33 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 127.275 2.23 . . . . 0.0 107.634 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 136.49 24.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.501 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -134.36 134.46 41.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.015 -170.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -58.39 -14.11 6.89 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.561 1.144 . . . . 0.0 113.955 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -61.07 -23.67 65.64 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.306 1.442 . . . . 0.0 114.492 169.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 p -145.28 -34.86 0.33 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.024 1.73 . . . . 0.0 113.646 -175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -70.25 129.99 89.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 123.775 0.83 . . . . 0.0 110.69 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.35 173.3 14.46 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.443 2.762 . . . . 0.0 112.069 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.33 5.97 32.32 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.214 1.406 . . . . 0.0 113.299 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -89.86 -37.2 14.61 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.968 1.707 . . . . 0.0 112.231 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.0 ttt -113.83 152.13 31.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.49 1.516 . . . . 0.0 109.279 -177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 68.5 p -133.21 144.31 49.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 0.0 110.756 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 92.8 t -96.88 119.94 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.077 0.951 . . . . 0.0 109.304 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 88.5 m -115.42 114.51 25.16 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.036 1.334 . . . . 0.0 109.419 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.39 129.87 39.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.934 0.894 . . . . 0.0 110.972 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -31.89 3.78 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.326 1.05 . . . . 0.0 112.508 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -146.71 169.23 19.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.847 2.059 . . . . 0.0 109.702 171.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -59.19 -2.09 0.25 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.503 ' CG2' ' HE3' ' A' ' 88' ' ' LYS . 7.3 t -156.64 32.62 0.31 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.586 2.354 . . . . 0.0 110.543 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -143.94 117.27 9.04 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.291 -1.506 . . . . 0.0 111.853 174.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 135.02 53.87 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.251 1.421 . . . . 0.0 110.616 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 49.3 mm -118.15 117.31 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -97.69 91.72 5.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.582 1.553 . . . . 0.0 108.898 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -75.51 127.08 32.32 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.231 0.612 . . . . 0.0 109.587 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 10.4 tp -111.18 110.56 21.12 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.722 0.809 . . . . 0.0 111.679 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -107.78 17.35 22.63 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 126.986 2.114 . . . . 0.0 112.866 -173.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.4 t -152.16 155.15 37.25 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.343 1.457 . . . . 0.0 111.723 171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.7 -9.73 15.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.107 0.963 . . . . 0.0 113.044 177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -91.79 139.93 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.34 1.456 . . . . 0.0 110.643 170.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.81 149.56 37.88 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.714 -0.616 . . . . 0.0 110.918 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.55 -24.44 47.05 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 113.324 170.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -111.58 12.51 21.27 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.0 1.72 . . . . 0.0 112.962 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -146.4 173.34 12.36 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.63 1.572 . . . . 0.0 111.145 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 HG12 ' HA ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -133.7 158.92 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.074 0.949 . . . . 0.0 110.788 -177.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.9 149.45 48.98 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.187 0.995 . . . . 0.0 110.665 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -127.2 132.01 50.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.133 1.373 . . . . 0.0 108.184 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -126.55 123.21 37.2 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 123.245 1.498 . . . . 0.0 110.443 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -83.59 33.52 0.47 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.644 1.578 . . . . 0.0 112.574 -166.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.53 148.56 11.15 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.972 1.748 . . . . 0.0 111.993 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.34 147.91 9.67 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.335 1.454 . . . . 0.0 112.025 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 49.62 42.67 23.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.323 1.049 . . . . 0.0 113.46 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m 56.38 65.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.873 1.669 . . . . 0.0 113.914 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -130.62 -179.88 5.55 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.883 1.273 . . . . 0.0 112.529 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.82 -95.09 1.23 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.01 1.291 . . . . 0.0 113.335 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -129.64 169.23 15.32 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.516 1.527 . . . . 0.0 110.36 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.9 p -135.07 149.72 50.14 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.048 0.939 . . . . 0.0 112.16 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.24 156.36 44.72 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.534 1.934 . . . . 0.0 110.271 -174.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -128.55 132.49 48.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.853 1.261 . . . . 0.0 109.642 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -128.25 122.0 30.67 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.077 1.351 . . . . 0.0 108.928 -171.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -74.56 158.76 33.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.332 0.653 . . . . 0.0 110.926 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -64.98 154.78 36.63 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.505 -0.747 . . . . 0.0 111.622 170.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.15 45.51 96.38 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.367 0.508 . . . . 0.0 112.582 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -121.78 148.96 43.98 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.703 1.201 . . . . 0.0 110.319 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -136.95 119.3 15.72 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -130.32 117.81 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.914 1.286 . . . . 0.0 109.664 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -106.05 100.04 9.6 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.78 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.79 162.33 26.99 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.239 170.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -107.91 162.91 13.59 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.031 0.932 . . . . 0.0 110.641 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -67.02 -15.3 63.64 Favored 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.029 -1.045 . . . . 0.0 113.35 170.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.32 -20.55 66.66 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.308 0.956 . . . . 0.0 114.449 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -80.99 109.55 15.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.563 1.182 . . . . 0.0 111.01 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.14 66.72 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.531 -1.355 . . . . 0.0 112.623 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -57.42 -28.28 63.14 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.904 2.082 . . . . 0.0 113.514 171.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -73.26 -52.07 15.33 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.55 1.14 . . . . 0.0 111.742 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -64.74 -15.22 61.25 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.104 0.962 . . . . 0.0 112.989 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.88 0.93 4.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.102 2.561 . . . . 0.0 114.73 168.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -44.07 135.2 4.38 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.693 1.133 . . . . 0.0 110.222 164.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.76 -54.56 0.05 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.4 p -146.46 164.22 33.18 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.662 0.744 . . . . 0.0 112.004 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 8.3 p -161.68 159.68 27.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.226 -0.922 . . . . 0.0 110.423 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mp -123.87 132.07 53.69 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.337 1.055 . . . . 0.0 108.499 -177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.431 ' HA ' HG12 ' A' ' 8' ' ' VAL . 74.4 t -123.49 127.01 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 124.752 1.221 . . . . 0.0 109.512 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.58 -96.2 0.01 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.548 2.023 . . . . 0.0 115.844 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -171.71 -21.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.256 1.422 . . . . 0.0 114.0 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -120.93 29.49 7.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.928 1.691 . . . . 0.0 111.751 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.93 138.21 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.296 1.439 . . . . 0.0 110.776 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -115.45 132.87 56.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.684 1.194 . . . . 0.0 109.316 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.26 143.49 26.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -123.05 131.45 53.7 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.732 1.613 . . . . 0.0 108.749 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.9 pt -137.56 118.37 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 124.822 1.249 . . . . 0.0 111.037 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -127.08 138.03 53.13 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 110.311 -174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.4 -46.03 4.5 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.501 0.72 . . . . 0.0 112.917 -164.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -151.93 131.62 13.16 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.821 1.248 . . . . 0.0 108.684 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -146.56 138.48 24.74 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.263 1.425 . . . . 0.0 107.86 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.32 9.72 0.56 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.247 0.619 . . . . 0.0 111.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt 43.47 27.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 129.655 3.182 . . . . 0.0 116.259 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -173.39 -23.52 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 127.294 2.238 . . . . 0.0 111.429 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 t -46.98 136.71 8.06 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.125 1.37 . . . . 0.0 113.241 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.38 -5.38 17.04 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.294 2.662 . . . . 0.0 113.01 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 90.54 50.67 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.467 1.507 . . . . 0.0 109.808 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.24 109.97 1.67 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.835 1.69 . . . . 0.0 108.092 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.37 159.1 20.99 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.37 153.62 18.6 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 122.454 1.121 . . . . 0.0 111.191 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -148.55 144.69 27.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.664 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.4 166.64 27.04 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.474 1.131 . . . . 0.0 111.071 170.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -126.34 111.63 14.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.055 1.342 . . . . 0.0 109.32 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.08 136.13 57.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.263 1.025 . . . . 0.0 109.819 176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -51.02 144.26 9.1 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.097 0.959 . . . . 0.0 112.665 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -61.45 -10.82 8.39 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.46 109.62 0.41 Allowed Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.04 1.781 . . . . 0.0 111.829 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.79 168.87 0.52 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.431 2.292 . . . . 0.0 111.331 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.1 m -111.21 142.38 43.49 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.527 1.131 . . . . 0.0 109.49 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -129.6 120.45 25.29 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.833 1.253 . . . . 0.0 108.095 -168.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -128.7 -18.28 3.9 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -75.63 -80.42 0.09 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 109.419 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mp 44.77 22.34 0.06 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.927 1.691 . . . . 0.0 113.762 -169.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -78.29 -36.22 46.9 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.434 1.494 . . . . 0.0 110.055 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.6 t -69.07 -30.44 68.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.551 1.14 . . . . 0.0 112.859 172.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.5 mm -59.39 -27.24 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.234 1.414 . . . . 0.0 112.105 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 57.02 45.57 20.85 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.491 1.516 . . . . 0.0 112.304 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.62 -167.94 43.87 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.533 1.063 . . . . 0.0 113.94 -172.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 -173.55 4.62 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.071 1.349 . . . . 0.0 111.246 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 85.6 p -149.19 -34.63 0.19 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.843 1.257 . . . . 0.0 112.819 167.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -99.29 127.28 45.28 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.293 1.037 . . . . 0.0 110.093 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.35 136.37 54.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.184 1.393 . . . . 0.0 108.796 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -143.89 153.55 42.44 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.408 0.683 . . . . 0.0 109.265 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.69 114.42 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 C-N-CA 124.75 1.22 . . . . 0.0 108.707 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.3 mt -121.63 115.27 31.02 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.492 0.717 . . . . 0.0 110.636 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.73 166.22 30.12 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.938 2.425 . . . . 0.0 112.633 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.1 33.65 0.19 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 127.158 2.313 . . . . 0.0 114.831 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -117.71 -27.11 6.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.055 2.542 . . . . 0.0 110.986 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -140.41 161.23 38.2 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.038 1.735 . . . . 0.0 110.749 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -104.21 -45.64 4.65 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.095 -1.003 . . . . 0.0 112.501 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.34 165.18 26.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.186 1.794 . . . . 0.0 108.333 174.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.28 141.74 37.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.252 0.549 . . . . 0.0 109.753 169.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.06 139.76 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 124.782 1.233 . . . . 0.0 108.978 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -97.2 121.44 39.09 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 m -111.34 162.1 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.943 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.42 167.46 29.36 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.689 1.196 . . . . 0.0 109.623 177.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.34 148.63 29.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 125.38 1.472 . . . . 0.0 109.678 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.8 t -131.61 114.08 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.964 0.906 . . . . 0.0 109.149 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -74.93 88.72 2.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.85 0.86 . . . . 0.0 111.92 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.41 19.48 20.44 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.86 1.264 . . . . 0.0 112.028 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.0 t -117.71 -66.08 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.544 1.538 . . . . 0.0 111.458 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -85.16 -19.59 31.55 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.949 1.3 . . . . 0.0 111.989 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 t 62.51 39.46 11.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.651 1.981 . . . . 0.0 113.358 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.8 m -131.43 -38.36 1.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.762 1.225 . . . . 0.0 113.915 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 55.04 -177.86 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.163 1.385 . . . . 0.0 114.338 -170.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 57.74 20.46 39.85 Favored Glycine 0 CA--C 1.54 1.653 0 O-C-N 120.618 -1.301 . . . . 0.0 115.037 -171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.6 p -139.63 17.66 2.53 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.772 1.629 . . . . 0.0 113.327 -166.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.38 132.45 27.89 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 126.404 1.882 . . . . 0.0 109.385 -170.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -117.23 121.89 42.46 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.541 1.136 . . . . 0.0 110.163 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttt -115.8 122.37 45.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.706 1.203 . . . . 0.0 109.637 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 52.1 m -119.41 116.22 25.72 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.02 1.328 . . . . 0.0 108.373 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.09 138.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 125.266 1.426 . . . . 0.0 108.818 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.7 t -154.67 99.2 2.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 123.405 0.682 . . . . 0.0 110.842 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 9.8 Cg_endo -66.38 168.26 16.63 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.346 2.697 . . . . 0.0 112.905 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -34.99 95.0 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.138 2.175 . . . . 0.0 114.884 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 37.55 65.85 0.5 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.892 2.077 . . . . 0.0 115.099 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -122.2 155.26 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.663 . . . . 0.0 110.41 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -49.01 100.62 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.352 1.461 . . . . 0.0 111.811 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -59.01 151.39 22.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.444 0.64 . . . . 0.0 110.327 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.72 124.0 31.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.13 107.83 15.4 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.673 1.589 . . . . 0.0 108.802 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.88 160.49 24.64 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.575 0.75 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 160.72 16.19 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.197 0.599 . . . . 0.0 110.848 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -64.54 53.77 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.842 2.457 . . . . 0.0 114.727 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -150.01 -21.81 0.07 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.74 2.591 . . . . 0.0 113.776 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -63.21 156.96 23.81 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.156 1.478 . . . . 0.0 111.808 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.7 -16.64 29.93 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.302 -0.874 . . . . 0.0 112.793 172.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -176.66 115.97 0.11 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.78 2.832 . . . . 0.0 108.253 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.56 126.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 120.238 -1.539 . . . . 0.0 109.559 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.69 127.98 33.11 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.922 0.489 . . . . 0.0 110.87 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.23 109.55 54.15 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.161 1.384 . . . . 0.0 109.817 174.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.59 138.87 33.08 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.429 2.086 . . . . 0.0 110.556 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.9 mm -132.62 123.76 18.57 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.733 1.213 . . . . 0.0 109.199 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -70.68 164.51 35.18 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.831 2.354 . . . . 0.0 112.055 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 134.02 55.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.29 0.567 . . . . 0.0 111.735 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.0 pp -139.15 146.59 40.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.921 1.688 . . . . 0.0 110.051 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 85.8 m -142.55 136.05 14.29 Favored Pre-proline 0 N--CA 1.473 0.691 0 C-N-CA 124.603 1.161 . . . . 0.0 109.874 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.7 154.95 75.72 Favored 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 119.844 0.98 . . . . 0.0 113.006 -4.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -64.33 -32.2 61.7 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.064 1.843 . . . . 0.0 112.509 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.59 -12.48 58.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.662 1.585 . . . . 0.0 114.168 170.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.32 174.75 6.07 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.161 0.981 . . . . 0.0 112.89 176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -123.81 149.23 45.95 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.994 1.317 . . . . 0.0 111.574 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.28 122.76 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.964 1.706 . . . . 0.0 109.139 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.84 140.69 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.411 0.624 . . . . 0.0 110.722 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 121' ' ' PRO . 36.6 t -141.14 137.93 33.1 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.87 1.268 . . . . 0.0 110.885 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -91.15 139.81 30.4 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.3 tt -130.48 116.72 18.61 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.869 1.268 . . . . 0.0 108.47 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.29 124.81 37.5 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.67 133.25 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 -136.33 157.03 47.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.719 1.208 . . . . 0.0 110.559 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -65.81 145.3 56.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.426 0.631 . . . . 0.0 111.585 169.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 43.7 p -81.68 -5.24 57.92 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.113 1.365 . . . . 0.0 113.076 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -135.56 166.55 22.95 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.087 1.755 . . . . 0.0 111.194 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 t -80.39 142.87 54.82 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.623 0.769 . . . . 0.0 112.671 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.36 132.3 21.32 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 120.117 1.077 . . . . 0.0 110.993 -9.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -75.08 36.26 0.11 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.627 1.571 . . . . 0.0 112.171 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.93 132.29 41.8 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.701 1.2 . . . . 0.0 109.565 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -52.36 148.44 6.69 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.221 -0.299 . . . . 0.0 110.96 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.57 -29.73 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.292 1.037 . . . . 0.0 112.404 -176.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.96 143.37 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.935 1.694 . . . . 0.0 109.306 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.95 122.0 14.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.366 1.467 . . . . 0.0 109.035 176.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.21 -165.25 31.67 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 121.906 0.725 . . . . 0.0 114.262 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.36 144.96 34.83 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.426 1.09 . . . . 0.0 110.256 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.86 155.58 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.215 1.806 . . . . 0.0 108.934 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -125.32 126.05 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.406 -0.809 . . . . 0.0 108.867 -175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -95.98 139.38 32.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -133.24 150.39 51.94 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.376 1.87 . . . . 0.0 108.414 175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -122.94 150.57 42.78 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.005 0.922 . . . . 0.0 109.417 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.25 105.89 56.14 Favored Pre-proline 0 C--O 1.24 0.59 0 C-N-CA 123.676 0.79 . . . . 0.0 109.326 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.9 51.42 1.97 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.354 4.036 . . . . 0.0 113.614 -176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 87.7 m -132.57 -41.24 0.96 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.72 2.008 . . . . 0.0 111.703 -174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.8 t -145.92 23.68 1.37 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 123.078 1.418 . . . . 0.0 112.098 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 52.15 46.41 56.52 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.483 1.516 . . . . 0.0 113.595 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -83.5 156.13 23.0 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.479 1.112 . . . . 0.0 110.423 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.7 t -130.23 134.82 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.9 m -124.83 150.26 46.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.855 2.062 . . . . 0.0 108.421 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 123.77 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.226 1.011 . . . . 0.0 109.155 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.5 mt -110.11 133.5 55.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.3 1.44 . . . . 0.0 107.338 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.32 138.9 25.33 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.639 1.576 . . . . 0.0 107.635 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.72 147.68 50.4 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.786 1.235 . . . . 0.0 108.494 -178.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.17 -17.84 59.19 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 121.311 -0.868 . . . . 0.0 112.593 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.35 -12.68 61.23 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.307 2.243 . . . . 0.0 114.013 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 58.4 p -137.02 -44.55 0.57 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.583 1.553 . . . . 0.0 111.872 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.504 ' CG ' ' HD2' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -68.68 160.97 74.51 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.107 1.763 . . . . 0.0 111.324 169.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.504 ' HD2' ' CG ' ' A' ' 191' ' ' PHE . 59.6 Cg_endo -76.72 -2.16 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.848 3.032 . . . . 0.0 113.859 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 53.69 15.56 0.81 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 127.709 2.404 . . . . 0.0 115.113 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.39 -0.67 8.72 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.867 1.667 . . . . 0.0 113.398 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 2.7 ttt -125.62 148.61 48.91 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.817 2.047 . . . . 0.0 107.507 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 57.9 p -133.75 156.97 47.01 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.724 0.81 . . . . 0.0 109.846 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.9 t -117.58 125.31 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.251 0.621 . . . . 0.0 109.563 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 41.5 m -110.61 110.35 21.01 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.602 1.961 . . . . 0.0 108.229 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -75.09 103.97 5.48 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.086 0.955 . . . . 0.0 110.543 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.8 -34.55 19.52 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.317 0.647 . . . . 0.0 111.257 173.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -142.44 -177.62 5.36 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.301 1.84 . . . . 0.0 112.739 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -66.97 -17.39 64.9 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 44.9 p -138.68 10.37 2.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.089 1.356 . . . . 0.0 112.644 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.4 m -125.18 114.13 18.59 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.279 1.032 . . . . 0.0 110.975 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -118.59 138.1 52.8 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.433 1.493 . . . . 0.0 109.258 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 48.8 mt -119.79 122.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -100.36 104.79 16.24 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.981 1.312 . . . . 0.0 109.094 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -87.23 126.88 35.09 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.774 0.83 . . . . 0.0 109.019 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.46 118.99 31.72 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.702 0.801 . . . . 0.0 109.981 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -110.86 -27.16 8.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.877 1.271 . . . . 0.0 113.374 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 20.7 m -103.8 177.88 4.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.028 1.331 . . . . 0.0 112.209 178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -134.3 72.97 1.47 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.248 1.419 . . . . 0.0 109.644 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.341 1.056 . . . . 0.0 113.672 178.848 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.4 m . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.369 0.604 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.66 152.27 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.363 1.465 . . . . 0.0 111.213 167.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 139.94 51.85 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.594 1.158 . . . . 0.0 111.082 171.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.6 -17.74 60.76 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 120.684 -1.26 . . . . 0.0 113.568 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -117.31 3.53 12.58 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.284 1.834 . . . . 0.0 113.837 -167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -149.1 173.19 13.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.076 2.55 . . . . 0.0 109.399 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 m -128.63 161.5 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.472 -0.767 . . . . 0.0 110.729 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -145.48 142.3 29.12 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.335 0.654 . . . . 0.0 110.341 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.51 138.04 54.04 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.413 1.485 . . . . 0.0 108.71 -172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.47 127.27 42.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.141 0.972 . . . . 0.0 110.365 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -80.49 58.24 3.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.145 1.378 . . . . 0.0 111.19 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.9 139.32 3.94 Favored Glycine 0 N--CA 1.45 -0.406 0 O-C-N 121.587 -0.696 . . . . 0.0 112.278 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -64.85 126.45 28.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.922 0.889 . . . . 0.0 108.831 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 t30 75.99 34.02 0.56 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.789 1.636 . . . . 0.0 112.874 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.7 t 62.89 63.96 0.92 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 125.622 1.569 . . . . 0.0 112.831 175.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.6 p -137.28 -178.53 5.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.253 1.821 . . . . 0.0 112.99 -172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.84 -95.39 0.63 Allowed Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.63 1.586 . . . . 0.0 114.317 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -123.37 164.23 19.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.99 1.316 . . . . 0.0 110.75 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.7 p -132.92 149.32 52.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.72 1.208 . . . . 0.0 112.036 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.95 148.42 29.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.523 1.529 . . . . 0.0 109.603 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -126.93 146.31 50.36 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.106 0.962 . . . . 0.0 110.258 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -138.42 132.31 31.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.875 1.322 . . . . 0.0 111.721 -173.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -70.7 146.75 49.7 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.964 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -62.66 142.62 58.0 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.415 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.55 52.45 34.75 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 118.083 0.401 . . . . 0.0 113.428 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 158.1 45.05 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.841 0.856 . . . . 0.0 112.101 175.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.6 p -138.6 135.33 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.18 1.392 . . . . 0.0 109.713 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -139.69 119.39 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.321 1.048 . . . . 0.0 109.29 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -99.9 103.5 15.09 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.228 1.411 . . . . 0.0 109.553 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -83.25 155.2 23.79 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.605 1.162 . . . . 0.0 110.663 174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -103.48 137.22 41.87 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.445 0.698 . . . . 0.0 110.029 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -59.78 -17.37 35.04 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 172.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.77 -25.41 63.64 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.424 1.012 . . . . 0.0 114.342 170.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -106.01 119.18 38.54 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.534 1.167 . . . . 0.0 109.975 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.05 -12.5 3.44 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 170.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -58.2 -25.82 62.06 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.196 1.398 . . . . 0.0 112.22 169.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.12 -56.03 10.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.098 168.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.07 -15.24 21.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.962 1.705 . . . . 0.0 113.771 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.46 -28.52 44.98 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.807 1.643 . . . . 0.0 113.522 171.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -47.36 122.22 4.49 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.229 0.538 . . . . 0.0 111.575 172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.9 tpt -149.23 -31.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 111.918 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 92.6 p -145.32 162.06 38.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.223 1.011 . . . . 0.0 111.684 165.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.1 p -156.05 149.16 24.37 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.322 1.449 . . . . 0.0 110.407 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.27 136.23 53.19 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.2 t -126.56 129.73 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.232 1.413 . . . . 0.0 109.563 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.36 -101.48 0.01 OUTLIER Glycine 0 CA--C 1.535 1.323 0 C-N-CA 126.574 2.035 . . . . 0.0 116.11 -172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -166.36 -20.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.471 1.508 . . . . 0.0 113.267 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -119.92 22.92 11.32 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.01 1.724 . . . . 0.0 111.607 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.21 143.25 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.93 2.092 . . . . 0.0 109.508 -174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -120.94 145.66 47.46 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.91 1.284 . . . . 0.0 109.807 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.4 m -112.29 142.89 44.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.606 1.194 . . . . 0.0 109.957 172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 4.6 m120 -132.33 130.79 41.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.44 123.61 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.461 1.105 . . . . 0.0 109.639 -172.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -131.92 134.31 45.53 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.094 1.358 . . . . 0.0 110.549 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.58 -34.22 7.42 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.05 0.94 . . . . 0.0 112.935 -168.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.42 157.27 46.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.593 1.957 . . . . 0.0 107.223 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -142.39 131.79 23.64 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.111 0.964 . . . . 0.0 109.743 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 178.53 162.68 0.7 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.105 1.762 . . . . 0.0 110.68 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.34 15.8 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.662 1.585 . . . . 0.0 112.556 -173.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -146.14 28.82 1.1 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.04 2.136 . . . . 0.0 111.147 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.6 t -99.53 139.96 21.26 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.929 1.291 . . . . 0.0 112.456 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.39 -16.69 11.91 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.45 2.767 . . . . 0.0 114.281 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.4 t -124.92 137.59 29.89 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.73 150.32 83.53 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.17 1.247 . . . . 0.0 110.099 177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.43 -161.29 5.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 122.426 1.014 . . . . 0.0 112.241 171.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.16 134.8 51.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.115 0.966 . . . . 0.0 108.59 167.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -159.43 155.66 27.0 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.568 1.547 . . . . 0.0 110.482 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -158.61 147.32 18.69 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 122.732 1.253 . . . . 0.0 113.027 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.73 95.26 9.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.848 2.059 . . . . 0.0 109.676 168.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.6 134.14 55.89 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.22 151.46 15.67 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -62.89 -8.61 7.39 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.46 89.93 0.11 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.236 -0.915 . . . . 0.0 112.644 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.1 p -162.42 169.41 20.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.355 1.074 . . . . 0.0 112.851 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.9 m -104.54 133.34 49.56 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.584 1.554 . . . . 0.0 109.107 172.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -128.67 115.4 17.97 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.084 0.954 . . . . 0.0 109.682 -177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -141.53 15.56 2.18 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.124 1.37 . . . . 0.0 112.257 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -153.71 50.57 0.68 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.932 1.293 . . . . 0.0 109.96 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.01 42.25 0.39 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.649 1.18 . . . . 0.0 110.841 -178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.4 m -66.31 -30.08 70.42 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 119.971 -1.706 . . . . 0.0 112.385 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 t -63.26 -23.94 67.65 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.196 0.998 . . . . 0.0 112.88 173.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.24 -34.26 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.674 1.99 . . . . 0.0 111.421 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.92 40.83 22.1 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.898 1.679 . . . . 0.0 113.24 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.32 168.89 33.95 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 124.668 1.128 . . . . 0.0 112.287 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.44 -173.91 3.74 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.409 1.484 . . . . 0.0 112.39 -170.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 84.8 p -145.83 -28.18 0.43 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -118.36 139.26 51.64 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.501 1.52 . . . . 0.0 110.03 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.79 127.39 40.25 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.023 1.329 . . . . 0.0 107.673 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 53' ' ' ASN . 1.5 pm0 -136.91 130.44 31.64 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.703 0.801 . . . . 0.0 109.11 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.61 118.77 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 125.218 1.407 . . . . 0.0 107.541 -171.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.84 123.27 27.46 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.473 1.109 . . . . 0.0 109.061 -168.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.54 160.48 41.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.999 2.466 . . . . 0.0 111.107 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.17 24.6 0.2 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 125.831 1.682 . . . . 0.0 116.01 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -122.13 -20.94 6.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.236 2.215 . . . . 0.0 112.816 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.06 158.93 32.58 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.821 1.648 . . . . 0.0 109.399 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -101.13 -38.8 7.98 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.252 -0.905 . . . . 0.0 112.826 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.2 p-90 -149.98 155.52 40.09 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.101 1.361 . . . . 0.0 108.878 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -134.78 146.06 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.03 0.532 . . . . 0.0 110.072 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.02 134.55 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 C-N-CA 124.253 1.021 . . . . 0.0 110.539 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -84.72 126.18 33.18 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 33.1 m -124.89 140.0 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.555 0.742 . . . . 0.0 109.548 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.29 161.83 30.37 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.295 1.038 . . . . 0.0 110.716 175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.01 134.94 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.984 0.913 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 83.7 t -127.4 108.27 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.992 2.117 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -76.21 118.31 18.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.735 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -102.33 -21.69 14.26 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.319 1.047 . . . . 0.0 112.466 170.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 58.1 t -89.21 -67.89 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 124.192 0.997 . . . . 0.0 111.971 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -85.2 97.62 10.01 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.852 1.261 . . . . 0.0 110.393 -176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.0 t -70.17 47.84 0.09 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.26 1.824 . . . . 0.0 114.417 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.8 m -144.68 -36.16 0.32 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.123 2.569 . . . . 0.0 111.82 -171.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 50.29 -153.58 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.963 0.905 . . . . 0.0 112.937 -170.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 53.03 25.18 23.5 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-N 120.224 1.375 . . . . 0.0 116.203 -173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.9 m -143.82 5.66 1.36 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.974 1.71 . . . . 0.0 114.935 -167.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -133.58 120.3 20.57 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.431 1.493 . . . . 0.0 111.855 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.26 137.99 32.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.315 1.046 . . . . 0.0 109.916 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.77 119.38 34.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.261 2.224 . . . . 0.0 108.662 175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 74.8 m -119.07 119.5 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.41 128.83 73.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 90.5 m -117.49 89.11 31.12 Favored Pre-proline 0 N--CA 1.469 0.494 0 C-N-CA 125.233 1.413 . . . . 0.0 109.226 -173.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.07 160.36 49.01 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.668 2.912 . . . . 0.0 112.035 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -42.94 83.88 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 128.288 2.635 . . . . 0.0 116.084 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 44.48 39.7 3.39 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.836 1.654 . . . . 0.0 113.948 -169.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.3 t -113.25 154.92 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.734 2.014 . . . . 0.0 109.683 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -45.95 98.56 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.165 1.786 . . . . 0.0 112.752 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.99 151.06 36.17 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 0.0 111.046 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.3 t -124.46 125.41 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.882 0.873 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.17 105.45 17.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.012 1.325 . . . . 0.0 108.638 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.4 p -103.06 164.99 11.28 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.053 0.941 . . . . 0.0 110.796 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -142.46 159.9 41.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.764 0.825 . . . . 0.0 110.65 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 p-10 -60.54 81.85 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 126.339 1.856 . . . . 0.0 114.526 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.22 0.18 Allowed Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.939 1.733 . . . . 0.0 112.159 -173.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -62.12 131.43 49.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.978 0.894 . . . . 0.0 111.217 170.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -74.95 70.52 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.32 1.448 . . . . 0.0 112.466 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 63.3 84.3 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.23 2.212 . . . . 0.0 110.919 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -56.61 147.96 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.603 -0.686 . . . . 0.0 110.599 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.1 146.06 24.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.886 0.474 . . . . 0.0 111.199 170.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -122.66 97.09 44.82 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.195 1.398 . . . . 0.0 108.106 166.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.51 137.51 27.99 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.542 2.161 . . . . 0.0 111.072 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 40.9 mt -128.68 127.62 23.52 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 124.508 1.123 . . . . 0.0 107.997 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.22 -178.7 3.77 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 124.326 3.35 . . . . 0.0 111.327 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.96 149.41 47.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.84 0.829 . . . . 0.0 112.358 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.02 143.39 21.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.432 1.893 . . . . 0.0 109.46 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.8 m -125.83 130.62 23.98 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 124.275 1.03 . . . . 0.0 109.534 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.1 150.78 79.37 Favored 'Cis proline' 0 CA--C 1.545 1.038 0 CA-C-N 119.368 0.81 . . . . 0.0 112.435 -3.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.27 -22.69 39.76 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.76 1.64 . . . . 0.0 112.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.01 4.87 15.65 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.543 1.537 . . . . 0.0 114.548 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 148.71 46.68 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.727 -1.233 . . . . 0.0 111.992 173.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 155.57 36.96 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.584 0.754 . . . . 0.0 112.182 168.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 tt -132.99 114.05 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 109.155 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.25 138.91 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.331 0.652 . . . . 0.0 109.844 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 89.1 p -142.57 145.99 34.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 122.033 0.921 . . . . 0.0 111.221 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -86.49 145.72 26.69 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.319 -0.863 . . . . 0.0 108.958 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 tt -134.6 122.49 22.39 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.993 0.917 . . . . 0.0 110.035 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 t -131.14 138.31 49.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.434 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 47.0 t -119.02 134.11 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -130.24 140.72 50.68 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.89 0.876 . . . . 0.0 109.885 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -64.26 129.46 40.04 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.156 -0.34 . . . . 0.0 110.253 169.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 44.9 p -77.41 -10.37 59.42 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.81 0.844 . . . . 0.0 112.855 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -121.74 164.43 17.43 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.085 2.154 . . . . 0.0 111.301 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.9 t -75.17 141.29 74.04 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.63 -0.669 . . . . 0.0 111.81 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.35 129.58 15.45 Favored 'Cis proline' 0 C--N 1.354 0.861 0 CA-C-N 120.279 1.135 . . . . 0.0 111.091 -9.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -73.73 34.38 0.08 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.978 1.711 . . . . 0.0 113.546 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.23 151.17 23.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.278 1.431 . . . . 0.0 113.039 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -70.21 102.62 2.14 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.916 0.886 . . . . 0.0 110.381 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.94 -39.1 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.82 2.048 . . . . 0.0 111.495 175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.53 143.76 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.2 1.4 . . . . 0.0 108.252 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -148.77 74.46 1.27 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.962 0.905 . . . . 0.0 109.273 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -140.69 -156.13 6.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.424 1.488 . . . . 0.0 112.039 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 55.2 m -141.69 164.73 29.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.95 0.9 . . . . 0.0 110.434 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.73 156.54 28.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.444 1.498 . . . . 0.0 108.176 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.01 134.39 53.6 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.141 -0.974 . . . . 0.0 108.65 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.05 160.08 16.33 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.486 1.115 . . . . 0.0 109.609 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -159.22 154.31 25.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.269 1.428 . . . . 0.0 109.262 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -128.94 142.83 50.81 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.937 1.295 . . . . 0.0 109.168 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.6 m -101.86 109.66 60.21 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 123.376 0.67 . . . . 0.0 109.197 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.63 47.65 1.71 Allowed 'Trans proline' 0 CA--C 1.548 1.182 0 C-N-CA 125.227 3.952 . . . . 0.0 113.098 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.5 m -130.27 -49.73 1.09 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.105 1.762 . . . . 0.0 110.462 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 67.2 p -138.46 24.71 2.68 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 125.196 1.398 . . . . 0.0 112.609 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.99 23.75 64.08 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.306 0.955 . . . . 0.0 114.154 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.14 158.73 35.23 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.327 1.051 . . . . 0.0 111.318 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.19 143.77 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.705 1.602 . . . . 0.0 107.819 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 59.4 m -139.49 128.73 23.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.841 1.256 . . . . 0.0 108.587 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.567 HG23 ' HE2' ' A' ' 186' ' ' LYS . 0.9 OUTLIER -102.07 126.61 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.866 0.866 . . . . 0.0 110.233 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.71 130.18 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.902 1.281 . . . . 0.0 108.224 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.567 ' HE2' HG23 ' A' ' 184' ' ' VAL . 14.8 mtmt -140.03 125.86 19.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.198 1.799 . . . . 0.0 108.468 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 158.56 42.05 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.164 1.386 . . . . 0.0 109.943 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -57.59 -18.36 19.33 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.648 1.179 . . . . 0.0 113.274 177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.78 -24.88 64.45 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.967 1.707 . . . . 0.0 114.609 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.0 p -150.15 -44.17 0.13 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.756 1.223 . . . . 0.0 114.1 -173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.86 144.28 51.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.895 1.278 . . . . 0.0 110.072 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.47 -78.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 121.268 1.312 . . . . 0.0 113.437 -170.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 156.06 -44.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 130.262 3.425 . . . . 0.0 112.003 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -57.97 -25.18 60.68 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 126.058 1.743 . . . . 0.0 113.533 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -119.46 131.85 55.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.737 1.615 . . . . 0.0 107.433 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -132.09 149.68 52.35 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.437 1.095 . . . . 0.0 110.174 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 10.2 p -124.69 131.23 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 1.3 t -120.08 153.76 35.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.882 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.432 ' HB3' ' CE2' ' A' ' 205' ' ' PHE . 11.3 pt20 -105.04 114.4 28.58 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.731 0.812 . . . . 0.0 109.897 -176.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -75.48 -33.62 60.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -134.42 -175.6 3.93 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.352 1.061 . . . . 0.0 112.968 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.85 -30.91 68.05 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.361 1.064 . . . . 0.0 113.319 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 21.1 p -139.81 13.72 2.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.47 1.908 . . . . 0.0 112.591 -168.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 t -129.07 123.57 32.6 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.668 1.187 . . . . 0.0 110.958 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 199' ' ' GLN . 94.4 m-85 -130.04 146.63 51.72 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.812 1.645 . . . . 0.0 109.819 -171.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.63 119.2 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -91.81 107.76 19.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.044 1.737 . . . . 0.0 109.685 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.25 140.69 29.44 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.842 1.657 . . . . 0.0 109.998 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.39 110.49 12.84 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.913 0.885 . . . . 0.0 110.569 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -118.5 13.06 13.41 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.567 1.947 . . . . 0.0 113.861 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.13 135.4 3.18 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.1 1.76 . . . . 0.0 109.849 166.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -73.91 -4.44 35.05 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.26 1.651 0 C-N-CA 126.206 1.802 . . . . 0.0 115.332 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.6 p -96.75 129.67 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.406 1.483 . . . . 0.0 110.122 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.74 148.31 49.36 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.24 -21.55 24.27 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 120.666 -1.271 . . . . 0.0 113.098 171.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -112.71 11.65 19.52 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.474 1.91 . . . . 0.0 113.729 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -144.08 172.65 12.6 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.912 2.085 . . . . 0.0 110.402 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.3 m -135.26 156.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 O-C-N 121.237 -0.914 . . . . 0.0 110.692 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 134.25 26.22 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.817 0.847 . . . . 0.0 110.783 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -118.5 154.46 32.48 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.425 1.09 . . . . 0.0 110.281 -168.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -138.15 126.12 22.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 122.782 1.277 . . . . 0.0 110.984 -166.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -96.92 44.01 1.06 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 122.287 1.041 . . . . 0.0 112.647 -165.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.57 137.6 3.84 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.72 1.628 . . . . 0.0 110.778 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -61.32 133.93 56.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.925 0.89 . . . . 0.0 109.6 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 83.94 27.5 0.09 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.913 2.085 . . . . 0.0 113.058 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.6 m 54.79 59.0 4.34 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.242 1.417 . . . . 0.0 113.154 -172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.3 p -128.05 -174.06 3.1 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.98 1.712 . . . . 0.0 112.032 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.6 -98.62 1.17 Allowed Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.861 1.219 . . . . 0.0 112.634 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -128.2 175.97 8.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.205 1.402 . . . . 0.0 110.753 173.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -133.42 158.61 42.62 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 111.228 177.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.58 152.33 37.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.963 1.305 . . . . 0.0 110.491 -176.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.49 140.96 52.06 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.768 0.827 . . . . 0.0 111.731 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -137.9 134.24 34.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.255 1.422 . . . . 0.0 110.393 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -84.71 159.37 20.53 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.727 0.811 . . . . 0.0 111.577 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -59.05 155.27 13.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 122.036 -0.415 . . . . 0.0 112.051 168.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.57 93.95 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 123.736 0.684 . . . . 0.0 113.254 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -125.16 124.34 41.57 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.448 1.099 . . . . 0.0 110.731 -174.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 m -122.62 124.18 42.88 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.732 1.613 . . . . 0.0 108.481 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.74 133.52 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 122.521 1.153 . . . . 0.0 109.858 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -114.51 83.69 1.93 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.649 1.98 . . . . 0.0 107.922 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -68.2 167.35 14.41 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.999 0.904 . . . . 0.0 111.382 171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -117.96 159.81 22.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 109.807 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -63.8 -17.97 63.63 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -36.24 73.55 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.052 1.31 . . . . 0.0 114.191 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -76.96 110.73 11.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.496 1.148 . . . . 0.0 109.345 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -24.31 66.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.182 -1.574 . . . . 0.0 112.563 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -61.47 -21.66 64.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.734 1.614 . . . . 0.0 112.363 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -71.88 -53.93 11.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.642 1.177 . . . . 0.0 112.243 168.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.81 -24.29 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.321 -0.862 . . . . 0.0 112.657 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -55.05 -27.62 46.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.023 1.729 . . . . 0.0 114.467 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -51.2 108.93 0.28 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.435 1.016 . . . . 0.0 111.707 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 3.9 tpt -132.35 -29.03 1.62 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.028 0.931 . . . . 0.0 112.663 -174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.9 m -139.33 164.24 30.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.643 2.377 . . . . 0.0 109.438 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.5 163.26 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.43 1.092 . . . . 0.0 111.111 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pp -146.75 148.86 32.39 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 123.17 1.462 . . . . 0.0 111.326 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.04 133.33 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.086 1.754 . . . . 0.0 107.803 -167.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.44 -92.03 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.181 1.372 . . . . 0.0 116.002 -168.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -170.25 -21.07 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.111 1.364 . . . . 0.0 113.772 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -122.11 28.17 7.65 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.679 1.992 . . . . 0.0 111.841 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 m -145.24 146.75 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.874 2.07 . . . . 0.0 109.375 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -116.43 149.78 38.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.48 1.112 . . . . 0.0 109.138 175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.1 144.85 44.22 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.958 0.903 . . . . 0.0 110.49 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -122.38 135.5 54.71 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.672 1.189 . . . . 0.0 109.27 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 33.5 mt -118.39 126.4 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.153 1.381 . . . . 0.0 108.475 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -131.59 124.74 30.61 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.062 0.945 . . . . 0.0 110.572 174.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.34 -26.59 11.43 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.863 1.265 . . . . 0.0 111.809 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.406 ' CE1' ' H ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -114.38 150.68 34.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.828 1.251 . . . . 0.0 110.759 174.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -142.77 103.6 4.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.842 1.257 . . . . 0.0 109.027 -174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.73 155.29 19.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.286 1.434 . . . . 0.0 109.88 -177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.34 27.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.525 1.53 . . . . 0.0 111.764 -168.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.2 -29.68 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.92 2.088 . . . . 0.0 111.37 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 t -54.44 122.19 36.69 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.027 0.931 . . . . 0.0 112.566 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.97 -15.26 10.6 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.791 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.2 t -82.77 113.2 43.5 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 119.11 0.868 . . . . 0.0 110.174 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -69.8 127.53 14.69 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.107 1.204 . . . . 0.0 109.055 174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' H ' ' CE1' ' A' ' 57' ' ' HIS . . . -84.08 -113.91 0.62 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 175.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.67 115.02 18.1 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.685 1.194 . . . . 0.0 109.621 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.17 143.29 34.14 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.337 2.255 . . . . 0.0 107.882 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -158.64 166.71 31.4 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.608 1.163 . . . . 0.0 110.015 166.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -126.72 104.99 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.047 1.339 . . . . 0.0 108.48 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.73 124.89 21.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.58 153.86 2.9 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -56.88 -18.77 14.4 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.62 126.49 1.85 Allowed Glycine 0 CA--C 1.529 0.909 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 160.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.14 164.32 0.7 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.927 2.091 . . . . 0.0 111.364 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 81.8 m -112.69 131.54 55.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.275 1.43 . . . . 0.0 109.036 174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -124.71 98.73 5.84 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.764 1.625 . . . . 0.0 107.571 -173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -112.39 17.57 19.23 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.246 1.018 . . . . 0.0 111.886 -176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -156.69 66.89 0.55 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.838 1.655 . . . . 0.0 110.803 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB3' HG22 ' A' ' 83' ' ' ILE . 4.0 mp -92.0 31.22 1.28 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.161 -0.962 . . . . 0.0 111.874 176.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.3 m -56.58 -28.39 60.16 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 119.995 -1.691 . . . . 0.0 113.038 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -60.28 -26.66 66.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.711 -1.243 . . . . 0.0 114.106 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.404 HG22 ' HB3' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -97.63 -23.32 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.786 1.234 . . . . 0.0 112.484 176.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 55.41 50.42 14.83 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.672 1.989 . . . . 0.0 113.464 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.22 -170.49 44.69 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.529 -0.732 . . . . 0.0 111.31 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.61 -175.0 5.16 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.66 -1.494 . . . . 0.0 111.987 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.2 m -135.02 -27.93 1.21 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.35 135.28 46.06 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.536 -0.728 . . . . 0.0 110.006 176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.86 131.24 52.42 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.503 1.521 . . . . 0.0 108.945 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -122.31 137.78 54.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.397 0.618 . . . . 0.0 109.635 167.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.81 116.65 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 125.637 1.575 . . . . 0.0 106.879 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 67.5 mt -123.69 130.39 24.48 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 109.352 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.12 162.07 37.41 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.753 1.636 . . . . 0.0 112.871 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.16 2.09 4.36 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.803 1.668 . . . . 0.0 116.029 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.28 -18.41 32.1 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.238 1.415 . . . . 0.0 113.263 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -132.75 161.05 35.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.763 1.625 . . . . 0.0 110.153 -175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -93.55 -55.19 3.36 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 61.7 p-90 -139.99 164.34 30.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.615 1.566 . . . . 0.0 109.145 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -139.92 163.63 32.14 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.524 0.73 . . . . 0.0 109.4 175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.445 HG21 ' CE2' ' A' ' 205' ' ' PHE . 6.0 p -135.5 142.59 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.151 0.58 . . . . 0.0 109.505 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.92 139.27 33.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.271 0.558 . . . . 0.0 110.479 171.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.55 137.14 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.479 1.111 . . . . 0.0 109.773 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 0.0 OUTLIER -136.79 153.93 50.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.787 0.835 . . . . 0.0 111.111 -178.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.83 137.75 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 108.789 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.5 t -109.87 119.16 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.625 1.17 . . . . 0.0 109.346 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -63.62 89.67 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.433 1.893 . . . . 0.0 112.877 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.84 10.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.454 1.101 . . . . 0.0 112.987 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -80.69 -70.1 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 125.133 1.373 . . . . 0.0 110.508 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.23 169.42 8.64 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.477 1.511 . . . . 0.0 110.729 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.6 t -83.99 -47.45 10.98 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.957 0.503 . . . . 0.0 112.347 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.9 t -61.32 -39.13 89.37 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 41.44 -148.36 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.123 1.369 . . . . 0.0 112.271 -170.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.91 26.52 55.12 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 120.927 -1.108 . . . . 0.0 114.137 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.0 m -138.19 15.64 2.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.468 1.507 . . . . 0.0 114.622 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -133.71 114.26 13.24 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.542 1.537 . . . . 0.0 110.624 -175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -111.12 114.43 27.69 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.606 0.762 . . . . 0.0 110.495 -176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -107.47 117.98 35.53 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 126.786 2.034 . . . . 0.0 110.161 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -108.13 126.43 52.75 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.1 pt -118.19 140.3 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.4 1.08 . . . . 0.0 110.056 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.0 m -145.24 93.98 5.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.188 0.995 . . . . 0.0 109.107 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.94 168.49 18.66 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.372 2.048 . . . . 0.0 112.627 173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -35.91 101.49 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.771 2.428 . . . . 0.0 113.65 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . 0.306 2.7 pp0? 42.15 42.08 2.31 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.619 2.367 . . . . 0.0 116.61 -174.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.45 156.8 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 126.021 1.729 . . . . 0.0 112.099 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -52.33 119.88 4.92 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.219 1.808 . . . . 0.0 112.62 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 142.87 56.37 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.592 0.757 . . . . 0.0 111.513 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.6 m -128.14 117.66 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.624 1.17 . . . . 0.0 110.615 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.73 102.18 13.41 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.209 1.004 . . . . 0.0 110.059 175.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 3.9 t -93.5 152.16 19.25 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.51 0.724 . . . . 0.0 110.333 170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -143.49 146.88 33.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.511 1.124 . . . . 0.0 109.289 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -54.9 85.57 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.106 . . . . 0.0 114.052 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.63 -21.44 1.84 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 125.547 1.546 . . . . 0.0 113.463 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.66 135.45 56.72 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.32 1.06 . . . . 0.0 110.602 171.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.15 64.02 3.22 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.213 1.005 . . . . 0.0 111.725 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 103' ' ' LYS . 6.5 m-85 60.54 81.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.0 2.12 . . . . 0.0 111.423 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.79 131.97 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.15 -0.969 . . . . 0.0 110.403 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 136.89 32.77 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.037 0.446 . . . . 0.0 110.515 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 tp -114.12 98.64 48.81 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.573 1.949 . . . . 0.0 108.873 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -71.63 138.34 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.717 2.278 . . . . 0.0 111.409 173.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.49 126.93 22.98 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.861 1.264 . . . . 0.0 108.541 -174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.86 167.18 23.93 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.723 2.949 . . . . 0.0 111.942 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -61.71 122.04 14.34 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.34 -0.85 . . . . 0.0 110.572 175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.06 153.02 47.27 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.351 2.261 . . . . 0.0 109.438 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.8 t -137.86 136.05 19.48 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.575 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.76 150.41 65.26 Favored 'Cis proline' 0 CA--C 1.548 1.18 0 CA-C-N 119.771 0.954 . . . . 0.0 112.471 -7.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -64.47 -29.09 62.1 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.295 1.996 . . . . 0.0 112.494 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -78.47 3.75 15.07 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.266 1.427 . . . . 0.0 113.786 169.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 5.7 p -67.97 147.7 52.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.138 1.335 . . . . 0.0 112.198 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.15 121.09 16.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.889 0.875 . . . . 0.0 110.829 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.0 tt -109.54 116.51 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.819 0.848 . . . . 0.0 110.668 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.2 p -68.15 142.68 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.0 0.52 . . . . 0.0 109.808 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 19.6 t -144.63 137.83 26.96 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.982 0.913 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -99.85 139.19 35.88 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.232 0.539 . . . . 0.0 109.55 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.27 124.41 47.77 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.842 2.057 . . . . 0.0 107.643 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.53 113.77 8.95 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 167' ' ' VAL . 2.0 p -124.23 140.64 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.181 1.392 . . . . 0.0 108.969 -175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 -139.84 156.45 46.72 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.056 0.942 . . . . 0.0 111.524 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -65.24 134.34 53.44 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.2 p -71.96 -8.55 55.13 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 174.94 10.1 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.35 2.26 . . . . 0.0 110.383 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.9 t -40.09 134.59 1.43 Allowed Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 125.729 1.612 . . . . 0.0 114.212 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.65 2.36 21.03 Favored 'Cis proline' 0 CA--C 1.546 1.105 0 N-CA-C 114.854 1.059 . . . . 0.0 114.854 3.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.41 6.89 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.84 2.056 . . . . 0.0 114.243 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -69.13 156.41 38.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.911 1.285 . . . . 0.0 111.735 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -55.21 143.29 28.23 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.908 0.883 . . . . 0.0 111.802 169.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.4 m -109.75 -23.01 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.487 1.515 . . . . 0.0 112.205 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' HB ' ' CG1' ' A' ' 156' ' ' VAL . 75.2 t -155.89 141.82 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.75 1.62 . . . . 0.0 108.324 171.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -136.81 113.68 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.676 1.99 . . . . 0.0 107.322 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -166.19 -179.11 39.42 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 124.139 0.876 . . . . 0.0 111.993 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.49 149.0 44.96 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.921 -0.752 . . . . 0.0 110.934 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 11.0 p -138.81 159.25 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.087 1.355 . . . . 0.0 109.133 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -115.43 130.73 56.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.052 0.941 . . . . 0.0 109.917 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -104.91 152.31 22.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 0.0 109.521 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -149.86 162.86 39.49 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.759 2.024 . . . . 0.0 110.578 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -133.7 123.52 25.1 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.574 1.55 . . . . 0.0 108.93 177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.8 m -77.82 112.51 25.32 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.367 0.667 . . . . 0.0 109.699 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.4 54.05 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.542 3.494 . . . . 0.0 112.072 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.3 m -136.92 -52.65 0.69 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.262 1.425 . . . . 0.0 111.273 -170.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 32.1 p -130.26 12.91 5.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.235 1.414 . . . . 0.0 112.551 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.66 28.81 72.89 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.084 1.326 . . . . 0.0 113.626 -171.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -68.34 156.37 37.9 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.476 -1.014 . . . . 0.0 111.141 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -136.02 131.07 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 171.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.8 m -135.53 132.17 36.92 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.206 1.403 . . . . 0.0 109.23 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.513 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -105.02 117.07 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.26 1.024 . . . . 0.0 110.255 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 20.4 mt -88.64 128.05 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.72 134.94 25.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.973 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -148.78 143.91 26.67 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.77 1.628 . . . . 0.0 109.678 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -57.17 -14.93 4.61 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.11 1.364 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -52.31 -30.43 28.27 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.324 1.85 . . . . 0.0 114.409 168.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 16.7 p -149.49 -34.72 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.705 1.602 . . . . 0.0 113.623 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -72.88 133.43 82.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.031 0.932 . . . . 0.0 111.608 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.68 130.2 11.44 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.545 2.83 . . . . 0.0 111.546 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -73.56 -20.09 60.72 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.417 HD21 ' CG2' ' A' ' 167' ' ' VAL . 0.8 OUTLIER -74.86 -13.04 60.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.29 1.036 . . . . 0.0 113.493 177.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.8 mtp -112.53 150.91 30.63 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.515 1.526 . . . . 0.0 108.828 167.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.1 p -142.21 118.28 10.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.238 0.615 . . . . 0.0 109.614 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.17 107.92 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.486 0.66 . . . . 0.0 109.708 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 95.2 m -88.11 143.82 26.85 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.555 0.693 . . . . 0.0 109.753 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.26 71.14 10.66 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.72 1.208 . . . . 0.0 110.408 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -52.43 -42.78 64.4 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.301 1.44 . . . . 0.0 113.259 -171.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.08 -177.38 6.54 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.076 1.75 . . . . 0.0 110.991 163.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -50.91 143.45 10.1 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.256 -1.528 . . . . 0.0 109.574 166.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 29.9 p 53.13 14.96 0.54 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 t -139.88 108.92 6.03 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.865 1.666 . . . . 0.0 110.958 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 184' ' ' VAL . 22.3 m-85 -120.76 147.62 45.08 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.177 0.991 . . . . 0.0 111.128 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . 0.272 9.8 tt -133.84 99.08 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 122.51 1.148 . . . . 0.0 110.513 -173.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -73.36 109.91 7.25 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.305 1.842 . . . . 0.0 110.11 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -81.04 138.21 36.01 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 168.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 30.9 tp -132.07 111.65 11.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.37 1.068 . . . . 0.0 108.667 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -120.73 -3.38 9.76 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.432 1.493 . . . . 0.0 114.609 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -141.18 -178.55 5.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.012 1.325 . . . . 0.0 111.502 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.1 46.67 0.99 Allowed 'General case' 0 CA--C 1.553 1.071 0 CA-C-O 122.082 0.944 . . . . 0.0 113.181 -170.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt . . . . . 0 C--O 1.258 1.531 0 C-N-CA 128.214 2.606 . . . . 0.0 116.986 176.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -109.79 138.51 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.724 1.209 . . . . 0.0 110.291 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.58 140.57 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.81 0.844 . . . . 0.0 111.023 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.15 -16.4 32.27 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.845 -1.159 . . . . 0.0 113.109 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.77 9.89 11.49 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 112.45 -170.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -148.17 171.72 15.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.622 1.969 . . . . 0.0 110.738 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.529 HG23 ' CD2' ' A' ' 23' ' ' TYR . 2.1 m -141.27 150.99 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 O-C-N 121.035 -1.041 . . . . 0.0 112.412 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -149.64 151.14 33.25 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.807 -0.558 . . . . 0.0 109.631 -170.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.6 159.4 42.07 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.741 -0.6 . . . . 0.0 110.877 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -130.86 136.46 48.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.223 1.009 . . . . 0.0 111.054 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.63 63.35 3.4 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.732 1.613 . . . . 0.0 111.287 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.47 135.72 1.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.686 171.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.9 tmmt? -58.58 126.73 28.82 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 90.28 22.7 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 127.735 2.414 . . . . 0.0 112.268 -174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t 66.39 55.1 0.86 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.254 1.421 . . . . 0.0 111.408 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.8 p -129.24 -178.78 4.8 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.682 1.593 . . . . 0.0 112.367 -170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.95 -107.31 2.15 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.651 1.12 . . . . 0.0 113.773 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -107.0 167.87 9.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.9 p -133.7 152.22 51.83 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.835 0.854 . . . . 0.0 112.589 -177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.49 150.48 29.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.995 0.918 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -141.97 140.75 32.81 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.082 0.953 . . . . 0.0 110.734 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.529 ' CD2' HG23 ' A' ' 8' ' ' VAL . 1.7 p90 -145.52 142.5 29.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.364 1.066 . . . . 0.0 109.277 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -70.97 163.89 26.6 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.749 -1.219 . . . . 0.0 112.09 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 93' ' ' PRO . 0.1 OUTLIER -76.11 161.31 28.95 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.196 -0.94 . . . . 0.0 111.326 171.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.22 43.65 70.12 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 114.644 0.617 . . . . 0.0 114.644 176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.29 169.88 19.15 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.438 1.495 . . . . 0.0 111.616 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.4 p -138.95 143.44 38.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.976 0.91 . . . . 0.0 111.502 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -135.59 129.15 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.149 0.979 . . . . 0.0 110.556 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.21 90.53 3.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.756 1.223 . . . . 0.0 108.921 -174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.42 166.42 14.62 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.973 0.892 . . . . 0.0 111.346 171.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -111.8 153.42 26.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.6 0.76 . . . . 0.0 110.163 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.92 57.43 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.65 73.59 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.815 1.198 . . . . 0.0 114.411 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -91.91 112.49 24.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.863 0.831 . . . . 0.0 109.381 167.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -21.75 33.9 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.529 -0.732 . . . . 0.0 111.494 171.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -61.32 -11.65 10.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.358 1.463 . . . . 0.0 112.533 173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -67.32 -52.05 45.12 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.444 -1.41 . . . . 0.0 111.392 167.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.09 -10.7 55.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.509 1.524 . . . . 0.0 112.883 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -57.97 -27.09 63.14 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.838 1.655 . . . . 0.0 113.313 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -58.43 104.66 0.23 Allowed 'General case' 0 CA--C 1.55 0.947 0 O-C-N 120.63 -1.294 . . . . 0.0 111.671 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.0 -27.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.917 1.687 . . . . 0.0 112.438 -169.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 t -142.12 137.17 30.74 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.474 1.91 . . . . 0.0 111.173 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.73 120.06 13.04 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.462 1.125 . . . . 0.0 112.178 -173.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp -95.46 112.97 24.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.894 1.678 . . . . 0.0 109.839 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 75' ' ' SER . 0.9 OUTLIER -98.93 140.62 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.724 1.209 . . . . 0.0 109.429 173.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.05 -116.78 0.03 OUTLIER Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.02 1.295 . . . . 0.0 114.552 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 73.7 m -147.08 -13.13 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.666 1.186 . . . . 0.0 113.024 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.18 36.03 3.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.493 1.517 . . . . 0.0 110.392 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.22 118.2 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.7 1.6 . . . . 0.0 110.959 -168.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -95.77 140.53 30.42 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.55 1.14 . . . . 0.0 110.652 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 51.6 m -125.79 112.93 16.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.683 1.193 . . . . 0.0 108.916 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.9 m-20 -109.25 134.6 51.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.45 144.04 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.437 0.637 . . . . 0.0 111.839 -171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -142.14 142.06 32.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.37 -166.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -118.62 -29.53 5.38 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.779 0.832 . . . . 0.0 111.588 -170.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.11 130.59 25.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.411 1.484 . . . . 0.0 111.85 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.93 121.53 41.69 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.192 0.597 . . . . 0.0 110.967 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -165.81 170.32 14.02 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 0.0 110.953 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.82 21.58 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.172 1.389 . . . . 0.0 111.539 -169.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.75 -17.19 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.572 1.549 . . . . 0.0 111.808 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.2 t -41.81 138.88 1.7 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 125.427 1.491 . . . . 0.0 114.908 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.56 -9.05 21.16 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.445 2.763 . . . . 0.0 112.71 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -143.79 115.08 5.58 Favored Pre-proline 0 C--O 1.239 0.523 0 C-N-CA 124.533 1.133 . . . . 0.0 111.52 172.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.85 49.62 1.92 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.388 2.726 . . . . 0.0 112.033 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 31.66 -107.41 0.02 OUTLIER Glycine 0 CA--C 1.527 0.827 0 C-N-CA 129.008 3.194 . . . . 0.0 114.548 -171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt -123.44 144.64 49.38 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.016 0.926 . . . . 0.0 110.252 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -146.56 153.98 40.99 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.96 1.704 . . . . 0.0 110.259 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -161.86 153.99 19.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.734 0.814 . . . . 0.0 110.86 167.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -118.1 93.75 4.25 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.942 1.297 . . . . 0.0 109.172 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.2 mt -60.74 134.81 57.45 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.57 176.3 0.28 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -66.54 -18.65 65.48 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.535 -1.353 . . . . 0.0 113.113 168.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 111.71 0.5 Allowed Glycine 0 CA--C 1.536 1.36 0 CA-C-N 119.028 0.831 . . . . 0.0 113.357 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER 175.46 162.47 0.28 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 127.728 2.411 . . . . 0.0 111.023 179.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 m -109.28 142.53 40.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.018 1.327 . . . . 0.0 110.743 171.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -134.18 136.29 43.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.698 1.199 . . . . 0.0 108.676 -174.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -150.24 -50.07 0.13 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.929 0.892 . . . . 0.0 111.374 -170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -81.23 46.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.981 1.312 . . . . 0.0 113.413 174.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.01 42.61 0.09 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.216 1.406 . . . . 0.0 113.433 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.0 m -60.29 -34.69 74.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 120.298 -1.501 . . . . 0.0 112.713 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.4 m -65.91 -26.42 67.6 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.6 mm -72.6 -38.91 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.397 1.079 . . . . 0.0 110.262 173.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.0 t30 58.82 32.6 22.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.714 1.606 . . . . 0.0 113.297 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.14 39.8 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.216 1.389 . . . . 0.0 113.411 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 -176.29 3.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.63 1.172 . . . . 0.0 112.399 -176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.1 t -140.53 -31.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 167.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.0 136.77 37.24 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.194 0.998 . . . . 0.0 110.153 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.402 ' CD2' HG23 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -145.44 133.86 21.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.78 0.8 . . . . 0.0 110.093 -168.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.32 138.54 53.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.72 -170.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.78 121.92 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.33 135.57 27.07 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 123.143 0.577 . . . . 0.0 110.313 -166.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.424 ' CB ' ' HE2' ' A' ' 25' ' ' LYS . 61.4 Cg_endo -76.44 152.59 34.39 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.04 1.827 . . . . 0.0 111.021 -175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.37 29.13 0.21 Allowed Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.851 1.691 . . . . 0.0 116.121 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.69 -18.23 3.92 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.605 1.962 . . . . 0.0 112.654 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -119.25 156.24 30.29 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.941 0.897 . . . . 0.0 110.167 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -88.24 -41.91 12.63 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.491 -0.755 . . . . 0.0 111.966 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -150.14 167.64 26.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.143 2.177 . . . . 0.0 108.561 172.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -137.63 166.55 23.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.668 -0.645 . . . . 0.0 110.72 167.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.92 149.14 27.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.238 0.615 . . . . 0.0 111.579 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -111.95 118.17 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -173.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.54 130.32 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.803 0.841 . . . . 0.0 111.326 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 tttm -127.6 145.58 50.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.39 1.076 . . . . 0.0 110.65 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 30.2 pt -98.14 147.46 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 O-C-N 123.808 0.692 . . . . 0.0 111.651 171.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.69 127.34 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 122.312 1.054 . . . . 0.0 110.132 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -64.03 125.54 24.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.561 1.544 . . . . 0.0 112.242 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -35.14 2.48 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 p -75.63 -35.86 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.492 1.117 . . . . 0.0 113.383 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -120.33 139.96 51.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.039 1.336 . . . . 0.0 109.05 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -87.15 6.81 30.98 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.955 -1.091 . . . . 0.0 113.181 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.8 t -88.66 -33.65 17.52 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -171.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 48.44 -167.35 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -171.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 62.37 17.13 55.95 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 p -141.25 5.95 1.9 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.43 1.115 . . . . 0.0 113.247 -162.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -113.32 152.01 30.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.242 1.017 . . . . 0.0 112.7 173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 159' ' ' THR . 3.5 tt0 -127.81 134.76 49.47 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.248 1.419 . . . . 0.0 109.454 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -124.37 139.83 53.53 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.817 -0.552 . . . . 0.0 110.94 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.2 p -135.63 119.26 17.07 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.971 1.309 . . . . 0.0 109.404 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.8 mt -123.91 115.15 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.796 1.638 . . . . 0.0 108.968 -170.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.8 m -122.96 92.18 49.33 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.019 0.528 . . . . 0.0 112.123 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.48 169.52 21.57 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.232 2.621 . . . . 0.0 113.249 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.2 57.71 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.135 1.774 . . . . 0.0 115.269 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.82 -53.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.556 1.143 . . . . 0.0 110.822 161.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.2 p -103.0 158.86 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.33 1.052 . . . . 0.0 111.716 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.2 p-10 -154.52 -165.2 2.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.239 1.415 . . . . 0.0 110.182 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt 56.88 58.79 3.83 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -134.68 122.52 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.562 1.945 . . . . 0.0 109.957 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.45 112.43 11.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.631 0.772 . . . . 0.0 110.069 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 36.7 t -97.48 137.55 36.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.682 0.393 . . . . 0.0 110.278 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -104.11 143.34 33.05 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.181 0.992 . . . . 0.0 109.932 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -56.19 131.62 48.31 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 121.962 -0.461 . . . . 0.0 110.984 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.84 8.66 44.9 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.823 1.202 . . . . 0.0 115.356 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.17 155.74 19.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.127 0.963 . . . . 0.0 112.354 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.44 49.55 1.17 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.51 1.124 . . . . 0.0 113.199 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 60.48 104.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.362 2.265 . . . . 0.0 112.44 -173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.28 141.0 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 134.25 35.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.745 0.784 . . . . 0.0 112.104 173.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 127' ' ' VAL . 1.0 OUTLIER -118.47 102.13 50.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 124.762 1.225 . . . . 0.0 110.152 169.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.63 121.22 4.12 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.046 1.83 . . . . 0.0 111.827 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.8 mm -99.76 123.04 49.07 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.368 1.067 . . . . 0.0 110.106 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.99 178.47 7.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.811 2.341 . . . . 0.0 111.97 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 139.8 43.71 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 120.966 -1.084 . . . . 0.0 113.227 -178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 pp -155.16 152.11 29.03 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.441 1.497 . . . . 0.0 111.724 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -145.14 135.69 12.1 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.215 1.406 . . . . 0.0 110.396 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -65.03 146.33 68.11 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 120.045 1.052 . . . . 0.0 110.782 -7.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.68 -31.05 33.62 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.502 2.135 . . . . 0.0 111.393 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -74.72 5.86 4.51 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.744 1.618 . . . . 0.0 114.979 168.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 3.5 t -77.1 149.16 35.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.104 0.866 . . . . 0.0 111.74 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.434 0.694 . . . . 0.0 111.374 174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 tt -106.0 121.72 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.441 1.096 . . . . 0.0 110.912 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.8 m -60.75 135.22 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.068 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.4 p -143.2 127.75 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.548 0.689 . . . . 0.0 111.485 169.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.98 140.77 42.2 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 172.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 tt -130.49 111.12 11.99 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.652 1.215 . . . . 0.0 109.425 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.3 p -109.06 144.09 37.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.263 -1.335 . . . . 0.0 111.634 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.34 133.57 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -138.9 147.8 42.79 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.755 1.222 . . . . 0.0 109.23 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -67.14 115.14 6.5 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.453 -0.78 . . . . 0.0 110.006 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 116' ' ' GLU . 3.3 t -65.08 -16.78 63.85 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.339 1.056 . . . . 0.0 112.528 173.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -114.37 156.7 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.372 1.869 . . . . 0.0 110.794 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.4 t -69.83 138.99 88.07 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.491 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.66 129.11 16.51 Favored 'Cis proline' 0 C--N 1.355 0.912 0 CA-C-N 120.721 1.293 . . . . 0.0 110.374 -5.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -76.0 36.68 0.14 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.174 1.39 . . . . 0.0 113.457 -174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 146.83 52.95 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 120.046 -1.659 . . . . 0.0 113.158 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -69.62 127.25 32.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.435 0.694 . . . . 0.0 111.01 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -94.07 -50.49 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 112.205 -171.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 24.4 m -146.57 139.18 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.884 1.274 . . . . 0.0 109.574 169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -130.39 98.29 4.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.465 1.506 . . . . 0.0 108.019 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.72 -168.05 11.46 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.326 1.441 . . . . 0.0 113.193 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.8 m -135.41 153.72 51.7 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.801 0.84 . . . . 0.0 111.502 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.51 165.09 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 125.682 1.593 . . . . 0.0 108.849 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -130.5 126.89 38.01 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.326 -0.859 . . . . 0.0 109.269 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.03 150.89 23.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.456 -0.777 . . . . 0.0 110.414 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -145.31 162.34 37.44 Favored 'General case' 0 C--O 1.251 1.144 0 C-N-CA 125.185 1.394 . . . . 0.0 108.344 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.06 170.11 19.65 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 169.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.5 m -133.64 105.52 11.86 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 123.63 0.772 . . . . 0.0 109.026 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 18.77 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.26 3.306 . . . . 0.0 113.037 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 84.8 m -63.65 -34.06 77.01 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.008 1.723 . . . . 0.0 112.5 168.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.6 t -164.3 26.83 0.07 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 123.176 1.465 . . . . 0.0 112.4 -173.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 60.59 27.99 67.01 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 119.259 -2.151 . . . . 0.0 113.778 -172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -79.07 142.89 36.1 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.69 0.745 . . . . 0.0 111.191 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 1.1 p -117.49 160.67 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.061 0.545 . . . . 0.0 111.414 177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.4 m -148.99 129.98 14.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.901 1.28 . . . . 0.0 111.118 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 6.5 p -99.91 128.07 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.392 0.542 . . . . 0.0 110.433 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.41 130.08 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 122.361 1.077 . . . . 0.0 108.612 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.67 135.94 22.72 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.015 0.926 . . . . 0.0 109.044 -176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -144.43 145.08 31.71 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.311 1.444 . . . . 0.0 109.693 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.57 -16.7 6.53 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.331 1.452 . . . . 0.0 113.786 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -60.4 -24.03 64.83 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.9 p -144.7 -30.2 0.45 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.121 1.369 . . . . 0.0 113.727 -175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -79.42 144.51 61.83 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.895 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -71.78 158.84 52.24 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.04 1.827 . . . . 0.0 112.284 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -93.65 -2.08 54.46 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -109.48 -16.47 13.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.135 1.374 . . . . 0.0 113.517 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.1 ttt -134.34 134.13 41.45 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.797 1.239 . . . . 0.0 107.966 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.3 p -136.73 153.36 50.88 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.86 138.61 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 C-N-CA 123.039 0.536 . . . . 0.0 111.039 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 52.2 m -127.12 143.73 51.2 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.803 1.241 . . . . 0.0 109.4 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -75.03 85.42 2.3 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.468 0.652 . . . . 0.0 110.943 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -57.28 -42.69 82.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.984 1.314 . . . . 0.0 112.136 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -152.26 178.5 9.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.625 1.57 . . . . 0.0 109.696 172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.45 135.3 54.07 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.668 -1.895 . . . . 0.0 110.944 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 m 58.61 23.21 10.68 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.558 1.143 . . . . 0.0 113.054 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.13 110.91 6.2 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.591 -0.693 . . . . 0.0 110.829 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -114.25 145.22 42.02 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.543 1.137 . . . . 0.0 111.935 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.0 tt -130.86 116.69 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.88 0.848 . . . . 0.0 110.663 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -96.7 117.1 30.29 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.267 1.427 . . . . 0.0 110.516 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -100.01 131.89 45.69 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.594 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 46.1 tp -122.49 114.42 20.67 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 118.89 0.768 . . . . 0.0 112.943 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -117.09 25.4 10.51 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.734 1.214 . . . . 0.0 113.339 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.0 m -143.74 166.81 23.85 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 52.39 1.18 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.023 2.129 . . . . 0.0 110.86 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt . . . . . 0 C--O 1.294 3.401 0 CA-C-O 115.565 -2.16 . . . . 0.0 111.186 177.519 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.191 0.519 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.91 137.97 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.97 0.908 . . . . 0.0 111.365 170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.57 147.93 29.38 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.736 -0.602 . . . . 0.0 110.488 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.12 -20.31 52.42 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.839 -1.163 . . . . 0.0 113.835 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -111.2 7.93 21.4 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.501 1.92 . . . . 0.0 113.636 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -143.92 -176.09 4.85 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 110.6 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG12 ' HA ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -145.57 154.03 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.596 0.758 . . . . 0.0 112.733 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 144.41 49.9 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.902 1.281 . . . . 0.0 110.309 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.414 ' HZ ' ' CE1' ' A' ' 89' ' ' PHE . 14.6 m-85 -132.48 129.66 39.47 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.765 1.626 . . . . 0.0 107.465 -165.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -128.29 121.43 29.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 123.796 1.76 . . . . 0.0 109.872 -170.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -88.34 59.26 5.13 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.735 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.57 149.19 5.78 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.592 1.568 . . . . 0.0 111.357 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.59 151.55 5.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.562 1.145 . . . . 0.0 111.957 175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 49.74 41.54 22.27 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 99.4 m 50.43 63.19 2.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.465 1.506 . . . . 0.0 113.636 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 18' ' ' GLY . 3.0 m -130.25 -178.21 4.65 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.202 1.401 . . . . 0.0 110.876 -174.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 17' ' ' THR . . . 74.02 -118.83 6.13 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.078 1.323 . . . . 0.0 111.972 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.11 166.41 11.26 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 117.685 0.742 . . . . 0.0 111.509 174.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.0 p -126.17 146.49 49.94 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.685 1.194 . . . . 0.0 110.965 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -148.74 155.8 41.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.78 1.232 . . . . 0.0 110.072 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -128.28 142.3 51.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.947 0.899 . . . . 0.0 110.116 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -125.63 125.14 42.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.359 1.064 . . . . 0.0 109.312 -174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.61 129.01 34.29 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.955 0.902 . . . . 0.0 109.509 174.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' HA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.48 144.68 25.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.475 1.11 . . . . 0.0 112.875 176.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.02 41.45 9.51 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.062 0.839 . . . . 0.0 112.939 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.13 153.45 42.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.954 1.301 . . . . 0.0 111.698 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.6 m -129.39 131.08 46.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.958 1.303 . . . . 0.0 109.037 176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -128.48 128.23 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 122.579 1.18 . . . . 0.0 109.753 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.6 mtm105 -124.36 89.46 3.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.817 1.247 . . . . 0.0 109.112 -171.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -78.22 168.69 19.45 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.821 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -116.18 157.85 24.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.632 1.173 . . . . 0.0 110.096 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.63 -19.68 65.06 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.263 -0.898 . . . . 0.0 113.073 175.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.93 -24.05 66.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.221 1.391 . . . . 0.0 114.464 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -98.67 105.14 17.24 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.283 1.041 . . . . 0.0 109.244 171.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -21.5 60.48 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 120.618 -1.301 . . . . 0.0 112.625 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -61.15 -24.21 66.12 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.64 1.976 . . . . 0.0 112.399 173.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -64.54 -56.14 15.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.693 1.597 . . . . 0.0 111.1 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.5 -18.55 65.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.424 1.49 . . . . 0.0 113.251 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -29.62 69.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.899 2.08 . . . . 0.0 113.222 172.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 86' ' ' LEU . 38.4 t80 -53.27 118.62 3.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.784 0.72 . . . . 0.0 110.259 169.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 mmm -146.12 -16.78 0.45 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.126 0.97 . . . . 0.0 113.435 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.7 m -136.9 151.79 49.48 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.637 1.175 . . . . 0.0 110.783 172.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 24.5 p -161.55 155.77 22.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.641 1.176 . . . . 0.0 110.743 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.7 121.7 29.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 8' ' ' VAL . 62.7 t -92.23 136.69 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 123.352 0.661 . . . . 0.0 110.137 172.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.19 -106.02 0.01 OUTLIER Glycine 0 CA--C 1.537 1.418 0 C-N-CA 126.85 2.166 . . . . 0.0 115.823 -177.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 m -161.27 -21.78 0.05 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.794 1.638 . . . . 0.0 112.866 174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.14 33.14 4.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.622 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.8 121.09 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.111 1.765 . . . . 0.0 110.109 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -84.69 145.63 27.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.856 -1.153 . . . . 0.0 109.558 173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 89' ' ' PHE . 58.5 m -126.65 147.82 49.88 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.594 -0.692 . . . . 0.0 110.771 173.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.85 140.09 52.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.667 0.787 . . . . 0.0 109.451 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.512 HG23 HD12 ' A' ' 86' ' ' LEU . 9.1 mt -122.44 138.14 53.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.454 1.102 . . . . 0.0 109.362 -178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 2.3 m95 -152.7 120.49 6.09 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.663 0.785 . . . . 0.0 112.379 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -83.51 -60.95 1.97 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -113.7 175.02 5.64 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.543 -0.723 . . . . 0.0 110.986 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 202' ' ' ASN . 3.1 p30 -153.92 134.48 13.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.927 0.891 . . . . 0.0 110.31 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -164.8 155.09 14.01 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.314 1.445 . . . . 0.0 110.461 -173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.35 41.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.84 1.656 . . . . 0.0 111.177 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.09 -34.07 0.06 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.148 1.779 . . . . 0.0 111.606 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.2 t -56.08 134.5 74.4 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.597 1.159 . . . . 0.0 113.251 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.1 -18.96 9.73 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.095 2.53 . . . . 0.0 113.312 175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.4 t -101.74 130.64 24.14 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.503 1.121 . . . . 0.0 110.637 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.04 174.67 11.61 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.356 2.038 . . . . 0.0 111.657 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.89 -151.64 19.73 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 124.576 1.084 . . . . 0.0 112.558 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 109.01 18.91 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.057 0.543 . . . . 0.0 110.329 168.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -140.7 148.71 41.19 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.988 1.315 . . . . 0.0 110.169 173.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -162.49 137.65 6.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.753 0.821 . . . . 0.0 109.51 168.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -87.91 110.36 20.49 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 165.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.5 mt -66.74 125.7 26.67 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.366 -0.834 . . . . 0.0 109.016 170.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.85 150.2 5.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.798 1.239 . . . . 0.0 112.181 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -15.49 6.35 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -172.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.18 104.86 0.26 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.128 1.823 . . . . 0.0 112.143 168.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -173.47 160.62 3.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.98 1.712 . . . . 0.0 111.993 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.7 m -113.98 143.66 44.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.013 1.325 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -141.44 112.54 7.36 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.606 1.163 . . . . 0.0 109.928 -164.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -126.44 -32.72 2.64 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.48 1.112 . . . . 0.0 112.379 -170.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -96.58 59.33 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.276 2.63 . . . . 0.0 109.621 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.72 52.4 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.186 1.394 . . . . 0.0 111.629 169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 50.8 m -62.33 -42.54 99.46 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.176 -1.578 . . . . 0.0 111.547 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -59.46 -28.21 66.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 118.366 -0.826 . . . . 0.0 113.004 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.5 mt -128.95 54.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.418 1.887 . . . . 0.0 108.513 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -65.0 -15.63 62.53 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.685 1.194 . . . . 0.0 113.401 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.73 154.38 20.1 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.014 1.292 . . . . 0.0 109.881 155.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD12 HG23 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -123.07 150.28 43.35 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.205 1.802 . . . . 0.0 108.452 173.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -118.53 -42.59 2.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.303 0.641 . . . . 0.0 112.635 171.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.06 156.36 46.01 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.893 1.277 . . . . 0.0 111.73 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 52' ' ' CYS . 8.4 t80 -145.97 150.54 36.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.33 1.052 . . . . 0.0 111.458 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.35 129.67 27.43 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.403 1.081 . . . . 0.0 110.949 172.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 25' ' ' LYS . 2.6 p -106.93 125.18 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.096 1.358 . . . . 0.0 109.209 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -124.93 147.67 57.38 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.06 1.344 . . . . 0.0 110.644 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 96' ' ' PHE . 29.6 Cg_endo -67.99 -177.03 1.16 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.261 3.307 . . . . 0.0 113.997 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.91 14.88 4.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 126.022 1.772 . . . . 0.0 114.144 171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.7 -47.98 2.87 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.562 1.945 . . . . 0.0 110.34 175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' A' ' 139' ' ' PRO . 1.3 m-85 -91.44 157.9 16.8 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.49 1.116 . . . . 0.0 111.146 -177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -127.66 -37.06 2.0 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.948 1.299 . . . . 0.0 111.958 -175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -141.64 167.13 22.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.882 2.073 . . . . 0.0 108.066 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -142.7 159.6 41.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.448 0.642 . . . . 0.0 109.793 170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.65 130.05 59.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 124.082 0.953 . . . . 0.0 109.237 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -82.89 127.68 33.73 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.873 0.869 . . . . 0.0 108.816 172.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.2 m -119.58 144.6 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.747 0.819 . . . . 0.0 109.296 166.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -144.41 133.85 23.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.677 0.791 . . . . 0.0 109.826 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.0 pt -78.81 148.75 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-O 121.391 0.615 . . . . 0.0 110.726 172.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -141.94 120.49 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.593 1.957 . . . . 0.0 107.542 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -69.15 110.93 4.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.471 0.708 . . . . 0.0 110.57 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.08 19.29 20.86 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.49 1.116 . . . . 0.0 112.379 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 95.8 t -126.45 -69.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.145 1.378 . . . . 0.0 111.597 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -89.08 134.61 33.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.442 0.697 . . . . 0.0 109.425 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -79.77 34.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 O-C-N 120.825 -1.172 . . . . 0.0 112.573 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 m -138.54 52.85 1.8 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 128.063 2.545 . . . . 0.0 108.536 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.23 144.35 41.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.026 -1.046 . . . . 0.0 111.097 166.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 128.09 6.34 4.91 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.362 1.458 . . . . 0.0 114.343 -178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.5 m -141.55 25.52 2.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.605 1.562 . . . . 0.0 113.388 -160.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -128.82 136.72 50.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 126.278 1.831 . . . . 0.0 109.149 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.63 121.76 43.55 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.772 1.229 . . . . 0.0 109.683 174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -105.23 144.9 31.38 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.0 0.92 . . . . 0.0 110.245 170.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -137.82 106.8 5.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.093 1.357 . . . . 0.0 107.348 178.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.4 tt -103.81 131.45 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.554 0.741 . . . . 0.0 109.507 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.7 m -129.95 86.7 53.97 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.958 1.703 . . . . 0.0 109.043 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -69.28 163.95 35.95 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.422 2.748 . . . . 0.0 112.265 174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -31.67 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.715 2.406 . . . . 0.0 114.39 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 34.01 36.15 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.693 2.397 . . . . 0.0 116.37 -172.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 t -104.26 155.88 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.69 1.596 . . . . 0.0 109.999 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -48.9 100.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.852 1.661 . . . . 0.0 111.996 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -59.18 165.2 2.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.255 1.026 . . . . 0.0 111.435 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -143.2 136.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.101 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.64 123.6 42.31 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 0.0 108.361 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -138.19 168.02 20.6 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.438 0.695 . . . . 0.0 111.111 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -132.46 155.64 48.17 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.34 1.056 . . . . 0.0 110.323 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.56 116.54 1.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.41 . . . . 0.0 111.79 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.69 15.86 19.31 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -171.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -63.03 160.62 14.7 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.51 1.124 . . . . 0.0 113.712 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -88.57 50.02 1.89 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.262 1.425 . . . . 0.0 112.325 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 59.81 78.66 0.26 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.186 1.794 . . . . 0.0 111.823 177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.1 t -40.92 98.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 126.068 1.747 . . . . 0.0 112.452 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -81.99 95.84 7.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 111.72 31.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.505 ' HB2' ' CD2' ' A' ' 96' ' ' PHE . 57.7 Cg_endo -78.98 137.29 13.71 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.586 2.191 . . . . 0.0 112.008 176.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.5 mt -128.65 128.47 23.53 Favored Pre-proline 0 N--CA 1.472 0.658 0 O-C-N 121.654 -0.654 . . . . 0.0 110.242 -172.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.91 174.78 11.37 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.431 2.754 . . . . 0.0 113.38 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -60.33 134.98 57.58 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.737 -0.602 . . . . 0.0 109.951 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.39 146.15 49.72 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.176 1.39 . . . . 0.0 108.567 173.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.2 m -131.29 126.8 21.55 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 123.942 0.897 . . . . 0.0 110.216 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.44 155.82 81.93 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 CA-C-N 119.008 0.681 . . . . 0.0 111.447 -5.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -69.0 -24.82 32.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 121.468 1.445 . . . . 0.0 113.364 -174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -72.22 -5.94 39.36 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 168.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.5 p -71.84 160.13 33.11 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.742 1.258 . . . . 0.0 112.935 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -103.14 162.68 12.76 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.15 1.38 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 tt -129.1 132.26 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.638 1.975 . . . . 0.0 109.193 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.56 136.08 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.038 0.935 . . . . 0.0 111.126 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.3 t -143.72 150.11 38.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.733 0.813 . . . . 0.0 111.21 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -112.29 136.69 51.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.019 1.328 . . . . 0.0 109.32 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.55 118.83 22.67 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.297 1.039 . . . . 0.0 109.166 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 8.4 t -125.64 123.04 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.233 171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.3 p -125.03 140.4 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.027 1.331 . . . . 0.0 108.635 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -148.52 153.09 37.95 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.955 1.302 . . . . 0.0 110.379 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.65 135.71 56.2 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.058 0.543 . . . . 0.0 110.449 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 76.0 p -72.49 -12.85 61.26 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.458 1.103 . . . . 0.0 113.83 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -141.61 -179.09 5.97 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.98 2.512 . . . . 0.0 110.034 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.5 p -52.9 146.79 17.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.763 1.225 . . . . 0.0 113.459 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -75.94 3.58 17.33 Favored 'Cis proline' 0 CA--C 1.545 1.058 0 N-CA-C 114.878 1.068 . . . . 0.0 114.878 1.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.27 27.0 15.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.144 1.378 . . . . 0.0 113.026 175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -80.86 139.34 36.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.054 1.342 . . . . 0.0 110.738 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -55.9 100.22 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.474 1.109 . . . . 0.0 112.232 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 t -63.49 -51.82 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.823 1.249 . . . . 0.0 110.443 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.4 t -145.36 126.14 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.742 1.217 . . . . 0.0 108.177 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -132.83 91.21 2.87 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.621 1.168 . . . . 0.0 108.361 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -150.79 -152.03 5.72 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.008 1.289 . . . . 0.0 111.103 -174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 12.2 m -143.05 170.15 16.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.749 0.785 . . . . 0.0 111.049 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.63 146.65 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.338 1.455 . . . . 0.0 108.52 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -101.37 143.02 31.92 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.01 154.17 33.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.331 1.052 . . . . 0.0 109.402 176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -157.44 158.77 36.44 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.594 1.558 . . . . 0.0 108.261 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -128.36 145.32 51.11 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.525 0.73 . . . . 0.0 109.818 166.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.6 m -91.73 117.24 67.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.18 -10.07 27.76 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 2.747 . . . . 0.0 113.129 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.7 p -45.62 -38.47 6.67 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.088 2.155 . . . . 0.0 113.061 172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.8 t -158.89 14.73 0.17 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.007 1.323 . . . . 0.0 112.933 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.39 29.91 76.37 Favored Glycine 0 CA--C 1.536 1.378 0 O-C-N 119.793 -1.817 . . . . 0.0 112.882 -169.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.3 160.35 31.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.705 1.202 . . . . 0.0 110.703 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.65 130.95 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 O-C-N 121.278 -0.889 . . . . 0.0 111.069 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 30.5 m -145.6 121.45 10.6 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.475 1.51 . . . . 0.0 110.13 -171.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' A' ' 205' ' ' PHE . 1.8 m -86.71 142.91 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.487 0.66 . . . . 0.0 111.153 171.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 139.8 29.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.515 1.526 . . . . 0.0 107.927 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 123.04 18.49 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.788 1.235 . . . . 0.0 109.273 -176.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -149.59 152.32 35.27 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.873 1.669 . . . . 0.0 110.046 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.88 -17.01 5.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.98 1.312 . . . . 0.0 114.449 -174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -56.79 -26.6 58.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.665 1.586 . . . . 0.0 114.63 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.6 p -147.81 -38.8 0.19 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.623 1.569 . . . . 0.0 112.984 -173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -60.95 124.21 78.85 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.047 1.339 . . . . 0.0 110.827 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.8 -7.93 15.63 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.519 2.813 . . . . 0.0 113.554 -174.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 65.39 -16.34 0.1 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 127.914 2.485 . . . . 0.0 115.461 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -73.52 -45.86 51.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.391 2.276 . . . . 0.0 112.716 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 4.7 ttt -114.17 135.78 53.66 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.219 1.008 . . . . 0.0 108.38 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 12.0 p -116.58 171.46 7.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.551 0.74 . . . . 0.0 109.323 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.07 131.38 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 121.385 -0.822 . . . . 0.0 109.689 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.4 m -109.2 132.72 53.86 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.571 1.148 . . . . 0.0 109.352 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -75.11 69.91 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.188 1.795 . . . . 0.0 110.624 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -53.96 -42.95 69.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.954 1.302 . . . . 0.0 111.848 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -160.37 178.36 9.67 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.469 1.907 . . . . 0.0 110.967 171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.4 ' H ' ' HB2' ' A' ' 58' ' ' ASN . 4.3 m-20 -51.82 142.57 14.89 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.51 -1.369 . . . . 0.0 110.476 164.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 72.9 p 46.17 27.86 0.6 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.526 1.53 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.1 t -146.9 101.06 3.39 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.52 1.128 . . . . 0.0 111.369 -171.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.426 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.6 m-85 -116.52 133.73 55.68 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.124 1.37 . . . . 0.0 111.858 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 50.5 mm -117.31 93.96 2.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -69.44 125.3 26.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.454 174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -121.45 115.05 22.15 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.844 1.258 . . . . 0.0 111.606 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.77 108.94 7.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.366 1.466 . . . . 0.0 110.523 -177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -89.95 -15.37 32.15 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.29 -174.52 3.02 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.124 1.37 . . . . 0.0 111.511 171.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -151.99 41.04 0.65 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -174.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.2 p . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.632 0.254 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.11 142.11 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.247 1.019 . . . . 0.0 110.474 167.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.3 143.07 57.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.49 0.716 . . . . 0.0 109.944 173.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.74 -14.56 62.71 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 120.435 -1.416 . . . . 0.0 113.126 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -119.01 6.02 11.33 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.273 2.229 . . . . 0.0 113.384 -171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -146.9 175.05 10.95 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.127 2.171 . . . . 0.0 109.042 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 m -134.18 154.63 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.229 1.012 . . . . 0.0 110.587 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.49 143.8 31.03 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.494 0.718 . . . . 0.0 111.525 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.18 131.74 51.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.977 1.311 . . . . 0.0 108.782 -165.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -114.8 135.02 54.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.116 1.436 . . . . 0.0 109.872 -174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.93 39.42 1.07 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.878 1.671 . . . . 0.0 111.235 -168.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.92 143.12 6.87 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.944 1.259 . . . . 0.0 111.866 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.7 mttm -55.46 147.65 17.08 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.15 0.98 . . . . 0.0 110.955 -176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.45 27.52 15.62 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 73.9 m 61.51 68.88 0.68 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.091 1.756 . . . . 0.0 113.101 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.1 p -131.66 -173.58 3.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.35 1.86 . . . . 0.0 111.514 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.91 -121.29 9.25 Favored Glycine 0 CA--C 1.535 1.302 0 O-C-N 120.887 -1.133 . . . . 0.0 112.39 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.27 172.67 6.86 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 111.415 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.4 p -134.96 146.97 49.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 111.515 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -141.88 154.33 45.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.244 1.818 . . . . 0.0 109.255 -169.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -129.98 150.73 51.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.829 0.823 . . . . 0.0 111.754 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -138.49 122.55 17.93 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.848 1.659 . . . . 0.0 110.341 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -68.76 128.63 37.34 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.934 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG3' HG12 ' A' ' 50' ' ' VAL . 2.9 ttmm -52.41 139.63 24.29 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.979 0.912 . . . . 0.0 111.406 171.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.1 48.47 4.35 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.043 0.83 . . . . 0.0 112.896 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.75 177.42 9.11 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.113 0.965 . . . . 0.0 112.745 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.8 m -138.75 135.65 34.92 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.821 1.649 . . . . 0.0 109.155 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.28 120.65 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.265 1.826 . . . . 0.0 109.926 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -117.55 100.4 7.62 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.57 1.148 . . . . 0.0 108.883 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.51 173.49 7.87 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.28 1.032 . . . . 0.0 110.364 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -119.15 154.47 33.24 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.515 1.126 . . . . 0.0 109.796 174.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -17.56 29.34 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.647 1.179 . . . . 0.0 113.429 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.84 -35.4 61.85 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.505 1.526 . . . . 0.0 114.477 175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.43 119.84 18.22 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.795 1.298 . . . . 0.0 109.677 172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -24.56 67.58 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 120.088 -1.632 . . . . 0.0 112.374 176.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 5.4 m0 -62.89 -25.22 68.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.541 1.536 . . . . 0.0 112.578 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.5 -56.5 10.57 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.524 1.53 . . . . 0.0 110.87 169.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.9 -21.51 66.83 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.012 1.325 . . . . 0.0 113.344 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -5.48 3.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.755 2.022 . . . . 0.0 115.336 170.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.2 139.25 1.44 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.883 0.765 . . . . 0.0 110.131 158.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 tpt -160.53 -41.34 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 91.1 p -155.46 169.09 25.07 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.839 1.256 . . . . 0.0 111.386 171.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.1 p -159.54 172.71 17.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.722 1.209 . . . . 0.0 110.814 171.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.48 141.95 50.5 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.365 1.466 . . . . 0.0 109.129 175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.5 t -123.36 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.507 1.523 . . . . 0.0 109.4 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.02 -110.87 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.688 2.089 . . . . 0.0 115.42 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.5 m -152.92 -28.31 0.15 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.953 1.301 . . . . 0.0 112.9 173.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -113.94 31.56 6.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.516 1.926 . . . . 0.0 110.723 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG12 ' HG3' ' A' ' 25' ' ' LYS . 34.4 m -144.76 133.22 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.447 1.499 . . . . 0.0 109.548 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 154.01 21.17 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.47 -0.769 . . . . 0.0 109.858 178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.82 104.33 6.54 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 0.0 109.365 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.98 130.47 55.05 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.806 0.843 . . . . 0.0 109.216 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 89' ' ' PHE . 11.3 tt -124.44 134.18 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.688 1.195 . . . . 0.0 109.611 -169.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -138.37 137.15 37.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.821 1.248 . . . . 0.0 111.256 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.97 -47.27 4.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.801 1.241 . . . . 0.0 113.124 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -129.12 132.52 47.38 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.814 0.846 . . . . 0.0 109.296 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -129.65 96.42 4.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.064 1.346 . . . . 0.0 110.531 -165.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.87 165.5 25.13 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.689 1.196 . . . . 0.0 111.658 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.4 pt -124.34 17.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 125.092 1.357 . . . . 0.0 113.049 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -147.9 39.22 0.93 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.09 1.356 . . . . 0.0 111.277 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.9 t -125.94 136.63 28.72 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 124.68 1.192 . . . . 0.0 111.742 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.38 -18.24 16.02 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.774 2.316 . . . . 0.0 112.776 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.8 p -75.3 118.61 72.0 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.852 0.861 . . . . 0.0 109.453 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.14 86.78 1.4 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.87 2.38 . . . . 0.0 109.485 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -44.32 128.26 6.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.529 1.538 . . . . 0.0 112.852 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -57.92 125.96 25.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.69 0.757 . . . . 0.0 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -142.78 149.52 38.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.182 1.393 . . . . 0.0 108.569 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.95 167.53 20.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.028 0.918 . . . . 0.0 109.957 169.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -135.36 82.42 1.95 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.328 1.051 . . . . 0.0 109.046 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 71' ' ' LEU . 3.1 mm? -43.43 125.29 3.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.326 1.45 . . . . 0.0 109.303 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.01 146.09 11.77 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.106 0.962 . . . . 0.0 112.18 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -57.82 -14.15 5.49 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -172.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.93 116.07 0.77 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.858 1.218 . . . . 0.0 111.598 160.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -176.34 168.85 2.76 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.298 1.839 . . . . 0.0 112.151 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 73.9 m -103.34 141.12 36.48 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.015 0.926 . . . . 0.0 109.477 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -119.35 89.27 3.09 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.818 1.247 . . . . 0.0 107.759 -172.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -113.13 -0.64 14.61 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.366 1.466 . . . . 0.0 113.322 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -144.78 69.92 1.27 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.882 1.673 . . . . 0.0 109.779 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.5 mp -92.86 10.36 31.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.119 0.967 . . . . 0.0 111.893 175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.6 m -52.68 -30.8 33.99 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.66 -1.275 . . . . 0.0 112.78 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.9 m -58.91 -27.45 65.27 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.9 -25.36 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.13 0.972 . . . . 0.0 111.424 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 36.7 t30 68.0 39.89 2.4 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 126.152 1.781 . . . . 0.0 113.986 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.18 153.92 30.62 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.07 -1.019 . . . . 0.0 110.932 -169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -110.58 148.6 31.84 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.033 1.333 . . . . 0.0 108.317 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -128.44 -40.79 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.738 1.215 . . . . 0.0 113.019 171.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -130.97 140.82 50.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.292 1.037 . . . . 0.0 110.404 173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' CE2' HD12 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -129.24 142.08 50.95 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.911 1.285 . . . . 0.0 110.55 172.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -135.37 126.17 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.135 1.374 . . . . 0.0 107.991 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.46 107.7 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 122.487 1.137 . . . . 0.0 109.468 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -90.97 150.62 42.18 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.253 1.021 . . . . 0.0 109.357 -171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.66 27.45 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.614 3.543 . . . . 0.0 115.601 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 56.72 34.7 65.13 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.073 1.32 . . . . 0.0 113.792 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.46 -44.51 0.19 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.156 1.782 . . . . 0.0 110.063 -173.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 5.0 m-85 -83.1 153.1 25.02 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.168 1.387 . . . . 0.0 110.546 168.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -90.45 -41.12 11.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.529 1.132 . . . . 0.0 111.01 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -155.99 177.89 10.9 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.363 2.265 . . . . 0.0 108.784 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.47 159.43 43.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.674 0.79 . . . . 0.0 109.713 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 173' ' ' PHE . 10.9 p -120.8 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.955 0.902 . . . . 0.0 110.59 -175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.75 125.9 30.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.285 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.27 137.76 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 108.666 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -132.21 159.09 40.04 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.494 -0.754 . . . . 0.0 109.562 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.0 pt -118.79 136.3 56.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.087 1.755 . . . . 0.0 109.009 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.43 135.61 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.718 1.207 . . . . 0.0 108.742 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -91.6 117.92 30.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.659 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -109.19 4.51 22.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.622 1.169 . . . . 0.0 113.082 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.5 t -116.89 -60.98 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 125.299 1.44 . . . . 0.0 110.933 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -74.42 -20.61 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.338 1.055 . . . . 0.0 110.841 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.7 m 48.47 31.94 3.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.675 1.99 . . . . 0.0 113.846 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -127.83 31.43 5.12 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.123 1.769 . . . . 0.0 111.331 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -37.95 104.21 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 128.123 2.569 . . . . 0.0 113.293 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.24 10.76 0.05 OUTLIER Glycine 0 CA--C 1.544 1.871 0 N-CA-C 116.427 1.331 . . . . 0.0 116.427 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.9 p -149.36 14.87 0.89 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.306 1.442 . . . . 0.0 114.136 -167.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -115.86 139.71 49.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.575 1.55 . . . . 0.0 108.064 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -115.12 140.75 48.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 109.067 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.3 ttp -134.46 127.66 31.92 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.797 0.839 . . . . 0.0 110.272 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.1 m -117.84 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.392 1.077 . . . . 0.0 109.124 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.77 122.9 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 126.361 1.864 . . . . 0.0 108.753 178.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 17.1 m -130.21 99.71 19.32 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.153 1.381 . . . . 0.0 110.175 -173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.85 169.59 18.67 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.969 3.113 . . . . 0.0 112.39 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -25.23 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.655 2.782 . . . . 0.0 113.724 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 41.53 48.9 3.53 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.97 1.708 . . . . 0.0 115.203 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.7 160.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.918 2.087 . . . . 0.0 111.362 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -45.85 129.12 9.31 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.762 1.625 . . . . 0.0 112.495 170.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -64.65 157.06 28.21 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.278 0.561 . . . . 0.0 111.505 169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.08 149.33 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 126.699 1.999 . . . . 0.0 109.701 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.44 91.79 3.72 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.978 0.911 . . . . 0.0 110.887 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.5 t -67.14 139.47 57.49 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 164.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.7 ttmm -134.32 133.02 40.22 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.519 1.127 . . . . 0.0 108.692 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.59 129.06 40.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.412 0.685 . . . . 0.0 111.296 -172.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.44 18.84 12.21 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.711 1.148 . . . . 0.0 114.867 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.03 156.16 16.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.203 1.401 . . . . 0.0 112.178 175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.16 57.54 0.66 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.611 1.564 . . . . 0.0 111.84 170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 57.21 101.21 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.204 2.201 . . . . 0.0 112.156 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -47.13 149.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 121.062 -1.024 . . . . 0.0 111.469 174.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -114.92 97.87 6.49 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.5 tp -75.05 116.39 53.75 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.442 ' HB3' ' CD2' ' A' ' 96' ' ' PHE . 65.9 Cg_endo -73.46 144.56 36.46 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.175 1.917 . . . . 0.0 112.694 172.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 33.4 mm -130.85 130.38 22.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.225 1.41 . . . . 0.0 109.063 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.68 178.76 4.19 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.751 2.301 . . . . 0.0 111.895 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 54.8 0.08 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.099 1.76 . . . . 0.0 113.6 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.8 pp -45.73 134.72 7.33 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.154 1.382 . . . . 0.0 111.164 175.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -139.68 133.81 15.83 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-O 119.141 -0.457 . . . . 0.0 111.989 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.02 150.04 78.26 Favored 'Cis proline' 0 CA--C 1.545 1.05 0 CA-C-N 119.216 0.756 . . . . 0.0 112.113 -5.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -65.08 -34.76 45.43 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.946 1.764 . . . . 0.0 112.431 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -63.77 -10.03 17.72 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.75 161.41 24.56 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.244 1.018 . . . . 0.0 112.654 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -84.73 161.28 20.08 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.976 . . . . 0.0 112.012 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.5 119.47 39.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 109.051 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.476 HG12 ' CE1' ' A' ' 172' ' ' TYR . 23.1 m -67.94 136.01 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.671 174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.2 p -134.42 142.39 47.12 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.985 0.914 . . . . 0.0 110.319 170.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -101.81 136.87 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.41 152.29 50.79 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 123.137 1.446 . . . . 0.0 112.946 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.32 132.78 28.54 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.737 -1.574 . . . . 0.0 109.777 175.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.4 t -104.93 129.27 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -144.13 133.75 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.85 1.26 . . . . 0.0 108.183 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -62.4 156.26 23.05 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.707 -0.621 . . . . 0.0 112.048 174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 55.0 p -89.76 -27.13 20.24 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.46 169.03 9.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.962 2.105 . . . . 0.0 111.267 175.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.0 p -52.65 150.74 8.94 Favored Pre-proline 0 N--CA 1.478 0.94 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.98 9.24 15.48 Favored 'Cis proline' 0 CA--C 1.547 1.146 0 N-CA-C 115.818 1.43 . . . . 0.0 115.818 2.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.28 30.07 17.46 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.256 1.022 . . . . 0.0 112.482 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.43 148.69 31.84 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.502 -1.374 . . . . 0.0 112.161 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.94 106.66 2.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.52 1.128 . . . . 0.0 111.539 173.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.63 -59.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.656 1.582 . . . . 0.0 109.956 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 194' ' ' ASN . 41.9 t -125.53 143.07 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.103 -1.623 . . . . 0.0 108.957 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.64 101.21 3.64 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.085 1.354 . . . . 0.0 107.391 175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.23 -164.81 15.93 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.461 1.029 . . . . 0.0 111.567 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.33 151.39 37.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.398 -1.06 . . . . 0.0 111.644 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.3 142.62 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.817 1.647 . . . . 0.0 109.285 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 151' ' ' VAL . 10.0 m-30 -107.51 105.36 15.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.607 -0.683 . . . . 0.0 109.162 -171.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.461 ' CE2' HG11 ' A' ' 100' ' ' VAL . 64.9 m-85 -84.11 160.9 20.81 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.726 0.774 . . . . 0.0 110.012 175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -158.95 161.34 36.71 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.832 2.053 . . . . 0.0 108.197 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.76 141.46 50.37 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.884 0.874 . . . . 0.0 109.256 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 69.0 m -96.42 110.24 51.73 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.104 174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -75.11 53.29 3.34 Favored 'Trans proline' 0 CA--C 1.541 0.85 1 C-N-CA 125.492 4.128 . . . . 0.0 112.704 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 2.0 m -134.86 -43.33 0.74 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.977 1.711 . . . . 0.0 111.187 -170.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 77.7 p -146.7 19.33 1.31 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.455 1.502 . . . . 0.0 113.584 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 72.41 31.7 63.06 Favored Glycine 0 CA--C 1.538 1.53 0 O-C-N 120.414 -1.428 . . . . 0.0 113.584 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -85.64 146.7 26.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.582 1.153 . . . . 0.0 111.097 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.1 t -127.03 85.78 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 125.469 1.508 . . . . 0.0 110.218 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.4 t -81.98 163.15 22.34 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.92 -1.112 . . . . 0.0 111.638 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.84 125.6 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.982 0.913 . . . . 0.0 109.327 -170.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 2.9 mp -101.91 139.73 22.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.842 2.057 . . . . 0.0 109.111 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 119.86 12.51 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 126.174 1.79 . . . . 0.0 109.088 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -147.62 150.99 35.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.924 1.69 . . . . 0.0 110.097 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -55.77 -17.78 6.88 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.77 -23.49 63.31 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.001 1.32 . . . . 0.0 114.083 171.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.4 p -150.05 -45.06 0.13 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.509 1.524 . . . . 0.0 113.65 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.409 ' CD1' ' HD2' ' A' ' 192' ' ' PRO . 36.8 t80 -61.35 138.37 94.7 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 125.458 1.503 . . . . 0.0 111.4 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 191' ' ' PHE . 73.6 Cg_endo -69.15 178.36 4.26 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.223 2.615 . . . . 0.0 112.502 174.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -128.1 -35.63 2.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.65 1.18 . . . . 0.0 112.434 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.497 HD21 HG22 ' A' ' 167' ' ' VAL . 15.9 p-10 -66.0 -17.7 64.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.534 1.934 . . . . 0.0 113.565 166.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 3.8 ttt -125.18 145.1 50.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.698 1.599 . . . . 0.0 109.055 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 13.9 p -128.42 167.63 16.75 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.879 1.672 . . . . 0.0 110.114 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 9.7 p -144.97 147.71 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 O-C-N 121.288 -0.882 . . . . 0.0 110.614 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 99.9 m -127.68 130.33 48.71 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.252 1.021 . . . . 0.0 109.386 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.03 103.4 7.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.517 0.727 . . . . 0.0 110.108 174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -76.13 -45.3 34.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 122.001 -0.437 . . . . 0.0 111.235 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -145.51 -175.15 4.61 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.17 1.788 . . . . 0.0 111.766 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.9 p-10 -56.4 -25.32 49.63 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.8 m -149.7 49.01 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.667 1.187 . . . . 0.0 108.14 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 58.8 m -151.76 110.45 3.82 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 127.31 2.244 . . . . 0.0 109.507 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 138.04 54.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.388 1.075 . . . . 0.0 110.382 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 5.3 tt -133.83 108.78 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.148 0.975 . . . . 0.0 110.005 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -90.54 133.98 34.69 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.707 1.603 . . . . 0.0 110.214 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -127.32 121.33 30.78 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.724 1.21 . . . . 0.0 109.381 -170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.55 101.15 13.89 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.337 0.655 . . . . 0.0 110.898 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -87.91 -18.28 29.5 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.624 1.97 . . . . 0.0 114.464 -174.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.5 m -152.86 140.89 20.29 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.065 2.546 . . . . 0.0 109.02 170.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.9 -46.2 82.09 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 119.937 1.244 . . . . 0.0 112.413 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.649 1.979 . . . . 0.0 111.932 175.594 . . . . . . . . 1 1 . 1 stop_ save_